Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.5804989432564461,-2.0816275097176393,0.0,0.0504051606286948,0.046,17/50,10.12%,GLI3;ZIC1;FGFR2;GPC3;SMO;DCDC2;GAS1;TULP3;IFT81;CREBBP;ARMC9;RORA;EVC;MEGF8;INTU;GLI1;PTCH1
prerank,mesonephric tubule development (GO:0072164),-0.776552679787205,-2.048072984813849,0.0,0.044589180556153095,0.078,8/15,11.56%,FGFR2;BMP7;SLIT2;BMP4;OSR1;SIX1;SALL1;PKD1
prerank,retinoid metabolic process (GO:0001523),-0.5355716517881212,-2.008650201066013,0.0,0.056544250705266606,0.147,12/71,3.85%,GPC6;ALDH1A1;LRP1;ALDH1A2;SDC2;GPC3;HSPG2;RBP1;CYP26B1;APOE;ABCA4;RBP4
prerank,ureteric bud development (GO:0001657),-0.73776385186955,-2.002730958468218,0.0,0.04822416810149167,0.165,8/17,11.31%,FGFR2;GPC3;BMP7;SLIT2;BMP4;OSR1;SIX1;SALL1
prerank,skeletal system morphogenesis (GO:0048705),-0.5831849876398418,-1.9977492273565176,0.0,0.04148732451746418,0.178,14/42,7.78%,FGFR2;HOXC4;PDGFRA;TGFBR1;CYP26B1;HOXA3;HOXB3;FBN2;HOXB4;MEGF8;SIX1;ANKRD11;SFRP4;WWOX
prerank,vasodilation (GO:0042311),0.8985567408464343,1.9863638200713036,0.0,0.17935798028198344,0.145,5/13,2.69%,NOS1;NOS3;KLF2;F2RL1;ADRB2
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.8152256470478176,1.9837101907556112,0.0,0.09778556552096837,0.157,7/26,6.04%,NOS1;ACER2;NOS3;GCH1;SPTLC2;SPTLC1;ASAH2
prerank,embryonic skeletal system development (GO:0048706),-0.6023221706173408,-1.9721883259155717,0.0,0.05395937067302585,0.257,15/35,7.82%,COL1A1;HOXC4;PDGFRA;SULF1;SULF2;OSR1;HOXA3;WNT5A;HOXB3;RBP4;XYLT1;HOXB4;MEGF8;SIX1;WNT9A
prerank,negative regulation of blood pressure (GO:0045776),0.8760906635020866,1.9442027950825664,0.0,0.17091363092784106,0.335,3/13,0.94%,NOS1;NOS3;BMPR2
prerank,establishment of endothelial barrier (GO:0061028),0.7682019335469027,1.940934298487785,0.0014619883040935672,0.1375584509789788,0.353,12/29,9.87%,PECAM1;RAPGEF2;F11R;RAPGEF1;F2RL1;SOX18;MSN;RAPGEF6;PPP1R16B;ROBO4;TJP2;TJP1
prerank,activation of protein kinase A activity (GO:0034199),-0.7151390705908068,-1.937026099937917,0.0026595744680851063,0.0817006724476097,0.405,10/16,14.50%,ADCY5;ADCY9;ADCY1;ADCY2;PRRC1;ADCY7;PRKACA;PRKAR2A;PRKAR2B;PRKAR1A
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.8493766365282359,1.9317926212872667,0.0033003300330033004,0.1317318499246206,0.401,3/14,1.04%,NOS3;EDN1;ACE
prerank,B cell receptor signaling pathway (GO:0050853),0.7351090586801635,1.9250477792835836,0.0014144271570014145,0.12717190127338374,0.444,4/32,5.56%,BMX;PLCG2;MEF2C;PLEKHA1
prerank,mesoderm development (GO:0007498),0.8281222309670876,1.921599358292838,0.0015772870662460567,0.11711106218573414,0.471,4/18,1.45%,BMX;TIE1;TBX1;TBXT
prerank,heterochromatin organization (GO:0070828),0.8629422270633695,1.9129573806159677,0.0016313213703099511,0.1231186135833954,0.523,2/14,0.09%,PRDM16;MECOM
prerank,B cell differentiation (GO:0030183),0.7055973934082668,1.9104078330959158,0.0,0.11506833386577969,0.543,8/46,6.29%,PTPRJ;PLCG2;VCAM1;KLF6;HDAC9;HHEX;TPD52;ADAM17
prerank,respiratory system development (GO:0060541),-0.5900474338300177,-1.9014355506014657,0.0,0.12225674777488715,0.575,11/32,9.74%,GLI2;FGFR2;PDPN;BMP4;FGF1;RBP4;LOXL3;NPHP3;FGF2;VEGFA;STRA6
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.6546275378492566,1.8873698691006875,0.0,0.16476614459802547,0.7,20/69,12.27%,PTPRJ;PLCG2;NOD2;ARHGEF2;IFNGR1;IFIH1;LGALS9;APP;TIRAP;TLR3;IL1A;HSPB1;JAK2;OAS2;HMGB1;DHX9;TYROBP;CYBA;CLU;DDT
prerank,regulation of glucose import (GO:0046324),-0.6159292593735197,-1.8813337169035993,0.0,0.145291798478866,0.684,13/30,8.20%,PRKAG2;PID1;IGF1;SORBS1;APPL2;RHOQ;GRB10;ENPP1;IRS2;OSBPL8;IRS1;PIK3R1;PRKCI
prerank,lung development (GO:0030324),-0.586061856682798,-1.8786098505876758,0.0,0.13473687168054957,0.693,13/33,11.56%,ERRFI1;GLI2;FGFR2;PDPN;BMP4;FGF1;RBP4;LOXL3;NPHP3;FGF2;VEGFA;STRA6;PKD1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.6467388829300057,1.878030843302444,0.0,0.17954222063152833,0.744,20/73,12.27%,PTPRJ;PLCG2;NOD2;ARHGEF2;IFNGR1;IFIH1;LGALS9;APP;TIRAP;TLR3;IL1A;HSPB1;JAK2;OAS2;HMGB1;DHX9;TYROBP;CYBA;CLU;DDT
prerank,lymphocyte differentiation (GO:0030098),0.6497053559209092,1.8753579073867497,0.0,0.1709980744213825,0.751,11/68,6.29%,PTPRJ;PLCG2;JAG2;VCAM1;KLF6;DLL4;HDAC9;HHEX;TPD52;GATA3;ADAM17
prerank,regulation of cell-cell adhesion (GO:0022407),0.7050441655697639,1.8734005115879935,0.0,0.16298893384164598,0.759,8/39,1.06%,PODXL;JAG1;PTPRG;PTPRR;EFNA5;CEACAM1;MAGI1;SMAD7
prerank,cardiac ventricle development (GO:0003231),0.7822649831791287,1.872209527219559,0.003105590062111801,0.15438683290616248,0.765,8/20,6.13%,GJA5;ENG;NOTCH1;DAND5;HEY1;DLL4;HEY2;GATA3
prerank,regulation of endothelial cell proliferation (GO:0001936),0.6312154126179097,1.8718066319072968,0.0,0.1449725897119158,0.765,22/88,7.58%,VEGFC;PTPRM;CDH13;TEK;TIE1;PDGFB;BMPR2;FLT4;EGFL7;ACVRL1;EGR3;CAV1;PRKD1;CAV2;VEGFD;NRAS;ANGPT1;VASH2;PPP1R16B;AKT3;STAT1;ATP5F1A
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.6943953091441161,1.870595622645543,0.0,0.13825510980069555,0.77,8/42,4.69%,PTPRJ;CDH13;TEK;UTRN;EMP2;PPM1F;RRAS;MAP4K4
prerank,regulation of plasminogen activation (GO:0010755),-0.7426300575627584,-1.8700578069646852,0.0,0.13570620169263986,0.734,5/12,11.21%,THBS1;SERPINE2;CLEC3B;RUNX1;SERPINE1
prerank,zinc ion homeostasis (GO:0055069),-0.6171820822342042,-1.869411230016786,0.0,0.12520512656166177,0.735,13/28,6.84%,SLC39A14;SLC30A10;PRKN;SLC39A8;SLC39A13;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X
prerank,regulation of calcium-mediated signaling (GO:0050848),0.750641614742341,1.859959019572157,0.0014705882352941176,0.15611118323646214,0.819,5/25,6.86%,PLCG2;CDH13;GPR143;CMKLR1;LRRK2
prerank,peptide hormone secretion (GO:0030072),0.7524755347606719,1.85845017827203,0.0044444444444444444,0.15121014910150893,0.825,3/26,0.75%,LTBP4;EDN1;EXOC3L1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.6350051888039381,1.858231123240773,0.0,0.14399837846011157,0.826,26/75,13.99%,VEGFC;CDH13;TEK;GATA2;PDGFB;BMPR2;FLT4;EGFL7;JCAD;EGR3;PRKD1;VEGFD;NRAS;VASH2;PPP1R16B;ADAM17;AKT3;HMGB1;PLCG1;APLN;PRKD2;NR4A1;AGGF1;HIF1A;HMGB2;PGF
prerank,regulation of vasculogenesis (GO:2001212),0.84423888195128,1.8562017622301639,0.0,0.14247306230308968,0.84,9/14,5.66%,RAPGEF2;CEACAM1;ASB4;HEY1;EMP2;TMEM100;HEY2;RRAS;CD34
prerank,negative regulation of cell adhesion (GO:0007162),0.6331932913683928,1.856132729962103,0.0,0.13583339103948974,0.84,22/72,12.61%,CDH13;PODXL;ACER2;JAG1;PLXNA4;RND1;ACVRL1;NOTCH1;DUSP1;PLXND1;PDE3B;ANGPT1;GCNT2;ARHGDIA;SNAI2;PTPRO;PTK2;ADAM10;SPINT2;SPOCK1;NF2;ITGB1BP1
prerank,positive regulation of interleukin-10 production (GO:0032733),0.7363072024802515,1.850606749587034,0.002844950213371266,0.14416807351890296,0.863,5/30,5.66%,PLCG2;NOD2;F2RL1;LGALS9;CD34
prerank,blood vessel diameter maintenance (GO:0097746),0.7101041599912089,1.8453464899993344,0.0014104372355430183,0.1493107824062004,0.877,6/34,2.47%,NOS1;NOS3;EDN1;ACE;KLF2;F2RL1
prerank,collagen fibril organization (GO:0030199),-0.4753092221815175,-1.8442434641506227,0.0,0.15673320657029063,0.834,32/88,8.51%,COL1A2;COL3A1;ADAMTS2;COL4A5;COL1A1;COL4A6;COL5A1;COL12A1;COL22A1;TGFBR1;COL4A3;COL25A1;COL4A4;LOXL1;COL6A2;COL6A3;COL11A1;COL26A1;COL8A2;TLL1;COL6A1;COL13A1;COL27A1;COL23A1;LOXL3;P4HA1;ADAMTS3;COL15A1;SERPINH1;COL20A1;COL16A1;P3H1
prerank,nitric oxide metabolic process (GO:0046209),0.8546249015063865,1.8400769703204283,0.0,0.15714934148058907,0.903,3/14,3.48%,NOS1;NOS3;GCH1
prerank,glutamine family amino acid catabolic process (GO:0009065),0.8427830964147167,1.8396934615784608,0.0017211703958691911,0.15163349248246327,0.906,6/13,5.95%,NOS1;NOS3;GLS2;GLS;ARG1;GLUD1
prerank,blood vessel morphogenesis (GO:0048514),0.6542529771024773,1.8395770184741442,0.0013020833333333333,0.14599630467977184,0.907,13/54,3.63%,GJA5;SOX17;ENG;FLT1;RASIP1;FLT4;SMAD7;TBX1;EGFL7;CAV1;ID1;SOX18;HEY2
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.8720676830724148,1.8349782878366623,0.0,0.1526738363228936,0.931,2/11,0.16%,PLCG2;CDH13
prerank,ceramide biosynthetic process (GO:0046513),0.694087133519115,1.831178488324321,0.0,0.15644966681981726,0.943,12/40,10.15%,SGMS1;ST6GALNAC3;ST8SIA6;SGMS2;DEGS2;CERS4;SPTLC2;SPTLC1;ASAH2;CERS6;CERS5;B4GALT6
prerank,endothelial cell development (GO:0001885),0.7350794812270858,1.829708515416905,0.004518072289156626,0.15461894851895122,0.946,8/25,5.70%,PECAM1;RAPGEF2;RAPGEF1;F2RL1;SOX18;MSN;PPP1R16B;ROBO4
prerank,diterpenoid metabolic process (GO:0016101),-0.5119630770980713,-1.8270955934592963,0.0,0.1798107172427478,0.892,13/55,9.74%,GPC6;ALDH1A1;LRP1;SDC2;GPC3;HSPG2;RBP1;APOE;ABCA4;RBP4;NAPEPLD;DHRS3;STRA6
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.6364042373607779,1.8244251375377654,0.0012391573729863693,0.16311105212461358,0.953,14/65,7.30%,PTPRJ;CDH13;AFAP1L2;HIP1;CEACAM1;HIP1R;ITGA1;DAB2IP;CBL;SHKBP1;SH3KBP1;BCAR3;DUSP3;PTPN12
prerank,cellular response to glucagon stimulus (GO:0071377),-0.6642614686850056,-1.823877312146174,0.008130081300813009,0.17551335418914754,0.902,10/17,17.71%,ADCY5;ADCY9;ADCY1;ADCY2;ADCY7;PRKACA;PRKAR2A;PRKAR2B;PRKAR1A;CYSLTR2
prerank,aortic valve development (GO:0003176),0.7067552221078574,1.8192891378403087,0.002911208151382824,0.17262429266797055,0.964,15/34,9.00%,ELN;JAG1;NOS3;TIE1;SMAD6;BMPR2;NOTCH1;HEY1;DLL4;HEY2;EFNA1;TNFRSF1B;GATA3;SNAI2;ROCK1
prerank,regulation of interleukin-10 production (GO:0032653),0.6770183453627617,1.8182250519296907,0.0,0.17011141773919755,0.965,10/44,11.22%,PLCG2;NOD2;F2RL1;LGALS9;FCGR2B;CD34;CD47;HMGB1;TYROBP;VSIR
prerank,energy reserve metabolic process (GO:0006112),-0.6648687092983255,-1.81709942435652,0.0,0.17890197035641317,0.915,5/19,6.63%,PRKAG2;PID1;LEPR;PHKB;PYGM
prerank,cellular zinc ion homeostasis (GO:0006882),-0.6047098927184658,-1.815083408062749,0.0,0.17248372273959475,0.917,12/26,6.84%,SLC39A14;SLC30A10;SLC39A8;SLC39A13;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X
prerank,positive regulation of vasculature development (GO:1904018),0.6117681635678017,1.8135166734961192,0.0,0.17754628351145835,0.974,20/94,7.53%,VEGFC;TEK;NOS3;GATA6;GATA2;FLT1;TIE1;PIK3R6;PRKD1;RHOB;BTG1;ANXA3;VEGFD;RRAS;VASH2;CD34;IL1A;ZC3H12A;ADAM12;HSPB1
prerank,nitric oxide biosynthetic process (GO:0006809),0.8573779592270702,1.8132022285107448,0.0,0.17318863798913356,0.974,3/13,3.48%,NOS1;NOS3;GCH1
prerank,regulation of hydrolase activity (GO:0051336),0.6201199784776409,1.8042811398461476,0.0012195121951219512,0.19238640499980303,0.987,16/71,5.31%,NOS1;FGD5;EFNA5;RASIP1;RABGAP1;PLXNA4;CHN2;DAB2IP;CAV1;PRKG1;CRK;APOA1;GPR137B;PLXND1;RAPGEF6;FGD6
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.6942322816896688,1.8007968633765203,0.0014265335235378032,0.19714740958804328,0.991,11/34,7.61%,VEGFC;FLT1;FLT4;NOTCH1;EGR3;DAB2IP;PRKD1;DLL4;VEGFD;HSPB1;NUS1
prerank,regulation of lymphocyte migration (GO:2000401),0.8842426135625523,1.7996519137925713,0.0,0.19505077654119501,0.991,3/10,4.11%,STK10;JAM2;MSN
prerank,B cell activation (GO:0042113),0.6302043631404641,1.7994695889627985,0.0,0.1903978559639253,0.991,11/68,6.29%,PTPRJ;PLCG2;VCAM1;CASP8;KLF6;HDAC9;HHEX;CTPS1;MEF2C;TPD52;ADAM17
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.8501844368176792,1.7940930704537192,0.004991680532445923,0.20029996668025643,0.995,2/11,1.06%,CEACAM1;SMAD7
prerank,embryonic limb morphogenesis (GO:0030326),-0.5552597705627231,-1.7930592658491669,0.003424657534246575,0.21142164597035876,0.963,14/34,11.92%,CACNA1C;AFF3;GLI3;OSR1;CYP26B1;CREBBP;FBXW4;NIPBL;MEGF8;INTU;PTCH1;TBX2;SALL1;HDAC1
prerank,response to glucagon (GO:0033762),-0.6381133708139679,-1.7930193525347906,0.002785515320334262,0.20034520828834462,0.963,11/19,17.71%,ADCY5;ADCY9;ADCY1;ADCY2;ADCY7;PRKACA;CREB1;PRKAR2A;PRKAR2B;PRKAR1A;CYSLTR2
prerank,cellular response to zinc ion (GO:0071294),-0.6835928196785166,-1.7916232346936463,0.002638522427440633,0.19328440441080275,0.965,9/15,7.36%,MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;P2RX4
prerank,ceramide metabolic process (GO:0006672),0.6637585609411747,1.7914941131315112,0.001272264631043257,0.20266438449941632,0.997,12/49,9.21%,SGMS1;ACER2;ST6GALNAC3;SGMS2;DEGS2;PLPP1;CERS4;SPTLC2;SPTLC1;ASAH2;CERS6;CERS5
prerank,regulation of angiogenesis (GO:0045765),0.5647339768948637,1.790139890846505,0.0,0.20115675920009138,0.997,40/192,7.53%,VEGFC;PTPRM;TEK;NOS3;GATA6;GATA2;CLDN5;FLT1;TIE1;CEACAM1;PIK3R6;FOXO4;ATP2B4;ECSCR;DAB2IP;PRKD1;TGFB2;RHOB;EMP2;CEMIP2;BTG1;HHEX;ANXA3;PLXND1;PDE3B;KLF4;VEGFD;RRAS;VASH2;PPP1R16B;CD34;TSPAN12;WARS1;IL1A;PGK1;STAT1;ZC3H12A;NPR1;ADAM12;HSPB1
prerank,negative regulation of catalytic activity (GO:0043086),0.7397818483928025,1.7894659444131675,0.007142857142857143,0.19824919612282188,0.997,2/24,1.61%,NOS1;NOTCH1
prerank,regulation of cellular respiration (GO:0043457),0.7696242894501338,1.7877551134236838,0.006514657980456026,0.1985875311833234,0.998,1/17,0.01%,PRDM16
prerank,membrane lipid biosynthetic process (GO:0046467),0.6363300800428239,1.7864365476347759,0.0012345679012345679,0.19773595514908957,0.999,23/58,15.29%,SGMS1;ACER2;SGPP2;ST8SIA6;SGMS2;DEGS2;PRKD1;PLPP1;CERS4;SPTLC2;SPNS2;SPTLC1;CERT1;ELOVL4;CERS6;CERS5;HACD4;ELOVL7;PRKD2;PPM1L;VAPA;ELOVL5;ST3GAL2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.7220078456917087,1.7789019182798398,0.008955223880597015,0.21419373615093867,1.0,8/24,10.32%,PTPRJ;TEK;PPM1F;MAP4K4;IQSEC1;DUSP3;ROCK1;RAC1
prerank,endocardial cushion development (GO:0003197),0.7429285864310066,1.7771211649930552,0.0030627871362940277,0.21548510969274895,1.0,8/21,4.00%,NOS3;ENG;BMPR2;ACVRL1;NOTCH1;HEY1;TGFB2;ACVR1
prerank,clathrin coat assembly (GO:0048268),0.7874903310296439,1.7707215565869423,0.014778325123152709,0.22868735387077752,1.0,5/15,8.76%,HIP1;HIP1R;PIK3C2A;FCHO2;NSG2
prerank,mesenchyme morphogenesis (GO:0072132),0.7713963063148637,1.768565474596457,0.009615384615384616,0.2295596371923597,1.0,8/17,5.12%,NOS3;ENG;ACVRL1;NOTCH1;HEY1;TGFB2;ACVR1;SMAD2
prerank,heart morphogenesis (GO:0003007),0.6457716432302246,1.768491701484088,0.0013477088948787063,0.2250608669905253,1.0,14/50,4.00%,SOX17;NOS3;ENG;TBX1;TBXT;MYBPC3;ACVRL1;NOTCH1;INSR;HEY1;TGFB2;FKBP1A;HEY2;ACVR1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.782554171121495,1.7684292491071796,0.0033444816053511705,0.2206812482814144,1.0,1/15,0.01%,BMX
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.6521548394908604,1.7649565414629285,0.004087193460490463,0.2262489555191033,1.0,16/45,12.68%,IRF6;VCAM1;B2M;IRF2;IFNGR1;IRF9;CAMK2D;FCGR1A;STAT1;JAK2;MT2A;OAS2;TRIM25;GBP2;TRIM8;IRF5
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.667569817038194,1.7647524691817191,0.0013568521031207597,0.2225800576684936,1.0,6/41,5.36%,NOS1;KCNN4;KCNQ1;KCNN3;NOS1AP;STAC
prerank,substrate-dependent cell migration (GO:0006929),0.7985717804507364,1.7647172014270869,0.00641025641025641,0.21862898459913446,1.0,4/14,4.56%,VEGFC;CD2AP;NTN1;SHTN1
prerank,cellular glucan metabolic process (GO:0006073),-0.7510267033960927,-1.7644901861899227,0.004975124378109453,0.24782537309108277,0.988,3/11,6.63%,PRKAG2;PHKB;PYGM
prerank,leukocyte cell-cell adhesion (GO:0007159),0.7199661951984542,1.7636537949058224,0.0014771048744460858,0.2177891524537246,1.0,6/24,9.80%,PECAM1;VCAM1;F11R;MSN;ROCK1;GFUS
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.8075343778078599,1.7636336144673421,0.00966183574879227,0.21386619775174767,1.0,5/12,4.07%,PODXL;JAG1;MYO1E;IQGAP1;PROM1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.796764535284401,1.763533507044306,0.003205128205128205,0.2102642989181444,1.0,5/14,8.19%,VEGFC;FLT4;VEGFD;NUS1;MYO1C
prerank,regulation of glucose metabolic process (GO:0010906),-0.5445808765630143,-1.7604321499108009,0.0,0.24576921851998218,0.99,12/34,15.22%,OGT;PDK1;PRKN;IRS2;RORA;IRS1;GPLD1;ZNF692;PDK3;FOXK2;SLC45A3;PDK2
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.7308232400126222,-1.7578358024677652,0.013736263736263736,0.24174247605869012,0.99,4/11,9.34%,EGFR;DDX5;BMP4;MAP2K2
prerank,positive regulation of sodium ion transport (GO:0010765),0.812149002085188,1.757139752460861,0.010344827586206896,0.2242996964236084,1.0,2/12,0.99%,NOS1;CNKSR3
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.6940533907086777,-1.756038492555789,0.014742014742014743,0.23635496794801442,0.99,8/12,26.45%,STX4;ANO1;GPLD1;PPP3CB;C2CD2L;PLA2G6;CFTR;BAIAP3
prerank,macrophage activation (GO:0042116),0.6877435118811241,1.7540289709845036,0.005797101449275362,0.2292728204987793,1.0,9/34,9.10%,PLCG2;CD93;DYSF;IFNGR1;APP;ITGAM;JAK2;NMI;FOXP1
prerank,positive regulation of positive chemotaxis (GO:0050927),0.7629405520213612,1.7540154847608458,0.006359300476947536,0.22538684049032542,1.0,4/15,3.90%,VEGFC;CDH13;F2RL1;VEGFD
prerank,response to molecule of bacterial origin (GO:0002237),0.6084241786215049,1.7532862218039558,0.0024449877750611247,0.22384281267960532,1.0,18/69,13.72%,NOS1;NOS3;SMAD6;LGALS9;GCH1;TIRAP;FCGR2B;TRIM6;IFNAR1;ADAM17;HNRNPA0;JAK2;ACOD1;FOXP1;TAB2;IRF5;RPS6KA3;HMGB2
prerank,cellular response to sterol (GO:0036315),-0.7177402823947355,-1.7517817750544842,0.013089005235602094,0.23624511054664418,0.992,9/13,17.01%,SMO;GRAMD1C;RORA;GPLD1;PTCH1;INSIG2;GRAMD1A;OSBPL7;GRAMD1B
prerank,respiratory tube development (GO:0030323),-0.5711686544175316,-1.7515348697363151,0.0,0.2279416805353846,0.992,11/28,9.74%,GLI2;FGFR2;PDPN;BMP4;FGF1;RBP4;LOXL3;NPHP3;FGF2;VEGFA;STRA6
prerank,positive regulation of angiogenesis (GO:0045766),0.5813444438347297,1.751236128214782,0.0011627906976744186,0.22640269642152006,1.0,22/108,7.53%,VEGFC;TEK;NOS3;GATA6;GATA2;FLT1;TIE1;PIK3R6;PRKD1;RHOB;BTG1;ANXA3;KLF4;VEGFD;RRAS;VASH2;CD34;IL1A;JMJD8;ZC3H12A;ADAM12;HSPB1
prerank,response to lipid (GO:0033993),0.579629652368615,1.7488864362542158,0.002277904328018223,0.22995870079893446,1.0,18/105,7.75%,NOS1;ACER2;NOS3;GATA6;SMAD6;ALPL;FOXO1;LGALS9;GCH1;TIRAP;TRIM6;RXRG;IFNAR1;PCK2;ADAM17;HNRNPA0;PAQR8;JAK2
prerank,intestinal lipid absorption (GO:0098856),0.8336308072232402,1.7485906412207628,0.0016474464579901153,0.22695194168942576,1.0,1/11,0.44%,LIMA1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.7263251677910598,1.7476238524884247,0.008695652173913044,0.22623995235251246,1.0,6/22,11.28%,PTPRJ;CEACAM1;FCGR2B;DUSP3;PRNP;LAPTM5
prerank,T cell mediated immunity (GO:0002456),0.8085173132962987,1.7472418339075584,0.0033500837520938024,0.22400650314400866,1.0,4/13,2.77%,JAG1;CRTAM;CADM1;EMP2
prerank,aortic valve morphogenesis (GO:0003180),0.6961763824657714,1.7449697363163514,0.004418262150220913,0.22690734382703587,1.0,13/30,9.00%,ELN;JAG1;NOS3;TIE1;SMAD6;NOTCH1;HEY1;DLL4;HEY2;EFNA1;GATA3;SNAI2;ROCK1
prerank,amide biosynthetic process (GO:0043604),0.6385630196819247,1.7421190140574492,0.0037688442211055275,0.23155162139448235,1.0,13/47,9.21%,SGMS1;SGMS2;DEGS2;CERS4;PCSK5;SPTLC2;FURIN;SPTLC1;ARG1;ASS1;ASAH2;CERS6;CERS5
prerank,regulation of tumor necrosis factor production (GO:0032680),0.5709729181286539,1.7408514614354316,0.0011325028312570782,0.23149935391164944,1.0,28/112,12.80%,PTPRJ;PLCG2;NOD2;ARHGEF2;IFNGR1;IFIH1;LGALS9;APP;TIRAP;TLR3;CD34;IL1A;NFKBIL1;CD47;ZC3H12A;HSPB1;JAK2;OAS2;FOXP1;CACTIN;HMGB1;DHX9;TYROBP;VSIR;CYBA;CLU;DDT;CX3CR1
prerank,positive regulation of interleukin-12 production (GO:0032735),0.6957445980570194,1.7405815912622669,0.0026917900403768506,0.22868766633513843,1.0,9/31,12.68%,PLCG2;PLCB1;LGALS9;TIRAP;TLR3;LTB;HMGB1;LAPTM5;IRF5
prerank,regulation of epithelial cell migration (GO:0010632),0.6199096905659452,1.740164378215445,0.0,0.22666563803513287,1.0,19/51,10.61%,PLCG2;PTPRG;PTPRR;CEACAM1;BMPR2;RAB11A;MACF1;DAB2IP;TGFB2;EMP2;EVL;PPM1F;ADIPOR1;CLASP1;MCC;PTK2;RTN4;CLASP2;PLCG1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.743647774312945,1.7401134880195228,0.010769230769230769,0.22357306923826453,1.0,6/19,10.32%,PTPRJ;TEK;PPM1F;MAP4K4;ROCK1;RAC1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.8283071085526824,1.7400729973970857,0.0032,0.22059455296137856,1.0,3/11,4.76%,NOS1;NOS1AP;CAMK2D
prerank,lamellipodium assembly (GO:0030032),0.701459737368265,1.7372421801958164,0.013452914798206279,0.22519344587219386,1.0,10/26,10.51%,CDH13;SPATA13;S1PR1;ABLIM1;PARVB;WHAMM;PTPRO;RAC1;CCDC88A;CYFIP1
prerank,positive regulation of vasculogenesis (GO:2001214),0.8498883318519855,1.7359172670569933,0.0034965034965034965,0.22543674067661423,1.0,6/10,5.66%,RAPGEF2;CEACAM1;ASB4;TMEM100;RRAS;CD34
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5761543591093986,-1.7356039534654877,0.009146341463414634,0.2578058821044568,0.997,11/25,14.92%,ANK2;DMD;WNK1;ACTN2;WNK4;ATP1B3;SLC6A9;COX17;TRPC6;ATP1B1;ATP1B2
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.8000675728059724,1.735348497826057,0.006688963210702341,0.22416032021532106,1.0,4/12,11.60%,LAMA3;LAMA5;ACTG1;ACTB
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.6756339873245482,1.7318015891024898,0.009859154929577466,0.22985074502535774,1.0,3/33,0.80%,PTPRJ;KCNN4;CEACAM1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.7419068379240066,1.7305937205709767,0.01228878648233487,0.23003723643180501,1.0,6/19,6.13%,PDGFB;KLF2;APP;SLCO1C1;KLF4;GATA3
prerank,sphingolipid biosynthetic process (GO:0030148),0.6046323448258618,1.7299174409219154,0.0024242424242424242,0.22878990227046286,1.0,26/71,15.01%,SGMS1;ACER2;SGPP2;SGMS2;DEGS2;PRKD1;PLPP1;CERS4;SPTLC2;SPNS2;SPTLC1;ASAH2;A4GALT;CERT1;ELOVL4;CERS6;CERS5;HACD4;B4GALT6;ELOVL7;PRKD2;ALOXE3;PPM1L;VAPA;ELOVL5;AGK
prerank,nitric oxide mediated signal transduction (GO:0007263),0.7565267441974644,1.7253258726879939,0.012326656394453005,0.2384384964214968,1.0,2/16,0.41%,NOS1;NOS3
prerank,regulation of cardiac conduction (GO:1903779),0.6199664302931441,1.724622997002,0.005201560468140442,0.23720599553253557,1.0,11/54,3.80%,NOS1;ATP2A3;GJA5;NPR2;ITPR3;ATP2B4;ATP2B2;ATP1A4;ATP1A3;ATP1A1;SLC8A1
prerank,hemidesmosome assembly (GO:0031581),0.8299395456063422,1.7243131885655436,0.00528169014084507,0.2350906860193229,1.0,3/11,6.93%,LAMA3;DST;PLEC
prerank,endothelial cell migration (GO:0043542),0.6437198114060665,1.7220963859619092,0.011461318051575931,0.23851373690385574,1.0,10/37,6.83%,CDH13;NOS3;EGR3;EMP2;ID1;SOX18;PLXND1;PLEKHG5;MYH9;STAT1
prerank,response to prostaglandin E (GO:0034695),-0.7497444649182761,-1.71903716653938,0.004761904761904762,0.2920452850712015,0.999,1/10,0.09%,TGFBR3
prerank,keratan sulfate catabolic process (GO:0042340),-0.7120330799751631,-1.7172731816605369,0.007594936708860759,0.2870888094428778,0.999,7/11,13.43%,OGN;FMOD;GNS;PRELP;HEXA;OMD;LUM
prerank,regulation of cell-matrix adhesion (GO:0001952),0.6046119008666762,1.7167155912299816,0.0050062578222778474,0.2504614366268389,1.0,16/64,9.01%,CDH13;ACER2;JAG1;EFNA5;UTRN;LIMCH1;MACF1;EMP2;SLK;ADAM15;MAP4K4;CLASP1;DUSP3;ACTG1;ROCK1;PTK2
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.6210930960751649,-1.7164262928273506,0.013297872340425532,0.2796840194884501,0.999,5/17,6.57%,ATP1A2;ANK2;CACNA1C;CACNA2D1;CACNA1G
prerank,cellular response to drug (GO:0035690),0.7008021985081488,1.7145789365894952,0.011477761836441894,0.2541025354223634,1.0,6/25,8.91%,ACER2;KCNQ1;AIM2;PPM1F;MEF2C;HTR1B
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.6551124166321112,1.7142831309836641,0.015151515151515152,0.2518999084983921,1.0,12/39,10.24%,PODXL;JAG1;NOTCH4;NOTCH1;APOA1;PPM1F;KLF4;ASS1;FXYD5;PTK2;MAD2L2;SPINT2
prerank,lipoprotein transport (GO:0042953),-0.7189891723558196,-1.712624479601236,0.01405152224824356,0.2805428667249688,0.999,5/10,13.79%,LRP1;PRKCB;ZDHHC17;PPARG;UNC119B
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.7359540387063228,1.7116586607149873,0.015060240963855422,0.25613479013071583,1.0,2/17,1.52%,JAG1;BACH2
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.6240525801019152,-1.7115523001014883,0.011204481792717087,0.2748353499904735,0.999,11/19,11.28%,TGFBR3;BMPR1A;FGFR2;TGFBR1;ZFPM2;RBPJ;RBP4;FGF2;RUNX1;GLI1;TBX2
prerank,regulation of cell junction assembly (GO:1901888),0.6914578671818548,1.7113032971599582,0.004213483146067416,0.25405261808627977,1.0,11/27,9.87%,RAPGEF2;CLDN5;F11R;OCLN;RAPGEF1;PDLIM5;MEF2C;SNAI2;MYO1C;ROCK1;TJP1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.6555306494850192,1.710373605965114,0.011267605633802818,0.25376805145443954,1.0,5/34,3.80%,NOS1;GJA5;KCNQ1;SMAD7;SLC8A1
prerank,cardiac atrium morphogenesis (GO:0003209),0.7548565676837926,1.7101311198982845,0.004784688995215311,0.25155432085000584,1.0,6/16,3.63%,ENG;BMPR2;NOTCH1;TGFB2;DLL4;HEY2
prerank,negative regulation of receptor binding (GO:1900121),0.8337352596334033,1.707606352351264,0.011764705882352941,0.25537964273420893,1.0,3/10,4.13%,ATP2A3;B2M;ADAM15
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.5705263351298536,1.7073621634259168,0.0,0.25318572034962794,1.0,18/86,11.75%,SYNPO;EDN1;FCHSD2;TRPV4;STMN2;OCLN;F2RL1;APP;FES;EVL;CDC42EP1;CLIP1;CLASP1;WDR1;NCKAP1;RAC1;NUMA1;CLU
prerank,artery development (GO:0060840),0.7012419702925098,1.7072116560083872,0.013719512195121951,0.2508081901867505,1.0,6/23,1.55%,GJA5;ENG;BMPR2;SMAD7;TBX1;ACVRL1
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.7160300063238585,1.706235907073032,0.006051437216338881,0.2509224790665085,1.0,5/20,7.73%,PLCB1;GNAQ;AGRN;CHRM3;LYPD1
prerank,positive regulation of lyase activity (GO:0051349),0.7748225412057903,1.7045000494542792,0.011589403973509934,0.25315800029703683,1.0,4/14,5.28%,NOS1;NOS3;ORAI1;AKAP5
prerank,lipoprotein localization (GO:0044872),-0.7087399172099984,-1.7030746086022255,0.01647058823529412,0.2904758936230553,0.999,5/11,13.79%,LRP1;PRKCB;ZDHHC17;PPARG;UNC119B
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.6605317455079882,1.7010422387537698,0.005449591280653951,0.2599117398472251,1.0,15/38,12.80%,EDN1;KLF2;ATP2B4;INSR;CAV1;NOS1AP;KLF4;CD34;ASS1;CD47;ZC3H12A;JAK2;RAC1;CLU;CX3CR1
prerank,atrioventricular valve morphogenesis (GO:0003181),0.727033337069596,1.700815366743047,0.012598425196850394,0.2577743194718878,1.0,8/19,4.93%,SMAD6;BMPR2;NOTCH1;HEY1;TGFB2;HEY2;ACVR1;EFNA1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.5746833877525329,1.6997821232107841,0.0011890606420927466,0.25796877890868997,1.0,11/86,4.93%,PTPRJ;PECAM1;PLCG2;EFNA5;PDGFB;FYN;ARHGEF2;APP;ACVR1;ANGPT1;EFNA1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.7464491151072147,1.6993763454745392,0.022970903522205207,0.25644282652908285,1.0,5/17,11.28%,PTPRJ;CEACAM1;DUSP3;PRNP;LAPTM5
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.7182681065638399,1.6992547797621886,0.012539184952978056,0.25422097564707086,1.0,4/18,6.23%,PLCB1;GNAQ;AGRN;CHRM3
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.7795617735288198,1.6992305396848777,0.009933774834437087,0.25168889910982506,1.0,3/13,2.95%,NOTCH4;ENG;DLL4
prerank,cellular response to fluid shear stress (GO:0071498),0.7895898319108575,1.6984026478437828,0.018487394957983194,0.25139413279217204,1.0,5/12,7.97%,KLF2;KLF4;MEF2C;ASS1;NFE2L2
prerank,artery morphogenesis (GO:0048844),0.6678071283402514,1.6962249322148342,0.01276595744680851,0.2544928204765465,1.0,9/30,3.63%,GJA5;JAG1;ENG;BMPR2;SMAD7;TBX1;NOTCH1;TGFB2;HEY2
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.7630619739548877,1.6937609951992991,0.01192504258943782,0.25622429419140147,1.0,3/15,2.64%,NANOS1;NANOS3;TNRC6C
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.7630619739548877,1.6937609951992991,0.01192504258943782,0.25622429419140147,1.0,3/15,2.64%,NANOS1;NANOS3;TNRC6C
prerank,endocardial cushion morphogenesis (GO:0003203),0.7233169806262763,1.6932952014759948,0.01564945226917058,0.2550579532350035,1.0,7/18,4.00%,NOS3;ENG;ACVRL1;NOTCH1;HEY1;TGFB2;ACVR1
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.47396729983911867,-1.6912259129513363,0.0,0.3148041762794389,0.999,19/55,13.81%,GPC6;SDC2;DCN;OGN;GPC3;HSPG2;CEMIP;FMOD;GNS;BGN;FGF2;PRELP;HEXA;VCAN;HYAL1;CSPG4;OMD;LUM;HPSE2
prerank,dephosphorylation (GO:0016311),0.5436749229326675,1.6899585255401468,0.0010905125408942203,0.26138925780035566,1.0,36/147,14.73%,PTPRM;PTPRJ;PTPRB;SGPP2;PTPRG;PTPRR;ALPL;PTPN14;DUSP12;DUSP1;PLPP1;INPP5K;PPM1F;ACP6;PTPRE;CTTNBP2NL;DUSP16;THTPA;DUSP3;PPP3CA;PTPN12;PTPRU;PTPRO;PP2D1;PPP2R5C;DUSP11;PTPN1;PLPP6;PDP1;PLPP4;PPM1D;PPM1L;DUSP28;DUSP26;PPP4R1;PPP2CB
prerank,skeletal system development (GO:0001501),-0.39971481931501696,-1.689791332876281,0.0,0.3093270544296111,0.999,39/148,11.56%,COL1A2;BMP6;IGF1;SOX5;COL1A1;GLI2;FGFR2;SULF1;TGFBR1;CDH11;BMP5;BMP7;NPR3;SULF2;MMP14;TLL1;WNT5A;GJA1;COL13A1;TRIP11;RBP4;SH3PXD2B;TNFRSF11B;FBN1;XYLT1;ITGB8;PRELP;EVC;ANKRD11;IGF2;WWOX;VCAN;P3H1;PKDCC;COL9A2;PTH1R;HYAL1;MMP16;PKD1
prerank,Rap protein signal transduction (GO:0032486),0.8133186872427345,1.6886432336662107,0.014975041597337771,0.2621283877831469,1.0,2/10,1.81%,RAPGEF2;RAPGEF1
prerank,cellular response to interferon-gamma (GO:0071346),0.5719584195201644,1.6885531994677632,0.0023752969121140144,0.2599452209516819,1.0,25/88,12.68%,IRF6;VCAM1;GBP5;B2M;IRF2;IFNGR1;LGALS9;GBP4;IRF9;CAMK2D;GBP3;FCGR1A;STAT1;CD47;JAK2;MT2A;OAS2;GAPDH;ACOD1;CASP1;TRIM25;CCL4;GBP2;TRIM8;IRF5
prerank,regulation of interleukin-12 production (GO:0032655),0.6248870541577002,1.6882107535255135,0.004987531172069825,0.2585179451449435,1.0,12/47,12.68%,PLCG2;PLCB1;LGALS9;TIRAP;TLR3;CMKLR1;CD47;LTB;FOXP1;HMGB1;LAPTM5;IRF5
prerank,polyol metabolic process (GO:0019751),0.6054454438780832,1.686693885718974,0.011873350923482849,0.25979731689329716,1.0,9/46,4.15%,PLCG2;PLCB1;ITPKB;IP6K3;PLCB4;INPP5D;INPP1;IPPK;MINPP1
prerank,axon extension (GO:0048675),-0.5822414533062243,-1.686348769320465,0.016286644951140065,0.31056256554025957,1.0,10/23,10.60%,ALCAM;AUTS2;NRP2;SLIT2;SEMA5A;SEMA3A;SPG11;USP9X;PPP3CB;ULK2
prerank,regulation of heart contraction (GO:0008016),0.5663021864635939,1.685402553898306,0.002380952380952381,0.2607341209769293,1.0,15/90,4.76%,NOS1;ATP2A3;GJA5;KCNQ1;NPR2;SMAD7;ITPR3;ATP2B4;ATP2B2;ATP1A4;ATP1A3;ATP1A1;TGFB2;SLC8A1;CAMK2D
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.7027816087687135,1.682407491454659,0.015965166908563134,0.26631366775626425,1.0,6/25,6.03%,EDN1;KLF2;INSR;NOS1AP;KLF4;ASS1
prerank,positive regulation of cyclase activity (GO:0031281),0.7668462161588486,1.6822328004449414,0.018518518518518517,0.2645397939262292,1.0,4/14,5.28%,NOS1;NOS3;ORAI1;AKAP5
prerank,early endosome to Golgi transport (GO:0034498),-0.6788381839591913,-1.6817395282860055,0.021844660194174758,0.31537282933899585,1.0,8/11,16.25%,SURF4;TRAPPC10;LMAN1;EHD3;STX5;SNX1;SNX8;SNX2
prerank,second-messenger-mediated signaling (GO:0019932),0.5725596384345907,1.6792706373611879,0.0,0.26995251566874007,1.0,6/82,1.49%,NOS1;PLCG2;NOS3;EDN1;CCR1;MCTP1
prerank,muscle cell differentiation (GO:0042692),0.6602128829230304,1.6790545827778487,0.008275862068965517,0.2681161691977495,1.0,8/32,5.51%,GATA6;MRTFB;NEBL;SYNE1;TBX1;HEY2;MEF2C;TMEM204
prerank,camera-type eye development (GO:0043010),-0.5580504525751143,-1.678502399834731,0.0060790273556231,0.3168178618463509,1.0,8/25,9.74%,CACNA1C;EFEMP1;LAMA1;FBN2;FBN1;SHROOM2;VEGFA;STRA6
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.6370532824354733,-1.6783827488893497,0.021739130434782608,0.30894287308415996,1.0,6/16,7.17%,IGF1;IGFBP5;IGFBP2;BMP5;IGFBP6;IGFBP3
prerank,negative regulation of cell growth (GO:0030308),0.5486802270469682,1.6767690924445027,0.0,0.27176245697313967,1.0,25/121,11.93%,SEMA3G;PTPRJ;SOX17;MSX1;BMPR2;SMARCA2;APBB2;ACVRL1;TGFB2;HNF4A;BTG1;PPT1;ADAM15;SERTAD2;WFDC1;HYAL2;SH3BP4;NPR1;HSPA1B;SERTAD3;RTN4;GNG4;DCC;DIP2B;TRIM46
prerank,eye development (GO:0001654),-0.4656139292598143,-1.676315187191934,0.004830917874396135,0.3076411125871541,1.0,13/54,6.60%,CACNA1C;SMOC1;EFEMP1;COL5A1;LAMA1;PBX3;RBP4;FBN2;SH3PXD2B;FBN1;NIPBL;MEIS1;SHROOM2
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.6148741909470289,-1.6745852396282912,0.00819672131147541,0.3053389538084397,1.0,4/16,0.71%,ATP1A2;ANK2;CACNA1C;DMD
prerank,sphingoid biosynthetic process (GO:0046520),0.7954370260038438,1.6713011673425606,0.01935483870967742,0.28215004309800096,1.0,4/11,6.04%,ACER2;SPTLC2;SPTLC1;ASAH2
prerank,sphingosine biosynthetic process (GO:0046512),0.7954370260038438,1.6713011673425606,0.01935483870967742,0.28215004309800096,1.0,4/11,6.04%,ACER2;SPTLC2;SPTLC1;ASAH2
prerank,negative regulation of vascular permeability (GO:0043116),0.7837531666790643,1.6710392328601402,0.025252525252525252,0.28058798880841457,1.0,4/12,4.38%,PTPRJ;CLDN5;CEACAM1;ANGPT1
prerank,positive regulation of interleukin-1 production (GO:0032732),0.6131866961463612,1.6709489371643844,0.008939974457215836,0.27847775300090627,1.0,15/51,10.27%,GBP5;NOD2;AIM2;CASP8;F2RL1;LGALS9;APP;TMED10;P2RX7;HSPB1;JAK2;EGR1;HMGB1;CASP1;TYROBP
prerank,eye morphogenesis (GO:0048592),-0.5939837510761329,-1.6709090579516137,0.00847457627118644,0.30833926098871905,1.0,9/19,9.01%,EFEMP1;COL5A1;NKD1;MFAP5;FBN2;FBN1;NIPBL;SHROOM2;VEGFA
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.6331495826214932,1.670815224371119,0.014905149051490514,0.27656988835095964,1.0,8/39,4.69%,ACER2;JAG1;EFNA5;NOTCH1;ACTN4;ADAM15;GCNT2;MAP4K4
prerank,sprouting angiogenesis (GO:0002040),0.6130836341329905,1.670792508312865,0.00273224043715847,0.27435275755738603,1.0,10/51,4.38%,VEGFC;CDH13;TEK;ENG;RECK;FLT4;ACVRL1;EGR3;VEGFD;ANGPT1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.7046908548019413,1.669466805345217,0.0243531202435312,0.27580480749070974,1.0,7/20,12.56%,NOS1;RPS6KA5;ARRB1;PRKAA1;BRCA1;DIP2B;GLYR1
prerank,response to laminar fluid shear stress (GO:0034616),0.821551781372458,1.668307454218842,0.008741258741258742,0.27619559948835776,1.0,6/10,7.97%,SMAD6;SMAD7;KLF2;KLF4;ASS1;NFE2L2
prerank,epithelial cell migration (GO:0010631),0.6267523130773487,1.6670178372259066,0.020086083213773313,0.277415116078181,1.0,8/37,6.83%,NANOS1;CDH13;NOS3;PKN3;PLXND1;PKN1;PLEKHG5;STAT1
prerank,plasma membrane tubulation (GO:0097320),0.7627428604679742,1.6666151016094555,0.023728813559322035,0.27637149100485875,1.0,6/13,8.25%,CAVIN2;PACSIN2;FNBP1L;PACSIN1;WHAMM;BIN3
prerank,inositol phosphate metabolic process (GO:0043647),0.5999291826814263,1.6665458439520595,0.013280212483399735,0.2743389579623398,1.0,9/46,4.15%,PLCG2;PLCB1;ITPKB;IP6K3;PLCB4;INPP5D;INPP1;IPPK;MINPP1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.6666336749626338,1.6638838159400942,0.013138686131386862,0.27901185809755574,1.0,9/26,13.63%,TRPV4;STMN2;OCLN;FES;CLIP1;CLASP1;RAC1;NUMA1;NAV3
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.6864925686706264,1.6624609786851985,0.0169971671388102,0.28038381939233203,1.0,6/26,6.03%,EDN1;KLF2;INSR;NOS1AP;KLF4;ASS1
prerank,response to growth factor (GO:0070848),0.6167818337009187,1.6621872789685432,0.02185792349726776,0.27888957742325443,1.0,7/41,4.00%,NOS1;GATA6;PDGFB;BMPR2;ACVRL1;KLF4;ACVR1
prerank,defense response to fungus (GO:0050832),0.7331623689003769,1.6619107429184052,0.0182370820668693,0.27752644225458234,1.0,4/17,14.47%,PLCG2;GAPDH;CX3CR1;FAM3A
prerank,lamellipodium organization (GO:0097581),0.6549303042822563,1.660259118047598,0.016200294550810016,0.27976897078396695,1.0,10/29,10.51%,CDH13;SPATA13;S1PR1;ABLIM1;PARVB;WHAMM;PTPRO;RAC1;CCDC88A;CYFIP1
prerank,positive regulation of cell migration (GO:0030335),0.5062143919797418,1.6593738664975424,0.0,0.2797454212656041,1.0,50/253,9.87%,SEMA3G;PECAM1;PLCG2;CDH13;PODXL;EDN1;PDGFD;RAPGEF2;FLT1;PDGFB;BMPR2;CCR1;NOTCH1;RAB11A;MYLK;ARHGEF2;INSR;FAM107A;DAB2IP;CAV1;F2RL1;TGFB2;SEMA3F;NEDD9;ACTN4;MGAT5;TNFRSF18;PPM1F;ACVR1;GCNT2;SHTN1;LEF1;MAP4K4;SEMA7A;SPAG9;ADAM17;CLASP1;PPP3CA;SNAI2;NUMB;MYO1C;SEMA6D;APC;ACTG1;PTK2;RIPOR1;RTN4;ADAM10;CLASP2;TJP1
prerank,vasculogenesis (GO:0001570),0.6457219068650631,1.6576215304492654,0.01721664275466284,0.28217990699984025,1.0,8/32,3.63%,SOX17;ENG;RASIP1;EGFL7;NOTCH1;CAV1;SOX18;HEY2
prerank,cellular response to copper ion (GO:0071280),-0.6062533342244032,-1.6572060796236214,0.01643835616438356,0.3384990572452957,1.0,8/16,6.84%,MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X
prerank,sphingolipid metabolic process (GO:0006665),0.5533295720898546,1.6563290255005758,0.0,0.28321221820546205,1.0,29/108,15.60%,SGMS1;ACER2;SGPP2;ST6GALNAC3;SGMS2;DEGS2;ESYT2;PRKD1;PPT1;PLPP1;CERS4;SPTLC2;SPNS2;SPTLC1;ASAH2;GLTP;CERT1;ELOVL4;CERS6;CERS5;HACD4;ELOVL7;PRKD2;ALOXE3;PPM1L;VAPA;ELOVL5;AGK;TECR
prerank,diol metabolic process (GO:0034311),0.7059882667929235,1.65614522376005,0.019817073170731708,0.28156192742089864,1.0,6/19,6.04%,SGPP2;NOS3;DEGS2;PLPP1;GCH1;ASAH2
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.5699999772594312,1.6560254963340941,0.0012360939431396785,0.27986915987915745,1.0,24/70,13.20%,PLCG2;FYN;ELMO1;CRK;FCGR2B;FCGR1A;MAPK1;CD247;MYO1C;ARPC5;NCKAP1;MYO10;ACTG1;YES1;PTK2;RAC1;CYFIP1;PLCG1;ACTB;WASF2;DOCK1;PIK3CB;PLPP4;ARPC3
prerank,sphingosine metabolic process (GO:0006670),0.7346010350320251,1.655958685947742,0.010852713178294573,0.27807609568814834,1.0,6/17,6.04%,ACER2;SGPP2;PLPP1;SPTLC2;SPTLC1;ASAH2
prerank,diol biosynthetic process (GO:0034312),0.7478193426973998,1.655867388957016,0.017377567140600316,0.2763525714965422,1.0,5/15,6.04%,ACER2;GCH1;SPTLC2;SPTLC1;ASAH2
prerank,lipid oxidation (GO:0034440),0.7892343403958084,1.6555173537306294,0.02152317880794702,0.2752978523012607,1.0,3/12,7.85%,ADIPOR2;ADIPOR1;ACOX1
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.6541481975160046,-1.6554385126385873,0.027989821882951654,0.33560848645871355,1.0,9/13,27.65%,IDH2;ADHFE1;L2HGDH;IDH1;GOT1;DLST;D2HGDH;PHYH;GOT2
prerank,regulation of biomineral tissue development (GO:0070167),0.6661274651404562,1.6546732041533416,0.011315417256011316,0.2754726426328768,1.0,8/26,9.00%,NOS3;SGMS2;S1PR1;NOTCH1;HEY1;HEY2;NBR1;ROCK1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.7541933015424637,1.6540101092977098,0.025039123630672927,0.27505267732906696,1.0,3/14,2.69%,RAPGEF2;ATP2B4;ADRB2
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.5777669122192153,1.6516543902209257,0.007614213197969543,0.27923042206991255,1.0,8/67,3.12%,BMX;TEK;FLT1;PDGFB;FYN;FLT4;INSR;FES
prerank,regulation of acrosome reaction (GO:0060046),0.7768133748299353,1.6514218875953681,0.03460207612456748,0.27799501769616114,1.0,1/10,0.83%,PLCB1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.7506360843690997,1.650894724026637,0.022116903633491312,0.27744754237970093,1.0,3/15,3.52%,SMAD7;TGFB2;APOA1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.7595749443585486,1.650237494533246,0.023411371237458192,0.2770949618751608,1.0,2/13,0.41%,NOS1;NOS3
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.6945387984782481,1.6487312745987808,0.018018018018018018,0.2792356764388556,1.0,4/23,2.76%,PIK3R6;CRTAM;LGALS9;CADM1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.6422646287793545,1.6486339498572378,0.021337126600284494,0.2775475052180013,1.0,6/29,2.72%,ENG;S1PR1;SMAD7;MYBPC3;NOTCH1;FKBP1A
prerank,regulation of axon extension (GO:0030516),0.6109296189096686,1.6475098707607294,0.02390998593530239,0.27837109350101036,1.0,10/37,11.93%,SEMA3G;MACF1;NTN1;SHTN1;SEMA7A;ISLR2;NRCAM;RTN4;DIP2B;TRIM46
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.5628260066891699,1.6469351396463285,0.00245398773006135,0.2781298458075156,1.0,24/73,13.20%,PLCG2;FYN;ELMO1;CRK;FCGR2B;FCGR1A;MAPK1;CD247;MYO1C;ARPC5;NCKAP1;MYO10;ACTG1;YES1;PTK2;RAC1;CYFIP1;PLCG1;ACTB;WASF2;DOCK1;PIK3CB;PLPP4;ARPC3
prerank,intestinal absorption (GO:0050892),0.7584899995962283,1.646383655436085,0.026058631921824105,0.2775629671284887,1.0,3/13,7.89%,KCNQ1;F11R;TJP2
prerank,regulation of feeding behavior (GO:0060259),-0.6876356473306929,-1.6443236128733378,0.027989821882951654,0.3602461138266205,1.0,3/11,15.14%,LEPR;CFAP20;EIF2AK4
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.7662305732299586,1.6440087195812287,0.02113821138211382,0.28204349062555284,1.0,4/13,8.71%,EDN1;NOD2;JAK2;NAMPT
prerank,regulation of Notch signaling pathway (GO:0008593),0.5706709765731502,1.6439995657016102,0.0036719706242350062,0.2802265611946014,1.0,21/76,11.39%,JAG1;JAG2;NOTCH4;NOS3;GATA2;EGFL7;MFNG;NOTCH1;NOD2;HEY1;TGFB2;DLL4;TSPAN14;ARRDC1;POGLUT1;ARRB1;TM2D3;FBXW7;EPN2;MAML2;HIF1AN
prerank,membrane repolarization during action potential (GO:0086011),0.7618541973045359,1.6431650337929118,0.019801980198019802,0.2806046323694029,1.0,3/13,2.18%,KCNQ1;KCNE3;ATP1A1
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.5270528500131572,-1.643132370614757,0.010416666666666666,0.35589162117810474,1.0,10/31,7.03%,FGFR2;HOXC4;PDGFRA;TGFBR1;OSR1;HOXA3;HOXB3;HOXB4;MEGF8;SIX1
prerank,cellular response to calcium ion (GO:0071277),0.564056032077758,1.6406590406353274,0.002560819462227913,0.28549527971256483,1.0,13/67,8.31%,PLCG2;SYT15;ITPKB;CPNE8;RASGRP2;IQGAP1;CLIC4;SYT7;CAMK2D;MEF2C;CPNE2;MCOLN1;PRKAA1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.5643778411342167,1.6402019834094281,0.0012391573729863693,0.28476944283507727,1.0,24/71,13.20%,PLCG2;FYN;ELMO1;CRK;FCGR2B;FCGR1A;MAPK1;CD247;MYO1C;ARPC5;NCKAP1;MYO10;ACTG1;YES1;PTK2;RAC1;CYFIP1;PLCG1;ACTB;WASF2;DOCK1;PIK3CB;PLPP4;ARPC3
prerank,positive regulation of interleukin-6 production (GO:0032755),0.5718507770814595,1.6392629872005708,0.0049382716049382715,0.28518880552519776,1.0,15/68,11.25%,PLCG2;NOD2;ARHGEF2;F2RL1;IFIH1;LGALS9;APP;TIRAP;TLR3;HYAL2;IL1A;HMGB1;DHX9;TYROBP;CYBA
prerank,negative regulation of platelet activation (GO:0010544),0.7006582280528476,1.6383972056004281,0.027993779160186624,0.2856092732567249,1.0,5/16,3.27%,NOS3;CEACAM1;PDGFB;PRKG1;ADAMTS18
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.7258742687214627,1.6363641470864567,0.022151898734177215,0.28907716404116424,1.0,4/16,2.51%,PTPRJ;PDGFD;PDGFB;PIK3C2A
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.7488971559851453,1.6338074680784287,0.014469453376205787,0.2937873583799664,1.0,5/13,10.31%,MMRN2;DAB2IP;HHEX;EPN2;PTPN1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.6479485289051555,1.6336465727164988,0.02335766423357664,0.2924220487027137,1.0,8/27,12.99%,NOS1;UTRN;ATP2B4;CAMK2D;FXYD5;SCN1B;NEDD4L;YWHAH
prerank,regulation of interleukin-6 production (GO:0032675),0.549921331828992,1.6331278030308891,0.0011695906432748538,0.2920181108134336,1.0,20/96,11.25%,PLCG2;AFAP1L2;NOD2;ARHGEF2;F2RL1;IFIH1;LGALS9;APP;TIRAP;TLR3;HYAL2;IL1A;CD47;ZC3H12A;ARRB1;CD200;HMGB1;DHX9;TYROBP;CYBA
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.6202924912940545,-1.6329756628398113,0.019444444444444445,0.3795648838831829,1.0,6/16,11.31%,FOXD1;BMP4;FGF1;FGF2;SIX1;SALL1
prerank,lymphocyte migration (GO:0072676),0.6289153786743769,1.6319218654664942,0.018105849582172703,0.29337223831018266,1.0,5/32,10.31%,S1PR1;CRTAM;MSN;GATA3;CCL4
prerank,hemopoiesis (GO:0030097),0.5484249270074708,1.6318506772282533,0.010714285714285714,0.2917131378349525,1.0,23/87,12.77%,MECOM;JAG1;TEK;NOTCH4;FLT1;PDGFB;FLT4;KITLG;TAL1;SNRK;TGFB2;TIRAP;RRAS;CD34;ZBTB16;CEBPA;TPO;ZFP36L2;KIRREL3;GLRX5;ETV6;RTKN2;ARMC6
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.4794375297946383,-1.630954348241268,0.008130081300813009,0.3779983159647073,1.0,10/40,5.68%,ARHGAP6;EGFR;NTRK3;LPAR1;PDGFRB;PDGFRA;KIT;EDNRA;NTRK2;FGF2
prerank,endothelial cell differentiation (GO:0045446),0.772466158010757,1.6305872110525692,0.019801980198019802,0.2929667211563683,1.0,5/12,3.31%,JAG1;TIE1;BMPR2;ACVRL1;SOX18
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.6108271593926177,1.6282714411751935,0.015706806282722512,0.29759311472081457,1.0,13/45,10.27%,GBP5;NOD2;AIM2;CASP8;F2RL1;LGALS9;APP;P2RX7;HSPB1;JAK2;EGR1;CASP1;TYROBP
prerank,response to lipopolysaccharide (GO:0032496),0.526847285735421,1.6271501183859856,0.0033149171270718232,0.29871759427863065,1.0,31/138,11.05%,NOS1;NOS3;SMAD6;NOD2;DAB2IP;LGALS9;VIM;GCH1;TIRAP;DEFA6;TRIM6;MEF2C;IFNAR1;TNFRSF1B;IL1A;ADAM17;PDCD4;NFKBIL1;IRGM;ZC3H12A;HNRNPA0;JAK2;NR1D1;ACOD1;FOXP1;STAP1;CACTIN;HMGB1;CASP1;NFKBIB;TAB2
prerank,neutrophil migration (GO:1990266),0.5817149220727937,1.6269538079385988,0.007518796992481203,0.2973798258623429,1.0,5/58,7.07%,PECAM1;EDN1;TGFB2;PIP5K1C;BSG
prerank,pulmonary valve morphogenesis (GO:0003184),0.7244725416932457,1.6255490466859448,0.019230769230769232,0.2990978547924374,1.0,8/17,3.63%,GJA5;JAG1;NOS3;SMAD6;NOTCH1;HEY1;TGFB2;HEY2
prerank,embryonic digestive tract development (GO:0048566),-0.6076933408401234,-1.6253085789409478,0.023255813953488372,0.3884639479064677,1.0,10/18,11.31%,GLI3;GLI2;FGFR2;PDGFRA;RARB;NIPBL;RBPMS2;PKDCC;STRA6;SALL1
prerank,acylglycerol biosynthetic process (GO:0046463),-0.5435709348346442,-1.6238037022834388,0.009708737864077669,0.3858902778131423,1.0,7/23,9.95%,PLCE1;AGMO;LPGAT1;MOGAT3;PLA2G4A;DGAT1;GK
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.5529351371766348,-1.6231730901157542,0.017045454545454544,0.3803955070975482,1.0,11/23,22.36%,SMO;BMP4;GJA1;FGF2;SIX1;VEGFA;MDK;PAX2;AGT;WNT5B;SIX4
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.5589378066937829,1.6228138816572828,0.006038647342995169,0.3044257483868879,1.0,17/73,11.28%,ATP2A3;ACER2;HIP1;HIP1R;FAS;NOD1;CASP8;CASP2;DAP;TNFSF10;BBC3;CRADD;JAK2;HSPE1;CASP1;CASP8AP2;LAPTM5
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.570270151532183,-1.622548446709204,0.025936599423631124,0.3753171242966498,1.0,8/20,12.40%,ATP1A2;ANK2;CACNA1C;DMD;CALM2;PRKACA;ATP2A2;ATP1B1
prerank,phosphatidylinositol metabolic process (GO:0046488),0.540396515272508,1.6219081671498117,0.0011560693641618498,0.30512841585553935,1.0,24/109,12.65%,BMX;PLCG2;PIP5K1B;PLCB1;PITPNM3;PIK3R6;IP6K3;INPP5D;PIK3C2A;INPP5K;PLEKHA1;PGAP1;PIP5K1C;FIG4;LCLAT1;MTMR10;INPP5B;PIK3C3;ARF3;PLCG1;MTMR11;OCRL;INPP5F;PIK3CB
prerank,cation transmembrane transport (GO:0098655),-0.4681556558014616,-1.6210774184345786,0.0,0.3719300967144911,1.0,8/44,6.67%,ATP1A2;TRPM3;SLC7A2;TRPM6;SFXN2;ABCC9;SLC25A20;SLC6A9
prerank,regulation of membrane depolarization (GO:0003254),0.6971858622517317,1.6209956314080003,0.02843601895734597,0.30585826121138654,1.0,6/18,11.20%,GJA5;SMAD7;CAMK2D;LRRK2;SCN1B;NEDD4L
prerank,negative regulation of axonogenesis (GO:0050771),0.6441961178798572,1.6201927495768185,0.022590361445783132,0.3060466500027313,1.0,6/27,11.93%,SEMA3G;ARHGDIA;RTN4;DCC;DIP2B;TRIM46
prerank,endoderm development (GO:0007492),0.745932595536933,1.6183329597849958,0.028523489932885907,0.3091214232537074,1.0,2/13,2.05%,SOX17;DUSP1
prerank,epithelial tube morphogenesis (GO:0060562),0.6296848674930359,1.6175288142122632,0.017142857142857144,0.30938744937680895,1.0,8/32,6.13%,PODXL;SOX17;RASIP1;ACVRL1;RHOB;ACVR1;MEF2C;GATA3
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.7620476563089635,1.6170590012138137,0.019261637239165328,0.30871197819528984,1.0,6/12,7.23%,INSR;ADRB2;SMCR8;SETX;IRGM;FYCO1
prerank,regulation of macrophage cytokine production (GO:0010935),0.7378882420350645,1.6168081267085292,0.04146730462519936,0.30762621572575244,1.0,3/13,4.84%,PLCG2;TGFB2;SEMA7A
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.6551287636857458,1.6166277321269897,0.023222060957910014,0.30641602515958094,1.0,5/25,5.05%,PLCG2;NOD2;B2M;F2RL1;TRIM6
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.7637777546120682,1.6165604653361052,0.02086677367576244,0.30494762749202675,1.0,3/12,11.25%,PLCG2;ADGRB1;CYBA
prerank,sphingolipid catabolic process (GO:0030149),0.7294792966799929,1.6156452797829843,0.02711323763955343,0.30561226225888366,1.0,4/15,6.04%,ACER2;PPT1;SMPDL3A;ASAH2
prerank,bicellular tight junction assembly (GO:0070830),0.5993756146005611,1.6151720469704487,0.015727391874180863,0.3052114433633889,1.0,5/46,3.32%,PECAM1;CLDN5;F11R;OCLN;ESAM
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.6898238854400496,-1.6150360610207106,0.02823529411764706,0.3837290308972966,1.0,5/10,5.60%,PID1;APPL2;PRKCB;GRB10;ENPP1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.694431877854546,-1.614934660739299,0.01873536299765808,0.3769988779749687,1.0,5/10,13.69%,IRS2;IRS1;GPLD1;PTH1R;SLC45A3
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.5286655340906752,1.6147337304103235,0.004514672686230248,0.3046591333907571,1.0,14/121,5.98%,PTPRJ;PECAM1;PLCG2;EFNA5;PDGFB;ACE;ARHGEF2;NEDD9;TNFRSF18;ACVR1;ANGPT1;EFNA1;FGFR3;FCGR1A
prerank,alcohol catabolic process (GO:0046164),-0.6953948218248334,-1.61435990685447,0.03178484107579462,0.3717553691011258,1.0,2/10,3.00%,CYP27A1;APOE
prerank,oogenesis (GO:0048477),0.7361063082756077,1.6141806160204135,0.03064516129032258,0.3043398880015551,1.0,2/15,0.40%,NANOS1;NANOS3
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.7151883886721703,1.6139489454767688,0.022653721682847898,0.3032586140446973,1.0,7/15,12.70%,ATL2;ATL1;REEP2;RTN4;REEP1;REEP3;RTN3
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5938565059348593,1.6137021662360862,0.014322916666666666,0.3022273714466025,1.0,18/48,12.00%,NOS3;GATA2;PDGFB;JCAD;PRKD1;PIK3C2A;HDAC9;HDAC7;ANGPT1;ADAM17;AKT3;HSPB1;ATP5F1A;NUS1;HMGB1;PLCG1;MAP3K3;PRKD2
prerank,positive regulation of interleukin-8 production (GO:0032757),0.5873348171953826,1.6124029684003054,0.0195822454308094,0.3038767214679689,1.0,10/49,9.48%,AFAP1L2;NOD1;NOD2;F2RL1;LGALS9;TIRAP;TLR3;HYAL2;HSPA1B;HMGB1
prerank,negative regulation of developmental growth (GO:0048640),0.6311514234412865,1.6113748651985338,0.02881844380403458,0.3047552134825447,1.0,8/30,11.93%,SEMA3G;FGFR3;SLC6A4;WWC2;RTN4;DCC;DIP2B;TRIM46
prerank,neurotransmitter biosynthetic process (GO:0042136),0.7233457329920638,1.6112771200382947,0.03305785123966942,0.3034683557469717,1.0,3/14,7.80%,NOS1;ALDH9A1;SLC6A4
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.5798650575114114,1.6105417980401724,0.01032258064516129,0.3036963332165327,1.0,11/51,9.48%,VEGFC;CCR1;F2RL1;LGALS9;ANO6;VEGFD;ADAM17;MAPK1;CMKLR1;PTK2;HMGB1
prerank,leukocyte tethering or rolling (GO:0050901),0.6916717196457633,1.6089363316556722,0.03134796238244514,0.30638054990363073,1.0,3/17,1.67%,GCNT1;VCAM1;JAM2
prerank,negative regulation of cell motility (GO:2000146),0.5273555568454663,1.6069394882629118,0.008083140877598153,0.31014547783904134,1.0,20/108,6.95%,PTPRJ;JAG1;ENG;CLDN5;DACH1;RECK;SMAD7;LIMCH1;MCTP1;ACVRL1;ADARB1;RHOB;CRK;CLIC4;STK24;ADAM15;SPOCK3;SRGAP1;GATA3;DUSP3
prerank,protein hydroxylation (GO:0018126),-0.6067732180470233,-1.6066021323049502,0.043731778425655975,0.38902444485223425,1.0,10/15,18.24%,P3H3;EGLN3;VIPAS39;P3H1;P3H2;PLOD2;JMJD4;VPS33B;PLOD3;P3H4
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.6606791087489596,-1.6063492272476703,0.02977667493796526,0.3828352170164164,1.0,8/11,20.21%,RENBP;GFPT1;NAGK;GFPT2;PGM3;AMDHD2;UAP1L1;GNPNAT1
prerank,vesicle transport along actin filament (GO:0030050),0.6833864715715858,1.6043415704178101,0.02147239263803681,0.31519589508005574,1.0,5/19,8.19%,MYO1D;MYO1E;ACTN4;FNBP1L;MYO1C
prerank,negative regulation of potassium ion transport (GO:0043267),0.7520666662996349,1.603856262204528,0.028052805280528052,0.31479134292867883,1.0,4/13,11.20%,NOS1;CAV1;STK39;NEDD4L
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.6537693034662586,1.6035752379169517,0.026124818577648767,0.31394175685445663,1.0,8/25,10.46%,AFAP1L2;HIP1;HIP1R;CBL;SHKBP1;BCAR3;RTN4;CCDC88A
prerank,atrioventricular valve development (GO:0003171),0.7282649991232786,1.603523528400095,0.03064516129032258,0.3124305330579078,1.0,5/14,4.00%,GJA5;BMPR2;NOTCH1;TGFB2;ACVR1
prerank,icosanoid secretion (GO:0032309),0.7373805748277062,1.603245803647563,0.02861952861952862,0.31156030109919197,1.0,2/12,1.04%,ABCC4;ACE
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.5539924274195244,1.6011940901466264,0.012224938875305624,0.314983661147367,1.0,28/67,17.20%,VEGFC;FLT1;FYN;FLT4;ELMO1;DAB2IP;PRKD1;CRK;VEGFD;SHB;CLEC14A;HSPB1;NCKAP1;ROCK1;PTK2;RAC1;CYFIP1;CYBA;PRKD2;WASF2;DOCK1;PIK3CB;PGF;NCF2;PAK2;NCK1;ELMO2;MAPK14
prerank,cellular response to cAMP (GO:0071320),0.6319342463800587,1.6005742235383085,0.022130013831258646,0.3149230530346359,1.0,4/30,3.59%,KCNQ1;RAPGEF2;RAPGEF1;INPP5K
prerank,pulmonary valve development (GO:0003177),0.6941229041916278,1.5997533746642871,0.0282574568288854,0.31551993107380233,1.0,9/18,5.70%,JAG1;NOS3;SMAD6;BMPR2;NOTCH1;HEY1;TGFB2;HEY2;TNFRSF1B
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.676632010923617,1.5994554289270604,0.024922118380062305,0.3146769898122437,1.0,6/19,11.97%,PTPRJ;VCAM1;GPR143;PRNP;TRPM2;GRM5
prerank,response to muramyl dipeptide (GO:0032495),0.7425482125358311,1.5991606910972,0.04873949579831933,0.3137617735843326,1.0,4/12,2.75%,NOD1;NOD2;ARHGEF2;VIM
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6258714264572871,1.5990371682716893,0.031292517006802724,0.31252954996777565,1.0,11/32,6.71%,MMRN2;GATA2;NOTCH1;JCAD;PIK3C2A;DLL4;HDAC9;HDAC7;KLF4;CARD10;AKT3
prerank,smooth muscle cell differentiation (GO:0051145),0.7586193849542981,1.5984807369784129,0.025423728813559324,0.31244758174807796,1.0,7/12,8.79%,GATA6;MRTFB;HEY1;HEY2;MEF2C;TMEM204;MRTFA
prerank,regulation of microtubule depolymerization (GO:0031114),0.6506824819348588,1.598151858922464,0.02745664739884393,0.31173557456897966,1.0,8/25,9.80%,TRPV4;STMN2;ARHGEF2;CAMSAP2;TTBK2;CLASP1;APC;CLASP2
prerank,cardiac cell development (GO:0055006),0.7525128366288494,1.5980013335683512,0.021885521885521887,0.31059552682977615,1.0,4/11,4.25%,JAG1;NOTCH1;SLC8A1;ALPK3
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.6234573784744452,1.594565940773848,0.02361111111111111,0.31786826520272526,1.0,9/33,10.46%,AFAP1L2;HIP1;HIP1R;CBL;SHKBP1;BCAR3;ADAM17;FBXW7;CCDC88A
prerank,cytoplasmic microtubule organization (GO:0031122),0.5771645079341141,1.5942328714408558,0.020253164556962026,0.3172285050414414,1.0,17/54,10.99%,CCDC88C;TRPV4;PLK3;RAB11A;CLIP2;SLK;DST;CAMSAP2;CLIP1;CLASP1;KPNB1;HOOK1;PCM1;KATNAL2;CCDC88A;LIMK2;NUMA1
prerank,regulation of Rho protein signal transduction (GO:0035023),0.5521992075108996,1.592971592858432,0.01338199513381995,0.3191282012264126,1.0,14/72,7.49%,EPS8L2;HEG1;ARHGEF3;RASIP1;ARHGEF28;F11R;ARHGEF2;F2RL1;APOA1;BCR;LPAR6;CUL3;ARHGDIA;ARRB1
prerank,metal ion transport (GO:0030001),0.5419476046729781,1.5926612008560048,0.008323424494649227,0.3183285365716191,1.0,17/86,11.34%,ATP2A3;KCNN4;TRPV4;FYN;CCR1;ATP2B2;CACNA1A;CAV1;SLC8A1;ATP2C1;NIPAL2;SLC30A1;NIPAL3;NDFIP2;NIPA2;GRIN3A;TRPM2
prerank,positive regulation of histone methylation (GO:0031062),-0.5449319216601701,-1.5921196688974297,0.009404388714733543,0.41852055471165955,1.0,9/24,11.80%,AUTS2;OGT;SNW1;JARID2;MTF2;PAF1;WDR5;CTR9;TET1
prerank,filopodium assembly (GO:0046847),0.7013096519110724,1.5908719616672717,0.024922118380062305,0.32156082340574055,1.0,4/16,5.31%,SPATA13;FGD5;DNM3;FGD6
prerank,regulation of cell migration (GO:0030334),0.4774320345562722,1.59087029121082,0.0,0.32003683846068964,1.0,68/382,9.29%,SEMA3G;PTPRJ;PECAM1;CDH13;PODXL;JAG1;SPATA13;EDN1;PDGFD;ENG;CLDN5;FLT1;CEACAM1;PDGFB;LDB2;DACH1;RECK;ACE;SMAD7;CCR1;PLXNA4;LIMCH1;MCTP1;ACVRL1;NOTCH1;MYLK;INSR;FAM107A;ADARB1;MACF1;CAV1;F2RL1;RHOB;SEMA3F;NEDD9;ACTN4;MGAT5;CLIC4;PPM1F;PLXND1;ACVR1;STK24;SLK;ADAM15;GCNT2;LEF1;MAP4K4;SEMA7A;TTBK2;SPAG9;ROBO4;SRGAP1;ADAM17;KIF2A;DUSP3;PPP3CA;PRR5L;SNAI2;NUMB;PTPRU;MYO1C;SEMA6D;APC;ACTG1;ROCK1;PTK2;SGK1;RIPOR1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.6965158900763257,1.5897754803198534,0.022796352583586626,0.32150983865492305,1.0,3/17,2.53%,PODXL;PIEZO1;TGFB2
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.6093428679402323,-1.589523952070854,0.0273224043715847,0.4204953592447655,1.0,6/17,1.66%,DOCK5;IGF1;PDGFRB;IGFBP5;DOCK7;VTN
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.5517226124134782,-1.5889150134650052,0.03374233128834356,0.41557243403582167,1.0,4/21,0.71%,ATP1A2;ANK2;CACNA1C;DMD
prerank,positive regulation of protein phosphorylation (GO:0001934),0.4813271141808063,1.5885064529475712,0.0,0.3232829949359938,1.0,48/348,8.04%,VEGFC;NOS1;PTPRJ;PECAM1;PLCG2;TEK;PDGFD;ENG;RAPGEF2;EFNA5;PDGFB;BMPR2;FLT4;RPS6KA5;FAS;TBX1;LIMCH1;CCND2;ACVRL1;ATP2B4;CCND3;ARHGEF2;INSR;RBPMS;CAV1;PRKD1;TGFB2;IQGAP1;APP;VEGFD;KRAS;ACVR1;ANGPT1;EFNA1;CSNK1D;TRIM6;BRAT1;BCAR3;ADAM17;MAPK1;LRRK2;IRGM;ARRB1;PDE8A;MAPRE3;JAK2;TOM1L1;THPO
prerank,positive regulation of phagocytosis (GO:0050766),0.5753914900389189,1.5882643389236284,0.026385224274406333,0.3224399827684054,1.0,11/47,12.06%,PTPRJ;GATA2;MERTK;F2RL1;APOA1;ANO6;FCGR2B;CD47;STAP1;CYBA;DOCK2
prerank,tight junction assembly (GO:0120192),0.5854427279505541,1.5876679023153888,0.01832460732984293,0.32238719136114125,1.0,6/49,3.78%,PECAM1;CLDN5;F11R;OCLN;ESAM;LSR
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.620660001361881,-1.587660318609747,0.016901408450704224,0.4125906293397196,1.0,7/15,16.68%,GGACT;ALDH4A1;PRODH;GGT5;SARDH;ABHD12;GGT7
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.7713326185507429,1.5875534590758973,0.03722504230118443,0.3211479885484269,1.0,3/10,4.01%,CEACAM1;LGALS9;FCGR2B
prerank,ameboidal-type cell migration (GO:0001667),0.5760900075092759,1.5874918298299987,0.019255455712451863,0.31980813448910195,1.0,7/51,5.08%,SEMA3G;NANOS1;TBX1;SEMA3F;PKN3;SEMA7A;PKN1
prerank,cGMP-mediated signaling (GO:0019934),-0.6431393142794057,-1.5871839537691996,0.02313624678663239,0.4076878941326393,1.0,3/13,3.00%,IRAG1;PDE3A;APOE
prerank,positive regulation of cell motility (GO:2000147),0.48908525391794333,1.5870024026711707,0.0032017075773745998,0.31961474949953816,1.0,40/205,9.87%,SEMA3G;PECAM1;CDH13;PODXL;EDN1;PDGFD;FLT1;PDGFB;CCR1;NOTCH1;MYLK;INSR;FAM107A;CAV1;F2RL1;SEMA3F;NEDD9;ACTN4;MGAT5;PPM1F;SPOCK2;ACVR1;NTN1;GCNT2;LEF1;MAP4K4;SEMA7A;SPAG9;ADAM17;PPP3CA;SNAI2;NUMB;MYO1C;SEMA6D;APC;ACTG1;PTK2;RIPOR1;ADAM10;TJP1
prerank,negative regulation of developmental process (GO:0051093),0.5469190319414047,1.5838789589733038,0.018633540372670808,0.32611383149586437,1.0,10/69,5.44%,NOTCH4;NOS3;TBX1;NOTCH1;ARHGEF15;HEY1;KLF7;HEY2;OMA1;FGFR3
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.638753721066667,-1.58368005048146,0.02056555269922879,0.41207127560844337,1.0,7/13,16.43%,BMP5;DKK3;APOE;ERLIN1;REST;NFKB1;SCAP
prerank,myeloid cell activation involved in immune response (GO:0002275),0.6764299895719876,1.582274491156451,0.045662100456621,0.32861108744832623,1.0,6/18,12.06%,PLCG2;DYSF;KARS1;NMI;TYROBP;DOCK2
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.5090309880740519,1.5822497946570744,0.001098901098901099,0.3271700111215238,1.0,41/151,15.29%,SGMS1;ACER2;SGPP2;GCNT1;SGMS2;DEGS2;GSTA2;PRKD1;PLPP1;GCH1;APOA1;GPHN;CERS4;SLC44A1;PCSK5;SPTLC2;LCAT;SPNS2;FURIN;SPTLC1;ARG1;ASS1;ALAS1;PCYT1A;CERT1;ELOVL4;CERS6;CERS5;CEPT1;HACD4;LPCAT3;ELOVL7;ACHE;PRKD2;TYW1;PPM1L;VAPA;ELOVL5;STARD10;CSNK2B;ST3GAL2
prerank,regulation of cell adhesion (GO:0030155),0.5127528052573056,1.5797463605877327,0.006772009029345372,0.3323285099605631,1.0,22/129,9.62%,PTPRJ;CDH13;PODXL;NUAK1;EFNA5;PLXNA4;RND1;ACVRL1;DUSP1;FES;CYTH1;TNFRSF18;PLXND1;PDE3B;ANGPT1;EFNA1;ARHGDIA;PPP3CA;RSU1;ROCK1;PTK2;ADAM10
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.5944850917298237,-1.5792376334373115,0.043478260869565216,0.42052518478359907,1.0,7/15,11.82%,UST;DSE;DCN;BGN;VCAN;B3GAT3;CSPG4
prerank,positive chemotaxis (GO:0050918),0.6955545715670243,1.576706723758756,0.03881987577639751,0.3390856883433956,1.0,2/17,4.38%,PTPRJ;ANGPT1
prerank,positive regulation of histone acetylation (GO:0035066),0.6441815552718492,1.5765296158022541,0.04874651810584958,0.33814190653041004,1.0,2/23,1.03%,NOS1;RPS6KA5
prerank,somite development (GO:0061053),-0.66673079193983,-1.5762494832287306,0.025380710659898477,0.42367064937527943,1.0,6/11,17.03%,SMO;MEOX2;LOXL3;MTHFD1;PTCH1;PPP2R3A
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5582896471617518,1.5761517862000145,0.028395061728395062,0.3377469522477606,1.0,13/65,9.42%,PRDM16;SMAD6;SMAD7;DAND5;CAV1;FKBP1A;IL17RD;WFIKKN1;SMAD2;ADAM17;UBA52;RPS27A;PMEPA1
prerank,negative regulation of cartilage development (GO:0061037),-0.6268973422949611,-1.5757101919754783,0.04221635883905013,0.4191701259745047,1.0,4/13,7.82%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.5094376000539416,1.5754756367382035,0.0056753688989784334,0.3380235682085508,1.0,22/124,10.51%,PTPRM;LIMA1;STMN2;RAPGEF2;FRYL;RAB11A;FRY;BTG2;APP;MAP4;BLOC1S6;TTC29;EHD1;FAM161A;PLEKHA1;UHMK1;FLRT3;RAB35;ROCK1;HMGB1;RAC1;CYFIP1
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.6206306749341217,1.574420558474515,0.034482758620689655,0.3392932130539017,1.0,7/29,6.85%,KANK4;LIMA1;HIP1R;FKBP4;KANK3;SHANK3;CLASP1
prerank,macrophage activation involved in immune response (GO:0002281),0.7172700249662091,1.5742305780359804,0.044850498338870434,0.3383428566484992,1.0,5/13,12.80%,PLCG2;DYSF;NMI;TYROBP;CX3CR1
prerank,retinoic acid metabolic process (GO:0042573),-0.6203480800561073,-1.57036364710667,0.03598971722365039,0.4301401928650638,1.0,2/14,2.53%,ALDH1A2;CYP26B1
prerank,response to cAMP (GO:0051591),0.5918316278403811,1.5698886782434502,0.03014416775884666,0.3481225427366393,1.0,6/37,8.24%,KCNQ1;RAPGEF2;RAPGEF1;INPP5K;STAT1;NDUFS4
prerank,cholesterol homeostasis (GO:0042632),0.5549200850322399,1.5697339910651205,0.015228426395939087,0.3470759756977178,1.0,10/64,5.31%,LIMA1;ACSM3;MALL;CYP39A1;CAV1;HNF4A;HDAC9;APOA1;EHD1;LCAT
prerank,cardiac ventricle morphogenesis (GO:0003208),0.5867430747371416,1.5695659388246497,0.02972972972972973,0.34609110994515035,1.0,12/41,6.13%,JAG1;ENG;SMAD7;MYBPC3;NOTCH1;HEY1;TGFB2;FKBP1A;DLL4;HEY2;MEF2C;GATA3
prerank,negative regulation of hydrolase activity (GO:0051346),0.5664398879433912,1.5682551707271986,0.026615969581749048,0.3480149316410451,1.0,8/49,6.86%,NOS1;F11R;DAB2IP;ZCCHC9;LRCH1;SH3BP4;GPATCH2;LRRK2
prerank,positive regulation of cell junction assembly (GO:1901890),0.5637065309221836,1.5681544208671154,0.019230769230769232,0.34674745442357213,1.0,9/56,10.32%,PTPRJ;TEK;CLDN5;CAV1;PPM1F;MAP4K4;IL1RAP;ROCK1;RAC1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.48976346691066425,1.567389803550852,0.003188097768331562,0.3471580280377074,1.0,38/199,9.92%,LAMA4;NOS3;PTPRG;PTPRR;SMAD6;BMPR2;RPS6KA5;SMAD7;NOVA2;NOTCH1;PAEP;ATP2B4;HEY1;DAB2IP;KLF7;IFNGR1;ID1;HDAC9;APOA1;EVL;HEY2;IL17RD;FCGR2B;EFNA1;MEF2C;GATA3;ADAM17;ADIPOR1;SLC6A4;PTPRO;WWC2;PROC;ABHD6;NR1D1;MCC;ROCK1;ACOT13;MAD2L2
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.5767860519476978,-1.567332560378778,0.040214477211796246,0.4334590945368947,1.0,8/16,21.69%,AUTS2;OGT;ARHGAP24;CADM4;GABARAP;ARF6;KBTBD7;RASGRF1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.6534527521211276,1.5670441063865286,0.046849757673667204,0.34661215360035275,1.0,6/20,11.95%,ENTPD1;APP;ANO6;P2RX7;CASP1;SUGT1
prerank,lymphocyte mediated immunity (GO:0002449),0.7233746727916563,1.5653801937041398,0.03588907014681892,0.349437194993983,1.0,1/12,0.25%,JAG1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7441726052230319,1.5650109851383038,0.043478260869565216,0.34885210539434336,1.0,5/11,11.25%,F2RL1;TIRAP;MFHAS1;ACOD1;CYBA
prerank,sterol homeostasis (GO:0055092),0.553037523592282,1.5649931381211006,0.01397712833545108,0.34743743210726613,1.0,10/65,5.31%,LIMA1;ACSM3;MALL;CYP39A1;CAV1;HNF4A;HDAC9;APOA1;EHD1;LCAT
prerank,establishment of epithelial cell polarity (GO:0090162),0.6706745839165573,1.564449894198268,0.044709388971684055,0.3475185413283401,1.0,6/19,6.85%,CYTH3;SIPA1L3;CYTH1;MSN;SYNE4;CLASP1
prerank,embryonic eye morphogenesis (GO:0048048),-0.6561844353340507,-1.5638973045435596,0.04415584415584416,0.4385525926128473,1.0,7/11,19.45%,EFEMP1;MFAP5;FBN2;FBN1;TBX2;RARG;MFAP2
prerank,regulation of cellular component organization (GO:0051128),0.5062748107119895,1.562645289051879,0.005555555555555556,0.3509724922062184,1.0,26/135,10.41%,CDH13;LTBP4;RAPGEF2;HIP1;CEACAM1;HIP1R;RAPGEF1;FAM107A;DAB2IP;RASGRP2;PACSIN2;CISH;WFDC1;CAMK2D;STK38L;CAMSAP2;PACSIN1;IRGM;ROCK1;SGK1;TAOK2;STON1;TJP1;MAD2L2;PTPN1;ERMN
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.5682153621038474,1.5621536296567604,0.029609690444145357,0.35081961794799377,1.0,13/44,13.15%,NANOS1;NANOS3;TNRC6C;BTG2;ZC3H12A;PRR5L;POLR2G;ROCK1;ZFP36L2;CNOT1;GTPBP1;TOB1;METTL14
prerank,modified amino acid transport (GO:0072337),-0.5738346324493662,-1.560028885014713,0.04632152588555858,0.44447194188184946,1.0,4/15,6.13%,SLC6A13;SLC16A12;PDPN;SLC19A1
prerank,negative regulation of epithelial cell migration (GO:0010633),0.6155512776911986,1.5596986772345078,0.02710413694721826,0.3558853588300494,1.0,7/33,3.54%,PTPRM;PTPRG;PTPRR;ACVRL1;DAB2IP;DLL4;EVL
prerank,positive regulation of immune effector process (GO:0002699),0.6303488623524186,1.559661138409101,0.035398230088495575,0.3545542515983204,1.0,2/27,2.63%,PTPRJ;LGALS9
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.48923022941142336,1.5576672681446357,0.0010893246187363835,0.3585498422160165,1.0,42/163,19.08%,BMX;PTPRJ;PLCG2;FYN;INPP5D;PSMD13;MEF2C;PLEKHA1;GATA3;PSMD4;CD247;ZC3H12A;PSMA5;PSMB10;EIF2B2;PLCG1;PSMB8;TAB2;PSMD14;PRKD2;CD38;PIK3CB;BTK;PSMA7;PSMA8;PSMC3;PSMB5;PSMC1;PSMC5;PAK2;PSMC6;PSMB9;PDE4D;CD79A;NCK1;PSMA4;PSMD5;PSMD9;RELA;PSMB6;GRAP2;MALT1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.5325600737539656,1.5574376550925215,0.01625,0.3577109106571636,1.0,20/76,16.84%,TEK;SYNPO;EDN1;FCHSD2;F2RL1;FES;EVL;CDC42EP1;P2RX7;WDR1;NCKAP1;STAP1;PFDN2;NUMA1;SORBS3;NES;VIL1;NCK1;PYCARD;TENM1
prerank,aorta morphogenesis (GO:0035909),0.681822441954339,1.5558326350857399,0.04866562009419152,0.36050781030496776,1.0,8/17,3.63%,JAG1;ENG;TBX1;ACVRL1;MYLK;HEY1;DLL4;HEY2
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.5915379340957161,1.555593003342136,0.03814713896457766,0.35965133464627186,1.0,9/39,4.20%,JAG1;JAG2;NOTCH4;NOS3;NOTCH1;NOD2;TGFB2;DLL4;TSPAN14
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.58487898286676,1.5555209865025217,0.02702702702702703,0.3583809105734638,1.0,9/41,11.34%,PLCG2;TRPV4;ITPR3;ATP2B4;SLC8A1;GRIN2B;GRIN2C;HTR2A;TRPM2
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.5129162713492782,1.5554264670600422,0.010309278350515464,0.35719801246319816,1.0,16/119,7.43%,BMX;PLCG2;EFR3B;PIP5K1B;PITPNM3;PIK3R6;ITPKB;IP6K3;INPP5D;PIK3C2A;INPP5K;CISH;PLEKHA1;PIP5K1C;FIG4;SOCS6
prerank,neuron projection regeneration (GO:0031102),-0.6637728072403144,-1.553218564089149,0.03282828282828283,0.4610645128341108,1.0,3/10,13.35%,PTN;GAP43;NREP
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.7363710455232988,1.5522772391130795,0.06610169491525424,0.364204112096211,1.0,5/11,9.87%,RAPGEF2;F11R;RAPGEF6;TJP2;TJP1
prerank,positive regulation of ruffle assembly (GO:1900029),0.7240312910924143,1.5517955747074328,0.04220779220779221,0.36411361558539546,1.0,2/13,7.55%,EPS8L2;PLEKHM1
prerank,apical junction assembly (GO:0043297),0.5626937380333669,1.550832441258879,0.022813688212927757,0.3652301729228767,1.0,8/53,8.54%,PECAM1;CLDN5;F11R;OCLN;ESAM;CTNNA1;WDR1;APC
prerank,neurotransmitter uptake (GO:0001504),-0.6477638389375519,-1.550419711282455,0.04065040650406504,0.46361859413879847,1.0,4/12,11.15%,ATP1A2;SLC1A3;SNAP25;SLC29A1
prerank,response to cadmium ion (GO:0046686),-0.5090997677542105,-1.5487255620737297,0.01892744479495268,0.462619297797197,1.0,9/26,6.84%,EGFR;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X
prerank,limb development (GO:0060173),-0.49809657309964284,-1.5479170778710305,0.02,0.45952704773160097,1.0,8/28,11.31%,GLI3;SMOC1;KAT2B;MEGF8;RSPO2;INTU;PTCH1;SALL1
prerank,regulation of integrin activation (GO:0033623),0.692752911968608,1.547771662854562,0.05065359477124183,0.3720133075311222,1.0,3/15,1.97%,RASIP1;PIEZO1;FBLIM1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.5961422528878721,-1.5473601501880434,0.03359173126614987,0.4550876863341243,1.0,4/15,2.62%,PIEZO2;ADGRV1;COL11A1;KIT
prerank,negative regulation of biomineral tissue development (GO:0070168),0.6424345268203979,1.5471262271215311,0.04431314623338257,0.37227213336965614,1.0,5/21,3.63%,NOS3;CCR1;NOTCH1;HEY1;HEY2
prerank,positive regulation of epithelial cell migration (GO:0010634),0.5178377547106202,1.546360037200528,0.01288056206088993,0.37279517456948513,1.0,29/92,12.65%,PLCG2;TEK;EDN1;BMPR2;FLT4;RAB11A;PRKD1;TGFB2;RHOB;ANXA3;PPM1F;ANGPT1;RRAS;MAP4K4;IQSEC1;GPI;GATA3;CLASP1;ZC3H12A;FOXP1;RTN4;GFUS;CLASP2;RAC1;PLCG1;PRKD2;DOCK1;ITGB1BP1;PIK3CB
prerank,cell differentiation in spinal cord (GO:0021515),0.746300042469509,1.5461742873643052,0.054635761589403975,0.37179018833743505,1.0,3/10,12.33%,SOX13;ZC4H2;SOX6
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.7380014261514453,1.5446645891887378,0.050761421319796954,0.3742430490106342,1.0,2/11,2.18%,KCNQ1;ATP1A1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.655891854755461,1.5435080536741805,0.04636785162287481,0.3760877546073955,1.0,3/18,1.67%,GCNT1;VCAM1;JAM2
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.6274113361165878,-1.543382117812707,0.04774535809018567,0.46167803718700123,1.0,6/12,11.82%,UST;DSE;DCN;BGN;VCAN;CSPG4
prerank,regulation of ruffle assembly (GO:1900027),0.6398007937937594,1.5429274102856148,0.05154639175257732,0.37626325331454374,1.0,5/23,9.16%,EPS8L2;CAV1;EVL;PLEKHM1;STAP1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5496514380217188,1.54263673200994,0.024111675126903553,0.3755916679655529,1.0,13/59,11.08%,PTPRM;PECAM1;CDH13;CEACAM1;CADM1;AMIGO2;ROBO4;BSG;TENM3;NECTIN4;NECTIN1;KIRREL3;CDH2
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.612894972968393,-1.5420520568375045,0.04155844155844156,0.45989738150545084,1.0,8/13,20.21%,RENBP;GFPT1;NAGK;GFPT2;PGM3;AMDHD2;UAP1L1;GNPNAT1
prerank,regulation of receptor binding (GO:1900120),0.7615370743277908,1.5415768675510058,0.04697986577181208,0.3769130481147095,1.0,3/10,4.13%,ATP2A3;B2M;ADAM15
prerank,vasoconstriction (GO:0042310),0.74711410432625,1.5408820599374211,0.05016722408026756,0.3773270486977682,1.0,3/11,3.80%,EDN1;PIK3C2A;SLC8A1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.6238281589816703,-1.54042854471175,0.025906735751295335,0.4597446357343149,1.0,6/13,5.09%,FSTL1;NBL1;LTBP1;GREM2;FBN2;FBN1
prerank,positive regulation of immune response (GO:0050778),0.5448514617763885,1.5403006930983745,0.014833127317676144,0.37753754836396014,1.0,14/64,11.25%,GBP5;NOD2;F2RL1;TGFB2;LGALS9;FCGR2B;KARS1;ITGAM;PLSCR1;NMI;SLC15A4;POLR3B;DHX9;CYBA
prerank,ketone body metabolic process (GO:1902224),-0.661427634852288,-1.5383995790735283,0.057007125890736345,0.46048022224348967,1.0,6/10,11.69%,OXCT1;ACSS3;HMGCS2;BDH2;BDH1;HMGCL
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.5513611623643438,1.5383683974686313,0.03571428571428571,0.3817767109820065,1.0,21/54,17.24%,NOS3;GATA2;PDGFB;ACVRL1;ATP2B4;PRKD1;ANGPT1;MEF2C;ADAM17;AKT3;HSPB1;ATP5F1A;NUS1;HMGB1;PLCG1;PRKD2;HIF1A;CSNK2B;TMSB4X;MAPK14;ETS1
prerank,protein autophosphorylation (GO:0046777),0.4924649678275268,1.5376543977326234,0.003303964757709251,0.3822709154416349,1.0,36/157,13.34%,BMX;TEK;FLT1;STK10;FLT4;INSR;PRKD1;OXSR1;FES;STK24;SLK;CAMK2D;FGFR3;MEX3B;UHMK1;EEF2K;LRRK2;ALK;SIK2;LMTK2;JAK2;STK39;PASK;PIM3;CAD;PTK2;TAOK2;MAP3K11;MARK3;MINK1;MAP3K3;PRKD2;MARK2;VRK1;STK33;ATM
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.4667481412741008,-1.537480000434618,0.016339869281045753,0.45759556792973216,1.0,9/35,5.86%,IRAG1;PDE7B;PDE3A;ADCY1;ADGRG6;APOE;NUDT4;KSR1;ADCY2
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.7481267808814778,1.5372496047313993,0.054514480408858604,0.3820261742623114,1.0,5/10,12.68%,GATA6;FURIN;CDH3;TYROBP;TSKU
prerank,positive regulation of endothelial cell migration (GO:0010595),0.5225539542033979,1.5360300677242613,0.014527845036319613,0.38388960967229324,1.0,28/84,12.65%,TEK;NOS3;EDN1;GATA2;PDGFB;BMPR2;FLT4;PRKD1;RHOB;ANXA3;ANGPT1;RRAS;GPI;GATA3;ADAM17;AKT3;ZC3H12A;HSPB1;ATP5F1A;NUS1;FOXP1;HMGB1;GFUS;RAC1;PLCG1;PRKD2;ITGB1BP1;PIK3CB
prerank,cellular response to peptide (GO:1901653),0.5473428144752994,1.5351488544805036,0.026217228464419477,0.3848165621721659,1.0,12/56,4.01%,FYN;VCAM1;NOD1;NOD2;ARHGEF2;CACNA1A;ATP1A3;CAV1;ADRB2;VIM;APP;FCGR2B
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.547529037478284,1.532922159602223,0.021170610211706103,0.38954128878624794,1.0,11/56,12.73%,PLCG2;NOD1;NOD2;TLR3;IRAK2;HSP90B1;UBA52;RPS27A;HMGB1;TAB2;RPS6KA3
prerank,cellular response to superoxide (GO:0071451),0.7392144815597083,1.5327689578405246,0.050505050505050504,0.3885489085711124,1.0,2/10,4.35%,NOS3;ATP7A
prerank,positive regulation of JNK cascade (GO:0046330),0.5323876192028962,1.5327065769540669,0.02195121951219512,0.387335761282759,1.0,17/70,10.77%,PLCB1;MAP4K2;FLT4;NOD2;DAB2IP;F2RL1;APP;TIRAP;FCGR2B;TRAF1;MFHAS1;GADD45G;TPD52L1;HMGB1;TAOK2;MAP3K11;MINK1
prerank,positive regulation of histone modification (GO:0031058),0.5954989935739741,1.5313540511673975,0.044897959183673466,0.3897191408544842,1.0,7/33,12.56%,NOS1;RPS6KA5;ING2;ARRB1;BRCA1;CHTOP;GLYR1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.589346775813633,1.531092335301816,0.04456824512534819,0.38903024679485937,1.0,7/34,8.10%,PTPRJ;PTPRB;DUSP1;DUSP16;DUSP3;PTPN12;PTPRO
prerank,microvillus organization (GO:0032528),0.6906541410214845,1.5310308484832598,0.061191626409017714,0.38778794462509664,1.0,5/13,10.77%,RAPGEF2;MAP4K4;RAPGEF6;FXYD5;MINK1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.5917063563422579,-1.530676426057966,0.06182795698924731,0.4735531741992293,1.0,7/14,11.21%,LRP1;BMPR1A;IGFBP5;SLIT2;TPM1;IGFBP3;SERPINE1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.5472139855870294,-1.530237690899563,0.03804347826086957,0.46924915525045346,1.0,14/19,32.39%,ADK;AMPD3;GMPR;PNP;TERT;APRT;TYMS;CDA;POLD2;DCK;AMPD2;ADA;POLL;POLD3
prerank,actin filament-based transport (GO:0099515),0.6358537873854907,1.529455515004389,0.05646359583952452,0.39086958636654695,1.0,5/21,8.19%,MYO1D;MYO1E;ACTN4;FNBP1L;MYO1C
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.6734692235679277,1.5294042946068098,0.06041335453100159,0.38961126483140507,1.0,2/16,3.78%,CEACAM1;STX7
prerank,embryonic heart tube development (GO:0035050),0.6813422320016012,1.5291307200164892,0.05909797822706065,0.3889144171351344,1.0,3/14,4.00%,SOX17;SOX18;ACVR1
prerank,regulation of cellular component biogenesis (GO:0044087),0.5662700182219416,1.5290273281581634,0.038157894736842106,0.38778882262812775,1.0,10/39,12.19%,RAPGEF2;TIE1;NOTCH1;RAPGEF1;DAB2IP;MSN;IRGM;ROCK1;TJP1;SNCAIP
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.6909928346902738,1.5288891588376485,0.05993690851735016,0.38675120041971944,1.0,2/15,2.18%,KCNQ1;ATP1A1
prerank,determination of heart left/right asymmetry (GO:0061371),0.5794694545844685,1.5283142030709602,0.02699055330634278,0.3870274512771621,1.0,7/42,5.46%,SOX17;ENG;NOTCH1;DAND5;SOX18;MEF2C;BBS7
prerank,regulation of GTPase activity (GO:0043087),0.4821521206427381,1.5282352830845771,0.006514657980456026,0.38588813382380854,1.0,30/177,7.14%,FGD5;RAPGEF2;EFNA5;DOCK9;RASIP1;RABGAP1;F11R;PLXNA4;CHN2;RAPGEF1;DAB2IP;RASGRP2;CAV2;F2RL1;PRKG1;AGRN;CRK;GPR137B;PLXND1;TBC1D30;MAP4K4;RAPGEF6;FGD6;RAP1GDS1;LRCH1;BCAR3;SH3BP4;LRRK2;RAB3GAP2;RGS7
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.5942841740654604,-1.5279506951454245,0.04712041884816754,0.4711174651618805,1.0,5/13,2.14%,BMP6;BMPR1A;TGFBR1;DAB2;BMP4
prerank,negative regulation of protein depolymerization (GO:1901880),0.6207976154461918,1.527640467201768,0.057803468208092484,0.38618345267590903,1.0,8/24,9.80%,LIMA1;STMN2;ARHGEF2;CAMSAP2;TTBK2;CLASP1;APC;CLASP2
prerank,regulation of MAPK cascade (GO:0043408),0.4817847660586746,1.5274484793574274,0.008820286659316428,0.385363104547088,1.0,30/157,9.66%,PTPRJ;PLCG2;TEK;FLT1;CEACAM1;PDGFB;FLT4;FAS;TBX1;JCAD;INSR;DUSP1;DAB2IP;CAV1;CAV2;ADRB2;IQGAP1;RRAS;MAP4K4;IAPP;FGFR3;BCAR3;MAPK1;P2RX7;DUSP3;THPO;NBR1;ROCK1;HMGB1;TAOK2
prerank,epidermis development (GO:0008544),0.5510893030935663,1.526102516798882,0.017654476670870115,0.3877205165779767,1.0,4/56,3.83%,LAMA3;GATA6;EMP1;ATP2C1
prerank,positive regulation of protein modification process (GO:0031401),0.4735311282714912,1.52610130635519,0.0031847133757961785,0.3863636492283083,1.0,30/203,8.04%,VEGFC;PECAM1;TEK;ENG;EFNA5;FLT4;ACE;FAS;TBX1;LIMCH1;CCND2;CCND3;INSR;APP;NOS1AP;VEGFD;KRAS;ANGPT1;EFNA1;CSNK1D;FAM161A;PPP1R16B;BRAT1;ADAM17;LRRK2;IRGM;RAB3GAP2;ARRB1;PDE8A;THPO
prerank,negative regulation of cell migration (GO:0030336),0.4904240358663306,1.525902243546483,0.008938547486033519,0.38557607767742974,1.0,24/137,6.95%,PTPRJ;JAG1;PTPRG;ENG;PTPRR;CLDN5;DACH1;RECK;SMAD7;LIMCH1;MCTP1;ACVRL1;ADARB1;DAB2IP;RHOB;CLIC4;EVL;STK24;ADAM15;HYAL2;SRGAP1;ADIPOR1;CLASP1;DUSP3
prerank,positive regulation of MAPK cascade (GO:0043410),0.47017798656727405,1.5247097620841423,0.0031446540880503146,0.38763270810839573,1.0,44/245,9.68%,PTPRJ;PLCG2;TEK;EDN1;PDGFD;RAPGEF2;FLT1;PDGFB;FLT4;CCR1;PIK3R6;TBX1;NOTCH1;JCAD;NOD2;INSR;DAB2IP;ARL6IP5;CAV2;F2RL1;TGFB2;LGALS9;ADRB2;IQGAP1;APP;TIRAP;ANGPT1;GCNT2;ARHGAP8;SEMA7A;IAPP;FGFR3;BCAR3;LRRK2;MFHAS1;ARRB1;PDE8A;THPO;TPD52L1;ROCK1;HTR2A;HMGB1;TAOK2;FBXW7
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.660910522495544,1.5241774496216356,0.061708860759493674,0.3877328560321385,1.0,6/17,7.68%,PDGFB;CCNY;CCND2;CCND3;ADAM17;MAPRE3
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.6167262654960004,1.5241704865546355,0.053973013493253376,0.3864227765901673,1.0,2/26,1.10%,PLCG2;ITPR3
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.5563752165318925,-1.5239660237560195,0.031578947368421054,0.47912271915248494,1.0,7/17,9.30%,FSTL1;SULF1;CASK;SLIT2;TWSG1;SFRP4;ZDHHC17
prerank,regulation of focal adhesion assembly (GO:0051893),0.5518960435316501,1.5235907467243441,0.0324254215304799,0.38669412826546384,1.0,17/54,10.32%,PTPRJ;TEK;EFNA5;LIMCH1;ACVRL1;FAM107A;MACF1;PPM1F;SLK;MAP4K4;CLASP1;DUSP3;ACTG1;ROCK1;PTK2;CLASP2;RAC1
prerank,female gamete generation (GO:0007292),0.612484168838835,1.5231114520343476,0.05788712011577424,0.3866745918894963,1.0,2/29,0.40%,NANOS1;NANOS3
prerank,regulation of DNA repair (GO:0006282),-0.4490091121576019,-1.5229730731578057,0.0326530612244898,0.47678638187710615,1.0,8/44,8.56%,EYA2;EGFR;EYA1;TRIP12;EYA4;UBE2V2;UBE2N;USP1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.4617736268951066,-1.52265976428346,0.023166023166023165,0.47268765244747496,1.0,18/37,21.44%,IFT80;TRIP11;IFT81;KIF3C;WDR35;DYNC2LI1;IFT43;DYNLRB1;DYNC2I2;TTC21B;WDR19;KIF3A;IFT27;IFT74;IFT20;IFT88;DYNC2H1;DYNC2I1
prerank,regulation of cell aging (GO:0090342),0.7258756206166029,1.5225050035013672,0.04470198675496689,0.3870091579410857,1.0,2/11,4.16%,NUAK1;ING2
prerank,adenine nucleotide transport (GO:0051503),0.6640864587000328,1.5218357802853204,0.0660377358490566,0.3875869892636448,1.0,3/17,4.80%,LRRC8C;ABCC4;SLC17A9
prerank,positive regulation of developmental growth (GO:0048639),0.5498488119524125,1.5211099517075928,0.0469361147327249,0.38817467645370346,1.0,12/49,13.67%,PLCB1;INSR;MACF1;ITSN2;AGRN;NTN1;SHTN1;SEMA7A;ISLR2;NEDD4L;SMURF1;RASAL1
prerank,positive regulation of heart rate (GO:0010460),0.6750637335752991,1.5203936889761227,0.04716981132075472,0.38877555427166843,1.0,2/17,0.48%,KCNQ1;EDN1
prerank,amino sugar biosynthetic process (GO:0046349),-0.6192202998888293,-1.5194961636531636,0.04884318766066838,0.4775272123197503,1.0,8/12,20.21%,RENBP;GFPT1;NAGK;GFPT2;PGM3;AMDHD2;UAP1L1;GNPNAT1
prerank,regulation of histone acetylation (GO:0035065),0.5964282219843441,1.5192711856755232,0.0577716643741403,0.3905739801949055,1.0,2/33,1.03%,NOS1;RPS6KA5
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.6682016629491497,1.5191338459948247,0.052132701421800945,0.3896035139793409,1.0,4/17,3.51%,GJA5;KCNQ1;KCNE3;NOS1AP
prerank,platelet degranulation (GO:0002576),0.5008924517684857,1.518526871125005,0.014606741573033709,0.3899725213411252,1.0,14/118,4.73%,VEGFC;PECAM1;ABCC4;PDGFB;VWF;TGFB2;APP;ACTN4;APOA1;VTI1B;VEGFD;TIMP3;SELENOP;TAGLN2
prerank,cellular response to cadmium ion (GO:0071276),-0.5171978569078843,-1.5183964250083861,0.025396825396825397,0.4760717321177352,1.0,9/24,6.84%,EGFR;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X
prerank,Rac protein signal transduction (GO:0016601),0.6542518045035626,1.5180093035272137,0.046686746987951805,0.3900577703942445,1.0,6/18,14.01%,CDH13;ELMO1;NCKAP1;RAC1;CYFIP1;RHOH
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.7388199399869262,1.5179409342902592,0.04213938411669368,0.3889568644710214,1.0,3/11,5.43%,RAPGEF2;LGALS9;MEF2C
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.6315081776333262,1.517431332374755,0.046511627906976744,0.38898769055431154,1.0,5/24,7.97%,TEK;GATA2;ANGPT1;GATA3;NFE2L2
prerank,circulatory system development (GO:0072359),0.492887816186015,1.5172269029325929,0.013761467889908258,0.38839085818835156,1.0,20/118,5.43%,HEG1;SOX17;TEK;NOTCH4;PDGFB;FLT4;TBX1;ACVRL1;NOTCH1;HEY1;CASP8;TGFB2;HDAC9;SOX18;HEY2;ACVR1;ALPK3;PDLIM5;PCSK5;MEF2C
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.6547342968330001,-1.5146240111439786,0.0430622009569378,0.4828017383552354,1.0,4/10,8.93%,MECP2;PCGF3;IGF2;DNMT3A
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.46766389388297896,1.5141132829690578,0.0031088082901554403,0.39510525376096606,1.0,49/259,11.00%,CDH13;SPATA13;EXOC6;EHD4;FGD5;CD2AP;ABCC4;RAPGEF2;S1PR1;ABLIM1;EMP1;NOTCH1;RAB11A;MYLK;PARVB;EMP2;DNM3;INPP5K;ANO6;NTN1;EHD1;TEKT5;SHTN1;MAP4K4;RAPGEF6;FAM161A;FGD6;BBS7;TTBK2;TTC36;SNX10;FNBP1L;RAB23;P2RX7;WHAMM;FXYD5;TMEM216;IFT140;PTPRO;CFAP43;PCM1;CDC14A;RAC1;CFAP52;CCDC88A;CYFIP1;DYNLL1;MINK1;EXOC8
prerank,purine ribonucleotide transport (GO:0015868),0.6707608440419833,1.5136861025050063,0.06132075471698113,0.3949488858848329,1.0,3/16,4.80%,LRRC8C;ABCC4;SLC17A9
prerank,regulation of ossification (GO:0030278),0.5859185043050691,1.5132694023743989,0.04183535762483131,0.39473374076655987,1.0,10/36,8.40%,SGMS2;SMAD6;S1PR1;BMPR2;NOTCH1;TGFB2;ACVR1;MEF2C;ZBTB16;NBR1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.6817073690756194,1.5129630776882483,0.07727975270479134,0.3942749501187827,1.0,5/14,4.08%,MMRN2;NOTCH1;DLL4;KLF4;CARD10
prerank,lung epithelium development (GO:0060428),-0.6508406160950502,-1.51290162007437,0.044226044226044224,0.48271569404280684,1.0,5/10,16.69%,ERRFI1;BMP4;STRA6;PKD1;RCN3
prerank,dermatan sulfate metabolic process (GO:0030205),-0.6036197893874004,-1.512515001646033,0.04289544235924933,0.4789122431473022,1.0,6/13,11.82%,UST;DSE;DCN;BGN;VCAN;CSPG4
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.5254127216083331,1.5110671550163604,0.027878787878787878,0.39818930542110886,1.0,12/75,8.54%,PTPRJ;HEG1;RASIP1;DUSP1;DAB2IP;HHEX;INPP5K;SLC8A1;STK38;HYAL2;CEBPA;APC
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.47870356786994517,1.5109443812787051,0.005417118093174431,0.39728470373745156,1.0,32/172,12.65%,BMX;PLCG2;PIP5K1B;PITPNM3;PIK3R6;INPP5D;PIK3C2A;APOA1;INPP5K;ACP6;SLC44A1;LPCAT4;FAR1;LCAT;PLEKHA1;PIP5K1C;FIG4;CRLS1;LCLAT1;PLD1;PLSCR1;PCYT1A;DGKH;PIK3C3;ARF3;CEPT1;LPCAT3;PTDSS1;ACHE;OCRL;INPP5F;PIK3CB
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.59616621200609,-1.5100873597741469,0.053763440860215055,0.48191335955920866,1.0,5/13,7.69%,IGF1;SORBS1;IRS2;IRS1;IGF2
prerank,positive regulation of protein depolymerization (GO:1901881),0.7343913188544248,1.508091697259453,0.061191626409017714,0.4036759720767015,1.0,4/11,7.48%,TRPV4;STMN2;F2RL1;WDR1
prerank,myotube differentiation (GO:0014902),0.661969176693582,1.507718325859468,0.06317411402157165,0.4034492202716203,1.0,5/17,7.18%,NOS1;JAM2;MEF2C;MYEF2;ADAM12
prerank,positive regulation of integrin activation (GO:0033625),0.7207652343020909,1.5074661748418592,0.05747126436781609,0.40282315948629155,1.0,2/11,1.13%,RASIP1;PIEZO1
prerank,myoblast fusion (GO:0007520),0.7110014404897362,1.507142607395775,0.07679465776293823,0.4024024771649548,1.0,2/12,1.67%,NOS1;JAM2
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.6104975116859946,-1.50698008355958,0.050761421319796954,0.48717082724660976,1.0,6/14,14.92%,ANK2;ACTN2;ATP1B3;ATP1B1;LRRC38;ATP1B2
prerank,regulation of DNA biosynthetic process (GO:2000278),0.6136856427162112,1.5047456280705822,0.0597667638483965,0.40771153236930496,1.0,9/27,13.34%,PDGFB;BMPR2;DACH1;ACVRL1;HMBOX1;TOM1L1;TNKS;PRKD2;ATM
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.6281194299237586,1.5046961406250583,0.06518518518518518,0.406584126412372,1.0,7/21,9.80%,STMN2;ARHGEF2;CAMSAP2;TTBK2;CLASP1;APC;CLASP2
prerank,regulation of interleukin-1 production (GO:0032652),0.6911433213639627,1.5043214266078786,0.07766990291262135,0.4062777530214886,1.0,4/15,9.48%,CEACAM1;TMED10;FOXP1;HMGB1
prerank,T cell proliferation (GO:0042098),0.7008447516910732,1.5039915496326506,0.06829268292682927,0.4059572851279764,1.0,4/13,4.55%,CRTAM;CADM1;MSN;CTPS1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.5437741680822138,1.5021745265774826,0.031746031746031744,0.40971130639865433,1.0,7/54,4.92%,KCNN4;KCNQ1;CAV1;KCNN3;NOS1AP;DPP6;DPP10
prerank,ganglioside metabolic process (GO:0001573),0.6343385939661497,1.5019686861401846,0.05846153846153846,0.4089295670253159,1.0,2/20,0.50%,ST6GALNAC3;ST8SIA6
prerank,response to cholesterol (GO:0070723),-0.5590439788428607,-1.501796915857637,0.04878048780487805,0.49858254432399657,1.0,9/17,17.01%,TGFBR1;SMO;GRAMD1C;GPLD1;PTCH1;GRAMD1A;OSBPL7;TGFBR2;GRAMD1B
prerank,bile acid and bile salt transport (GO:0015721),0.6228158992641195,1.5015828549827674,0.058997050147492625,0.4087054498879059,1.0,3/24,3.07%,ABCC4;CEACAM1;SLCO1C1
prerank,calcium-mediated signaling (GO:0019722),0.49568560475647877,1.5012491934327041,0.023174971031286212,0.40841623423144097,1.0,24/93,14.53%,PTPRJ;PLCG2;EDN1;VCAM1;CCR1;MCTP1;SLC8A1;GPR143;CHRM3;P2RX7;LRRK2;IRGM;PPP3CA;PRKAA1;PRNP;PLCG1;TPCN2;TRPM2;GRM5;CX3CR1;BTK;KSR2;CXCR4;RCAN2
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.5720604691043584,-1.5010721191737642,0.07446808510638298,0.49564064899453963,1.0,7/15,22.36%,SMO;BMP4;SIX1;VEGFA;PAX2;AGT;SIX4
prerank,negative regulation of angiogenesis (GO:0016525),0.5148154549108345,1.5005437051315835,0.03132530120481928,0.40901271505351827,1.0,20/84,10.73%,PTPRM;TEK;CLDN5;KLF2;FOXO4;ATP2B4;ECSCR;DAB2IP;TGFB2;HHEX;PDE3B;KLF4;PGK1;STAT1;NPR1;ISM1;ROCK1;EPN2;ADAMTS1;ADGRB1
prerank,regulation of hemopoiesis (GO:1903706),-0.6745010703867546,-1.5004850134860679,0.0477326968973747,0.4924895977922216,1.0,5/10,9.44%,PTN;PRKCB;CREBBP;RUNX1;IL17D
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.5198216629746506,1.5003625627735053,0.030562347188264057,0.40828061981654146,1.0,18/75,10.73%,PTPRM;TEK;CLDN5;FOXO4;ATP2B4;ECSCR;DAB2IP;TGFB2;HHEX;PDE3B;KLF4;PGK1;STAT1;NPR1;ISM1;ROCK1;ADAMTS1;ADGRB1
prerank,bone development (GO:0060348),-0.45783772870440154,-1.5000990627470925,0.022058823529411766,0.48888851538353567,1.0,9/39,8.51%,RANBP3L;FGFR2;SULF1;SULF2;CYP26B1;GJA1;SH3PXD2B;SFRP4;P3H1
prerank,cholesterol transport (GO:0030301),0.5526286305856242,1.5000353283649357,0.042440318302387266,0.4079608962216656,1.0,14/45,19.11%,LIMA1;CAV1;APOA1;LCAT;STX12;ABCG4;CLU;VPS4A;TSKU;LDLRAP1;ABCA7;SCARB1;SOAT1;RELCH
prerank,regulation of protein metabolic process (GO:0051246),0.5484356879328757,1.4984492847530018,0.030707610146862484,0.411261706304317,1.0,7/44,5.58%,LTBP4;ACE;KLF2;FKBP1A;APP;KLF4;FURIN
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.541119631112997,-1.49812430756185,0.05454545454545454,0.49061806308909073,1.0,7/20,1.84%,IGF1;LRP1;BMPR1A;PDGFRB;IGFBP5;VTN;SLIT2
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.550632675052852,-1.4974239769502724,0.06835443037974684,0.487999501286733,1.0,6/16,22.58%,PID1;PPARA;FLCN;ANTKMT;SPHK2;PARP1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.6087792796555977,1.4973918473933014,0.06395348837209303,0.4129146528063261,1.0,4/26,2.95%,PLCG2;LMCD1;ATP2B4;HOMER2
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.5814236658587956,-1.497154292318516,0.07407407407407407,0.4841371530682615,1.0,4/14,7.82%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.6208056489199925,1.4970933256629217,0.06676557863501484,0.4124748643970559,1.0,2/24,1.10%,PLCG2;ITPR3
prerank,regulation of cell-substrate adhesion (GO:0010810),0.5511546171663912,1.497045677833363,0.04330175913396482,0.41132813059502327,1.0,14/42,12.65%,PDGFB;NOTCH1;FBLN2;EMP2;PPM1F;GCNT2;JAK2;PTPRO;RSU1;PTK2;RAC1;MINK1;SPOCK1;PIK3CB
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6956251401341221,1.4968352827837383,0.06643356643356643,0.4106826924490992,1.0,5/12,9.48%,F2RL1;TIRAP;KLF4;FOXP1;HMGB1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.7127584278073634,1.4968314597185122,0.08267090620031796,0.40944981681737697,1.0,2/12,2.58%,PTPRJ;CBL
prerank,modulation by symbiont of host process (GO:0044003),0.7357447802231442,1.4959583836405563,0.07226890756302522,0.4105243468559994,1.0,4/10,8.39%,B2M;PGK1;UBA52;RPS27A
prerank,positive regulation of neuron migration (GO:2001224),0.7291222352041198,1.4956491119988835,0.06197654941373534,0.4100769934755485,1.0,4/11,4.56%,RAPGEF2;ARHGEF2;DAB2IP;SHTN1
prerank,toll-like receptor signaling pathway (GO:0002224),0.5115261801389077,1.495378527266699,0.025089605734767026,0.40955908280781134,1.0,17/84,12.82%,PLCG2;CASP8;LGALS9;TIRAP;TLR3;IRAK2;UBE2D1;ITGAM;HSP90B1;UBA52;RPS27A;NMI;PIK3C3;HMGB1;TAB2;RPS6KA3;BTK
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.5131730087582442,1.4950628268490318,0.03931203931203931,0.409132529969167,1.0,10/67,4.13%,CDH13;UTRN;PDGFB;FBLN2;EMP2;NEDD9;CRK;APOA1;PPM1F;LIMS2
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6288017280969107,1.494955881730021,0.06501547987616099,0.40817456529614476,1.0,6/20,7.68%,PDGFB;CCNY;CCND2;CCND3;ADAM17;MAPRE3
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.6373496735053381,1.4943278633385673,0.07208588957055215,0.4086833182885319,1.0,4/21,3.51%,GJA5;KCNQ1;KCNE3;NOS1AP
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.725552618020691,1.4941762815064066,0.07130124777183601,0.40790429555184604,1.0,2/10,1.13%,PODXL;PIEZO1
prerank,ganglioside biosynthetic process (GO:0001574),0.6559854984737172,1.4941442107176277,0.06525285481239804,0.4067931244179901,1.0,2/15,0.50%,ST6GALNAC3;ST8SIA6
prerank,actin filament depolymerization (GO:0030042),-0.6233391274332959,-1.4931661595198977,0.05513784461152882,0.4931323887978134,1.0,3/11,1.41%,MICAL3;GSN;MICAL2
prerank,digestive tract development (GO:0048565),-0.4751250019897752,-1.4929461276913936,0.033582089552238806,0.4890034636720707,1.0,15/32,11.56%,GLI3;CLMP;GLI2;FGFR2;RARB;SMO;COBL;KIT;NIPBL;MEGF8;GLI1;PKDCC;STRA6;SALL1;PKD1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.5302690965546784,1.4925752578439393,0.04305043050430504,0.4098497437299734,1.0,16/66,10.27%,GBP5;NOD2;AIM2;CASP8;F2RL1;LGALS9;APP;APOA1;P2RX7;ZC3H12A;HSPB1;JAK2;FOXP1;EGR1;CASP1;TYROBP
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.5571304450990809,-1.4920361741489878,0.06166219839142091,0.4870696901135971,1.0,6/16,10.68%,DPYSL3;DPYD;TET2;NT5M;NT5E;UPB1
prerank,heart looping (GO:0001947),0.5673256160776483,1.4918195423289302,0.044715447154471545,0.410727174285056,1.0,6/39,5.46%,SOX17;ENG;NOTCH1;SOX18;MEF2C;BBS7
prerank,maintenance of blood-brain barrier (GO:0035633),0.5896807513932505,1.4917893444805277,0.05316091954022988,0.40958472107332033,1.0,12/30,11.91%,PECAM1;CLDN5;F11R;OCLN;JAM2;ESAM;LSR;TJP2;ACTG1;TJP1;ACTB;SLC1A1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.5667349053288222,1.490650009204362,0.043941411451398134,0.41134035330737095,1.0,9/39,10.61%,TEK;GATA2;ECSCR;ANO6;ANGPT1;GATA3;PDCD4;NFE2L2;PLCG1
prerank,microvillus assembly (GO:0030033),0.6654518989539744,1.4903488134951628,0.0816,0.4110175938268864,1.0,5/14,10.77%,RAPGEF2;MAP4K4;RAPGEF6;FXYD5;MINK1
prerank,phospholipid biosynthetic process (GO:0008654),0.5747001767100011,1.4890532299569164,0.0698005698005698,0.41339103000902083,1.0,5/36,7.61%,SGMS1;SGMS2;FAR1;CRLS1;NUS1
prerank,endochondral bone morphogenesis (GO:0060350),0.7053480196650013,1.488185568916349,0.07588532883642496,0.41446044911435864,1.0,4/11,5.44%,TRPV4;BMPR2;MEF2C;FGFR3
prerank,regulation of striated muscle contraction (GO:0006942),0.6048513963092839,1.4879257325446786,0.05580693815987934,0.41403158887233654,1.0,4/27,1.46%,NOS1;GJA5;SMAD7;MYBPC3
prerank,negative regulation of protein polymerization (GO:0032272),0.6015454242595246,1.4878291352878645,0.06442166910688141,0.41316004882761065,1.0,4/27,3.05%,KANK4;STMN2;HIP1R;KANK3
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5972229102731259,1.4877127020435694,0.06569343065693431,0.41231105348497243,1.0,9/26,11.25%,CAV1;F2RL1;TIRAP;TLR3;MFHAS1;SLC15A4;HMGB1;RTN4;CYBA
prerank,fat cell differentiation (GO:0045444),0.5364196030713858,1.4871393203376202,0.03880983182406209,0.41255887915274136,1.0,12/57,14.04%,PRDM16;SMAD6;NR4A2;FOXO1;KLF4;BBS7;CEBPA;PSMB8;NR4A1;ALOXE3;CTBP2;SDF4
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.5675722364346392,-1.4869162243526821,0.05817174515235457,0.49854027278963464,1.0,8/16,19.26%,PPARGC1B;DDX5;DDX17;PADI2;SAFB;TADA3;AR;TRIP4
prerank,response to zinc ion (GO:0010043),-0.4913771623756028,-1.4862504346836034,0.023880597014925373,0.49588545816622515,1.0,10/25,12.04%,MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;P2RX4;CRIP1
prerank,negative regulation of growth (GO:0045926),0.4885347974834642,1.4860400860105194,0.0145413870246085,0.4144602803061487,1.0,21/121,7.83%,PTPRJ;SOX17;MSX1;BMPR2;SMARCA2;APBB2;ACVRL1;NOTCH1;TGFB2;HNF4A;BTG1;PPT1;ADAM15;SERTAD2;WFDC1;FGFR3;HYAL2;SH3BP4;NPR1;HSPA1B;MT2A
prerank,Notch signaling pathway (GO:0007219),0.5211347841194917,1.485904252513949,0.05144291091593475,0.4136351135578158,1.0,16/59,11.74%,JAG1;JAG2;NOTCH4;SORBS2;NOTCH1;HEY1;DLL4;HEY2;PLXND1;ADAM17;STAT1;SNAI2;APH1A;ADAM10;MAML2;DTX3L
prerank,alanine transport (GO:0032328),0.7115540273624644,1.4858615485667224,0.0986159169550173,0.4126039007500937,1.0,1/10,0.19%,SLC6A6
prerank,striated muscle contraction (GO:0006941),0.532714034271745,1.4847573240379301,0.04409857328145266,0.41448896887776926,1.0,5/53,5.36%,NOS1;KCNQ1;MYBPC3;SLC8A1;STAC
prerank,negative regulation of ossification (GO:0030279),0.6101463526845171,1.4846308428581318,0.06395348837209303,0.4136420276037944,1.0,4/23,5.43%,SMAD6;CCR1;NOTCH1;MEF2C
prerank,negative regulation of MAP kinase activity (GO:0043407),0.5543884993896573,1.4842894735435572,0.0494148244473342,0.4133237072178563,1.0,9/44,10.31%,PTPRJ;DUSP1;DAB2IP;INPP5K;STK38;HYAL2;PDCD4;AIDA;PTPN1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.6030575234194415,-1.4839318971414834,0.04522613065326633,0.49891506313876866,1.0,6/12,13.19%,STX4;SNAP23;SNAP25;STX3;SNAP47;SNAP29
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.49552811478285935,1.483806417547624,0.03981264637002342,0.41338967353159817,1.0,15/95,8.39%,PRDM16;LTBP4;ENG;SMAD6;SMAD7;DAND5;CAV1;FKBP1A;IL17RD;ING2;WFIKKN1;SMAD2;ADAM17;UBA52;RPS27A
prerank,sulfur compound catabolic process (GO:0044273),-0.43936265205908726,-1.48374974973235,0.046153846153846156,0.49494169922887726,1.0,13/38,13.43%,DCN;OGN;FMOD;GNS;BGN;PRELP;HEXA;VCAN;GGT5;HYAL1;CSPG4;OMD;LUM
prerank,melanocyte differentiation (GO:0030318),-0.6278684399304842,-1.482642497314872,0.058355437665782495,0.4940648392816509,1.0,5/11,6.75%,LRMDA;MITF;KIT;ENPP1;USP13
prerank,regulation of T cell cytokine production (GO:0002724),0.6559494746853175,1.482176712369107,0.0782472613458529,0.4165436239837722,1.0,3/15,5.70%,SMAD7;B2M;TNFRSF1B
prerank,negative regulation of ion transport (GO:0043271),0.5982791376169224,1.4821079672176807,0.07863501483679525,0.41556133351032276,1.0,4/24,8.91%,NOS1;INPP5K;PXK;HTR1B
prerank,cellular response to growth factor stimulus (GO:0071363),0.4652418979187256,1.4815831146149494,0.018826135105204873,0.4157733441217774,1.0,32/151,8.49%,NOS1;STMN2;RAPGEF2;FLT1;PDGFB;BMPR2;FLT4;SMAD7;TBX1;ACVRL1;NOTCH1;EGR3;RAPGEF1;DAB2IP;PRKD1;DLL4;IQGAP1;TMEM100;INPP5K;KLF4;ACVR1;EHD1;MEF2C;HYAL2;SETX;DUSP3;PTPN12;HSPB1;PDE8A;SNAI2;SYAP1;RAB35
prerank,cellular response to catecholamine stimulus (GO:0071870),0.6099779449296896,1.4813263432038644,0.07368421052631578,0.4153123891656075,1.0,4/23,6.86%,KCNQ1;ATP2B4;MAPK1;LRRK2
prerank,response to calcium ion (GO:0051592),0.4798092677600279,1.481164807635095,0.023612750885478158,0.4146259976377433,1.0,16/102,8.31%,PLCG2;SYT15;ITPR3;ITPKB;CPNE8;RASGRP2;CAV1;IQGAP1;CLIC4;SYT7;CAMK2D;MEF2C;CPNE2;PPP3CA;MCOLN1;PRKAA1
prerank,cellular response to dsRNA (GO:0071359),0.659405157311179,1.4803713761391817,0.08225806451612903,0.4156781261407903,1.0,7/15,22.14%,CAV1;IFIH1;DHX9;NPM1;RIOK3;RALB;PQBP1
prerank,inositol phosphate dephosphorylation (GO:0046855),0.7064671905617735,1.480103909834901,0.07967479674796749,0.41410530928624534,1.0,6/11,17.60%,INPP1;INPP5K;INPP5B;OCRL;INPP5J;SYNJ1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.7064671905617735,1.480103909834901,0.07967479674796749,0.41410530928624534,1.0,6/11,17.60%,INPP1;INPP5K;INPP5B;OCRL;INPP5J;SYNJ1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.5850679785048977,1.478616556042418,0.07234042553191489,0.4167954530613751,1.0,6/29,10.27%,CRTAM;CADM1;STX7;ITGAM;STAP1;TYROBP
prerank,endodermal cell fate commitment (GO:0001711),0.7278305598371012,1.4778286336882926,0.09256198347107437,0.4176829677799614,1.0,2/10,6.25%,SOX17;RTF1
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.5453261386854847,1.4776084844405624,0.047106325706594884,0.4171480894554993,1.0,12/45,16.65%,NANOS1;NANOS3;APP;PUM2;GCNT2;ZC3H7A;CYFIP1;GRM5;METTL18;EIF2A;TCOF1;ATG14
prerank,embryonic heart tube morphogenesis (GO:0003143),0.5580366271284143,1.477420695134891,0.03967168262653899,0.4164200882431672,1.0,7/43,5.46%,SOX17;ENG;NOTCH1;SOX18;ACVR1;MEF2C;BBS7
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.5512710104101268,1.4763279346366862,0.052,0.41821007322014064,1.0,5/39,2.95%,NOTCH4;ENG;TIE1;RASIP1;DLL4
prerank,regulated exocytosis (GO:0045055),0.46925065528104765,1.4757721275986542,0.007526881720430108,0.4186886908225408,1.0,20/173,6.45%,VEGFC;PECAM1;SYT15;ABCC4;PDGFB;VWF;TGFB2;APP;ACTN4;APOA1;VTI1B;SYT7;VEGFD;TIMP3;SELENOP;TAGLN2;TMED10;MYH9;PIP5K1C;CYB5R1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.598978845987789,-1.4756123433858677,0.06753246753246753,0.5122116025705444,1.0,5/12,7.69%,IGF1;SORBS1;IRS2;IRS1;IGF2
prerank,phasic smooth muscle contraction (GO:0014821),0.7103277852780387,1.475558038021334,0.07192982456140351,0.4181267510091809,1.0,1/10,0.48%,EDN1
prerank,protein localization to cell-cell junction (GO:0150105),0.6599561601995988,1.4753209667211198,0.06836248012718601,0.4176852875362364,1.0,8/15,15.59%,F11R;LSR;TJP2;ACTG1;DSP;TJP1;ACTB;PAK2
prerank,actin filament organization (GO:0007015),0.4689462732892678,1.4742231883878267,0.00989010989010989,0.4193681807960099,1.0,26/151,10.41%,MYO1D;CD2AP;TRPV4;NEBL;HIP1;MYO1E;SHROOM4;ELMO1;HIP1R;RND1;ARHGEF2;PLS3;RHOB;EMP2;NEDD9;FLII;EVL;WHAMM;ARHGAP25;ENAH;MYO1C;BIN3;GAS2L3;MAD2L2;RAC1;ERMN
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.7312782747217923,1.4740489289232768,0.05650684931506849,0.41873558853642806,1.0,3/10,7.72%,ACER2;PDE3B;SNAI2
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.41163340866893927,-1.473191494138808,0.02145922746781116,0.5157272299460895,1.0,14/53,13.13%,EYA2;EGFR;EYA1;DDX5;PLA2R1;FXR2;EYA4;UBE2N;FBH1;SPRED1;BCLAF1;ATR;SPRED2;HMGA2
prerank,adherens junction organization (GO:0034332),0.5358022046044418,1.473143672103805,0.056833558863328824,0.4200436122102808,1.0,21/48,20.12%,CDH13;SMAD7;CADM1;PIP5K1C;CTNNA1;CDH3;CDH15;NECTIN4;NECTIN1;CDH12;TJP1;CDH2;ACTB;CTNNB1;PAK2;CDH22;VCL;CDH18;CDH24;ANG;JUP
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.49764623291289883,-1.4717282557328413,0.036544850498338874,0.5157528042900379,1.0,10/26,8.20%,IGF1;SORBS1;RHOQ;IRS2;C2CD5;OSBPL8;IRS1;PIK3R1;CLIP3;PRKCI
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.47977107584635315,1.4704798401290502,0.022935779816513763,0.42604377128646626,1.0,22/108,11.28%,ATP2A3;ACER2;HIP1;HIP1R;FAS;NOD1;CASP8;ARL6IP5;LGALS9;PPM1F;CASP2;DAP;TNFSF10;BBC3;CRADD;JAK2;GRAMD4;HMGB1;HSPE1;CASP1;CASP8AP2;LAPTM5
prerank,heart trabecula morphogenesis (GO:0061384),0.6278144073959127,1.4700569902983316,0.09200603318250378,0.42612612345603995,1.0,8/18,2.95%,TEK;ENG;S1PR1;NOTCH1;HEY1;TGFB2;FKBP1A;DLL4
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.6342757710396264,-1.4697262192030163,0.059431524547803614,0.5177508985817108,1.0,5/10,13.03%,CPEB1;NUDT21;NCBP1;PAF1;CPEB3
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.4693459872465213,-1.4689763511317908,0.030303030303030304,0.5157005722217172,1.0,10/30,11.82%,DSE;DCN;NDNF;CHST15;BGN;HEXA;VCAN;HYAL1;CHPF2;CSPG4
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.5473776885652482,1.4687567866116518,0.058355437665782495,0.4284792775358813,1.0,8/41,9.87%,PODXL;MAGI1;SMAD7;PIEZO1;GCNT2;CD47;PTPRU;TJP1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5955171756386879,1.4665595776190958,0.07407407407407407,0.43352217285836114,1.0,8/26,11.05%,NOD1;NOD2;CASP8;IFIH1;IRAK2;UBA52;RPS27A;TAB2
prerank,regulation of sodium ion transport (GO:0002028),0.5587173132800888,1.466180364539758,0.07215007215007214,0.43337292109664766,1.0,7/34,8.97%,NOS1;CNKSR3;ATP2B4;ATP1A1;P2RX7;NKAIN3;SCN1B
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.5914116833595647,1.466033611355222,0.07449856733524356,0.4326484613566816,1.0,3/24,4.76%,NOS1;FKBP1A;CAMK2D
prerank,sphingoid metabolic process (GO:0046519),0.6915716268676231,1.4659046707832788,0.07479674796747968,0.4318506750648192,1.0,4/12,6.04%,SGPP2;DEGS2;PLPP1;ASAH2
prerank,regulation of cell growth (GO:0001558),0.45908155213357116,1.4652862470905255,0.007376185458377239,0.43229851765335575,1.0,37/204,10.49%,PTPRJ;SOX17;LTBP4;CEACAM1;MSX1;BMPR2;SMARCA2;APBB2;ACVRL1;FAM107A;RASGRP2;TGFB2;HNF4A;BTG1;PPT1;CISH;ADAM15;SERTAD2;KIF26A;WFDC1;CAMK2D;BRAT1;HYAL2;TAF9B;ADAM17;SH3BP4;SLC25A33;NPR1;HSPA1B;SGK1;SERTAD3;RTN4;ADAM10;TAOK2;MAD2L2;RPS6KA1;GNG4
prerank,clathrin-dependent endocytosis (GO:0072583),0.5946530736197175,1.464891030323089,0.07342143906020558,0.4321698940738532,1.0,8/26,12.19%,FCHSD2;ITSN2;AP2B1;FCHO2;FNBP1L;PIP5K1C;AP2M1;INPP5F
prerank,ruffle organization (GO:0031529),0.6470401232424585,1.4644537039998136,0.07655502392344497,0.4321606890716199,1.0,5/16,10.51%,LIMA1;INPP5K;PLEKHA1;RAC1;CYFIP1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.7101898583702533,1.464421435327947,0.09028960817717206,0.4311618980100244,1.0,2/10,2.34%,KCNE3;CAV1
prerank,regulation of protein neddylation (GO:2000434),0.7195367929510046,1.4643289800485728,0.08032786885245902,0.4302811650437413,1.0,1/10,0.19%,EPAS1
prerank,cellular response to increased oxygen levels (GO:0036295),0.6807368602042617,1.4631297969478336,0.0946843853820598,0.4324999358974171,1.0,3/11,2.34%,FAS;FOXO1;CAV1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.4815569960529283,1.463073963255619,0.02813599062133646,0.43153410964402766,1.0,13/90,8.54%,PRDM16;EPAS1;ADIPOR2;CAV1;ADRB2;YBX2;OMA1;ADIPOR1;CMKLR1;KDM3A;JAK2;GADD45G;APC
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.554179349803018,-1.4622602799524298,0.072,0.5331230776930297,1.0,6/15,7.21%,GPC3;RSPO3;NPHP3;DACT1;DAAM2;SFRP4
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5611804942924977,1.4622033379682113,0.08149171270718232,0.432698880668953,1.0,8/33,5.43%,MMRN2;ACVRL1;NOTCH1;ATP2B4;DLL4;KLF4;CARD10;MEF2C
prerank,negative regulation of cellular process (GO:0048523),0.43750178161052056,1.462104838164505,0.001006036217303823,0.4318388294481601,1.0,95/521,12.61%,NOS1;PTPRJ;CDH13;PODXL;SOX17;NOTCH4;NOS3;IRF6;RAPGEF2;SMAD6;MSX1;BMPR2;SMARCA2;PLXNA4;TBX1;PTPN14;APBB2;FOXO4;ITGA1;RND1;ACVRL1;NOTCH1;JAM2;DYSF;DUSP1;ADARB1;DAB2IP;AQP11;PRKD1;TGFB2;RHOB;HNF4A;BTG2;DLL4;APP;BTG1;PPT1;PLPP1;PPP1R13B;APOA1;PLXND1;PDE3B;KLF4;DDX4;FCGR2B;TMEM109;ADAM15;SERTAD2;ANGPT1;WFDC1;CTTNBP2NL;HYAL2;CD34;TNFRSF1B;GMNC;MYH9;WARS1;GATA3;IL1A;PDCD4;SH3BP4;ARHGDIA;IGFBP7;NPR1;VAMP8;HSPA1B;PDE8A;JAK2;PLSCR1;CEBPA;PTPRU;CD200;APC;NMI;PPP2R5C;KLF11;SERTAD3;RTN4;ADAM10;LPCAT3;CHD5;GNG4;ADAMTS1;ADGRB1;NPM1;VPS35;E2F7;CLU;TMBIM6;NR4A1;TMEM98;NF2;COPS8;TOB1;ITGB1BP1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.5015149909606633,1.4620665608960894,0.0422360248447205,0.43085618827401473,1.0,17/72,11.75%,KANK4;LIMA1;STMN2;HIP1R;ARHGEF2;KANK3;IAPP;CAMSAP2;TTBK2;SHANK3;CLASP1;PFDN6;VBP1;APC;CLASP2;PFDN2;CLU
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.4649550186420508,-1.4618286147351867,0.06810035842293907,0.5298224145394174,1.0,7/27,9.34%,EGFR;DDX5;BMP4;LIMD1;EIF4E2;PUM1;MAP2K2
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.6127090201857026,-1.4615633855080026,0.06367924528301887,0.5262964873336353,1.0,7/11,21.03%,FBH1;TIPIN;LIG3;SMARCAL1;DONSON;ZRANB3;TIMELESS
prerank,negative regulation of MAPK cascade (GO:0043409),0.49799423551049,1.4614483319739466,0.03484320557491289,0.431504528660071,1.0,20/87,14.41%,PTPRJ;PTPRR;CNKSR3;FOXO1;DUSP1;DAB2IP;CAV1;INPP5K;TIMP3;STK38;HYAL2;P2RX7;DUSP3;PTPN1;RANBP9;ITGB1BP1;PIK3CB;PIN1;DUSP26;SPRY4
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.5374945856499508,-1.4612983563873807,0.05181347150259067,0.5227153163502457,1.0,5/17,11.08%,PID1;NUPR1;PPARA;FLCN;HDAC4
prerank,T-helper cell differentiation (GO:0042093),0.6659609068834688,1.461145603105255,0.07603305785123966,0.43127548275478206,1.0,5/14,12.16%,ATP7A;LEF1;FOXP1;HMGB1;TMEM98
prerank,regulation of endothelial cell migration (GO:0010594),0.49224389087655945,1.4608865383994185,0.03540903540903541,0.4308572801732134,1.0,27/85,12.94%,PTPRM;TEK;EDN1;CEACAM1;BMPR2;FLT4;ACVRL1;DAB2IP;PRKD1;RHOB;EMP2;DLL4;ANXA3;ANGPT1;RRAS;GPI;GATA3;ZC3H12A;PTK2;FOXP1;GFUS;RAC1;ADGRB1;PRKD2;ITGB1BP1;PIK3CB;APOH
prerank,regulation of JNK cascade (GO:0046328),0.48286488007065675,1.4608157164804274,0.025142857142857144,0.4299537744014896,1.0,21/101,10.77%,MECOM;PLCB1;MAP4K2;FLT4;NOD2;DAB2IP;F2RL1;APP;TIRAP;FCGR2B;MAP4K4;TRAF1;DUSP3;MFHAS1;GADD45G;TPD52L1;HMGB1;TAOK2;MAP3K11;AIDA;MINK1
prerank,pteridine-containing compound metabolic process (GO:0042558),0.6645986357711708,1.4602294435929635,0.11092715231788079,0.43046734113674,1.0,2/13,3.48%,NOS3;GCH1
prerank,regulation of fatty acid oxidation (GO:0046320),-0.5452234056927594,-1.459669904835016,0.058823529411764705,0.5236907210697184,1.0,3/16,3.96%,PRKAG2;APPL2;PPARA
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.6409420512962505,1.4586562716632656,0.07936507936507936,0.43359202755754844,1.0,2/15,7.35%,ENTPD1;CMPK1
prerank,positive regulation of metabolic process (GO:0009893),0.47376512939641063,1.4586374663507915,0.03214695752009185,0.4325586131222153,1.0,15/103,8.54%,PRDM16;EPAS1;ADIPOR2;FASN;INSR;CAV1;ADRB2;YBX2;OMA1;ADIPOR1;CMKLR1;KDM3A;JAK2;GADD45G;APC
prerank,Rho protein signal transduction (GO:0007266),0.531059059217531,1.457990325017528,0.040455120101137804,0.43316083653929754,1.0,14/53,10.16%,EPS8L2;CDH13;ARHGEF3;RHOB;CDC42EP1;NTN1;SHTN1;PLEKHG5;ARHGDIA;ARHGAP5;ROCK1;TAX1BP3;RIPOR1;ARHGEF1
prerank,protein dephosphorylation (GO:0006470),0.471994426100933,1.4567101416156036,0.027901785714285716,0.43549029602195816,1.0,32/135,15.06%,PTPRM;PTPRJ;PTPRB;PTPRG;PTPRR;PTPN14;DUSP12;DUSP1;PPM1F;PTPRE;CTTNBP2NL;DUSP16;DUSP3;PPP3CA;PTPN12;PTPRU;PTPRO;PP2D1;PPP2R5C;DUSP11;PTPN1;PPP2R2C;RPRD1B;PDP1;EYA3;PPM1D;DUSP22;PPM1L;DUSP26;PPP4R1;PPP2CB;PPP1R15B
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.6614338755549825,1.456314171485387,0.0765625,0.43553890262340267,1.0,1/14,0.10%,ENTPD1
prerank,microglial cell activation (GO:0001774),0.6217301866283851,1.4562456749188502,0.08945686900958466,0.4346420044135553,1.0,7/21,12.80%,IFNGR1;APP;ITGAM;JAK2;TYROBP;CLU;CX3CR1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.5037378554193458,1.4551714144731553,0.03640776699029126,0.4363067493590411,1.0,22/76,17.06%,AIM2;DAB2IP;KLF4;DAP;IRAK2;COMMD7;NFKBIL1;CMKLR1;ZC3H12A;ARRB1;NLRC5;CD200;ACOD1;CACTIN;NFKBIB;NFKBIA;NWD1;HAVCR2;PTGIS;TMSB4X;PYCARD;PYDC1
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.5442357444964421,1.4544950154602159,0.053763440860215055,0.43705778464137734,1.0,7/39,9.67%,MYO1D;MYO1E;TANC2;ACTN4;FNBP1L;MYO1C;PPFIA2
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.48330521056543024,1.4540117351377695,0.039627039627039624,0.4372921950726603,1.0,17/104,9.42%,PRDM16;SMAD6;BMPR2;SMAD7;NOTCH1;DAND5;CAV1;FKBP1A;IL17RD;ACVR1;WFIKKN1;SMAD2;ADAM17;UBE2D1;UBA52;RPS27A;PMEPA1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.5404482568118234,1.4539693993727816,0.06060606060606061,0.4363124595059232,1.0,7/39,7.30%,PTPRJ;ITGA1;DAB2IP;CBL;SH3KBP1;DUSP3;PTPN12
prerank,Notch signaling involved in heart development (GO:0061314),0.6972392040903317,1.4524104783836653,0.08717948717948718,0.43944808994698986,1.0,6/11,7.72%,JAG1;NOTCH1;HEY1;DLL4;HEY2;SNAI2
prerank,Ras protein signal transduction (GO:0007265),0.46678494193901043,1.4510465102578947,0.02,0.4422107066191308,1.0,31/137,10.51%,EPS8L2;CDH13;ARHGEF3;RAPGEF2;ELMO1;RAPGEF1;RASGRP2;PRKD1;RHOB;CDC42EP1;NRAS;KRAS;NTN1;RRAS;SHTN1;RAPGEF6;PLEKHG5;ARHGDIA;SHOC2;PLD1;ARHGAP5;KPNB1;NCKAP1;ROCK1;TAX1BP3;RIPOR1;JUN;RRAS2;ARHGEF1;RAC1;CYFIP1
prerank,modulation by symbiont of entry into host (GO:0052372),0.6510077210364101,1.4509345238358722,0.07309486780715396,0.4413921281769928,1.0,5/16,11.51%,TRIM14;CAV1;TRIM6;TRIM25;HS3ST5
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.5579914788788142,1.4508899341604147,0.062154696132596686,0.4404218372367254,1.0,11/36,12.80%,SGMS1;FAS;NR4A2;DAB2IP;TRAF1;ASAH2;MADD;CRADD;TPD52L1;TMBIM6;CX3CR1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.6512297308454809,1.4491234707392096,0.10130718954248366,0.44409387991713334,1.0,2/14,4.84%,PLCG2;SEMA7A
prerank,negative regulation of T cell differentiation (GO:0045581),-0.6173067141026541,-1.4488447822570063,0.07600950118764846,0.5548606544206804,1.0,2/10,2.14%,GLI3;BMP4
prerank,inositol phosphate catabolic process (GO:0071545),0.680576813804297,1.4481945261946843,0.08653846153846154,0.44569931762957793,1.0,6/12,17.60%,INPP1;INPP5K;INPP5B;OCRL;INPP5J;SYNJ1
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.6152589024946504,1.4462047264437787,0.09267563527653214,0.4501210329627714,1.0,8/19,12.30%,CLDN5;F11R;OCLN;SNAI2;MYO1C;ROCK1;TJP1;CBFB
prerank,aminoglycan catabolic process (GO:0006026),-0.4703788721819524,-1.4458201030956475,0.0707395498392283,0.5603608678983746,1.0,5/28,4.65%,GPC6;SDC2;GPC3;HSPG2;GNS
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.5769384423610452,1.445248349153859,0.08529411764705883,0.45174576643418196,1.0,7/28,9.80%,STMN2;FKBP4;CAMSAP2;PRUNE1;CLASP1;MAPRE3;CLASP2
prerank,regulation of histone modification (GO:0031056),-0.5752617299672571,-1.4451933911063655,0.08461538461538462,0.5580242191732537,1.0,7/13,22.23%,UBE2N;IGF2;FLCN;AKAP8L;NNMT;PARG;MTHFR
prerank,positive regulation of lipid kinase activity (GO:0090218),0.5633179284110719,1.4447079636589202,0.08104196816208394,0.45212470790161946,1.0,6/29,5.44%,TEK;FLT1;PDGFB;NOD2;PRKD1;FGFR3
prerank,metal ion export (GO:0070839),0.5718511607564312,1.4447041284447815,0.06647398843930635,0.4510524848815074,1.0,7/31,4.35%,KCNQ1;KCNE3;ATP2B4;ATP1A4;ATP1A3;ATP1A1;ATP7A
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.5748865993421066,1.4432021025671393,0.07658321060382917,0.45417963376612,1.0,6/27,5.44%,TEK;FLT1;PDGFB;NOD2;PRKD1;FGFR3
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.4092711609490437,-1.4424080333057434,0.036290322580645164,0.5629915994611208,1.0,14/45,17.40%,EGFR;DDX5;BMP4;PIK3R1;LIN28B;MAP2K2;BUD23;NFKB1;RBM20;HNRNPLL;SUPV3L1;NMD3;ZPR1;U2AF2
prerank,atrial septum development (GO:0003283),0.6672980349692766,1.442312708945453,0.10158730158730159,0.4555318400346988,1.0,5/13,3.63%,GJA5;BMPR2;DAND5;TGFB2;HEY2
prerank,regulation of B cell activation (GO:0050864),0.5890012114877738,1.4413696402272902,0.09197080291970802,0.45705171877555123,1.0,8/25,20.84%,NOD2;SH3KBP1;FCGR2B;ZFP36L2;LAPTM5;BANK1;FOXJ1;ZFP36L1
prerank,cell-substrate junction assembly (GO:0007044),0.5657700071912994,1.4411378531983792,0.08192090395480225,0.45661974697589325,1.0,6/33,9.66%,LAMA3;BCR;DST;WHAMM;PLEC;TAOK2
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.4862517378149533,-1.440971786162624,0.08176100628930817,0.5631103824268037,1.0,9/21,13.74%,BMP6;BMPR1A;TGFBR1;DAB2;BMP4;CCN3;SLC2A10;SH2B1;NUP93
prerank,nucleoside phosphate catabolic process (GO:1901292),0.6565869461136487,1.4408952252268052,0.08386075949367089,0.4561826064774985,1.0,2/13,5.91%,ENTPD1;SMPDL3A
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.5905578091486463,-1.4407660112108376,0.06906077348066299,0.5592413798553204,1.0,8/13,11.28%,TGFBR3;BMPR1A;FGFR2;ZFPM2;RBPJ;FGF2;GLI1;TBX2
prerank,regulation of interleukin-8 production (GO:0032677),0.508979662357044,1.4403677174093883,0.05198019801980198,0.45663359410800947,1.0,13/69,9.48%,AFAP1L2;NOD1;NOD2;F2RL1;LGALS9;TIRAP;TLR3;KLF4;HYAL2;ARRB1;HSPA1B;CACTIN;HMGB1
prerank,regulation of calcium ion transport (GO:0051924),0.5196326052367656,1.4390389297613055,0.06615776081424936,0.4592911558219278,1.0,10/54,8.02%,NOS1;CCR1;MYLK;HOMER2;INPP5K;ORAI1;EPB41;STIM2;CASQ1;CRACR2A
prerank,angiogenesis involved in wound healing (GO:0060055),0.6952039964056154,1.438187600608952,0.08585858585858586,0.46046638709772447,1.0,4/11,6.24%,GATA2;ADIPOR2;CD34;MCAM
prerank,protein import into peroxisome membrane (GO:0045046),-0.4796777033517937,-1.4377982573341548,0.06666666666666667,0.5647347422819334,1.0,15/22,36.40%,ABCD3;ATAD1;PEX2;PXMP4;PXMP2;GDAP1;PEX11B;PEX13;PEX3;PEX16;PEX12;SLC25A17;ACBD5;RAB8B;ALDH3A2
prerank,negative regulation of stem cell differentiation (GO:2000737),0.6683745745093101,1.4377705035081785,0.09317803660565724,0.460474940164562,1.0,2/12,1.61%,JAG1;NOTCH1
prerank,regulation of platelet aggregation (GO:0090330),0.6222330256186462,1.4376521968516498,0.10778443113772455,0.4596984853897147,1.0,4/17,3.27%,CEACAM1;F11R;PRKG1;ADAMTS18
prerank,mesoderm formation (GO:0001707),0.6227572690486202,1.43687411966416,0.0888529886914378,0.4608194165720158,1.0,6/17,16.56%,BMPR2;TBXT;SMAD2;TBX20;ITGA3;ITGA8
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.43710766850761035,-1.4355773259200482,0.03515625,0.5682105675596326,1.0,13/40,8.73%,PTN;BMP6;BMPR1A;WNT4;BMP7;ADGRV1;BMP4;OSR1;WNT6;FBN2;KL;CEBPB;PKDCC
prerank,regulation of response to cytokine stimulus (GO:0060759),0.6224556103684046,1.4354271765288475,0.0992,0.4634882386860774,1.0,7/19,12.30%,LIFR;IFIH1;APOA1;KLF4;IRAK2;DHX9;CBFB
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.5459778168817798,1.4351450000606496,0.06896551724137931,0.46314716997525124,1.0,13/41,11.97%,PDGFB;FYN;ACE;NEDD9;EFNA1;FCGR1A;ADAM17;DOCK3;STAP1;FBXW7;PRNP;PTPN1;GRM5
prerank,potassium ion export across plasma membrane (GO:0097623),0.6585870648863236,1.4349197181899958,0.09555189456342669,0.46269221606260924,1.0,2/13,1.44%,KCNQ1;KCNE3
prerank,mitochondrion morphogenesis (GO:0070584),-0.5965539456667055,-1.4348987672919287,0.09761904761904762,0.5663007680008709,1.0,2/11,3.11%,PID1;WASF1
prerank,cellular response to interferon-beta (GO:0035458),0.6495593612039151,1.4348603343136206,0.11908646003262642,0.46180912292956905,1.0,5/14,8.81%,AIM2;TRIM6;STAT1;IRGM;ACOD1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.4933429611231099,1.434196807560494,0.04744069912609238,0.46256738370432754,1.0,27/73,18.87%,GATA2;LMO2;KITLG;TAL1;PSMD13;LMO1;GATA3;PSMD4;TCF3;PSMA5;PSMB10;PSMB8;PSMD14;CBFB;PSMA7;METTL14;PSMA8;PSMC3;PSMB5;PSMC1;PSMC5;PSMC6;PSMB9;PSMA4;PSMD5;PSMD9;PSMB6
prerank,phosphorylation (GO:0016310),0.431973845625876,1.4333639228185577,0.003051881993896236,0.46382997319879116,1.0,88/384,15.71%,BMX;NUAK1;CDK19;ERG;STK10;MAP4K2;PDGFB;FYN;BMPR2;RPS6KA5;CDK17;MERTK;ACVRL1;IP6K3;MAP4K3;INSR;CDK14;SNRK;PRKD1;PRKG1;TGFB2;CDC42BPA;OXSR1;APP;MAP3K6;PKN3;CDC42BPG;ACVR1;BCR;STK24;MAP4K4;CAMK2D;CCNE1;STK38;CSNK1D;PKN1;STK38L;NLK;MEX3B;PGK1;MAPK1;PXK;AKT3;MAST1;LRRK2;ALK;SIK2;LMTK2;JAK2;TLK1;GNPTAB;PRKAA1;STK39;PASK;DGKH;PIM3;NEK7;ROCK1;SGK1;ADAM10;TAOK2;MAP3K11;MARK3;PRKCG;MINK1;LIMK2;NEK11;PRKD2;MARK2;COPS8;MATK;VRK1;PIK3CB;BTK;TTBK1;ATM;ACVR2A;LTK;PPP4R1;MAP3K20;PRKG2;PANK3;AGK;ACVR2B;DGKI;PKN2;PAK2;GK5
prerank,regulation of MAP kinase activity (GO:0043405),0.4821957379640582,1.4332758545408997,0.04518430439952437,0.46294802799280255,1.0,12/92,5.46%,PTPRJ;EDN1;PDGFD;FLT1;PDGFB;PIK3R6;NOD2;DUSP1;DAB2IP;INPP5K;STK38;HYAL2
prerank,negative regulation of DNA metabolic process (GO:0051053),0.5962634563564848,1.432868960256777,0.0659025787965616,0.46304152906748824,1.0,3/24,1.55%,BMPR2;DACH1;ACVRL1
prerank,dicarboxylic acid transport (GO:0006835),-0.4591951140047412,-1.4328132676411445,0.036303630363036306,0.5688314050019119,1.0,8/28,6.13%,SLC1A3;SLC13A3;PDPN;SLC26A7;SLC25A13;GJA1;SLC22A6;SLC19A1
prerank,histone modification (GO:0016570),-0.3503798882595414,-1.4321432066603301,0.009615384615384616,0.5667225197609391,1.0,27/109,15.42%,EYA2;EYA1;PRDM5;TBL1XR1;CREBBP;BAZ1B;EYA4;NSD1;NSD3;UBE2N;EHMT1;PHF20;USP3;RBM14;HDAC4;TAF6L;USP22;HDAC1;HDAC6;PADI2;MSL3;ATXN7L3;KDM4A;SIN3B;SIRT2;MTA2;HLCS
prerank,cardiocyte differentiation (GO:0035051),0.7054505991714879,1.4320390966345078,0.08207705192629816,0.46435477098428757,1.0,2/10,2.53%,GATA6;TGFB2
prerank,ventricular septum development (GO:0003281),0.5380969791996891,1.4319979765876316,0.07015130674002751,0.4633965209054045,1.0,10/37,6.13%,GJA5;BMPR2;SMAD7;NOTCH1;DAND5;HEY1;TGFB2;HEY2;ACVR1;GATA3
prerank,regulation of chromatin binding (GO:0035561),0.6878914960965776,1.4317605732531753,0.08823529411764706,0.4629840101644713,1.0,4/10,15.31%,HMBOX1;BTAF1;DTX3L;KDM4D
prerank,glycogen metabolic process (GO:0005977),-0.484170087771323,-1.4316614174724107,0.0749185667752443,0.5638836862698643,1.0,9/27,12.62%,PRKAG2;PHKB;PYGB;PYGM;PGM1;AGL;PHKA2;GYS1;GYG1
prerank,regulation of epithelial cell differentiation (GO:0030856),0.6125354332038634,1.4315923678300857,0.10737179487179487,0.4623656362081785,1.0,7/17,10.81%,CEACAM1;KLF7;CAV1;MAFF;GATA3;DSPP;APOLD1
prerank,regulation of membrane repolarization (GO:0060306),0.6673256057008172,1.4310585659371458,0.10367892976588629,0.46275187994324674,1.0,2/13,2.34%,KCNQ1;CAV1
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.5938552243914571,1.4307968180966817,0.0915805022156573,0.46243325067206953,1.0,7/22,12.82%,NOD2;F2RL1;APOA1;TRIM6;TNFRSF1B;LAPTM5;BTK
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.46914632714256427,-1.4287620312907041,0.06597222222222222,0.5696502805142398,1.0,12/29,15.72%,ZBTB20;SORBS1;LPGAT1;APOE;PPARA;GPLD1;SLC27A1;CREB1;SREBF1;SLC45A3;MFSD2A;NR1H3
prerank,regulation of interleukin-2 production (GO:0032663),0.5303834897816617,1.4282775452257779,0.07029177718832891,0.46820975019849315,1.0,12/43,17.43%,PLCG2;HOMER2;HDAC7;CD34;IL1A;PRNP;LAPTM5;PRKD2;NAV3;HAVCR2;PDE4D;SPTBN1
prerank,negative regulation of axon extension (GO:0030517),0.5585598727386771,1.427845530844572,0.07625899280575539,0.46833314604908005,1.0,8/30,11.93%,SEMA3G;SEMA3F;SEMA7A;SEMA6D;RTN4;SEMA4G;DIP2B;TRIM46
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.6366340007926786,1.4259194153817931,0.10333863275039745,0.47245678185109985,1.0,1/14,0.26%,KCNN4
prerank,cellular copper ion homeostasis (GO:0006878),0.663408856398789,1.4254834599537243,0.10610932475884244,0.4726338388038803,1.0,6/14,9.94%,ATOX1;APP;ATP7A;SLC31A1;MT2A;PRNP
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.46402849452966244,1.424585741471619,0.03121387283236994,0.4729538389541132,1.0,29/104,19.08%,PLCG2;FYN;RPS6KA5;ICAM2;NRAS;KRAS;PSMD13;PSMD4;PSMA5;PSMB10;TYROBP;PSMB8;TAB2;PSMD14;PSMA7;PSMA8;PSMC3;PSMB5;PSMC1;PSMC5;PAK2;PSMC6;PSMB9;PSMA4;PSMD5;PSMD9;RELA;PSMB6;MALT1
prerank,cellular response to lectin (GO:1990858),0.46402849452966244,1.424585741471619,0.03121387283236994,0.4729538389541132,1.0,29/104,19.08%,PLCG2;FYN;RPS6KA5;ICAM2;NRAS;KRAS;PSMD13;PSMD4;PSMA5;PSMB10;TYROBP;PSMB8;TAB2;PSMD14;PSMA7;PSMA8;PSMC3;PSMB5;PSMC1;PSMC5;PAK2;PSMC6;PSMB9;PSMA4;PSMD5;PSMD9;RELA;PSMB6;MALT1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.47026810547608233,1.424039803473962,0.04262672811059908,0.47334121740857527,1.0,19/101,8.99%,EDN1;PDGFD;RAPGEF2;FLT1;PDGFB;CCNY;PIK3R6;CCND2;NOD2;ATP2B4;CCND3;DAB2IP;ADRB2;ADAM17;LRRK2;IRGM;MAPRE3;SYAP1;TPD52L1
prerank,protein phosphorylation (GO:0006468),0.42869114569819855,1.4239037161873511,0.003033367037411527,0.4727022642155484,1.0,96/478,12.89%,BMX;NUAK1;CDK19;TEK;ERG;FLT1;STK10;MAP4K2;PDGFB;FYN;BMPR2;FLT4;RPS6KA5;SMAD7;CDK17;MERTK;ACVRL1;IP6K3;MAP4K3;INSR;SBK1;CDK14;DAB2IP;SNRK;PRKD1;PRKG1;TGFB2;MAST4;CDC42BPA;OXSR1;APP;MAP3K6;FES;PKN3;TLR3;CDC42BPG;ACVR1;BCR;STK24;SLK;MAP4K4;CAMK2D;CCNE1;STK38;CSNK1D;PKN1;STK38L;SMAD2;NLK;FGFR3;TTBK2;MEX3B;MAPK1;PXK;AKT3;UHMK1;EEF2K;MAST1;LRRK2;ALK;SIK2;LMTK2;JAK2;TLK1;PRKAA1;STK39;PASK;PIM3;CAD;NEK7;ROCK1;PTK2;SGK1;CSNK1G3;ADAM10;TAOK2;MAP3K11;MARK3;PRKCG;RPS6KA1;MINK1;LIMK2;MAP3K3;TNKS;GTF2H3;NEK11;PRKD2;MARK2;COPS8;MATK;VRK1;RPS6KB1;RPS6KA3;BTK;STK33;TTBK1
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.5998461308821993,1.4232080873787467,0.08227848101265822,0.47352083072989726,1.0,6/22,7.14%,GATA2;RASSF10;DLL4;TAFA1;LRRK2;SLC16A2
prerank,cellular response to exogenous dsRNA (GO:0071360),0.6706603801525669,1.4226055539411693,0.1054421768707483,0.47415377372151685,1.0,3/12,9.69%,CAV1;IFIH1;DHX9
prerank,renal water homeostasis (GO:0003091),-0.4812560446806525,-1.4222769736707264,0.07210031347962383,0.5864665219013612,1.0,10/23,15.27%,ADCY5;ADCY9;ADCY1;ADCY2;ADCY7;PRKACA;PRKAR2A;PRKAR2B;PRKAR1A;WFS1
prerank,activation of phospholipase C activity (GO:0007202),-0.44770175457237,-1.4216349789060905,0.06734006734006734,0.5843540873631738,1.0,5/29,5.38%,ARHGAP6;EGFR;LPAR1;EDNRA;NTRK2
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.6789473007907355,1.4213330130514297,0.11663807890222985,0.4766693225778196,1.0,2/11,3.48%,NOS3;GCH1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.3567024079576241,-1.4211159447990014,0.013422818791946308,0.5819354777028244,1.0,26/95,11.82%,GPC6;UST;DSE;SDC2;DCN;OGN;GPC3;HSPG2;CEMIP;HS3ST3A1;FMOD;B3GNT2;CHST15;PXYLP1;XYLT1;BGN;PRELP;ST3GAL4;HEXA;B4GALT1;VCAN;B3GAT3;HYAL1;HS2ST1;CHPF2;CSPG4
prerank,JNK cascade (GO:0007254),0.5441023585909207,1.419860304272376,0.08309859154929577,0.47952719762847534,1.0,10/40,11.05%,MAP4K2;NOD1;NOD2;MAP4K3;IRAK2;UBA52;RPS27A;MAP3K11;MINK1;TAB2
prerank,vasculature development (GO:0001944),0.6326700686713466,1.4192942034549174,0.11538461538461539,0.48002889697709766,1.0,5/16,3.31%,NOTCH4;BMPR2;FLT4;ACVRL1;SOX18
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.4630632310397567,1.4191487187232732,0.03143189755529686,0.47937253593786666,1.0,29/105,19.08%,PLCG2;FYN;RPS6KA5;ICAM2;NRAS;KRAS;PSMD13;PSMD4;PSMA5;PSMB10;TYROBP;PSMB8;TAB2;PSMD14;PSMA7;PSMA8;PSMC3;PSMB5;PSMC1;PSMC5;PAK2;PSMC6;PSMB9;PSMA4;PSMD5;PSMD9;RELA;PSMB6;MALT1
prerank,mesenchymal cell development (GO:0014031),0.6178011927023302,1.4190585745634832,0.09486780715396578,0.47855683327963594,1.0,9/18,21.06%,NOTCH1;HEY2;SNAI2;CDH2;CYP26C1;TBX20;TCOF1;SOX11;NOLC1
prerank,calcium ion homeostasis (GO:0055074),0.4711156045568212,1.419047707417289,0.03832752613240418,0.47754070565082923,1.0,12/95,7.11%,ATP2A3;EDN1;TRPV4;CCR1;ATP2B4;ATP2B2;CAV1;SLC8A1;ATP2C1;STIM2;ATP13A3;SLC30A1
prerank,cAMP biosynthetic process (GO:0006171),-0.6222432753155146,-1.418938714777278,0.08684863523573201,0.5847910943528212,1.0,5/10,7.11%,ADCY5;ADCY9;ADCY1;ADCY2;ADCY7
prerank,ceramide catabolic process (GO:0046514),0.6558223759297559,1.4186744240874534,0.1130298273155416,0.47749808731746207,1.0,2/14,6.04%,ACER2;ASAH2
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.6272717992435278,1.4184512241953684,0.11214953271028037,0.4770207430972427,1.0,2/15,6.10%,PLCG2;CUL3
prerank,secretion (GO:0046903),0.64185150112168,1.4183051804618567,0.10793650793650794,0.4763912731245573,1.0,3/14,6.97%,FBLN5;TPD52;NPR1
prerank,miRNA mediated inhibition of translation (GO:0035278),0.6665335849816802,1.41690651329622,0.11409395973154363,0.47829672076860075,1.0,2/11,2.64%,NOTCH4;TNRC6C
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.6665335849816802,1.41690651329622,0.11409395973154363,0.47829672076860075,1.0,2/11,2.64%,NOTCH4;TNRC6C
prerank,chordate embryonic development (GO:0043009),-0.39084102800553633,-1.4164409736434285,0.02880658436213992,0.5887795398254967,1.0,18/55,10.12%,ALDH1A2;COL1A1;FGFR2;SULF1;ARNT2;TGFBR1;BMP5;BMP7;SULF2;WNT5A;RBP4;ZNF568;XYLT1;DACT1;IGF2;FLCN;VEGFA;PTCH1
prerank,response to peptide hormone (GO:0043434),-0.416422602184031,-1.416029701041403,0.032846715328467155,0.5857492683929053,1.0,9/43,8.24%,TGFBR3;OGT;ROCK2;IGFBP5;GNAI1;ANXA1;SRC;IRS1;SLC27A1
prerank,inositol lipid-mediated signaling (GO:0048017),-0.40853518705032005,-1.4160211794793793,0.03669724770642202,0.5815770864625429,1.0,16/50,10.24%,IGF1;PLCE1;OGT;PDGFRB;PDGFRA;PLCL1;ADAP2;PITPNM2;NGF;IRS2;PLCB3;IRS1;PIK3R1;PI4KB;TNFAIP8L3;PI4KA
prerank,"phagocytosis, engulfment (GO:0006911)",0.5346513227047245,1.4157822885991607,0.0875,0.48035617466864344,1.0,13/36,14.01%,ELMO1;GULP1;FCGR2B;MYH9;FCGR1A;ITGAM;ARHGAP25;XKR6;VAMP7;RAC1;ADGRB1;DOCK1;RHOH
prerank,ceramide transport (GO:0035627),0.6549718467245327,1.4151196805208137,0.10526315789473684,0.4812296384306991,1.0,4/12,8.38%,PLTP;ABCB4;GLTP;CERT1
prerank,negative regulation of cell activation (GO:0050866),0.6269371552080353,1.414676618624383,0.10321489001692047,0.48141943903717793,1.0,4/14,8.61%,NOS3;PDGFB;CD200;NR1D1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.45173157311011275,1.4145151400993516,0.030735455543358946,0.48086256792556786,1.0,25/138,9.16%,TEK;PTPRG;FLT1;TIE1;NPR2;FYN;BMPR2;FLT4;MPZL1;MERTK;LIFR;RAPGEF1;INSR;TRIO;FES;NEDD9;FGFR3;NPR1;ALK;LMTK2;JAK2;PTPRU;YES1;PTK2;STAP1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.5928066008042466,1.41425729023981,0.10260336906584992,0.4805966723127058,1.0,4/20,5.24%,FASN;FAR2;PPT1;FAR1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.4714707710003782,1.414209432004065,0.04186046511627907,0.4796758520175982,1.0,20/93,10.77%,PLCB1;MAP4K2;FLT4;NOD2;DAB2IP;ARL6IP5;F2RL1;TGFB2;APP;TIRAP;FCGR2B;TRAF1;ZC3H12A;MFHAS1;GADD45G;TPD52L1;HMGB1;TAOK2;MAP3K11;MINK1
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.5378808854122907,-1.4129478288947177,0.09340659340659341,0.5876147771149312,1.0,7/15,23.43%,PPARA;OSBPL8;PPARG;OSBPL11;LPL;PLIN3;FITM2
prerank,cell-cell junction assembly (GO:0007043),0.4999710475801011,1.4125526181127954,0.0690505548705302,0.4830736788862792,1.0,19/63,16.01%,GJA5;TRPV4;CLDN5;SMAD7;GJB1;GJA4;PIP5K1C;CTNNA1;WDR1;ACTG1;CDH12;TJP1;CDH2;ACTB;CTNNB1;CD9;PKN2;PAK2;CDH22
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.4589214943014854,1.4119458314205808,0.04,0.4837879138532821,1.0,15/113,5.36%,VEGFC;CDH13;TEK;PDGFB;BMPR2;FLT4;TBX1;EGFL7;EGR3;NOD2;PRKD1;VEGFD;NRAS;VASH2;PPP1R16B
prerank,positive regulation of filopodium assembly (GO:0051491),-0.4737695294580747,-1.4117268364554845,0.05555555555555555,0.5875927290310695,1.0,7/24,8.39%,DPYSL3;DOCK11;RHOQ;ARAP1;RIPOR2;PIK3R1;BCAS3
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.45111964072588695,1.4116865221025507,0.030434782608695653,0.4834728854933952,1.0,29/159,11.08%,PTPRM;PECAM1;CDH13;CLDN5;CEACAM1;VCAM1;CRTAM;MPZ;TGFB2;CADM1;ATP2C1;ACVR1;MILR1;AMIGO2;ROBO4;BSG;ITGAM;TENM3;FLRT3;CDH3;CDH15;LRRC4C;NECTIN4;NECTIN1;CDH12;TENM4;FAT4;KIRREL3;CDH2
prerank,regulation of vesicle-mediated transport (GO:0060627),0.4766164961271577,1.4115473267137808,0.05562130177514793,0.4829101552557755,1.0,29/91,19.16%,CDH13;HIP1;HIP1R;RAB11A;FES;PACSIN2;SYT7;PACSIN1;MAPK1;LRRK2;PLD1;STON1;PTPN1;INPP5F;CHMP3;NSF;ZFYVE16;OPHN1;RNF139;CPLX1;RUFY1;RIT2;STXBP5;STXBP5L;SCARB1;SYT1;HAP1;MAP2K1;RAB5C
prerank,muscle organ development (GO:0007517),-0.39556381294692206,-1.410104213230519,0.037209302325581395,0.5892502533355315,1.0,16/54,9.57%,LAMA2;IGF1;DMD;CHD2;COL6A3;LARGE1;VAMP5;MRAS;ITGA11;FHL1;SGCD;SPEG;EVC;POU6F1;SMTN;SGCE
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.5944514562511949,-1.4098143923212945,0.09319899244332494,0.5859701601059067,1.0,4/11,4.26%,DAB2;NKD1;RSPO3;PLEKHA4
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.5338071756132444,1.4096082482291612,0.0937062937062937,0.48716576147111273,1.0,7/34,5.44%,TEK;FLT1;PDGFB;NOD2;DAB2IP;PRKD1;FGFR3
prerank,endoderm formation (GO:0001706),0.5463231423084502,1.4090205757263519,0.08786610878661087,0.48779265051444953,1.0,3/35,2.05%,LAMA3;SOX17;DUSP1
prerank,positive regulation of potassium ion transport (GO:0043268),0.5336696231800324,1.4086888317685993,0.08174386920980926,0.48761690903352717,1.0,4/38,3.51%,KCNN4;KCNQ1;KCNN3;NOS1AP
prerank,morphogenesis of an epithelium (GO:0002009),0.5586022859757381,1.4084753619322412,0.0927536231884058,0.48713109713722097,1.0,5/25,12.22%,LAMA3;LAMA5;ACTG1;ACTB;SOX10
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.6820988614930621,1.4078971373258469,0.11336717428087986,0.4877180019552358,1.0,3/10,3.27%,CEACAM1;PRKG1;ADAMTS18
prerank,positive regulation of hormone secretion (GO:0046887),0.6215891703381998,1.407794161844844,0.12164296998420221,0.48695630168868637,1.0,3/17,9.05%,EDN1;VAMP8;VAMP7
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.3969658351962512,-1.4077805978895641,0.04149377593360996,0.5887333531765021,1.0,18/52,21.70%,SHC1;LMNA;DNAJC3;SSR1;ARFGAP1;SEC31A;TSPYL2;SRPRB;EXTL2;VAPB;GFPT1;FKBP14;WFS1;TLN1;PDIA6;ADD1;ACADVL;PREB
prerank,pyroptosis (GO:0070269),0.6314254468002619,1.4077465199769208,0.10236220472440945,0.48607085212189344,1.0,4/15,9.69%,AIM2;CASP8;CASP1;DHX9
prerank,renal absorption (GO:0070293),0.6695376935089183,1.4077142021749576,0.13448275862068965,0.485140536919509,1.0,5/10,9.26%,KCNQ1;HNF1A;KLHL3;HYAL2;SGK1
prerank,mesonephros development (GO:0001823),-0.5838784997945055,-1.407400792900531,0.0916030534351145,0.5860301851715215,1.0,4/11,2.39%,BMP7;BMP4;OSR1;FGF1
prerank,dendrite morphogenesis (GO:0048813),-0.428661090211107,-1.407198080161822,0.08391608391608392,0.5826337297328426,1.0,8/35,6.64%,PTN;SDC2;DCDC2;FARP1;PHACTR1;DOCK10;DLG4;CTNND2
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.5057577164505764,-1.407089366715045,0.08408408408408409,0.5790329094670748,1.0,10/19,20.21%,RENBP;GFPT1;NAGK;GFPT2;PGM3;AMDHD2;PMM1;UAP1L1;NANS;GNPNAT1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.5928432572884431,1.4067152427957623,0.08727810650887574,0.48684535625268305,1.0,9/21,9.01%,EFNA5;LIMCH1;MACF1;SLK;CLASP1;DUSP3;ACTG1;ROCK1;PTK2
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5574600345418388,1.4057225991559446,0.09335219236209336,0.4885157713873949,1.0,6/30,8.13%,NOS3;FAS;ARHGEF2;CASP8;TNFSF10;BCL2L1
prerank,response to exogenous dsRNA (GO:0043330),0.6241021778688862,1.4049759795339956,0.0985691573926868,0.48949323186594523,1.0,4/18,9.69%,CAV1;IFIH1;TLR3;DHX9
prerank,regulation of phagocytosis (GO:0050764),0.4965846914202285,1.4049251831880758,0.08781127129750983,0.48864518615951724,1.0,16/53,18.49%,GATA2;MERTK;DYSF;APOA1;SYT7;FCGR2B;CD47;PLSCR1;CYBA;DOCK2;TUB;ABCA7;RACK1;PYCARD;SCARB1;RAB27A
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.4835155061305195,-1.404411814509755,0.07507507507507508,0.5837986483627,1.0,6/23,10.12%,GLI3;GPC3;TULP3;ENPP1;MEGF8;PTCH1
prerank,phospholipid translocation (GO:0045332),0.557240679031773,1.4041749932309573,0.10112359550561797,0.4897457977752699,1.0,10/28,15.36%,ATP10A;PLSCR4;ANO6;ABCB4;P2RX7;PLSCR1;ATP11C;ATP8B1;ABCC1;ABCA7
prerank,regulation of oxidoreductase activity (GO:0051341),0.6418311099519902,1.4041492437694527,0.12227805695142378,0.48880689618199236,1.0,3/13,6.43%,NOD2;ATP7A;SIRT4
prerank,nerve growth factor signaling pathway (GO:0038180),0.681033511591179,1.4037854634548572,0.11713286713286714,0.4887520048072011,1.0,2/10,1.81%,RAPGEF2;RAPGEF1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.5727198362999681,1.40368987662101,0.1037037037037037,0.48798925893892237,1.0,6/23,8.14%,IFNGR1;ARG1;STAT1;IRGM;JAK2;NLRC5
prerank,cell-cell junction organization (GO:0045216),0.47866809557436796,1.4032750973111583,0.06641604010025062,0.48813934295962674,1.0,18/79,9.87%,CDH13;TRPV4;CLDN5;OCLN;F2RL1;TGFB2;CADM1;LIMS2;GJA4;CTNNA1;TJP2;CDH3;CDH15;NECTIN4;DSP;NECTIN1;CDH12;TJP1
prerank,activation of adenylate cyclase activity (GO:0007190),-0.44044756199818125,-1.4028963494604019,0.039568345323741004,0.5849613872290076,1.0,8/35,9.87%,LGR4;ADCY5;ADCY9;ADCY1;EDNRA;ADCY2;ADCY7;RAF1
prerank,epithelial cell differentiation (GO:0030855),0.47423120825248516,1.4027961017545638,0.06286379511059371,0.48844391468675136,1.0,12/88,6.22%,JAG1;GATA6;IRF6;TBX1;RHCG;DEUP1;GSTA2;TST;TAGLN2;GATA3;PCK2;PGK1
prerank,regulation of synapse maturation (GO:0090128),0.6832306338747292,1.402459160375579,0.10873146622734761,0.48834480633578803,1.0,2/10,2.22%,ARHGEF15;DAB2IP
prerank,positive regulation of cell death (GO:0010942),0.4944760238764987,1.4021698696569178,0.07904642409033877,0.4881163462278828,1.0,17/59,15.09%,SLC6A6;ACER2;FYN;FCGR2B;LRRK2;ZC3H12A;ITGAM;CIDEB;GRIN2B;APC;EGR1;PRNP;TYROBP;CLU;BNIP3;EIF2S1;SARM1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.540624386569895,1.401822916926059,0.07464788732394366,0.48807585613045024,1.0,4/36,2.47%,MECOM;FOXO1;DUSP1;F2RL1
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.6751471585396952,1.4011547040207242,0.12478632478632479,0.48882731591617307,1.0,3/10,9.94%,CRTAM;LGALS9;PRNP
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.6881204301393957,1.399420807001658,0.11872909698996656,0.49247854856357154,1.0,3/10,8.71%,NOD2;JAK2;NAMPT
prerank,small GTPase mediated signal transduction (GO:0007264),0.46109243697970737,1.3991849328820056,0.05098493626882966,0.4921475762940664,1.0,29/103,14.56%,CCDC88C;RAPGEF2;ARHGAP31;RASGRP2;ABR;RAPGEF5;PRKD1;NUCB2;NRAS;KRAS;BCR;NTN1;RRAS;SHTN1;RAPGEF6;SHOC2;TIAM2;PLD1;SIAH2;JUN;RRAS2;RHEBL1;RAC1;CCDC88A;RGS19;KSR2;RRAD;SOS1;RHEB
prerank,cGMP biosynthetic process (GO:0006182),0.6698974066795403,1.3990616433096812,0.11320754716981132,0.49149375444480675,1.0,3/10,11.54%,NPR2;NPR1;NPPC
prerank,cellular response to osmotic stress (GO:0071470),0.5856320155163895,1.3986298711830674,0.11278195488721804,0.4917704194235736,1.0,4/21,2.83%,TRPV4;MYLK;ARHGEF2;OXSR1
prerank,innate immune response (GO:0045087),0.4338611065958535,1.3982303613874045,0.01597444089456869,0.49190788756729564,1.0,53/217,20.99%,PLCG2;FYN;TRIM14;NOD2;B2M;IFIH1;APP;FES;GCH1;TLR3;DEFA6;ADAM15;TRIM11;TRIM6;IRGM;MFHAS1;SERINC3;NLRC5;YES1;PTK2;ADAR;HMGB1;TRIM25;TYROBP;TRIM17;CYBA;SERINC5;TRIM8;CFB;CHGA;IRF5;AKAP1;CX3CR1;BTK;CR2;RNASE6;NCF2;SLPI;SRPK1;PYDC1;SLA;CXCL10;IFITM3;RELA;MALT1;ANG;AGER;SETD2;DHX58;ANKRD17;CAPZA2;RPL39;MID2
prerank,regulation of cellular senescence (GO:2000772),0.5575330499093742,1.3982293115209998,0.10263929618768329,0.49092812507985106,1.0,6/28,10.98%,NUAK1;B2M;ING2;AKT3;RBL1;MAP3K3
prerank,embryonic organ morphogenesis (GO:0048562),-0.41271053319101225,-1.3982022167126953,0.0449438202247191,0.5965644626408448,1.0,15/42,7.03%,EFEMP1;FGFR2;HOXC4;PDGFRA;MFAP5;HOXA3;HOXB3;RBP4;FBN2;FBN1;NIPBL;HOXB4;RBPMS2;MEGF8;SIX1
prerank,sterol transport (GO:0015918),0.6072041756339341,1.3977859041261667,0.09701492537313433,0.49124066915848535,1.0,3/19,5.31%,CAV1;APOA1;LCAT
prerank,calcium ion import across plasma membrane (GO:0098703),0.6187499581949706,1.3974737722543542,0.11831442463533225,0.49110788273690725,1.0,3/14,3.80%,TRPV4;ATP2B4;SLC8A1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.5365550331821205,-1.3972317096676405,0.09641873278236915,0.595682179747721,1.0,6/15,29.76%,GLI3;CD55;PNP;SYK;NKAP;CCR2
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.6049079392102105,-1.3971149230775424,0.11241217798594848,0.5921394711356527,1.0,3/10,15.22%,OGT;ZNF692;PDK2
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.5587441522098482,1.3970850670374757,0.11412268188302425,0.49116297804820275,1.0,7/29,9.92%,SMAD7;DAB2IP;IL17RD;EFNA1;GATA3;ADIPOR1;MAD2L2
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.5386124574079298,1.3965584231921664,0.09809264305177112,0.4916581672293479,1.0,5/35,6.10%,HEG1;RASIP1;DAB2IP;TGFB2;CUL3
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5738365350864293,1.3956807695480047,0.10164424514200299,0.49298211858386237,1.0,7/23,9.94%,NOS1;FYN;DIAPH1;NOS1AP;CAMK2D;CASQ1;PRNP
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.3739207644875587,-1.3946057326774264,0.027777777777777776,0.5966954805797339,1.0,10/61,6.62%,EYA2;EGFR;EYA1;PDGFRB;EYA4;FGF2;UBE2N;MECP2;RAD50;USP9X
prerank,regulation of coagulation (GO:0050818),0.6743095443286492,1.394261948743276,0.10887772194304858,0.49596901313745007,1.0,4/11,11.51%,CAV1;F2RL1;PROC;HS3ST5
prerank,calcium-ion regulated exocytosis (GO:0017156),0.5543239092764659,1.394261765561712,0.10404624277456648,0.4949907705079876,1.0,8/27,18.16%,SYT15;DOC2B;SYT7;VAMP7;RIMS3;SDF4;SYT2;SYT1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.5376834380086114,1.3940634704010728,0.10320781032078104,0.49457290839355594,1.0,11/38,11.97%,PDGFB;ACE;CAV1;APP;NEDD9;EFNA1;HYAL2;FCGR1A;PRNP;PTPN1;GRM5
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.4804491327137199,-1.3939966828035384,0.08579881656804733,0.594891675991409,1.0,5/22,3.83%,NOTCH2;FGFR2;CASK;PTPRK;STXBP4
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.601210481179403,1.393898422976898,0.09302325581395349,0.49400936828691216,1.0,9/18,21.81%,RNF103;RNF185;UBA52;RPS27A;UGGT1;RNF139;SEL1L;RNF5;UBB
prerank,regulation of protein phosphorylation (GO:0001932),0.4256130438433644,1.3933536894580687,0.014767932489451477,0.4945090458014973,1.0,45/256,11.21%,VEGFC;PECAM1;TEK;CCDC88C;ENG;EFNA5;FYN;FLT4;FAS;TBX1;LIMCH1;CCND2;OCLN;CCND3;INSR;DAB2IP;APP;INPP5K;VEGFD;KRAS;ANGPT1;WWTR1;EFNA1;CSNK1D;BRAT1;WARS1;ADAM17;LRRK2;IRGM;ZC3H12A;ARRB1;HSPB1;PDE8A;PRR5L;THPO;NDUFS4;PPP2R5C;PTK2;CACTIN;PRNP;RAC1;CCDC88A;FGF20;LIMK2;NPM1
prerank,endothelial cell proliferation (GO:0001935),0.6097319632799676,1.393262755701517,0.10110584518167456,0.4938308382768067,1.0,4/17,5.66%,TEK;BMPR2;ACVRL1;CD34
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.5711590908883015,-1.3932412620854329,0.10824742268041238,0.5936302068881173,1.0,5/12,15.72%,ABCA1;ITGAV;PPARA;PPARG;NR1H3
prerank,atrial septum morphogenesis (GO:0060413),0.6783775383081593,1.3929559644228187,0.13,0.49368964898282613,1.0,4/10,4.00%,BMPR2;TGFB2;HEY2;ACVR1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.6814881602923745,1.3928355053673405,0.13590604026845637,0.49306308968037327,1.0,2/10,2.63%,RAPGEF2;LGALS9
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.4714226383913501,-1.392040142217706,0.0749185667752443,0.5935282227875898,1.0,11/24,22.81%,PID1;LEPR;SLC25A13;COQ10A;COX10;GFPT1;GFPT2;ACADVL;LYRM7;MTLN;CYCS
prerank,regulation of hormone secretion (GO:0046883),0.6402596131850865,1.3917161553530175,0.12096774193548387,0.495159560283856,1.0,2/15,4.37%,EDN1;SCG5
prerank,cellular component maintenance (GO:0043954),0.6374738196400068,1.3914750384916763,0.10743801652892562,0.49481198140916705,1.0,4/12,13.79%,FYN;INSR;PRNP;ITGA3
prerank,copper ion homeostasis (GO:0055070),0.6253593209939381,1.3912124536147545,0.10634920634920635,0.49459339688081877,1.0,6/17,9.94%,ATOX1;APP;ATP7A;SLC31A1;MT2A;PRNP
prerank,positive regulation of cell projection organization (GO:0031346),-0.34846323402096124,-1.3911185194993143,0.007692307692307693,0.5929397858032782,1.0,24/115,6.23%,ROBO1;PTN;NTRK3;DPYSL3;ROR1;CAMK1D;EPHA3;PLXNA2;CUX1;PTK7;SLIT2;GRIP1;NDNF;WNT5A;MAGI2;APOE;DLG4;OBSL1;CBFA2T2;NTRK2;PLXNB2;CAMK1;NGF;ROR2
prerank,regulation of secretion (GO:0051046),0.6465049616705737,1.3906975271535817,0.12755102040816327,0.4950420592048992,1.0,3/13,9.26%,KCNQ1;OAS2;SGK1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.6012695016358043,1.3905462207358903,0.12314540059347182,0.4944737110995894,1.0,6/18,6.71%,GATA2;JCAD;PIK3C2A;HDAC9;HDAC7;AKT3
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.5695205273153003,1.3900180505674717,0.12223858615611193,0.4949638289986756,1.0,7/24,11.05%,NOD1;NOD2;CASP8;IRAK2;UBA52;RPS27A;TAB2
prerank,endocrine system development (GO:0035270),-0.4910299132097651,-1.3895380741143786,0.08227848101265822,0.5942729174122627,1.0,11/21,20.84%,GLI2;WNT4;TGFBR1;DKK3;SIX1;STRA6;SALL1;MDK;FOXE1;SOX2;NF1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.5233810000796826,1.3895026075146504,0.09444444444444444,0.4953974983407847,1.0,4/33,1.91%,PLCG2;PLCB1;CCND2;CCND3
prerank,negative regulation of protein kinase activity (GO:0006469),0.4632328962256343,1.3888464797542495,0.05355064027939464,0.49611346645832644,1.0,27/88,17.06%,PTPRB;CEACAM1;GNAQ;ADARB1;DAB2IP;CAV1;INPP5K;SLC8A1;PPM1F;WWTR1;HYAL2;WARS1;SMCR8;DUSP3;HSPB1;PTPRO;ADAR;PTPN1;NPM1;ITGB1BP1;LRP5;DUSP26;SH3BP5L;PAK2;PYCARD;TRIB3;PYDC1
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.6089525151112495,1.3885547352194842,0.13213703099510604,0.4959531380215409,1.0,4/16,10.15%,ST6GALNAC3;ST8SIA6;A4GALT;B4GALT6
prerank,phagosome-lysosome fusion (GO:0090385),0.670124291774924,1.3885245237932877,0.1281198003327787,0.4951056037996448,1.0,3/10,4.77%,SYT7;RAB39A;RAB34
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.5308381410107617,-1.3881340725885474,0.08174386920980926,0.5954246768605906,1.0,4/16,5.41%,PTN;SOX5;NUDT21;HOXB4
prerank,histone H3-K4 trimethylation (GO:0080182),-0.5941325357540673,-1.388093344943039,0.1015625,0.5918607887571767,1.0,5/11,10.75%,OGT;SETD1A;SETD1B;TET2;CTR9
prerank,regulation of small molecule metabolic process (GO:0062012),-0.4493444131790167,-1.3875496833162009,0.059375,0.5898644054318102,1.0,11/28,20.24%,PDK1;APOE;PPARA;PRKN;RORA;EPHX2;PDK3;FOXK2;PDK2;ACADVL;PANK2
prerank,response to estrogen (GO:0043627),0.5446339831936373,1.3875237653462555,0.09691011235955056,0.49696478544815836,1.0,13/31,19.13%,CAV1;PELP1;GATA3;TRIM24;NCOA4;ARID5A;TRIM25;SFR1;BRCA1;ESR1;RARA;CD24;WBP2
prerank,epidermal cell differentiation (GO:0009913),0.5274535840202936,1.3874199162074856,0.09187749667110519,0.4963134968170991,1.0,4/41,4.02%,JAG1;GATA6;CLIC4;BCR
prerank,neural tube development (GO:0021915),-0.5303075476728679,-1.3872790782131992,0.10512129380053908,0.5870489926925303,1.0,4/15,11.56%,ALDH1A2;DACT1;PTCH1;PKD1
prerank,regulation of phospholipase activity (GO:0010517),-0.6066090860480169,-1.3869811793442597,0.11246943765281174,0.5844346355717602,1.0,2/10,1.02%,LRP1;FGFR2
prerank,calcium ion import into cytosol (GO:1902656),0.6106501789072891,1.3859272145680004,0.12295081967213115,0.4995850459988605,1.0,3/15,3.80%,TRPV4;ATP2B4;SLC8A1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5772236806409536,1.3855530629849464,0.11861861861861862,0.4996138552789927,1.0,5/21,3.83%,CNKSR3;SMAD7;CAV1;INPP5K;PPM1F
prerank,negative regulation of endothelial cell migration (GO:0010596),0.5325036021133952,1.3847896635761416,0.1093969144460028,0.500767189233411,1.0,7/36,5.43%,PTPRM;ACVRL1;NOTCH1;ATP2B4;DAB2IP;DLL4;MEF2C
prerank,regulation of programmed cell death (GO:0043067),0.43395153436692424,1.3844175807452337,0.042505592841163314,0.5009047563768891,1.0,44/161,19.18%,MECOM;ACER2;HIP1;FAS;ACTN4;PPP1R13B;GLS2;SLK;CASP2;OMA1;TNFRSF25;AMIGO2;APEX1;TOX3;TRIM24;MADD;STAT1;LRRK2;FANK1;CRADD;ALK;CIDEB;JAK2;DCPS;SGK1;RTN4;CASP1;CLU;NF2;ATM;BNIP3L;BNIP3;ANP32B;PSMC5;TM7SF3;DFFA;DAXX;LRP8;CXCL10;FBXO10;MAGED1;BID;MALT1;PLSCR3
prerank,positive regulation of telomerase activity (GO:0051973),0.5358249597335746,1.3840105730001484,0.10659186535764376,0.5010762191058729,1.0,18/33,27.06%,HMBOX1;KLF4;MAPK1;NVL;NEK7;DKC1;PTGES3;TNKS;CCT2;CCT4;CTNNB1;MAPKAPK5;PARM1;TCP1;GREM1;WRAP53;HSP90AA1;MAP3K4
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.6269016709047158,1.3839375707008148,0.14992025518341306,0.5003234054959743,1.0,2/14,2.34%,NOTCH4;CAV1
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.6044766163096669,-1.3838517005483868,0.11848341232227488,0.5908716584064247,1.0,7/10,36.59%,PLA2G4A;PLA2G15;PLA2G6;ENPP2;PLA2G7;LIPC;PLA2G5
prerank,regulation of transferase activity (GO:0051338),0.6095284914955501,1.3831710870530758,0.11916264090177134,0.5015048288346318,1.0,5/17,8.14%,LDB2;EMP2;HMBOX1;JMJD8;NLRC5
prerank,neural crest cell migration (GO:0001755),0.5393727072842502,1.3828075525795605,0.09457579972183588,0.5015715376340479,1.0,4/36,4.84%,SEMA3G;TBX1;SEMA3F;SEMA7A
prerank,nuclear migration (GO:0007097),-0.5440744304422167,-1.382740392070021,0.09943181818181818,0.5907155840951654,1.0,4/13,8.34%,DOCK7;SYNE2;CLMN;SYNE3
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5694827071368335,1.3818300780444688,0.10895522388059702,0.5033268664586019,1.0,9/24,13.59%,MMRN2;DAB2IP;HHEX;TMEM204;EPN2;PTPN1;PRKD2;HIF1A;ITGA5
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.6117418688677526,1.381744797643448,0.13761467889908258,0.5026966943629587,1.0,1/16,0.66%,CLDN5
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.5129391324701611,1.381593985881511,0.09126984126984126,0.5021426041687497,1.0,4/46,0.89%,ELN;CDH13;EDN1;PDGFB
prerank,negative regulation of JNK cascade (GO:0046329),0.5328689635754592,1.381555815891972,0.12146892655367232,0.5013169618360421,1.0,5/31,10.01%,MECOM;F2RL1;PDCD4;DUSP3;AIDA
prerank,positive regulation of bone mineralization (GO:0030501),-0.4241871710022639,-1.381414163655269,0.0576271186440678,0.5913905761112516,1.0,10/35,5.83%,PTN;BMP6;BMPR1A;WNT4;BMP7;ADGRV1;BMP4;OSR1;FBN2;KL
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.47809566957332056,-1.3811625304179567,0.1023391812865497,0.5886329053059877,1.0,9/21,21.45%,SMO;DCDC2;ARMC9;EVC;GLI1;KIF7;GAS8;ULK3;STK36
prerank,neuron development (GO:0048666),0.4459570351293457,1.3810228866315046,0.04540295119182747,0.5018693423436474,1.0,24/141,10.39%,PTPRM;STMN2;RAPGEF2;FRYL;RAB11A;TGFB2;FRY;BTG2;APP;MAP4;PPT1;BLOC1S6;EHD1;ATP7A;MEF2C;UHMK1;ALK;TENM3;FLRT3;RAB35;ROCK1;HMGB1;B4GALT6;TENM4
prerank,establishment of spindle localization (GO:0051293),0.6159438997153749,1.3804238246292637,0.1426256077795786,0.5025644334765164,1.0,6/14,18.12%,MAP4;CLASP1;KPNB1;CLASP2;CFL1;ZBED3
prerank,blood circulation (GO:0008015),0.504555029385133,1.380291726032465,0.07733333333333334,0.5019471377868506,1.0,12/49,13.57%,ELN;NOS3;ACE;ACVRL1;DLL4;TBC1D8;STAT1;NPR1;ROCK1;MYOF;ITGB1BP1;SGCZ
prerank,regulation of ion transport (GO:0043269),0.4745636393467702,1.3802196937024331,0.07035175879396985,0.5011878990349798,1.0,8/76,7.79%,NOS1;SYT15;B2M;ATP1A1;SYT7;PXK;P2RX7;NKAIN3
prerank,cardiac conduction system development (GO:0003161),0.5799166510597729,1.3795142487513359,0.10962962962962963,0.5021795356983092,1.0,5/24,3.63%,GJA5;GATA6;MSX1;HEY1;HEY2
prerank,protein localization to cell junction (GO:1902414),0.5715993281764086,1.379158293189135,0.1021671826625387,0.5022325764933188,1.0,5/22,9.87%,HEG1;TJP2;DSP;NECTIN1;TJP1
prerank,calcium import into the mitochondrion (GO:0036444),0.6568506682459628,1.37865031443071,0.15270935960591134,0.5026151244550414,1.0,3/10,8.24%,MCUB;SMDT1;MCUR1
prerank,negative regulation of interleukin-2 production (GO:0032703),0.6002955405668323,1.3782275506143884,0.11178247734138973,0.5028623985188866,1.0,7/18,15.09%,HOMER2;HDAC7;CD34;PRNP;LAPTM5;NAV3;HAVCR2
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.5882857933106661,1.377262491443252,0.11861861861861862,0.5045619372662254,1.0,3/20,4.84%,SEMA3G;SEMA3F;SEMA7A
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.549478987616402,1.3763802326244832,0.1111111111111111,0.5059959108460244,1.0,8/28,11.05%,NOD1;NOD2;CASP8;IRAK2;IRGM;UBA52;RPS27A;TAB2
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.6080009966866815,1.3761295200912222,0.11800302571860817,0.5057456430886209,1.0,4/16,5.36%,GATA2;JCAD;DLL4;PPP1R16B
prerank,chondrocyte differentiation (GO:0002062),-0.4364422890442511,-1.375742565270019,0.06153846153846154,0.603298305917692,1.0,10/32,7.56%,SOX5;SULF1;SULF2;BMP4;OSR1;SLC39A14;RUNX2;CCN3;RUNX1;GPLD1
prerank,calcium ion transport (GO:0006816),0.45404711264197684,1.375588427870189,0.05802047781569966,0.5063268787932184,1.0,20/113,8.24%,ATP2A3;KCNN4;TRPV4;FYN;CCR1;ATP2B4;ATP2B2;CACNA1A;CAV1;FKBP1A;SLC8A1;ATP2C1;ANO6;ORAI1;STIM2;P2RX7;CRACR2B;MCOLN1;CRACR2A;MCUR1
prerank,regulation of intracellular pH (GO:0051453),-0.43480880324506593,-1.3754478093747586,0.06164383561643835,0.6007150305103655,1.0,17/34,22.32%,SLC4A10;SLC9A2;CA2;SLC9A9;SLC4A2;ATP5F1B;VPS33A;SLC4A3;SLC26A6;SLC9B1;SLC9A6;SLC9A1;TMEM165;CLN3;SLC4A8;TM9SF4;CFTR
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.5314430107137751,1.3753837539315177,0.09236947791164658,0.5059387390783247,1.0,10/35,14.27%,HIP1;HIP1R;B2M;CBL;PPT1;HNRNPK;RAC1;CLU;PIK3CB;LDLRAP1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.5377249747587638,1.3748642468971497,0.09002770083102493,0.5063262523739591,1.0,8/35,7.58%,PTPRM;FLT1;CAV1;CAV2;DLL4;MEF2C;STAT1;ATP5F1A
prerank,carnitine shuttle (GO:0006853),-0.5688933497849527,-1.3747048357682083,0.13349514563106796,0.5995876318903169,1.0,6/11,20.20%,PRKAG2;PRKAA2;SLC25A20;PRKAB2;CPT2;ACACA
prerank,cellular response to mechanical stimulus (GO:0071260),0.5036575316414629,1.3736980998299662,0.10353866317169069,0.5086655763560893,1.0,12/46,14.37%,PIEZO1;F11R;FAS;CASP8;TLR3;CASP2;CRADD;CASP1;TMEM150C;CASP8AP2;HABP4;BNIP3
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.562027494060926,-1.3734451907871783,0.12628865979381443,0.6001003064323152,1.0,5/12,22.46%,PPARA;IRS2;IRS1;TWIST1;MTLN
prerank,glycolipid metabolic process (GO:0006664),0.5052418031749781,1.3730549522293094,0.09803921568627451,0.5093967471984289,1.0,6/47,7.92%,ST6GALNAC3;ST8SIA6;ST3GAL6;ESYT2;PGAP1;GLTP
prerank,phagolysosome assembly (GO:0001845),0.6379642705256307,1.3727168931451805,0.13509060955518945,0.509417416369846,1.0,3/12,4.77%,SYT7;RAB39A;RAB34
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.5497193007663936,-1.3727151569616485,0.09819121447028424,0.599045947471796,1.0,6/13,19.78%,GLI3;RUNX1;NCKAP1L;PNP;TGFBR2;ZBTB7B
prerank,regulation of actin filament polymerization (GO:0030833),0.4678986443151398,1.3725074617733297,0.09595959595959595,0.5090673725888131,1.0,7/69,3.91%,KANK4;FCHSD2;HIP1R;KANK3;ESAM;EVL;CDC42EP1
prerank,negative regulation of heart contraction (GO:0045822),-0.5639246968105445,-1.372419229617801,0.1347517730496454,0.5965245688276304,1.0,1/11,0.03%,ATP1A2
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.5899719572059766,1.3719926474435047,0.1308980213089802,0.5094257262780877,1.0,3/18,6.10%,HEG1;RASIP1;CUL3
prerank,purine-containing compound salvage (GO:0043101),-0.5520220531974178,-1.37180582692919,0.09547738693467336,0.5950293558699735,1.0,8/12,30.17%,ADK;AMPD3;GMPR;PNP;APRT;DCK;AMPD2;ADA
prerank,positive regulation of cell adhesion (GO:0045785),0.47546013339487053,1.3701332005676254,0.08009708737864078,0.5134667732989207,1.0,12/74,8.49%,PTPRJ;PDGFB;MAGI1;SMAD7;FBLN2;TGFB2;TNFRSF18;PPM1F;CD47;PPP3CA;JAK2;RSU1
prerank,negative regulation of phagocytosis (GO:0050765),0.5877823193233015,1.3700387363175535,0.12833333333333333,0.5128062683914263,1.0,5/17,9.48%,DYSF;FCGR2B;CD47;PLSCR1;HMGB1
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5446229911245156,1.3699303599340569,0.11965811965811966,0.5121861941998308,1.0,4/29,3.90%,CCR1;JAM2;LGALS9;ANO6
prerank,extracellular matrix assembly (GO:0085029),0.5592365528513391,1.3681199970710345,0.1469265367316342,0.5161065691689599,1.0,3/23,4.35%,FBLN5;NTN4;ATP7A
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.5487239738080356,-1.3678247937613857,0.10199004975124377,0.6051610350909254,1.0,6/13,11.82%,DCN;BGN;HEXA;VCAN;HYAL1;CSPG4
prerank,retina homeostasis (GO:0001895),0.5766084465062206,1.3671033153543615,0.13313161875945537,0.5178960100149077,1.0,6/23,11.60%,B2M;HSPB1;CDH3;ACTG1;POTEF;ACTB
prerank,protein O-linked mannosylation (GO:0035269),-0.5057210475988083,-1.367103018605715,0.0893854748603352,0.6041734829334781,1.0,4/18,3.46%,TMTC4;TMTC1;LARGE1;CRPPA
prerank,regulation of metal ion transport (GO:0010959),-0.5132525263614116,-1.3664468764490554,0.11428571428571428,0.6028356444682167,1.0,4/16,6.30%,ANK2;BCL2;SLC30A10;CACNA2D1
prerank,regulation of transport (GO:0051049),0.5215892860964825,1.3657626369265579,0.10555555555555556,0.5206112667901064,1.0,8/36,11.60%,RAB11A;ARL6IP5;ICA1;FES;EPB41;LRRK2;ACTG1;ACTB
prerank,female gonad development (GO:0008585),-0.48782581574978057,-1.3657239787120796,0.11242603550295859,0.6016979908194812,1.0,5/19,9.01%,NR2F2;KIT;NUP107;CEBPB;VEGFA
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.4479368708869573,-1.3656576664775708,0.08038585209003216,0.5985477443370903,1.0,10/27,20.76%,ABCA1;ITGAV;PPARA;PPARG;NFKB1;AGTR1;NR1H3;MAPK9;LPL;AGT
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.45504787270826547,1.3655654449628822,0.07311320754716981,0.5202535139282884,1.0,30/86,18.87%,EPAS1;KLF2;PSMD13;ELOC;PSMD4;NFE2L2;UBA52;RPS27A;PSMA5;PSMB10;RBX1;CUL2;PSMB8;PSMD14;HIF1AN;GCN1;PSMA7;PSMA8;PSMC3;HIF1A;PSMB5;PSMC1;PSMC5;PSMC6;PSMB9;PSMA4;PSMD5;PSMD9;EPO;PSMB6
prerank,neural crest cell development (GO:0014032),0.5159379286639731,1.3648027181842377,0.0876010781671159,0.5214098258970842,1.0,10/44,13.14%,SEMA3G;TBX1;SEMA3F;SEMA7A;SNAI2;SEMA6D;CDH2;SEMA4G;SOX10;CYP26C1
prerank,response to copper ion (GO:0046688),-0.47369034957519685,-1.3647803232342492,0.09912536443148688,0.598001225125432,1.0,8/20,6.84%,MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X
prerank,autophagy of nucleus (GO:0044804),-0.5144913865163421,-1.3645483020583549,0.1366120218579235,0.5953239344419464,1.0,7/16,21.84%,ATG3;ATG5;ATG2A;ULK2;ATG7;WIPI2;WDR45
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.4391155730425446,-1.3640929883020323,0.052980132450331126,0.5936933284489897,1.0,6/32,3.96%,PID1;IGF1;ZBTB20;NUPR1;PRKAA2;PPARA
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.4812926184016411,-1.363642467253926,0.09385113268608414,0.5885729688629074,1.0,4/21,4.93%,EYA2;EYA1;BCL2;EYA4
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.4812926184016411,-1.363642467253926,0.09385113268608414,0.5885729688629074,1.0,4/21,4.93%,EYA2;EYA1;BCL2;EYA4
prerank,protein import (GO:0017038),-0.3534034149447541,-1.3628391706732141,0.015228426395939087,0.5878436363050444,1.0,33/84,24.61%,APPL2;APOE;ABCD3;HSPA4;NUP107;HEATR3;CSE1L;PPP1R10;ATAD1;PEX2;NUP155;TNPO3;PXMP4;RANBP6;FAM53C;IPO5;NUP93;PXMP2;TNPO2;GDAP1;RANBP17;TSC2;PHB2;TOMM22;PEX11B;SEC13;SYK;IPO7;PEX13;POM121;PEX3;IPO8;PEX16
prerank,cAMP metabolic process (GO:0046058),-0.5503814031935746,-1.3616145341798496,0.13659793814432988,0.5885813525025632,1.0,5/13,7.11%,ADCY5;ADCY9;ADCY1;ADCY2;ADCY7
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.3863815122649091,-1.3614675823812796,0.07661290322580645,0.5858951975216726,1.0,13/52,8.96%,EGFR;LRP1;EPHA3;SORBS1;PTPN9;EPB41L2;GNAI1;STX4;GPSM2;PIK3R1;CLIP3;PRKCI;STX3
prerank,positive regulation of heart contraction (GO:0045823),0.5861389547308281,1.3612431505718272,0.1390532544378698,0.5303170960409948,1.0,3/19,2.53%,KCNQ1;EDN1;TGFB2
prerank,neuron remodeling (GO:0016322),0.639937810310723,1.3611584445719167,0.1490787269681742,0.5296272043965842,1.0,2/10,2.99%,RND1;APP
prerank,T cell receptor signaling pathway (GO:0050852),0.433773289764269,1.3610460036383616,0.04525386313465784,0.5290130199516642,1.0,36/138,19.08%,PTPRJ;PLCG2;FYN;INPP5D;PSMD13;GATA3;PSMD4;CD247;ZC3H12A;PSMA5;PSMB10;EIF2B2;PLCG1;PSMB8;TAB2;PSMD14;PRKD2;PIK3CB;PSMA7;PSMA8;PSMC3;PSMB5;PSMC1;PSMC5;PAK2;PSMC6;PSMB9;PDE4D;NCK1;PSMA4;PSMD5;PSMD9;RELA;PSMB6;GRAP2;MALT1
prerank,neuron projection extension (GO:1990138),-0.4336131880475085,-1.360920723667418,0.08365019011406843,0.5843152248944451,1.0,11/32,11.84%,ALCAM;AUTS2;NRP2;SEMA5A;SEMA3A;SPG11;USP9X;FLRT1;PPP3CB;ULK2;LLPH
prerank,phospholipid dephosphorylation (GO:0046839),0.5231876222655365,1.3600608798773373,0.11080711354309165,0.5306631322789558,1.0,13/37,17.60%,SGPP2;PLPP1;INPP5K;MTMR10;INPP5B;MTMR11;PLPP6;OCRL;INPP5F;PLPP4;INPP5J;PLPPR1;SYNJ1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.6561952240823385,1.3599391492787671,0.14375,0.5300190110472608,1.0,3/11,1.88%,NOTCH1;ATP2B4;FOXO1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.501862666814115,1.3595864786541303,0.10091743119266056,0.5300402535340831,1.0,12/47,9.66%,FAS;NOD2;FOXO1;DAB2IP;ARL6IP5;F2RL1;TGFB2;LGALS9;MAP4K4;MAPK1;NBR1;TAOK2
prerank,positive regulation of DNA repair (GO:0045739),-0.3931414167588657,-1.3586852860091394,0.0625,0.5879781476512095,1.0,8/46,8.67%,EYA2;EGFR;EYA1;EYA4;UBE2N;SLF1;FMN2;XRCC1
prerank,myoblast differentiation (GO:0045445),0.6100586407954731,1.35842164223434,0.14423076923076922,0.5322300370092027,1.0,3/14,4.67%,EPAS1;JAG1;MBNL1
prerank,cellular calcium ion homeostasis (GO:0006874),0.43587754132151657,1.3582213232280376,0.048752834467120185,0.5318788590925022,1.0,17/133,7.11%,ATP2A3;EDN1;TRPV4;CCR1;ATP2B4;ATP2B2;CAV1;CAV2;MCUB;SLC8A1;ATP2C1;CAMK2D;SMDT1;STIM2;ATP13A3;HCRTR1;SLC30A1
prerank,outflow tract septum morphogenesis (GO:0003148),0.5557958658452457,1.358054419126207,0.10998552821997105,0.5313485250147872,1.0,7/24,4.00%,ENG;GATA6;SMAD6;BMPR2;TBX1;TGFB2;ACVR1
prerank,stress-activated MAPK cascade (GO:0051403),0.4799417562421427,1.356820486002531,0.08996088657105607,0.5340012340947294,1.0,13/61,11.05%,MAP4K2;NOD1;NOD2;MAP4K3;LGALS9;IRAK2;MAPK1;UBA52;RPS27A;TAOK2;MAP3K11;MINK1;TAB2
prerank,male gonad development (GO:0008584),0.531412080748343,1.356191237027133,0.11171662125340599,0.5348806550658377,1.0,7/34,8.77%,GATA6;KITLG;TGFB2;ING2;GATA3;NCOA4;COL9A3
prerank,regulation of multicellular organismal development (GO:2000026),0.5507893302532769,1.3561140805371255,0.14457831325301204,0.5341895401430448,1.0,6/25,10.46%,SOX17;SPAAR;INSR;GATA3;OAS2;BAG6
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.41120451555099624,1.3560594506343104,0.008072653884964682,0.5334217921930997,1.0,73/390,12.39%,VEGFC;PTPRJ;TEK;PTPRG;PDGFD;RAPGEF2;KALRN;EFNA5;FLT1;TIE1;PLCB1;PDGFB;ARHGEF28;FYN;FLT4;MPZL1;ELMO1;MERTK;FOXO4;ESRP2;IRS4;RAPGEF1;FOXO1;INSR;PRKD1;CAV2;PIK3C2A;CBL;ADRB2;FES;NEDD9;CRK;AP2B1;VEGFD;SHB;ANGPT1;EFNA1;FGFR3;BCAR3;MAPK1;SETX;SHOC2;ALK;LMTK2;FRS3;NUS1;JAK2;FLRT3;GRIN2B;ARPC5;NCKAP1;APC;POLR2G;ACTG1;NAMPT;YES1;ROCK1;PTK2;STAP1;APH1A;AP2M1;ANKS1B;POLR2D;RAC1;CYFIP1;FGF20;CYBA;ACTB;TIAL1;PRKD2;AP3S1;WASF2;DOCK1
prerank,negative regulation of dephosphorylation (GO:0035305),0.5843973499664329,1.3559421630605197,0.1552511415525114,0.5328372754783054,1.0,6/18,12.29%,INPP5K;ZCCHC9;PPP1R16B;GPATCH2;MFHAS1;ARPP19
prerank,cellular response to interleukin-1 (GO:0071347),0.43434267344462174,1.355454240862847,0.046223224351747465,0.5332348473818667,1.0,46/143,18.87%,PLCB1;RPS6KA5;NOD1;NOD2;DAB2IP;PSMD13;HYAL2;IRAK2;GBP3;IL1A;PSMD4;CD47;ZC3H12A;IL1RAP;UBA52;RPS27A;NR1D1;ACOD1;CACTIN;PSMA5;EGR1;PSMB10;RBX1;CCL4;NFKBIA;PSMB8;MAP3K3;TAB2;PSMD14;GBP2;PSMA7;PSMA8;PSMC3;HIF1A;PSMB5;PSMC1;PSMC5;PSMC6;PSMB9;PTGIS;PYCARD;PSMA4;PSMD5;PSMD9;RELA;PSMB6
prerank,positive regulation of phospholipase activity (GO:0010518),-0.4546726577433664,-1.3553608266310635,0.11388888888888889,0.5953063743198898,1.0,6/22,5.68%,NTRK3;PDGFRB;FGFR2;PDGFRA;KIT;FGF2
prerank,long-chain fatty acid transport (GO:0015909),-0.42790067137646803,-1.3553085861824392,0.09433962264150944,0.5923164626758184,1.0,9/30,11.46%,PRKAG2;ACSL1;PRKAA2;APOE;ABCD3;SLC25A20;SLC27A1;PPARG;PRKAB2
prerank,synaptic membrane adhesion (GO:0099560),-0.5227623789651294,-1.3549021965608177,0.11621621621621622,0.590539066896941,1.0,8/14,19.51%,GPC6;PTPRF;LRRC4;SLITRK1;PTPRS;NTNG1;PTPRD;GPC4
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.6552272331010655,1.3548134063052055,0.1437908496732026,0.5340765605723756,1.0,3/10,8.40%,FAS;MAPK1;NBR1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.4340947720747486,1.354757889166198,0.0457516339869281,0.533333477876334,1.0,32/149,12.82%,TRIM14;RPS6KA5;NOD1;NOD2;ARHGEF2;AIM2;CAV1;PRKD1;LGALS9;APP;TIRAP;TRIM6;TRAF1;IRAK2;ALK;IL1RAP;HSPA1B;UBA52;RPS27A;DHX9;TRIM25;RHEBL1;NFKBIB;NFKBIA;TAB2;NPM1;TRIM8;CLU;PRKD2;RTKN2;CX3CR1;BTK
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.525339157410363,-1.3547346111317988,0.11666666666666667,0.5880518366092797,1.0,8/15,23.00%,PPARA;IRS2;IRS1;GPLD1;PPARG;SLC45A3;ADM;PPARD
prerank,I-kappaB phosphorylation (GO:0007252),0.652817646052845,1.3545234428715347,0.15719063545150502,0.5330839397636881,1.0,2/10,3.65%,DAB2IP;TLR3
prerank,positive regulation of phosphorylation (GO:0042327),0.41580245049955267,1.3541485750598192,0.031315240083507306,0.5331863572334944,1.0,39/240,10.85%,VEGFC;PECAM1;TEK;ENG;EFNA5;FLT1;TIE1;FLT4;FAS;TBX1;MERTK;LIMCH1;CCND2;CCND3;INSR;APP;VEGFD;KRAS;ANGPT1;EFNA1;CSNK1D;BRAT1;FGFR3;ADAM17;P2RX7;LRRK2;IRGM;ALK;LMTK2;ARRB1;PDE8A;THPO;PRKAA1;PTK2;PFKFB3;PTGES3;RAC1;FGF20;LIMK2
prerank,positive regulation of JUN kinase activity (GO:0043507),0.5622814315647249,1.3535087901452871,0.12445730824891461,0.5340605613823617,1.0,2/23,2.22%,EDN1;DAB2IP
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.5921690184296063,1.3532487071754333,0.12844036697247707,0.5338543644302188,1.0,2/17,3.51%,KCNE3;NOS1AP
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5256226727997672,1.3532261675458706,0.11522048364153627,0.5330228941981449,1.0,16/33,21.77%,CACNA1A;ABR;BCR;GRID1;BTBD9;PXK;LRRC4C;GRIK5;GRIK2;CX3CR1;PSMC5;GRIK1;LRP8;GRID2;BDNF;NLGN1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.514495860313652,1.3516329113659065,0.13360881542699724,0.5364477922071219,1.0,12/35,24.23%,CDH13;ATP2C1;CDH12;PCDHB16;PCDHB14;CDH22;PCDHB9;CDH18;CDH24;NLGN1;DCHS1;CDH5
prerank,embryonic axis specification (GO:0000578),0.6138442267928792,1.3515273961939278,0.13614262560777957,0.5358422199452126,1.0,4/15,10.11%,SMAD6;TBXT;SMAD2;TASOR
prerank,regulation of cell population proliferation (GO:0042127),0.401755177830324,1.3512311963071306,0.0,0.5357049352648323,1.0,111/691,13.24%,VEGFC;PTPRJ;ELN;CDH13;ACER2;NUAK1;JAG1;JAG2;NOS3;EDN1;PDGFD;ENG;IRF6;RAPGEF2;CLDN5;FLT1;SMAD6;PDGFB;BMPR2;FLT4;SMARCA2;KITLG;TBX1;PTPN14;FOXO4;ITGA1;CCND2;LIFR;ACVRL1;NOTCH1;ARHGEF2;INSR;ADARB1;DAB2IP;AQP11;TGFB2;HNF4A;EMP2;BTG2;DLL4;APP;FES;BTG1;PLPP1;HHEX;KLF4;VEGFD;KRAS;IER5;WWTR1;GCNT2;LEF1;SERTAD1;FGFR3;TBC1D8;WARS1;CUL3;GATA3;IL1A;BCL6B;ADAM17;SH3BP4;IGFBP7;SLC25A33;STAT1;CD47;GNAI2;ALK;HSPA1B;JAK2;CNOT6L;CEBPA;THPO;PTPRU;CD200;APC;NMI;NAMPT;PPP2R5C;TSPO;PTK2;KLF11;SGK1;JUN;ADAM10;HP1BP3;TJP1;CHD5;CCDC88A;RPRD1B;ADAMTS1;RPS9;ADGRB1;FGF20;NPM1;E2F7;CLU;NF2;COPS8;MATK;CHTOP;TOB1;ITGB1BP1;RTKN2;PPM1D;MCTS1;PRC1;CTBP2;DUSP22;PHIP;POU3F2
prerank,regulation of tube diameter (GO:0035296),0.6186367511208131,1.3511088289752664,0.14333333333333334,0.5342161162679158,1.0,5/13,12.61%,NOS3;ACE;NPR1;ROCK1;ITGB1BP1
prerank,vascular process in circulatory system (GO:0003018),0.6186367511208131,1.3511088289752664,0.14333333333333334,0.5342161162679158,1.0,5/13,12.61%,NOS3;ACE;NPR1;ROCK1;ITGB1BP1
prerank,regulation of dendrite development (GO:0050773),-0.4056667315607063,-1.3500019623637853,0.07553956834532374,0.5997454639753662,1.0,7/37,2.64%,PTN;CAMK1D;SDC2;BMP5;BMP7;COBL;MARK1
prerank,cytosolic calcium ion transport (GO:0060401),0.5346836093739147,1.3499796047995347,0.13138686131386862,0.5365693631941345,1.0,6/28,8.24%,ATP2A3;ITPR3;MCUB;SLC8A1;SMDT1;MCUR1
prerank,organic hydroxy compound transport (GO:0015850),0.5252039348038866,1.3498560010833087,0.11404728789986092,0.5360250825237345,1.0,3/36,3.07%,ABCC4;CEACAM1;SLCO1C1
prerank,outer dynein arm assembly (GO:0036158),-0.5121817197067416,-1.3493653766878129,0.15263157894736842,0.5986930119289323,1.0,11/14,41.43%,DNAAF5;ODAD1;DNAH5;DNAL1;ODAD2;ODAD3;ODAD4;DNAH17;CCDC63;DNAH8;DNAAF4
prerank,histone H3-K4 methylation (GO:0051568),-0.4465458194058844,-1.3487521356804701,0.07718120805369127,0.5975424968407987,1.0,10/26,16.22%,OGT;KMT2C;ASH2L;SETD1A;SETD1B;TET2;WDR5;CTR9;DPY30;SETD4
prerank,spinal cord development (GO:0021510),-0.5499632788264346,-1.348602883468497,0.1650485436893204,0.5949767296037825,1.0,6/12,20.84%,GLI2;VIT;LOXL3;PKD1;ZPR1;NF1
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.4493285709164319,-1.3485936375234575,0.1268882175226586,0.5919962746565939,1.0,13/23,26.37%,CAMK1D;SLIT2;DPP4;RIPOR2;NCKAP1L;MDK;DAPK2;DNM1L;CD74;MCU;C1QBP;CCL19;MOSPD2
prerank,pancreas development (GO:0031016),-0.549306825505181,-1.3483106108302128,0.16183574879227053,0.5899469099713706,1.0,7/12,30.43%,TCF7L2;NPHP3;MET;NKX6-1;PROX1;FOXF1;CCDC39
prerank,glucose import (GO:0046323),0.6138192196834478,1.3477888790664174,0.15824915824915825,0.5408221927266621,1.0,2/13,2.74%,SLC2A1;HNF1A
prerank,positive regulation of protein polymerization (GO:0032273),0.4628018882408217,1.3477782124721742,0.10814249363867684,0.539942199919865,1.0,15/65,16.84%,FCHSD2;OCLN;FES;EVL;CDC42EP1;CLIP1;CLASP1;NCKAP1;RAC1;NUMA1;TTBK1;NAV3;NCK1;PYCARD;TENM1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.4238864165161746,1.3477629112547218,0.03270042194092827,0.5390838623593115,1.0,27/198,7.16%,PLCG2;PTPRB;PLCB1;ALPL;ITPKB;IP6K3;PLCB4;DUSP12;INPP5D;INPP1;PLPP1;IPPK;INPP5K;MINPP1;ACP6;PGM2L1;LPCAT4;GPI;LCAT;GPD2;PGK1;DUSP16;THTPA;LRRK2;DUSP3;ALK;PPP3CA
prerank,negative regulation of cell projection organization (GO:0031345),0.49266123037394294,1.3476414396871577,0.1328125,0.5385559901357144,1.0,12/48,12.99%,TRPV4;STMN2;RAPGEF2;FYN;FKBP4;PTPRO;GRIN2B;PRNP;SPOCK1;DCC;TSKU;YWHAH
prerank,protein localization to cell periphery (GO:1990778),0.4361749630003837,1.34742943546728,0.06370875995449374,0.538175611941853,1.0,26/133,9.80%,EHD4;EFR3B;RAPGEF2;F11R;RAB11A;TMEM88;CAV1;ZDHHC22;PACS1;EMP2;INPP5K;FCHO2;TSPAN14;EHD1;DPP6;RAB34;DPP10;RAPGEF6;TSPAN32;PACSIN1;MRAP2;BSG;ROCK1;NKD2;RAB40B;CLASP2
prerank,negative regulation of DNA binding (GO:0043392),0.5334057880741565,1.3473077950506134,0.1257396449704142,0.5375901176909684,1.0,10/28,13.30%,HEY1;HEY2;SUMO3;LEF1;JAK2;JUN;MAD2L2;NFKBIA;TNKS;HABP4
prerank,heart process (GO:0003015),0.6149969021841806,1.3471966309055363,0.1518578352180937,0.5369829309093951,1.0,2/14,1.04%,FYN;ACE
prerank,regulation of tissue remodeling (GO:0034103),0.5895610027597072,1.3468694289842706,0.13076923076923078,0.5369864322935199,1.0,3/18,3.76%,CEACAM1;FLT4;SYT7
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4360232672019489,1.346484237232054,0.07276736493936053,0.5371346823197819,1.0,39/136,20.42%,FZD6;SMAD7;TBXT;AIM2;DAB2IP;ID1;KLF4;NFKBIE;DAP;IRAK2;COMMD7;NFKBIL1;CMKLR1;ZC3H12A;ARRB1;NLRC5;CD200;CTNNBIP1;ACOD1;CACTIN;MAD2L2;PRNP;NFKBIA;NWD1;KEAP1;HAVCR2;PTGIS;TMSB4X;PYCARD;ESR1;PYDC1;MEN1;TBX6;ID3;TAF3;ERBIN;FOXJ1;EGLN1;SIGIRR
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.46230317456661296,1.346433519732316,0.09339975093399751,0.536376668637456,1.0,25/70,18.87%,GATA2;LMO2;TAL1;PSMD13;LMO1;GATA3;PSMD4;TCF3;PSMA5;PSMB10;PSMB8;PSMD14;CBFB;PSMA7;PSMA8;PSMC3;PSMB5;PSMC1;PSMC5;PSMC6;PSMB9;PSMA4;PSMD5;PSMD9;PSMB6
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.4652822417750935,-1.3464296112761107,0.1130952380952381,0.5926386760918791,1.0,6/22,12.39%,ZBTB20;SORBS1;APOE;PPARA;PPARG;CREB1
prerank,primary alcohol metabolic process (GO:0034308),-0.44331995280040937,-1.3463687883268631,0.10031347962382445,0.5898831264619873,1.0,5/25,9.61%,IGF1;RBP4;NAPEPLD;NAAA;DHRS3
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.40958530312982644,-1.346320276426887,0.08627450980392157,0.5870636848966007,1.0,19/39,28.21%,STEAP3;ABCA1;TANGO2;COPG1;MTTP;PPY;TVP23B;SVBP;RAB3D;RCN3;AFM;PDIA4;MON1A;PREB;TMEM167A;RAB3C;NECAB3;RAB15;LTBP2
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.46255948388030443,-1.3454450371012912,0.10946745562130178,0.5836554577210096,1.0,9/23,13.64%,DAB2;ZEB2;THBS1;SNW1;CREBBP;FLCN;SDCBP;SLC2A10;CITED2
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.46255948388030443,-1.3454450371012912,0.10946745562130178,0.5836554577210096,1.0,9/23,13.64%,DAB2;ZEB2;THBS1;SNW1;CREBBP;FLCN;SDCBP;SLC2A10;CITED2
prerank,protein localization to microtubule organizing center (GO:1905508),0.6059798141079689,1.3450551425658734,0.15275590551181104,0.5394412543672005,1.0,6/15,14.68%,CSNK1D;SNX10;NEDD1;PCM1;CCDC14;CEP83
prerank,defense response to tumor cell (GO:0002357),-0.5986963056832417,-1.34482294367829,0.12408759124087591,0.5826524491697618,1.0,2/10,0.65%,RBMS3;DAPK1
prerank,monocyte chemotaxis (GO:0002548),0.5247617671540912,1.3447852154369013,0.14950634696755993,0.5392413546971577,1.0,4/32,10.31%,FLT1;PDGFB;PTPRO;CCL4
prerank,cellular metal ion homeostasis (GO:0006875),0.4482630792887685,1.3443775168173018,0.06916764361078546,0.5395353985361523,1.0,14/102,5.68%,ATP2A3;EDN1;TRPV4;CCR1;ATP2B4;ATP2B2;ATP1A4;ATP1A3;ATP1A1;CAV1;SLC8A1;ATP2C1;STIM2;ATP13A3
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.45060457385309727,1.3440079000394558,0.0893719806763285,0.5396348238731905,1.0,21/87,9.40%,ENG;CLDN5;SMAD6;SMAD7;F11R;ACVRL1;ZYX;TGFB2;CBL;FKBP1A;ID1;APOA1;ACVR1;GCNT2;SMAD2;NLK;FURIN;UBA52;RPS27A;PTK2;JUN
prerank,glutamate receptor signaling pathway (GO:0007215),0.5136522064547001,1.3438693956117065,0.13802435723951287,0.5391639285717942,1.0,13/37,20.17%,PLCB1;GNAQ;HOMER2;APP;GRIN2B;GRIN2C;GRIK2;GRIN3A;GRM5;GRIK1;GRIN2A;GRM7;GRID2
prerank,regulation of pseudopodium assembly (GO:0031272),0.6427177498772837,1.34306103800625,0.16611295681063123,0.5395274763905158,1.0,3/10,8.54%,F2RL1;CDC42EP1;APC
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.6427177498772837,1.34306103800625,0.16611295681063123,0.5395274763905158,1.0,3/10,8.54%,F2RL1;CDC42EP1;APC
prerank,negative regulation of chemokine production (GO:0032682),0.6048825231465154,1.3428318279572455,0.1610305958132045,0.539258084630996,1.0,3/14,3.86%,F2RL1;LGALS9;KLF4
prerank,membrane depolarization during action potential (GO:0086010),-0.44317546590800205,-1.3427872286584277,0.08360128617363344,0.5859458758520903,1.0,5/26,6.57%,ATP1A2;CACNA1C;SCN7A;SCN2A;CACNA1G
prerank,neuron projection development (GO:0031175),0.424598612251048,1.3426807585331726,0.043429844097995544,0.538751144549057,1.0,31/168,10.77%,PTPRM;STMN2;RAPGEF2;FRYL;RAB11A;DAB2IP;TRIO;FRY;BTG2;APP;MAP4;BLOC1S6;EHD1;ATP7A;VASH2;SHTN1;MAP4K4;CAMSAP2;SHANK3;PACSIN1;UHMK1;LRRK2;FLRT3;NCKAP1;RAB35;ROCK1;SGK1;HMGB1;TAOK2;NEFH;MINK1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5888846005236722,1.342618150422558,0.1498371335504886,0.5380359206106853,1.0,6/17,4.00%,JAG1;NOTCH1;HEY1;DLL4;HEY2;ACVR1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.49800577247543515,1.3422795631052764,0.09726027397260274,0.5381135495204452,1.0,8/43,9.65%,PTPRJ;ITGA1;DAB2IP;CBL;SH3KBP1;DUSP3;GPRC5A;RNF115
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.5307189404249908,1.342231026223844,0.13314447592067988,0.5373539055937044,1.0,12/26,15.86%,DAB2IP;IQGAP1;INPP5K;DUSP3;PTPN12;PDE8A;SNAI2;SYAP1;ZFP36L2;PLCG1;DUSP22;VIL1
prerank,regulation of cellular pH (GO:0030641),-0.4342439056036324,-1.3420119211277222,0.09032258064516129,0.5855221548393479,1.0,16/29,22.11%,SLC4A10;SLC9A2;CA2;LACC1;SLC9A9;ATP6AP1;SLC4A2;ATP5F1B;SLC4A3;SLC26A6;SLC9B1;SLC9A6;SLC9A1;CLN3;SLC4A8;TM9SF4
prerank,T cell differentiation (GO:0030217),0.5006360151725393,1.341977513343603,0.11310344827586206,0.5371938641762491,1.0,5/40,6.29%,SOX13;JAG2;DLL4;GATA3;ADAM17
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.4514544700030069,1.3419617642198909,0.08019441069258809,0.5363708373878798,1.0,33/94,18.87%,PLCB1;RPS6KA5;NOD1;NOD2;PSMD13;IRAK2;IL1A;PSMD4;IL1RAP;UBA52;RPS27A;PSMA5;EGR1;PSMB10;RBX1;NFKBIA;PSMB8;MAP3K3;TAB2;PSMD14;PSMA7;PSMA8;PSMC3;PSMB5;PSMC1;PSMC5;PSMC6;PSMB9;PSMA4;PSMD5;PSMD9;RELA;PSMB6
prerank,negative regulation of actin filament polymerization (GO:0030837),0.5603014560963708,1.339849733007923,0.15926493108728942,0.5411089875749828,1.0,3/22,3.05%,KANK4;HIP1R;KANK3
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.44678663891808174,1.3395345226533566,0.08450704225352113,0.5411040844300248,1.0,12/93,6.92%,NOS1;CNKSR3;SMAD7;ATP2B4;CAV1;PRKD1;APP;INPP5K;PPM1F;TRIM6;BCAR3;IRGM
prerank,T cell activation (GO:0042110),0.4605609875338684,1.3393454291709797,0.1011378002528445,0.5407772222327409,1.0,10/69,7.16%,JAG2;CRTAM;CASP8;F2RL1;FKBP1A;DLL4;MSN;CTPS1;GATA3;PPP3CA
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.522267385704494,-1.3389950813187925,0.12060301507537688,0.5922280157040647,1.0,9/14,21.83%,SEC24D;SEC31A;SEC24C;SAR1A;SEC23B;SCAP;TBC1D20;SEC13;SEC23A
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5511615554361659,1.338586300139493,0.15419161676646706,0.5419102046781413,1.0,6/22,12.09%,PDGFD;PDGFB;ACE;TOM1L1;TAOK2;CALM3
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.4389407671914213,1.3385609330228552,0.08558030480656506,0.5410992443991289,1.0,18/100,9.01%,TEK;PDGFD;PIP5K1B;FLT1;CEACAM1;PDGFB;FBXL2;INSR;DAB2IP;F2RL1;TGFB2;CBL;PPP1R16B;MAPK1;PIP5K1C;JAK2;PPP2R5C;PTK2
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.5693941653987653,1.338186677212092,0.15822784810126583,0.5412895707669402,1.0,8/20,7.72%,ENG;ACVRL1;NOTCH1;HEY1;TGFB2;HEY2;PDCD4;SNAI2
prerank,cGMP metabolic process (GO:0046068),0.622453760339082,1.3368727928402464,0.15424610051993068,0.5439232766870311,1.0,3/12,11.54%,NPR2;NPR1;NPPC
prerank,regulation of melanin biosynthetic process (GO:0048021),0.6522738002910818,1.3365875014229036,0.16666666666666666,0.5438182601602017,1.0,3/10,8.31%,RAPGEF2;ATP7A;CDH3
prerank,plasma membrane invagination (GO:0099024),0.5308330690291775,1.336071673461737,0.11824817518248175,0.54439829987342,1.0,9/29,12.39%,ELMO1;GULP1;FCGR2B;MYH9;FCGR1A;ITGAM;ARHGAP25;VAMP7;DOCK1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.6372533870409072,1.3359035342660113,0.16026711185308848,0.5440326616246531,1.0,2/10,6.94%,SMAD7;ZC3H12A
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.45579260996644394,1.3349489363511313,0.0865265760197775,0.5458319851188261,1.0,29/74,18.87%,EPAS1;NOTCH1;PSMD13;ELOC;PSMD4;NFE2L2;UBA52;RPS27A;PSMA5;PSMB10;RBX1;CUL2;PSMB8;PSMD14;HIF1AN;PSMA7;PSMA8;PSMC3;HIF1A;PSMB5;PSMC1;PSMC5;PSMC6;PSMB9;PSMA4;PSMD5;PSMD9;EPO;PSMB6
prerank,cardiac muscle tissue development (GO:0048738),0.4928277507053438,1.3344646328563337,0.12269129287598944,0.5463319506626753,1.0,7/50,3.63%,GJA5;GATA6;MSX1;BMPR2;NOTCH1;HEY1;HEY2
prerank,regulation of macrophage migration (GO:1905521),0.6367265455414963,1.334448185604856,0.15815485996705106,0.5454888838026353,1.0,7/10,24.76%,MTUS1;CD200;CX3CR1;CD200R1;P2RY12;EMILIN1;CSF1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5829487380491107,1.3343165312900593,0.15748031496062992,0.544948792114112,1.0,5/18,12.04%,EDN1;NOD2;ATP7A;RFK;PDP1
prerank,negative regulation of protein binding (GO:0032091),0.46412284328979264,1.3339288439102315,0.10196560196560196,0.5451639875884853,1.0,19/71,15.76%,ATP2A3;PDGFB;B2M;CAV1;ADRB2;ADAM15;TTBK2;LRRK2;CTNNBIP1;ROCK1;ACTB;TMBIM6;ITGB1BP1;TTBK1;PIN1;NES;RACK1;MAP2;SLPI
prerank,regulation of trophoblast cell migration (GO:1901163),-0.5218953127656932,-1.3326082972609428,0.13953488372093023,0.6095555254976168,1.0,4/14,9.79%,GJA1;SYDE1;VEGFA;ACVR1B
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.5467945764826058,1.3323670832477472,0.14622641509433962,0.5486105678504934,1.0,4/23,5.12%,LTBP4;ENG;SMAD7;SMAD2
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.4964209363632934,1.3322374275529163,0.11835106382978723,0.5480649114098766,1.0,5/44,3.90%,KCNN4;KCNQ1;KCNN3;NOS1AP;ANO6
prerank,regulation of mitochondrial fusion (GO:0010635),-0.5511320059538757,-1.3318696899336595,0.16273584905660377,0.6088777233087116,1.0,2/11,4.11%,PID1;PRKN
prerank,cellular response to alcohol (GO:0097306),-0.40513283622023066,-1.3314583872942813,0.08856088560885608,0.6072140458675142,1.0,14/42,17.01%,ADCY5;SMO;ADCY1;GNAI1;CDH1;GRAMD1C;ADCY2;ADCY7;GPLD1;PTCH1;GRAMD1A;OSBPL7;LARP1;GRAMD1B
prerank,heart development (GO:0007507),0.4231435230181363,1.3303392944367323,0.06408839779005525,0.5524455585373025,1.0,22/150,5.43%,HEG1;SOX17;TEK;PDGFB;BMPR2;TBX1;TBXT;MYBPC3;ACVRL1;NOTCH1;DAND5;INSR;CASP8;TGFB2;FKBP1A;HDAC9;SOX18;ACVR1;ALPK3;PDLIM5;PCSK5;MEF2C
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.6236743017848045,1.3302930915261966,0.14308426073131955,0.5517187347834739,1.0,1/12,0.48%,EDN1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.519552826660425,-1.3298095336892297,0.12935323383084577,0.6092467741556329,1.0,7/14,19.93%,NMNAT2;ME1;AK5;PNP;CMPK2;AK1;NME2
prerank,negative regulation of calcium ion transport (GO:0051926),0.6014571019498268,1.3297183038820932,0.1444991789819376,0.5523908910853125,1.0,3/15,7.11%,NOS1;INPP5K;SLC30A1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.5566477727206144,1.3291674842073138,0.14871016691957512,0.5530482340831014,1.0,12/23,25.20%,CCDC88C;TUBB;HOOK1;MYO10;CCDC88A;TUBA1A;KIF1A;HOOK2;DYNC1I2;TUBA1B;KIF5A;MAP6
prerank,regulation of calcium ion import (GO:0090279),0.5639307330116894,1.3287639481085611,0.16642120765832105,0.5533261008625026,1.0,7/21,16.01%,PDGFB;FYN;SLC30A1;PRNP;PLPP4;CTNNB1;PSEN2
prerank,oligodendrocyte differentiation (GO:0048709),0.5599468080080245,1.3285803919638906,0.1480916030534351,0.5529365234810755,1.0,4/19,12.33%,SOX13;EIF2B2;SOX10;SOX6
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.5351331037897417,1.3284138036234676,0.16619318181818182,0.5525181255664743,1.0,8/28,11.39%,GATA2;EGFL7;HEY1;DLL4;ARRDC1;ARRB1;FBXW7;HIF1AN
prerank,cellular response to fatty acid (GO:0071398),-0.5313466595188928,-1.3283815297728236,0.14754098360655737,0.610768924519423,1.0,7/12,25.79%,PID1;IRS1;PDK3;LPL;DGAT2;PDK4;NR1H4
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.602618558750791,1.3282118028931853,0.1776,0.5522336152489431,1.0,7/13,19.24%,CAV1;SLC8A1;CAMK2D;CALM3;PDE4D;ANK3;IRX3
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.32950620548624626,-1.3280361134922407,0.06976744186046512,0.6090744364753842,1.0,23/108,7.87%,TRABD2B;WLS;LRP1;FGFR2;SULF1;GPC3;RNF43;PTK7;NKD1;RSPO3;SULF2;DCDC2;APCDD1;PRKN;GRB10;DACT1;DAAM2;CTNND2;RUNX1;SFRP4;WWOX;RSPO2;FZD7
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.6596550481090763,1.327580007939237,0.17733990147783252,0.5530405322891149,1.0,1/10,0.07%,PTPRJ
prerank,negative regulation of transport (GO:0051051),0.4814007171072078,1.3275420159808338,0.13185378590078328,0.5522730356108784,1.0,10/51,9.08%,MCTP1;DYSF;PRKD1;ARL6IP5;PPM1F;FCGR2B;CTTNBP2NL;PXK;PLSCR1;NDFIP2
prerank,regulation of histone methylation (GO:0031060),-0.5316463505964649,-1.327222626841874,0.12435233160621761,0.608716705034278,1.0,7/13,16.46%,JARID2;NSD1;PAF1;CTR9;TET1;PIH1D1;NNMT
prerank,positive regulation of protein ubiquitination (GO:0031398),0.4586574264137387,1.327093113387054,0.10306748466257669,0.5525903665263735,1.0,25/80,19.08%,SMAD7;FAM107A;CAV1;FKBP1A;ANGPT1;CUL3;UBE2D1;LRRK2;UBE3A;NDFIP2;FBXW7;NSMCE3;RBX1;LAPTM5;BRCA1;FBXO4;PIN1;SPRTN;BMI1;TRIB3;GSK3A;ARRDC4;XIAP;CRY1;MALT1
prerank,peptide cross-linking (GO:0018149),-0.44510559754658385,-1.3266697950106696,0.12,0.6074602704934129,1.0,4/25,6.35%,COL3A1;NDNF;THBS1;ANXA1
prerank,cellular protein modification process (GO:0006464),0.39396503293905616,1.3266606039942426,0.0,0.5529788710434229,1.0,200/982,15.77%,BMX;PTPRM;PTPRJ;LMO7;PTPRB;EPAS1;NUAK1;CDK19;PTPRG;ST8SIA6;ERG;PTPRR;STK10;MAP4K2;PDGFB;FYN;ASB4;BMPR2;RPS6KA5;CDK17;PTPN14;MERTK;ACVRL1;IP6K3;FBXL2;ST3GAL6;RAB11A;MAP4K3;INSR;DUSP12;DUSP1;ST6GALNAC2;CDK14;SNRK;PRKD1;PRKG1;TGFB2;CDC42BPA;OXSR1;GOLM1;APP;TULP4;MAP3K6;KLHL2;FBXO7;PKN3;UBA7;APOA1;SERP2;COPS4;PPM1F;CDC42BPG;CISH;ACVR1;PSMD13;BCR;STK24;FBXL14;FBXL5;KLHL3;GCNT2;MANBA;MAP4K4;PTPRE;CAMK2D;CCNE1;STK38;CSNK1D;PKN1;STK38L;NLK;TMEM132A;CTTNBP2NL;ELOC;RHBDD1;MEX3B;GAN;CUL3;CHRM3;DUSP16;MAPK1;PGAP1;PXK;PSMD4;SIRT4;PGGT1B;IGFBP7;CD247;AKT3;KLHL20;MAST1;LRRK2;PRKCSH;FBXL18;ZBTB16;PPP3CA;SIK2;PTPN12;LMTK2;HSP90B1;SOCS6;NUS1;ASB5;JAK2;TLK1;B3GNT3;PTPRU;PTPRO;FEM1C;UBA52;PRKAA1;STK39;PASK;PROC;IGFBP4;PIM3;YES1;PP2D1;PPP2R5C;NEK7;ROCK1;FBXL16;PIK3C3;SGK1;CSNK1G3;DSP;PSMA5;PSMB10;ADAM10;TAOK2;FBXW7;MAP3K11;RBX1;DUSP11;CUL2;MARK3;PTPN1;PRKCG;PSMB8;MINK1;LIMK2;APLP2;TNKS;LIPT1;CDH2;FBXW2;CP;PSMD14;MGAT1;HS3ST5;NEK11;PRKD2;PDP1;MARK2;FBXO4;COPS8;MATK;VRK1;SETD3;METAP2;BTK;DCAF10;TTBK1;PPM1D;B3GALNT2;KEAP1;DCAF17;PSMA7;PSMA8;ATM;NAGPA;ST3GAL1;PSMC3;HIF1A;FBXO2;ACVR2A;UBE2E1;PPM1L;LTK;PSMB5;PSMC1;DUSP26;PPP4R1;MAP3K20;PSMC5;PPP2CB;UBE2D3;PRKG2;MSRA;EVPL;ACVR2B;ST3GAL2;ABCA7;KLHL25;PKN2;PAK2;PSMC6;PSMB9;DDOST;MPI
prerank,sulfate transport (GO:0008272),-0.5214799713562299,-1.3263520345733726,0.13896457765667575,0.6056570461717665,1.0,3/14,2.75%,SLC13A4;SLC26A7;SLC26A2
prerank,regulation of leukocyte activation (GO:0002694),0.6004678176765582,1.326053031582258,0.16071428571428573,0.553821934556473,1.0,4/14,8.17%,GPR137B;MFHAS1;PLSCR1;CD200
prerank,positive regulation of glucose import (GO:0046326),-0.47213306780290965,-1.3257469955658872,0.13149847094801223,0.6047418729098127,1.0,8/21,8.20%,IGF1;SORBS1;RHOQ;IRS2;OSBPL8;IRS1;PIK3R1;PRKCI
prerank,negative regulation of locomotion (GO:0040013),0.6225051506220238,1.3256505234181342,0.180623973727422,0.5540321973568805,1.0,8/12,17.16%,CRK;SPOCK3;GATA3;DUSP3;SPINT2;PIN1;FRMD5;PTPN2
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.49523832394236844,1.3251046437386518,0.13820078226857888,0.5545931179492154,1.0,9/47,9.68%,RAPGEF2;CEACAM1;FYN;ATP2B4;CAV1;CD34;ZC3H12A;SNAI2;FBXW7
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.6472474024599285,1.3250163760460896,0.17,0.5539799771155467,1.0,3/10,3.83%,NOTCH4;NOTCH1;PPM1F
prerank,type I interferon signaling pathway (GO:0060337),0.49567706129766653,1.3250110742052277,0.12670299727520437,0.5522946396049201,1.0,11/41,12.68%,IRF6;IRF2;IRF9;IFNAR1;STAT1;OAS2;ADAR;EGR1;PSMB8;GBP2;IRF5
prerank,cellular response to type I interferon (GO:0071357),0.49567706129766653,1.3250110742052277,0.12670299727520437,0.5522946396049201,1.0,11/41,12.68%,IRF6;IRF2;IRF9;IFNAR1;STAT1;OAS2;ADAR;EGR1;PSMB8;GBP2;IRF5
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6038150744580084,1.3233456451785224,0.15654952076677317,0.5558978544781118,1.0,1/13,0.16%,CDH13
prerank,odontogenesis (GO:0042476),-0.4102366245192695,-1.323170839255984,0.09558823529411764,0.6094739908895344,1.0,7/35,2.67%,COL1A2;GLI2;FGFR2;EDA;BMP4;OSR1;WNT6
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.5451394651911643,1.3212472578321326,0.15519765739385066,0.5606985994274524,1.0,3/24,4.84%,SEMA3G;SEMA3F;SEMA7A
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.6179768380220035,1.3191034406768027,0.1697792869269949,0.5657894557185231,1.0,1/12,0.06%,NOS1
prerank,homeostasis of number of cells (GO:0048872),0.6175115358661789,1.3189577445899394,0.18092105263157895,0.5653332273799533,1.0,5/12,16.25%,NOS3;NOTCH1;LPCAT3;CX3CR1;OCIAD2
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.5206113106684285,-1.317737098335779,0.14698795180722893,0.6234422214579046,1.0,6/13,15.90%,LARGE1;MGAT3;RENBP;EXTL2;NAGK;PGM3
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.5436268847172692,1.3171889844988969,0.14929577464788732,0.5693959219754339,1.0,4/26,11.25%,PLCG2;SLC25A33;ADGRB1;CYBA
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.3909265135618565,-1.31657872618142,0.1,0.6240643112227596,1.0,11/43,9.40%,PID1;OGT;SORBS1;PRKCB;NUCKS1;GRB10;ENPP1;IRS1;IGF2;PIP4K2A;PRKCZ
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.64501302962669,1.3164407183087328,0.1711864406779661,0.5697790769915759,1.0,3/10,13.60%,AP2B1;AP2M1;VLDLR
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.64501302962669,1.3164407183087328,0.1711864406779661,0.5697790769915759,1.0,3/10,13.60%,AP2B1;AP2M1;VLDLR
prerank,response to alcohol (GO:0097305),-0.42432149372113137,-1.3158885941481182,0.11326860841423948,0.6233534257479518,1.0,3/27,1.84%,TGFBR3;TGFBR1;SLIT2
prerank,regulation of chemokine production (GO:0032642),0.5036879861010206,1.3133926189843053,0.14147018030513175,0.5772342271417238,1.0,13/36,20.46%,F2RL1;LGALS9;APP;TLR3;ADAM17;SNAI2;FOXP1;EGR1;HIF1A;PYCARD;AGER;SIGIRR;EIF2AK2
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.4299392477106566,1.313370526356347,0.10220673635307782,0.5764176744700003,1.0,17/116,11.24%,PLCG2;FYN;GPR39;ADRB2;FCGR2B;IAPP;HRH2;FURIN;MYH9;FCGR1A;ADAM17;CD247;MC4R;YES1;ADCY4;PLCG1;GLP1R
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.39484602136043506,1.3129211968146763,0.008032128514056224,0.5768403925214202,1.0,72/509,10.32%,PTPRJ;PLCG2;CDH13;TEK;PDGFD;ENG;RAPGEF2;HIP1;FLT1;PDGFB;FYN;TRIM14;FLT4;VWF;KITLG;NOD1;TBX1;JCAD;NOD2;INSR;DAB2IP;CAV1;CASP8;PRKD1;CAV2;F2RL1;TGFB2;CBL;LGALS9;ADRB2;FKBP1A;IQGAP1;APP;ACTN4;NOS1AP;TIRAP;TLR3;ATP2C1;PUM2;ANGPT1;GCNT2;IAPP;TRIM6;TNFSF10;PLEKHG5;FGFR3;BCAR3;GATA3;SMCR8;BBC3;PDCD4;JMJD8;MFHAS1;WDR59;JAK2;THPO;BCL2L1;NMI;GAPDH;ROCK1;PTK2;NDFIP2;HMGB1;RTN4;CASP1;RPL37;TRIM25;LURAP1;CHD5;RRAGD;CCL4;RAC1
prerank,positive regulation of ossification (GO:0045778),-0.39180121481271996,-1.3124883335523305,0.07575757575757576,0.6310599184989033,1.0,11/39,5.83%,PTN;BMP6;BMPR1A;WNT4;BMP7;ADGRV1;BMP4;OSR1;WNT5A;FBN2;KL
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5013538685450709,1.3123872847000215,0.14246947082767977,0.5774467704770925,1.0,7/38,8.13%,NOS3;FAS;ARHGEF2;CASP8;TNFSF10;MADD;BCL2L1
prerank,axon guidance (GO:0007411),0.41094605752234903,1.312005020082527,0.05561497326203209,0.5776881132317623,1.0,35/201,11.55%,SEMA3G;LAMA3;PTPRM;EFNA5;FYN;RPS6KA5;PLXNA4;NTN4;NOTCH1;KLF7;SEMA3F;SH3KBP1;EVL;PLXND1;LAMA5;NTN1;TMEFF1;DAB1;SEMA7A;EFNA1;ROBO4;SHANK3;MAPK1;BSG;ENAH;PTPRO;SEMA6D;SCN1B;PTK2;RAC1;CYFIP1;PLCG1;RANBP9;SEMA4G;DCC
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5156483413108921,1.3116881790384651,0.16502115655853314,0.5777062564583212,1.0,7/31,2.95%,ENG;SMAD7;MYBPC3;NOTCH1;TGFB2;FKBP1A;DLL4
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.573699434620601,1.3115349339968236,0.15919629057187018,0.5772755014062165,1.0,4/17,5.58%,HDAC9;APOA1;PCSK5;FURIN
prerank,protein targeting to ER (GO:0045047),0.43530604905134007,1.3112419494628538,0.07547169811320754,0.5772364783543907,1.0,47/99,26.25%,RPS21;RPL27;SRP14;RPL7;UBA52;RPS27A;RPS14;RPL35;RPL21;RPL37;RPS28;RPL34;RPS9;RPLP2;RPS25;RPL30;RPL27A;RPS5;SGTB;SRP9;RPL23A;RPS15;SRPRA;RPL19;RPS18;RPL32;SEC62;RPL37A;RPL18A;SRP19;ZFAND2A;RPL18;RPL39;RPS19;RPL31;SEC63;RPS8;SGTA;RPL3;SPCS2;RPL28;RPL9;RPL26;RPS16;RPLP1;CHMP4A;CHMP4B
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.4354022176783838,-1.3102266344962654,0.10682492581602374,0.6353698587284291,1.0,7/24,8.44%,IGF1;SORBS1;ENPP1;IRS2;IRS1;IGF2;PPP1R3B
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.4153271054787987,-1.310121753403642,0.11038961038961038,0.6328303294931827,1.0,9/27,11.82%,DCN;CHST15;PXYLP1;XYLT1;BGN;VCAN;B3GAT3;CHPF2;CSPG4
prerank,regulation of response to interferon-gamma (GO:0060330),0.5889328002395854,1.3094626329798178,0.1669421487603306,0.5813358089712412,1.0,3/14,7.75%,IFNGR1;STAT1;JAK2
prerank,basement membrane organization (GO:0071711),-0.5052908865670306,-1.3079199799600554,0.1424731182795699,0.6369355993603162,1.0,3/14,2.94%,FLRT2;NID1;NID2
prerank,gene silencing by miRNA (GO:0035195),0.5141370268777729,1.3079022378943725,0.14224137931034483,0.5849790828100266,1.0,9/32,14.75%,NOTCH4;TNRC6C;PUM2;ZC3H7A;ADAR;CNOT1;AGO4;RAN;EIF6
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.5084915620948359,1.3077951941117198,0.1563845050215208,0.5843812402832871,1.0,6/33,9.01%,ACER2;TGFB2;PDE3B;EFNA1;SNAI2;PTK2
prerank,nucleus organization (GO:0006997),0.4878534167836399,1.3075863770748943,0.13671875,0.5841264773981836,1.0,25/47,26.25%,SYNE1;IRAG2;SUN3;CHMP1B;NUP54;NUP35;NUMA1;VPS4A;REEP3;CHMP3;CEP55;CHMP2B;CHMP7;NUP205;SUN1;RPS19;CHMP1A;LEMD3;ATXN7;CTDNEP1;SEH1L;TPR;VPS4B;CHMP4A;CHMP4B
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.5373207699715876,-1.3074363546191314,0.15577889447236182,0.6356029264740203,1.0,2/12,3.18%,B3GALT1;B3GNT2
prerank,aminoglycan biosynthetic process (GO:0006023),-0.38080952986516353,-1.3068314458448136,0.10176991150442478,0.6345412819934705,1.0,10/49,7.02%,GPC6;B3GALT1;SDC2;GPC3;HSPG2;HS3ST3A1;B3GNT2;PXYLP1;XYLT1;HEXA
prerank,positive regulation of MAP kinase activity (GO:0043406),0.45416546052133017,1.3068015214302047,0.12392638036809817,0.5855568188481981,1.0,7/66,2.22%,EDN1;PDGFD;FLT1;PDGFB;PIK3R6;NOD2;DAB2IP
prerank,positive regulation of neuron projection development (GO:0010976),-0.3434588015877052,-1.3059797825278008,0.042682926829268296,0.634576760229376,1.0,19/85,6.23%,PTN;NTRK3;DPYSL3;ROR1;CAMK1D;EPHA3;BMP5;BMP7;PTK7;COBL;NDNF;WNT5A;MAGI2;APOE;CBFA2T2;NTRK2;PLXNB2;CAMK1;ROR2
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4533327573041254,1.3059285042349775,0.12317073170731707,0.5871364889062287,1.0,16/76,12.25%,SMAD7;FAM107A;CAV1;FKBP1A;ANGPT1;CUL3;UBE2D1;LRRK2;ZC3H12A;UBE3A;NDFIP2;FBXW7;NSMCE3;LAPTM5;BRCA1;FBXO4
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.4993088142902641,-1.3053275674931715,0.1807909604519774,0.6337985356443894,1.0,7/16,18.32%,AUTS2;SNW1;WDR5;CTR9;PIH1D1;BCOR;DNMT3B
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.4318166159261695,-1.3052023137762387,0.10365853658536585,0.6314534612526326,1.0,8/25,12.05%,ERRFI1;CBLB;PPARA;SNX6;SLC6A9;TSG101;PPARG;CNRIP1
prerank,protein localization to plasma membrane (GO:0072659),0.42300904158357483,1.3051848019129018,0.08247422680412371,0.5883792101734759,1.0,26/129,10.46%,EHD4;EFR3B;RAPGEF2;F11R;RAB11A;TMEM88;ZDHHC22;PACS1;EMP2;INPP5K;FCHO2;TSPAN14;EHD1;DPP6;RAB34;DPP10;RAPGEF6;TSPAN32;PACSIN1;MRAP2;BSG;ROCK1;NKD2;RAB40B;CLASP2;CCDC88A
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5820931080750946,1.3047144378331623,0.1890547263681592,0.5888301100305818,1.0,2/15,0.80%,CDH13;CEACAM1
prerank,actin filament polymerization (GO:0030041),-0.41888868406961377,-1.304528467080263,0.10927152317880795,0.6308207523939796,1.0,7/29,7.30%,ARHGAP6;GAS7;GSN;COBL;WASF1;WASHC3;PREX1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.4760295568741943,1.3044660295390058,0.1248339973439575,0.5886426021705642,1.0,10/48,14.75%,PRDM16;JMJD8;NUP54;NUP35;RANBP2;NUP153;HIF1A;NUP160;NUP42;EIF6
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.4916097769548856,-1.3043722902625936,0.15608465608465608,0.6286001123039393,1.0,7/17,11.91%,ROBO1;SLIT2;EFNB2;FGF2;GPLD1;VEGFA;EPHB4
prerank,anion transmembrane transport (GO:0098656),-0.3491298832885373,-1.3037041048244777,0.0893854748603352,0.6279601503965403,1.0,14/67,8.24%,SLC6A13;SLC1A3;SLC16A12;SLC7A2;SLC13A4;SLC13A3;SLC25A13;SLC25A4;SFXN2;SLC39A8;SLC19A1;SLC6A9;LRRC8D;SLC27A1
prerank,regulation of superoxide anion generation (GO:0032928),0.5917390931771817,1.3036503683365839,0.1625615763546798,0.5899195017786739,1.0,4/14,10.27%,F2RL1;ITGAM;AATF;TYROBP
prerank,regulation of cytoplasmic translation (GO:2000765),-0.5230353267088186,-1.3031478532940721,0.1424802110817942,0.6269750262456825,1.0,5/14,13.03%,CPEB1;UNK;YBX3;CPEB2;CPEB3
prerank,intraciliary retrograde transport (GO:0035721),-0.5235263955865008,-1.3020769999561672,0.1752021563342318,0.6275836802006234,1.0,8/12,21.44%,WDR35;DYNC2LI1;IFT43;DYNC2I2;TTC21B;WDR19;DYNC2H1;DYNC2I1
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.47741891451183804,-1.3020033477508635,0.14018691588785046,0.6251605977975193,1.0,3/18,2.14%,EGFR;DDX5;BMP4
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.49268471847874135,-1.3019427126616752,0.16489361702127658,0.6227008580189404,1.0,6/16,15.22%,PDK1;PRKN;RORA;PDK3;FOXK2;PDK2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.511397276205556,1.3013436116522625,0.16164383561643836,0.5957346484712266,1.0,6/32,4.69%,ACER2;JAG1;ACVRL1;FAM107A;ADAM15;MAP4K4
prerank,iron ion transmembrane transport (GO:0034755),-0.5471287456515563,-1.3013244216151587,0.1722488038277512,0.6220178520261029,1.0,3/10,4.72%,SLC39A14;SCARA5;SLC39A8
prerank,actin polymerization or depolymerization (GO:0008154),-0.37092431178700963,-1.3004194156934266,0.11618257261410789,0.6223542953875169,1.0,9/50,4.45%,ARHGAP6;MICAL3;GAS7;GSN;MICAL2;COBL;WASF1;SVIL;WASHC3
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.5826360659962606,1.3003655914169143,0.17828200972447325,0.5976868188932932,1.0,2/16,2.76%,CRTAM;CADM1
prerank,regulation of monooxygenase activity (GO:0032768),0.5311190013529009,1.3000856851192224,0.16541353383458646,0.5975857412824847,1.0,4/23,6.18%,NOS3;CAV1;NOS1AP;IL1A
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.5679694403288679,1.2998771183643787,0.1643835616438356,0.5973108655663744,1.0,4/17,9.00%,CLDN5;F11R;PROC;ROCK1
prerank,hematopoietic stem cell proliferation (GO:0071425),0.6307436522535053,1.2996942051595828,0.18717504332755633,0.5969580480460702,1.0,2/11,5.66%,MECOM;CD34
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.48676242944103876,1.2996699327698689,0.1731301939058172,0.5961493044392531,1.0,4/38,5.56%,PTPRJ;INPP5K;HYAL2;PLEKHA1
prerank,urogenital system development (GO:0001655),-0.5387172999124528,-1.2994292135180718,0.17688679245283018,0.6227683890124951,1.0,5/11,20.26%,OSR1;ANXA1;EPHB2;EPHB3;PAX2
prerank,regulation of osteoblast differentiation (GO:0045667),-0.3375878794307198,-1.2985123393185332,0.052941176470588235,0.6227144228496533,1.0,22/82,11.11%,RANBP3L;BMP6;IGF1;BMPR1A;SMOC1;FGFR2;WNT4;BMP7;DDX5;BMP4;TMEM64;LIMD1;RUNX2;FBN2;NOCT;IL6R;ATP6AP1;PRKACA;PTCH1;REST;IFITM1;PPARG
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.53333141296515,-1.298394919841169,0.15789473684210525,0.6205547023079722,1.0,6/12,22.36%,SMO;SIX1;VEGFA;PAX2;AGT;SIX4
prerank,positive regulation of GTPase activity (GO:0043547),0.40686494554888153,1.2982537388400035,0.06437768240343347,0.5991991784515491,1.0,42/188,14.13%,RAPGEF2;DOCK9;RABGAP1;SIPA1L2;F11R;ARHGEF15;RAPGEF1;RASGRP2;ABR;CAV2;F2RL1;AGRN;SIPA1L3;RALGAPA1;BCR;TBC1D30;SGSM1;MAP4K4;RAPGEF6;RAP1GDS1;TBC1D8;BCAR3;TIAM2;RGS7;RANGAP1;ARHGAP25;TBC1D12;TBC1D5;RSU1;TBC1D1;TAX1BP3;RAP1GAP2;CCL4;RALGAPB;ARHGAP27;USP6NL;PIN1;TBC1D10A;TBC1D4;ARHGEF10;RALGAPA2;TBC1D9
prerank,response to interleukin-4 (GO:0070670),0.628940507413061,1.2981929800959309,0.16474464579901152,0.5984975134683092,1.0,2/10,6.13%,LEF1;GATA3
prerank,cartilage development (GO:0051216),-0.3788904123156776,-1.2980309569316957,0.0984251968503937,0.6191555725586853,1.0,17/49,13.13%,SOX5;SULF1;SULF2;BMP4;OSR1;SLC39A14;TRIP11;RUNX2;ITGB8;FGF2;CCN3;RUNX1;GPLD1;HYAL1;NFIB;PKD1;HMGA2
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.4320207088044273,-1.297616751503031,0.12987012987012986,0.6180171205655629,1.0,4/26,4.93%,EYA2;EYA1;BCL2;EYA4
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.4248697061756227,1.297375157251617,0.10957324106113034,0.5999072581575069,1.0,17/117,11.24%,PLCG2;FYN;GPR39;ADRB2;IAPP;HRH2;KARS1;FURIN;MYH9;FCGR1A;ADAM17;CD247;MC4R;YES1;ADCY4;PLCG1;GLP1R
prerank,regulation of amyloid fibril formation (GO:1905906),0.5781247469173775,1.297371492789228,0.18093699515347333,0.5990399306895775,1.0,6/15,11.75%,APP;IAPP;PFDN6;VBP1;PFDN2;CLU
prerank,cellular biogenic amine metabolic process (GO:0006576),0.6111418913941675,1.2972881887740753,0.1837748344370861,0.5984210907448935,1.0,4/12,11.18%,AMD1;ATP7A;MAOA;SMS
prerank,regulation of vasoconstriction (GO:0019229),0.5272099667567547,1.2971974652709175,0.17024320457796852,0.5977996350006767,1.0,4/27,6.23%,BMPR2;ACE;CAV1;CHRM3
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.3804187751105292,-1.2969985766805636,0.12727272727272726,0.6174080525788721,1.0,15/41,22.96%,ACSL1;PTGS1;PLA2G4A;SCP2;DEGS1;FADS3;SCD;GSTM2;FADS2;ELOVL1;ALOX12;PLA2G4C;FAAH;GPX4;GPX1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.6347943862791335,1.296331368503223,0.17264957264957265,0.5993960715644838,1.0,4/11,11.20%,KCNE3;CAV1;STK39;NEDD4L
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.5751891257954983,1.2962893599535803,0.18095238095238095,0.5986312907584206,1.0,2/17,2.76%,CRTAM;CADM1
prerank,negative regulation of inflammatory response (GO:0050728),0.4096519078721526,1.295929515077327,0.08415300546448087,0.5987282867299843,1.0,29/182,11.29%,PLCG2;TEK;FYN;AOAH;GPR39;ADRB2;APOA1;KLF4;IAPP;HRH2;FURIN;TNFRSF1B;MYH9;FCGR1A;GATA3;ADAM17;CD247;MFHAS1;MC4R;CD200;PROC;NR1D1;ACOD1;YES1;LPCAT3;ADCY4;PLCG1;GLP1R;VPS35
prerank,regulation of cytokine production (GO:0001817),0.4206418556102692,1.2957332790991354,0.09610983981693363,0.5984302020218695,1.0,19/126,10.79%,AFAP1L2;RPS6KA5;CRTAM;CASP8;IFIH1;LGALS9;CADM1;HDAC9;FCGR2B;TNFRSF1B;GATA3;IL1A;BCL6B;CD47;SNAI2;GAPDH;FOXP1;LURAP1;POLA1
prerank,cellular amino acid catabolic process (GO:0009063),0.4393742878063307,1.2946766169155335,0.109375,0.6005042080508606,1.0,8/87,6.89%,NOS1;NOS3;BCAT2;GLS2;GLS;ARG1;GLUD1;HGD
prerank,protein mannosylation (GO:0035268),-0.43972703491014786,-1.2944300746468886,0.1467065868263473,0.6225257104772055,1.0,4/22,3.46%,TMTC4;TMTC1;LARGE1;CRPPA
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.6285103548747673,1.2934035264683257,0.20512820512820512,0.60325313972841,1.0,2/10,3.86%,APOA1;KLF4
prerank,cellular response to estrogen stimulus (GO:0071391),0.5824539072931006,1.2932964911175069,0.20414673046251994,0.6026775811720465,1.0,7/14,19.13%,PELP1;TRIM24;NCOA4;ARID5A;SFR1;RARA;WBP2
prerank,regulation of intracellular signal transduction (GO:1902531),0.39028995865490573,1.293277145278843,0.027439024390243903,0.6018681531259674,1.0,63/420,10.80%,PLCG2;RASGRF2;SGMS1;NUAK1;ARHGEF3;TEK;PIP5K1B;KALRN;ARHGAP31;CEACAM1;VWF;PLK3;CHN2;FBXL2;CASTOR1;ARHGEF2;DAB2IP;ABR;F2RL1;RHOB;TRIO;BOP1;CRK;PPP1R13B;RBBP8;ARAP3;BCR;ING2;RRAS;MAP4K4;ARHGAP8;TRIM6;PLEKHG5;AKAP5;PPP1R16B;TAF9B;TRAF1;SRGAP1;GPR143;MAPK1;PAK1IP1;ARHGDIA;PIP5K1C;TIAM2;CMKLR1;LRRK2;MCF2L;ARHGAP5;ARHGAP25;HSPB1;PRKAA1;WWC2;INPP5B;SLC15A4;PPP2R5C;SGK1;TAOK2;ARHGEF1;RAC1;DIPK2A;NFKBIA;MINK1;BRIP1
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.5770427874625521,1.2931521664474754,0.20063191153238547,0.6013630084838589,1.0,2/16,1.04%,BMPR2;ACE
prerank,inositol phosphate biosynthetic process (GO:0032958),0.6033905065551405,1.2922791161296372,0.19145299145299147,0.602909147801257,1.0,3/11,3.58%,ITPKB;IP6K3;IPPK
prerank,regulation of microtubule polymerization (GO:0031113),0.4810942408317953,1.2919151040070003,0.14464534075104313,0.6030698565576594,1.0,10/40,10.99%,STMN2;OCLN;FES;CAMSAP2;PRUNE1;CLIP1;CLASP1;MAPRE3;RAC1;NUMA1
prerank,positive regulation of cell cycle (GO:0045787),0.4584223319354726,1.2913935556495086,0.14068441064638784,0.603650758269745,1.0,11/62,7.68%,PDGFB;CCNY;CCND2;CCND3;TAL1;TGFB2;APP;TTL;ADAM17;DUSP3;MAPRE3
prerank,protein catabolic process (GO:0030163),0.4571653768181612,1.2911852129351913,0.13814955640050697,0.6033870135343056,1.0,19/59,20.70%,CEACAM1;DENND3;DAB2IP;PPT1;MANBA;TRIM24;SOCS6;NR1D1;SIAH2;BAG6;PSMA8;FBXO2;OGA;FBXO6;LAMP2;NGLY1;NEU4;RNF5;RAB12
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.40993190648121997,1.2907752338543408,0.08738938053097345,0.6037121206251104,1.0,25/151,10.31%,TEK;PDGFD;RAPGEF2;PDGFB;FLT4;CCR1;NOTCH1;NOD2;F2RL1;LGALS9;APP;TIRAP;ANGPT1;GCNT2;ARHGAP8;SEMA7A;FGFR3;MFHAS1;ARRB1;PDE8A;THPO;HTR2A;HMGB1;FBXW7;CCL4
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.4330462031936211,1.290624472451279,0.11652794292508918,0.6032849489407376,1.0,39/87,25.98%,RPS21;RPL27;SRP14;RPL7;UBA52;RPS27A;RPS14;RPL35;RPL21;RPL37;RPS28;RPL34;RPS9;RPLP2;RPS25;RPL30;RPL27A;RPS5;SRP9;RPL23A;RPS15;RPL19;RPS18;RPL32;RPL37A;RPL18A;SRP19;RPL18;RPL39;RPS19;RPL31;SEC63;RPS8;RPL3;RPL28;RPL9;RPL26;RPS16;RPLP1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.5034783841803031,1.2905937545778337,0.16981132075471697,0.6024967804037399,1.0,3/30,1.04%,FLT1;FLT4;ACE
prerank,triglyceride biosynthetic process (GO:0019432),-0.467656266724104,-1.290242655315611,0.14551083591331268,0.6326207249066973,1.0,5/18,9.95%,AGMO;LPGAT1;MOGAT3;DGAT1;GK
prerank,negative regulation of lipid metabolic process (GO:0045833),0.5360069590351366,1.289411383083701,0.17771084337349397,0.6049345288285021,1.0,4/22,8.31%,CEACAM1;PDE3B;ALK;PRKAA1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.529732664641868,1.2893238956549797,0.2006172839506173,0.6043598139317282,1.0,4/22,4.28%,STMN2;RAPGEF2;RAPGEF1;EHD1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.5099625978072666,-1.2889987290439806,0.16052631578947368,0.6337199330850013,1.0,7/13,20.01%,SORBS1;IRS1;IGF2;PRKCZ;ECHDC3;ZBTB7B;SNX5
prerank,positive regulation of establishment of protein localization (GO:1904951),0.5604338185901602,1.2884829021271922,0.1943620178041543,0.6058834974053666,1.0,11/18,26.06%,CCT8;CEP135;DKC1;CCT2;CCT4;CCT6A;CEP120;TCP1;CCT3;WRAP53;PTP4A3
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6060888215344156,1.2884021588042298,0.1941747572815534,0.605254754621656,1.0,6/13,18.79%,HEY1;HEY2;MAD2L2;TMSB4X;SIN3A;SOX11
prerank,ear morphogenesis (GO:0042471),-0.45667387494395556,-1.2883409809262152,0.1585014409221902,0.6331120814166968,1.0,5/20,7.03%,ZIC1;FGFR2;OSR1;NIPBL;SIX1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.6102346378636048,1.2879263935796534,0.21018062397372742,0.6057224560634703,1.0,2/11,1.74%,MERTK;NOD2
prerank,histone H4-K16 acetylation (GO:0043984),-0.4595639242023609,-1.2879190316844629,0.1564245810055866,0.6317907648921686,1.0,6/19,13.51%,OGT;KANSL2;PHF20;WDR5;MEAF6;MSL3
prerank,catecholamine biosynthetic process (GO:0042423),0.6193734092811366,1.2878771914362144,0.2020033388981636,0.6050002195499453,1.0,3/11,6.13%,TGFB2;GCH1;GATA3
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.45810845088235436,1.2877926038969532,0.13927227101631118,0.6043554416528801,1.0,19/60,15.54%,PDGFB;HMBOX1;KLF4;MAPK1;CCT8;NVL;NEK7;DKC1;PTGES3;TNKS;POLG2;CCT2;PRKD2;FBXO4;CCT4;ATM;CTNNB1;CCT6A;RFC2
prerank,microtubule polymerization or depolymerization (GO:0031109),0.5210729416708647,1.2875865596110831,0.1797583081570997,0.6040663533974643,1.0,5/24,13.56%,TRPV4;STMN2;KIF2A;PIN1;KIF24
prerank,embryonic hemopoiesis (GO:0035162),0.5966585035661576,1.287508668633708,0.18494271685761046,0.6034360432837698,1.0,3/12,8.04%,KITLG;TAL1;TPO
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.46680368324817795,-1.2867705995573722,0.16944444444444445,0.6327647843209365,1.0,5/17,12.36%,BMP6;SASH1;CD55;PRKCA;CD180
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.5005178614810877,-1.2863675248885902,0.16052631578947368,0.6315242498927024,1.0,7/13,22.11%,GCC2;CD81;SAR1A;SEC16B;SEC16A;SAR1B;TM9SF4
prerank,melanosome transport (GO:0032402),0.5477516416511188,1.2862508740864538,0.20280811232449297,0.6052546368501597,1.0,4/18,6.14%,RAB11A;BLOC1S6;BBS7;GPR143
prerank,pigment granule transport (GO:0051904),0.5477516416511188,1.2862508740864538,0.20280811232449297,0.6052546368501597,1.0,4/18,6.14%,RAB11A;BLOC1S6;BBS7;GPR143
prerank,oligosaccharide metabolic process (GO:0009311),0.4705758933962905,1.285791228452865,0.15323645970937913,0.6056400419209022,1.0,5/46,5.72%,ST6GALNAC3;ST8SIA6;ST3GAL6;MANBA;ST6GAL2
prerank,regulation of interleukin-13 production (GO:0032656),0.5966893981247989,1.2857454977258533,0.19935691318327975,0.6049249614933622,1.0,3/13,6.13%,LGALS9;LEF1;GATA3
prerank,keratinocyte differentiation (GO:0030216),0.5159182764158554,1.2853509126174167,0.1729957805907173,0.6051857303138064,1.0,3/29,4.02%,JAG1;CLIC4;BCR
prerank,vesicle organization (GO:0016050),0.4730162952231682,1.2850708311344765,0.14877102199223805,0.6051192599347225,1.0,16/46,20.25%,ALS2CL;CAV1;CAV2;CD34;SNX10;FNBP1L;HOOK1;EXOC8;SNX11;CHMP2B;ZFYVE16;SRGN;PHETA1;HOOK2;EPS15;SORT1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.46311969634711925,1.2850541189815938,0.14829396325459318,0.604323550808041,1.0,8/56,4.00%,ENG;SMAD6;BMPR2;SMAD7;ACVRL1;RBPMS;TGFB2;ACVR1
prerank,SNARE complex assembly (GO:0035493),0.6233438478270198,1.2846436679255784,0.21147540983606558,0.6046303843482447,1.0,2/10,7.44%,STXBP6;VAMP8
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.5168682552641629,-1.2843920796167594,0.17010309278350516,0.6348386489812242,1.0,2/13,3.18%,B3GALT1;B3GNT2
prerank,regulation of viral entry into host cell (GO:0046596),0.512017734837628,1.2843447284522544,0.16690856313497823,0.604616815308352,1.0,7/30,11.51%,TRIM14;LY6E;LGALS9;TRIM11;TRIM6;TRIM25;HS3ST5
prerank,defense response to bacterium (GO:0042742),0.4233809694538636,1.28365812213822,0.12427409988385599,0.6057187776362907,1.0,29/105,21.64%,NOD1;NOD2;GBP4;TIRAP;TLR3;ANXA3;DEFA6;ADAM17;IRGM;GALP;OAS2;ADGRB1;GBP2;CHGA;RPL30;HMGB2;RNASE6;LYST;SLPI;GBP7;PYCARD;STAB2;DROSHA;EPX;ANG;ANKRD17;RPL39;STAB1;RPS19
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.525940534191813,1.2834865552895587,0.17804154302670624,0.6053557211289358,1.0,7/24,13.45%,KLF2;NOTCH1;MBTPS2;NFE2L2;CHD6;GCN1;HIF1A
prerank,glycoprotein biosynthetic process (GO:0009101),0.43655041086768726,1.282933459129373,0.1402439024390244,0.6060530467871319,1.0,11/79,8.09%,GCNT1;ST8SIA6;BMPR2;ST3GAL6;ST6GALNAC2;SERP2;ATP7A;GCNT2;CHST11;NUS1;B3GNT3
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.49768304071997915,1.2825632385299728,0.18349928876244664,0.606176979543622,1.0,13/31,21.98%,LSM1;EXOSC3;DCP1B;DCPS;POLR2G;EXOSC8;EDC3;DDX6;NT5C3B;EXOSC9;LSM2;DIS3L2;EXOSC1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.49575368636309786,-1.2822343462175443,0.16580310880829016,0.6388416960858084,1.0,6/14,15.50%,SULF1;SULF2;THBS1;FGF2;CREB3L1;GPC1
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.4548640169288533,1.2820957781419209,0.138676844783715,0.6066889191007492,1.0,18/59,12.89%,SBK1;PRKD1;CDC42BPA;OXSR1;CDC42BPG;ACVR1;CAMK2D;NLK;MAPK1;LRRK2;LMTK2;STK39;CAD;ROCK1;TNKS;PRKD2;MARK2;TTBK1
prerank,regulation of autophagosome maturation (GO:1901096),0.6078563864549653,1.2820341463542921,0.2064516129032258,0.6060262803565022,1.0,6/13,17.81%,ADRB2;SMCR8;IRGM;FYCO1;RUBCN;UBQLN4
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.5080868941328054,1.2816442853495893,0.1900709219858156,0.606259401332223,1.0,3/27,4.76%,NOS1;FKBP1A;CAMK2D
prerank,peptidyl-tyrosine modification (GO:0018212),0.4611983752956164,1.2815536834986834,0.14490861618798956,0.6057086739794045,1.0,9/56,5.44%,TEK;FLT1;PDGFB;FYN;FLT4;INSR;FES;TTL;FGFR3
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.4997936884759742,1.281030996855205,0.1786703601108033,0.606318126823083,1.0,8/32,9.80%,STMN2;ARHGEF2;FKBP4;CAMSAP2;TTBK2;CLASP1;APC;CLASP2
prerank,bicarbonate transport (GO:0015701),-0.43172918242366126,-1.2809921628572527,0.1456953642384106,0.639909265793977,1.0,10/25,22.32%,SLC4A10;SLC26A7;CA2;SLC39A8;SLC4A2;SLC4A3;SLC26A6;CYB5RL;SLC4A8;CFTR
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.5202535238402042,1.2805853591235992,0.17991004497751126,0.6067710844948555,1.0,6/26,7.97%,FYN;FBXO7;LRRK2;HSPB1;PDE8A;NFE2L2
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5503091525776851,1.280497592833243,0.1901081916537867,0.6061998221939933,1.0,6/19,9.92%,NOTCH4;NOTCH1;PPM1F;PTPRU;TJP1;MAD2L2
prerank,synaptic vesicle membrane organization (GO:0048499),-0.47920262713536876,-1.2795267301349804,0.18435754189944134,0.6419076838818892,1.0,11/17,30.67%,STX4;SNAP23;SNAP25;STX3;SNAP47;SNAP29;TOR1A;STX2;SYNGR1;STX1A;SYP
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.6110973088344546,1.2794887392547254,0.20853858784893267,0.6081737591742314,1.0,4/11,6.13%,JAG1;TGFB2;HEY2;GATA3
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.4569659284307603,-1.279388451828154,0.15047021943573669,0.6398216785617798,1.0,3/20,2.40%,PID1;DAB2;RHOQ
prerank,positive regulation of signaling receptor activity (GO:2000273),0.48747472379717754,1.278526656956367,0.1829787234042553,0.6100542172455018,1.0,6/36,9.68%,EDN1;ADRB2;SHANK3;ADAM17;JAK2;FBXW7
prerank,plasma membrane repair (GO:0001778),0.5805956519167703,1.278117788394504,0.2059800664451827,0.6103690290505894,1.0,4/13,10.62%,DYSF;SYT7;MYH9;MYOF
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.39774149561887895,1.277851208258711,0.06512605042016807,0.6103122601745329,1.0,42/234,12.82%,PLCG2;EDN1;TRIM14;RPS6KA5;NOD1;NEUROG2;NOD2;ARHGEF2;AIM2;CAV1;PRKD1;LGALS9;APP;TIRAP;ANXA3;TRIM6;TRAF1;IRAK2;FANK1;ALK;IL1RAP;MBTPS2;HSPA1B;CD200;UBA52;RPS27A;TCF3;DHX9;TRIM25;RHEBL1;NFKBIB;NFKBIA;CRTC1;TAB2;NPM1;ARID5B;TRIM8;CLU;PRKD2;RTKN2;CX3CR1;BTK
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.517748408025108,1.2777669134402174,0.2009132420091324,0.6097441847499793,1.0,2/26,0.50%,GCNT1;ST8SIA6
prerank,positive regulation of immune system process (GO:0002684),0.5764997360551934,1.277605061461902,0.21671826625386997,0.6093501832620254,1.0,3/16,3.49%,TGFB2;LGALS9;TNFRSF18
prerank,regulation of Ras protein signal transduction (GO:0046578),0.42831706231049227,1.2769398555572566,0.12976190476190477,0.6104327841456644,1.0,13/85,7.75%,EPS8L2;ARHGEF28;DENND3;NOTCH1;RAPGEF1;ARHGEF2;DAB2IP;TGFB2;BCR;ARHGDIA;SHOC2;MADD;JAK2
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.5043042135764592,-1.276285131227995,0.1918158567774936,0.6466928215409905,1.0,2/13,2.14%,GLI2;BMP4
prerank,regulation of mitotic cell cycle (GO:0007346),0.39883395318085735,1.275717426651646,0.08974358974358974,0.6129491444103,1.0,47/171,19.37%,AFAP1L2;TAL1;TTC28;CAV2;BTG2;IQGAP1;APP;BTG1;RPRM;TTL;PSMD13;ASAH2;CDC25C;UBE2D1;PSMD4;DUSP3;PIM3;NEK7;PSMA5;PSMB10;PSMB8;ANGEL2;PSMD14;NEK11;RPS6KB1;PSMA7;PSMA8;PIN1;PSMC3;UBE2E1;CDC27;PSMB5;PSMC1;PSMC5;MEIS2;XPC;BTG3;PKN2;PSMC6;PSMB9;ANAPC7;PSMA4;PSMD5;PSMD9;PSMB6;ANAPC4;MAEA
prerank,regulation of platelet activation (GO:0010543),0.5393008319739456,1.27564871497776,0.17480314960629922,0.6123096593995992,1.0,2/21,0.89%,NOS3;PDGFB
prerank,autophagy of peroxisome (GO:0030242),0.5848574420832495,1.2755523856350328,0.17647058823529413,0.6117672328628181,1.0,4/12,13.34%,TRAPPC8;NBR1;PIK3C3;ATM
prerank,positive regulation of interleukin-2 production (GO:0032743),0.5185897171362707,1.275360205334665,0.19523099850968703,0.6114710919624436,1.0,1/25,0.08%,PLCG2
prerank,anion transport (GO:0006820),-0.40479618457376954,-1.2750391002965218,0.13138686131386862,0.6477920625028747,1.0,9/33,8.34%,SLC13A4;SLC13A3;SLC26A7;SLCO2B1;SLC17A5;SLC22A6;SLC19A1;LRRC8D;SLC4A2
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.5935749832603534,1.2746416484927943,0.2066115702479339,0.6125965690416036,1.0,4/12,16.95%,CEACAM1;BRCA1;ERLIN2;TRIB3
prerank,calcium ion transport into cytosol (GO:0060402),0.5371143460438779,1.2743938198815368,0.18712574850299402,0.6124439021297253,1.0,7/21,11.34%,TRPV4;ITPR3;ATP2B4;SLC8A1;GRIN2B;GRIN2C;TRPM2
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.4931109599910736,1.274302813657954,0.180028129395218,0.6118649102555973,1.0,11/32,14.31%,HMBOX1;MAPK1;CCT8;NEK7;TNKS;CCT2;FBXO4;CCT4;ATM;CTNNB1;CCT6A
prerank,O-glycan processing (GO:0016266),0.4592815636363167,1.2742877341258794,0.15223097112860892,0.6110980584543648,1.0,12/54,15.29%,GCNT1;POMGNT1;ST6GALNAC2;GALNT5;GALNT15;GALNT7;B3GNT3;C1GALT1C1;XXYLT1;GALNT4;ST3GAL1;ST3GAL2
prerank,negative regulation of GTPase activity (GO:0034260),0.527697055761501,1.2742691090366212,0.19523099850968703,0.6103251450158889,1.0,5/22,6.86%,F11R;DAB2IP;LRCH1;SH3BP4;LRRK2
prerank,dendritic cell chemotaxis (GO:0002407),0.5909348445983462,1.2738963001431958,0.20458265139116202,0.6105244343592403,1.0,4/14,14.18%,CCR1;HMGB1;TRPM2;CXCR4
prerank,histone H4-K5 acetylation (GO:0043981),-0.48351931161705686,-1.2738267345696155,0.1717171717171717,0.6464099276808792,1.0,5/15,11.18%,OGT;KANSL2;PHF20;WDR5;MEAF6
prerank,histone H4-K8 acetylation (GO:0043982),-0.48351931161705686,-1.2738267345696155,0.1717171717171717,0.6464099276808792,1.0,5/15,11.18%,OGT;KANSL2;PHF20;WDR5;MEAF6
prerank,negative regulation of hormone secretion (GO:0046888),-0.5433809219984138,-1.273707296628879,0.18706697459584296,0.6443390901279842,1.0,2/10,8.55%,GJA1;RAB11FIP1
prerank,calcium ion import (GO:0070509),0.5058654869791316,1.2735733426323588,0.16428571428571428,0.6106005709450998,1.0,6/28,8.24%,TRPV4;CACNA1A;MCUB;SLC8A1;SMDT1;MCUR1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.496647414217782,-1.2735463693460496,0.15406976744186046,0.6423757333531499,1.0,6/15,8.08%,FGFR2;PDGFRA;TGFBR1;NIPBL;SIX1;MTHFD1
prerank,mesenchyme development (GO:0060485),-0.48608823472733953,-1.2735297036171047,0.16886543535620052,0.639984594623926,1.0,4/15,2.14%,FGFR2;TGFBR1;BMP7;BMP4
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.5460712159094647,1.2734196773192779,0.21060842433697347,0.6101893571868481,1.0,4/17,9.66%,NOD2;ARL6IP5;TGFB2;TAOK2
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.49610788160431185,1.2733563553220584,0.1752873563218391,0.609562861728324,1.0,9/35,11.52%,SEMA3G;PLXNA4;SEMA3F;PLXND1;SEMA7A;ARHGDIA;SEMA6D;RAC1;SEMA4G
prerank,negative regulation of cell population proliferation (GO:0008285),0.385536696625696,1.2731789256651362,0.050515463917525774,0.6092507464007386,1.0,44/351,9.08%,PTPRJ;CDH13;NOS3;GATA6;IRF6;RAPGEF2;GATA2;SMAD6;BMPR2;SMARCA2;PTPN14;FOXO4;ITGA1;ACVRL1;NOTCH1;B2M;ADARB1;DAB2IP;AQP11;TGFB2;HNF4A;BTG2;DLL4;APP;BTG1;PLPP1;KLF4;WARS1;GATA3;IL1A;SH3BP4;IGFBP7;SLC16A2;HSPA1B;JAK2;CEBPA;PTPRU;CD200;APC;NMI;CTNNBIP1;MCC;PPP2R5C;KLF11
prerank,positive regulation of cytokine production (GO:0001819),0.389516224590902,1.2728623892860014,0.05327868852459016,0.6092959959700308,1.0,41/292,12.00%,PLCG2;AFAP1L2;PLCB1;FLT4;NOD1;CRTAM;GBP5;NOD2;PAEP;ARHGEF2;F2RL1;IFIH1;LRRFIP1;LGALS9;CADM1;APP;TIRAP;TLR3;TRIM6;HYAL2;DDX41;TMED10;CD34;GATA3;IL1A;ADAM17;HSPA1B;CD200;GAPDH;POLR3B;LTB;FOXP1;EGR1;HMGB1;DHX9;LURAP1;TYROBP;CYBA;LAPTM5;BRCA1;PRKD2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.4496834448419067,-1.2727038645353888,0.1691842900302115,0.6375831687389809,1.0,13/21,24.35%,DDB2;CUL4B;CUL4A;ERCC5;ERCC2;GTF2H5;GTF2H1;RPA3;GTF2H4;RPA1;PARP1;CHD1L;RPA2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.4496834448419067,-1.2727038645353888,0.1691842900302115,0.6375831687389809,1.0,13/21,24.35%,DDB2;CUL4B;CUL4A;ERCC5;ERCC2;GTF2H5;GTF2H1;RPA3;GTF2H4;RPA1;PARP1;CHD1L;RPA2
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.5047655530245213,-1.2724613665691675,0.18518518518518517,0.6357972991615325,1.0,7/13,22.11%,BCAP31;CD81;SAR1A;SEC16B;SEC16A;SAR1B;TM9SF4
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.40409842445484584,1.2718436221878375,0.10543840177580466,0.611268713266215,1.0,19/150,10.75%,PTPRJ;TEK;ENG;HIP1;PDGFB;FYN;KITLG;INSR;ANGPT1;GCNT2;IAPP;FGFR3;GATA3;MFHAS1;THPO;PTK2;RTN4;RAC1;FGF20
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.4965808189346392,1.2716717667439832,0.19204389574759945,0.6109569195961065,1.0,9/33,13.45%,GATA2;PDGFB;TGFB2;KLF4;GATA3;JUN;EGR1;APLN;HIF1A
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.46500492207195887,1.2715828252404844,0.17662337662337663,0.6104096392422802,1.0,9/47,11.25%,PLCG2;PDGFB;F2RL1;ZC3H12A;ITGAM;ACOD1;TYROBP;ADGRB1;CYBA
prerank,protein destabilization (GO:0031648),0.4976034541215847,1.2714653133495328,0.18258426966292135,0.609927798379227,1.0,6/32,9.94%,SOX17;CCDC88C;CUL3;IRGM;NR1D1;PRNP
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.5259301359068997,-1.271147865105055,0.17721518987341772,0.6372498017029528,1.0,5/11,17.91%,PDPN;RREB1;SRC;ARPIN;ENPP2
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.53324410506546,1.2708613579187624,0.19236417033773862,0.6108120792668775,1.0,4/21,7.34%,CD2AP;DAB2IP;TGFB2;ARHGAP25
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.5916531354306924,1.2700222033407023,0.19806763285024154,0.6123004365782595,1.0,3/12,3.76%,UNC13B;DOC2B;SYT7
prerank,positive regulation of programmed cell death (GO:0043068),0.38864289243587785,1.2698765369506093,0.05973223480947477,0.61189371245811,1.0,52/272,14.40%,RASGRF2;ARHGEF3;KALRN;UNC13B;HIP1R;FAS;TNFAIP8;FOXO1;ARHGEF2;DAB2IP;ABR;CASP8;ARL6IP5;RHOB;TRIO;PNMA1;ANO6;ING3;HRK;CASP2;OMA1;IAPP;TNFSF10;PLEKHG5;STPG1;RYBP;TIAM2;LRRK2;FANK1;CRADD;MCF2L;GADD45G;UBA52;RPS27A;APC;KLF11;APH1A;JUN;HMGB1;MAP3K11;ARHGEF1;LAPTM5;CLU;IRF5;ATM;ITGB3BP;BNIP3L;SOS1;CTNNB1;FZD9;BNIP3;MAP3K20
prerank,regulation of cellular component movement (GO:0051270),-0.3595685222021564,-1.2697405290434138,0.0954356846473029,0.6391295385273071,1.0,14/49,12.68%,TGFBR3;EGFR;ROCK2;TGFBR1;PDPN;ARHGAP18;ARAP1;YTHDF1;MEMO1;VEGFA;RAF1;ERBB2;HDAC6;HBEGF
prerank,presynapse organization (GO:0099172),-0.5559472423828293,-1.26958136448785,0.2100238663484487,0.6373076564730127,1.0,2/10,3.99%,WNT5A;NLGN2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.48693185916866977,1.268811698147773,0.16204986149584488,0.614041252930954,1.0,2/33,1.83%,PLCG2;ATP2B4
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.4940989005330754,1.26788079901722,0.17404129793510326,0.6157407612429358,1.0,12/33,18.31%,TAL1;FES;STAT1;HSPA1B;THPO;BRD1;HIF1A;HMGB2;ACVR2A;MAPK14;ETS1;FAM210B
prerank,positive regulation of ion transport (GO:0043270),0.46537262716233946,1.2678063984809689,0.1736842105263158,0.6151088958234601,1.0,12/48,10.31%,CNKSR3;CCR1;MYLK;ANO6;ORAI1;STIM2;P2RX7;VAMP8;CRACR2A;SCN1B;VAMP7;CCL4
prerank,ethanol metabolic process (GO:0006067),-0.5231298364087357,-1.267427939091294,0.17412935323383086,0.6411191464524499,1.0,1/12,0.24%,ALDH1A1
prerank,cellular response to inorganic substance (GO:0071241),0.5188428185806346,1.2671576988957542,0.18512898330804248,0.6161261518749009,1.0,4/21,9.89%,FOXO1;ADCY10;NSMCE3;SPIDR
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.586753505760305,1.266942614551267,0.21490467937608318,0.6159176475952769,1.0,2/11,4.86%,FYN;LANCL1
prerank,cellular response to cytokine stimulus (GO:0071345),0.3844256076653953,1.2668036827082991,0.03458799593082401,0.6154698616754251,1.0,66/416,9.69%,PTPRJ;S1PR1;NPR2;FYN;VCAM1;CCR1;PTPN14;LIFR;GBP5;ST3GAL6;RAPGEF1;FOXO1;ARHGEF2;DUSP1;AIM2;MMP1;INPP5D;DAB2IP;IFNGR1;CBL;LGALS9;VIM;OXSR1;CSF2RB;GBP4;CRK;INPP5K;LAMA5;MAOA;LEF1;TRIM6;HYAL2;LRCH1;IFNAR1;TNFRSF1B;IRAK2;GBP3;ASAH2;GATA3;IL1A;STAT1;CD47;IRGM;ZC3H12A;ITGAM;IL1RAP;PTPN12;IL20RB;HSP90B1;SOCS6;JAK2;MT2A;CEBPA;NFE2L2;BCL2L1;UBA52;RPS27A;STK39;NR1D1;GAPDH;ACOD1;CACTIN;ZFP36L2;EGR1;CASP1;DHX9
prerank,carbohydrate derivative catabolic process (GO:1901136),0.5583257288711168,1.2666058267032194,0.19968304278922344,0.6152166912029067,1.0,8/18,19.53%,AOAH;MANBA;BPGM;FBXO2;OGA;FBXO6;NGLY1;NEU4
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.41735960220912777,-1.2662940837155006,0.16312056737588654,0.6420834898767276,1.0,11/29,14.23%,TCF7L2;CREBBP;PYGO1;BCL9;ASH2L;TLE1;PYGO2;TLE2;HDAC1;AXIN2;TERT
prerank,regulation of JUN kinase activity (GO:0043506),0.4936939144815441,1.2662169725172512,0.17622377622377622,0.6155082958495308,1.0,5/33,10.01%,EDN1;DAB2IP;PDCD4;MAP3K11;AIDA
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.4043918446230305,1.2661629215483396,0.10428100987925357,0.6148868927948223,1.0,20/140,7.34%,RASGRF2;ARHGEF3;CD2AP;KALRN;ARHGAP31;CHN2;ARHGEF2;ABR;RHOB;TRIO;ARAP3;BCR;ARHGAP8;PLEKHG5;SRGAP1;ARHGDIA;TIAM2;MCF2L;ARHGAP5;ARHGAP25
prerank,regulation of lymphocyte activation (GO:0051249),0.587367119278297,1.2658463203416972,0.200339558573854,0.615022173095182,1.0,1/12,1.38%,CRTAM
prerank,regulation of neuron death (GO:1901214),0.4277652785121669,1.2657556379290207,0.13423645320197045,0.6144697730726585,1.0,39/82,27.03%,FYN;SNCG;FCGR2B;LANCL1;MEF2C;CD34;TNFRSF1B;LRRK2;ITGAM;CD200;GRIN2B;EGR1;PRNP;RRAS2;TYROBP;VPS35;DCC;CLU;CHGA;TRIM2;EIF2S1;SARM1;DAXX;GSK3B;NENF;GRID2;CD200R1;SORL1;AKT1S1;UBB;EIF4G1;FOS;CSF1;ATP13A2;NSMF;CHMP4A;CHMP4B;TRAF2;SNCA
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.616840025906468,1.2654001591107578,0.21070234113712374,0.6145882448235073,1.0,4/11,8.17%,GATA6;LGALS9;CD34;CD200
prerank,lipid modification (GO:0030258),0.48283294460160675,1.265087560716132,0.16413793103448276,0.6146763772087387,1.0,9/37,15.75%,SGPP2;PLPP1;MBOAT2;DGKH;LPCAT3;PLPP6;PLPP4;DGKI;PLPPR1
prerank,regulation of neurotransmitter transport (GO:0051588),0.5609892982679072,1.2638118392479627,0.19743178170144463,0.6173373640190875,1.0,4/16,16.57%,MCTP1;MEF2C;SNCAIP;CPLX1
prerank,rRNA metabolic process (GO:0016072),0.4008725545416509,1.263708744054668,0.097669256381798,0.6168134826231206,1.0,67/160,26.59%,BOP1;PELP1;RPL27;DHX37;RPL7;TRIR;EXOSC3;NVL;UBA52;MRM2;RPS14;RPL35;WDR46;RPL21;DKC1;RPL37;RPS28;RPL34;RPS9;RPLP2;EXOSC8;XRN2;RPS25;XRN1;RPL30;RPL27A;NOL8;RPL23A;RPS15;RPL19;RPL32;UTP18;RPL37A;RPL18A;EXOSC9;NOB1;LAS1L;DDX47;DCAF13;WDR18;RRP9;PWP2;RPL18;C1D;RPL39;NOLC1;IMP4;EXOSC10;RPS19;RPL31;EXOSC1;FBL;NOP53;HELQ;WDR43;RPL3;UTP20;MRTO4;MDN1;RPL28;RPL9;RPL26;RPS16;RPLP1;DDX27;ESF1;UTP15
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.39427707726236993,1.263177907998016,0.07822410147991543,0.61742264081042,1.0,34/214,10.76%,TEK;PDGFD;RAPGEF2;PTPRR;CEACAM1;PDGFB;CNKSR3;FLT4;CCR1;NOTCH1;NOD2;DAB2IP;F2RL1;LGALS9;APP;TIRAP;TIMP3;ANGPT1;RRAS;GCNT2;ARHGAP8;SEMA7A;FGFR3;DUSP3;MFHAS1;ARRB1;PDE8A;THPO;HTR2A;HMGB1;FBXW7;CCL4;PTPN1;RANBP9
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.5116791927209208,-1.2618889616974245,0.18478260869565216,0.6526739535056523,1.0,1/12,1.31%,IL1R1
prerank,positive regulation of lipid transport (GO:0032370),-0.5148276517182442,-1.2617387699264804,0.178117048346056,0.6508046452810095,1.0,3/12,10.29%,LRP1;APOE;SPP1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.605595795792131,1.2614023656217508,0.2109500805152979,0.6214547454994216,1.0,8/11,25.18%,CCT8;DKC1;CCT2;CCT4;CCT6A;TCP1;CCT3;WRAP53
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.6191856823766883,1.2612353724833982,0.22824302134646962,0.6210910853901926,1.0,8/10,25.18%,CCT8;DKC1;CCT2;CCT4;CCT6A;TCP1;CCT3;WRAP53
prerank,integrin-mediated signaling pathway (GO:0007229),0.4299260930147462,1.2610689897315466,0.15659679408138102,0.6207503840954148,1.0,13/73,6.88%,LAMA3;CEACAM1;ZYX;PRKD1;NEDD9;APOA1;LAMA5;ADAM15;DST;SEMA7A;MYH9;CUL3;CD47
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.43614794472196783,1.2610112394602953,0.1559074299634592,0.6201116036671668,1.0,8/73,6.92%,NOS1;ATP2B4;CAV1;PRKD1;APP;TRIM6;BCAR3;IRGM
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.47540873983292753,-1.261001967786318,0.17468354430379746,0.6507224757250439,1.0,7/16,25.67%,CREBBP;KAT2B;NAA60;NAA40;NAA10;NAA50;NAA15
prerank,regulation of cell differentiation (GO:0045595),0.40245280473451217,1.2598240600046129,0.10774410774410774,0.622571288656214,1.0,25/148,10.93%,SLC6A6;LTBP4;NOTCH4;SMAD7;CASZ1;TBX1;HEY1;EMP2;FES;HEY2;KLF4;SPOCK2;MBOAT2;GATA3;BCL6B;CLASP1;ALK;SNAI2;APC;NR1D1;ROCK1;PTK2;CLASP2;RPS6KA1;MCRIP1
prerank,Golgi ribbon formation (GO:0090161),-0.519771020482186,-1.2594303928795454,0.1913265306122449,0.6531254637419882,1.0,6/13,17.63%,TRIP11;GOLGA2;GCC2;OPTN;STX16;FHDC1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3771440227438245,1.2587431076889626,0.03323262839879154,0.6246877935283823,1.0,79/476,14.48%,PRDM16;NOS1;MECOM;SOX17;NOTCH4;AFAP1L2;GATA6;IRF6;PLCB1;PDGFB;KLF2;SMARCA2;CASZ1;TBX1;ACVRL1;NOTCH1;FOXO1;HEY1;TAL1;HNF4A;HNF1A;KLF6;SOX18;HHEX;FLI1;INPP5K;HEY2;KLF4;ACVR1;ING2;LEF1;ZBTB48;SMAD2;KARS1;MEF2C;FOXF2;GATA3;RYBP;STAT1;FANK1;KDM3A;ZBTB16;MAPRE3;EBF3;DNAJC2;KMT2E;NR1D1;KMT2B;TCF3;JUN;EGR1;SERTAD3;SEC14L2;MAD2L2;RPS6KA1;SFR1;DEAF1;RAI1;NPM1;DTX3L;BRCA1;ILF2;HINFP;CD38;SOX10;SETD3;MED30;ELF2;YWHAH;PHIP;HIF1A;SMARCC1;LRP5;HMGB2;NFATC1;CTNNB1;MED17;MED4;PSMC5
prerank,negative regulation of chemotaxis (GO:0050922),0.5024344293138476,1.2587261242421726,0.18811881188118812,0.6239420154616222,1.0,6/31,8.52%,SEMA3G;NOTCH1;SEMA3F;SEMA7A;DUSP3;SEMA6D
prerank,negative regulation of intracellular protein transport (GO:0090317),0.521371344029388,1.258406008541611,0.21649484536082475,0.6240479324710776,1.0,10/22,20.29%,INPP5K;UFM1;RAB23;LRRK2;RANGAP1;ITGB1BP1;CABP1;GDI1;BARD1;BAG4
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.5618618732284929,1.2581483709649524,0.21236133122028525,0.6239426862453699,1.0,2/14,10.27%,CCR1;TYROBP
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5421760527078788,1.2580315263467117,0.1984,0.623472962283873,1.0,7/18,11.50%,FLT1;MEF2C;ADAM17;AKT3;HMGB1;PLCG1;APLN
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.38045970803680434,-1.2578742790839612,0.13978494623655913,0.655281035367451,1.0,19/40,26.89%,NUCKS1;BOD1L1;FBH1;TIPIN;THOC1;ATR;RTEL1;SMARCAL1;DONSON;RFWD3;ATRX;ZRANB3;TIMELESS;EME2;RAD51;MMS22L;SETMAR;POLE;CENPX
prerank,sulfation (GO:0051923),-0.527505183362873,-1.2577850540455098,0.19852941176470587,0.6531929304052263,1.0,1/11,0.05%,UST
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5667195067036446,1.2577179312123399,0.22006472491909385,0.6235380248637453,1.0,2/15,1.74%,GBP5;NOD2
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.48194851488328494,1.2573574543919246,0.19616519174041297,0.623727186181067,1.0,7/32,12.01%,CDK17;CDK14;CCNE1;KLF11;POLA1;E2F7;HINFP
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.49301726012570996,1.2571758323375575,0.17427385892116182,0.6234898140099719,1.0,9/34,9.18%,DAB2IP;F2RL1;TLR3;NFKBIL1;MFHAS1;NR1D1;GRAMD4;ACOD1;CACTIN
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.4380848922797995,1.256153738710394,0.15403726708074533,0.6255863643796359,1.0,16/67,13.33%,PODXL;RABGAP1;CAV1;PPP1R16B;TBC1D8;PLD1;IFT140;TBC1D5;MYO10;TBC1D1;RAC1;TRPM2;ATP8B1;USP6NL;FXR1;TBC1D10A
prerank,plasma membrane organization (GO:0007009),0.4406857071569418,1.2560218505757312,0.15217391304347827,0.6251583674246793,1.0,14/61,8.25%,CAVIN2;DYSF;PLSCR4;PACSIN2;SYT7;ANO6;FNBP1L;MYH9;PACSIN1;P2RX7;WHAMM;PLSCR1;A4GALT;BIN3
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.4090238151486747,1.2554338472464386,0.13568985176738882,0.6259601796863229,1.0,24/112,9.45%,ENG;CLDN5;SMAD6;SMAD7;F11R;ACVRL1;ZYX;TGFB2;CBL;FKBP1A;ID1;APOA1;ACVR1;GCNT2;SMAD2;NLK;MEF2C;HYAL2;FURIN;UBA52;RPS27A;PTK2;JUN;ZFP36L2
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.4882064635437371,-1.2552967844012894,0.20334261838440112,0.6585281912851361,1.0,4/15,6.64%,LRP1;PDPN;DPP4;FAP
prerank,cellular response to organonitrogen compound (GO:0071417),0.4143474562850314,1.2552010284991013,0.15105386416861827,0.6258268555237032,1.0,30/99,21.18%,KCNQ1;RAPGEF2;SPAAR;RAPGEF1;DIAPH1;INPP5K;MEF2C;SH3BP4;P2RX7;HSP90B1;CTNNA1;HTR1B;EGR1;RRAGD;TRPM2;ACTB;BRCA1;CTNNB1;GLRA2;P2RY1;CIB2;GOLPH3;RELA;GABRB1;RRAGA;RRAGC;JUP;LAMTOR3;ZFP36L1;GABRB3
prerank,protein localization to nucleus (GO:0034504),-0.31244379151374757,-1.2551305417443455,0.05161290322580645,0.6566986609666888,1.0,42/102,23.95%,COL1A1;APPL2;BMP7;BMP4;LMNA;TOR1AIP1;NUP107;SIX1;TOR1B;INTS13;HEATR3;CSE1L;BANP;PPP1R10;PAF1;NUP155;TNPO3;RANBP6;FAM53C;IPO5;MDM2;NUP93;BCL3;TNPO2;HNRNPU;RANBP17;TOPORS;TSC2;PHB2;SUPT7L;PML;MORC3;RRS1;CHCHD10;SEC13;SYK;IPO7;SIX4;POM121;TOR1A;IPO8;TBRG1
prerank,cardiac muscle cell action potential (GO:0086001),-0.39997701859362417,-1.2544478700655546,0.13398692810457516,0.6564495332941638,1.0,7/30,6.57%,ATP1A2;ANK2;CACNA1C;DMD;KCND3;CACNA2D1;CACNA1G
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.4197358527152814,1.2541934232331602,0.15042117930204574,0.6277446667554536,1.0,33/88,19.23%,FBXL2;PSMD13;FBXL14;FBXL5;PSMD4;FBXL18;FBXL16;PSMA5;PSMB10;FBXW7;RBX1;CUL2;PSMB8;PSMD14;FBXO4;PSMA7;PSMA8;PSMC3;FBXO2;PSMB5;PSMC1;PSMC5;PSMC6;PSMB9;FBXL13;AMN1;PSMA4;FBXO6;PSMD5;PSMD9;PSMB6;FBXL6;FBXL15
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.5610104106656917,1.253455837763735,0.20440251572327045,0.629109106191487,1.0,3/15,11.74%,SMAD7;MAD2L2;DTX3L
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.5355954851235345,-1.2534435906746744,0.1937046004842615,0.6570687404216525,1.0,2/11,1.62%,WNT4;BMP5
prerank,development of primary male sexual characteristics (GO:0046546),0.48820591829999693,1.2533417777061222,0.18478260869565216,0.6286261126435618,1.0,6/34,8.77%,GATA6;KITLG;TGFB2;GATA3;NCOA4;COL9A3
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.47761283335777455,1.252017682358276,0.19131614654002713,0.6314705557901031,1.0,10/36,14.28%,FZD6;PLCB1;TNRC6C;LEF1;NLK;PPP3CA;AGO4;NFATC1;CTNNB1;FZD3
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.573952147987515,1.252015934025881,0.228125,0.6306859982495007,1.0,11/15,26.32%,CCT8;DKC1;NHP2;CCT2;CCT4;CCT6A;SHQ1;TCP1;CCT3;RUVBL1;RUVBL2
prerank,sodium ion transport (GO:0006814),-0.3288041947564077,-1.2517713699408866,0.059880239520958084,0.6598099693212444,1.0,14/85,6.71%,ATP1A2;SLC24A3;NALCN;SLC6A13;SLC12A2;SCN7A;SLC6A12;SLC8A3;ATP1B3;SLC9B2;SCN2A;SLC6A1;SLC6A9;SLC5A5
prerank,regulation of steroid metabolic process (GO:0019218),-0.4231486141597752,-1.2513407841083202,0.1791044776119403,0.6588008912697405,1.0,11/23,33.11%,APOE;RORA;EPHX2;STUB1;ACADVL;PANK2;STAR;NR1H4;ARV1;ABCG1;RORC
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.48648665964122195,1.2510607601838086,0.19115549215406563,0.6326451784731124,1.0,7/36,7.61%,NOS3;ATP2B4;CAV1;GCH1;NOS1AP;IL1A;NUS1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.4234835389135491,-1.250594580505398,0.15151515151515152,0.6586733002784546,1.0,4/26,4.50%,ANK2;ACTN2;ATP1B3;FHL1
prerank,negative regulation of wound healing (GO:0061045),-0.401360946291439,-1.2503392615536566,0.13356164383561644,0.6571044245025695,1.0,8/28,5.68%,PHLDB2;TFPI;CASK;SLC12A2;VTN;APOE;SERPINE2;FGF2
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.515347144770166,1.2502665111818085,0.2171875,0.6340379245548083,1.0,6/22,8.81%,DAB2IP;F2RL1;TIRAP;MFHAS1;NR1D1;ACOD1
prerank,regulation of potassium ion transport (GO:0043266),0.492716576098933,1.250247586182545,0.19321533923303835,0.6332921720931294,1.0,3/31,4.92%,NOS1;DPP6;DPP10
prerank,supramolecular fiber organization (GO:0097435),0.3781926602992316,1.2499569163764117,0.07194244604316546,0.6333387894106448,1.0,55/333,10.46%,LAMA3;MYO1D;FBLN5;CD2AP;CCDC88C;TRPV4;STMN2;HIP1;MYO1E;SHROOM4;ELMO1;HIP1R;PLK3;RND1;B2M;ARHGEF2;TGFB2;RHOB;FKBP1A;VIM;EMP2;APP;FLII;APOA1;EVL;CLIP2;SLK;TSPAN14;DST;ATP7A;IAPP;COL5A2;CAMSAP2;FURIN;CLIP1;KIF2A;WHAMM;PLEC;ARHGAP25;HOOK1;MYO1C;BIN3;UBA52;RPS27A;COL9A3;PCM1;APH1A;DSP;SIAH2;ADAM10;MAD2L2;KATNAL2;RAC1;ERMN;CCDC88A
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.5201461778031279,1.2497402913648297,0.20239880059970014,0.6331351036298823,1.0,4/21,12.00%,KCNN4;FOXP1;STAP1;PRKD2
prerank,cytokine-mediated signaling pathway (GO:0019221),0.3761549395523037,1.2495229539854367,0.028169014084507043,0.6329695926065382,1.0,92/532,14.26%,PTPRJ;IRF6;ADIPOR2;S1PR1;CEACAM1;PLCB1;PDGFB;FYN;VCAM1;RPS6KA5;CCR1;NOD1;LIFR;NOD2;B2M;RAPGEF1;FOXO1;GSTA2;AIM2;MMP1;INPP5D;IRF2;IFNGR1;CBL;VIM;CSF2RB;CRK;ACTN4;TNFRSF18;CISH;PSMD13;LAMA5;MSN;MAOA;IRF9;CAMK2D;TNFRSF25;TRAF1;IFNAR1;TNFRSF1B;IRAK2;COMMD7;FCGR1A;GATA3;IL1A;ADAM17;PDCD4;PSMD4;ADIPOR1;STAT1;ITGAM;IL1RAP;IL20RB;HSP90B1;SOCS6;JAK2;MT2A;CEBPA;BCL2L1;OAS2;UBA52;RPS27A;PITPNA;LTB;ADAR;PSMA5;EGR1;PSMB10;CASP1;RBX1;BOLA2;TRIM25;CCL4;NFKBIA;PSMB8;MAP3K3;TAB2;PSMD14;GBP2;TRIM8;TALDO1;PIK3CB;IRF5;PSMA7;PSMA8;PSMC3;HIF1A;NDN;SOS1;CFL1;PSMB5;PSMC1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.44691373646737415,1.248498054450868,0.18791064388961892,0.6350167435798915,1.0,23/53,22.68%,AZIN1;PSMD13;PSMD4;PSMA5;PSMB10;PSMB8;PSMD14;PSMA7;PSMA8;PSMC3;PSMB5;PSMC1;PSMC5;PSMC6;PSMB9;PPM1K;PSMA4;PSMD5;PSMD9;PSMB6;PSMB2;OAZ2;NQO1
prerank,negative regulation of phosphorylation (GO:0042326),-0.32229873767343625,-1.2480703890851357,0.06936416184971098,0.661436469812482,1.0,15/85,7.17%,PID1;PTPN13;NTRK3;PLPP3;FBLN1;BMP7;SLIT2;NUPR1;BMP4;PPARA;PRKN;NIBAN1;IRS2;XDH;IGFBP3
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.5297483150585945,-1.247951206483726,0.21393034825870647,0.6595100032778567,1.0,3/10,4.70%,VTN;PRKCB;GRB10
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.49057140038284264,1.2479416820978082,0.21480406386066764,0.6357874841041948,1.0,3/31,3.76%,SYT15;DOC2B;SYT7
prerank,pinocytosis (GO:0006907),0.6080566687014478,1.247847510692619,0.24033613445378152,0.6352352500220717,1.0,6/10,21.28%,PPT1;RAB34;DOCK2;PYCARD;CARMIL1;MAPKAPK2
prerank,positive regulation of protein sumoylation (GO:0033235),-0.5358993184997441,-1.2476021971897417,0.21307506053268765,0.658305436383343,1.0,4/10,22.36%,PIAS3;HDAC4;GNL3;PIAS4
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.5661074473773666,1.2474941491421818,0.2288961038961039,0.6354028242921065,1.0,7/14,16.22%,DUSP1;PPM1F;PPP3CA;PPP2R2C;PPP2CB;PPP1R15B;NCK1
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.466439920261891,-1.247213102522909,0.1978319783197832,0.6572823619095088,1.0,9/17,16.96%,ATP1A2;TFPI;BMP7;BMP4;SRC;URI1;UBE2L3;GPER1;AR
prerank,regulation of endocytosis (GO:0030100),0.4403129605621787,1.2470905703637885,0.18569636135508155,0.6356935312244407,1.0,17/61,16.96%,CDH13;HIP1;HIP1R;MCTP1;PRKD1;PACSIN2;PACSIN1;ROCK1;STON1;PTPN1;NEDD4L;RUBCN;ABCA7;ZFYVE16;OPHN1;RUFY1;RIT2
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.4447176761723406,1.246817503359135,0.190224570673712,0.6356607058175481,1.0,16/54,17.16%,CASP8;F2RL1;SPATA2;SPPL2A;APOA1;TRAF1;ADAM17;MADD;HSPA1B;CASP1;LAPTM5;TRAIP;RACK1;PYCARD;PYDC1;PTPN2
prerank,negative regulation of TORC1 signaling (GO:1904262),0.572390589963203,1.2467368721984509,0.2483108108108108,0.6350864438191659,1.0,2/13,1.81%,SPAAR;CASTOR1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.43853904247960407,1.246653498392877,0.17967781908302355,0.634527267790286,1.0,14/66,9.68%,PTPRM;CEACAM1;B2M;DAB2IP;AQP11;CAV1;CAV2;TGFB2;GATA3;STAT1;ATP5F1A;SNAI2;MCC;FBXW7
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.4521280052911623,-1.2466467218150683,0.19658119658119658,0.6566314533612827,1.0,3/18,7.69%,IGF1;IGFBP2;IGF2
prerank,positive regulation of protein kinase activity (GO:0045860),0.3947872972020396,1.246469697126434,0.1450719822812846,0.6342116164267794,1.0,31/148,12.89%,RAPGEF2;PDGFB;ACE;INSR;DAB2IP;TGFB2;ADRB2;EMP2;IQGAP1;NEDD9;MAP4K4;EFNA1;FCGR1A;IRGM;MAPRE3;TOM1L1;SYAP1;PTK2;EGR1;TAOK2;PRNP;PTPN1;CCDC88A;MINK1;MMD;TAB2;CLU;GRM5;CALM3;MARK2;TTBK1
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.536753034768057,-1.2460528210739432,0.19458128078817735,0.6561272444977542,1.0,5/10,21.75%,PFKP;HK2;GFPT1;GFPT2;PFKL
prerank,regulation of stress fiber assembly (GO:0051492),-0.3259951307596733,-1.2456094435753864,0.08433734939759036,0.6551714739881663,1.0,15/74,7.01%,ARHGAP6;PHLDB2;LPAR1;ROCK2;ARHGAP28;ASAP3;TGFBR1;CCN2;ARHGEF10L;PPM1E;TPM1;ARAP1;ALMS1;TMEFF2;PIK3R1
prerank,intracellular lipid transport (GO:0032365),-0.43046733219161254,-1.2455121527823882,0.16091954022988506,0.6532298522154188,1.0,4/21,6.20%,PRKAG2;PRKAA2;ABCD3;SLC25A20
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.4647445064738138,-1.2451364123353204,0.18857142857142858,0.6499765698242165,1.0,6/16,8.39%,ARHGAP6;PHLDB2;APOD;THBS1;SRC;BCAS3
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.4647445064738138,-1.2451364123353204,0.18857142857142858,0.6499765698242165,1.0,6/16,8.39%,ARHGAP6;PHLDB2;APOD;THBS1;SRC;BCAS3
prerank,regulation of embryonic development (GO:0045995),0.47493235912513454,1.2447263082135176,0.18207282913165265,0.6382253711982077,1.0,7/34,10.46%,SOX17;PLCB1;INSR;POGLUT1;CLASP1;CLASP2;BAG6
prerank,peptidyl-threonine modification (GO:0018210),0.43640023183930116,1.2446461641678248,0.1689106487148103,0.6376582147183437,1.0,19/66,12.89%,SBK1;PRKD1;CDC42BPA;OXSR1;CDC42BPG;ACVR1;CAMK2D;NLK;MAPK1;LRRK2;LMTK2;STK39;CAD;ROCK1;TNKS;GALNT4;PRKD2;MARK2;TTBK1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.42895604770015267,1.2441040157290428,0.15782828282828282,0.6383049651945322,1.0,8/72,2.58%,TEK;PDGFD;FLT1;PDGFB;INSR;F2RL1;TGFB2;CBL
prerank,metanephric mesenchyme development (GO:0072075),-0.5293644436996766,-1.2440292153442138,0.22303921568627452,0.6510482256707469,1.0,6/10,22.36%,WNT4;OSR1;SIX1;BASP1;PAX2;SIX4
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.4197986974808856,1.243977212959239,0.15186915887850466,0.6378651423183976,1.0,20/95,10.26%,NOD2;DAB2IP;VIM;TIRAP;FCGR2B;DEFA6;MEF2C;TNFRSF1B;IL1A;PDCD4;NFKBIL1;IRGM;ZC3H12A;NR1D1;ACOD1;STAP1;CACTIN;HMGB1;CASP1;NFKBIB
prerank,muscle cell development (GO:0055001),0.48482026971557546,1.2438686683500455,0.20170454545454544,0.6374103455820436,1.0,6/30,4.25%,ENG;NEBL;DYSF;HEY2;SLC8A1;ALPK3
prerank,regulation of stem cell differentiation (GO:2000736),0.4158139583481949,1.2436777587906334,0.15560916767189384,0.6371107493734084,1.0,29/89,18.87%,JAG1;GATA2;LMO2;NOTCH1;TAL1;PSMD13;LMO1;GATA3;PSMD4;TCF3;PSMA5;ZFP36L2;PSMB10;PSMB8;PSMD14;CBFB;PSMA7;PSMA8;PSMC3;PSMB5;PSMC1;PSMC5;PSMC6;PSMB9;NELFB;PSMA4;PSMD5;PSMD9;PSMB6
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.4789586365909315,1.2435998668343162,0.20534458509142053,0.6365705554680633,1.0,10/36,14.18%,EDN1;TRIM6;ADAM17;IRGM;HSPA1B;NLRC5;CASP1;LAPTM5;HIF1A;CXCR4
prerank,glucose transmembrane transport (GO:1904659),0.5267528061673057,1.2430156289252217,0.20977917981072555,0.6373954761256552,1.0,3/18,8.57%,SLC2A1;HNF1A;SLC2A9
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.37147963753258184,-1.2428865859143403,0.1366906474820144,0.6522261799745687,1.0,7/40,10.66%,SLC7A11;SLC13A3;SLC38A11;SLC19A1;SLC38A10;SLC27A1;SLC38A5
prerank,regulation of filopodium assembly (GO:0051489),-0.37538253001947264,-1.2422440410590492,0.13937282229965156,0.6520230637325704,1.0,11/38,12.50%,DPYSL3;DOCK11;RHOQ;FXR2;ARAP1;RIPOR2;PIK3R1;BCAS3;CAPZB;GAP43;PALM
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.4965214299009113,1.241553034123533,0.2070015220700152,0.6406000105607095,1.0,7/27,15.02%,CCDC88C;MAPK1;UBA52;RPS27A;TAOK2;MAP3K20;KAT7
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.5235252573315229,-1.241393776486625,0.1919191919191919,0.6524718109288652,1.0,4/10,10.41%,DSE;PXYLP1;XYLT1;B3GAT3
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.5794277394770817,1.2410479413452136,0.23162939297124602,0.6410917315478509,1.0,7/12,26.43%,CAV1;CAMK2D;CALM3;PDE4D;IRX3;SRI;CALM1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.5688045454779488,1.2406234237186968,0.2176,0.6414548323150236,1.0,7/14,23.05%,BOP1;RPL7;RPL35;RPL7L1;FTSJ3;URB1;RPF2
prerank,actin filament capping (GO:0051693),-0.4493182643542194,-1.2405483518243097,0.20555555555555555,0.6506091855406778,1.0,6/18,13.34%,ADD3;GSN;SVIL;VILL;CAPZB;TRIOBP
prerank,barbed-end actin filament capping (GO:0051016),-0.4493182643542194,-1.2405483518243097,0.20555555555555555,0.6506091855406778,1.0,6/18,13.34%,ADD3;GSN;SVIL;VILL;CAPZB;TRIOBP
prerank,protein O-linked glycosylation (GO:0006493),0.41701132501212007,1.2403473463280987,0.171875,0.6414193149344358,1.0,18/96,13.40%,EOGT;GCNT1;ST8SIA6;GALNT18;POMGNT1;ST6GALNAC2;GALNT5;GALNT15;GALNT7;POGLUT1;B3GNT3;DPM1;C1GALT1C1;TET3;XXYLT1;GALNT4;B3GALNT2;ST3GAL1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.4491797685062887,1.2388175816624891,0.15837696335078533,0.6447807730151031,1.0,10/50,12.73%,NOD1;NOD2;LGALS9;APP;ACTN4;TLR3;PDCD4;NMI;LAPTM5;RTKN2
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.5038690055237205,1.2384932274513567,0.20386904761904762,0.6448731879979981,1.0,8/28,19.55%,ATP2A3;DAB2IP;BBC3;BAG6;TRIB3;DNAJC10;SELENOK;ERN1
prerank,T cell homeostasis (GO:0043029),0.5936183343557905,1.2380423951922834,0.24489795918367346,0.6453494917602202,1.0,1/10,1.17%,FAS
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.5404509341234904,1.2376144250775656,0.212443095599393,0.6457418309812712,1.0,12/18,26.32%,CCT8;DKC1;NHP2;CCT2;CCT4;CCT6A;SHQ1;EXOSC10;TCP1;CCT3;RUVBL1;RUVBL2
prerank,regulation of ion transmembrane transport (GO:0034765),0.4793949427573385,1.2375888350696698,0.20699708454810495,0.6450371861319598,1.0,4/33,6.69%,KCNQ1;ANO6;CHRM3;P2RX7
prerank,positive regulation of protein binding (GO:0032092),0.44575799093016394,1.2373486598783627,0.18733850129198967,0.6449733285979147,1.0,15/56,14.73%,RAPGEF2;CLDN5;HIP1R;B2M;CAV1;FKBP1A;APP;EPB41;LRRK2;NVL;MARK3;DTX3L;PIN1;RAN;PPP2CB
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.4461265731432473,1.237140955864808,0.2032520325203252,0.6447737053869215,1.0,6/46,4.93%,TEK;NTN4;PARVB;ATRNL1;LAMA5;EFNA1
prerank,midbody abscission (GO:0061952),0.5419149393164273,1.2369550075471165,0.24804992199687986,0.6444860758913346,1.0,11/17,26.39%,CHMP1B;VPS4A;CHMP3;CEP55;CHMP2B;CHMP7;CHMP1A;VPS4B;CHMP4A;CHMP4B;MITD1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.29018861481548985,-1.236785801190963,0.08695652173913043,0.6596992221098926,1.0,41/152,16.36%,RNF220;LGR4;WLS;EGFR;COL1A1;FGFR2;TBL1XR1;SULF1;GPC3;PTK7;RSPO3;SULF2;WNK1;ZEB2;LRRK1;PSME4;PLEKHA4;SEMA5A;DACT1;DAAM2;SFRP4;PSMF1;RSPO2;PPM1A;LYPD6;PSMB3;SALL1;CSNK1G2;NFKB1;DDX3X;AXIN2;PSMA3;TERT;PPM1B;USP8;PSMC4;PSMB4;ZRANB1;PSMB7;GID8;AMER1
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.4377170844878235,-1.2365907970807253,0.20359281437125748,0.658082912404875,1.0,3/19,3.31%,CAMK1D;IL34;THBS1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.48946591780490933,1.2363429288852663,0.20373027259684362,0.6453286789079115,1.0,3/30,1.55%,BMPR2;DACH1;ACVRL1
prerank,negative regulation of blood coagulation (GO:0030195),0.45943934352078875,1.236199363966837,0.1936813186813187,0.6449443364429576,1.0,3/38,0.89%,NOS3;EDN1;PDGFB
prerank,actomyosin structure organization (GO:0031032),0.4298415188223409,1.2358765708871604,0.18787878787878787,0.6450862916195009,1.0,16/75,9.87%,EPB41L4A;FRMD3;F11R;ZYX;CDC42BPA;FLII;CDC42BPG;EPB41;CSRP2;MYH9;CUL3;WDR1;ARRB1;CASQ1;ROCK1;TJP1
prerank,regulation of immune response (GO:0050776),0.39785086315302753,1.2358341388272533,0.13963963963963963,0.6444244892832631,1.0,19/135,10.27%,VCAM1;CLEC2D;CRTAM;B2M;CASP8;ICAM2;TGFB2;FKBP1A;SPPL2A;TIRAP;FCGR2B;CD34;FCGR1A;OSCAR;CD247;PLSCR1;CD200;FOXP1;TYROBP
prerank,positive regulation of response to stimulus (GO:0048584),0.4732326430464461,1.2357704904328892,0.22236842105263158,0.6438365548661956,1.0,12/40,17.84%,B2M;TGFB2;IFIH1;FCGR2B;IER5;GATA3;DHX9;FXR1;NSMCE4A;RSAD2;EEF1E1;CDKN2AIP
prerank,regulation of cell motility (GO:2000145),0.4018756304499481,1.235692010911178,0.15880322209436135,0.6432921384255196,1.0,26/121,11.35%,SPATA13;CEACAM1;LDB2;PLXNA4;MACF1;RHOB;FES;DIAPH1;CRK;PLXND1;SPOCK2;NTN1;SLK;PKN1;TTBK2;SPOCK3;ROBO4;GATA3;KIF2A;ROCK1;SGK1;SPINT2;RAC1;FGF20;MINK1;CAVIN1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.47279965106861677,1.2350710788065307,0.2,0.6442311321429933,1.0,5/33,8.78%,CCR1;CASP8;FES;LEF1;CTNNBIP1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.4543968441893881,-1.2349905193289348,0.19420289855072465,0.6607472872609939,1.0,7/19,20.19%,CUX1;OBSL1;DBN1;PTPRD;FBXW8;CUX2;SS18L2
prerank,regulation of gluconeogenesis (GO:0006111),-0.41172171033059746,-1.2349592689565934,0.1701388888888889,0.6586644793554727,1.0,7/27,16.46%,OGT;C1QTNF3;ZNF692;PDK2;SIK1;CLK2;NNMT
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.5141684548574585,-1.2349574199898228,0.21374045801526717,0.656532252669332,1.0,9/12,42.53%,GOLGA2;CDC14B;FZR1;BTRC;GORASP1;PLK1;CDC20;UBE2C;RAB1A
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.48435660152527404,1.2342294950652772,0.22740963855421686,0.6458402470561583,1.0,5/30,5.12%,LTBP4;ENG;SMAD7;FKBP1A;SMAD2
prerank,negative chemotaxis (GO:0050919),0.48241296641262965,1.2341623865546272,0.21030640668523676,0.6452534203076061,1.0,5/33,4.84%,SEMA3G;SEMA3F;APOA1;NTN1;SEMA7A
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.5062841205493284,1.2341616015614527,0.20266272189349113,0.6444931049689978,1.0,10/25,19.00%,HRK;TNFSF10;BBC3;CIDEB;BNIP3;PYCARD;PLAUR;BMF;BID;PPIF
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.53848346876384,1.2341180069437605,0.20833333333333334,0.6438279014847366,1.0,4/19,8.61%,LGALS9;TIRAP;ITGAM;NMI
prerank,cellular response to amyloid-beta (GO:1904646),0.47971203437911125,1.2339281931553694,0.2216142270861833,0.6436255195441692,1.0,7/35,4.01%,FYN;VCAM1;CACNA1A;ATP1A3;ADRB2;APP;FCGR2B
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.4799694640534117,1.2338523653513804,0.20933521923620935,0.6431300016447643,1.0,7/30,10.32%,ARHGEF3;F11R;F2RL1;APOA1;LPAR6;ARRB1;RAC1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.4391629209568827,1.2334669897646071,0.1878238341968912,0.6433974293268587,1.0,12/57,9.61%,FYN;NOD1;AIM2;CASP8;ARL6IP5;PPM1F;TNFSF10;CIDEB;GRIN2B;GRAMD4;HMGB1;CASP1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.42351669616025417,1.23333335547159,0.18079800498753118,0.6429914589577486,1.0,26/70,18.87%,B2M;MFSD6;PSMD13;FCGR1A;PSMD4;VAMP8;PSMA5;PSMB10;TAP1;PSMB8;CYBA;PSMD14;PSMA7;PSMA8;TAPBP;PSMC3;PSMB5;PSMC1;PSMC5;NCF2;PSMC6;PSMB9;PSMA4;PSMD5;PSMD9;PSMB6
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.4599681632405415,1.232986368967193,0.1932555123216602,0.6431680312656799,1.0,13/46,18.77%,PTPRR;CNKSR3;DAB2IP;TIMP3;DUSP3;PTPN1;RANBP9;ITGB1BP1;PIN1;DUSP26;PTPN2;SMAD4;SEMA6A
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.5041941523385831,1.2327794945337507,0.22205438066465258,0.642962857405103,1.0,10/25,18.31%,TAL1;STAT1;HSPA1B;BRD1;HIF1A;HMGB2;ACVR2A;MAPK14;ETS1;FAM210B
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.4379321451172822,-1.2327668783523713,0.17080745341614906,0.6610454243616094,1.0,3/20,2.40%,PID1;DAB2;RHOQ
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.4847644948532515,1.2319960294776975,0.20833333333333334,0.6443552733049503,1.0,5/33,7.97%,TEK;GATA2;ANGPT1;GATA3;NFE2L2
prerank,positive regulation of apoptotic process (GO:0043065),0.3769725007414202,1.2319382856270709,0.0796277145811789,0.6437711209793505,1.0,45/293,10.16%,RASGRF2;ARHGEF3;KALRN;UNC13B;HIP1R;FAS;TNFAIP8;FOXO1;ARHGEF2;DAB2IP;ABR;CASP8;ARL6IP5;TGFB2;RHOB;TRIO;BTG1;PNMA1;ANO6;ING3;HRK;CASP2;OMA1;IAPP;TNFSF10;PLEKHG5;STPG1;RYBP;TIAM2;ZC3H12A;FANK1;CRADD;MCF2L;GADD45G;UBA52;RPS27A;APC;TPD52L1;KLF11;APH1A;JUN;HMGB1;MAP3K11;PRNP;ARHGEF1
prerank,manganese ion transport (GO:0006828),-0.47172869660495154,-1.2309748095045747,0.20987654320987653,0.6642161929943304,1.0,6/14,9.38%,SLC39A14;SLC30A10;TRPC3;SLC39A8;TRPC6;TRPC4
prerank,cellular response to tumor necrosis factor (GO:0071356),0.3857074057870329,1.2305759344421987,0.11987041036717062,0.6467823117160781,1.0,55/175,21.13%,ARHGEF2;AIM2;DAB2IP;ACTN4;TNFRSF18;INPP5K;PSMD13;TNFRSF25;HYAL2;TRAF1;TNFRSF1B;GBP3;COMMD7;GATA3;ADAM17;PSMD4;STAT1;ZC3H12A;JAK2;NFE2L2;NR1D1;ACOD1;LTB;CACTIN;PSMA5;ZFP36L2;PSMB10;DHX9;CCL4;NFKBIA;PSMB8;PSMD14;GBP2;BRCA1;PSMA7;PSMA8;PSMC3;PSMB5;PSMC1;PSMC5;PSMC6;PSMB9;TMSB4X;PYCARD;PSMA4;PYDC1;PSMD5;PSMD9;RELA;PSMB6;ERBIN;BAG4;TNFRSF11A;ZFP36L1;PSMB2
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.5171501744765906,-1.230526129227811,0.2182741116751269,0.663286657694281,1.0,1/10,0.03%,ATP1A2
prerank,neural crest cell differentiation (GO:0014033),0.5423346297905282,1.2304500125129163,0.23208722741433022,0.64635276821196,1.0,7/18,21.06%,MEF2C;SNAI2;CDH2;CYP26C1;TCOF1;SOX11;NOLC1
prerank,cotranslational protein targeting to membrane (GO:0006613),0.40849421183332335,1.2295385938952965,0.1630952380952381,0.6479768524331425,1.0,35/91,22.22%,RPS21;RPL27;SRP14;RPL7;UBA52;RPS27A;RPS14;RPL35;RPL21;RPL37;RPS28;RPL34;RPS9;RPLP2;RPS25;RPL30;RPL27A;RPS5;SRP9;RPL23A;RPS15;SRPRA;RPL19;RPS18;RPL32;SEC62;RPL37A;RPL18A;SRP19;RPL18;RPL39;RPS19;RPL31;SEC63;RPS8
prerank,phosphate ion transmembrane transport (GO:0035435),0.5749053925139571,1.228820570873217,0.23615635179153094,0.6491241144664744,1.0,5/12,16.42%,SLC25A30;XPR1;SLC37A2;SLC37A3;SLC25A10
prerank,regulation of cell communication (GO:0010646),0.47242274280064944,1.228581533745792,0.20491803278688525,0.6490633266733167,1.0,7/35,6.53%,GJA5;KAZALD1;CRK;SLC8A1;SCG5;CAMK2D;IGFBP7
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.5665350972078778,1.2283948729000165,0.24193548387096775,0.6488014279937935,1.0,7/13,25.81%,STAT1;JAK2;OAS2;IL27RA;OASL;CANX;JAK1
prerank,regulation of telomerase activity (GO:0051972),0.45283929256647387,1.2283334446145289,0.19895287958115182,0.6482215636023935,1.0,13/45,14.21%,HMBOX1;KLF4;MAPK1;NVL;NEK7;DKC1;PTGES3;TNKS;CCT2;CCT4;ATM;ERCC4;CTNNB1
prerank,membrane repolarization (GO:0086009),0.5490416383545912,1.2279760863269782,0.23427672955974843,0.648470843688564,1.0,3/15,2.18%,KCNQ1;KCNE3;ATP1A1
prerank,cellular response to chemokine (GO:1990869),0.44581326090767626,1.2273605750146805,0.20860495436766624,0.6493212066289805,1.0,7/46,10.31%,CCR1;DUSP1;OXSR1;LRCH1;ZC3H12A;STK39;CCL4
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.4678198188756574,1.2271134581117609,0.20656634746922026,0.6492757714737369,1.0,7/37,14.16%,ENTPD1;DFFB;ADPRM;RNASEH2B;XRN2;RNASE6;NUDT9
prerank,regulation of osteoblast proliferation (GO:0033688),-0.4487074119763428,-1.2269732000288676,0.20935960591133004,0.671661814050598,1.0,6/17,20.51%,FGFR2;NPR3;PLXNB1;ATRAID;CCN1;MN1
prerank,negative regulation of cell death (GO:0060548),0.409403618600438,1.2265017406733092,0.17375886524822695,0.6502028090527954,1.0,20/88,14.80%,MECOM;FYN;PRKD1;TMEM109;AMIGO2;CD34;TNFRSF1B;LRRK2;HSPA1B;PDE8A;DCPS;CD200;VPS35;CLU;CHGA;BNIP3L;BNIP3;RAD18;PSMC5;TM7SF3
prerank,regulation of cellular amine metabolic process (GO:0033238),0.44396435634593084,1.2264797124989828,0.20107238605898123,0.6495264958717856,1.0,22/50,22.68%,AZIN1;PSMD13;PSMD4;PSMA5;PSMB10;PSMB8;PSMD14;PSMA7;PSMA8;PSMC3;PSMB5;PSMC1;PSMC5;PSMC6;PSMB9;PSMA4;PSMD5;PSMD9;PSMB6;PSMB2;OAZ2;NQO1
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.31790113216878163,-1.2264557035065442,0.09302325581395349,0.6710829615651893,1.0,10/78,3.13%,PID1;EGFR;LRP1;EPHA3;SORBS1;PTPN9;DAB2;RHOQ;MMP14;STX4
prerank,neutrophil mediated immunity (GO:0002446),0.36922756305838333,1.2258547860135491,0.05673758865248227,0.6504732895763868,1.0,62/432,12.06%,PTPRJ;PECAM1;PTPRB;CEACAM1;STK10;ACE;IRAG2;ADGRE5;CD93;B2M;STOM;IQGAP1;DIAPH1;ANXA3;ANO6;NRAS;PSMD13;TSPAN14;MANBA;SRP14;ENPP4;TUBB;ACTR1B;GPI;PPIE;TNFRSF1B;ARG1;ADAM17;MAPK1;OSCAR;TUBB4B;CD47;PLD1;ITGAM;KPNB1;VAMP8;HSPA1B;CCT8;CRACR2A;ARPC5;KMT2E;SLC15A4;ROCK1;VAMP7;DSN1;DSP;HMOX2;PSMA5;HMGB1;ADAM10;NFASC;TYROBP;RAC1;CYFIP1;DYNLL1;CYBA;PSMD14;TRPM2;EEF2;CCT2;ILF2;DOCK2
prerank,smoothened signaling pathway (GO:0007224),-0.3855728914652194,-1.2254726923349908,0.1773049645390071,0.6718228743349439,1.0,9/32,14.84%,GLI3;GLI2;CC2D2A;SMO;GLI1;PTCH1;TMEM231;TCTN2;IFT27
prerank,dendritic spine morphogenesis (GO:0060997),-0.46764249530300167,-1.2254428645217423,0.21882951653944022,0.6697762659730505,1.0,7/15,24.38%,DOCK10;DLG4;CTNND2;EPHB2;EPHB3;PAK3;DIP2A
prerank,regulation of fibrinolysis (GO:0051917),-0.4822237236372086,-1.225203894692341,0.25495049504950495,0.6683469083361748,1.0,4/13,17.11%,THBS1;FAP;SERPINE1;THBD
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.5184637076681772,1.2251569470458112,0.23458646616541354,0.651635960855324,1.0,4/22,4.76%,EDN1;LMCD1;NOTCH1;CAMK2D
prerank,positive regulation of calcium ion transport (GO:0051928),0.48574419741635666,1.2251210587966885,0.2111111111111111,0.6509789682932803,1.0,9/36,10.31%,PDGFB;CCR1;MYLK;CAV1;ORAI1;STIM2;P2RX7;CRACR2A;CCL4
prerank,regulation of phospholipase C activity (GO:1900274),-0.4671961017277414,-1.2249710032416787,0.23393316195372751,0.6670121877832494,1.0,5/15,5.68%,NTRK3;PDGFRB;PDGFRA;KIT;FGF2
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.396099335579411,1.2247186377152979,0.17593643586833144,0.6513600742594443,1.0,31/124,15.74%,CCDC88C;FZD6;PLCB1;TNRC6C;AP2B1;PSMD13;LEF1;NLK;PSMD4;PPP3CA;PSMA5;PSMB10;AP2M1;RAC1;AGO4;PSMB8;PSMD14;SMURF1;PSMA7;PSMA8;PSMC3;NFATC1;PSMB5;CTNNB1;PSMC1;FZD9;FZD3;PSMC5;PRICKLE2;PSMC6;PSMB9
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.40300553700060454,1.2235552557710154,0.1574074074074074,0.6537611396422255,1.0,14/107,7.83%,ATP2A3;EDN1;TRPV4;CCR1;ATP2B4;ATP2B2;CAV1;SLC8A1;ATP2C1;STIM2;ATP13A3;SLC30A1;SLC39A6;MT2A
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.6074365401307694,1.2235459680628145,0.23652173913043478,0.6530412907400721,1.0,2/10,2.34%,ENG;CAV1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.4715979274627106,-1.223394924538936,0.21367521367521367,0.6694321088214084,1.0,7/16,5.68%,TGFBR3;IGF1;BMPR1A;FGFR2;ZFPM2;RBPJ;FGF2
prerank,translation (GO:0006412),0.3771006102962399,1.2233148957940037,0.12169312169312169,0.6529538066246955,1.0,91/208,28.30%,RPS21;GARS1;RPL27;VARS1;KARS1;RPL7;FARSB;WARS1;MRPL18;EEF2K;MRPL41;UBA52;RPS27A;RPS14;RPL35;ETF1;RPL21;FARS2;RPL37;RPS28;TUFM;MRPL47;GTPBP1;MRPL52;RPL34;RPS9;MRPL36;RPLP2;GTPBP2;EEF2;RPS25;MRPL23;RPL30;RPL27A;RPS5;MRPL24;MRPL32;RPL23A;MRPS34;MRPS12;RPS15;RPL19;RPS18;RPL32;GATB;EEFSEC;RPL22L1;RPL37A;RPL18A;EEF1E1;RARS1;EEF1D;MRPS18B;COPS5;ZC3H15;DARS1;EEF1G;MRPL11;RSL24D1;RPL18;RPL39;MRPS28;RPS19;RPL31;RPS8;EIF4G1;TSFM;MRPL34;PPA2;RPL3;EIF4EBP2;WARS2;MRPS24;MRPL35;RPL28;RPL9;RPL26;RPS16;RPLP1;MRPL10;MRPL27;MRPS18C;RPS17;EEF1A1;RPL14;DARS2;RPL11;APEH;MRPL13;CARS1;RPS13
prerank,protein targeting to peroxisome (GO:0006625),-0.3842450182795323,-1.2232716491247433,0.18241042345276873,0.6676435180766178,1.0,18/29,36.40%,ABCD3;ATAD1;PEX2;PXMP4;PXMP2;GDAP1;HACL1;PEX7;PEX11B;PEX13;PEX3;PEX16;PEX12;ZFAND6;SLC25A17;ACBD5;RAB8B;ALDH3A2
prerank,hepaticobiliary system development (GO:0061008),-0.42576990024583494,-1.2230495753479367,0.2050561797752809,0.666214458997077,1.0,4/20,5.14%,TGFBR3;WNT4;COBL;NIPBL
prerank,neuron projection organization (GO:0106027),0.5500614468309631,1.2227306348742433,0.22953451043338685,0.6537281356276828,1.0,4/15,9.94%,INSR;ATP1A3;APP;PRNP
prerank,negative regulation of translational initiation (GO:0045947),-0.4855183275741813,-1.2225369785463724,0.23134328358208955,0.6655250758710719,1.0,5/13,17.48%,PAIP2;EIF2AK4;EIF3E;LARP1;EIF4EBP1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.44736999589622767,-1.2223729851166214,0.18579234972677597,0.6638887066656615,1.0,10/16,26.87%,PIGA;PIGB;PIGN;PIGH;DPM2;PIGG;PIGP;PIGZ;PIGL;PIGW
prerank,regulation of cellular protein metabolic process (GO:0032268),0.4523992789878424,1.2214085311472371,0.18915343915343916,0.6567505953170296,1.0,11/47,15.91%,NANOS3;EDN1;APP;KLF4;CYFIP1;NFKBIA;VPS35;GRM5;METTL18;EIF2A;TCOF1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.45852804866250263,1.2213868109303667,0.20816864295125165,0.6560537297425659,1.0,10/40,11.75%,HIP1;B2M;INSR;CBL;PPT1;ANGPT1;ARRB1;TBC1D5;HNRNPK;CLU
prerank,external encapsulating structure organization (GO:0045229),0.38004291917382177,1.221305853941063,0.13052631578947368,0.6555246455895015,1.0,27/205,7.23%,LAMA4;LAMA3;PECAM1;ELN;FBLN5;PDGFB;VCAM1;RECK;F11R;VWF;ITGA1;JAM2;MMP1;ICAM2;AGRN;APP;ADAMTS18;SPOCK2;LAMA5;ADAM15;ATP7A;COL5A2;FURIN;CD47;BSG;ADAM12;ITGAM
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.5397595534781175,-1.2212514551947546,0.22248803827751196,0.6649393811419705,1.0,2/10,2.21%,ATP1A2;OSR1
prerank,muscle tissue morphogenesis (GO:0060415),0.5421014374013006,1.2211908322622107,0.22297297297297297,0.6551028239906758,1.0,4/16,3.63%,TBX1;NOTCH1;MYLK;HEY2
prerank,determination of bilateral symmetry (GO:0009855),0.4987249250399613,1.2211541690081809,0.22349570200573066,0.6544505091381861,1.0,3/24,5.46%,TBX1;NOTCH1;BBS7
prerank,positive regulation of innate immune response (GO:0045089),0.4849533148900991,1.2210985876922222,0.2349570200573066,0.6538744378210736,1.0,8/30,9.69%,GBP5;TRIM6;PLSCR1;NLRC5;NMI;SLC15A4;POLR3B;DHX9
prerank,positive regulation of nuclear division (GO:0051785),0.49516356360463154,1.2209327338284846,0.23837209302325582,0.6535535777142855,1.0,4/25,6.18%,EDN1;PDGFB;INSR;IL1A
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.5213639869075474,1.2209057598028492,0.23244929797191888,0.6528926101434339,1.0,7/18,20.23%,HIP1R;TMEM14A;FZD9;GSK3A;BID;GSK3B;ACAA2
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.5773492259953342,1.220627782141884,0.23322683706070288,0.6521545243782376,1.0,4/12,14.41%,EFNA5;ACTN4;ITGB1BP1;SPRY4
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.5773492259953342,1.220627782141884,0.23322683706070288,0.6521545243782376,1.0,4/12,14.41%,EFNA5;ACTN4;ITGB1BP1;SPRY4
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.4956708347020564,1.2202059026794514,0.229607250755287,0.6526307847771864,1.0,3/23,5.43%,EDN1;PIEZO1;MEF2C
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.5452936264742354,1.2198434176947888,0.25040650406504067,0.6528786307642133,1.0,3/15,5.40%,APOA1;LCAT;PLTP
prerank,positive regulation of hydrolase activity (GO:0051345),0.39400107255032063,1.2196240997114827,0.14672686230248308,0.6527128300981793,1.0,23/137,13.72%,RAPGEF2;DOCK9;F11R;RAPGEF1;RASGRP2;CAV2;F2RL1;AGRN;APOA1;TBC1D30;MAP4K4;RAPGEF6;RAP1GDS1;BCAR3;RGS7;CD200;RSU1;CCL4;CALM3;ARHGAP27;USP6NL;PIN1;HMGB2
prerank,protein localization to centrosome (GO:0071539),0.5330363630926417,1.2178443486191382,0.25,0.6568286590634513,1.0,8/17,20.08%,CSNK1D;SNX10;NEDD1;PCM1;CCDC14;CEP83;NUDCD3;CEP192
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.4732993719071459,-1.2175907243209,0.2219178082191781,0.673295429694193,1.0,6/15,17.57%,LARGE1;MGAT3;RENBP;EXTL2;NAGK;AMDHD2
prerank,tRNA metabolic process (GO:0006399),0.5439795131910259,1.2174201667874789,0.23483670295489892,0.6572451531874385,1.0,4/17,10.06%,DTD2;KARS1;TRPT1;FARS2
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.40281624065974475,-1.216936396691447,0.20655737704918034,0.6730192488867598,1.0,9/24,20.88%,ERRFI1;ROCK2;RUNX1;SRSF6;HOXA7;CTSL;ZFP36;NME2;ETV4
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.5182072066971091,-1.2155451270027942,0.236318407960199,0.674885614000553,1.0,3/10,9.13%,EMC2;EMC7;EMC1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4630140133551168,1.215478516499803,0.22074468085106383,0.6617026272489192,1.0,7/40,5.12%,JAG1;NOTCH1;TGFB2;WWTR1;GCNT2;LEF1;SMAD2
prerank,cyclooxygenase pathway (GO:0019371),-0.5281959804508558,-1.2152657024527895,0.22384428223844283,0.6736369294113306,1.0,3/10,6.50%,PTGDS;PTGS1;PTGES
prerank,positive regulation of microtubule polymerization (GO:0031116),0.47957428607884645,1.2149497171856,0.2272069464544139,0.6624035422873972,1.0,8/28,13.63%,OCLN;FES;CLIP1;CLASP1;HSPA1B;RAC1;NUMA1;NAV3
prerank,protein polyglutamylation (GO:0018095),0.5821002586395687,1.2145075104781702,0.2793388429752066,0.662854379687461,1.0,4/11,12.71%,TTLL7;TTLL1;TTLL5;TTLL11
prerank,rRNA catabolic process (GO:0016075),0.5315784455632152,1.2139720270335865,0.25493421052631576,0.6636295143100713,1.0,7/16,21.57%,TRIR;EXOSC3;EXOSC8;PELO;XRN1;EXOSC9;EXOSC10
prerank,Golgi to endosome transport (GO:0006895),0.5321438725870625,1.2131756929739748,0.22168284789644013,0.6650946929834085,1.0,6/16,20.25%,DOP1B;KLHL20;KIF16B;MON2;EPS15;SORT1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.5559845837976505,1.2131479722469065,0.27257799671592775,0.6644168633590769,1.0,2/12,5.92%,LMO2;BRD8
prerank,positive regulation of lymphocyte migration (GO:2000403),0.5704340175710049,1.2127675149058625,0.24871355060034306,0.6646375100621827,1.0,2/12,2.99%,JAM2;APP
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.4173945603711395,-1.2119408122045767,0.192090395480226,0.681264637308271,1.0,6/21,7.21%,ERRFI1;ROCK2;BMP4;MAFG;RUNX1;SFRP4
prerank,epithelial cell-cell adhesion (GO:0090136),-0.5101955197511177,-1.2116140875218362,0.21962616822429906,0.680233965140975,1.0,4/11,6.79%,ITGB5;KIT;CCN3;PLEKHA7
prerank,phosphate ion transport (GO:0006817),0.5328214332978545,1.211574273773642,0.24386503067484663,0.6673289070067834,1.0,5/16,16.42%,SLC25A30;XPR1;SLC37A2;SLC37A3;SLC25A10
prerank,establishment of melanosome localization (GO:0032401),0.507138213579132,1.21058108697249,0.2465331278890601,0.6693075835517236,1.0,4/19,6.14%,RAB11A;BLOC1S6;BBS7;GPR143
prerank,extracellular structure organization (GO:0043062),0.3763417926231938,1.2103336369882132,0.14210526315789473,0.6692405823204669,1.0,27/204,7.23%,LAMA4;LAMA3;PECAM1;ELN;FBLN5;PDGFB;VCAM1;RECK;F11R;VWF;ITGA1;JAM2;MMP1;ICAM2;AGRN;APP;ADAMTS18;SPOCK2;LAMA5;ADAM15;ATP7A;COL5A2;FURIN;CD47;BSG;ADAM12;ITGAM
prerank,rRNA processing (GO:0006364),0.3801833592137587,1.2099171637753303,0.1539301310043668,0.6696190966094893,1.0,72/172,26.59%,BOP1;PELP1;RPL27;DHX37;RPL7;EXOSC3;NVL;UBA52;MRPL1;MRM2;RPS14;RPL35;WDR46;RPL21;DKC1;RPL37;RRP15;RPS28;RPL34;RPS9;RPLP2;EXOSC8;XRN2;NHP2;RPS25;RPL30;RPL27A;NOL8;RIOK3;SART1;RPL23A;RPS15;EIF6;RPL19;RPL32;UTP18;RPL37A;RPL18A;EXOSC9;NOB1;LAS1L;DDX47;DCAF13;WDR18;RRP9;PWP2;RPL18;C1D;RPL39;NOLC1;IMP4;EXOSC10;RPS19;RPL31;EXOSC1;FBL;NOP53;HELQ;WDR43;RPL3;UTP20;MRTO4;MDN1;RPL28;RPL9;RPL26;RPS16;RPLP1;DDX27;ERI1;ESF1;UTP15
prerank,ephrin receptor signaling pathway (GO:0048013),0.4114647724331741,1.209568565024519,0.1981242672919109,0.6698349996064743,1.0,18/82,11.60%,KALRN;EFNA5;ARHGEF28;FYN;CRK;AP2B1;EFNA1;GRIN2B;ARPC5;ACTG1;YES1;ROCK1;PTK2;APH1A;AP2M1;ANKS1B;RAC1;ACTB
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.460559040150736,-1.2095241994877612,0.21164021164021163,0.684314677535338,1.0,5/17,13.03%,CPEB1;NUDT21;NCBP1;CTR9;CPEB3
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5267772261940356,1.2092916015569386,0.26174496644295303,0.6698282342240038,1.0,6/15,12.48%,TNRC6C;BTG2;TENT4A;POLR2G;CNOT1;TOB1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.5619479386947408,1.209094002713854,0.2620232172470978,0.669617474307098,1.0,5/13,11.75%,AQP11;FCGR2B;MBTPS2;LPCAT3;CLU
prerank,negative regulation of interferon-gamma production (GO:0032689),0.49317268758739635,1.2089044902055606,0.2463768115942029,0.6694127786216244,1.0,8/23,16.99%,LGALS9;ZC3H12A;HMGB1;PRNP;VSIR;LAPTM5;HAVCR2;RARA
prerank,negative regulation of response to stimulus (GO:0048585),0.4296378124529465,1.208852807691794,0.193138500635324,0.6688025349598866,1.0,16/60,11.75%,MCTP1;KLF7;AQP11;APOA1;KLF4;ACVR1;FCGR2B;KIF26A;CD34;AKT3;RBL1;PIM3;LPCAT3;PTPN1;MAP3K3;CLU
prerank,glycoprotein metabolic process (GO:0009100),0.4328309266141244,1.2081447922211197,0.21794871794871795,0.6700001876994733,1.0,14/53,19.53%,GCNT1;ST6GALNAC3;ST8SIA6;MANBA;PRKCSH;HIF1A;FBXO2;ST3GAL2;ENGASE;OGA;FBXO6;GOLPH3;NGLY1;NEU4
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.555098485419949,1.2081060716799827,0.2654424040066778,0.668636401665291,1.0,1/13,0.83%,PLCB1
prerank,cellular response to interleukin-15 (GO:0071350),0.555098485419949,1.2081060716799827,0.2654424040066778,0.668636401665291,1.0,1/13,0.83%,PLCB1
prerank,positive regulation of dendrite development (GO:1900006),-0.5106937496923533,-1.2078739771608404,0.23095823095823095,0.6872432646141617,1.0,4/10,2.54%,PTN;BMP5;BMP7;COBL
prerank,response to estradiol (GO:0032355),-0.3905930548637937,-1.2077114326291014,0.19322033898305085,0.6856170444250761,1.0,8/31,16.72%,EGFR;LCOR;ANXA1;CCDC62;GGT5;SOCS2;GGT7;GPER1
prerank,regulation of actin filament depolymerization (GO:0030834),0.5697244216862843,1.207485704796022,0.2896890343698854,0.6695608118442529,1.0,3/12,7.48%,LIMA1;F2RL1;WDR1
prerank,protein targeting to lysosome (GO:0006622),0.5184582769700142,1.2070896720421704,0.2577639751552795,0.6699014501397639,1.0,10/20,20.95%,GNPTAB;NCOA4;LAPTM5;CLU;VPS4A;NAGPA;ZFYVE16;AP3M1;LAMP2;SORL1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.4018695770392969,1.2065295645411527,0.19976218787158145,0.670669114382172,1.0,5/88,2.90%,NANOS1;NANOS3;EDN1;DAB2IP;BTG2
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.5275508964621505,1.2059476229290333,0.24648985959438377,0.6714739428510891,1.0,4/17,3.80%,GJA5;ATP1A3;ATP1A1;SLC8A1
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.5073899025297146,-1.205455720557073,0.2524752475247525,0.6898107495948804,1.0,7/11,27.00%,P4HA1;EGLN3;P4HTM;P3H2;P4HB;P4HA3;OGFOD1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.3896661797492692,1.2053209917015002,0.19296254256526674,0.6724688096522318,1.0,34/114,18.87%,AIM2;ACTN4;TNFRSF18;PSMD13;TNFRSF25;TRAF1;TNFRSF1B;COMMD7;ADAM17;PSMD4;STAT1;JAK2;LTB;PSMA5;PSMB10;NFKBIA;PSMB8;PSMD14;PSMA7;PSMA8;PSMC3;PSMB5;PSMC1;PSMC5;PSMC6;PSMB9;TMSB4X;PYCARD;PSMA4;PYDC1;PSMD5;PSMD9;RELA;PSMB6
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.53800266147727,1.2053081346155345,0.27129337539432175,0.6717737394659559,1.0,5/14,17.16%,F2RL1;APOA1;TRAIP;PYDC1;PTPN2
prerank,regulation of cellular catabolic process (GO:0031329),0.4215283126399965,1.2052954536858362,0.20959595959595959,0.6710624869539298,1.0,20/62,19.54%,ACER2;DRAM1;FBXL2;GPR137B;SMCR8;DEPP1;LRRK2;HSPB1;ROCK1;RRAGD;TPCN2;DRAM2;KEAP1;ATM;RMC1;TRIB3;LONP2;TYSND1;RRAGA;RRAGC
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.47120397986343615,-1.2051274501876816,0.24938271604938272,0.6887060714044824,1.0,3/14,3.61%,DMD;WNK1;WNK4
prerank,negative regulation of viral process (GO:0048525),0.43255392997242736,1.2050145950973146,0.19525065963060687,0.6710677467525683,1.0,18/57,21.28%,TRIM14;IFIH1;TRIM11;TRIM6;STAT1;PLSCR1;OAS2;TRIM8;CHMP3;SLPI;SRPK1;RSAD2;IFITM3;ZC3HAV1;EIF2AK2;HEXIM1;MID2;BANF1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.4871523771174504,1.2047140832891938,0.24599708879184862,0.671208766983527,1.0,11/26,22.25%,FYN;AIM2;EFNA1;GRIN2B;APH1A;VSIR;TTBK1;PYCARD;AGER;APH1B;EPHA4
prerank,positive regulation of protein secretion (GO:0050714),0.41786542212691613,1.2042851764097682,0.21026894865525672,0.6716306523393768,1.0,9/69,6.18%,MYRIP;CD2AP;UNC13B;DOC2B;F2RL1;TGFB2;TMED10;GLUD1;IL1A
prerank,xenobiotic transport (GO:0042908),-0.4383984943160214,-1.203865570317469,0.22554347826086957,0.6903886633573664,1.0,3/17,7.09%,SLC47A1;GJA1;SLC22A4
prerank,dendritic cell migration (GO:0036336),0.5439086590342284,1.2036195841364448,0.2802547770700637,0.6727168884240055,1.0,4/16,14.18%,CCR1;HMGB1;TRPM2;CXCR4
prerank,apoptotic process (GO:0006915),0.37332400959193773,1.2035367996761186,0.1518716577540107,0.6722109175051839,1.0,36/203,10.61%,HIP1;EFNA5;ELMO1;FAS;TBX1;PLK3;PAEP;FOXO1;CASP8;RHOB;APP;ADAM15;CASP2;IAPP;DAP;TNFRSF25;BRAT1;DDX41;IL1A;BBC3;PDCD4;ZBTB16;CIDEB;JAK2;PLSCR1;BCL2L1;RFK;NCKAP1;GAPDH;MAL;RTN4;CASP1;TAOK2;PRUNE2;BAG6;NFKBIA
prerank,wound healing (GO:0042060),-0.33190020606553505,-1.2035094001754862,0.17757009345794392,0.6894071219917123,1.0,17/62,11.68%,COL3A1;IGF1;PDGFRA;TGFBR1;FGF1;WNT5A;TPM1;AHNAK2;FGF2;SMAD3;FZD7;CFLAR;PRCP;RAF1;ERBB2;SYTL4;DCBLD2
prerank,positive regulation of chemokine production (GO:0032722),0.44287792097868744,1.2033965673390268,0.2197070572569907,0.6718785946163729,1.0,8/44,9.48%,F2RL1;LGALS9;APP;TIRAP;TLR3;ADAM17;EGR1;HMGB1
prerank,Golgi to plasma membrane transport (GO:0006893),0.43582256707021033,1.2033840560492155,0.22786458333333334,0.6711836011852338,1.0,18/47,23.20%,EXOC6;MACF1;STXBP6;RAB34;GOPC;EXOC8;NSF;ANK3;SPTBN1;EXOC4;GOLPH3L;GOLPH3;STEAP2;RAB31;EXOC2;EXOC5;OSBPL5;EXOC6B
prerank,regulation of cellular amide metabolic process (GO:0034248),0.4763259076013897,1.2033187659019375,0.24857142857142858,0.6706271956622919,1.0,9/32,15.91%,NANOS3;APP;TMED10;ROCK1;CYFIP1;GRM5;METTL18;EIF2A;TCOF1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.40128953130482786,-1.2029035053459896,0.2111801242236025,0.6892022676467451,1.0,2/25,1.67%,ANK2;CEMIP
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.39283840135935977,-1.2025199855436504,0.1896551724137931,0.6882529869868266,1.0,7/25,11.91%,EGFR;THBS1;SRC;FZD7;PTH1R;SDCBP;NCKAP1L
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.5200613942683431,1.2022902727731002,0.2534775888717156,0.6728380881559459,1.0,3/17,9.16%,TEK;FES;STAP1
prerank,positive regulation of locomotion (GO:0040017),0.48312436069408904,1.2022058102287998,0.2529585798816568,0.6723292468756229,1.0,5/27,4.10%,PDGFB;F2RL1;PPM1F;SPOCK2;NTN1
prerank,positive regulation of vascular permeability (GO:0043117),0.5626107465206331,1.2020900778178671,0.2707641196013289,0.6719133254702195,1.0,5/12,9.87%,TRPV4;OCLN;ANGPT1;TJP2;TJP1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.4138871255851359,1.2020179594144902,0.22596754057428214,0.6714022095751945,1.0,25/67,18.87%,B2M;PSMD13;FCGR1A;PSMD4;VAMP8;PSMA5;PSMB10;TAP1;PSMB8;CYBA;PSMD14;PSMA7;PSMA8;TAPBP;PSMC3;PSMB5;PSMC1;PSMC5;NCF2;PSMC6;PSMB9;PSMA4;PSMD5;PSMD9;PSMB6
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.42528017035165827,-1.2008884993259725,0.20057306590257878,0.6911551736649061,1.0,6/21,8.32%,IGF1;BMPR1A;IGFBP5;GJA1;FGF2;MMP2
prerank,response to peptide (GO:1901652),0.46758261208510044,1.2007578458895298,0.24157303370786518,0.6741743099305287,1.0,11/33,20.17%,FYN;NOD2;CACNA1A;STAT1;EIF2B2;PRNP;IRF5;KAT7;ERBIN;STAT5A;AGER
prerank,regulation of AMPA receptor activity (GO:2000311),0.49263942309664893,1.2007298160446123,0.2564885496183206,0.6735354692014391,1.0,6/25,10.77%,ADRB2;SHISA8;MEF2C;SHANK3;SHISA6;MINK1
prerank,cytoplasmic translation (GO:0002181),0.4025826847700518,1.2006381064369076,0.1937799043062201,0.6730884748932896,1.0,44/91,28.30%,RPS21;RPL27;RPL7;UBA52;RPS27A;RPS14;RPL35;ETF1;RPL21;RPL37;RPS28;RPL34;RPS9;RPS25;EIF3I;RPL30;RPL27A;RPS5;RPL23A;RPS15;RPL19;RPS18;RPL32;RPL22L1;RPL37A;RPL18A;EIF3M;ZC3H15;RPL18;RPL39;RPS19;RPL31;RPS8;RPL3;RPL28;RPL9;RPL26;RPS16;RPLP1;EIF4A1;RPS17;RPL14;RPL11;RPS13
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.5215363323394737,1.2006264581059363,0.25,0.672399981872586,1.0,2/17,1.44%,KCNQ1;KCNE3
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.41223015427128246,1.1999209881636177,0.21189591078066913,0.6736266552114548,1.0,10/72,13.34%,ACER2;PLK3;BTG2;CASP2;CDC25C;CRADD;CNOT6L;CNOT1;E2F7;ATM
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.4601195730188391,-1.1997033165980224,0.23545706371191136,0.6925720387853894,1.0,8/15,27.96%,SIRT3;SPHK1;PLA2G6;PRKCD;ORMDL2;SPHK2;SMPD3;TNFRSF1A
prerank,peptide metabolic process (GO:0006518),-0.3117313939220361,-1.1993681624730081,0.12432432432432433,0.6915842736113477,1.0,20/75,14.64%,AEBP1;DMD;CPQ;BACE2;ANPEP;GSTT1;MGAT3;CPE;BACE1;HM13;CARNMT1;CPXM2;GSTZ1;CPXM1;ENPEP;SPCS3;ETHE1;GSTA3;CLN5;GSTM1
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.4233386624228186,-1.1985323891284128,0.19827586206896552,0.6919372393321673,1.0,6/20,12.38%,B3GALT1;ST6GALNAC6;ST3GAL4;B4GALT1;MPDU1;ST6GALNAC5
prerank,regulation of ERAD pathway (GO:1904292),0.5633359878782352,1.1984672099928575,0.2773972602739726,0.6767851268813029,1.0,3/11,10.46%,AQP11;RNF185;BAG6
prerank,regulation of multicellular organism growth (GO:0040014),-0.4616606160876848,-1.1976896450663108,0.24242424242424243,0.6923135812590137,1.0,5/15,14.80%,IGF1;MBD5;GHR;PTCH1;MFSD2A
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.4805325281851759,1.1976798366687074,0.25323741007194245,0.6782396637126803,1.0,11/28,16.35%,ECSCR;DAB2IP;PTK2;FBXW7;LAPTM5;CLU;SMURF1;PSMC3;PSMC5;PSMC6;RNF139
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.38682120124495273,1.1976638248263027,0.17406143344709898,0.677567013914141,1.0,24/128,9.40%,ENG;CLDN5;SMAD6;BMPR2;SMAD7;F11R;ACVRL1;ZYX;TGFB2;CBL;FKBP1A;ID1;APOA1;TMEM100;ACVR1;GCNT2;SMAD2;NLK;FURIN;PDCD4;UBA52;RPS27A;PTK2;JUN
prerank,positive regulation of T cell differentiation (GO:0045582),-0.3698698079471747,-1.1976314191603656,0.23049645390070922,0.6904560218677518,1.0,8/36,13.24%,GLI3;GLI2;ZMIZ1;DUSP10;BCL6;NCKAP1L;PNP;MDK
prerank,positive regulation of transmembrane transport (GO:0034764),0.5563171714342892,1.1973034104259161,0.2662440570522979,0.6777988135338323,1.0,4/13,6.69%,AZIN1;ACSL5;ANO6;P2RX7
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.48499400950568816,-1.1970789829431376,0.2436548223350254,0.690073059737596,1.0,6/12,20.01%,SORBS1;IRS1;IGF2;PRKCZ;ZBTB7B;SNX5
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.29375190319487865,-1.1968255390520899,0.10071942446043165,0.6888658593724509,1.0,34/117,20.77%,IGF1;ALDH1A2;PCCA;ABAT;CYP26B1;PPARA;CPT1C;ME1;GNPAT;ACOT11;ALDH4A1;AASDH;MCCC2;NAAA;SCP2;GGT5;CKB;LDHB;PPARG;ECHDC3;THEM4;AMACR;GBA2;PDHA1;PDHX;HLCS;ACOT6;DLAT;HACL1;ACSF2;LPL;ALOX12;PANK2;AGXT
prerank,response to thyroid hormone (GO:0097066),0.5391749591224844,1.1961948150089485,0.27823240589198034,0.6800664854612717,1.0,2/13,5.92%,LMO2;BRD8
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3593760162458841,1.1961663808585021,0.043043043043043044,0.6794145430580193,1.0,138/834,14.29%,NOS1;LMO7;CDH13;EPAS1;SOX17;JAG1;NOTCH4;EDN1;ERG;ENG;GATA6;MRTFB;IRF6;GATA2;PDGFB;LDB2;BMPR2;RPS6KA5;SMAD7;KLF2;SMARCA2;CASZ1;LMO2;TBX1;NR4A2;FOXO4;ACVRL1;NOTCH1;NOD2;FOXO1;ELK3;ARHGEF2;NR1I3;HEY1;TAL1;DAB2IP;KLF7;IRF2;PRKD1;ZNF296;F2RL1;TGFB2;HNF4A;HNF1A;AGRN;KLF6;APP;ZGLP1;SOX18;HHEX;PELP1;HEY2;TLR3;PLXND1;KLF4;ACVR1;IER5;WWTR1;BCLAF3;LEF1;MAFF;SMAD2;RXRG;MEF2C;FOXF2;HYAL2;LMO1;BRD8;FOSL2;APEX1;GATA3;TOX3;SETX;CHCHD2;STAT1;ZC3H12A;PPP3CA;GAL;AATF;ARRB1;RBL1;TMPRSS6;PLSCR1;CEBPA;NFE2L2;NLRC5;UBA52;RPS27A;NR1D1;NAMPT;MRTFA;TCF3;JUN;EGR1;HMGB1;DHX9;SS18;PLAG1;RPS6KA1;NFKBIA;RPRD1B;TET3;CRTC1;MAML2;TNKS;NPM1;PCBP1;APLN;PHOX2A;E2F7;EAF2;BRCA1;HELZ2;PRKD2;HINFP;NR4A1;GCN1;SETD3;MED30;GLYR1;ITGB1BP1;IRF5;RPS6KA3;CTBP2;PHIP;POU3F2;PIN1;ATM;PSMC3;HIF1A;LRP5;HMGB2;ACVR2A;EAPP;NFATC1;CTNNB1;MED17;USF2
prerank,cellular protein-containing complex assembly (GO:0034622),0.3811557008605525,1.1958705516462393,0.17853231106243153,0.679523979208136,1.0,41/159,20.20%,HIP1;HIP1R;STXBP6;PIK3C2A;ADRB2;FKBP1A;PSMD13;FCHO2;ANGPT1;OMA1;DNAAF3;SMAD2;PSMD4;PFDN6;VBP1;VAMP8;TTC12;CASQ1;IMMP2L;NSG2;RTN4;DHX9;AP2M1;PTGES3;CYBA;CCT2;CLU;NUP153;CHMP3;CSNK2B;SAMM50;NUP205;NCK1;SMAD4;SRP19;SHQ1;PSMG2;NSG1;HOPX;EPS15;DNAJC28
prerank,negative regulation of protein modification process (GO:0031400),-0.31444181213235745,-1.1957849351458112,0.15254237288135594,0.6900232956958777,1.0,15/79,8.67%,PID1;PTPN13;NTRK3;DMD;PLPP3;FBLN1;SNTA1;SLIT2;PRKAA2;PRKN;NIBAN1;XDH;IGFBP3;P3H1;XRCC1
prerank,negative regulation of protein metabolic process (GO:0051248),0.4323199493483093,1.1952999757714824,0.21465968586387435,0.6803309857445203,1.0,13/48,13.32%,EDN1;AZIN1;IAPP;PFDN6;VBP1;ROCK1;MAD2L2;PRNP;PRKCG;ADGRB1;PFDN2;CLU;PIN1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.3941144840537865,-1.194886709798119,0.17073170731707318,0.6905807832686663,1.0,8/28,9.40%,PID1;APPL2;PRKCB;GRB10;ENPP1;IRS1;PIP4K2A;PRKCZ
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.35771067218022506,-1.194831260047604,0.17928286852589642,0.6887881309120514,1.0,9/43,5.44%,BMP6;IGF1;BMPR1A;WNT4;BMP7;BMP4;RUNX2;FBN2;IL6R
prerank,negative regulation of T cell proliferation (GO:0042130),0.4806409465984031,1.1946224668743886,0.2562962962962963,0.6814234943406011,1.0,4/28,9.94%,CRTAM;LGALS9;ARG1;PRNP
prerank,protein modification process (GO:0036211),0.40856821498928514,1.194575215195285,0.2057001239157373,0.6808233832110402,1.0,17/76,14.87%,FBXL2;ST3GAL6;DUSP12;UBA7;MANBA;STK38;CHRM3;UBA52;YES1;CSNK1G3;LIPT1;FBXW2;NAGPA;ST3GAL1;FBXO2;UBE2D3;MSRA
prerank,muscle contraction (GO:0006936),0.38841362632677373,1.1945305887001563,0.2085201793721973,0.6802116622924848,1.0,18/126,13.25%,NOS1;UTRN;MYBPC3;ITGA1;DYSF;MYLK;VIM;SLC8A1;MYL6;MYL12B;ROCK1;CLCN1;MYOF;TPCN2;TPM4;GAMT;SORBS3;TMOD3
prerank,regulation of urine volume (GO:0035809),0.5769824200123785,1.1941940825181325,0.2645051194539249,0.6803893752944293,1.0,3/10,6.97%,INPP5K;HYAL2;NPR1
prerank,dopamine metabolic process (GO:0042417),0.5155061064595544,1.1935755353082786,0.25152439024390244,0.6813497340673479,1.0,4/18,4.53%,TGFB2;GCH1;ATP7A;MAOA
prerank,cellular response to estradiol stimulus (GO:0071392),-0.44803669663075507,-1.1929396285190925,0.2440318302387268,0.6921237847470253,1.0,3/18,9.52%,EGFR;LCOR;CCDC62
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.40377057093442265,-1.1927090327321679,0.2161290322580645,0.6908257583601393,1.0,9/26,16.22%,OGT;KMT5C;SETD1A;SETD1B;TET2;CTR9;KMT5B;SUV39H1;SETD4
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.5656772306810399,1.1926742959276717,0.2687074829931973,0.6832443441228843,1.0,2/11,6.94%,SMAD7;ZC3H12A
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.46854983332898165,1.192452833587068,0.25828729281767954,0.6831136577907065,1.0,13/34,20.66%,MEF2C;LRRK2;GRIN2B;GRIN2C;GABRA4;GABRA2;GABRE;GRIN2A;GABRG3;GSK3A;GSK3B;GRID2;INSYN2A
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.41480928079964124,1.1919190430086186,0.21514423076923078,0.6838887231581514,1.0,12/78,8.54%,PDGFB;CCNY;CCND2;CCND3;HHEX;CCNE1;SERTAD1;CDC25C;ADAM17;MAPRE3;CEBPA;APC
prerank,regulation of protein binding (GO:0043393),0.3901404017658155,1.1917311193151083,0.20385050962627407,0.6836637680517099,1.0,27/114,15.76%,RAPGEF2;CLDN5;PDGFB;HIP1R;B2M;CAV1;FKBP1A;APP;CRK;EPB41;LRRK2;NVL;CTNNBIP1;ROCK1;MARK3;ACTB;DTX3L;TMBIM6;MARK2;ITGB1BP1;TTBK1;PIN1;LDLRAP1;RAN;NES;RACK1;SLPI
prerank,positive regulation of defense response (GO:0031349),0.4050677306635707,1.1917206820089337,0.22987164527421236,0.682965123833493,1.0,18/89,13.88%,GBP5;APP;TLR3;MEF2C;HYAL2;PDCD4;CD47;PLSCR1;CEBPA;NMI;SLC15A4;POLR3B;DHX9;NFKBIA;CYBA;DDT;ABCC1;RIOK3
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3904447216308994,1.1913563488635481,0.20372526193247964,0.6832131467955428,1.0,25/107,20.11%,RASGRF2;ATP2A3;DAB2IP;RHBDD1;RNF185;BBC3;UFM1;HSP90B1;MBTPS2;JUN;BAG6;TMX1;EIF2S1;PPP1R15B;NCK1;RNF139;UBXN6;SEL1L;TRIB3;CCDC47;DNAJC10;SELENOK;ERN1;GSK3B;RNF5
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.387613619495805,-1.1911146503172672,0.2182890855457227,0.6933628591595581,1.0,8/27,13.95%,SLC1A3;SLC7A2;SLC47A1;SLC25A13;SLC6A9;SLC38A5;SLC1A4;SLC25A12
prerank,regulation of mitotic nuclear division (GO:0007088),0.42505453044547514,1.1905218655991716,0.242503259452412,0.6847206560453521,1.0,8/55,7.78%,EDN1;PDGFB;INSR;DUSP1;CAV2;CDC25C;IL1A;TOM1L1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.43235435439799036,1.1901630337011877,0.22010178117048346,0.6849450752164313,1.0,4/48,4.76%,NOS1;FKBP1A;DIAPH1;CAMK2D
prerank,regulation of cell cycle (GO:0051726),0.36301618135607533,1.1899306163783865,0.12668743509865005,0.6848857186894489,1.0,34/271,10.64%,MECOM;NANOS3;AFAP1L2;GATA6;IRF6;APBB2;FOXO4;NOTCH1;DUSP1;ADARB1;TTC28;DAB2IP;TGFB2;RHOB;IQGAP1;BOP1;RPRM;PPP1R13B;GMNC;ASAH2;GATA3;PDCD4;MADD;UHMK1;WHAMM;GADD45G;APC;PIM3;NEK7;JUN;ADAM10;MLF1;CDC14A;RPRD1B
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.38732060829951664,-1.1898628207741515,0.2059800664451827,0.6950178566008482,1.0,5/27,3.24%,IGF1;PDGFRA;PDGFC;WNT5A;S100A6
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.46957256425440064,1.1894923685175052,0.24714285714285714,0.6853437469022493,1.0,11/32,23.06%,DEFA6;GALP;GAPDH;RPL30;RNASE6;FAM3A;CXCL10;ANG;RPL39;RPS19;RNASE7
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.5378308862898117,1.189149749540845,0.28013029315960913,0.6855255162265705,1.0,5/16,16.24%,TUBB;TUBB4B;VAMP7;LYST;PLEKHM2
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.46637392594750926,1.1888622096334223,0.267425320056899,0.685564110187441,1.0,13/29,26.07%,LSM1;EXOSC3;DCP1B;DCPS;EXOSC8;EDC3;DDX6;NT5C3B;EXOSC9;LSM2;EXOSC1;LSM7;LSM5
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.4941173026690618,-1.1887165478536563,0.28431372549019607,0.6964198021608994,1.0,4/10,30.17%,PRKN;HDAC6;AOC3;ETFBKMT
prerank,negative regulation of viral transcription (GO:0032897),0.5415408600577895,1.1884537318946231,0.27164685908319186,0.6859904121333319,1.0,2/13,4.54%,TRIM14;TRIM11
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.43369220909041073,1.187835321370423,0.235370611183355,0.6868749874463004,1.0,10/53,16.57%,CCR1;HRH2;CHRM3;HTR5A;MTNR1B;HTR1B;HTR2A;HTR1F;HRH3;HTR4
prerank,regulation of protein kinase B signaling (GO:0051896),0.36769521037470376,1.187554872949432,0.1607717041800643,0.6869363089317443,1.0,24/193,10.75%,PTPRJ;TEK;ENG;HIP1;PDGFB;FYN;KITLG;INSR;INPP5K;ANGPT1;RRAS;GCNT2;IAPP;FGFR3;HYAL2;PLEKHA1;GATA3;MFHAS1;THPO;PPP2R5C;PTK2;RTN4;RAC1;FGF20
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.5145342737624368,1.1873409572998954,0.2445141065830721,0.6868258070114314,1.0,2/17,2.69%,RAPGEF2;ADRB2
prerank,epithelial cell morphogenesis (GO:0003382),0.510213359399996,1.1863299707667792,0.2609375,0.6888695013311936,1.0,2/17,3.18%,CCDC88C;SIPA1L3
prerank,cardiac muscle cell development (GO:0055013),0.4904809632061898,1.1862432556266818,0.2706422018348624,0.6883966740914043,1.0,5/20,4.50%,SORBS2;HEY2;SLC8A1;ALPK3;PDLIM5
prerank,peroxisomal membrane transport (GO:0015919),-0.3786738190012277,-1.1862019924345608,0.22364217252396165,0.7022400014068048,1.0,16/27,36.40%,ABCD3;ATAD1;PEX2;PXMP4;PXMP2;GDAP1;PEX7;PEX11B;PEX13;PEX3;PEX16;PEX12;SLC25A17;ACBD5;RAB8B;ALDH3A2
prerank,cellular response to interleukin-12 (GO:0071349),0.4352996652405135,1.1861976930399254,0.261038961038961,0.6877925174135269,1.0,12/48,15.59%,PLCB1;GSTA2;MSN;PDCD4;CD47;JAK2;PITPNA;BOLA2;TALDO1;CFL1;LCP1;PAK2
prerank,regulation of epithelial cell proliferation (GO:0050678),0.3978755818527272,1.185941415647569,0.21660649819494585,0.687726693176306,1.0,11/85,4.38%,SGPP2;TIE1;TBX1;ACVRL1;NOD2;B2M;DAB2IP;AQP11;PRKD1;TGFB2;ANGPT1
prerank,negative regulation of lipid storage (GO:0010888),-0.4293474954021441,-1.1855858387418616,0.24778761061946902,0.7021026093470915,1.0,6/19,15.72%,ABCA1;ITGAV;PPARA;OSBPL8;PPARG;NR1H3
prerank,response to amyloid-beta (GO:1904645),0.4510164358325301,1.1855269594829185,0.24364123159303883,0.6881451361331576,1.0,7/44,4.01%,FYN;VCAM1;CACNA1A;ATP1A3;ADRB2;APP;FCGR2B
prerank,positive regulation of developmental process (GO:0051094),-0.27624409991338256,-1.1852736706845268,0.0821917808219178,0.7010509611810616,1.0,28/164,9.01%,PHLDB2;PTN;BMPR1A;SOX5;DCN;FOXD1;CCN2;BMP5;BMP7;BMP4;COBL;GRIP1;WNT5A;APOE;GJA1;ADGRL1;LMNA;DLG4;PRKN;RREB1;DDHD1;CAMK1;DAG1;SRC;KMT5C;CEBPB;SYDE1;VEGFA
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.41097418671953756,1.1852175611826012,0.23687580025608196,0.688295775395639,1.0,8/70,5.43%,TEK;NTN4;PARVB;ATRNL1;SIPA1L3;LAMA5;EFNA1;MEF2C
prerank,regulation of DNA metabolic process (GO:0051052),-0.3395758194061136,-1.1852101588676554,0.17886178861788618,0.6992768368225171,1.0,13/44,14.31%,NUCKS1;UBE2V2;UBE2N;USP1;KPNA1;YLPM1;HELB;THOC1;WDR70;SUB1;MPHOSPH8;MPV17;XRCC5
prerank,neutrophil degranulation (GO:0043312),0.35709673023685085,1.1847299573777388,0.09634888438133875,0.6888894974410035,1.0,59/425,12.06%,PTPRJ;PECAM1;PTPRB;CEACAM1;STK10;IRAG2;ADGRE5;CD93;B2M;STOM;IQGAP1;DIAPH1;ANXA3;ANO6;NRAS;PSMD13;TSPAN14;MANBA;SRP14;ENPP4;TUBB;ACTR1B;GPI;PPIE;TNFRSF1B;ARG1;MAPK1;OSCAR;TUBB4B;CD47;PLD1;ITGAM;KPNB1;VAMP8;HSPA1B;CCT8;CRACR2A;ARPC5;SLC15A4;ROCK1;VAMP7;DSN1;DSP;HMOX2;PSMA5;HMGB1;ADAM10;NFASC;TYROBP;RAC1;CYFIP1;DYNLL1;CYBA;PSMD14;TRPM2;EEF2;CCT2;ILF2;DOCK2
prerank,actin cytoskeleton reorganization (GO:0031532),0.4133395861795731,1.1844336418159296,0.22952853598014888,0.6889910042825903,1.0,11/63,6.91%,TRPV4;S1PR1;PLEK2;THSD7A;PARVB;CDC42BPA;NEDD9;ATP2C1;CDC42BPG;MYH9;WHAMM
prerank,defense response to Gram-positive bacterium (GO:0050830),0.44641954344038803,1.18416882627749,0.2693409742120344,0.6889942049713472,1.0,13/40,20.94%,GBP4;TIRAP;DEFA6;ADAM17;GBP2;CHGA;HMGB2;RNASE6;GBP7;STAB2;DROSHA;ANG;RPL39
prerank,activation of GTPase activity (GO:0090630),0.39748613602773825,1.184162779486473,0.21997621878715815,0.6883030859052064,1.0,26/89,14.67%,RABGAP1;SIPA1L2;ARHGEF15;ABR;SIPA1L3;RALGAPA1;BCR;TBC1D30;SGSM1;TBC1D8;TIAM2;RANGAP1;ARHGAP25;TBC1D12;TBC1D5;TBC1D1;TAX1BP3;RAP1GAP2;RALGAPB;USP6NL;TBC1D10A;TBC1D4;ARHGEF10;RALGAPA2;TBC1D9;RUNDC1
prerank,liver development (GO:0001889),-0.3654213684298973,-1.1836869907697585,0.23684210526315788,0.7018111292549609,1.0,7/32,10.80%,TGFBR3;WNT4;COBL;NPHP3;ANXA1;CEBPB;MET
prerank,positive regulation of axon extension (GO:0045773),0.48473051646600557,1.1833190596567713,0.2649310872894334,0.6898597752922603,1.0,5/22,7.11%,MACF1;NTN1;SHTN1;SEMA7A;ISLR2
prerank,protein K63-linked ubiquitination (GO:0070534),-0.3519842094216461,-1.1832556881300065,0.18181818181818182,0.7011514013286728,1.0,10/41,14.08%,UBE2E2;PRKN;UBE2V2;TRAF3IP2;UBE2N;RNF135;RNF4;RNF152;BFAR;ARIH2
prerank,central nervous system neuron development (GO:0021954),0.5254692865453048,1.1829006985530899,0.27388535031847133,0.6903073531984225,1.0,3/15,10.15%,RAPGEF2;ATP7A;B4GALT6
prerank,protein N-linked glycosylation (GO:0006487),-0.31877048766277877,-1.1828379261029494,0.12796208530805686,0.7003825531678827,1.0,23/66,18.77%,MGAT4C;MGAT4A;ST6GAL1;TUSC3;MGAT3;MAN1C1;SLC39A8;STT3A;B4GALT1;LMAN1;UGGT2;MPDU1;GFPT1;GFPT2;DPM2;PGM3;OST4;ALG8;MAGT1;STT3B;PMM1;ALG9;ALG13
prerank,negative regulation of cell junction assembly (GO:1901889),-0.3853487059265094,-1.1824608492239794,0.21794871794871795,0.699604564250908,1.0,7/25,8.39%,ARHGAP6;PHLDB2;ROCK2;APOD;THBS1;SRC;BCAS3
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.5291292820959519,1.182279564194498,0.29853181076672103,0.6912352109961784,1.0,5/14,10.31%,OXSR1;ADAM17;STK39;ADAM10;CCL4
prerank,positive regulation of superoxide anion generation (GO:0032930),0.5406801013775523,1.18141925119058,0.2833607907742998,0.6927540023002358,1.0,3/13,10.27%,F2RL1;ITGAM;TYROBP
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.3725367960274154,-1.181130179660475,0.23322683706070288,0.7016961265207288,1.0,7/29,6.87%,IGF1;NOTCH2;ITGAV;SHC1;NGF;IRS2;SRC
prerank,T cell migration (GO:0072678),0.5448759399080421,1.1810661829540647,0.2981878088962109,0.6930924886251302,1.0,2/13,4.11%,S1PR1;MSN
prerank,neutrophil activation involved in immune response (GO:0002283),0.3561070357493209,1.180716952504259,0.09959349593495935,0.6933494656631078,1.0,59/428,12.06%,PTPRJ;PECAM1;PTPRB;CEACAM1;STK10;IRAG2;ADGRE5;CD93;B2M;STOM;IQGAP1;DIAPH1;ANXA3;ANO6;NRAS;PSMD13;TSPAN14;MANBA;SRP14;ENPP4;TUBB;ACTR1B;GPI;PPIE;TNFRSF1B;ARG1;MAPK1;OSCAR;TUBB4B;CD47;PLD1;ITGAM;KPNB1;VAMP8;HSPA1B;CCT8;CRACR2A;ARPC5;SLC15A4;ROCK1;VAMP7;DSN1;DSP;HMOX2;PSMA5;HMGB1;ADAM10;NFASC;TYROBP;RAC1;CYFIP1;DYNLL1;CYBA;PSMD14;TRPM2;EEF2;CCT2;ILF2;DOCK2
prerank,BMP signaling pathway (GO:0030509),0.41643054811634317,1.1801097533569722,0.2531969309462916,0.6943532297020731,1.0,10/62,6.36%,ENG;SMAD6;BMPR2;SMAD7;ACVRL1;TGFB2;TMEM100;ACVR1;SMAD2;PDCD4
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.5026097762201212,-1.1788529039439388,0.2887139107611549,0.7064684841688014,1.0,6/11,36.59%,AGTR1;AGT;PLA2G7;ABCG1;LIPC;PLA2G5
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.3951783101312256,-1.178748858403896,0.24922118380062305,0.7048675721067591,1.0,4/24,1.42%,SOX5;ADAMTS12;EFEMP1;TGFBR1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.4481633159683555,1.1785309843681269,0.26740947075208915,0.6978624000001992,1.0,9/37,12.17%,STMN2;EFNA5;FAM107A;CLASP1;MAPRE3;PRKAA1;ROCK1;CLASP2;MARK2
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.45191593513307327,1.1784454434359413,0.2639664804469274,0.6973803358481037,1.0,8/35,11.34%,TEK;F11R;FES;ESAM;ARHGDIA;STAP1;TJP1;TRPM2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3737977665580571,1.178230441697588,0.18777777777777777,0.6972480343621059,1.0,38/161,16.20%,DKK2;SOX17;SOX13;CCDC88C;FZD6;TMEM88;DAB2IP;CAV1;PSMD13;WWTR1;CUL3;PSMD4;SHISA6;SNAI2;PTPRU;PTPRO;APC;IGFBP4;MCC;NKD2;SIAH2;PSMA5;PSMB10;ZNRF3;RBX1;MAD2L2;PSMB8;PSMD14;PSMA7;PSMA8;PSMC3;PSMB5;PSMC1;PSMC5;MLLT3;PSMC6;PSMB9;LZTS2
prerank,central nervous system myelination (GO:0022010),0.5620801788006256,1.1780569841457544,0.28685897435897434,0.6969809611885446,1.0,4/11,12.22%,B4GALT6;TENM4;CLU;SOX10
prerank,cellular response to leucine (GO:0071233),-0.5102524978852189,-1.1779554478251821,0.2632850241545894,0.7034905959679764,1.0,3/10,10.21%,KLHL22;SESN1;SESN2
prerank,response to leucine (GO:0043201),-0.5102524978852189,-1.1779554478251821,0.2632850241545894,0.7034905959679764,1.0,3/10,10.21%,KLHL22;SESN1;SESN2
prerank,chromatin organization (GO:0006325),0.37919443438702,1.1778530869458081,0.2016036655211913,0.6968307980999316,1.0,15/132,13.72%,PRDM16;MECOM;SMARCA2;NPM3;HDAC11;CHRAC1;TCF7L1;HP1BP3;CDAN1;NPM1;SMARCAD1;SUV39H2;GATAD1;SMARCC1;HMGB2
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.39092108243833373,-1.1777750913016243,0.22077922077922077,0.7021531594100082,1.0,6/24,7.01%,ARHGAP6;PHLDB2;ARHGAP28;ARAP1;TMEFF2;PIK3R1
prerank,response to interferon-beta (GO:0035456),0.4905623197978538,1.177625482983129,0.27217125382262997,0.6967015149754071,1.0,6/22,8.81%,AIM2;TRIM6;STAT1;IRGM;PLSCR1;ACOD1
prerank,regulation of response to biotic stimulus (GO:0002831),0.47208681760722343,1.1775248928147524,0.27314814814814814,0.6962857630373658,1.0,4/28,4.01%,GATA6;CASP8;TIRAP;FCGR2B
prerank,positive regulation of lymphocyte activation (GO:0051251),0.47098833032187815,1.1775030830696698,0.2619718309859155,0.6956285597621075,1.0,4/28,10.27%,NOD2;SH3KBP1;CD47;TYROBP
prerank,arachidonic acid secretion (GO:0050482),0.565435734479174,1.1772694215260242,0.2698961937716263,0.6948458053953496,1.0,1/10,1.04%,ACE
prerank,arachidonate transport (GO:1903963),0.565435734479174,1.1772694215260242,0.2698961937716263,0.6948458053953496,1.0,1/10,1.04%,ACE
prerank,regulation of innate immune response (GO:0045088),0.4215240239977486,1.1771923411136116,0.2402088772845953,0.6943742413823865,1.0,12/57,10.31%,GBP5;CASP8;TIRAP;FCGR2B;PLSCR1;NMI;SLC15A4;POLR3B;ACOD1;CACTIN;DHX9;PTPN1
prerank,epithelial to mesenchymal transition (GO:0001837),0.4221231512035411,1.1768663434618847,0.2444733420026008,0.6944803329620715,1.0,11/47,10.11%,NOTCH4;ENG;NOTCH1;HEY1;TGFB2;HEY2;LEF1;FOXF2;SNAI2;ROCK1;TASOR
prerank,regulation of establishment of protein localization (GO:0070201),0.5342037622255531,1.1764769896384302,0.29754601226993865,0.6948007243608745,1.0,9/13,33.47%,CEP135;SPIDR;CEP120;DNAJA1;PTP4A3;SCFD1;GAPVD1;CEP295;CTSD
prerank,nucleosome disassembly (GO:0006337),-0.4589809288583504,-1.176444452311723,0.25196850393700787,0.7020647692702453,1.0,3/14,10.14%,SET;SMARCB1;SMARCD1
prerank,chromatin disassembly (GO:0031498),-0.4589809288583504,-1.176444452311723,0.25196850393700787,0.7020647692702453,1.0,3/14,10.14%,SET;SMARCB1;SMARCD1
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.4122819810773058,-1.1762897773599224,0.23622047244094488,0.7005930640483485,1.0,3/20,2.40%,FMNL2;ROCK2;RHOQ
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.38566224470287785,-1.1760963002703888,0.2150170648464164,0.6992543460603875,1.0,7/27,7.01%,ARHGAP6;PHLDB2;ARHGAP28;PRKN;ARAP1;TMEFF2;PIK3R1
prerank,RNA destabilization (GO:0050779),-0.4250214606078731,-1.1756898573616663,0.2471264367816092,0.6985179176401065,1.0,6/18,12.78%,ROCK2;YTHDF1;FTO;PUM1;LIN28B;YTHDF2
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.49149769052667225,1.1754696561954567,0.2662807525325615,0.6968215859127539,1.0,7/21,16.63%,FYN;AIM2;GRIN2B;DELE1;TTBK1;PSMB9;PYCARD
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.40667049728965887,1.1753194904209137,0.2427307206068268,0.696525275266193,1.0,23/70,20.25%,FAS;DAB2IP;CASP8;TGFB2;TLR3;CASP2;FGFR3;TNFRSF1B;P2RX7;CRADD;JAK2;BCL2L1;DELE1;CASP8AP2;DCC;SIVA1;DAXX;GSK3A;DDX47;BID;MCL1;GSK3B;SORT1
prerank,negative regulation of cytokine production (GO:0001818),0.3749498425059387,1.175162072992973,0.20819848975188782,0.6962804809185449,1.0,30/163,11.28%,CEACAM1;RPS6KA5;F2RL1;IFIH1;LGALS9;HOMER2;HDAC9;HDAC7;UBA7;APOA1;KLF4;FCGR2B;LEF1;CD34;RNF125;PDCD4;CMKLR1;ZC3H12A;ARRB1;NLRC5;CD200;ACOD1;CACTIN;HMGB1;PRNP;TRIM25;TYROBP;RAC1;VSIR;LAPTM5
prerank,protein stabilization (GO:0050821),0.371242845166082,1.1749708331622404,0.18102508178844057,0.6960585607385575,1.0,31/168,14.31%,SOX17;HIP1;MSX1;SMAD7;HIP1R;GNAQ;TMEM88;SAXO1;APOA1;EFNA1;NLK;TAF9B;IRGM;DNLZ;HSPA1B;CCT8;STX12;GAPDH;RTN4;FBXW7;GET1;PTGES3;TYROBP;BAG6;CCT2;CLU;SUGT1;CCT4;PIN1;HYPK;CCT6A
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.42770598824922595,-1.1742251157100587,0.23607427055702918,0.7009240868173705,1.0,12/17,28.77%,CAMK1D;RIPOR2;NCKAP1L;MDK;DAPK2;DNM1L;CD74;MCU;C1QBP;CCL19;MOSPD2;THBS4
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.5638185519516026,1.1735155996786835,0.277602523659306,0.6986306365198389,1.0,7/11,23.84%,CCT8;DKC1;CCT2;CCT4;CCT6A;TCP1;CCT3
prerank,regulation of protein localization to Cajal body (GO:1904869),0.5638185519516026,1.1735155996786835,0.277602523659306,0.6986306365198389,1.0,7/11,23.84%,CCT8;DKC1;CCT2;CCT4;CCT6A;TCP1;CCT3
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.38152647628691516,1.1729051219657338,0.2113163972286374,0.6995025134181654,1.0,34/109,19.42%,PLCG2;PSMD13;MAPK1;PSMD4;PPP3CA;JUN;PSMA5;PSMB10;RAC1;PLCG1;PSMB8;TAB2;PSMD14;PIK3CB;BTK;PSMA7;PSMA8;PSMC3;SOS1;NFATC1;PSMB5;PSMC1;PSMC5;PAK2;PSMC6;PSMB9;PSMA4;PSMD5;PSMD9;RELA;PSMB6;GRAP2;MALT1;NFATC3
prerank,carbohydrate biosynthetic process (GO:0016051),0.4790120601413209,1.172435953456756,0.2781954887218045,0.7000382503282713,1.0,2/21,1.73%,ST8SIA6;ST3GAL6
prerank,cellular response to metal ion (GO:0071248),0.3788787176926797,1.1722154201367316,0.22325581395348837,0.6999260509923272,1.0,19/123,9.94%,PLCG2;SYT15;ITPKB;B2M;CPNE8;RASGRP2;IQGAP1;CLIC4;SYT7;CAMK2D;MEF2C;MAPK1;CPNE2;LRRK2;MCOLN1;MT2A;PRKAA1;JUN;PRNP
prerank,connective tissue development (GO:0061448),-0.3614936939568175,-1.1721257120398763,0.24390243902439024,0.7049174638323129,1.0,7/35,5.78%,SOX5;SULF1;SULF2;TRIP11;SH3PXD2B;ITGB8;SLC39A13
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.44925739841955936,-1.1718517954599654,0.28342245989304815,0.7037825708792214,1.0,6/14,22.46%,PPARA;IRS2;IRS1;MFSD2A;TWIST1;MTLN
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.41696589140274276,-1.1713317528309417,0.2611111111111111,0.7035073260691542,1.0,12/19,28.77%,CAMK1D;RIPOR2;NCKAP1L;MDK;DAPK2;DNM1L;CD74;MCU;C1QBP;CCL19;MOSPD2;THBS4
prerank,regulation of insulin secretion (GO:0050796),0.386309795940749,1.171323994615201,0.22765196662693682,0.7016657646691218,1.0,13/101,8.61%,MYRIP;EFNA5;ITPR3;SLC2A1;DOC2B;CACNA1A;HNF4A;SYT7;RAPGEF4;GLUD1;SIRT4;MTNR1B;NR1D1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.5647428380373163,1.1708794685318717,0.2815699658703072,0.7021846086111581,1.0,4/11,10.27%,F2RL1;ITGAM;STAP1;TYROBP
prerank,proteoglycan metabolic process (GO:0006029),-0.38680459459466165,-1.170699697366418,0.2208955223880597,0.7033232903597306,1.0,5/26,5.18%,IGF1;ADAMTS12;SULF1;SULF2;XYLT1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.5242790782129277,1.1705558317565739,0.3082942097026604,0.7023451321862141,1.0,6/15,15.23%,SMAD7;FKBP1A;ACVR1;ACVR2A;CSNK2B;ACVR2B
prerank,polyamine metabolic process (GO:0006595),0.5297952884081335,1.1705437778672547,0.3,0.7016765297240138,1.0,3/13,11.18%,AMD1;PAOX;SMS
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.4746084927494555,-1.1704865911588436,0.2686230248306998,0.702132531818263,1.0,6/12,23.10%,GMDS;EXTL2;GFPT1;GFPT2;PARG;CSGALNACT1
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.5434278358886836,1.1702512127455569,0.30642504118616143,0.7017697515723601,1.0,5/12,11.75%,IAPP;PFDN6;VBP1;PFDN2;CLU
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.46133595958565976,1.1701560906578568,0.2697947214076246,0.7013073228299266,1.0,5/34,6.18%,EDN1;PDGFB;INSR;CUL3;IL1A
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.5278424708932595,1.1700704273471718,0.27474402730375425,0.7008739594360196,1.0,5/13,12.48%,TNRC6C;BTG2;POLR2G;CNOT1;TOB1
prerank,cellular response to interleukin-4 (GO:0071353),0.5643392692720672,1.1696914185911977,0.2939244663382594,0.7012247960682133,1.0,2/10,6.13%,LEF1;GATA3
prerank,B cell homeostasis (GO:0001782),-0.5023892431752556,-1.169385319254894,0.270935960591133,0.7033713654572393,1.0,3/10,11.91%,DOCK11;DOCK10;NCKAP1L
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.5691094506968739,1.1691961648978422,0.30701754385964913,0.7011415935252185,1.0,2/10,3.86%,APOA1;KLF4
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.5691094506968739,1.1691961648978422,0.30701754385964913,0.7011415935252185,1.0,2/10,3.86%,APOA1;KLF4
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.48853913023033607,1.1688234331695597,0.27876106194690264,0.7014040120237728,1.0,9/22,21.81%,RNF103;RNF185;UBA52;RPS27A;UGGT1;RNF139;SEL1L;RNF5;UBB
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.29987234695245346,-1.1685154531775157,0.1404494382022472,0.7039523876779135,1.0,22/77,16.96%,IGF1;TGFBR1;BMP4;BCL2;SH3RF1;TCF7L2;THBS1;ITGAV;PRKN;NDUFS3;SRC;CFLAR;NDUFA13;BIRC6;URI1;QARS1;DDX3X;MPV17L;PIH1D1;FXN;BCL2L2;AR
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.27940516583288477,-1.1684025511542777,0.128,0.7024597571909778,1.0,21/129,8.33%,RNF220;LGR4;WLS;EGFR;COL1A1;FGFR2;TBL1XR1;GPC3;PTK7;WNK1;ZEB2;LRRK1;PSME4;PLEKHA4;SEMA5A;DACT1;DAAM2;SFRP4;PSMF1;PPM1A;LYPD6
prerank,negative regulation of viral release from host cell (GO:1902187),0.5328861456709989,1.167715657261093,0.2815198618307427,0.7037105619858879,1.0,4/13,20.99%,TRIM11;TRIM8;CHMP3;MID2
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.34820270955127786,1.1675744581955716,0.05,0.7034262931754716,1.0,160/1082,13.48%,PRDM16;NOS1;LMO7;MECOM;CDH13;EPAS1;SOX17;JAG1;NOTCH4;EDN1;AFAP1L2;ERG;ENG;GATA6;MRTFB;IRF6;GATA2;PLCB1;PDGFB;LDB2;BMPR2;RPS6KA5;SMAD7;KLF2;SMARCA2;CASZ1;LMO2;TBX1;NR4A2;FOXO4;ACVRL1;NOTCH1;NOD2;FOXO1;ELK3;ARHGEF2;NR1I3;HEY1;TAL1;DAB2IP;KLF7;IRF2;PRKD1;ZNF296;F2RL1;HNF4A;HNF1A;AGRN;KLF6;APP;ZGLP1;SOX18;HHEX;FLI1;PELP1;INPP5K;HEY2;TLR3;KLF4;ACVR1;IER5;ING2;SERTAD2;WWTR1;BCLAF3;LEF1;ZBTB48;SERTAD1;MAFF;SMAD2;KARS1;RXRG;MEF2C;FOXF2;HYAL2;LMO1;BRD8;FOSL2;APEX1;GATA3;TOX3;SETX;CHCHD2;RYBP;STAT1;ZC3H12A;FANK1;KDM3A;ZBTB16;PPP3CA;GAL;AATF;ARRB1;MAPRE3;EBF3;RBL1;TMPRSS6;PLSCR1;CEBPA;NFE2L2;NLRC5;DNAJC2;UBA52;RPS27A;KMT2E;NR1D1;KMT2B;NAMPT;MRTFA;TCF3;JUN;EGR1;ASF1A;HMGB1;SERTAD3;DHX9;SEC14L2;SS18;MAD2L2;PLAG1;RPS6KA1;NFKBIA;RPRD1B;SFR1;TET3;CRTC1;MAML2;DEAF1;TNKS;RAI1;NPM1;PCBP1;PHOX2A;E2F7;DTX3L;EAF2;BRCA1;ILF2;HELZ2;PRKD2;HINFP;NR4A1;CD38;SOX10;SETD3;MED30;GLYR1;ITGB1BP1;ELF2;IRF5;RPS6KA3;YWHAH;CTBP2;PHIP;POU3F2;PIN1;ATM;PSMC3;HIF1A;SMARCC1
prerank,regulation of establishment of cell polarity (GO:2000114),-0.4395056843256815,-1.1662675532921152,0.26139088729016785,0.7064821328849359,1.0,4/16,8.39%,GSN;ROCK2;RIPOR2;BCAS3
prerank,myeloid cell differentiation (GO:0030099),0.4281588911163453,1.166203972702566,0.25492772667542707,0.7063502725173745,1.0,9/47,8.51%,TAL1;SNRK;TIRAP;MFHAS1;ZBTB16;JAK2;CEBPA;KMT2E;RPS14
prerank,response to axon injury (GO:0048678),-0.41905801828252065,-1.1660495836008153,0.26136363636363635,0.7051875837956821,1.0,5/18,13.35%,DPYSL3;APOD;P2RX4;GAP43;NREP
prerank,response to organic cyclic compound (GO:0014070),0.4182730044692579,1.1659441815761469,0.2544529262086514,0.7063312587289253,1.0,11/52,14.21%,ALPL;ARL6IP5;TLR3;ABCB4;LRRK2;PAQR8;STRN3;TRPM2;SLC1A1;CDKN2D;CTNNB1
prerank,response to tumor necrosis factor (GO:0034612),0.3894510537071329,1.1656687805380206,0.2165680473372781,0.706396974921783,1.0,21/91,11.82%,MAP4K3;ARHGEF2;DAB2IP;CASP8;GCH1;INPP5K;HYAL2;GBP3;GATA3;ZC3H12A;JAK2;NFE2L2;NR1D1;ACOD1;CACTIN;ZFP36L2;ADAM10;DHX9;CCL4;GBP2;BRCA1
prerank,mononuclear cell differentiation (GO:1903131),-0.3970079362927159,-1.1653811057178027,0.25386996904024767,0.7054582408769801,1.0,8/24,16.35%,AXL;BMP4;IL31RA;MT1G;VEGFA;PPARG;RELB;FLT3
prerank,positive regulation of organelle organization (GO:0010638),0.4569613071215523,1.1651149803226568,0.2820874471086037,0.7071623314674205,1.0,10/32,12.95%,DOC2B;ADRB2;SMCR8;P2RX7;IRGM;RAB3GAP2;FYCO1;PFDN2;TMED9;SORBS3
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.47140997331674406,1.1650973566468017,0.26527570789865873,0.7064981875284682,1.0,6/24,13.47%,ACE;B2M;MFSD6;TAP1;TAPBP;SEC24B
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.5257261588093731,1.1650515542566307,0.29936305732484075,0.7059525732706261,1.0,5/15,15.49%,STOX2;TGFB2;CELF4;BRCA1;RICTOR
prerank,positive regulation of actin nucleation (GO:0051127),0.5557455900556049,1.1649018168024976,0.30477759472817134,0.7056422530404284,1.0,5/11,12.26%,FCHSD2;WHAMM;NCKAP1;CYFIP1;WASF2
prerank,regulation of T cell mediated immunity (GO:0002709),0.5636148664154536,1.164709322015422,0.31069609507640067,0.7054644107516717,1.0,3/10,20.17%,TNFRSF1B;HMGB1;AGER
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.3906588373929376,1.1639206175634995,0.24317617866004962,0.7069114009531131,1.0,22/78,17.88%,SMAD7;PLK3;CAV1;SUMO2;CSNK1D;BBS7;ARIH1;LRRK2;HSPA1B;CEBPA;NFE2L2;NKD2;RBX1;RNF144B;CLU;KEAP1;RACK1;UBQLN2;CBFA2T3;TRIB3;SOCS5;GSK3A
prerank,arachidonic acid metabolic process (GO:0019369),-0.36387636106188487,-1.1629434156240754,0.22456140350877193,0.7107700206269689,1.0,11/35,22.96%,PTGDS;PTGS1;PTGES;PLA2G4A;EPHX2;CYP2A6;ALOX12;PLA2G4C;FAAH;GPX4;GPX1
prerank,cell part morphogenesis (GO:0032990),-0.4636980112828559,-1.1620422313495447,0.2875,0.711458172129708,1.0,2/13,3.11%,PID1;WASF1
prerank,RNA transport (GO:0050658),-0.30968278314988795,-1.1618410965738615,0.19662921348314608,0.7101466561513502,1.0,33/71,27.42%,SIDT1;SRSF5;HNRNPA2B1;NCBP1;CKAP5;SRRM1;ATXN2;SRSF1;NUP155;SRSF6;THOC1;SIDT2;RTRAF;TGFBR2;NXF1;MAGOH;U2AF2;MAGOHB;ZFP36;UPF3B;SRSF3;KIF5C;SLBP;SRSF11;POM121;EIF4A3;NCBP2;ZC3H11A;U2AF1;SRSF2;THOC7;NUP188;PNPT1
prerank,amide transport (GO:0042886),0.46334225018174985,1.1618249823764468,0.2692307692307692,0.7119358371850149,1.0,6/26,9.82%,AQP11;SLC25A32;PLTP;GLTP;CERT1;TAP1
prerank,regulation of intracellular protein transport (GO:0033157),0.45130013867083196,1.1617366157570852,0.2936170212765957,0.711484462897941,1.0,11/32,16.84%,PTPN14;PLK3;UHMK1;PRR5L;PCM1;RIPOR1;PTPN1;ICE1;LCP1;PDCD10;TENM1
prerank,base conversion or substitution editing (GO:0016553),0.5565979640377643,1.1617153557446043,0.3089430894308943,0.710843353345304,1.0,2/11,9.21%,ADARB1;ADAR
prerank,protein modification by small protein conjugation (GO:0032446),0.3489184666061295,1.161520959360051,0.15297741273100615,0.7107017664703361,1.0,73/361,16.52%,LMO7;EPAS1;TRIM14;RNF103;FBXL2;TRIM69;CBL;IFIH1;HERC2;KLHL2;FBXO7;UBA7;FBXL5;KLHL3;TRIM11;SUMO3;SUMO2;TRIM6;RNF38;ELOC;ARIH1;GAN;CUL3;RTF1;ARRDC1;UBE2D1;TRIM24;UFM1;KLHL20;RANGAP1;ARRB1;ASB5;NFE2L2;WWP1;UBA52;RPS27A;NUP54;FBXW7;ZNRF3;RBX1;CUL2;TRIM47;ENC1;NUP35;TRIM17;RANBP2;NEDD4L;DTX3L;BRCA1;SMURF1;KCTD10;FBXO4;NUP153;UBE2T;RNF103-CHMP3;KEAP1;UBE2J2;HIF1A;NUP160;FBXO2;UBE2E1;CDC27;RAD18;NUP42;UBE2D3;TRAIP;KLHL25;RACK1;ANAPC7;KLHL24;NUP205;RNF139;KLHL9
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.33406938840912437,-1.1610572382875721,0.2,0.710498964054732,1.0,11/52,9.67%,EGFR;LRP1;EPHA3;SORBS1;PTPN9;STX4;PIK3R1;CLIP3;PRKCI;STX3;CNST
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.5551259257761013,1.1609737738416244,0.3117117117117117,0.7114702761986901,1.0,4/11,9.94%,ATL2;ATL1;RTN4;LPCAT3
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.4313624506643538,-1.1602065547919107,0.2776203966005666,0.7110706713305992,1.0,4/18,5.44%,PTN;CAMK1D;SLIT2;IL6R
prerank,N-terminal protein amino acid modification (GO:0031365),-0.4502722087830409,-1.160156494259676,0.2647814910025707,0.7094156971860145,1.0,7/14,25.67%,METAP1D;METAP1;NAA60;NAA40;NAA10;NAA50;NAA15
prerank,regulation of developmental growth (GO:0048638),0.45665577748693115,1.1598932688160701,0.2781844802342606,0.7136543672944072,1.0,6/29,7.87%,PLCB1;SPAAR;INSR;APP;FGFR3;NRCAM
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.39612075422243087,1.1596950717621735,0.24786324786324787,0.7135025932071052,1.0,9/79,3.36%,MMRN2;SMAD6;BMPR2;SMAD7;NOTCH1;ATP2B4;DAND5;DAB2IP;HHEX
prerank,regulation of sprouting angiogenesis (GO:1903670),0.459983798988706,1.1594604535337696,0.2681564245810056,0.7133923933864564,1.0,10/33,13.59%,CEACAM1;KLF2;CEMIP2;KLF4;PPP1R16B;JMJD8;TJP1;EPN2;PIK3CB;ITGA5
prerank,excitatory postsynaptic potential (GO:0060079),0.5019923635683554,1.158713510643571,0.3020833333333333,0.7146580505552068,1.0,8/19,20.17%,MEF2C;LRRK2;GRIN2B;GRIN2C;GRIN2A;GSK3A;GSK3B;GRID2
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.2977154823569738,-1.1585740145184222,0.1949685534591195,0.7121954441381919,1.0,33/84,25.30%,CELF2;DDX5;SON;NOVA1;SNW1;FXR2;RBMX;DDX17;NCBP1;JMJD6;DAZAP1;PUF60;SRSF6;REST;TRA2A;RBM39;HNRNPL;HNRNPU;PCBP4;MAGOH;U2AF2;NCL;SRSF3;SF1;RBFOX3;SRPK2;ZC3H10;C1QBP;KHDRBS1;QKI;CELF5;CELF1;LARP7
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.4771606920363456,1.1577288772348535,0.29393939393939394,0.7165598560852426,1.0,4/21,8.24%,MCUB;SMDT1;RAP1GDS1;MCUR1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.5436785830805286,1.1571787969285547,0.2956810631229236,0.7172770808341672,1.0,3/11,12.20%,CAV1;ADIPOR1;NF2
prerank,maturation of LSU-rRNA (GO:0000470),0.4647988406306001,1.1570639863685668,0.2829912023460411,0.7168807131642951,1.0,12/26,23.05%,BOP1;RPL7;MRPL1;RPL35;RRP15;NHP2;EIF6;RPL7L1;LAS1L;FTSJ3;URB1;RPF2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.4389075365335635,-1.1566666694423422,0.2937853107344633,0.7160191683964313,1.0,6/16,18.34%,SNW1;RBMX;NCBP1;DAZAP1;TRA2A;NCL
prerank,protein localization to membrane (GO:0072657),0.3617700271772881,1.1566294439447269,0.21176470588235294,0.7173614972105401,1.0,31/187,11.01%,EHD4;EFR3B;RAPGEF2;F11R;RAB11A;TMEM88;CAV1;ZDHHC22;PACS1;EMP2;AGRN;INPP5K;FCHO2;TSPAN14;EHD1;DPP6;RAB34;DPP10;RAPGEF6;TSPAN32;SHANK3;PACSIN1;MRAP2;BSG;ROCK1;NKD2;RAB40B;NUP54;CLASP2;PDZD11;TM9SF1
prerank,negative regulation of protein processing (GO:0010955),-0.47097163106333345,-1.156344964329797,0.26903553299492383,0.7151490488184069,1.0,5/12,13.42%,GAS1;THBS1;SERPINE2;SERPINE1;SNX12
prerank,positive regulation of RNA splicing (GO:0033120),-0.37537718256422714,-1.156198169425932,0.2271186440677966,0.7137729029027653,1.0,11/29,18.34%,SNW1;RBMX;NCBP1;PIK3R1;DAZAP1;TRA2A;RBM20;HNRNPLL;ZPR1;U2AF2;NCL
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.4130581920577537,-1.1560419599229932,0.28703703703703703,0.7124355286588118,1.0,9/20,20.22%,LDB1;MEIS1;PAF1;HOXA5;CTR9;MAFB;ZFP36;HOXB8;CIB1
prerank,interstrand cross-link repair (GO:0036297),-0.32599861921557705,-1.1560084905278007,0.1888412017167382,0.7107484127693235,1.0,37/53,40.16%,NUCKS1;FAN1;USP1;ATR;FAAP100;MSH6;POLN;DCLRE1B;RFWD3;RPA3;FANCB;RPA1;RNF168;FANCI;FANCD2;FANCG;MCM8;RPA2;EXO5;RAD51;RAD51AP2;CENPX;FANCM;XRCC3;SLX4;FANCC;DCLRE1C;RAD51AP1;ERCC6L2;DCLRE1A;UBC;FAAP24;ERCC1;XPA;FANCF;MUS81;MCM9
prerank,negative regulation of peptidase activity (GO:0010466),-0.33180102797873956,-1.1556971878362043,0.22325581395348837,0.7098320871450694,1.0,11/47,13.26%,LRP1;SERPING1;VTN;SERPINE2;TIMP2;SERPINH1;SERPIND1;SERPINE1;SERPINA2;SERPINF1;ECM1
prerank,anterograde trans-synaptic signaling (GO:0098916),0.358670611858674,1.155643789948993,0.21785334750265675,0.7192582457886348,1.0,70/224,21.77%,UNC13B;APBA1;PTCHD1;MPZ;CACNA1A;NRGN;SNCG;HRH2;AKAP5;GABRQ;HCRTR1;CHRM3;MAPK1;HTR5A;GRIA1;MTNR1B;GRIN2B;HTR1B;HTR2A;ASIC2;SLC6A2;RPS6KA1;GRIK2;GABRA4;MINK1;NPY5R;HTR1F;SLC1A1;GRM5;GABRA2;SLC1A2;PCDHB16;KCNC4;KCNA1;RPS6KA3;GABRE;SYPL1;NPTX2;PCDHB14;GRIK1;HRH3;CACNA1E;GLRA2;PCDHB9;CPLX1;HTR4;SST;GRIN2A;RIT2;NPTX1;EXOC4;GABRG3;SYT1;KCNQ3;PENK;HAP1;GABRB1;GRM7;GIPC1;SLC1A6;HTR6;APBA2;UTS2;HCRTR2;KCNK3;MYCBPAP;GABRB3;NRXN1;KCNIP2;NLGN1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.3173740948438708,-1.1553745179315882,0.19213973799126638,0.7090393951595145,1.0,9/57,8.19%,LPAR1;ADCY5;ADCY9;ADCY1;GNAI1;AKAP12;ADCY2;ADCY7;FLNA
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.38700429906801415,1.1551604716273751,0.2616707616707617,0.7198705320743669,1.0,26/85,17.88%,SMAD7;ECSCR;DAB2IP;SUMO2;CSNK1D;BBS7;RNF185;ARIH1;LRRK2;HSPA1B;CEBPA;NKD2;FBXW7;RBX1;RNF144B;BAG6;CLU;KEAP1;PSMC3;PSMC5;RACK1;PSMC6;CBFA2T3;TRIB3;SOCS5;GSK3A
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.43236704824579153,-1.1551504467916613,0.25274725274725274,0.7078653579540815,1.0,4/16,7.11%,APPL2;APOD;PPARA;ADCY7
prerank,protein-containing complex subunit organization (GO:0043933),0.38171300816028836,1.154897432799,0.22800925925925927,0.7199208504313144,1.0,21/109,16.21%,CD2AP;SKAP2;MAGI1;FAS;SLC2A1;OCLN;CARD10;TRAF1;CD247;IL1RAP;APC;NUP54;NUP35;RANBP9;CAPG;TAPBP;PPIH;KPNA3;CLDN14;VIL1;NUP205
prerank,positive regulation of neutrophil migration (GO:1902624),-0.4190078350202291,-1.1547411396097889,0.2602739726027397,0.7072894103430948,1.0,12/18,28.77%,CAMK1D;RIPOR2;NCKAP1L;MDK;DAPK2;DNM1L;CD74;MCU;C1QBP;CCL19;MOSPD2;THBS4
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.39907738290600325,-1.154630605055458,0.2693498452012384,0.7058410376098027,1.0,4/20,16.11%,WNT4;C1QTNF3;SIK1;CLK2
prerank,regulation of postsynapse organization (GO:0099175),0.45978057067262157,1.154292248944456,0.28005865102639294,0.720831421308311,1.0,9/28,15.82%,TANC2;FCGR2B;PDLIM5;SHANK3;LRRK2;PPFIA2;VPS35;CFL1;KIF1A
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.4529031301077409,-1.1542818805953758,0.2898172323759791,0.7050709274542767,1.0,5/14,16.46%,IRS2;IRS1;GPLD1;SLC45A3;NNMT
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.45271723665794084,1.1542732019314548,0.30113636363636365,0.7201876505828706,1.0,9/32,15.12%,APOA1;SLC44A1;LCAT;PCYT1A;CEPT1;LPCAT3;ACHE;STARD10;CSNK2B
prerank,myelination in peripheral nervous system (GO:0022011),-0.4613752774348536,-1.1542476393592855,0.2555831265508685,0.7034288736499835,1.0,5/13,14.94%,ADGRG6;PARD3;DICER1;LGI4;SIRT2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3476517711555901,1.154159623045337,0.13953488372093023,0.7197619780629654,1.0,72/497,13.72%,PRDM16;NANOS1;MECOM;SOX13;NANOS3;GATA6;PLCB1;PDGFB;BMPR2;DACH1;RPS6KA5;SMARCA2;ACVRL1;NOTCH1;FOXO1;ELK3;HEY1;DAB2IP;HNF4A;ID1;BTG2;HDAC9;SOX18;HHEX;INPP5K;HEY2;HMBOX1;PPM1F;KLF4;LEF1;DAP;SMAD2;BTAF1;GMNC;COMMD7;GATA3;EID2B;PDCD4;PHC3;ZBTB16;TMPRSS6;CEBPA;WWP1;ZHX3;GATAD2A;PASK;NR1D1;GAPDH;MBD1;FOXP1;ARID5A;JUN;ZBTB14;CNOT1;ENC1;CDAN1;DEAF1;SAMD1;ARID5B;DMAP1;BRCA1;HINFP;CD38;ATP8B1;TOB1;SUV39H2;CTBP2;FXR1;ATXN1;RIOX1;TBX20;HMGB2
prerank,signal transduction in response to DNA damage (GO:0042770),0.4208551109292798,1.1535647690619284,0.28667563930013457,0.7207021431711985,1.0,15/49,19.78%,ACER2;MAD2L2;BRIP1;E2F7;HINFP;STK33;ATM;RAD1;MAP3K20;MAPK14;FBXO6;TIPRL;ATRIP;BID;HUS1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5606907215884644,1.153158851585308,0.3181818181818182,0.7211018159449466,1.0,3/10,5.58%,DAB2IP;EFNA1;FURIN
prerank,negative regulation of protein secretion (GO:0050709),-0.34612409339947076,-1.1530718705315883,0.22348484848484848,0.7050116683490434,1.0,15/38,23.78%,APOE;PRKN;CCN3;IRS1;RAB11FIP1;REST;ADRA2A;DRD2;SERGEF;KCNB1;NR1H3;RHBDF1;CYP51A1;ERP29;INHBB
prerank,mRNA metabolic process (GO:0016071),-0.30023095936797833,-1.1527119531406214,0.15527950310559005,0.704328079351464,1.0,34/90,24.92%,DDX5;SON;SRSF5;SCAF11;NUDT21;HNRNPA2B1;NCBP1;PRPF8;SRSF1;PRKACA;SSB;CNOT10;PRPF3;SNRPF;AKAP8L;YTHDF2;PCF11;U2AF2;SNRPD3;ZFP36;AGO3;LSM11;LSM6;SLBP;SRSF11;SF3A2;NCBP2;LSM10;TCERG1;DHX15;DCP2;U2AF1;SRSF2;CELF1
prerank,myofibril assembly (GO:0030239),-0.33414348198842914,-1.1523421403351053,0.21755725190839695,0.7035787817731587,1.0,8/42,9.55%,PDGFRB;PDGFRA;ACTN2;TPM1;OBSL1;TMOD2;CFLAR;PGM5
prerank,Wnt signaling pathway (GO:0016055),0.3851562088010147,1.1522394457190122,0.2459016393442623,0.7229077382536189,1.0,18/92,14.28%,PLCG2;CCDC88C;FZD6;NR4A2;LEF1;LRRK2;UBA52;RPS27A;APC;TCF7L1;CSNK1G3;RBX1;NXN;VPS35;LRP5;CTNNB1;FZD9;FZD3
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.5005056217494862,1.1516211976199335,0.2909967845659164,0.7238848248810437,1.0,4/17,6.83%,NOTCH4;NOTCH1;PLXND1;STAT1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.4219285856261561,1.151608978839389,0.2804878048780488,0.7232234382093305,1.0,3/39,5.95%,MYRIP;DOC2B;GLUD1
prerank,regulation of regulated secretory pathway (GO:1903305),0.4367897192406137,1.151296063593838,0.2989985693848355,0.7233648823077448,1.0,8/34,19.95%,SYT15;SYT7;LRRK2;RIMS3;SYT2;SYT1;RAB27A;GSK3B
prerank,regulation of dendrite extension (GO:1903859),0.5041336321773333,1.1512727827157514,0.3059006211180124,0.7227390618735953,1.0,6/18,18.16%,ITSN2;NEDD4L;SMURF1;RASAL1;SYT2;SYT1
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.4717860978765401,-1.1512163231850412,0.2803738317757009,0.7050806723972899,1.0,3/12,2.67%,NOTCH2;DOCK11;DOCK10
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.4987950766228779,1.1511813379445195,0.30666666666666664,0.7222958663559197,1.0,6/17,16.60%,FCHSD2;NCKAP1;CYFIP1;WASF2;CTNNA2;ARFIP2
prerank,regulation of viral transcription (GO:0046782),0.4318519217934643,1.1509707224931003,0.28591160220994477,0.7221668630512287,1.0,14/39,23.89%,TRIM14;TRIM11;POLR2G;DHX9;POLR2D;POLR2I;NELFB;NELFA;IFITM3;HEXIM1;MID2;POLR2C;POLR2B;POLR2J
prerank,negative regulation of secretion by cell (GO:1903531),0.43973005443518887,1.1509069129422658,0.2958904109589041,0.7216528114933161,1.0,11/38,19.78%,NOTCH1;STXBP6;TNFRSF1B;SLC30A1;VAMP8;HTR1B;CHGA;HRH3;RSAD2;GRM7;DPH3
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.4825668170869093,-1.150857447839567,0.30025445292620867,0.7043711187854985,1.0,5/11,15.72%,GPLD1;SLC27A1;SREBF1;MFSD2A;NR1H3
prerank,negative regulation of neurogenesis (GO:0050768),0.4483753068860745,1.150790116608896,0.29517241379310344,0.7212927450149785,1.0,6/34,9.55%,RAPGEF2;NOTCH1;B2M;ARHGDIA;PCM1;RTN4
prerank,positive regulation of protein transport (GO:0051222),0.3993381457179967,1.1506980731105352,0.25,0.7208679861668373,1.0,21/67,19.93%,CD2AP;UNC13B;PLK3;TGFB2;ATP2C1;TMED10;IL1A;PRR5L;PCM1;VPS28;RIPOR1;ACHE;ICE1;PDCD10;RACK1;TENM1;GOLPH3L;PPID;GOLPH3;MYO18A;ANG
prerank,reticulophagy (GO:0061709),-0.45530492088355873,-1.150490164524359,0.3028720626631854,0.7037477740947968,1.0,4/12,10.60%,TEX264;UBA5;ATG2A;ULK2
prerank,glycerophospholipid metabolic process (GO:0006650),0.39628622424954646,1.1499816568898649,0.2644230769230769,0.7221152933498254,1.0,20/75,17.60%,PLCB1;IP6K3;GPCPD1;APOA1;ACP6;FAR1;LCAT;CRLS1;PNPLA6;DGKH;ABHD6;GDPD1;ENPP6;PLCG1;SERINC5;PIGF;AGK;PIGQ;PIGC;SYNJ1
prerank,MAPK cascade (GO:0000165),0.3517425460497679,1.1497491427049884,0.19499478623566216,0.7221127775085594,1.0,58/295,14.85%,RASGRF2;TEK;RAPGEF2;PDGFB;FYN;KITLG;DAB2IP;LGALS9;CSF2RB;APOA1;NRAS;KRAS;IL17RD;PSMD13;ANGPT1;MAP4K4;KARS1;MEF2C;FGFR3;SHANK3;CUL3;MAPK1;PSMD4;SETX;SHOC2;LRRK2;FRS3;JAK2;BCL2L1;UBA52;RPS27A;GRIN2B;PTK2;PSMA5;ZFP36L2;PSMB10;TAOK2;RBX1;MARK3;PSMB8;FGF20;RANBP9;MINK1;MAP3K3;PSMD14;PIK3CB;PSMA7;PSMA8;PSMC3;SPTAN1;RASAL1;SOS1;PSMB5;PSMC1;MAP3K20;PSMC5;GFRA3;PRKG2
prerank,cAMP-mediated signaling (GO:0019933),-0.39069181966403355,-1.1496531150810076,0.2727272727272727,0.7044458458667225,1.0,6/24,5.86%,PDE7B;PDE3A;ADCY1;ADGRG6;KSR1;ADCY2
prerank,ncRNA processing (GO:0034470),0.35931327186172124,1.149401301285145,0.21972132904608788,0.722337472951413,1.0,78/200,26.59%,BOP1;PELP1;RPL27;DHX37;SMAD2;KARS1;RPL7;TRPT1;INTS11;EXOSC3;NVL;UBA52;MRM2;RPS14;RPL35;ADAR;WDR46;RPL21;DKC1;FARS2;RPL37;RPS28;AGO4;RPL34;RPS9;RPLP2;EXOSC8;XRN2;RPS25;INTS12;RPL30;RPL27A;NOL8;RPL23A;INTS5;RPS15;RPL19;RPL32;UTP18;DROSHA;RPL37A;POP1;RPL18A;TUT7;EXOSC9;NOB1;LAS1L;DDX47;DCAF13;WDR18;RRP9;PWP2;RPL18;C1D;RPL39;NOLC1;IMP4;EXOSC10;RPS19;RPL31;EXOSC1;FBL;NOP53;INTS6;HELQ;WDR43;RPL3;UTP20;MRTO4;MDN1;RPL28;RPL9;RPL26;RPS16;RPLP1;DDX27;ESF1;UTP15
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.5432511365092679,1.1490305829877592,0.33878887070376434,0.7226833805807235,1.0,1/12,1.74%,NOD2
prerank,positive regulation of secretion by cell (GO:1903532),0.40355617230331875,1.149000335036831,0.26134969325153373,0.7220928192247074,1.0,8/70,6.85%,EDN1;CD2AP;CADPS2;UNC13B;TGFB2;TMED10;IL1A;CLASP1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.4791982334352976,1.148709130769842,0.31160572337042924,0.7222040938044483,1.0,10/20,21.36%,SPPL2A;RHBDD1;ADAM17;MBTPS2;APH1A;ADAM10;PSEN2;RELA;SPPL2B;APH1B
prerank,regulation of viral release from host cell (GO:1902186),0.4773970653383167,1.147691107132732,0.3111455108359133,0.7242434309783099,1.0,6/21,15.00%,TRIM11;TRIM25;TRIM8;VPS4A;CHMP3;CHMP2B
prerank,negative regulation of nuclear division (GO:0051784),-0.47773601407131694,-1.147647928098268,0.2860520094562648,0.7082485021105595,1.0,3/11,11.93%,BMP7;BMP4;TOM1L2
prerank,respiratory electron transport chain (GO:0022904),0.5072228570042482,1.1474981697373163,0.2807308970099668,0.7241005717082841,1.0,5/14,11.90%,GPD2;ETFDH;ETFB;ETFA;UQCRFS1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.52509394386949,1.147089942926147,0.33386837881219905,0.7245223147869491,1.0,4/14,12.28%,TIRAP;TLR3;CARD10;COPS8
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.46885467246564694,1.1463220505379712,0.2869692532942899,0.7258756355685908,1.0,8/26,15.59%,TAL1;APP;TTL;CUL3;DUSP3;RPS6KB1;MEIS2;PKN2
prerank,regulation of protein ubiquitination (GO:0031396),0.3758035142110662,1.1462313424052555,0.24133949191685913,0.7254557180973401,1.0,22/108,12.25%,SMAD7;FAM107A;CAV1;FKBP1A;ANGPT1;FOXF2;CUL3;UBE2D1;LRRK2;ARRB1;HSPA1B;UBE3A;NDFIP2;VPS28;FBXW7;NSMCE3;PRKCG;ADGRB1;NXN;LAPTM5;BRCA1;FBXO4
prerank,activation of protein kinase B activity (GO:0032148),-0.37304219896083113,-1.146135293340915,0.255663430420712,0.7107606446036927,1.0,9/29,11.76%,IGF1;NTRK3;FGF1;WNT5A;OSBPL8;MAPKAP1;PPIA;TXN;ADRA2A
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.47267893214994994,1.1460845684887537,0.30626780626780625,0.7251658678084556,1.0,3/26,3.65%,CEACAM1;GPR137B;TLR3
prerank,positive regulation of dendrite extension (GO:1903861),0.5104525766550682,1.146051536097793,0.31329113924050633,0.7245745585966316,1.0,6/17,18.16%,ITSN2;NEDD4L;SMURF1;RASAL1;SYT2;SYT1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.38897329544576204,1.1459015180768224,0.2777101096224117,0.7242955641872444,1.0,27/84,19.13%,PSMD13;CUL3;UBE2D1;PSMD4;PTTG1;UBA52;RPS27A;PSMA5;PSMB10;PSMB8;PSMD14;PSMA7;PSMA8;PSMC3;UBE2E1;CDC27;PSMB5;PSMC1;PSMC5;PSMC6;PSMB9;ANAPC7;PSMA4;PSMD5;PSMD9;PSMB6;ANAPC4
prerank,peptidyl-glutamic acid modification (GO:0018200),0.4751734144577396,1.1458151697177674,0.31458966565349544,0.723842675255013,1.0,7/24,16.40%,TTLL8;TTLL7;TTLL1;TTLL10;TTLL5;TTLL11;VKORC1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.44334480495056156,1.1457677322070676,0.2984441301272984,0.7233091882784167,1.0,12/31,23.48%,TANC2;PDLIM5;EFNA1;SHANK3;LRRK2;PPFIA2;CFL1;KIF1A;LRP8;NLGN1;EPHA4;DHX36
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.424656235670578,1.1456711235643866,0.27417218543046357,0.722889288867395,1.0,8/46,9.79%,LAMA4;NOVA2;NOTCH1;ID1;ADAM17;ABHD6;NR1D1;ACOT13
prerank,receptor-mediated endocytosis (GO:0006898),0.3686809021558121,1.1455257385088091,0.24387527839643652,0.7226015644060461,1.0,17/132,7.36%,FCHSD2;HIP1R;INSR;CAV1;CAV2;ADRB2;PPT1;DNM3;APOA1;AP2B1;FCGR2B;FCHO2;FNBP1L;FCGR1A;PIP5K1C;ITGAM;HSP90B1
prerank,translational elongation (GO:0006414),0.37200741188673025,1.1450960186443409,0.24881516587677724,0.7230462723201472,1.0,49/101,28.95%,MRPL4;MRPL18;EEF2K;MRPL41;MRPL1;MRPS31;MRPL15;MRPL19;TUFM;MRPL47;GTPBP1;MRPL52;MRPL36;GTPBP2;EEF2;MRPL23;MRPL24;MRPL14;MRPL32;MRPS34;MRPS12;RACK1;MRPL39;EEFSEC;MRPL54;EEF1D;MRPS18B;MRPS30;EEF1G;GFM1;MRPL11;MRPS28;MRPS35;MRPS9;MRPS27;TSFM;MRPL34;MRPS24;MRPL35;MRPL10;MRPL27;MRPL38;MRPS18C;EEF1A1;MRPL13;AURKAIP1;MRPS18A;MRPL40;ERAL1
prerank,cellular response to chemical stress (GO:0062197),0.38099298836594814,1.145046548765546,0.28125,0.7225221183084474,1.0,22/96,15.12%,TRPV4;FAS;FOXO1;CAV1;PRKD1;SETX;CHCHD2;LRRK2;ZC3H12A;HSPA1B;PRR5L;NFE2L2;PRKAA1;BRF2;CYBA;RBM11;KEAP1;ATM;PYROXD1;MSRA;EIF2S1;NCF2
prerank,regulation of macrophage chemotaxis (GO:0010758),0.48129929089215345,1.1447470913806592,0.2981651376146789,0.722672916373593,1.0,6/21,12.27%,MTUS1;MAPK1;CMKLR1;PTK2;STAP1;DDT
prerank,AMP metabolic process (GO:0046033),-0.4599678657852973,-1.1441800040612702,0.3073286052009456,0.7144992394915349,1.0,8/13,32.82%,AMPD3;XDH;NT5E;NUDT2;NT5C1A;AMPD2;AK3;AK9
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.4366812239399651,-1.143805182992663,0.29896907216494845,0.7139033788321035,1.0,5/16,16.00%,ANK2;BCAP29;BCAP31;SEC16B;SEC16A
prerank,peptidyl-serine phosphorylation (GO:0018105),0.3639878999586764,1.1437644067773771,0.2262295081967213,0.7246664369352037,1.0,48/153,19.95%,PDGFB;RPS6KA5;SBK1;PRKD1;MAST4;PKN3;CAMK2D;STK38;CSNK1D;PKN1;STK38L;NLK;TTBK2;MAPK1;AKT3;UHMK1;MAST1;LRRK2;LMTK2;TLK1;STK39;ROCK1;SGK1;CSNK1G3;MARK3;PRKCG;RPS6KA1;TNKS;PRKD2;MARK2;VRK1;RPS6KB1;RPS6KA3;TTBK1;ATM;PRKX;RICTOR;PKN2;PAK2;CSNK1G1;STK32B;MAPK14;SGK3;MAPKAPK5;ERN1;DYRK1A;CAB39;GSK3B
prerank,glucan catabolic process (GO:0009251),-0.43415712921630556,-1.1435286508788562,0.28421052631578947,0.7129981467777173,1.0,5/15,11.45%,PHKB;PYGB;PYGM;AGL;PHKA2
prerank,action potential (GO:0001508),0.41761873361775975,1.1435052143191984,0.2834008097165992,0.7246587787757518,1.0,4/44,4.20%,KCNQ1;KCNE3;GNAQ;SCN11A
prerank,neuromuscular synaptic transmission (GO:0007274),0.49186972002481216,1.1431424666266747,0.30109204368174725,0.7249491153897232,1.0,1/18,0.53%,FCHSD2
prerank,regulation of neurotransmitter secretion (GO:0046928),0.4447055253114188,1.142834610352875,0.3103448275862069,0.725073626858572,1.0,7/32,16.57%,MCTP1;MEF2C;LRRK2;SLC30A1;SNCAIP;RIMS3;CPLX1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.5194941344319549,1.1427282966704946,0.30158730158730157,0.7246874937452206,1.0,6/14,23.75%,TLR3;PUM2;ZDHHC5;DHX58;ANKRD17;OASL
prerank,replicative senescence (GO:0090399),-0.4709633615815668,-1.142415021325714,0.30456852791878175,0.7145333663223223,1.0,6/12,20.57%,PLA2R1;SERPINE1;ATR;TERT;WNT16;ROMO1
prerank,protein homooligomerization (GO:0051260),0.37488315922191173,1.1416649100256637,0.26497695852534564,0.7268077267420094,1.0,18/114,12.11%,EHD4;GBP5;B2M;AQP11;ATL2;GLS;EHD1;SSBP1;ATL1;ELAVL1;ALDH9A1;MCOLN1;MLKL;ACOT13;ACACB;TRMT61B;TRPM2;SLC1A2
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5003724747112843,1.141548056638254,0.320695102685624,0.7264516100702345,1.0,2/16,3.23%,FASN;PPT1
prerank,protein-DNA complex disassembly (GO:0032986),-0.4299477063658765,-1.1414494055033282,0.29945054945054944,0.7155765753128219,1.0,3/16,10.14%,SET;SMARCB1;SMARCD1
prerank,positive regulation of cellular process (GO:0048522),0.34283025379045695,1.1414087102622616,0.13654618473895583,0.7261766179771099,1.0,88/565,14.44%,VEGFC;PTPRJ;SLC6A6;ACER2;EDN1;PDGFD;GATA2;CLDN5;FLT1;PDGFB;FLT4;FASN;KITLG;TBX1;MERTK;CCND2;LIFR;NOTCH1;INSR;TAL1;AQP11;CAV1;TGFB2;EMP2;ACTN4;TNFRSF18;APOA1;VEGFD;KRAS;FCGR2B;IER5;WWTR1;GCNT2;LEF1;SERTAD1;BRAT1;FGFR3;TAF9B;TBC1D8;TNFRSF1B;CUL3;ADAM17;SLC25A33;P2RX7;CD47;ZC3H12A;GNAI2;PPP3CA;CIDEB;CNOT6L;THPO;PRKAA1;CDH3;APC;NAMPT;PTK2;ADAM10;TJP1;ACACB;RAC1;TENM4;RPS6KA1;RPRD1B;RPS9;FGF20;NUMA1;NPM1;CYBA;PRKD2;DOCK2;MATK;CHTOP;ITGB1BP1;RPS6KA3;RTKN2;MCTS1;PRC1;PHIP;FXR1;POU3F2;ATM;LRP5;PGF;EAPP;DUSP26;NSMCE4A;RAD18;TUB
prerank,response to interferon-gamma (GO:0034341),0.39626969959231056,1.1413212577667728,0.28087167070217917,0.7257329346627807,1.0,12/67,11.45%,GBP5;LGALS9;GBP4;GCH1;GBP3;STAT1;CD47;GAPDH;ACOD1;CASP1;CCL4;GBP2
prerank,Fc receptor signaling pathway (GO:0038093),0.36953620531876685,1.1409408954989753,0.2611683848797251,0.7260811140535056,1.0,34/110,19.42%,PLCG2;PSMD13;MAPK1;PSMD4;PPP3CA;JUN;PSMA5;PSMB10;RAC1;PLCG1;PSMB8;TAB2;PSMD14;PIK3CB;BTK;PSMA7;PSMA8;PSMC3;SOS1;NFATC1;PSMB5;PSMC1;PSMC5;PAK2;PSMC6;PSMB9;PSMA4;PSMD5;PSMD9;RELA;PSMB6;GRAP2;MALT1;NFATC3
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.42232925519670683,1.1407829579306332,0.2977602108036891,0.7258305496955177,1.0,11/46,15.59%,PLCB1;GSTA2;MSN;PDCD4;JAK2;PITPNA;BOLA2;TALDO1;CFL1;LCP1;PAK2
prerank,kidney development (GO:0001822),-0.3037691894135988,-1.1407759585201258,0.23809523809523808,0.7158166690953213,1.0,19/65,11.56%,GLI2;WNT4;SULF1;TGFBR1;BMP7;SULF2;BMP4;OSR1;GREB1L;PYGO1;NPHP3;NIPBL;KANK2;SIX1;VEGFA;PYGO2;STRA6;SALL1;PKD1
prerank,cochlea morphogenesis (GO:0090103),0.5605438913576677,1.1407156389976876,0.3316151202749141,0.725335272792083,1.0,1/10,1.29%,TBX1
prerank,ion transport (GO:0006811),-0.27613733932347245,-1.1404481392627877,0.1510791366906475,0.7150055120609965,1.0,15/111,6.74%,SLC24A3;TRPM3;SLC1A3;PIEZO2;SLC12A2;SLC26A7;WNK1;SLC26A2;SLC8A3;WNK4;ANO1;SLC9A2;SLC17A5;SLC5A5;SLC9A9
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.4082646881003914,1.140309958332989,0.27307692307692305,0.7257704056611289,1.0,13/51,13.80%,SYNPO;LIMCH1;ARHGEF15;APOA1;EVL;PPM1F;CD47;RAC1;CCDC88A;NF2;ITGB1BP1;SORBS3;ARHGEF10
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.4735732108946422,1.1401396909395412,0.3209509658246657,0.7255357049874627,1.0,12/22,21.13%,NFE2L2;PSMA5;PSMB10;ENC1;PSMB8;PSMA7;PSMA8;PSMB5;PSMB9;PSMA4;PSMB6;PSMB2
prerank,regulation of wound healing (GO:0061041),0.42373462614210816,1.1398888586444622,0.2937158469945355,0.7255199034451122,1.0,7/42,9.01%,OCLN;MYLK;CAV1;F2RL1;CRK;ACTG1;PTK2
prerank,regulation of viral life cycle (GO:1903900),0.48675939433482374,1.139850181974771,0.31130690161527164,0.7249561382628089,1.0,5/21,12.34%,TRIM14;TRIM6;TRIM25;HS3ST5;VPS4A
prerank,regulation of cell size (GO:0008361),0.4675226313373161,1.1396890931230743,0.3142857142857143,0.7247534504031187,1.0,4/23,10.32%,EDN1;MSN;RAP1GAP2;RAC1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.42125038967290523,1.1394015091440006,0.2934051144010767,0.7248552227138754,1.0,6/45,4.00%,ENG;BMPR2;ACVRL1;RBPMS;TGFB2;ACVR1
prerank,chemical synaptic transmission (GO:0007268),0.3497502998206814,1.1391672362781002,0.2190775681341719,0.7248169446088014,1.0,83/284,21.77%,FCHSD2;UNC13B;APBA1;PTCHD1;MPZ;CACNA1A;NRGN;SYN3;SNCG;HRH2;AKAP5;GABRQ;GRID1;HCRTR1;CHRM3;MAPK1;SHISA6;HTR5A;GRIA1;MTNR1B;GRIN2B;HTR1B;GRIN2C;HTR2A;ASIC2;SLC6A2;RPS6KA1;GRIK5;GRIK2;GABRA4;MINK1;PDZD11;NPY5R;HTR1F;SLC1A1;GRM5;GABRA2;SLC1A2;PCDHB16;KCNC4;KCNA1;RPS6KA3;GABRE;SYPL1;STXBP3;NPTX2;PCDHB14;ERC2;GRIK1;HRH3;SLC32A1;CACNA1E;GLRA2;PCDHB9;CPLX1;HTR4;SST;SNPH;GRIN2A;RIT2;NPTX1;EXOC4;GABRG3;SYT1;KCNQ3;PENK;HAP1;GABRB1;GRM7;GIPC1;SLC1A6;HTR6;NSG1;APBA2;GRID2;UTS2;HCRTR2;KCNK3;MYCBPAP;GABRB3;NRXN1;KCNIP2;NLGN1
prerank,regulation of cytoskeleton organization (GO:0051493),0.37002639883492155,1.1388770700359248,0.2712456344586729,0.724872202641063,1.0,25/108,14.01%,EFNA5;HIP1R;F11R;RND1;FAM107A;RHOB;IQGAP1;DIAPH1;CRK;CLIC4;MAPK1;P2RX7;CLASP1;PRKAA1;ROCK1;PTK2;TAOK2;TJP1;RAC1;CCDC88A;PFDN2;MARK2;SORBS3;RND2;RHOH
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.41217163211071706,-1.1383667096441854,0.25773195876288657,0.7191853078063779,1.0,4/17,4.52%,PTN;IL34;SERPINE2;DICER1
prerank,proteasome assembly (GO:0043248),0.5434447698960967,1.1381759301127703,0.3080895008605852,0.7260026275344555,1.0,6/11,21.93%,PSMD13;PSMD4;PSMD5;PSMD9;PSMG2;POMP
prerank,regulation of actomyosin structure organization (GO:0110020),-0.46221007008681825,-1.1379242604289497,0.3225,0.7186686213334971,1.0,3/13,5.05%,ROCK2;ASAP3;ALMS1
prerank,monocyte differentiation (GO:0030224),-0.48603936532593317,-1.137847631307742,0.33419689119170987,0.717205671853383,1.0,5/10,11.11%,BMP4;IL31RA;MT1G;VEGFA;PPARG
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3727944961957089,1.1375973539123223,0.2505800464037123,0.7268621886819653,1.0,9/110,4.97%,ADGRL4;RAPGEF2;S1PR1;ADGRE5;GNAQ;GNAL;ADRB2;LGR5;IAPP
prerank,V(D)J recombination (GO:0033151),0.5348452142474959,1.1370415492004358,0.32372881355932204,0.7276398936094821,1.0,4/11,13.72%,TCF3;HMGB1;LIG1;HMGB2
prerank,neutral amino acid transport (GO:0015804),0.4494106242010903,1.1368941764162719,0.30453879941434847,0.7273549152406849,1.0,1/28,0.19%,SLC6A6
prerank,protein K48-linked deubiquitination (GO:0071108),-0.3960451408759144,-1.1366591049919053,0.29354838709677417,0.7188542225038795,1.0,9/23,24.41%,USP33;USP20;USP50;OTUD7B;USP8;USP34;VCPIP1;TNFAIP3;BAP1
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.47876720315568166,1.1364339033886,0.2953125,0.7278700581314013,1.0,7/21,15.40%,RASSF10;DLL4;CX3CR1;CTNNB1;FZD9;FZD3;NES
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.513097212064372,1.1361736640128435,0.30973451327433627,0.7279121179775924,1.0,6/13,16.19%,RAB23;LRRK2;GTPBP1;MFN1;RAN;EFL1
prerank,negative regulation of histone methylation (GO:0031061),-0.4884458915275839,-1.1361372972580275,0.3071593533487298,0.7185153012677987,1.0,5/10,18.32%,JARID2;MTF2;WDR5;BCOR;DNMT3B
prerank,cellular response to amino acid stimulus (GO:0071230),0.43877397039788607,1.136104393293684,0.31563845050215206,0.7274115788637421,1.0,4/33,6.37%,FYN;SPAAR;CASTOR1;SH3BP4
prerank,regulation of protein autophosphorylation (GO:0031952),0.43035051266835267,1.1358738105427233,0.29514824797843664,0.7273510841353688,1.0,6/36,9.66%,PDGFD;ENG;PDGFB;TOM1L1;PPP2R5C;TAOK2
prerank,calcium ion transmembrane transport (GO:0070588),0.38371186555722514,1.1356199623001424,0.275,0.7274311322001105,1.0,18/86,11.35%,ATP2A3;TRPV4;ATP2B4;CACNA1A;FKBP1A;MCUB;SLC8A1;ATP2C1;ANO6;ORAI1;SMDT1;P2RX7;MCOLN1;MCUR1;GRIN2B;GRIN2C;TRPM2;TRPC7
prerank,fatty acid transmembrane transport (GO:1902001),-0.4027979646720249,-1.1354613508733984,0.3062330623306233,0.7186626362172752,1.0,6/19,11.46%,PRKAG2;PRKAA2;ABCD3;SLC25A20;SLC27A1;PRKAB2
prerank,hematopoietic stem cell differentiation (GO:0060218),0.5367077748645482,1.1352591806626047,0.34429065743944637,0.7276724332623453,1.0,1/10,1.04%,ACE
prerank,pre-replicative complex assembly (GO:0036388),0.39066141037249863,1.1351138615021588,0.2765957446808511,0.7274176314654525,1.0,22/64,18.87%,PSMD13;PSMD4;ORC3;UBA52;RPS27A;PSMA5;PSMB10;PSMB8;PSMD14;ORC5;PSMA7;PSMA8;PSMC3;PSMB5;PSMC1;PSMC5;PSMC6;PSMB9;PSMA4;PSMD5;PSMD9;PSMB6
prerank,defense response to symbiont (GO:0140546),0.380753438127033,1.1346600274470893,0.2862232779097387,0.7279852982232082,1.0,29/92,22.14%,IFI44L;IRF2;F2RL1;IFIH1;TLR3;STAT1;SERINC3;PLSCR1;BCL2L1;NLRC5;OAS2;ACOD1;MLKL;RNASE1;SERINC5;BNIP3L;RNASE6;LYST;BNIP3;PYCARD;RSAD2;IFITM3;RELA;G3BP1;SETD2;EIF2AK2;AGBL4;NT5C3A;PQBP1
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.48686096315206684,1.1345834902680179,0.3138801261829653,0.7268661401088015,1.0,10/19,25.72%,POLR2G;POLR2D;POLR2I;DAXX;TERF2IP;POLR2C;TERF2;POLR2B;POLR2J;TINF2
prerank,regulation of DNA recombination at telomere (GO:0072695),0.48686096315206684,1.1345834902680179,0.3138801261829653,0.7268661401088015,1.0,10/19,25.72%,POLR2G;POLR2D;POLR2I;DAXX;TERF2IP;POLR2C;TERF2;POLR2B;POLR2J;TINF2
prerank,determination of left/right symmetry (GO:0007368),0.43174444211472246,1.1343440055190068,0.308843537414966,0.7268384698571319,1.0,4/36,5.46%,TBX1;NOTCH1;DAND5;BBS7
prerank,regulation of microtubule nucleation (GO:0010968),-0.48396682985193484,-1.134175441339256,0.3050847457627119,0.7206094653814792,1.0,3/10,6.98%,EML2;MECP2;CKAP5
prerank,regulation of nervous system process (GO:0031644),0.49404429957884144,1.1341599022382018,0.33072100313479624,0.726684070166467,1.0,2/18,2.99%,NOS3;APP
prerank,regulation of apoptotic process (GO:0042981),0.3387613135081398,1.1340648159659812,0.13226452905811623,0.7262738839102981,1.0,119/676,14.40%,RASGRF2;ACER2;ARHGEF3;TEK;GATA6;HIP1;KALRN;UNC13B;SMAD6;FLT4;HIP1R;FAS;TNFAIP8;CCND2;PLK3;EGR3;FOXO1;ARHGEF2;DAB2IP;ABR;CASP8;ARL6IP5;CBL;RHOB;TRIO;PPT1;ACTN4;PPP1R13B;PNMA1;ANO6;GLS2;SLK;ING3;HRK;ANGPT1;CASP2;LEF1;MAP4K4;OMA1;LANCL1;IAPP;TNFSF10;TNFRSF25;PLEKHG5;MEF2C;RHBDD1;TAF9B;SPTLC1;STPG1;APEX1;TOX3;ARHGDIA;SETX;TRIM24;UFM1;RYBP;TIAM2;MADD;STAT1;KLHL20;FANK1;CRADD;ALK;MCF2L;HSP90B1;AATF;HSPB1;HSPA1B;CIDEB;JAK2;GADD45G;BCL2L1;UBA52;PRKAA1;RPS27A;PROC;APC;PIM3;PTK2;KLF11;BABAM2;APH1A;SGK1;SIAH2;JUN;HMGB1;RTN4;CASP1;ADAM10;MAP3K11;TJP1;ARHGEF1;HNRNPK;RNF144B;RPS6KA1;NFKBIA;NPM1;CLU;TMBIM6;CD38;NF2;TMEM14A;RPS6KB1;IRF5;RPS6KA3;PHIP;ATM;HYPK;ITGB3BP;NOL3;BNIP3L;SOS1;LTK;CFL1;CTNNB1;FZD9;BNIP3;ANP32B;MAP3K20
prerank,adrenergic receptor signaling pathway (GO:0071875),0.47425108490660706,1.1336668433692279,0.30538922155688625,0.7266983995890077,1.0,2/20,2.69%,RAPGEF2;ADRB2
prerank,tRNA wobble base modification (GO:0002097),0.5155045025009017,1.1334262953783483,0.3285024154589372,0.7266555156468927,1.0,6/14,20.83%,ADAT2;ELP4;ALKBH8;ELP3;DPH3;KTI12
prerank,protein complex oligomerization (GO:0051259),0.38097380931379005,1.133331768496444,0.27163461538461536,0.7262600907737962,1.0,9/85,8.87%,LRRC8C;EHD4;AQP11;ATL2;EHD1;ATL1;ZC3H12A;ELAVL1;KCNC1
prerank,mammary gland epithelium development (GO:0061180),0.5148615454702332,1.1332896739701286,0.32377740303541314,0.7257082914895474,1.0,2/14,7.75%,IRF6;JAK2
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.5325980157979392,1.13311208141849,0.3395904436860068,0.7255502898695867,1.0,4/11,12.30%,LGALS9;HMGB1;VSIR;CBFB
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.3883314548093042,-1.1330956062168955,0.3018292682926829,0.721953822299197,1.0,6/21,11.82%,DCN;CHST15;BGN;VCAN;CHPF2;CSPG4
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.4513836276347955,1.13308112039905,0.2962962962962963,0.7249765469623396,1.0,7/26,10.68%,PLCB1;CCND2;CCND3;ADAM17;MTBP;KMT2E;ADAMTS1
prerank,positive regulation of mRNA processing (GO:0050685),-0.39842559058352395,-1.1329016093023447,0.3102409638554217,0.720826785843894,1.0,6/21,12.53%,SNW1;RBMX;NCBP1;DAZAP1;PAF1;TRA2A
prerank,negative regulation of metabolic process (GO:0009892),0.4087779607550844,1.1326768758894288,0.2989821882951654,0.7253392732523704,1.0,8/54,9.79%,LAMA4;NOVA2;NOTCH1;ID1;ADAM17;ABHD6;NR1D1;ACOT13
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.3761380667587499,-1.1326281203238038,0.2796352583586626,0.7199574680729275,1.0,13/25,30.75%,ADK;AMPD3;PRPSAP2;MTHFD1;GMPR;PNP;APRT;PRPSAP1;DCK;PPAT;AMPD2;ADA;SHMT2
prerank,heart contraction (GO:0060047),0.42979614688761936,1.132537881526638,0.2905027932960894,0.7250671208636059,1.0,4/41,3.80%,KCNQ1;ACE;MYBPC3;SLC8A1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.41614374118319764,1.1321671714023853,0.30930537352555704,0.7253540918047976,1.0,5/42,10.31%,CCR1;OXSR1;THPO;STK39;CCL4
prerank,synaptonemal complex organization (GO:0070193),0.5068562337234578,1.1321586448976464,0.33116883116883117,0.724091151571414,1.0,3/15,10.46%,SYCP2;RAD21;BAG6
prerank,synaptonemal complex assembly (GO:0007130),0.5068562337234578,1.1321586448976464,0.33116883116883117,0.724091151571414,1.0,3/15,10.46%,SYCP2;RAD21;BAG6
prerank,axonogenesis (GO:0007409),0.3506499329579922,1.1319486448135654,0.23165618448637318,0.7240239228159218,1.0,46/237,14.18%,SEMA3G;LAMA3;EFNA5;FYN;RPS6KA5;NTN4;NOTCH1;KLF7;APP;SEMA3F;SH3KBP1;EVL;LAMA5;SHTN1;DAB1;SEMA7A;EFNA1;ROBO4;SHANK3;ATL1;MAPK1;BSG;LMTK2;NRCAM;ENAH;PTPRO;SEMA6D;SCN1B;PTK2;TAOK2;B4GALT6;NEFH;CYFIP1;PLCG1;ADGRB1;RANBP9;SEMA4G;DCC;ACTB;PIK3CB;SLITRK2;CTNNA2;SPTAN1;VLDLR;SOS1;CXCR4
prerank,regulation of muscle contraction (GO:0006937),-0.3787517492819614,-1.1319453725175377,0.27147766323024053,0.7201334830888282,1.0,3/26,3.54%,ATP1A2;PLCE1;TPM1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.38386092606380334,1.1312472998285446,0.2903225806451613,0.7251872115747781,1.0,23/76,17.88%,SMAD7;SUMO2;CSNK1D;BBS7;ARIH1;LRRK2;HSPA1B;CEBPA;PTK2;NKD2;FBXW7;RBX1;RNF144B;LAPTM5;CLU;SMURF1;KEAP1;RACK1;CBFA2T3;RNF139;TRIB3;SOCS5;GSK3A
prerank,limb morphogenesis (GO:0035108),-0.40230539871932974,-1.131087993883971,0.3231707317073171,0.721010998715267,1.0,6/20,10.12%,GLI3;CYP26B1;FBXW4;NIPBL;MEGF8;PTCH1
prerank,positive regulation of interferon-gamma production (GO:0032729),0.4140906380510967,1.1307887712005915,0.2908366533864542,0.7257238822237491,1.0,4/48,3.65%,CRTAM;F2RL1;LGALS9;TLR3
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.4287860649515861,1.1307830401969452,0.30434782608695654,0.7250997200232798,1.0,7/36,11.82%,FOXO4;DAB2IP;RBBP8;RYBP;PHC3;UXT;BRCA1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.39391246899294535,-1.130624672159924,0.3058823529411765,0.7205323241371897,1.0,6/22,13.02%,SCAF8;CCNK;CDK12;ELL;THOC1;HMGN1
prerank,cellular response to organic cyclic compound (GO:0071407),0.3645061349111538,1.1304972257956714,0.24803591470258138,0.7251791624928404,1.0,25/141,11.91%,KCNQ1;RAPGEF2;PDGFB;RAPGEF1;ATP1A3;ATP1A1;ARL6IP5;FES;DIAPH1;INPP5K;MSN;MEF2C;ABCB4;P2RX7;LRRK2;ZC3H12A;HSP90B1;CTNNA1;NCOA4;EGR1;SPIDR;TRPM2;ACTB;BRCA1;SLC1A1
prerank,protein polymerization (GO:0051258),-0.31350108277438077,-1.1297857761192802,0.2661290322580645,0.7213602073384142,1.0,11/55,7.30%,ARHGAP6;GAS7;GSN;COBL;WASF1;PRKN;WASHC3;RNF135;HDGFL3;CKAP5;PREX1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.41315516300957084,1.129703281088699,0.3109987357774968,0.7265895150829715,1.0,8/50,13.94%,CCND2;CCND3;CCNE1;SERTAD1;CDC25C;ACTB;TTBK1;CDKN2D
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5332279774695259,1.1296501886959573,0.31756756756756754,0.7260684728408271,1.0,2/11,3.65%,CASP8;TLR3
prerank,response to acidic pH (GO:0010447),-0.43323125892274705,-1.1295979766438542,0.31496062992125984,0.7202188840176477,1.0,4/13,29.61%,GPR4;LGMN;SLC9A1;IMPACT
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.43143734669065475,1.129550963861167,0.29891304347826086,0.7256791610011305,1.0,7/39,9.23%,EFR3B;ITPKB;IP6K3;PIK3C2A;CISH;SOCS6;PIK3C3
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.36797095406808666,1.1292011618418616,0.27364864864864863,0.7259261010948725,1.0,24/113,15.71%,UNC13B;RASIP1;PIEZO1;GBP5;TAL1;MMP1;DAB2IP;TIRAP;HRK;WARS1;RBX1;SPIDR;GTF2H3;CLU;TTBK1;CAPG;ATM;PSMC3;ERCC4;ICE1;PSMC5;LCP1;RACK1;PSMC6
prerank,glycogen catabolic process (GO:0005980),-0.4309886305252115,-1.1291178756346005,0.2953929539295393,0.7199520806082774,1.0,5/15,11.45%,PHKB;PYGB;PYGM;AGL;PHKA2
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.4255279200116432,1.1290765938579603,0.29093369418132614,0.7255939474868996,1.0,6/38,9.33%,KCNQ1;KCNE3;CAV1;CAMK2D;SCN1B;DSP
prerank,microtubule anchoring (GO:0034453),0.5274528220904127,1.1289054422169311,0.3301282051282051,0.7253946298152102,1.0,4/12,9.80%,SAXO1;CLASP1;PCM1;CLASP2
prerank,negative regulation of defense response to virus (GO:0050687),-0.4824680525016706,-1.128781029790138,0.31654676258992803,0.7192295600921068,1.0,6/10,39.17%,PPM1B;C1QBP;TRAF3IP1;TSPAN6;RNF26;PCBP2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.4538063118239634,-1.1280901619409962,0.30238726790450926,0.7196832723326487,1.0,6/12,27.81%,INSIG2;RER1;KDELR1;ANKRD13C;GPAA1;KDELR3
prerank,ether lipid biosynthetic process (GO:0008611),-0.4987012910101837,-1.1277707487583974,0.32779097387173395,0.7189072467344589,1.0,7/10,20.71%,GNPAT;LPCAT2;PLA2G4A;PEDS1;CHPT1;PEX7;PLA2G4C
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.4733694117586454,1.1276558901074643,0.3248502994011976,0.728039214309597,1.0,8/23,17.60%,INPP5K;MTMR10;INPP5B;MTMR11;OCRL;INPP5F;INPP5J;SYNJ1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.36401872881177366,1.127598253472795,0.2729331823329558,0.7275499762044165,1.0,31/118,15.82%,EFNA5;CEACAM1;FLT4;TBX1;TANC2;EMP2;PLXND1;VASH2;PDLIM5;MEF2C;SHANK3;TSPAN12;WARS1;POGLUT1;CLASP1;LRRK2;LZTS1;LRRC4C;PPFIA2;CLASP2;CDH2;NEDD4L;INF2;MARK2;PHIP;ADGRA2;CFL1;CTNNB1;SARM1;PAK2;KIF1A
prerank,response to chemokine (GO:1990868),0.5127874726056788,1.127378858135126,0.3283333333333333,0.7274920599679927,1.0,5/13,8.43%,DUSP1;OXSR1;LRCH1;ZC3H12A;STK39
prerank,carbohydrate transport (GO:0008643),0.5468514476928832,1.1273292432401907,0.3338709677419355,0.7269738874912718,1.0,1/11,2.28%,AQP11
prerank,protein secretion (GO:0009306),-0.31636474280841514,-1.126971833662246,0.2175925925925926,0.719438937996164,1.0,21/56,26.53%,WLS;STEAP3;ABCA1;TANGO2;ANXA1;COPG1;MTTP;PPY;TVP23B;SVBP;RAB3D;RCN3;PDIA4;MON1A;PREB;PORCN;TMEM167A;RAB3C;ADCYAP1;NECAB3;RAB15
prerank,neutrophil chemotaxis (GO:0030593),0.4074800380094658,1.1269210133937504,0.2864321608040201,0.7274263535048716,1.0,5/53,10.31%,EDN1;TGFB2;PIP5K1C;BSG;CCL4
prerank,inner ear morphogenesis (GO:0042472),-0.3927679436690934,-1.126855833732216,0.25227963525835867,0.7180976967798369,1.0,4/22,7.46%,ZIC1;FGFR2;SIX1;TBX18
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.38045182807960687,-1.1268186856688567,0.26006191950464397,0.716567342693276,1.0,7/23,18.05%,GJA1;GPSM2;NDE1;UBXN2B;NDEL1;FBXW11;ZW10
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3861189969815822,1.1257452840775362,0.29314420803782504,0.7297260049086857,1.0,14/80,10.51%,EPS8L2;OCLN;SAXO1;F2RL1;AGRN;CDC42EP1;FNBP1L;P2RX7;PLEKHM1;NCKAP1;APC;RAC1;CCDC88A;CYFIP1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.47174398304394055,1.1257144899058742,0.32286995515695066,0.7291814820697711,1.0,2/22,3.78%,B2M;STX7
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3763223760738145,1.1256455006431763,0.2987012987012987,0.7287133352458215,1.0,19/87,12.61%,TBX1;ESRP2;EGR3;CBL;DLL4;FGFR3;HYAL2;MAPK1;SETX;SHOC2;FRS3;FLRT3;POLR2G;ZFP36L2;POLR2D;FGF20;TIAL1;NR4A1;ITGB1BP1
prerank,positive regulation of tissue remodeling (GO:0034105),-0.4794239698469191,-1.1256294435941108,0.3324742268041237,0.7183698155289506,1.0,1/10,0.82%,ROCK2
prerank,negative regulation of nervous system development (GO:0051961),0.5055423831001175,1.1255754989944597,0.3384853168469861,0.7282522133974673,1.0,3/17,8.88%,NOTCH1;B2M;PCM1
prerank,negative regulation of B cell proliferation (GO:0030889),0.5378941613984854,1.1252205986837247,0.3160621761658031,0.7285324021880154,1.0,3/11,13.34%,FCGR2B;TYROBP;ATM
prerank,cellular response to BMP stimulus (GO:0071773),0.39309661822530756,1.1251281718068429,0.3,0.7281297686381039,1.0,10/66,6.36%,ENG;SMAD6;BMPR2;SMAD7;ACVRL1;TGFB2;TMEM100;ACVR1;SMAD2;PDCD4
prerank,regulation of actin filament-based process (GO:0032970),0.38411168209343594,1.124617469110651,0.3002481389578164,0.7288180872675454,1.0,8/70,3.33%,EFNA5;HIP1R;F11R;RND1;FAM107A;RHOB;IQGAP1;CRK
prerank,acute-phase response (GO:0006953),-0.4621982937965024,-1.1245805477884128,0.3230769230769231,0.7195790780292388,1.0,3/12,8.41%,LBP;IL6R;CEBPB
prerank,mammary gland development (GO:0030879),0.46512403519808837,1.1243552892328812,0.325,0.7288134610821881,1.0,4/21,11.50%,NOTCH4;CAV1;JAK2;APLN
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.2770901005654869,-1.1242766143798,0.23529411764705882,0.7189422677537587,1.0,31/102,14.59%,ADCY5;SORBS1;ADCY9;ADCY1;RHOQ;SLC39A14;SLC30A10;CPEB1;KAT2B;ENPP1;ADCY2;IRS2;C2CD5;SRC;IRS1;PIK3R1;ADCY7;GPLD1;PRKCI;PRKACA;PPARG;INSIG2;NFKB1;CPEB2;PRKAR2A;EPRS1;FER;PRKAR2B;PIK3R2;PRKAR1A;GOT1
prerank,positive regulation of transport (GO:0051050),0.3765501470054598,1.1237549761688592,0.29859484777517564,0.7297082985652937,1.0,15/85,12.06%,GATA2;HIP1R;MERTK;DOC2B;APOA1;INPP5K;FCGR2B;CD47;CDH3;SGK1;NUMA1;NEDD4L;CYBA;ACTB;DOCK2
prerank,regulation of translation (GO:0006417),0.35544497107612993,1.1234513580771848,0.270032930845225,0.729903982596997,1.0,41/173,16.35%,NANOS1;NANOS3;VIM;BTG2;APP;MTG2;YBX2;PLD1;ELAVL1;HSPB1;PASK;GAPDH;ETF1;EIF3B;EIF2B2;DHX9;EIF1;CNOT1;ENC1;RPS6KA1;CYFIP1;METTL5;NPM1;EEF2;GRM5;TOB1;RPS6KB1;RPS6KA3;METTL14;FXR1;METTL18;EIF6;EIF2A;YBX1;EIF3H;MTIF2;DDX6;KLHL25;RACK1;TCOF1;RNF139
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.4554480710118,1.123303367033387,0.31721194879089615,0.7296472966162616,1.0,6/24,13.94%,ING2;TAF9B;SNAI2;BCL2L1;CLU;CDKN2D
prerank,negative regulation of immune response (GO:0050777),0.3578614026320933,1.1232896565136727,0.2685904550499445,0.7290503480707607,1.0,20/154,11.24%,PLCG2;FYN;GPR39;ADRB2;FCGR2B;IAPP;HRH2;FURIN;MYH9;FCGR1A;ADAM17;CD247;MC4R;NMI;ACOD1;YES1;CACTIN;ADCY4;PLCG1;GLP1R
prerank,linoleic acid metabolic process (GO:0043651),-0.41569364110904167,-1.1232413445528526,0.31564245810055863,0.7202752271677241,1.0,5/17,19.75%,ACSL1;GSTM2;FADS2;ELOVL1;ALOX12
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.3991223225752329,-1.1232121185739472,0.2909090909090909,0.7187571197031876,1.0,6/19,6.44%,ROBO1;DCN;CCBE1;CD63;ADAMTS3;XDH
prerank,presynapse assembly (GO:0099054),-0.4325032154623936,-1.1231485174219853,0.3242506811989101,0.7173431552419393,1.0,7/16,30.73%,WNT5A;NLGN2;PTPRD;PCLO;NLGN3;LRP4;BSN
prerank,positive regulation of lipid localization (GO:1905954),-0.462288421854251,-1.122951553668037,0.32997481108312343,0.7161923938995357,1.0,3/11,11.63%,LRP1;IKBKE;NFKB1
prerank,negative regulation of cell differentiation (GO:0045596),0.35477668277908225,1.1229357364764918,0.25674217907227614,0.7292891950127085,1.0,24/181,8.40%,JAG1;NOTCH4;GATA2;SMAD6;SMAD7;TBX1;NOTCH1;FOXO1;HEY1;DAB2IP;CAV1;TRIO;HDAC7;IL17RD;WWTR1;EFNA1;COL5A2;GATA3;EID2B;PDCD4;ADIPOR1;ZBTB16;SNAI2;NBR1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.48800784225608795,1.1227836408296499,0.33540372670807456,0.7290398621100165,1.0,3/17,9.48%,CCR1;ANO6;HMGB1
prerank,actin filament bundle organization (GO:0061572),0.43274161587747306,1.122087980340733,0.3178621659634318,0.7302046946848163,1.0,4/33,3.12%,LIMA1;FAM107A;PLS3;NEDD9
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3508101581348779,1.1219809914541274,0.27213822894168466,0.7298119952823547,1.0,45/186,15.74%,DKK2;SOX17;SOX13;CCDC88C;FZD6;TMEM88;DAB2IP;CAV1;PSMD13;WWTR1;NLK;CUL3;PSMD4;SHISA6;SNAI2;PTPRU;PTPRO;APC;IGFBP4;CTNNBIP1;MCC;NKD2;TAX1BP3;SIAH2;PSMA5;PSMB10;ZNRF3;RBX1;MAD2L2;PSMB8;NXN;PSMD14;HMGXB4;TSKU;PSMA7;PSMA8;PSMC3;NFATC1;PSMB5;PSMC1;PSMC5;MLLT3;RACK1;PSMC6;PSMB9
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.38594787722608637,-1.1216445497586247,0.3165680473372781,0.7181356786905148,1.0,6/21,14.94%,SLC30A10;PPARA;PRKN;TRAP1;HDAC6;SIRT2
prerank,apoptotic cell clearance (GO:0043277),-0.3516604590378517,-1.1214809436726256,0.2974683544303797,0.7170033082778691,1.0,6/30,8.98%,LRP1;THBS1;ITGAV;RHOBTB2;ANXA1;TXNDC5
prerank,regulation of exocytosis (GO:0017157),0.41609906569262833,1.1214043279233972,0.34320323014804843,0.73066734302048,1.0,14/46,18.63%,CADPS2;STXBP6;CLASP1;CLASP2;CADPS;CHMP3;NSF;RAB27B;CPLX1;STXBP5;STXBP5L;SYT1;RAB27A;HAP1
prerank,cellular response to organic substance (GO:0071310),0.3636714686884282,1.1213339025799838,0.28554778554778554,0.7302179943747227,1.0,14/116,8.12%,NOS1;PDGFB;BMPR2;PTPN14;ACVRL1;ARL6IP5;INPP5K;KLF4;ACVR1;LEF1;ASAH2;LRRK2;PTPN12;DCPS
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.37231882633613234,1.1212877609371203,0.3062953995157385,0.729729168949049,1.0,20/84,16.35%,NANOS1;NANOS3;BTG2;RTN1;GAPDH;ROCK1;RTN4;PRNP;CNOT1;ENC1;CLU;TOB1;RTN3;FXR1;PIN1;YBX1;ABCA7;DDX6;RACK1;RNF139
prerank,organophosphate catabolic process (GO:0046434),-0.46783988921411956,-1.1202163901527566,0.3128205128205128,0.7189083214446946,1.0,8/11,47.29%,ABHD12;ENPP2;ANGPTL3;PLBD2;PLBD1;NUDT15;PDXP;PON1
prerank,smooth muscle tissue development (GO:0048745),0.5488181443729063,1.1199732953741426,0.3439153439153439,0.7324761233025734,1.0,2/10,1.88%,ENG;MYLK
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.5100489183368848,1.1199636089213425,0.3322734499205087,0.7318787469505689,1.0,6/13,16.96%,YAE1;BOLA2;ISCA2;GLRX5;GLRX3;MMS19
prerank,negative regulation of defense response (GO:0031348),0.3881420481131183,1.1196337239715626,0.2914634146341463,0.7320775213514489,1.0,13/77,11.29%,TEK;AOAH;APOA1;KLF4;GATA3;MFHAS1;PROC;NMI;NR1D1;ACOD1;CACTIN;LPCAT3;VPS35
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.4327403367786776,1.1196248686226287,0.32248939179632247,0.7314632031700835,1.0,11/35,14.31%,HMBOX1;MAPK1;CCT8;NEK7;TNKS;CCT2;FBXO4;CCT4;ATM;CTNNB1;CCT6A
prerank,ventricular septum morphogenesis (GO:0060412),0.44777622363406505,1.1192876401858853,0.3442622950819672,0.7316750625441502,1.0,7/27,4.00%,BMPR2;SMAD7;NOTCH1;HEY1;TGFB2;HEY2;ACVR1
prerank,regulation of tau-protein kinase activity (GO:1902947),0.5368434535022809,1.1190974159950826,0.34024179620034545,0.7315479133730284,1.0,5/10,29.82%,EGR1;CLU;SORL1;HSP90AA1;HSP90AB1
prerank,defense response to protozoan (GO:0042832),0.5340507774278437,1.118856422186595,0.36195286195286197,0.7315653699851483,1.0,4/12,16.14%,GBP4;GBP2;LYST;GBP7
prerank,carbohydrate homeostasis (GO:0033500),0.38839394176815356,1.1187972833681274,0.3084455324357405,0.7311022074408661,1.0,10/67,8.31%,ADIPOR2;INSR;KLF7;HNF4A;HNF1A;INPP5K;ADIPOR1;MTNR1B;CEBPA;PRKAA1
prerank,central nervous system neuron differentiation (GO:0021953),0.43047413613448826,1.1186405294145634,0.3145275035260931,0.7308673368149923,1.0,10/33,20.17%,NR4A2;ATP7A;CHD5;ZC4H2;SPOCK1;CTNNB1;MAP2;OPHN1;SIN3A;GRID2
prerank,endoplasmic reticulum organization (GO:0007029),0.3808137703924742,1.1182831406035612,0.3053152039555006,0.7311872456837482,1.0,20/72,18.43%,ATL2;CAV2;APP;DOP1B;SHTN1;ATL1;LRRK2;REEP2;RTN4;PRNP;LPCAT3;GET1;REEP1;REEP3;RTN3;UBE2J2;VAPA;CCDC47;ZBED3;TOR1AIP2
prerank,glycerolipid catabolic process (GO:0046503),0.4769614916416952,1.1182486931311886,0.327639751552795,0.7306423797240462,1.0,9/19,24.21%,GPCPD1;PNPLA6;ABHD6;GDPD1;ENPP6;ABHD2;GDE1;MGLL;GDPD3
prerank,histone deacetylation (GO:0016575),-0.32957388655050357,-1.1181920397181797,0.27450980392156865,0.7229062088842331,1.0,11/43,15.07%,PRDM5;TBL1XR1;RBM14;REST;HDAC4;HDAC1;HDAC6;MSL3;SIN3B;SIRT2;MTA2
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.3869974212448227,-1.1174554917618609,0.3065015479876161,0.723566422439015,1.0,7/23,18.66%,NUPR1;PPARA;C1QTNF3;HDAC4;SIK1;CLK2;PFKFB1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3504545978241499,1.117445334379475,0.266304347826087,0.7320757220386863,1.0,53/190,20.48%,PTPRJ;CD2AP;ATP2B4;DUSP1;DAB2IP;CAV1;CASP8;HDAC7;INPP5K;PDE3B;HYAL2;PLEKHA1;SH3BP4;ADIPOR1;P2RX7;STAT1;ZC3H12A;DUSP3;ARHGAP25;BCL2L1;PRKAA1;WWC2;NMI;NR1D1;PPP2R5C;CACTIN;MARK3;PIK3IP1;PIK3CB;RTKN2;RIOK3;RHOH;CARD19;EPM2A;PHLDA3;ABCA7;RACK1;PDE4D;TMSB4X;PYCARD;ESR1;TRIB3;MAPK14;PLAUR;GSK3A;RELA;PPIF;BANK1;MAPKAPK5;MCL1;SHANK2;NPRL3;RNF34
prerank,regulation of protein localization (GO:0032880),0.39800802238128824,1.1167881785993818,0.30200501253132833,0.7331769188903884,1.0,14/58,16.24%,TRIM14;FKBP1A;PPM1F;TRIM6;FBXW7;TRIM25;TRIM17;MMD;TRIM46;VPS4A;DNAJB6;RACK1;MAP2;PLEKHM2
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.3890742007970872,1.1166390170919105,0.3041301627033792,0.7329153417662253,1.0,11/61,7.75%,ARHGEF3;F11R;NOTCH1;RAPGEF1;F2RL1;APOA1;MAP4K4;LPAR6;SHOC2;ARRB1;JAK2
prerank,ribosome biogenesis (GO:0042254),0.3497483877510418,1.1165941944991922,0.26939655172413796,0.7324097348468206,1.0,76/187,26.59%,BOP1;PELP1;RPL27;DHX37;RPL7;PAK1IP1;EXOSC3;NVL;UBA52;MRM2;RPS14;RPL35;XPO1;WDR46;RPL21;DKC1;RPL37;RPS28;RPL34;RPS9;MRPL36;RPLP2;EXOSC8;XRN2;NPM1;RPS25;RPL30;RPL27A;NOL8;RPL23A;RAN;RPS15;EIF6;EIF2A;RPL19;RPL32;UTP18;RPL37A;RPL18A;EXOSC9;NOB1;LAS1L;DDX47;DCAF13;WDR18;RRP9;PWP2;RPL18;C1D;RPL39;NOLC1;IMP4;EXOSC10;RPS19;RPL31;EXOSC1;FBL;LSG1;NOP53;RPF2;HELQ;WDR43;RPL3;UTP20;MRTO4;GLUL;MDN1;NIP7;RPL28;RPL9;RPL26;RPS16;RPLP1;DDX27;ESF1;UTP15
prerank,response to cytokine (GO:0034097),-0.2613771243624657,-1.1163732718618211,0.14285714285714285,0.7250055891527588,1.0,25/141,11.08%,PID1;PTPN13;AFF3;COL3A1;DPYSL3;ALDH1A2;IL1R1;PTPN9;BCL2;IKBKE;PTPN4;TIMP2;IL6R;ANXA1;ADAM9;SMAD3;SRC;TBK1;CXCL16;PRKCA;CASP3;MAP2K7;GGT5;IFITM1;HDAC4
prerank,regulation of blood coagulation (GO:0030193),0.4529623522334199,1.1163595302002554,0.3258258258258258,0.7323935243686188,1.0,6/27,8.54%,EDN1;CAV1;F2RL1;ENPP4;CD34;PROC
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.38771563657256614,-1.1152263009544434,0.2807017543859649,0.7266127530760723,1.0,9/22,20.84%,CACNA1C;ADGRV1;GRM3;GABBR2;PALM;DRD2;EDNRB;CAP2;NF1
prerank,peptide biosynthetic process (GO:0043043),0.35324698753896716,1.115020577856479,0.2828729281767956,0.7351404763250018,1.0,64/153,28.30%,RPS21;RPL27;PCSK5;FURIN;RPL7;FARSB;WARS1;MRPL18;MRPL41;RPS27A;RPS14;RPL35;RPL21;RPL37;RPS28;MRPL52;RPL34;RPS9;MRPL36;RPLP2;RPS25;MRPL23;RPL30;RPL27A;RPS5;MRPL24;MRPL32;RPL23A;MRPS12;RPS15;RPL19;RPS18;RPL32;RPL37A;RPL18A;MRPS18B;COPS5;DARS1;MRPL11;RSL24D1;RPL18;RPL39;RPS19;RPL31;RPS8;EIF4G1;MRPL34;RPL3;EIF4EBP2;MRPL35;RPL28;RPL9;RPL26;RPS16;RPLP1;MRPL10;MRPL27;MRPS18C;RPS17;EEF1A1;RPL14;RPL11;MRPL13;RPS13
prerank,retinol metabolic process (GO:0042572),-0.4339797564906017,-1.114851934016258,0.3058510638297872,0.7261618066065241,1.0,2/14,9.61%,RBP4;DHRS3
prerank,hexose transmembrane transport (GO:0008645),0.46284352589464883,1.1146902600907083,0.33640552995391704,0.7353916735349122,1.0,3/21,8.57%,SLC2A1;SLC5A10;SLC2A9
prerank,cellular response to lipopolysaccharide (GO:0071222),0.3709628002427944,1.1141497756264769,0.28128587830080365,0.7361650321828309,1.0,18/101,10.26%,NOD2;DAB2IP;VIM;DEFA6;MEF2C;TNFRSF1B;IL1A;PDCD4;NFKBIL1;IRGM;ZC3H12A;NR1D1;ACOD1;STAP1;CACTIN;HMGB1;CASP1;NFKBIB
prerank,negative regulation of leukocyte migration (GO:0002686),-0.49516871925602757,-1.1140348796699013,0.31695331695331697,0.726857823956801,1.0,4/10,15.51%,BMP5;SLIT2;HOXA7;CD300A
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.36576748732383485,-1.1137321623896022,0.2692307692307692,0.7261020931088327,1.0,8/26,24.12%,ATP1A2;CALM2;ADRA2A;DRD2;GSTM2;GSTO1;CASQ2;CBARP
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.5051058738287076,1.113358948408284,0.35038759689922483,0.7375891134962478,1.0,1/13,0.24%,SOX13
prerank,regulation of myotube differentiation (GO:0010830),0.4591718295168626,1.1132442428124065,0.3373493975903614,0.7372617458911674,1.0,3/24,3.17%,PIEZO1;NOTCH1;HDAC9
prerank,negative regulation of histone modification (GO:0031057),-0.43009698724194356,-1.1131345500727385,0.3179347826086957,0.7260808600345411,1.0,6/14,21.92%,SET;JARID2;TAF7;TWIST1;NOC2L;SPHK2
prerank,cardiac muscle cell contraction (GO:0086003),-0.38798490049457224,-1.113125338824888,0.30831099195710454,0.7245289766724987,1.0,4/19,6.57%,CACNA1C;GSN;CACNA2D1;CACNA1G
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.4494997008110613,-1.1130208468771252,0.3170731707317073,0.7232104080464515,1.0,6/12,18.15%,APOBEC1;TET1;RESF1;MPHOSPH8;SETDB2;ATF7IP
prerank,regulation of interferon-gamma production (GO:0032649),0.38107753208737133,1.1123708765802331,0.3031400966183575,0.7389323795801027,1.0,14/71,16.99%,CRTAM;F2RL1;LGALS9;TLR3;CD47;ZC3H12A;HMGB1;PRNP;VSIR;LAPTM5;HAVCR2;PDE4D;PYCARD;RARA
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.505809661067671,1.1122033693802371,0.33766233766233766,0.7387399961688249,1.0,7/14,21.28%,TIRAP;HNRNPA0;ELAVL1;ELAVL4;ANGEL2;MAPK14;MAPKAPK2
prerank,spliceosomal complex assembly (GO:0000245),-0.3251318166051636,-1.111788496119565,0.26495726495726496,0.7249520761912294,1.0,9/46,10.96%,CELF2;SRSF5;SCAF11;NCBP1;SRSF1;PUF60;SMN1;SRSF6;DDX1
prerank,regulation of keratinocyte migration (GO:0051547),0.5228322866430994,1.111442744107078,0.3305921052631579,0.7400302002117096,1.0,2/12,4.97%,MAP4K4;IQSEC1
prerank,response to X-ray (GO:0010165),-0.4389283955559622,-1.1110709665120762,0.3248730964467005,0.7253993679917456,1.0,5/14,18.10%,NUCKS1;NIPBL;ANXA1;XRCC5;IKBIP
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.39379495156117406,-1.1106514330588613,0.3135593220338983,0.7250442569788348,1.0,10/20,40.56%,LBP;PTPN22;TICAM1;HCK;IL18;CCL2;MTDH;CD14;BCL10;CCL5
prerank,melanosome localization (GO:0032400),0.4615578239168354,1.1104750052233865,0.3287461773700306,0.7418809892884022,1.0,4/21,6.14%,RAB11A;BLOC1S6;BBS7;GPR143
prerank,detection of visible light (GO:0009584),0.49530660218847605,1.1100691794865298,0.3312597200622084,0.7423250642341416,1.0,1/16,1.73%,GNAQ
prerank,leukotriene biosynthetic process (GO:0019370),-0.4331887762645721,-1.1095516388375541,0.3172043010752688,0.7264941230957697,1.0,9/14,36.96%,PLA2G4A;GGT5;GGT7;GGTA1;GGT1;MGST2;ALOX5;PLA2G5;ALOX5AP
prerank,membrane organization (GO:0061024),0.347354615434614,1.1092366700704102,0.2797494780793319,0.7438945879748491,1.0,49/227,15.14%,HIP1;HIP1R;DYSF;PIK3C2A;CBL;ADRB2;TTPA;PPT1;DNM3;SH3KBP1;PACSIN2;VTI1B;AP2B1;ATP2C1;FCHO2;FNBP1L;PIP5K1C;TMEM43;VAMP8;ARRB1;SUN3;GLTP;A4GALT;UBA52;CERT1;RPS27A;ARPC5;ACTG1;VAMP7;CHMP1B;LPCAT3;AP2M1;EPN2;CCDC88A;MYOF;REEP1;ACTB;OCRL;VPS4A;REEP3;CHMP3;ARPC3;SGCZ;CEP55;LDLRAP1;VAPA;ARPC2;CHMP2B;CHMP7
prerank,protein polyubiquitination (GO:0000209),0.3366880051816211,1.109191599924124,0.2604166666666667,0.7433869745525681,1.0,78/297,19.36%,LMO7;TRIM14;ZNRF1;TRIM69;FBXO7;PSMD13;FBXL14;FBXL5;KLHL3;TRIM6;TRAF1;RNF125;ARIH1;UBE2Q1;CUL3;UBE2D1;PSMD4;KLHL20;FBXL18;UBE4A;WWP1;UBA52;RPS27A;UBE3A;HERC6;FBXL16;SIAH2;PSMA5;PSMB10;RNF115;FBXW7;RBX1;RNF144B;PSMB8;TNKS;FBXW2;NEDD4L;PSMD14;DTX3L;BRCA1;SMURF1;FBXO4;CBFB;UBE2T;UBE2J2;PSMA7;PSMA8;PSMC3;FBXO2;UBE2E1;CDC27;PSMB5;CTNNB1;PSMC1;PSMC5;UBE3B;UBE2D3;NHLRC1;TRIM2;IRF2BP1;PSMC6;PSMB9;ANAPC7;FBXL13;PSMA4;FBXO6;UNKL;RUSC1;ANAPC13;FBXO10;PSMD5;PSMD9;MKRN1;PSMB6;ANAPC4;FBXL15;RNF166;BARD1
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.5390589031476538,1.1090509719347674,0.3602693602693603,0.7431294919038454,1.0,4/10,17.86%,GABRA4;GABRA2;GABRE;GABRG3
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.4692943583872063,1.108731840618198,0.3458528951486698,0.7433176902389955,1.0,3/20,9.47%,EPAS1;HSPA1B;EGR1
prerank,negative regulation of endocytosis (GO:0045806),0.45293675757596197,1.1087066969258574,0.3373676248108926,0.7427572989655479,1.0,6/24,15.36%,MCTP1;CAV1;PRKD1;RAC1;RUBCN;ABCA7
prerank,iron ion transport (GO:0006826),-0.3128863180775977,-1.1085604397120872,0.3,0.7277426685416758,1.0,8/47,8.29%,STEAP3;SLC39A14;SCARA5;ATP6V0A4;ATP6V1B2;ATP6V0B;ATP6AP1;TCIRG1
prerank,protein glycosylation (GO:0006486),0.3550408780734119,1.108208085189218,0.2945823927765237,0.7434163904262517,1.0,25/125,15.77%,EOGT;ST8SIA6;GALNT18;ST3GAL6;POMGNT1;ST6GALNAC2;AQP11;MGAT5;SERP2;GCNT2;GALNT7;POGLUT1;NUS1;B3GNT3;DPM1;C1GALT1C1;TET3;MGAT1;KRTCAP2;B3GALNT2;ST3GAL1;ALG11;ST3GAL2;DDOST;MPI
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.5297065051712915,1.1081092365464482,0.3586206896551724,0.743044036856674,1.0,4/10,9.62%,OXSR1;ADAM17;STK39;ADAM10
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.4290806269011826,-1.1080771767725537,0.3333333333333333,0.7276043759342572,1.0,9/15,36.59%,NFKB1;AGTR1;MAPK9;LPL;AGT;MSR1;IL18;CD36;PLA2G5
prerank,granulocyte differentiation (GO:0030851),0.48167846734907216,1.1077187893880602,0.3442088091353997,0.7434212481535888,1.0,5/18,16.99%,TAL1;LEF1;CEBPA;CBFA2T3;RARA
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.46491663340965106,1.1065053281564345,0.3152492668621701,0.7458304166491134,1.0,5/25,5.12%,ENG;BMPR2;ACVRL1;NOTCH1;SMAD2
prerank,cell junction organization (GO:0034330),0.3813095666017971,1.1064767708293963,0.31806615776081426,0.7452821491083895,1.0,16/71,13.32%,APBB2;OCLN;FBLIM1;TGFB2;AGRN;APP;PPFIBP1;SNCG;LIMS2;TJP2;ACTG1;PPFIA2;TJP1;ACTB;GRM5;PIN1
prerank,positive regulation of keratinocyte migration (GO:0051549),0.539796499357919,1.1061860635690006,0.37372013651877134,0.7454131736790288,1.0,2/10,4.97%,MAP4K4;IQSEC1
prerank,neuron projection morphogenesis (GO:0048812),-0.2616676629867512,-1.1054288773608711,0.2222222222222222,0.7332826531333139,1.0,28/137,12.02%,ALCAM;GAS7;SDC2;FGFR2;DOCK7;NBL1;DCLK1;BMP7;DCDC2;FARP1;DOCK10;S100A6;DLG4;PARD3;DICER1;EPB41L3;NGF;MAP1A;CTNND2;BRSK1;FLRT1;NRK;ZDHHC17;PLXNB1;DTNBP1;SLITRK1;NCKAP1L;DBN1
prerank,neutrophil activation (GO:0042119),0.5194127354499894,1.105030197769369,0.35526315789473684,0.74778582680969,1.0,3/12,10.27%,F2RL1;KMT2E;TYROBP
prerank,actin filament bundle assembly (GO:0051017),0.42518225483524835,1.1049930024624317,0.33753501400560226,0.7472525377042764,1.0,4/33,3.12%,LIMA1;FAM107A;PLS3;NEDD9
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.4782317425677121,1.1043710153398834,0.34840871021775544,0.7482722638793243,1.0,3/18,9.00%,TEK;SHTN1;ROCK1
prerank,regulation of sister chromatid cohesion (GO:0007063),0.5193513142586255,1.1042097531386543,0.3509700176366843,0.7480732886192216,1.0,4/12,14.21%,RAD21;FEN1;BUB1;CTNNB1
prerank,response to iron ion (GO:0010039),-0.44306769669970025,-1.1038713446788104,0.34316353887399464,0.736055588670055,1.0,3/12,5.64%,BMP6;BCL2;ACO1
prerank,sodium ion import across plasma membrane (GO:0098719),-0.4070006064595111,-1.1034912657963212,0.3297587131367292,0.7355938815953167,1.0,4/17,6.74%,SLC12A2;SLC9A2;SLC6A1;SLC9A9
prerank,muscle tissue development (GO:0060537),0.501805571062261,1.10333207297656,0.36198347107438017,0.7496876467908866,1.0,3/13,6.39%,ENG;CSRP2;POGLUT1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.49176407369491865,1.1029559277757544,0.3463338533541342,0.750032875135731,1.0,5/16,16.95%,CEACAM1;SIRT4;BRCA1;ERLIN2;TRIB3
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.4863532495072558,1.1028401003231554,0.3617693522906793,0.7497022621190034,1.0,7/16,22.22%,CAV1;ADIPOR1;INPP5F;NF2;PTPN2;LEPROT;PARP14
prerank,cellular response to heat (GO:0034605),0.4280249433859297,1.1027779620698865,0.3590462833099579,0.7492416377373932,1.0,6/35,10.01%,TRPV4;HSBP1L1;IER5;IL1A;HSPA1B;POLR2D
prerank,hexose biosynthetic process (GO:0019319),-0.3237005082148553,-1.1024927078229938,0.2689393939393939,0.7367893851220493,1.0,15/42,21.23%,SLC39A14;SLC25A13;RBP4;CHST15;ENO2;PGM1;MDH2;SLC25A12;GOT1;AKR1B1;PFKFB1;CRTC2;G6PC3;TPI1;ENO3
prerank,polyol biosynthetic process (GO:0046173),0.47783031920366104,1.102353778131903,0.36276083467094705,0.7496898967470932,1.0,3/16,3.58%,ITPKB;IP6K3;IPPK
prerank,multivesicular body organization (GO:0036257),0.42846139435820146,1.102159376200655,0.35336194563662376,0.749540350708667,1.0,15/31,26.25%,RAB11A;VPS36;VPS28;CHMP1B;VPS4A;CHMP3;CHMP2B;CHMP7;RAB27A;MVB12A;STAM2;CHMP1A;VPS4B;CHMP4A;CHMP4B
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5216818120250907,1.1018934426089044,0.3475298126064736,0.7496145548555317,1.0,3/10,7.97%,LRRK2;PDE8A;NFE2L2
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.3332544331322389,1.101854037443301,0.25,0.749095922477478,1.0,44/417,9.40%,PRDM16;MECOM;SOX13;GATA6;PLCB1;PDGFB;DACH1;RPS6KA5;SMARCA2;NOTCH1;FOXO1;ELK3;HEY1;DAB2IP;HNF4A;ID1;HDAC9;SOX18;HHEX;INPP5K;HEY2;HMBOX1;PPM1F;KLF4;LEF1;DAP;SMAD2;BTAF1;COMMD7;GATA3;EID2B;PDCD4;PHC3;ZBTB16;TMPRSS6;CEBPA;WWP1;ZHX3;GATAD2A;NR1D1;MBD1;FOXP1;ARID5A;JUN
prerank,stabilization of membrane potential (GO:0030322),0.48286348457387274,1.1017781071513901,0.36217948717948717,0.7486519669155963,1.0,2/16,5.92%,KCNN4;KCNK12
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.35644634915342094,-1.1014851889094595,0.3065015479876161,0.7378548249325217,1.0,10/28,18.47%,ZIC1;CDH1;SMAD3;PIK3R1;FLNA;IPO5;BAG3;PIK3R2;ZPR1;PRKCD
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5148743722635327,1.1010855037466467,0.3500837520938023,0.7498691185824908,1.0,2/11,2.63%,FAS;LGALS9
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.41300908348074017,1.1009533409798946,0.330567081604426,0.7495994487023431,1.0,8/43,10.68%,CDH13;EDN1;PDGFB;STAT1;HTR1B;FOXP1;JUN;ADAMTS1
prerank,inner dynein arm assembly (GO:0036159),-0.4735686887611935,-1.100770531078218,0.36515513126491644,0.7381795692071853,1.0,8/10,46.74%,DNAAF5;CCDC39;CFAP100;CCDC40;DNAAF4;DNAH1;DNAAF1;DNAI3
prerank,regulation of glycolytic process (GO:0006110),-0.2945673521654223,-1.1007504433860846,0.27149321266968324,0.7366744836305179,1.0,9/68,7.66%,PRKAG2;IGF1;ZBTB20;OGT;NUPR1;PRKAA2;PPARA;NUP107;PFKFB4
prerank,zinc ion transport (GO:0006829),-0.3817692870055018,-1.1005990344161718,0.31805157593123207,0.7355667121998057,1.0,5/21,8.25%,SLC39A14;SLC30A10;SLC39A8;SLC39A13;SLC30A6
prerank,import into nucleus (GO:0051170),-0.2895495510648759,-1.1004871098477722,0.24285714285714285,0.7343172715489488,1.0,27/73,23.77%,APPL2;NUP107;HEATR3;CSE1L;PPP1R10;GEMIN5;NUP155;TNPO3;SMN1;RANBP6;FAM53C;IPO5;SNRPF;NUP93;TNPO2;RANBP17;HTATIP2;SNUPN;TSC2;SNRPD3;PHB2;SEC13;SYK;IPO7;GEMIN7;POM121;IPO8
prerank,cellular response to retinoic acid (GO:0071300),-0.3299336018048746,-1.1002917718600906,0.2775800711743772,0.7333103214686278,1.0,8/42,9.18%,EPHA3;PTK7;WNT6;WNT5A;SNW1;WNT9A;FZD7;NDUFA13
prerank,defense response to virus (GO:0051607),0.3653473010185782,1.1002235670905298,0.32314923619271446,0.750853972513878,1.0,31/100,22.14%,IFI44L;IRF2;F2RL1;IFIH1;TLR3;STAT1;SERINC3;PLSCR1;BCL2L1;NLRC5;OAS2;ACOD1;MLKL;RNASE1;SERINC5;AKAP1;BNIP3L;RNASE6;LYST;BNIP3;PYCARD;RSAD2;CXCL10;IFITM3;RELA;G3BP1;SETD2;EIF2AK2;AGBL4;NT5C3A;PQBP1
prerank,sensory perception of light stimulus (GO:0050953),-0.2799982376765639,-1.1002108044605274,0.2647058823529412,0.7320080750592283,1.0,14/87,10.38%,COL1A1;EFEMP1;SLC4A10;ADGRV1;EML2;COL11A1;EYA4;RP2;OPA3;IMPG2;DHRS3;ZIC2;WHRN;OAT
prerank,regulation of protein localization to cell periphery (GO:1904375),0.4766838518785151,1.0999239551569664,0.35348837209302325,0.7510228739993572,1.0,7/18,17.43%,VTI1B;STX7;VAMP8;ACTB;VPS4A;LDLRAP1;SPTBN1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.47793432256415946,-1.099727468303026,0.37681159420289856,0.7303690040993707,1.0,4/10,18.66%,NUPR1;PPARA;HDAC4;PFKFB1
prerank,negative regulation of glycolytic process (GO:0045820),-0.47793432256415946,-1.099727468303026,0.37681159420289856,0.7303690040993707,1.0,4/10,18.66%,NUPR1;PPARA;HDAC4;PFKFB1
prerank,response to fatty acid (GO:0070542),-0.4138898511431365,-1.0996114822465193,0.3324324324324324,0.7291392859616475,1.0,5/17,14.63%,PID1;FOXO3;IRS1;PDK3;SCD
prerank,glucose homeostasis (GO:0042593),0.3717885905259899,1.0994930295604963,0.3222354340071344,0.7514730217213661,1.0,12/83,8.61%,ADIPOR2;FOXO1;INSR;KLF7;HNF4A;HNF1A;INPP5K;ADIPOR1;MTNR1B;CEBPA;PRKAA1;NR1D1
prerank,regulation of peptide hormone secretion (GO:0090276),0.37875728898070465,1.0994761330295675,0.32151898734177214,0.7508965854745178,1.0,8/67,8.44%,ITPR3;SLC2A1;CACNA1A;HNF4A;SYT7;RAPGEF4;MTNR1B;PASK
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.34050296524801443,1.0993799957646635,0.28969957081545067,0.7505404426746737,1.0,30/182,10.58%,ENG;GATA2;CLDN5;PDGFB;CCR1;OCLN;ACVRL1;NOTCH1;ATP2B4;TGFB2;LGALS9;TNRC6C;DLL4;APP;HEY2;KLF4;TRIM6;MEF2C;CD34;SMCR8;ANKRD13A;ZC3H12A;RBL1;PRKAA1;NDFIP2;FOXP1;ADAM10;FBXW7;TCEAL1;AGO4
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.329790328769485,1.099213573202331,0.23493975903614459,0.7503398838906061,1.0,65/572,9.48%,PRDM16;SOX13;NOTCH4;KLF8;EDN1;GATA6;PDGFB;LDB2;DACH1;SMAD7;KLF2;SMARCA2;NR4A2;TBXT;PLK3;NOTCH1;ZFP69;NR1I3;HEY1;KLF12;DAB2IP;KLF7;IRF2;CAV1;LRRFIP1;SAP30;ID1;DLL4;HDAC9;ZGLP1;SOX18;HHEX;HEY2;HMBOX1;KLF4;MAFK;EFNA1;SMAD2;MEF2C;TAF9B;PHF6;GATA3;RTF1;BCL6B;UBE2D1;STAT1;GTF2IRD1;ZBTB16;PURA;SNAI2;TMPRSS6;UBA52;GATAD2A;RPS27A;WWC2;RPS14;NR1D1;TCF3;ERF;KLF11;FOXP1;UXT;ARID5A;JUN;HMGB1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.29427838323404987,-1.0986990101277594,0.2222222222222222,0.73019449190262,1.0,12/74,4.93%,EYA2;IGF1;EYA1;TGFBR1;BMP5;BMP4;BCL2;SH3RF1;TCF7L2;THBS1;ITGAV;EYA4
prerank,protein ubiquitination (GO:0016567),0.32703493633225617,1.0986930049110015,0.2487360970677452,0.7511163404990261,1.0,117/471,19.58%,LMO7;EPAS1;ASB4;TRIM14;RNF103;FBXL2;ZNRF1;TRIM69;CBL;HERC2;KLHL2;FBXO7;PSMD13;FBXL14;FBXL5;KLHL3;TRIM11;TRIM6;RNF38;ELOC;RNF125;RNF185;ARIH1;GAN;UBE2Q1;CUL3;RTF1;ARRDC1;UBE2D1;PSMD4;TRIM24;KLHL20;FBXL18;ARRB1;ASB5;NFE2L2;UBE4A;WWP1;UBA52;RPS27A;UBE3A;HERC6;FBXL16;SIAH2;PSMA5;PSMB10;RNF141;RNF115;FBXW7;ZNRF3;RBX1;CUL2;TRIM25;RNF144B;TRIM47;ENC1;TRIM17;PSMB8;TNKS;FBXW2;NEDD4L;PSMD14;OBI1;DTX3L;BRCA1;SMURF1;KCTD10;FBXO4;CBFB;UBE2T;RNF103-CHMP3;KEAP1;UBE2J2;PSMA7;PSMA8;PSMC3;HIF1A;FBXO2;UBE2E1;CDC27;PSMB5;CTNNB1;PSMC1;RAD18;PSMC5;UBE3B;UBE2D3;NHLRC1;TRIM2;IRF2BP1;TRAIP;KLHL25;RACK1;PSMC6;PSMB9;ANAPC7;KLHL24;FBXL13;RNF139;KLHL9;PSMA4;FBXO6;UNKL;RUSC1;ARRDC4;FBXO10;PSMD5;PSMD9;MKRN1;PSMB6;RRAGA;FBXO45;FBXL15;RNF166;BARD1;TRIM33;MKRN2
prerank,sensory perception of sound (GO:0007605),0.37252530568978826,1.0986871928012072,0.31547619047619047,0.750515467572941,1.0,6/88,2.95%,EPS8L2;KCNQ1;TBX1;ATP2B2;USP53;HOMER2
prerank,positive regulation of binding (GO:0051099),0.37173089440831225,1.0984449390763302,0.3309692671394799,0.7505224098636526,1.0,23/84,17.41%,RAPGEF2;CLDN5;HIP1R;B2M;CAV1;FKBP1A;APP;HMBOX1;EPB41;LRRK2;NVL;HMGB1;DHX9;MARK3;DTX3L;PIN1;HMGB2;RAN;KDM4D;TRIB3;RARA;PLAUR;MEN1
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.3315539772996579,1.0978157266021855,0.2795477903391572,0.7514853518660138,1.0,99/306,24.28%,GCNT1;NR4A2;EXT1;RBBP8;RPS21;RPL27;RPL7;FARSB;WARS1;MRPL18;ORC3;EEF2K;ALAS1;MRPL41;RPS27A;RPS14;POLR2G;RPL35;FEN1;MLF1;RPL21;POLR2D;RPL37;NFKBIB;RPS28;TUFM;GTPBP1;MRPL52;RPL34;RPS9;POLA1;MRPL36;BRIP1;RPLP2;GTPBP2;EEF2;RPS25;BRCA1;MRPL23;ORC5;RPL30;RPL27A;RPS5;ATM;MRPL24;RAD1;MRPL32;TAF1B;RPL23A;MRPS12;RPS15;KAT7;ST3GAL2;RPL19;RPS18;RFC2;RAD9B;RPL32;POLR2I;EEFSEC;RPL37A;MMS19;PWP1;RPL18A;EEF1D;MRPS18B;COPS5;ATRIP;HOXD3;GOLPH3;MEF2A;PTMA;BARD1;DARS1;RRAGC;EEF1G;HUS1;MRPL11;RSL24D1;BLM;RPL18;RPL39;RMI1;RPS19;RPL31;RPS8;PAX8;POLR2C;KIN;POLR2B;RNASEH2A;EIF4G1;ORC4;TSFM;MRPL34;POLR2J;RPL3;WRN;EIF4EBP2
prerank,positive regulation of axonogenesis (GO:0050772),0.4078133763915829,1.0975911708848793,0.36639118457300274,0.7514325647338165,1.0,9/43,7.11%,PLXNA4;MACF1;PLXND1;NTN1;SHTN1;SEMA7A;ARHGDIA;TIAM2;ISLR2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3437237902792991,1.0975776262625268,0.27742616033755274,0.7508541306911455,1.0,36/208,14.68%,PLCG2;TRIM14;NOD1;NOD2;DAB2IP;CASP8;PRKD1;F2RL1;LGALS9;FKBP1A;TIRAP;ATP2C1;TRIM6;TNFSF10;PLEKHG5;TRAF1;JMJD8;STAT1;ZC3H12A;HSPB1;NR1D1;GAPDH;NDFIP2;CACTIN;CASP1;TRIM25;LURAP1;MAP3K3;TAB2;TRIM8;DDX21;RIOK3;RHOH;VAPA;CARD19;TMED4
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3549733559876387,1.0970764442588996,0.2955056179775281,0.7515277595847427,1.0,28/132,11.74%,TRIM14;FOXO1;INSR;PRKD1;PIK3C2A;APP;APOA1;MSN;TRIM6;FURIN;TNFRSF1B;SH3BP4;P2RX7;LRRK2;IRGM;ZC3H12A;PRR5L;PRKAA1;ROCK1;PFKFB3;HMGB1;CNOT1;PTPN1;GTPBP1;LAPTM5;VPS35;TRIM8;DTX3L
prerank,positive regulation of chemotaxis (GO:0050921),0.4048160415935039,1.0967458380469575,0.3386880856760375,0.7517788981872138,1.0,7/43,7.53%,CDH13;PDGFB;PRKD1;F2RL1;PPM1F;ADAM17;HSPB1
prerank,cellular response to hypoxia (GO:0071456),0.35223918917359565,1.0967127142498345,0.3152542372881356,0.7512652925173647,1.0,35/126,18.87%,EPAS1;GATA6;PLK3;PSMD13;ELOC;PGK1;PSMD4;UBA52;RPS27A;PSMA5;PSMB10;HP1BP3;RBX1;CUL2;PSMB8;PSMD14;HIF1AN;SUV39H2;PSMA7;PSMA8;PSMC3;HIF1A;BNIP3L;PSMB5;PSMC1;BNIP3;PSMC5;PSMC6;PSMB9;PTGIS;PSMA4;PSMD5;PSMD9;EPO;PSMB6
prerank,regulation of BMP signaling pathway (GO:0030510),0.3784662326240969,1.0967015253960448,0.34487021013597036,0.7506756577060374,1.0,7/73,1.87%,ENG;SMAD6;BMPR2;SMAD7;ACVRL1;NOTCH1;DAND5
prerank,lipid translocation (GO:0034204),0.465155589532374,1.0965318668170692,0.3505917159763314,0.7505312930364589,1.0,6/21,15.36%,ATP10A;ABCB4;ATP11C;ATP8B1;ABCC1;ABCA7
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.49405855772078205,1.096363929611167,0.36891679748822603,0.7503393030068108,1.0,4/14,10.61%,ECSCR;ANO6;PDCD4;PLCG1
prerank,ATP transport (GO:0015867),0.5412512583218678,1.0962504928060695,0.3968804159445407,0.7500173529416092,1.0,3/10,11.31%,SLC17A9;CD47;ABCC6
prerank,regulation of neuron migration (GO:2001222),0.4493742356648221,1.0958941813811787,0.3318840579710145,0.7503632359311662,1.0,4/26,4.56%,RAPGEF2;ARHGEF2;DAB2IP;SHTN1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.4698688953559145,-1.095700593380919,0.35853658536585364,0.7368830729926673,1.0,4/10,10.68%,DPYD;NT5M;NT5E;UPB1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.44707965552510787,1.0953372838707562,0.3591654247391952,0.7511497759349223,1.0,4/25,4.76%,GJA5;CAV1;NOS1AP;CAMK2D
prerank,regulation of kinase activity (GO:0043549),0.36658214789019844,1.0951951333246395,0.3212996389891697,0.7509200721624051,1.0,13/89,8.14%,TEK;FLT1;TIE1;LDB2;FLT4;MERTK;INSR;EMP2;FGFR3;ALK;LMTK2;RBL1;NLRC5
prerank,positive regulation of autophagy (GO:0010508),0.37656641619385406,1.095099130117415,0.33052884615384615,0.7505584256307823,1.0,19/81,14.84%,TRIM14;PLK3;FOXO1;PRKD1;PIK3C2A;FBXO7;TRIM6;SH3BP4;LRRK2;IRGM;ZC3H12A;PRKAA1;ROCK1;HMGB1;TRIM8;PIK3CB;BNIP3L;BNIP3;EPM2A
prerank,protein deacetylation (GO:0006476),-0.31864276543131304,-1.094709764416856,0.3147410358565737,0.7380678573913589,1.0,12/41,15.07%,PRDM5;TBL1XR1;SIRT3;FLNA;RBM14;HDAC4;HDAC1;HDAC6;MSL3;SIN3B;SIRT2;MTA2
prerank,regulation of inflammatory response (GO:0050727),0.34502631323406585,1.0946630056205904,0.3090128755364807,0.75107683669402,1.0,31/190,12.83%,TEK;NOD2;AOAH;SPATA2;APP;APOA1;TLR3;KLF4;SEMA7A;HYAL2;TNFRSF1B;GATA3;BCL6B;PDCD4;CD47;MFHAS1;JAK2;CEBPA;CD200;PROC;NMI;NR1D1;ACOD1;FOXP1;CASP1;DHX9;LPCAT3;NFKBIA;VPS35;DDT;ABCC1
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.39510583619417067,-1.0943996704006682,0.3389355742296919,0.737424787469376,1.0,10/18,22.23%,SLC25A13;MTHFD1;NAALAD2;ASPG;SLC25A12;GOT1;ASPA;ADI1;ASNS;MTHFR
prerank,receptor clustering (GO:0043113),-0.36023626703211165,-1.094370949794845,0.3005952380952381,0.7359901846213559,1.0,5/27,8.19%,PTN;MAGI2;DLG4;DNAJA3;FLNA
prerank,electron transport chain (GO:0022900),0.4894462450268737,1.0943356359738443,0.3758278145695364,0.7513096934825749,1.0,5/15,14.06%,ETFDH;ETFB;ETFA;UQCRFS1;CYB561
prerank,sulfur amino acid catabolic process (GO:0000098),0.536729227448783,1.0940207476333448,0.3696369636963696,0.7514864243776779,1.0,1/10,2.93%,TST
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3301551894819856,1.093742923347901,0.278118609406953,0.7515358970999616,1.0,58/348,12.19%,PLCG2;NOS3;GATA2;CLDN5;PDGFB;KLF2;OCLN;NOTCH1;INSR;HEY1;IFNGR1;LGALS9;TNRC6C;DLL4;APP;NOS1AP;HEY2;TLR3;MED26;PPM1F;KLF4;KRAS;MSN;ANGPT1;LEF1;MEF2C;CD34;WARS1;IL1A;MAPK1;P2RX7;ZC3H12A;ARRB1;HSPA1B;PLSCR1;NFE2L2;TBC1D5;PRKAA1;CDH3;ACTG1;ROCK1;STAP1;EGR1;TASOR;TYROBP;PTPN1;AGO4;FGF20;VSIR;LAPTM5;VPS35;VSTM2A;NWD1;DTX3L;CLU;BRCA1;HINFP;INPP5F
prerank,tyrosine metabolic process (GO:0006570),0.5172100762973566,1.093644575289488,0.37181663837011886,0.75116784710341,1.0,2/11,9.99%,HGD;TYR
prerank,replication fork processing (GO:0031297),-0.3286895241785737,-1.0935365740970717,0.3184931506849315,0.7367106725085362,1.0,15/38,26.89%,NUCKS1;BOD1L1;FBH1;THOC1;ATR;RTEL1;SMARCAL1;RFWD3;ATRX;ZRANB3;EME2;RAD51;MMS22L;SETMAR;CENPX
prerank,renal filtration (GO:0097205),0.5227510221650451,1.0931903704485295,0.3758278145695364,0.7516836742467212,1.0,6/10,17.83%,MYO1E;CD34;MCAM;ITGA3;XPNPEP3;TBC1D8B
prerank,positive regulation of signal transduction (GO:0009967),0.3399419102459235,1.0929573471485308,0.29442691903259727,0.7516634066210629,1.0,33/238,9.60%,JAG1;TEK;JAG2;NOTCH4;NOS3;KLF2;FAS;VWF;NOTCH1;JCAD;NOD2;MACF1;DAB2IP;CAV2;TGFB2;EMP2;DLL4;HHEX;MGAT5;LIMS2;TSPAN14;RAB34;SHANK3;GATA3;POGLUT1;LRRK2;CRADD;JAK2;MYO1C;CDH3;TPD52L1;GKAP1;TM2D3
prerank,regulation of microtubule-based process (GO:0032886),0.4104275985874023,1.09272745206469,0.34705075445816186,0.7516243913169468,1.0,9/36,9.80%,EFNA5;FAM107A;MACF1;DIAPH1;CLASP1;PRKAA1;APC;ROCK1;CLASP2
prerank,regulation of G0 to G1 transition (GO:0070316),0.40904607655719527,1.09220891685386,0.34609929078014184,0.7523344159125573,1.0,7/38,11.82%,FOXO4;DAB2IP;RBBP8;RYBP;PHC3;UXT;BRCA1
prerank,endothelial tube morphogenesis (GO:0061154),0.5375398547975563,1.0918889008311474,0.3783303730017762,0.7525329686073841,1.0,5/10,15.12%,ACVRL1;RHOB;PRKD2;CTNNB1;CSNK2B
prerank,inorganic anion transport (GO:0015698),-0.30889691146255366,-1.091188843165639,0.29333333333333333,0.7416008918878957,1.0,8/53,6.71%,SLC13A4;SLC4A10;SLC26A7;ANO1;CLCN2;ENPP1;ENPP3;SLC5A5
prerank,glutamate metabolic process (GO:0006536),0.46488826511763426,1.0908633315210459,0.3516819571865443,0.7544393500530843,1.0,4/19,5.95%,DGLUCY;GLS2;GLS;GLUD1
prerank,negative regulation of anoikis (GO:2000811),0.5063993598174238,1.0906613632877185,0.3895705521472393,0.7543428843289318,1.0,5/14,13.59%,NOTCH1;CAV1;SNAI2;PTK2;ITGA5
prerank,response to hydrogen peroxide (GO:0042542),0.3978429387231266,1.0905443530587844,0.36575342465753424,0.7540066617543071,1.0,8/45,11.34%,FYN;RHOB;STK24;PLEKHA1;SETX;NFE2L2;OSER1;TRPM2
prerank,negative regulation of macrophage activation (GO:0043031),0.4786113786034605,1.0902693856143135,0.3677621283255086,0.7541317270507369,1.0,4/16,8.61%,FCGR2B;ZC3H12A;CD200;NR1D1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.28878946575995457,-1.0898105056312308,0.25510204081632654,0.7440062834431264,1.0,22/80,16.25%,DENND2A;SGSM2;VPS54;SNX6;VPS26B;GCC2;SNX32;TMEM87A;SURF4;TRAPPC10;LMAN1;EHD3;RHOBTB3;STX5;SNX1;STX16;TBC1D17;SNX12;CLN5;SNX8;GGA1;SNX2
prerank,visual perception (GO:0007601),-0.28159786054905367,-1.089586027102746,0.25139664804469275,0.7431661705728448,1.0,13/84,10.38%,COL1A1;EFEMP1;SLC4A10;ADGRV1;EML2;COL11A1;EYA4;RP2;OPA3;IMPG2;DHRS3;ZIC2;OAT
prerank,regulation of axonogenesis (GO:0050770),-0.3108846844939107,-1.089004951433212,0.29464285714285715,0.7431786216475865,1.0,13/51,11.60%,ROBO1;PLXNA2;SLIT2;SIPA1L1;NTRK2;PLXNB2;NGF;BRSK1;CHN1;KIF13B;PLXNB1;ARHGAP35;SLITRK1
prerank,regulation of protein localization to membrane (GO:1905475),-0.3519978877426409,-1.088633442011016,0.32063492063492066,0.7427938525101746,1.0,5/28,4.11%,GPC6;GSN;GPC3;MMP14;PRKN
prerank,post-translational protein modification (GO:0043687),0.33017927795062385,1.08809028768883,0.2937563971340839,0.7590576917038434,1.0,79/332,18.89%,LMO7;EPAS1;ASB4;RAB11A;GOLM1;APP;TULP4;KLHL2;FBXO7;APOA1;COPS4;CISH;PSMD13;FBXL14;FBXL5;KLHL3;TMEM132A;ELOC;RHBDD1;GAN;CUL3;PSMD4;IGFBP7;KLHL20;PRKCSH;FBXL18;ZBTB16;HSP90B1;SOCS6;ASB5;FEM1C;PROC;IGFBP4;FBXL16;PSMA5;PSMB10;ADAM10;FBXW7;RBX1;CUL2;PSMB8;APLP2;CDH2;FBXW2;CP;PSMD14;FBXO4;COPS8;DCAF10;KEAP1;DCAF17;PSMA7;PSMA8;PSMC3;HIF1A;FBXO2;PSMB5;PSMC1;PSMC5;KLHL25;PSMC6;PSMB9;FBXL13;KLHL9;CALU;PSMA4;CST3;SOCS5;FBXO6;MEN1;COPS5;FBXO10;PSMD5;PSMD9;PENK;TIMP1;PSMB6;FEM1A;DCAF13
prerank,prostanoid metabolic process (GO:0006692),-0.43101864819313324,-1.0880708989815846,0.3226600985221675,0.7429286636591326,1.0,4/13,14.64%,PTGS1;PTGES;HPGD;GSTM1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.33277937625099513,1.0880166022212532,0.2830578512396694,0.7586600877696744,1.0,36/308,10.14%,PRDM16;EPAS1;ADIPOR2;PLCB1;PDGFB;BMPR2;CRTAM;CAV1;F2RL1;TGFB2;ADRB2;CADM1;INPP5K;ACVR1;WWTR1;GCNT2;YBX2;LEF1;OMA1;SMAD2;IL1A;ADIPOR1;CMKLR1;NPR1;KDM3A;ZBTB16;VAMP8;JAK2;GADD45G;APC;GAPDH;ROCK1;VAMP7;RTN4;MAD2L2;LURAP1
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.45411380510870847,-1.0879268706007408,0.3480392156862745,0.7418311956163678,1.0,3/11,22.96%,CAT;PRDX3;GPX1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.4573244913783373,-1.0875128239246588,0.38563829787234044,0.7414338816469693,1.0,4/12,17.88%,WNK1;PPARA;MDK;SKAP1
prerank,negative regulation of gene expression (GO:0010629),0.32941278732896145,1.0874541892987586,0.28865979381443296,0.7594912661718666,1.0,50/302,13.45%,NANOS1;NANOS3;ENG;GATA2;CLDN5;PDGFB;RPS6KA5;CCR1;OCLN;ACVRL1;NOTCH1;ATP2B4;TGFB2;LGALS9;TNRC6C;BTG2;DLL4;APP;HDAC9;HEY2;KLF4;FCGR2B;TRIM6;MEF2C;CD34;SMCR8;ZC3H12A;HSPA1B;RBL1;PRKAA1;GAPDH;NDFIP2;FOXP1;ZFP36L2;ADAM10;FBXW7;TCEAL1;TASOR;CNOT1;ENC1;AGO4;PTBP3;APLN;TMBIM6;HINFP;TOB1;TTBK1;PPM1D;FXR1;HIF1A
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.3798830138686654,1.0872217493975984,0.33248081841432225,0.7594625056494774,1.0,20/69,20.11%,RNF103;RNF185;HSP90B1;UBE4A;TMUB2;TRIM25;BAG6;RNF103-CHMP3;YOD1;UBE2J2;SGTB;FOXRED2;FBXO2;PSMC6;UBQLN2;SEL1L;ERLIN2;FBXO6;DNAJC10;RNF5
prerank,phospholipid catabolic process (GO:0009395),0.45077411171478987,1.0871451803085828,0.36199095022624433,0.7590485344928518,1.0,5/24,9.92%,GPCPD1;SMPDL3A;PNPLA6;GDPD1;ENPP6
prerank,monoacylglycerol metabolic process (GO:0046462),-0.43029469988494495,-1.0867611761676221,0.36363636363636365,0.7419626382080933,1.0,6/13,22.24%,MOGAT3;PLA2G4A;DGAT1;ABHD12;FAAH;DGAT2
prerank,regulation of protein targeting to membrane (GO:0090313),0.43366935618433294,1.0865319257679984,0.35900962861072905,0.7600165120879726,1.0,8/28,17.83%,FYN;INPP5K;ITGAM;MYO1C;PRNP;ITGB1BP1;ANK3;GDI1
prerank,positive regulation of cilium assembly (GO:0045724),0.47951665487445544,1.0861476162534045,0.38028169014084506,0.760359922571901,1.0,8/18,25.99%,SAXO1;CEP135;CCDC88A;CEP120;HAP1;MARK4;WRAP73;KCTD17
prerank,positive regulation of cellular senescence (GO:2000774),0.5266954510243459,1.0861160276184587,0.36288998357963875,0.7598428751527,1.0,1/10,1.75%,B2M
prerank,cell junction assembly (GO:0034329),0.35918612712967213,1.0860780970592774,0.3459715639810427,0.7593282646273553,1.0,19/100,12.18%,TRPV4;CLDN5;FBLIM1;DNM3;PLXND1;SPOCK2;LIMS2;SHANK3;GJA4;NRCAM;FLRT3;ACTG1;CDH12;TJP1;KIRREL3;CDH2;ACTB;ACHE;PCDHB16
prerank,regulation of cell development (GO:0060284),0.42629994379748953,1.086012331815142,0.36415362731152207,0.7588894442053064,1.0,11/36,14.56%,FOXO1;HEY1;HDAC9;HEY2;PRUNE1;CX3CR1;ADGRA2;HMGB2;HES3;CTNNB1;RHEB
prerank,lipoprotein biosynthetic process (GO:0042158),-0.4519434608204832,-1.08518836645751,0.35766423357664234,0.7449281678455764,1.0,5/11,23.31%,APOE;ATG7;WIPI2;WDR45;PORCN
prerank,positive regulation of ERAD pathway (GO:1904294),0.5025995468740216,1.0849746459151046,0.37649063032367974,0.7609048815072402,1.0,5/13,15.89%,CAV1;RNF185;NFE2L2;BAG6;UBQLN2
prerank,negative regulation of interleukin-1 production (GO:0032692),0.4448112213590736,1.0848005246017236,0.34252539912917274,0.7607689390746635,1.0,6/23,18.64%,CEACAM1;APOA1;ZC3H12A;CX3CR1;PYDC1;GIT1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.4240945079129427,1.0846433274696148,0.3664772727272727,0.7605415309164524,1.0,5/31,7.59%,HIP1R;CASP8;PPP1R13B;BBC3;NMT1
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.5240287626079698,1.084448929546727,0.37435008665511266,0.7604438607803178,1.0,3/10,5.33%,TBX1;ACTN4;RXRG
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.46151722538546636,-1.0841418875709798,0.3918269230769231,0.7463374882267734,1.0,3/10,6.87%,DCN;BCL2;SRC
prerank,natural killer cell mediated immunity (GO:0002228),0.49544892628393283,1.0840897422665505,0.37420382165605093,0.760728549261759,1.0,4/15,16.24%,TUBB;TUBB4B;LYST;PLEKHM2
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.4948104849488376,1.0839999648067515,0.3892733564013841,0.7603324251008882,1.0,5/13,11.50%,ADAM17;AKT3;HMGB1;PLCG1;APLN
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3684980467874558,1.0837733713353388,0.33095238095238094,0.7603032949011745,1.0,6/85,2.95%,EPS8L2;KCNQ1;TBX1;ATP2B2;USP53;HOMER2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.36127471919797577,1.0833646342790835,0.33451957295373663,0.760734010585977,1.0,31/88,24.30%,EXOC6;STXBP6;APP;AP1S2;DOP1B;BLOC1S6;GOPC;KLHL20;VAMP8;ARRB1;VAMP7;EXOC8;AP1B1;CLVS1;KIF16B;MON2;EXOC4;STEAP2;SORCS1;EPS15;SORT1;EXOC2;SCAMP1;SORL1;EXOC5;OSBPL5;EXOC6B;SCAMP3;MYO5A;FTH1;FTL
prerank,inorganic cation transmembrane transport (GO:0098662),0.3313416607014555,1.0830631628803475,0.3007284079084287,0.7608903048419772,1.0,33/268,10.09%,ATP2A3;SLC6A6;KCNN4;KCNQ1;TRPV4;RHCG;ATP2B4;KCNH8;CACNA1A;ATP1A4;ATP1A3;ATP1A1;FKBP1A;KCNN3;KCNG3;SLC8A1;ATP2C1;ANO6;ORAI1;SCN11A;KCNK12;P2RX7;SLC30A1;SLC39A6;MCOLN1;SLC6A4;KCNC1;SCN1B;KCNH7;ASIC2;SLC9A7;SLC6A17;SLC6A2
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.3655390588395247,-1.082968294891252,0.334384858044164,0.7481269646712575,1.0,3/24,2.40%,PID1;DAB2;RHOQ
prerank,positive regulation of interleukin-13 production (GO:0032736),0.5271399129136307,1.0826862523513257,0.3704918032786885,0.761182315071389,1.0,2/10,6.13%,LGALS9;GATA3
prerank,regulation of response to external stimulus (GO:0032101),0.3510487923674217,1.0820804455904305,0.3453908984830805,0.7621211760395735,1.0,16/121,9.61%,GATA6;SPAAR;NOD2;CAV1;CASP8;F2RL1;SPATA2;TIRAP;FCGR2B;STK24;SEMA7A;BCL6B;NMT1;JAK2;FOXP1;CASP1
prerank,epithelium development (GO:0060429),0.35933214873414393,1.0818895692571313,0.3516609392898053,0.7620021153171355,1.0,13/107,7.75%,SOX17;GATA6;TBX1;RHCG;GSTA2;TST;SOX18;TAGLN2;CD34;PGK1;STAT1;SNAI2;JAK2
prerank,amino acid import across plasma membrane (GO:0089718),-0.36282821774088153,-1.0812624529659813,0.3383233532934132,0.7513333032634653,1.0,7/24,7.09%,SLC6A13;SLC1A3;SLC7A2;SLC47A1;SLC1A5;SLC6A9;SLC22A4
prerank,mesenchymal to epithelial transition (GO:0060231),-0.46371193819007006,-1.0809874984530456,0.36318407960199006,0.7506592022313675,1.0,5/10,20.26%,BMP4;FZD7;SALL1;BASP1;PAX2
prerank,signal transduction by p53 class mediator (GO:0072331),0.4200029367951206,1.0807827724718775,0.36231884057971014,0.7641819668625391,1.0,2/30,3.51%,ACER2;PPP1R13B
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.43474524655035596,1.0806571008452501,0.373134328358209,0.7638541835836674,1.0,3/27,4.76%,GJA5;CAV1;CAMK2D
prerank,gland development (GO:0048732),-0.2948584325456584,-1.0803706250406897,0.2930232558139535,0.7508183605179083,1.0,16/59,13.64%,TGFBR3;GLI2;FGFR2;WNT4;TGFBR1;DKK3;COBL;IGSF3;ANXA1;SIX1;STRA6;MET;ARHGAP35;SALL1;MDK;CITED2
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.36365754692502555,1.0781780828617566,0.3474065138721351,0.7695303700960658,1.0,25/85,18.87%,FZD6;AP2B1;PSMD13;PSMD4;PSMA5;PSMB10;AP2M1;RAC1;PSMB8;PSMD14;SMURF1;PSMA7;PSMA8;PSMC3;PSMB5;PSMC1;FZD3;PSMC5;PRICKLE2;PSMC6;PSMB9;PSMA4;PSMD5;PSMD9;PSMB6
prerank,positive regulation of cell population proliferation (GO:0008284),0.32444363767260415,1.077969786075371,0.2998986828774063,0.7694480518015349,1.0,63/423,14.28%,VEGFC;CDH13;ACER2;EDN1;PDGFD;CLDN5;FLT1;PDGFB;FLT4;KITLG;TBX1;CCND2;LIFR;NOTCH1;NOD2;INSR;AQP11;TGFB2;EMP2;RASSF10;DLL4;VEGFD;KRAS;WWTR1;GCNT2;LEF1;SERTAD1;MEF2C;FGFR3;TBC1D8;CUL3;ADAM17;SLC25A33;STAT1;CD47;GNAI2;CNOT6L;THPO;NDUFS4;NAMPT;PTK2;FOXP1;ADAM10;DHX9;TJP1;RPRD1B;RPS9;FGF20;MAP3K3;NPM1;MATK;CHTOP;ITGB1BP1;RTKN2;MCTS1;PRC1;PHIP;POU3F2;TBX20;LRP5;PGF;EAPP;FZD9
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.4646091095631936,-1.077330156251931,0.3806146572104019,0.7580333789191042,1.0,4/10,10.65%,HNMT;SMOX;ALDH7A1;SARDH
prerank,nucleoside catabolic process (GO:0009164),-0.4499843875090152,-1.076698397358007,0.3765586034912718,0.7583423785675836,1.0,4/11,10.68%,DPYD;NT5M;NT5E;UPB1
prerank,amyloid fibril formation (GO:1990000),0.3931707771976038,1.0765358573800101,0.37433155080213903,0.7724567332145492,1.0,12/51,9.62%,B2M;FKBP1A;APP;APOA1;TSPAN14;IAPP;FURIN;UBA52;RPS27A;APH1A;SIAH2;ADAM10
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.34511611436863415,1.076420121675917,0.35920177383592017,0.7721409730329781,1.0,13/140,6.72%,EDN1;TRPV4;ITPR3;CCR1;CACNA1A;CAV1;F2RL1;SLC8A1;GPR157;IAPP;LPAR6;P2RX7;CMKLR1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.48573967814192953,1.0762513948414836,0.40705128205128205,0.7719710352904195,1.0,3/14,4.13%,PRKD1;EMP2;LIMS2
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.4594442980419559,-1.0761416580009797,0.3907766990291262,0.7568956998548296,1.0,6/10,27.96%,SIRT3;PLA2G6;PRKCD;SPHK2;SMPD3;TNFRSF1A
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.4594442980419559,-1.0761416580009797,0.3907766990291262,0.7568956998548296,1.0,6/10,27.96%,SIRT3;PLA2G6;PRKCD;SPHK2;SMPD3;TNFRSF1A
prerank,regulation of mast cell degranulation (GO:0043304),0.48878960429734264,1.0760964771377024,0.38510301109350237,0.7717624813389988,1.0,2/14,3.12%,LGALS9;FES
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5091580608928652,1.075857047723967,0.38316151202749144,0.7705355314710445,1.0,5/12,22.32%,CUL3;CDC27;ANAPC7;ANAPC4;ANAPC11
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5091580608928652,1.075857047723967,0.38316151202749144,0.7705355314710445,1.0,5/12,22.32%,CUL3;CDC27;ANAPC7;ANAPC4;ANAPC11
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5091580608928652,1.075857047723967,0.38316151202749144,0.7705355314710445,1.0,5/12,22.32%,CUL3;CDC27;ANAPC7;ANAPC4;ANAPC11
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.4398545108893793,1.075409947596167,0.38200589970501475,0.7710090435406795,1.0,10/24,18.93%,MEF2C;SPAG9;CTNNA1;CDH15;TCF3;CDH2;CTNNA2;CTNNB1;MAPK14;MEF2A
prerank,methylguanosine-cap decapping (GO:0110156),0.5222273517955858,1.0752932405562448,0.39195979899497485,0.7706921846081977,1.0,4/10,15.26%,LSM1;DCP1B;DCPS;EDC3
prerank,response to organonitrogen compound (GO:0010243),0.4063145924811682,1.0752771554068599,0.35382513661202186,0.7701436164572052,1.0,18/38,27.71%,RHBDD1;RNF185;TRPM2;IRF5;KAT7;RNF139;GLRA2;UBXN6;SEL1L;CCDC47;RRAGC;RNF5;KYNU;BRSK2;MEAK7;GLRB;IRAK3;DNAJB12
prerank,dendrite self-avoidance (GO:0070593),0.4744542034688836,1.0750627168856386,0.37267080745341613,0.7700867799044175,1.0,9/16,27.60%,ROBO4;BSG;NPTN;MYPN;DSCAM;CNTN4;CNTN6;IGSF9;CNTN2
prerank,positive regulation of protein processing (GO:0010954),-0.3854578525048542,-1.074984558187321,0.3563218390804598,0.7586781905455383,1.0,3/19,3.93%,GSN;CCBE1;CLEC3B
prerank,cellular component assembly (GO:0022607),0.32862235441982485,1.0746653103418315,0.3185108583247156,0.7704905609982012,1.0,45/253,16.32%,LIMA1;CD2AP;SKAP2;MAGI1;FAS;SLC2A1;OCLN;FBLIM1;FAM107A;PLS3;PARVB;NEDD9;CFAP206;STX7;CARD10;LIMS2;SYCP2;TRAF1;RAD21;CD247;IL1RAP;NCKAP1;APC;ACTG1;RTN4;NEFH;RAC1;BAG6;CYFIP1;CDAN1;RANBP9;ACTB;SHROOM1;RTN3;CAPG;TAPBP;RHOH;PPIH;KPNA3;LCP1;PDCD10;CLDN14;VIL1;OPHN1;ANK3
prerank,regulation of dopamine secretion (GO:0014059),0.4385555061243571,1.0745154742240963,0.37894736842105264,0.7702822539317629,1.0,2/25,3.76%,SYT15;SYT7
prerank,response to retinoic acid (GO:0032526),0.38259704485754054,1.0741345414603383,0.35,0.7706813189060223,1.0,5/59,6.50%,ACER2;GATA6;TBX1;RXRG;SETX
prerank,regulation of osteoclast differentiation (GO:0045670),0.4183057218613567,1.073836887616143,0.38271604938271603,0.770846102249125,1.0,3/33,3.65%,CCR1;GPR137B;TLR3
prerank,regulation of glucose transmembrane transport (GO:0010827),0.46424827280496966,1.073779408563181,0.3858267716535433,0.7704013789540418,1.0,3/18,3.59%,SLC2A1;OCLN;INPP5K
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.5126920603634891,1.0734206192230864,0.3979933110367893,0.7707499357104236,1.0,5/11,25.81%,STAT1;JAK2;IL27RA;CANX;JAK1
prerank,regulation of neuron projection arborization (GO:0150011),-0.406444221702018,-1.0732754594124574,0.35658914728682173,0.7620000348481054,1.0,6/15,16.37%,GRIP1;WNT5A;DLG4;MFSD2A;NTNG1;MYO9A
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.4126817997898903,-1.0732536354906201,0.3641304347826087,0.7605724397806054,1.0,2/15,5.65%,MOXD1;SMOX
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.4349444092935865,1.0729172178959725,0.3742690058479532,0.7714127023641009,1.0,13/25,26.25%,CHMP1B;CHMP3;LYST;CHMP2B;CHMP7;UBXN6;MVB12A;SORT1;LEPROT;CHMP1A;VPS4B;CHMP4A;CHMP4B
prerank,positive regulation of cartilage development (GO:0061036),0.46221628474482207,1.0722835720712847,0.36349453978159124,0.772416399996804,1.0,3/17,7.13%,BMPR2;ACVRL1;ZBTB16
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.31786874069826426,1.0722138456402437,0.183,0.7719969163745379,1.0,248/1668,14.30%,PRDM16;NOS1;LMO7;MECOM;CDH13;EPAS1;SOX17;SOX13;JAG1;NOTCH4;KLF8;EDN1;ERG;ENG;GATA6;MRTFB;IRF6;GATA2;SMAD6;TAL2;MSX1;LDB2;BMPR2;DACH1;EBF1;RPS6KA5;SMAD7;KLF2;SMARCA2;CASZ1;LMO2;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;PLK3;BACH2;ACVRL1;NOTCH1;FOXQ1;EGR3;NOD2;ATP2B4;ZFP69;FOXO1;ELK3;ARHGEF2;NR1I3;HEY1;KLF12;TAL1;OLIG2;DAB2IP;KLF7;IRF2;CAV1;PRKD1;ZNF296;F2RL1;ZNF235;LRRFIP1;TNRC6C;SAP30;HNF4A;HNF1A;KLF3;AGRN;ID1;KLF6;DLL4;APP;ARID3B;HDAC9;ZGLP1;SOX18;CRK;HHEX;TEAD4;FLI1;PELP1;RBBP8;HEY2;TLR3;MED26;HMBOX1;KLF4;ACVR1;IER5;WWTR1;SIM2;BCLAF3;MAFK;IRF9;LEF1;CAMK2D;ZBTB46;EFNA1;ZBTB48;PKN1;SP4;MAFF;SMAD2;RXRG;ELOC;MEF2C;FOXF2;BBS7;HYAL2;LMO1;TAF9B;BRD8;FOSL2;PHF6;APEX1;GATA3;RTF1;BCL6B;UBE2D1;TOX3;RAD21;SRCAP;SETX;CHCHD2;STAT1;GTF2IRD1;ZC3H12A;MRGBP;KDM3A;ZBTB16;PPP3CA;LCORL;ELP4;GAL;AATF;ARRB1;TOX4;ELP2;PURA;EBF3;SNAI2;RBL1;TMPRSS6;PLSCR1;CEBPA;NFE2L2;NLRC5;ZHX3;UBA52;GATAD2A;RPS27A;WWC2;RPS14;NR1D1;NAMPT;MRTFA;ZBTB40;TCF7L1;TCF3;ERF;KLF11;FOXP1;UXT;ZNF182;ELOA;ARID5A;JUN;EGR1;HMGB1;DHX9;SS18;MAD2L2;ZBTB14;PLAG1;HNRNPK;CHD5;CNOT1;RPS6KA1;ZXDB;AGO4;NFKBIA;RPRD1B;BRIP1;TET3;CRTC1;MAML2;ZBTB34;DEAF1;TNKS;RAI1;NEDD4L;NPM1;HDX;PCBP1;ARID5B;GTF2H3;TIAL1;PHOX2A;E2F7;DMAP1;EAF2;BRCA1;HELZ2;PRKD2;HINFP;NR4A1;SOX10;KLF13;CBFB;SOX6;TLX3;ETV6;SETD3;MED30;SUV39H2;GLYR1;ITGB1BP1;ELF2;IRF5;RPS6KA3;PPM1D;ZNF32;CTBP2;ASCL4;TGIF1;DUSP22;PHIP;POU3F2;ATXN1;PIN1;ATM;PSMC3;HIF1A;SMARCC1;TBX20;LRP5;HMGB2;IKZF5;MYT1L;ACVR2A;MED27;HES3;VPS72;NFATC1;CTNNB1;MED17;USF2;DUSP26
prerank,neurotrophin signaling pathway (GO:0038179),0.45190619751980876,1.0717077886796742,0.37990580847723704,0.7727213964107652,1.0,2/21,1.81%,RAPGEF2;RAPGEF1
prerank,cardiac muscle cell differentiation (GO:0055007),0.4448634914374214,1.0716722670379888,0.39083969465648855,0.7722146864684304,1.0,4/21,5.43%,SLC8A1;ACVR1;ALPK3;MEF2C
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.3780756298476939,1.0715097587595557,0.39816031537450725,0.7720363679654558,1.0,9/56,10.68%,PLCB1;CCND2;RAB11A;CCND3;CUL3;CDC25C;ADAM17;KMT2E;ADAMTS1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.4035216662912448,1.0713904653297,0.36662106703146374,0.7717005055986891,1.0,9/37,10.54%,VCAM1;CRTAM;CADM1;AMIGO2;TENM3;NECTIN4;NECTIN1;TENM4;FAT4
prerank,peptidyl-serine modification (GO:0018209),0.3394856889891248,1.0713346863775555,0.33945945945945943,0.7712605496934932,1.0,44/166,17.60%,PDGFB;RPS6KA5;SBK1;PRKD1;MAST4;PKN3;CAMK2D;STK38;CSNK1D;PKN1;STK38L;TTBK2;MAPK1;POGLUT1;AKT3;UHMK1;MAST1;LRRK2;LMTK2;TLK1;STK39;ROCK1;SGK1;CSNK1G3;MARK3;PRKCG;RPS6KA1;TNKS;GALNT4;PRKD2;MARK2;VRK1;RPS6KB1;RPS6KA3;TTBK1;ATM;PRKX;RICTOR;PKN2;PAK2;CSNK1G1;STK32B;MAPK14;SGK3
prerank,positive regulation of cellular metabolic process (GO:0031325),0.35165026759707,1.0713309336011965,0.3557919621749409,0.7706730562567623,1.0,17/98,10.61%,PDGFB;FASN;INSR;SLCO1C1;APOA1;KLF4;ANGPT1;LIPT2;IFNAR1;GATA3;CHCHD2;ZC3H12A;ARRB1;TBC1D5;ACOD1;ACACB;NFKBIA
prerank,embryonic organ development (GO:0048568),0.3848892746695186,1.0712972584996348,0.37168141592920356,0.7701535017986529,1.0,10/61,6.13%,SOX17;KITLG;HEY1;TAL1;TGFB2;SOX18;TEAD4;HEY2;PCSK5;GATA3
prerank,NIK/NF-kappaB signaling (GO:0038061),0.3696116089391641,1.071078776239139,0.36600496277915634,0.7700864960138446,1.0,24/72,19.08%,TIRAP;TLR3;PSMD13;CARD10;PSMD4;PSMA5;PSMB10;PSMB8;PSMD14;COPS8;PSMA7;PSMA8;PSMC3;PSMB5;PSMC1;PSMC5;PSMC6;PSMB9;PSMA4;PSMD5;PSMD9;RELA;PSMB6;MALT1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.3400531312588342,1.0707605012092647,0.33774834437086093,0.7702717562155638,1.0,71/168,26.26%,RPS21;RPL27;RPL7;LSM1;ZC3H12A;MTPAP;CNOT6L;DCP1B;DCPS;UBA52;RPS27A;RPS14;POLR2G;RPL35;ETF1;RPL21;POLR2D;RPL37;RPS28;CNOT1;RPL34;RPS9;RPLP2;EXOSC8;XRN2;PELO;RPS25;HELZ2;XRN1;RPL30;RPL27A;RPS5;ATM;RPL23A;RPS15;RPL19;RPS18;RPL32;RPL37A;RPL18A;CNOT2;TUT7;DXO;EXOSC9;TENT2;CTIF;NBDY;SMG7;RPL18;ZFP36L1;RPL39;EXOSC10;RPS19;CSDE1;DIS3L2;RPL31;SMG9;RPS8;SMG8;EIF4G1;PATL2;RPL3;PPP2R2A;MRTO4;PPP2R1A;RPL28;RPL9;RPL26;RPS16;RPLP1;ERI1
prerank,regulation of cellular response to heat (GO:1900034),0.3642147141444689,1.0705476034456916,0.373508353221957,0.7702000964212525,1.0,28/77,25.44%,FKBP4;IER5;CAMK2D;CD34;MAPK1;HSPA1B;DNAJC2;NUP54;PTGES3;NUP35;RANBP2;NUP153;ATM;NUP160;NUP42;DNAJB6;NUP205;DNAJC7;GSK3B;BAG4;MAPKAPK2;NUP50;AKT1S1;RAE1;SEH1L;TPR;RPTOR;MLST8
prerank,"phototransduction, visible light (GO:0007603)",0.49086424994575306,1.0701500905959085,0.40522875816993464,0.7706569659420385,1.0,1/14,1.73%,GNAQ
prerank,mitochondrion transport along microtubule (GO:0047497),0.500975583003901,1.0701111419753344,0.3843537414965986,0.7701557207735673,1.0,6/13,21.81%,UXT;RHOT2;HIF1A;SYBU;LRPPRC;UBB
prerank,protein homotetramerization (GO:0051289),0.39867329700187115,1.0698518850289827,0.35325365205843295,0.7702720815918666,1.0,9/49,11.34%,GBP5;B2M;GLS;SSBP1;ALDH9A1;MCOLN1;ACOT13;ACACB;TRPM2
prerank,multivesicular body assembly (GO:0036258),0.4184370439396537,1.069557633798333,0.37464387464387466,0.7704169505888159,1.0,14/30,26.25%,RAB11A;VPS36;VPS28;CHMP1B;VPS4A;CHMP3;CHMP2B;CHMP7;MVB12A;STAM2;CHMP1A;VPS4B;CHMP4A;CHMP4B
prerank,regulation of defense response to virus by host (GO:0050691),0.41972246650626593,1.0695410052054508,0.36746143057503505,0.769868231773358,1.0,6/30,11.74%,AIM2;TRIM6;STAT1;ZC3H12A;DHX9;DTX3L
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.38866201414693347,1.0688821210945383,0.3785900783289817,0.7709939968647523,1.0,11/47,14.41%,EFNA5;NEDD9;CRK;ACTN4;APOA1;LIMS2;PTK2;RAC1;DOCK1;ITGB1BP1;SPRY4
prerank,cellular senescence (GO:0090398),-0.3444266789279054,-1.0688069420225084,0.3602693602693603,0.7716720513666142,1.0,11/27,28.03%,SMC6;TBX2;HMGA2;ECRG4;CDKN1A;PRKCD;PML;ULK3;SRF;OPA1;NSMCE2
prerank,GTP metabolic process (GO:0046039),0.4681079649820859,1.0685510734257693,0.3637901861252115,0.7712269387615669,1.0,6/15,16.19%,RAB23;LRRK2;GTPBP1;MFN1;RAN;EFL1
prerank,regulation of protein import into nucleus (GO:0042306),-0.3300699921546323,-1.0680647755148724,0.3655913978494624,0.7721849479907035,1.0,10/36,13.68%,ZIC1;BMP4;APOD;CDH1;SMAD3;PIK3R1;FLNA;IPO5;BAG3;PIK3R2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.43723469374468166,-1.0679396410458,0.3968253968253968,0.7710330566929846,1.0,4/12,18.44%,GLI2;NFIB;EPHB2;SZT2
prerank,embryonic digit morphogenesis (GO:0042733),-0.4003050201000973,-1.067921669590636,0.37960339943342775,0.7695763670696093,1.0,7/18,11.92%,GLI3;OSR1;CREBBP;INTU;TBX2;SALL1;HDAC1
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.3694112359421995,1.0668079634926924,0.39060568603213847,0.7748944624583689,1.0,10/72,7.75%,LIFR;IFNGR1;CASP8;SPATA2;SPPL2A;TRAF1;IRAK2;MADD;STAT1;JAK2
prerank,regulation of vasculature development (GO:1901342),0.4372048729716683,1.066800699759008,0.3751891074130106,0.7743239227537397,1.0,10/26,21.87%,EMP2;PLXND1;VASH2;TSPAN12;WARS1;ADGRA2;CTNNB1;ETS1;EGLN1;EPHA2
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.4088144058868334,1.0665827162983779,0.39305555555555555,0.7742667012790782,1.0,11/38,16.69%,DAB2IP;CASP8;STAT1;ZC3H12A;NR1D1;CACTIN;RIOK3;RHOH;CARD19;PYCARD;ESR1
prerank,extracellular matrix organization (GO:0030198),0.3259781146785351,1.066547757634894,0.35330578512396693,0.7737599727740767,1.0,30/276,7.23%,LAMA4;LAMA3;PECAM1;ELN;FBLN5;PDGFB;VCAM1;RECK;F11R;VWF;ITGA1;JAM2;MMP1;ICAM2;TGFB2;AGRN;APP;ADAMTS18;SPOCK2;LAMA5;ADAM15;DST;ATP7A;COL5A2;FURIN;CD47;PLEC;BSG;ADAM12;ITGAM
prerank,granulocyte chemotaxis (GO:0071621),0.3830343268221367,1.0662961778098325,0.3653366583541147,0.7737880317590375,1.0,5/55,10.31%,EDN1;TGFB2;PIP5K1C;BSG;CCL4
prerank,response to ethanol (GO:0045471),0.48165180294772153,1.0662240646498733,0.4170542635658915,0.7733956273035324,1.0,6/14,22.49%,GRIN2B;GRIN3A;SDF4;GLRA2;GRIN2A;SOD1
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.4914727383244537,1.0662218508328454,0.3993174061433447,0.7728160810559405,1.0,3/13,5.77%,APP;AKAP5;SHANK3
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.43719326775014294,1.065948561181011,0.381635581061693,0.7728932288086409,1.0,6/27,12.82%,TIRAP;IRAK2;UBA52;RPS27A;TAB2;BTK
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.49857480641620266,1.065747656296712,0.3996569468267582,0.7727843430505378,1.0,3/11,4.00%,SMAD7;TGFB2;ACVR1
prerank,negative regulation of viral genome replication (GO:0045071),0.398618865506503,1.0653936611392008,0.3790322580645161,0.773089395389209,1.0,17/40,26.29%,IFIH1;INPP5K;TRIM6;PLSCR1;OAS2;TASOR;SLPI;SRPK1;RSAD2;IFITM3;ZC3HAV1;EIF2AK2;BANF1;OASL;SETDB1;BST2;FAM111A
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.4422929267308512,1.0653334030236454,0.38273381294964026,0.7726460760555774,1.0,9/25,20.66%,MEF2C;LRRK2;GRIN2B;GRIN2C;GRIN2A;GSK3A;GSK3B;GRID2;INSYN2A
prerank,RNA methylation (GO:0001510),0.3740148647655481,1.0650880925186312,0.3669609079445145,0.7726510673432815,1.0,19/60,22.19%,TRDMT1;TRMT61A;MRM2;TRMT5;METTL2B;METTL2A;TRMT61B;METTL5;ALKBH8;VIRMA;FBLL1;METTL14;TFB2M;RBM15;NSUN5;FTSJ3;NSUN4;NSUN6;FBL
prerank,amino acid import (GO:0043090),0.4474654578624456,1.0650386679835149,0.3938931297709924,0.7721788783284222,1.0,5/21,7.88%,SLC6A6;SFXN1;SH3BP4;SLC16A2;SLC7A1
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.4300249974868438,-1.064773071221287,0.351010101010101,0.7772276256359726,1.0,4/13,8.96%,STX4;MAP1A;RIC3;STX3
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.4966991210973211,1.0644599298701327,0.392,0.7730199759261857,1.0,6/13,19.36%,UFM1;RAB23;RANGAP1;NUP153;CABP1;BARD1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.43459659575093207,-1.064429437134167,0.3916256157635468,0.7766982147457613,1.0,3/12,11.92%,DAB2;HEYL;HDAC1
prerank,negative regulation of response to external stimulus (GO:0032102),0.3573650220776519,1.0639688626185653,0.36480186480186483,0.7736601986432189,1.0,18/105,12.76%,TEK;AOAH;CRK;APOA1;KLF4;GATA3;NFKBIL1;DUSP3;MFHAS1;PROC;NMI;NR1D1;ACOD1;CACTIN;LPCAT3;VPS35;INPP5F;CTNNA2
prerank,regulation of neurogenesis (GO:0050767),0.38382176011817665,1.0639128551057426,0.4098573281452659,0.7732295833987666,1.0,13/55,15.91%,NOTCH1;B2M;HEY1;RASSF10;HEY2;PRUNE1;NUMB;PCM1;CX3CR1;HMGB2;HES3;CTNNB1;SPEN
prerank,cellular response to acid chemical (GO:0071229),0.4251553022965803,1.06387387847094,0.40416047548291234,0.7727446366185713,1.0,8/27,20.65%,SPAAR;KLF2;SH3BP4;RRAGD;GLRA2;RRAGA;RRAGC;LAMTOR3
prerank,positive regulation of interferon-alpha production (GO:0032727),0.4587439944359923,1.0638176771671073,0.4058192955589586,0.7722779701830882,1.0,5/19,12.68%,IFIH1;TLR3;STAT1;DHX9;IRF5
prerank,protein import into nucleus (GO:0006606),-0.2902496751658867,-1.0630757226171446,0.3146551724137931,0.7792250851156572,1.0,22/66,23.77%,APPL2;CBLB;NUP107;HEATR3;CSE1L;PPP1R10;KPNA1;NUP155;TNPO3;RANBP6;FAM53C;IPO5;NUP93;TNPO2;RANBP17;TSC2;PHB2;SEC13;SYK;IPO7;POM121;IPO8
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.38662731399809613,1.0628955712033996,0.3907894736842105,0.7739065096572895,1.0,5/51,1.87%,SMAD6;BMPR2;SMAD7;NOTCH1;DAND5
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.39085058950797563,-1.0625959825262092,0.3626062322946176,0.7790924476904576,1.0,5/19,13.24%,AXL;MMP14;ZMIZ1;NCKAP1L;MDK
prerank,regulation of cation channel activity (GO:2001257),0.3547815384391013,1.0622885335439283,0.37222870478413067,0.7748522269091311,1.0,10/89,8.45%,NOS1;FKBP1A;APP;SHISA8;CAMK2D;STAC;MEF2C;SHISA6;GRIA1;GRIN2B
prerank,nuclear transport (GO:0051169),0.4676171555419829,1.0620313283575378,0.38461538461538464,0.7748882638544041,1.0,6/16,22.59%,XPO1;NPM1;RSRC1;NUP205;BANF1;NXT2
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3397287553458255,1.0618413435873766,0.3659621802002225,0.7747804645254712,1.0,14/142,6.72%,EDN1;TRPV4;ITPR3;CCR1;ATP2B4;ATP2B2;CACNA1A;CAV1;CAV2;F2RL1;SLC8A1;IAPP;HCRTR1;CMKLR1
prerank,positive regulation of T cell activation (GO:0050870),0.37686842647173896,1.0617616186410832,0.3804755944931164,0.7743968810560967,1.0,6/62,7.88%,VCAM1;NOD2;LGALS9;GATA3;CD47;SLC7A1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.42875860745391337,1.0615336121926915,0.39285714285714285,0.7743389864546139,1.0,9/26,16.95%,ADIPOR2;CEACAM1;APOA1;ADIPOR1;BRCA1;ELOVL5;EIF6;ERLIN2;TRIB3
prerank,negative regulation of myoblast differentiation (GO:0045662),0.49451742030195434,1.0614130541556692,0.40649149922720246,0.774049670581851,1.0,2/13,6.15%,NOTCH1;EID2B
prerank,positive regulation of protein import (GO:1904591),-0.33939386886081646,-1.0612743325541134,0.3353846153846154,0.78140699252092,1.0,10/30,18.47%,ZIC1;CDH1;SMAD3;PIK3R1;FLNA;IPO5;BAG3;PIK3R2;ZPR1;PRKCD
prerank,regulation of blood circulation (GO:1903522),0.4051455496427116,1.0610265855384364,0.394109396914446,0.7743910801202716,1.0,3/34,4.76%,KCNQ1;ACE;CAMK2D
prerank,regulation of cellular localization (GO:0060341),0.3897728051793689,1.060952064922476,0.3783422459893048,0.7739733138445584,1.0,12/46,15.83%,EFNA5;FES;TTL;PPM1F;CAMK2D;LRRK2;NR1D1;NUMA1;TRIM46;LRP5;MAP2;GOSR1
prerank,regulation of actin filament-based movement (GO:1903115),-0.4564997682882506,-1.0609425811162783,0.37411764705882355,0.7808531117202143,1.0,2/10,1.66%,ANK2;PDPN
prerank,dorsal/ventral pattern formation (GO:0009953),-0.38479154502953195,-1.0608917201114758,0.3735294117647059,0.7795087763637524,1.0,3/20,1.27%,BMPR1A;GLI2;NBL1
prerank,synaptic vesicle exocytosis (GO:0016079),0.4071122532011104,1.0608899624956938,0.39183673469387753,0.7735440545806477,1.0,11/40,18.16%,UNC13B;DOC2B;SYT7;BLOC1S6;PIP5K1C;STX19;RIMS3;CPLX1;SNPH;SYT2;SYT1
prerank,response to muscle stretch (GO:0035994),-0.40556825546002817,-1.0602152842368604,0.43137254901960786,0.7798724185777878,1.0,2/15,0.82%,DMD;GSN
prerank,dopaminergic neuron differentiation (GO:0071542),0.45290040827356626,1.0597480198362856,0.4056603773584906,0.7757550681951517,1.0,3/19,14.21%,NR4A2;PHOX2A;CTNNB1
prerank,stem cell development (GO:0048864),0.46943480618829014,1.059608796041476,0.4043887147335423,0.7755126601259847,1.0,6/16,21.06%,SNAI2;CDH2;CYP26C1;TCOF1;SOX11;NOLC1
prerank,positive regulation of cell differentiation (GO:0045597),0.32942113743327595,1.0596001240500859,0.3638275499474238,0.7749638211213997,1.0,47/237,14.25%,SLC6A6;RAPGEF2;CEACAM1;PLCB1;ASB4;BMPR2;KITLG;ACVRL1;ARHGEF2;PRKD1;TGFB2;FES;BTG1;TMEM100;BLOC1S6;ACVR1;WWTR1;RRAS;GCNT2;LEF1;SMAD2;MEF2C;SPAG9;CD34;CMKLR1;ZC3H12A;ZBTB16;CTNNA1;NRCAM;ZHX3;CDH15;SYAP1;CTNNBIP1;TCF3;RPS6KA1;ZC4H2;MMD;CDH2;HIF1AN;PCP4;SOX6;RPS6KA3;CTNNA2;LRP5;ACVR2A;CTNNB1;NELL1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.5041743125160867,1.0593625310050496,0.38126009693053314,0.7749987244433248,1.0,1/12,1.77%,PAEP
prerank,regulation of neuroinflammatory response (GO:0150077),-0.37369544379990804,-1.0589447236705225,0.3837837837837838,0.7820139375168301,1.0,2/19,1.86%,IGF1;NUPR1
prerank,skeletal muscle tissue development (GO:0007519),0.41601404436642225,1.058051246119058,0.3982808022922636,0.7775642397692796,1.0,4/32,8.01%,CAV1;CAV2;MEF2C;MYL6
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4053746852353085,1.0578057693905074,0.3852813852813853,0.7775783073223401,1.0,6/34,9.45%,GATA2;FOXO1;TRIO;WWTR1;GATA3;ZFP36L2
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.4142178285656625,1.0575700479648047,0.3949930458970793,0.7775705053803387,1.0,8/35,15.52%,NUAK1;ITGA1;FKBP1A;HSP90B1;CALM3;PPP1R15B;CSNK2B;BOD1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.37910397991740397,1.0575064233972213,0.36988110964332893,0.7771606987557743,1.0,9/54,13.34%,PLK3;BTG2;CASP2;CDC25C;CRADD;CNOT6L;CNOT1;E2F7;ATM
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.42233939686924443,-1.0574933599837386,0.3765586034912718,0.7844969074757332,1.0,6/13,15.98%,ADGRV1;GRM3;GABBR2;PALM;DRD2;EDNRB
prerank,positive regulation of cell cycle process (GO:0090068),0.3574743858199415,1.0573605509108477,0.3919716646989374,0.7769222682927959,1.0,18/91,16.31%,EDN1;PDGFB;INSR;CUL3;IL1A;RAD21;PLSCR1;FEN1;CDC14A;RANBP1;NUMA1;E2F7;PHIP;LRP5;MAP3K20;PKN2;NDC80;CEP120
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.3859418892906226,-1.0572836505887713,0.38439306358381503,0.7836506940029102,1.0,6/18,15.09%,PRKN;CCN3;IRS1;REST;ADRA2A;KCNB1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.39891583345320725,-1.0572020463507124,0.38190954773869346,0.7824041177055586,1.0,5/15,15.70%,NTRK2;NGF;CASP3;ZFYVE27;DDIT4
prerank,regulation of catecholamine secretion (GO:0050433),0.4169744286948508,1.0568986152950028,0.3916184971098266,0.777445686471075,1.0,7/29,18.16%,SYT15;SYT7;FGF20;CHGA;HRH3;SYT2;SYT1
prerank,negative regulation of cyclase activity (GO:0031280),-0.4171563646954686,-1.0568110589051338,0.3932291666666667,0.7820010094122066,1.0,6/14,15.98%,ADGRV1;GRM3;GABBR2;PALM;DRD2;EDNRB
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.4289264674350327,-1.0567391839678488,0.38242894056847543,0.7807200547946036,1.0,3/12,9.01%,NKD1;SDK2;VEGFA
prerank,cellular response to unfolded protein (GO:0034620),0.4320305023063181,1.0567377015597232,0.39824304538799415,0.7772832659320275,1.0,8/26,19.55%,DAB2IP;RHBDD1;HSPA1B;PTPN1;TMBIM6;TM7SF3;DAXX;ERN1
prerank,regulation of gastrulation (GO:0010470),-0.41462791777696884,-1.056408731470013,0.37371134020618557,0.780116427253886,1.0,3/14,6.06%,PHLDB2;OSR1;DAG1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.3392800185155439,-1.0555490894798754,0.35611510791366907,0.7809690725710801,1.0,10/33,18.29%,IGFBP5;OGN;APOD;TPM1;IGFBP3;EFEMP2;PPARG;CDKN1A;GPER1;NDRG4
prerank,aorta development (GO:0035904),0.4789241404049771,1.0553889194519956,0.40894568690095845,0.7799478788753518,1.0,2/14,1.29%,JAG1;TBX1
prerank,N-glycan processing (GO:0006491),0.449058660808343,1.0550644607184918,0.38975155279503104,0.7801603734020093,1.0,3/18,8.05%,ST8SIA6;PRKCSH;GNPTAB
prerank,regulation of T cell chemotaxis (GO:0010819),0.49272837516666246,1.0547530056764538,0.4041095890410959,0.7803485696368224,1.0,4/11,9.62%,OXSR1;ADAM17;STK39;ADAM10
prerank,protein tetramerization (GO:0051262),0.37396694639038314,1.054636323401839,0.39397741530740277,0.7800436821927941,1.0,12/67,11.34%,GBP5;B2M;GLS;SSBP1;FARSB;ALDH9A1;MCOLN1;GRIN2B;KCNC1;ACOT13;ACACB;TRPM2
prerank,coenzyme A metabolic process (GO:0015936),0.48638863235763163,1.0544162542480413,0.41833333333333333,0.7800191434739516,1.0,5/14,18.10%,SLC25A16;PANK3;PPCS;CROT;ACAT1
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3195466398791967,1.0542430597273014,0.3595505617977528,0.7798876999894421,1.0,67/366,17.39%,SOX17;SOX13;NANOS3;ENG;RPS6KA5;SMARCA2;CASZ1;APBB2;MLF2;FOXO4;ACVRL1;NOTCH1;INSR;IRF2;SAP30;APP;BTG1;SOX18;ING2;WWTR1;NLK;MEF2C;PPIE;RYBP;ORC3;GTF2IRD1;SNAI2;TOM1L1;CEBPA;WWC2;TCF7L1;TCF3;SERTAD3;MLF1;HP1BP3;PLAG1;CCDC88A;CYFIP1;NUP35;ASCC1;TRAPPC2;SAP30L;OBI1;TESMIN;GRM5;HINFP;SOX6;ORC5;ATXN1;HIF1A;RHOH;METTL18;ELAVL2;EIF2A;YBX1;KAT7;ACVR2B;TRRAP;TCOF1;NFIL3;ESRRG;ESR1;DAXX;FOXN2;DRAP1;SOX7;SOX12
prerank,sulfur compound biosynthetic process (GO:0044272),-0.26351061945008925,-1.0542307027260567,0.2900763358778626,0.7831310267170095,1.0,30/104,18.86%,UST;DSE;DCN;OGN;FMOD;SLC26A2;B3GNT2;GSTT1;CHST15;BGN;PRELP;GCLC;ST3GAL4;B4GALT1;VCAN;GSTZ1;GGT5;CHPF2;CSPG4;OMD;LUM;GSTA3;GSTM1;B4GALT2;GSTM2;GGT7;GGTA1;AKR1A1;PAPSS2;CHPF
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.40044660260124126,-1.0537145365244356,0.4146341463414634,0.7830710638084627,1.0,7/16,20.63%,WNT4;BMP4;RUNX1;CREB3L1;LARP6;TGFB3;RGCC
prerank,regulation of cellular biosynthetic process (GO:0031326),0.4208592741238378,1.0535617684303047,0.4126984126984127,0.7809311864084237,1.0,9/28,14.75%,ADIPOR2;NOS1AP;TNFRSF1B;ADIPOR1;CD47;JAK2;RAC1;CX3CR1;EIF6
prerank,presynaptic endocytosis (GO:0140238),0.44203744120243516,1.0534345065682404,0.402046783625731,0.7806641051759867,1.0,9/24,18.16%,SNCG;FCHO2;PACSIN1;PIP5K1C;STON1;OPHN1;SYNJ1;SYT2;SYT1
prerank,zinc ion transmembrane transport (GO:0071577),-0.3603070103741105,-1.0533409158337392,0.3538011695906433,0.7826275948835292,1.0,5/22,8.25%,SLC39A14;SLC30A10;SLC39A8;SLC39A13;SLC30A6
prerank,positive regulation of T cell migration (GO:2000406),0.4435993214475526,1.0529798609205192,0.41379310344827586,0.7812077763517209,1.0,5/20,9.62%,OXSR1;APP;ADAM17;STK39;ADAM10
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.5063277223881637,1.0527026456953923,0.4192982456140351,0.7812920801067877,1.0,2/10,3.61%,F2RL1;TIRAP
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.4076322123444753,1.052310339830885,0.4098360655737705,0.7816362961732083,1.0,7/33,13.94%,PLK3;FAM107A;KLF4;RBL1;APC;E2F7;CDKN2D
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.3935857178655427,-1.0521671548279061,0.358600583090379,0.7844729700654938,1.0,3/18,5.29%,DCN;PRKN;DDHD1
prerank,endodermal cell differentiation (GO:0035987),0.4174508547966991,1.0520920019073945,0.40331491712707185,0.7816084798579546,1.0,1/31,0.04%,LAMA3
prerank,maintenance of protein localization in organelle (GO:0072595),-0.38607329290504055,-1.0519115115473003,0.3858695652173913,0.7837060325226927,1.0,8/19,20.61%,HK2;BCL3;HNRNPU;TOPORS;SUPT7L;PML;MORC3;CHCHD10
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.4523049084123983,-1.051767589313528,0.3960880195599022,0.7826616467023012,1.0,7/10,33.73%,ST6GAL1;RENBP;NAGK;AMDHD2;NPL;NANP;GNPDA1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.45608002481451865,1.051553549238982,0.4292168674698795,0.7823961234984184,1.0,5/18,12.00%,RPS6KA5;PRKD1;CD200;CRTC1;PRKD2
prerank,mitotic cytokinetic process (GO:1902410),0.44618348917374784,1.0512684155945864,0.40916030534351144,0.7825484488064017,1.0,12/20,26.39%,CHMP1B;VPS4A;CHMP3;CEP55;CHMP2B;CHMP7;CHMP1A;CNTROB;VPS4B;CHMP4A;CHMP4B;MITD1
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.3430868837416238,-1.0508063132062206,0.3559870550161812,0.7839605392195442,1.0,10/29,21.80%,TENT5A;NOCT;FUS;AXIN2;HNRNPU;LARP1;PABPC1;TENT5D;DHX34;E2F1
prerank,cellular response to ketone (GO:1901655),-0.3258683560992182,-1.050716528677349,0.37755102040816324,0.7827231743910228,1.0,6/35,6.87%,ROCK2;ADCY5;ADCY1;GNAI1;ADCY2;SRC
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.34857230263933175,-1.0505088822787574,0.3926174496644295,0.7818842474146439,1.0,7/27,9.40%,PID1;PRKCB;GRB10;ENPP1;IRS1;PIP4K2A;PRKCZ
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.3592395922428974,1.0501872030822395,0.39039408866995073,0.7845704417304474,1.0,15/76,12.73%,NOD1;NOD2;LGALS9;APP;HDAC7;ACTN4;TLR3;TRIM6;PDCD4;ADIPOR1;ZC3H12A;NMI;NFKBIA;LAPTM5;RTKN2
prerank,exit from mitosis (GO:0010458),0.48966878559007393,1.050179707159121,0.4095238095238095,0.7840164509407768,1.0,3/12,15.14%,CLASP1;CLASP2;CHMP7
prerank,axonal fasciculation (GO:0007413),-0.43169662017381727,-1.0499947873732318,0.4103896103896104,0.7818956938080046,1.0,6/12,19.18%,EPHA3;SEMA5A;MEGF8;ARHGAP35;EPHB2;EPHB3
prerank,regulation of protein modification process (GO:0031399),0.38020745310294446,1.0498533027836985,0.40414507772020725,0.7841998954736675,1.0,14/50,17.36%,CCDC88C;PPP1R16B;WARS1;HSPB1;NDUFS4;PTK2;CCDC88A;GRM5;PHIP;PIN1;ASPSCR1;KDM4D;ATG14;PPP1R16A
prerank,TOR signaling (GO:0031929),0.4227313851398652,1.049646741138177,0.406827880512091,0.7841065763151484,1.0,13/26,25.44%,GATA3;PRR5L;SYAP1;RHEBL1;CCDC88A;RPS6KB1;RICTOR;TIPRL;NPRL3;EIF4EBP2;MEAK7;RPTOR;MLST8
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.4676504726786933,1.0491088009095833,0.41252006420545745,0.7848970873407347,1.0,2/15,1.29%,MSX1;TBX1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5108856213265968,1.0490965763368452,0.4222972972972973,0.784346697196291,1.0,3/10,6.74%,ETFDH;ETFB;ETFA
prerank,cellular response to oxygen-containing compound (GO:1901701),0.31866751413371536,1.0489015241312423,0.3757700205338809,0.7842335046537177,1.0,39/291,10.26%,KCNQ1;RAPGEF2;PDGFB;SPAAR;TBX1;NOD2;RAPGEF1;ATP2B4;FOXO1;DAB2IP;PRKD1;VIM;FES;INPP5K;TIRAP;DEFA6;MEF2C;TNFRSF1B;ABCB4;IL1A;MAPK1;PDCD4;SH3BP4;NFKBIL1;SETX;P2RX7;IRGM;ZC3H12A;HSP90B1;NR1D1;ACOD1;STAP1;CACTIN;JUN;EGR1;HMGB1;CASP1;RRAGD;NFKBIB
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.32731691259921014,-1.0488235439685514,0.36335403726708076,0.7836325411419497,1.0,12/32,19.33%,DDX5;SNW1;FHIT;RRP8;MYBBP1A;BCL3;BOK;PDK2;DDIT4;AEN;JMY;PML
prerank,carboxylic acid transport (GO:0046942),-0.29162430971840825,-1.0480859931973894,0.3452914798206278,0.7841772491905005,1.0,9/55,6.67%,SLC6A13;SLC16A12;SLC13A3;SLC1A5;SLC6A12;SLC16A6;SLC16A9;SLC17A5;SLC6A9
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.30617281242053396,-1.0477823355351028,0.36398467432950193,0.7835364043585487,1.0,15/45,16.20%,EGFR;PLCE1;EFEMP1;REPS2;SLC30A10;SHC1;TGFA;SRC;PIK3R1;GAREM1;DGKD;HBEGF;SHC3;GAB1;AAMP
prerank,sterol metabolic process (GO:0016125),-0.2847800587957094,-1.0474242217028364,0.34183673469387754,0.7831117383705577,1.0,6/60,3.26%,PRKAG2;CYP27A1;CYP26B1;LIPA;APOE;ABCA1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.39682736840085103,-1.0473626313883275,0.4156171284634761,0.7818260160084606,1.0,7/15,23.00%,LPGAT1;PPARA;PPARG;SLC45A3;NR1H3;MLXIPL;PPARD
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.3784743424923358,-1.0470522642357045,0.3926553672316384,0.7812338311727651,1.0,6/19,22.51%,DDO;ALDH7A1;GOT1;DLST;ASPA;HYKK
prerank,protein oxidation (GO:0018158),-0.4437401278199967,-1.0464975335666427,0.41102756892230574,0.7812994826700582,1.0,5/11,16.16%,LOXL1;LOXL3;SUMF1;PRDX3;CHCHD4
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.47656390631575424,1.0461851243962887,0.411663807890223,0.79037040442458,1.0,1/12,1.48%,PLK3
prerank,regulation of neuron apoptotic process (GO:0043523),-0.2630451709264537,-1.0455513473286546,0.3270440251572327,0.7824916522598823,1.0,16/96,8.20%,EPHA7;NUPR1;BCL2;SLC30A10;NDNF;APOE;SET;PRKN;SNX6;BACE1;NTRK2;NGF;EGLN3;FOXO3;SIX1;PRKCI
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.34958514892496634,1.0451073291915525,0.4074074074074074,0.7925012021224861,1.0,15/87,11.34%,EFNA5;HIP1R;F11R;RND1;FAM107A;RHOB;IQGAP1;ESAM;CRK;ARHGDIA;ROCK1;TAOK2;RAC1;CCDC88A;TRPM2
prerank,carboxylic acid metabolic process (GO:0019752),0.40114580075823153,1.0450588708770876,0.40807799442896936,0.7920339652429009,1.0,9/33,15.88%,SLC2A1;GLYAT;LIPT2;GLUD1;SIRT4;LIPT1;ST3GAL1;PON3;PTGIS
prerank,membrane lipid metabolic process (GO:0006643),0.43920767452442766,1.0449447457690368,0.42836041358936483,0.7917082705474178,1.0,7/22,17.58%,ST3GAL6;B4GALT4;SPTLC1;ALOXE3;AGK;TECR;CERKL
prerank,acyl-CoA metabolic process (GO:0006637),0.40868785449209943,1.0448434799332587,0.40694444444444444,0.7913948409720443,1.0,5/35,12.60%,ACSM3;GLYAT;ACOT13;ACACB;HMGCS1
prerank,spindle assembly (GO:0051225),0.3607593215177286,1.0446407682478231,0.4,0.791307949688355,1.0,13/67,11.03%,RAB11A;CSNK1D;KIF2A;CLASP1;KPNB1;MAPRE3;STARD9;HAUS3;NEK7;STAG1;CLASP2;NUMA1;TNKS
prerank,synaptic vesicle recycling (GO:0036465),0.41736490479639926,1.0446332725613852,0.4039829302987198,0.7907509502522269,1.0,10/31,18.16%,SNCG;SYT7;FCHO2;PACSIN1;PIP5K1C;STON1;OPHN1;SYNJ1;SYT2;SYT1
prerank,regulation of exosomal secretion (GO:1903541),-0.37263770099427196,-1.0445632915759797,0.39009287925696595,0.7837695258413948,1.0,9/19,26.44%,PRKN;TSG101;SDCBP;ATP9A;SDC1;SNF8;PDCD6IP;SMPD3;STAM
prerank,positive regulation of endocytosis (GO:0045807),0.39133820033293026,1.0442192708861842,0.4105263157894737,0.7911867558032692,1.0,11/45,11.75%,HIP1;B2M;F2RL1;CBL;PPT1;ANO6;STAP1;VPS28;HNRNPK;NEDD4L;CLU
prerank,nucleic acid-templated transcription (GO:0097659),0.38690920063960954,1.0442114685791555,0.4097693351424695,0.7906277127885096,1.0,17/42,23.89%,NR4A2;POLR2G;MLF1;POLR2D;NFKBIB;TAF1B;POLR2I;MMS19;PWP1;HOXD3;MEF2A;PTMA;RRAGC;PAX8;POLR2C;POLR2B;POLR2J
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.45005358660111366,-1.0435998976235694,0.41578947368421054,0.7848947094807643,1.0,4/10,19.17%,SET;KLF15;TAF7;NOC2L
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.35222810356048956,1.0435509247289194,0.4151838671411625,0.7917186981244444,1.0,29/87,21.13%,FAM107A;KLF4;PSMD13;PSMD4;RBL1;APC;PSMA5;ZFP36L2;PSMB10;RBX1;PSMB8;PSMD14;E2F7;PSMA7;PSMA8;PSMC3;CDKN2D;PSMB5;PSMC1;PSMC5;PSMC6;PSMB9;PSMA4;PSMD5;PSMD9;PSMB6;USP47;ZFP36L1;PSMB2
prerank,negative regulation of T cell activation (GO:0050868),0.40520115616817615,1.0433782409429833,0.42083333333333334,0.791573186164047,1.0,5/35,11.28%,CEACAM1;FCGR2B;ARG1;DUSP3;LAPTM5
prerank,regulation of stem cell population maintenance (GO:2000036),-0.38198702881580326,-1.0432352294054346,0.3959537572254335,0.7843973269161378,1.0,4/18,13.13%,PTN;REST;TAF6L;HMGA2
prerank,cytoskeleton organization (GO:0007010),0.3399063430049705,1.0431248543279805,0.4197247706422018,0.7915994602773004,1.0,17/114,6.86%,FGD5;RND1;RHOB;MAST4;NEDD9;SIPA1L3;DIAPH1;SH3KBP1;PACSIN2;ARAP3;DST;FMNL3;FGD6;PACSIN1;LRCH3;KLHL20;MAST1
prerank,UV protection (GO:0009650),-0.45275603994319913,-1.0422361786023018,0.3905882352941176,0.785763141050687,1.0,5/10,15.13%,CAT;SCARA3;ERCC5;MFAP4;ERCC2
prerank,regulation of establishment of planar polarity (GO:0090175),0.34912989550627627,1.0420328193449406,0.4074074074074074,0.7936091110326166,1.0,25/88,18.87%,FZD6;AP2B1;PSMD13;PSMD4;PSMA5;PSMB10;AP2M1;RAC1;PSMB8;PSMD14;SMURF1;PSMA7;PSMA8;PSMC3;PSMB5;PSMC1;FZD3;PSMC5;PRICKLE2;PSMC6;PSMB9;PSMA4;PSMD5;PSMD9;PSMB6
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.35543299072199264,-1.0419562408342309,0.38819875776397517,0.7850661612205653,1.0,3/23,1.74%,PRKAG2;CEMIP;BMP7
prerank,rRNA modification (GO:0000154),0.44681155279618806,1.0419327514289272,0.4030534351145038,0.793270720300022,1.0,9/21,22.19%,MRM2;DKC1;METTL5;NHP2;FBLL1;TFB2M;FTSJ3;NSUN4;FBL
prerank,positive regulation of interferon-beta production (GO:0032728),0.40728671023446383,1.0418067205149215,0.4146685472496474,0.793003055694521,1.0,7/33,13.88%,IFIH1;TLR3;OAS2;POLR3B;DHX9;IRF5;RIOK3
prerank,positive regulation of intracellular transport (GO:0032388),0.3880517580259956,1.0416641918086276,0.4065934065934066,0.7927672151668546,1.0,10/38,16.84%,PLK3;EHD1;PGAP1;PRR5L;PCM1;RIPOR1;NUMA1;ICE1;PDCD10;TENM1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.3411003359966374,-1.0411977490497435,0.3953488372093023,0.785832691353901,1.0,8/27,16.98%,NAPEPLD;NAAA;SLC27A1;CHKB;ETNK2;PLA2G15;SELENOI;PLA2G6
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.364062000979655,-1.0409447892919013,0.3971830985915493,0.7851468305497568,1.0,10/21,30.78%,AMPD3;NUDT4;XDH;NT5E;PNP;NT5C1A;FITM2;PDE2A;NUDT18;NUDT11
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.4277876348108548,1.04091225857765,0.42040185471406494,0.7940432958639188,1.0,6/23,9.26%,PDGFB;INSR;APP;P2RX7;PRKAA1;PFKFB3
prerank,regulation of macrophage activation (GO:0043030),0.4120154251372777,1.040500108657177,0.39942938659058486,0.7944356265294482,1.0,7/30,8.17%,GPR137B;FCGR2B;KARS1;ZC3H12A;MFHAS1;CEBPA;CD200
prerank,negative regulation of lyase activity (GO:0051350),-0.392549087925209,-1.040294365566088,0.40302267002518893,0.7855739822263852,1.0,6/16,15.98%,ADGRV1;GRM3;GABBR2;PALM;DRD2;EDNRB
prerank,regulation of mRNA catabolic process (GO:0061013),0.3367851368836887,1.0394096809130045,0.4121699196326062,0.7965702476280333,1.0,42/121,21.98%,VIM;PSMD13;PUM2;APEX1;PSMD4;ZC3H12A;ELAVL1;EXOSC3;HSPB1;PRR5L;UBA52;RPS27A;PSMA5;XPO1;ZFP36L2;PSMB10;CNOT1;GTPBP1;PSMB8;EXOSC8;PSMD14;XRN1;PSMA7;FXR1;PSMA8;PSMC3;PSMB5;PSMC1;PSMC5;PSMC6;PSMB9;PSMA4;EXOSC9;PSMD5;PSMD9;PSMB6;ZC3HAV1;ZFP36L1;PSMB2;MAPKAPK2;UBB;EXOSC1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.4335571450939168,1.0391440449486493,0.404099560761347,0.7966561992613495,1.0,2/22,3.47%,NOTCH1;MGAT5
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.43625350995023937,1.0390866117099171,0.43883792048929665,0.7962218893878865,1.0,6/22,14.73%,DUSP1;PPM1F;DUSP16;PDP1;PPM1D;PPP2CB
prerank,modulation of chemical synaptic transmission (GO:0050804),0.34461930335381297,1.0388282980878036,0.4138728323699422,0.7962708417661208,1.0,33/107,20.47%,MCTP1;CACNA1A;ABR;SYN3;APP;BCR;MEF2C;GRID1;BTBD9;PXK;LRRK2;LRRC4C;GRIK5;GRIK2;CDH2;GRM5;SNCAIP;CX3CR1;RIMS3;NPTX2;PSMC5;DGKI;GRIK1;NMU;OPHN1;CPLX1;LRP8;NPTX1;SYT1;GRM7;GRID2;AGER;BDNF
prerank,negative regulation of autophagy (GO:0010507),-0.29432361785602634,-1.0386606802354672,0.37719298245614036,0.788754446480726,1.0,15/54,14.94%,LEPR;NUPR1;SNRNP70;BCL2;KLHL22;GOLGA2;PTPN22;TAB3;DAPL1;MET;FOXK2;KDM4A;TSC1;ATG7;SIRT2
prerank,response to UV (GO:0009411),-0.2607782722684471,-1.0385611432790665,0.3291139240506329,0.7876327493401353,1.0,22/95,15.14%,EGFR;PTPRK;CREBBP;DDB2;CAT;SCARA3;DCUN1D3;BRSK1;TAF1;USP1;ERCC5;MAP2K7;CDC25A;ATR;UVSSA;REV1;MSH6;MFAP4;BCL3;RHNO1;ERCC2;EIF2AK4
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.34162843432683454,-1.037945416498418,0.3911671924290221,0.787909235963412,1.0,2/26,1.32%,LGR4;APPL2
prerank,adipose tissue development (GO:0060612),0.5065305340914225,1.0377707458943959,0.43508771929824563,0.798304176269133,1.0,4/11,13.71%,SPTLC2;NAMPT;ARID5B;LRP5
prerank,positive regulation of calcium ion import (GO:0090280),0.4839352891209452,1.0375168693745371,0.4255663430420712,0.7983370263302312,1.0,1/12,0.89%,PDGFB
prerank,inflammatory response (GO:0006954),0.32753966262002754,1.036892699993346,0.40488841657810837,0.7993068796744112,1.0,19/195,11.25%,AFAP1L2;F11R;CCR1;NOD1;ADGRE5;LGALS9;HDAC9;FCGR2B;LY75;IL1A;PXK;CMKLR1;MFHAS1;HNRNPA0;HMGB1;CCL4;RAC1;GPR68;CYBA
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.28993155925831593,-1.0367944803442128,0.41530054644808745,0.7898014391189131,1.0,21/62,18.91%,PRKCB;THBS1;CREBBP;KAT2B;TNRC6A;KMT2C;MEIS1;RUNX1;ASH2L;SETD1A;MYL9;PAF1;HOXA5;WDR5;CTR9;HDAC1;DPY30;TNRC6B;MAFB;HOXB8;AGO3
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.2960850013774446,-1.0367371935338021,0.3659574468085106,0.7885421894610181,1.0,9/54,7.02%,GPC6;SDC2;GPC3;HSPG2;HS3ST3A1;GNS;PXYLP1;XYLT1;HEXA
prerank,lipid droplet formation (GO:0140042),-0.4306456333243529,-1.0364991078754942,0.3975609756097561,0.7877686365516798,1.0,5/10,28.55%,BSCL2;SQLE;PLA2G4C;FITM2;AUP1
prerank,cellular response to oxidative stress (GO:0034599),-0.25453315258596887,-1.0363997304103618,0.35036496350364965,0.7866552087460943,1.0,41/118,22.96%,EGFR;DAPK1;PDGFRA;PTPRK;PRKAA2;PLA2R1;STX4;TPM1;MGAT3;CAT;FOXO3;ERMP1;SOD3;PPIA;GPX8;SESN2;NOX4;PRDX3;CPEB2;FER;CHUK;MPV17;SIRT2;PDK2;WNT16;ETV5;GPX7;NUDT2;MAPK9;PRKCD;HTRA2;ALDH3B1;ROMO1;MAPK8;TXNRD2;ABL1;SRXN1;PARP1;CYBB;CYCS;GPX1
prerank,cholesterol efflux (GO:0033344),0.4330079667830077,1.0361410259180845,0.43010752688172044,0.8005715006673666,1.0,7/20,18.10%,APOA1;STX12;ABCG4;TSKU;ABCA7;SCARB1;SOAT1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.39599434233674663,-1.0360680172370214,0.4030612244897959,0.7862211666681019,1.0,8/14,34.97%,RBMX;SRSF6;PCBP4;U2AF2;C1QBP;SAP18;SRSF10;RNPS1
prerank,amino sugar metabolic process (GO:0006040),-0.4382214025871669,-1.0359806084472212,0.4393203883495146,0.7850629502344315,1.0,5/10,23.10%,ST6GAL1;EXTL2;GFPT1;GFPT2;CSGALNACT1
prerank,regulation of telomere maintenance (GO:0032204),-0.3410097632283856,-1.0356705772994779,0.382089552238806,0.7845099480536075,1.0,13/26,30.45%,RAD50;PPP1R10;YLPM1;XRCC5;RTEL1;PML;ATRX;GNL3;HDAC8;HNRNPD;SMG6;SIRT6;UPF1
prerank,regulation of neuron differentiation (GO:0045664),0.35173069318381167,1.035466072669266,0.4059040590405904,0.8016217819571885,1.0,25/76,22.18%,CASZ1;ARHGEF2;HEY1;MEF2C;LRRK2;ALK;NRCAM;ROCK1;TCF3;ZC4H2;MMD;PCP4;YWHAH;HES3;LTK;SIN3A;HOXD3;SOX11;MMD2;BDNF;CNTN4;CDK5RAP1;NLGN1;ECT2;ZEB1
prerank,regulation of RNA metabolic process (GO:0051252),-0.2803453487417598,-1.0350247626123266,0.375,0.78492822650985,1.0,18/59,16.11%,SON;MITF;SNRNP70;NOVA1;AFF2;AHNAK2;HNRNPH1;BRDT;AHNAK;CLK1;FUS;CLK4;YTHDF2;RBM20;HNRNPLL;HNRNPL;PCBP4;CLK2
prerank,synaptic vesicle endocytosis (GO:0048488),0.4077882173536098,1.0349562505461978,0.4191279887482419,0.8022834978184029,1.0,11/33,18.16%,ITSN2;DNM3;SNCG;FCHO2;PACSIN1;PIP5K1C;STON1;OPHN1;SYNJ1;SYT2;SYT1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.42622123084134583,1.0349433189263724,0.41602465331278893,0.8017433472184147,1.0,7/23,15.60%,FAR2;ACSL5;FAR1;ACSBG1;ELOVL7;ELOVL5;TECR
prerank,gastrulation (GO:0007369),-0.3902096846913048,-1.0347890171832224,0.39528795811518325,0.7841794469464268,1.0,3/15,6.53%,GPC3;NPHP3;MEGF8
prerank,nitrogen compound transport (GO:0071705),0.333771176987855,1.034720146503898,0.40331491712707185,0.8017004960041642,1.0,17/141,10.43%,SLC6A6;EDN1;RHCG;ARL6IP5;SLC7A7;PPT1;SLC44A1;MYH9;ARRDC1;HSP90B1;SLC6A4;SLC7A1;CERT1;SLC15A4;CHMP1B;SLC6A2;SLC22A5
prerank,positive regulation of biosynthetic process (GO:0009891),0.39394123842669804,1.0345256151846374,0.436241610738255,0.8015911637660443,1.0,4/40,6.43%,PLCG2;VIM;APOA1;SIRT4
prerank,regulation of cell cycle phase transition (GO:1901987),0.3479146606740823,1.0344526981604862,0.42092746730083236,0.8011964937997431,1.0,27/91,19.13%,ATP2B4;PSMD13;UBE2D1;PSMD4;PSMA5;PSMB10;FBXW7;PSMB8;PSMD14;NEK11;PSMA7;PSMA8;PSMC3;UBE2E1;CDC27;PSMB5;PSMC1;PSMC5;XPC;PSMC6;PSMB9;ANAPC7;PSMA4;PSMD5;PSMD9;PSMB6;ANAPC4
prerank,macrophage differentiation (GO:0030225),-0.4157173948465239,-1.0344444869493865,0.42857142857142855,0.783777419969241,1.0,3/13,9.01%,BMP4;IL31RA;VEGFA
prerank,cognition (GO:0050890),0.3879536994112345,1.0339698603812757,0.43342391304347827,0.8017940407539844,1.0,5/42,3.49%,SHROOM4;PTCHD1;FAM107A;APP;DOP1B
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3427298198643679,1.0337277272271057,0.4369158878504673,0.8018220059640403,1.0,14/94,10.46%,ATP2A3;DAB2IP;ARL6IP5;PPP1R13B;PPM1F;STK24;CASP2;TNFRSF1B;CUL3;BBC3;CIDEB;BCL2L1;CUL2;BAG6
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.40111993874971175,1.0337156846609605,0.42836879432624114,0.8012794419419859,1.0,3/30,2.18%,KCNQ1;KCNE3;ATP1A1
prerank,organophosphate biosynthetic process (GO:0090407),0.39258199922082,1.0337064874020505,0.4309859154929577,0.8007383704163512,1.0,4/37,3.89%,ITPKB;IP6K3;IPPK;GPHN
prerank,transport along microtubule (GO:0010970),0.47545549165462664,1.0330233911143287,0.4276094276094276,0.8018163582389061,1.0,2/13,2.99%,APBA1;APP
prerank,protein localization to cell surface (GO:0034394),0.4218176844166814,1.0328350808830014,0.4178885630498534,0.8016974116233124,1.0,7/26,14.21%,FBLN5;EMP2;ANGPT1;PTPRU;SMURF1;MESD;CTNNB1
prerank,negative regulation of establishment of protein localization (GO:1904950),0.5139522071284568,1.0323570533221649,0.4539363484087102,0.8022712023424214,1.0,4/10,21.52%,PPM1F;NDFIP2;DNAJA1;WWP2
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.4110179658500702,1.032300764780967,0.4265129682997118,0.8012776672466132,1.0,3/29,9.79%,ACSM3;GLYAT;ACOT13
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.4110179658500702,1.032300764780967,0.4265129682997118,0.8012776672466132,1.0,3/29,9.79%,ACSM3;GLYAT;ACOT13
prerank,regulation of organelle assembly (GO:1902115),-0.27393882831960253,-1.0321457681622677,0.3707865168539326,0.7887999499438278,1.0,27/72,20.49%,GSN;DCDC2;TBC1D24;TBC1D2B;STX18;ALMS1;TBC1D9B;ATG3;ATG5;ATXN2;RNF4;ADPRH;DYNC2LI1;TBC1D16;TSG101;TBC1D17;KIF9;CYLD;TBC1D20;CDKL1;EZR;TRAPPC12;SDCCAG8;IFT20;TBC1D19;PDCD6IP;IFT88
prerank,regulation of brown fat cell differentiation (GO:0090335),0.45318364734918354,1.032067407095607,0.4349157733537519,0.801223309957193,1.0,1/16,0.24%,SOX13
prerank,regulation of interferon-beta production (GO:0032648),0.3785320086983116,1.0320431891747537,0.4227212681638045,0.8007165128811369,1.0,9/46,13.88%,IFIH1;TIRAP;TLR3;OAS2;POLR3B;CACTIN;DHX9;IRF5;RIOK3
prerank,positive regulation of cell development (GO:0010720),-0.32352660081786677,-1.031030043400672,0.38153846153846155,0.790443638440502,1.0,10/31,18.29%,PDE3A;BMP4;SNW1;ATP6AP1;NUMBL;NAP1L1;SERPINF1;GPER1;RFX3;NKX6-1
prerank,transepithelial transport (GO:0070633),-0.39634029601884374,-1.0309178051082013,0.39325842696629215,0.7893888081151401,1.0,3/15,1.61%,SLC1A3;CXADR;SLC12A2
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.48557458364604433,1.0304971683891113,0.44922547332185886,0.803832306038781,1.0,2/11,5.43%,TGFB2;MEF2C
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.4815847703556226,1.0299483660040465,0.4135090609555189,0.8045768903341156,1.0,5/12,20.78%,WRNIP1;KAT7;WDR18;METTL4;BLM
prerank,mRNA splice site selection (GO:0006376),-0.33524104429607726,-1.0299421429205016,0.37142857142857144,0.7907821305439162,1.0,5/30,10.86%,CELF2;SRSF5;SRSF1;PUF60;SRSF6
prerank,protein localization to lysosome (GO:0061462),0.4100569953056727,1.0297897599588635,0.4261119081779053,0.804400847624507,1.0,15/28,26.83%,SH3BP4;NCOA4;RTN4;RNF128;LAPTM5;VPS4A;NAGPA;ZFYVE16;AP3M1;SORL1;SCARB2;ATP13A2;GLMP;LMBRD1;LAMTOR4
prerank,regulation of protein polymerization (GO:0032271),0.3906002530271189,1.0296343948966764,0.41802067946824223,0.8042207626805189,1.0,5/35,7.68%,FCHSD2;ESAM;CAMSAP2;PRUNE1;MAPRE3
prerank,ERAD pathway (GO:0036503),0.3534742431462461,1.029435959606796,0.42910915934755334,0.8041466945309016,1.0,27/83,21.53%,RNF103;RHBDD1;RNF185;HSP90B1;UBE4A;TMUB2;TRIM25;BAG6;RNF103-CHMP3;YOD1;UBE2J2;SGTB;FOXRED2;FBXO2;UGGT1;PSMC6;UBQLN2;RNF139;UBXN6;SEL1L;ERLIN2;FBXO6;CCDC47;DNAJC10;RNF5;POMT2;TMEM129
prerank,regulation of protein sumoylation (GO:0033233),-0.38163683173151786,-1.0290536490171887,0.40443213296398894,0.7918227201724343,1.0,6/17,22.36%,ZMIZ1;GNL3L;PIAS3;HDAC4;GNL3;PIAS4
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.4517514244581077,1.0287894115627587,0.4263322884012539,0.8051853139722281,1.0,4/18,10.59%,UNC13B;GRID1;GRIK5;GRIK2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.39709809977855637,1.0285963175653352,0.43235704323570434,0.8050899762798327,1.0,5/35,7.75%,NOTCH1;CAV1;NLK;ADIPOR1;JAK2
prerank,regulation of DNA binding (GO:0051101),-0.3021257325936435,-1.028421854171821,0.3940520446096654,0.7922359475683777,1.0,13/44,16.55%,IGF1;SMO;PRKN;RSF1;NGF;DOT1L;PPARG;TXN;HMGA2;MDFI;BCL3;SIRT2;TFAP4
prerank,RNA modification (GO:0009451),0.3728304814421814,1.0283927950474783,0.4447334200260078,0.8049940596665802,1.0,13/54,21.53%,ADAT2;ADARB1;TRDMT1;TRMT61A;MRM2;ADAR;TRUB1;RBM15;NSUN5;FTSJ3;NSUN4;TRMT1;NSUN6
prerank,neuron maturation (GO:0042551),0.4404492862790584,1.0283691339370935,0.4375,0.8044792672043815,1.0,3/18,10.15%,RND1;APP;B4GALT6
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.396141799281609,-1.0282891766083462,0.41798941798941797,0.7912105737748819,1.0,4/14,10.75%,AUTS2;SNW1;WDR5;CTR9
prerank,cellular response to hormone stimulus (GO:0032870),0.3583425779766735,1.0282702256965044,0.4351515151515152,0.8041496328327313,1.0,12/69,10.65%,LMO2;ATP1A3;ATP1A1;CAV1;PELP1;INPP5K;MEF2C;BRD8;TRIM24;NCOA4;ARID5A;SFR1
prerank,positive regulation of wound healing (GO:0090303),-0.31738284068919387,-1.0282250375877573,0.39215686274509803,0.7900073197496377,1.0,10/36,12.68%,PLPP3;VTN;THBS1;RREB1;FOXC2;ANXA1;ST3GAL4;SERPINE1;ADRA2A;HBEGF
prerank,antibacterial humoral response (GO:0019731),0.44376515968506386,1.0276430464742283,0.4344262295081967,0.805076439796721,1.0,6/16,23.06%,DEFA6;RNASE6;SLPI;ANG;RPL39;RNASE7
prerank,relaxation of muscle (GO:0090075),-0.4162503134952527,-1.0272729410227763,0.4473684210526316,0.7911661496431643,1.0,2/13,0.82%,ATP1A2;GSN
prerank,tRNA modification (GO:0006400),0.35970958726660207,1.0272103180970915,0.44,0.8055539510237975,1.0,11/62,12.70%,ADAT2;TRDMT1;OSGEP;TRMT61A;TRMT5;TRUB1;METTL2B;METTL2A;TRMT61B;ALKBH8;TYW1
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.37034931186215014,-1.0267429845709302,0.4257142857142857,0.7913064447402939,1.0,4/18,8.37%,PDPN;SMAD3;RUNX1;EFEMP2
prerank,lipid catabolic process (GO:0016042),0.4474162069714225,1.0267303582502736,0.4510433386837881,0.8061295665459461,1.0,2/18,3.23%,PNLIP;PPT1
prerank,long-term synaptic potentiation (GO:0060291),-0.35433842874064314,-1.0266772108593196,0.4230769230769231,0.7901176054412063,1.0,5/21,9.40%,SLC8A3;STX4;TSHZ3;GRIN2D;PRKCZ
prerank,cytosolic transport (GO:0016482),0.340119187097196,1.0264171221674687,0.4197674418604651,0.806340090703494,1.0,25/108,20.25%,MYO1D;RAB6B;EMP2;DOP1B;VTI1B;SPAG9;KLHL20;LMTK2;HOOK1;TBC1D5;PIK3C3;HEATR5A;LAPTM5;VPS35;TBC1D10A;KIF16B;GOSR1;DENND5A;MON2;VTI1A;PHETA1;HOOK2;EPS15;CCDC91;SORT1
prerank,cardiac muscle contraction (GO:0060048),0.39527492143414966,1.0261128380092541,0.4347202295552367,0.8065418046990076,1.0,4/34,4.76%,KCNQ1;MYBPC3;SLC8A1;CAMK2D
prerank,regulation of interleukin-4 production (GO:0032673),0.4272325606287712,1.0259337197321836,0.438136826783115,0.8064127899024465,1.0,5/21,16.99%,LGALS9;LEF1;GATA3;HAVCR2;RARA
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.4425304417649868,-1.0248717730861325,0.4512820512820513,0.7936777372832254,1.0,4/10,24.93%,DICER1;TERT;TSNAX;MRPL44
prerank,cell-cell junction maintenance (GO:0045217),0.4874328971759941,1.0240943916855474,0.4303571428571429,0.81027842804764,1.0,2/11,9.87%,F2RL1;TJP1
prerank,protein localization to synapse (GO:0035418),-0.41381105702095033,-1.0232716390228256,0.43601895734597157,0.7965544322548725,1.0,2/12,4.01%,NLGN2;DLG4
prerank,positive regulation of chromatin organization (GO:1905269),0.48353450424891303,1.0230776815166738,0.4340567612687813,0.812133263285215,1.0,7/12,25.72%,TAL1;DAXX;SIN3A;TERF2IP;H3-3A;TERF2;TINF2
prerank,negative regulation of programmed cell death (GO:0043069),0.31087623211220833,1.022654567186827,0.4300202839756592,0.8125596394834699,1.0,61/355,14.48%,MECOM;TEK;GATA6;SMAD6;FLT4;FAS;TNFAIP8;CCND2;PLK3;EGR3;FOXO1;CBL;PPT1;ANGPT1;CASP2;LEF1;MAP4K4;AMIGO2;RHBDD1;TAF9B;ARHGDIA;SETX;UFM1;KLHL20;FANK1;HSP90B1;AATF;HSPB1;HSPA1B;DCPS;BCL2L1;UBA52;PRKAA1;RPS27A;PROC;PIM3;PTK2;BABAM2;SIAH2;ADAM10;TJP1;HNRNPK;RNF144B;RPS6KA1;NFKBIA;NPM1;LAPTM5;TMBIM6;CD38;TMEM14A;RPS6KB1;RPS6KA3;PHIP;HYPK;NOL3;BNIP3L;LTK;CFL1;CTNNB1;BNIP3;PSMC5
prerank,positive regulation of neurogenesis (GO:0050769),-0.2738784004953693,-1.0226297656573948,0.41450777202072536,0.7969206199741578,1.0,24/68,22.16%,ROBO1;PLXNA2;CUX1;SLIT2;SNW1;OBSL1;NTRK2;PLXNB2;NGF;NUMBL;VEGFA;PLXNB1;NAP1L1;SLITRK1;SERPINF1;DRD2;GPER1;PTPRD;FBXW8;CUX2;SS18L2;PLXNC1;FAIM;DISC1
prerank,gonad development (GO:0008406),0.3892841091789388,1.0223075574794465,0.4463350785340314,0.8128411654203246,1.0,6/41,8.77%,GATA6;KITLG;TGFB2;GATA3;NCOA4;COL9A3
prerank,regulation of transforming growth factor beta production (GO:0071634),0.4419455398608011,1.0220500962809216,0.44837758112094395,0.8129067734783543,1.0,5/18,13.45%,TGFB2;LGALS9;CD34;CD200;HIF1A
prerank,miRNA metabolic process (GO:0010586),-0.3584580120470634,-1.0217584375504958,0.44077134986225897,0.7979942932066687,1.0,6/20,18.96%,DDX17;DICER1;LIN28B;TENT4B;TUT4;DGCR8
prerank,actin crosslink formation (GO:0051764),-0.41657345018959824,-1.021686779108392,0.421875,0.7968605198365386,1.0,4/12,19.66%,DPYSL3;FLNA;BAIAP2;GAS2L1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.4701423585188479,1.0215391586147669,0.446843853820598,0.8135732217732683,1.0,6/12,15.36%,FKBP1A;TMED10;ROCK1;PRNP;RANBP9;ABCA7
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.4294000737391052,-1.0207521956345262,0.4406779661016949,0.7980960458930797,1.0,3/11,5.88%,BACE2;ITM2A;NECAB1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.3733025370709617,1.02074243267451,0.42818791946308726,0.814931695995273,1.0,5/44,8.47%,FCHSD2;EVL;CDC42EP1;WHAMM;NCKAP1
prerank,striated muscle tissue development (GO:0014706),-0.33346665456230395,-1.0207076057724365,0.43157894736842106,0.7968817443516332,1.0,10/29,12.09%,BMP5;BMP7;SVIL;RBP4;SGCD;SIX1;CFLAR;PGM5;TBX2;NDUFV2
prerank,myeloid leukocyte differentiation (GO:0002573),0.35724621819170793,1.0204792011292116,0.42946317103620474,0.8149823141637574,1.0,11/65,10.27%,CASP8;F2RL1;LGALS9;LEF1;PIR;SNX10;MYH9;OSCAR;CEBPA;FOXP1;TYROBP
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.2707443809951881,-1.0203510478292601,0.38207547169811323,0.7965057244244732,1.0,13/63,8.81%,IGF1;TGFBR1;BMP4;DEPTOR;SH3RF1;TCF7L2;STX4;THBS1;ITGAV;SRC;WWOX;CFLAR;TNFSF12
prerank,regulation of dendritic spine development (GO:0060998),0.4313958294485797,1.0203326271453277,0.45329249617151607,0.8147805884625682,1.0,5/19,11.15%,TANC2;MEF2C;SHANK3;PPFIA2;GRIN3A
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.2941076072175253,-1.019618784034803,0.40875912408759124,0.7971217056978782,1.0,10/46,13.68%,ZIC1;TCF7L2;CDH1;CAMK1;SMAD3;PIK3R1;FLNA;IPO5;BAG3;PIK3R2
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.3365383389091382,1.0195082400918727,0.4506880733944954,0.8161684882168883,1.0,44/110,25.98%,RPS21;RPL27;RPL7;UBA52;RPS27A;RPS14;RPL35;ETF1;RPL21;RPL37;RPS28;RPL34;RPS9;RPLP2;RPS25;HELZ2;RPL30;RPL27A;RPS5;RPL23A;RPS15;RPL19;RPS18;RPL32;RPL37A;RPL18A;CTIF;SMG7;RPL18;RPL39;RPS19;RPL31;SMG9;RPS8;SMG8;EIF4G1;RPL3;PPP2R2A;PPP2R1A;RPL28;RPL9;RPL26;RPS16;RPLP1
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.4193911580424411,1.0192772670840085,0.47690014903129657,0.8161639574723455,1.0,3/23,2.72%,SMAD7;MYBPC3;FKBP1A
prerank,positive regulation of mitochondrion organization (GO:0010822),0.3615670088385835,1.0190385235750805,0.4232258064516129,0.8161671682979877,1.0,16/57,19.95%,HIP1R;FBXO7;HRK;TNFSF10;BBC3;CIDEB;VPS35;BNIP3;PYCARD;PLAUR;BMF;GSK3A;BID;SPIRE1;PPIF;GSK3B
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.2650469365598121,-1.0189588825201663,0.3950617283950617,0.7974858732011398,1.0,27/80,21.01%,PLPP3;KIF3C;ERGIC2;STX18;COPZ2;SURF4;COPA;PITPNB;ARFGAP1;ERGIC3;COPG1;ARCN1;COPB2;ARF5;TMED3;BICD2;ATP9A;COG3;KIF3A;NAPA;ZW10;RER1;LMAN2;PICK1;KDELR1;RACGAP1;KIF11
prerank,negative regulation of apoptotic process (GO:0043066),0.3087108274824598,1.0188333994867207,0.45601617795753285,0.8160719939011604,1.0,77/444,14.37%,TEK;GATA6;SMAD6;FLT4;FAS;TNFAIP8;TBX1;MERTK;NR4A2;CCND2;PLK3;NOTCH1;FOXQ1;EGR3;FOXO1;CAV1;CBL;PPT1;KLF4;ANGPT1;CASP2;LEF1;MAP4K4;MEF2C;RHBDD1;TAF9B;ASAH2;MAPK1;TOX3;ARHGDIA;SETX;UFM1;KLHL20;ZC3H12A;FANK1;HSP90B1;AATF;HSPB1;HSPA1B;SNAI2;BCL2L1;UBA52;PRKAA1;RPS27A;PROC;PIM3;PTK2;BABAM2;SIAH2;ADAM10;TJP1;HNRNPK;RNF144B;PRKCG;RPS6KA1;NFKBIA;FGF20;NPM1;TMBIM6;CD38;TMEM14A;RPS6KB1;RPS6KA3;CX3CR1;APOH;PHIP;ITGA5;HYPK;NOL3;BNIP3L;CDKN2D;LTK;CFL1;CTNNB1;FZD9;FZD3;BNIP3
prerank,protein K63-linked deubiquitination (GO:0070536),-0.32810462166309873,-1.0187291408843462,0.3945578231292517,0.7967203835414157,1.0,11/31,16.43%,USP33;USP20;USP13;USP50;ABRAXAS2;OTUD7B;CYLD;USP8;ZRANB1;STAMBPL1;OTUD1
prerank,regulation of sensory perception of pain (GO:0051930),0.48392041241268113,1.0180323761850896,0.4602368866328257,0.8174375956287875,1.0,2/11,4.20%,TMEM100;SCN11A
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.3645222469809438,-1.0179925927292668,0.4437869822485207,0.7974393105037542,1.0,5/20,10.61%,SULF1;SULF2;THBS1;FGF2;CREB3L1
prerank,superoxide metabolic process (GO:0006801),0.40146563732207674,1.0178095838585346,0.42714285714285716,0.8173943042414131,1.0,4/29,11.25%,NOS3;ATP7A;TAFA4;CYBA
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3092595904345641,1.0177254880608353,0.4367934224049332,0.8170362066530518,1.0,80/314,19.39%,RNF103;FBXL2;ZNRF1;PSMD13;FBXL14;FBXL5;RNF185;CUL3;UBE2D1;PSMD4;KLHL20;FBXL18;HSP90B1;PTTG1;ARRB1;NFE2L2;UBE4A;WWP1;FEM1C;UBA52;RPS27A;TMUB2;PPP2R5C;FBXL16;SIAH2;PSMA5;PSMB10;FBXW7;RBX1;CUL2;TRIM25;BAG6;PSMB8;NEDD4L;PSMD14;SMURF1;KCTD10;FBXO4;RNF103-CHMP3;YOD1;RMND5B;UBE2J2;PSMA7;PSMA8;SGTB;FOXRED2;PSMC3;FBXO2;UBE2E1;CDC27;PSMB5;CTNNB1;PSMC1;PSMC5;UBE2D3;NHLRC1;TRIM2;PSMC6;PSMB9;UBQLN2;SPOPL;ANAPC7;FBXL13;AMN1;PSMA4;SEL1L;ERLIN2;FBXO6;GSK3A;PSMD5;PSMD9;PSMB6;FEM1A;DNAJC10;FBXL6;FBXO45;ANAPC4;FBXL15;MAEA;ZFAND2A
prerank,mitochondrial translational elongation (GO:0070125),0.3388233323476337,1.0174611622569212,0.43403205918618987,0.8171053768696538,1.0,40/88,28.95%,MRPL4;MRPL18;MRPL41;MRPL1;MRPS31;MRPL15;MRPL19;TUFM;MRPL47;MRPL52;MRPL36;MRPL23;MRPL24;MRPL14;MRPL32;MRPS34;MRPS12;MRPL39;MRPL54;MRPS18B;MRPS30;GFM1;MRPL11;MRPS28;MRPS35;MRPS9;MRPS27;TSFM;MRPL34;MRPS24;MRPL35;MRPL10;MRPL27;MRPL38;MRPS18C;MRPL13;AURKAIP1;MRPS18A;MRPL40;ERAL1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.4966298039961174,1.0174218570345466,0.4642857142857143,0.8155115528106758,1.0,4/11,18.10%,SLC25A16;PANK3;PPCS;ACAT1
prerank,coenzyme A biosynthetic process (GO:0015937),0.4966298039961174,1.0174218570345466,0.4642857142857143,0.8155115528106758,1.0,4/11,18.10%,SLC25A16;PANK3;PPCS;ACAT1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.4966298039961174,1.0174218570345466,0.4642857142857143,0.8155115528106758,1.0,4/11,18.10%,SLC25A16;PANK3;PPCS;ACAT1
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.36200459322194856,-1.016890328151542,0.4434782608695652,0.7992068737963616,1.0,7/21,6.39%,BACE2;RBMX;BACE1;HM13;DAG1;ADAM9;ADAM19
prerank,protein localization to phagophore assembly site (GO:0034497),0.47391219491502007,1.0166863760157085,0.44932432432432434,0.8166696817902461,1.0,1/11,1.84%,TRAPPC8
prerank,positive regulation of leukocyte activation (GO:0002696),-0.37724911855247456,-1.016297878238975,0.4198250728862974,0.799485117042546,1.0,3/18,3.31%,LBP;WNT5A;THBS1
prerank,regulation of bone mineralization (GO:0030500),0.36456951109028274,1.0160019514984604,0.44740177439797213,0.8177514898162216,1.0,10/55,8.40%,SGMS2;S1PR1;BMPR2;CCR1;SLC8A1;ANO6;ACVR1;MEF2C;P2RX7;NBR1
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.48650771139622245,1.015517114786292,0.4557823129251701,0.8183663217138516,1.0,2/12,2.05%,PLCB1;DUSP1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.42272925481216395,1.0153866665881794,0.4329268292682927,0.8181420327480016,1.0,3/22,4.47%,APOA1;KLF4;GCNT2
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3030373999167116,1.0151701836418578,0.443,0.8180860100553655,1.0,84/807,9.48%,PRDM16;MECOM;SOX13;NOTCH4;KLF8;EDN1;GATA6;PLCB1;PDGFB;LDB2;DACH1;RPS6KA5;SMAD7;KLF2;SMARCA2;NR4A2;TBXT;PLK3;NOTCH1;ZFP69;FOXO1;ELK3;NR1I3;HEY1;KLF12;DAB2IP;KLF7;IRF2;CAV1;LRRFIP1;SAP30;HNF4A;ID1;DLL4;HDAC9;ZGLP1;SOX18;HHEX;INPP5K;HEY2;HMBOX1;PPM1F;KLF4;MAFK;LEF1;EFNA1;DAP;SMAD2;MEF2C;TAF9B;BTAF1;COMMD7;PHF6;GATA3;EID2B;RTF1;BCL6B;UBE2D1;PDCD4;STAT1;GTF2IRD1;PHC3;ZBTB16;PURA;SNAI2;TMPRSS6;CEBPA;WWP1;ZHX3;UBA52;GATAD2A;RPS27A;WWC2;RPS14;NR1D1;MBD1;TCF3;ERF;KLF11;FOXP1;UXT;ARID5A;JUN;HMGB1
prerank,regulation of lipid catabolic process (GO:0050994),0.4383823638604803,1.0147739005531131,0.4601226993865031,0.8184667329921393,1.0,5/19,18.06%,PDE3B;ALK;PRKAA1;LONP2;TYSND1
prerank,regulation of proteolysis (GO:0030162),0.3697032395831089,1.014164433103694,0.44339622641509435,0.8193960476534847,1.0,3/48,2.35%,LTBP4;CAV1;CASP8
prerank,positive regulation of defense response to virus by host (GO:0002230),0.4210116772709852,1.014109346586316,0.4421364985163205,0.8189651085976841,1.0,5/24,11.74%,AIM2;TRIM6;STAT1;ZC3H12A;DTX3L
prerank,regulation of transmembrane transport (GO:0034762),0.3963728212728648,1.0140772941768559,0.434654919236417,0.8184763799922414,1.0,5/31,11.60%,SLC2A1;OCLN;CTTNBP2NL;NEDD4L;ACTB
prerank,positive regulation of DNA replication (GO:0045740),-0.3869907107094351,-1.013779700335373,0.42857142857142855,0.804915350779065,1.0,2/16,0.92%,EGFR;GLI2
prerank,focal adhesion assembly (GO:0048041),-0.3553268653270393,-1.0136579241798973,0.4264705882352941,0.8038868474092912,1.0,4/21,6.87%,SORBS1;PTPRK;ACTN2;SRC
prerank,intermediate filament organization (GO:0045109),0.4425997754152003,1.0130791060107813,0.4599686028257457,0.8202490224045773,1.0,4/17,16.08%,VIM;DSP;DNAJB6;KLHL24
prerank,brain morphogenesis (GO:0048854),0.4752458493691452,1.0130558914858556,0.4551386623164764,0.8197344038212383,1.0,3/12,12.76%,SHANK3;SLC6A4;CTNNA2
prerank,smooth muscle contraction (GO:0006939),0.4677741083062232,1.0129102158836898,0.45741324921135645,0.8195402305790617,1.0,5/14,10.64%,MYLK;PIK3C2A;SLC8A1;ROCK1;TPCN2
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.491657600357265,1.012326597148515,0.46037099494097805,0.8204220244847642,1.0,4/10,20.21%,RNF125;RIOK3;SEC14L1;DHX58
prerank,nucleotide biosynthetic process (GO:0009165),-0.37014731999168826,-1.0122442697744647,0.46070460704607047,0.8063916446308471,1.0,5/18,13.01%,NMNAT2;ME1;PRPSAP2;MTHFD1;PNP
prerank,mesenchymal cell differentiation (GO:0048762),0.3624335579693716,1.0115924356788317,0.4576271186440678,0.8215588871010019,1.0,10/51,9.00%,NOTCH4;ENG;NOTCH1;TGFB2;HEY2;LEF1;MEF2C;FOXF2;SNAI2;ROCK1
prerank,RNA processing (GO:0006396),-0.23851323379939873,-1.0114259875312077,0.42424242424242425,0.8072946676110521,1.0,59/176,25.22%,CELF2;RBMS1;SON;NOVA1;SNRNP40;SRSF5;HNRNPH1;SCAF11;DDX17;DICER1;NUDT21;APOBEC1;HNRNPA2B1;NCBP1;PRPF8;LIN28B;SRRM1;FUS;SRSF1;PRKACA;CDK12;PRPF3;PABPN1;TARDBP;THOC1;SNRPF;AKAP8L;TENT4B;WBP4;RBM39;TUT1;SNRPA1;SCNM1;HNRNPL;HNRNPU;RNASEL;MAGOH;PPP2CA;BCAS2;U2AF2;SNRPD3;TUT4;MAGOHB;RNGTT;MPHOSPH10;LSM6;SF3B1;SRPK2;DHX8;SRSF11;SF3A2;NCBP2;TCERG1;DHX15;U2AF1;SRSF2;CELF1;MRPL44;SNRPD1
prerank,negative regulation of neuron projection development (GO:0010977),0.3618447838789749,1.0114240716343044,0.43523316062176165,0.8213894754350403,1.0,10/56,12.68%,TRPV4;STMN2;FKBP4;EFNA1;ARHGDIA;PTPRO;RTN4;SPOCK1;DCC;TSKU
prerank,cellular response to virus (GO:0098586),0.39026954136783093,1.0108545102666013,0.45170454545454547,0.8221872739199204,1.0,10/30,22.65%,IFIH1;LGALS9;IRGM;ZC3H12A;HIF1A;RIOK3;MAPK14;CXCL10;POU2F2;MAPK11
prerank,negative regulation of protein ubiquitination (GO:0031397),0.3645646819386069,1.0108200688753253,0.461038961038961,0.8217114562681792,1.0,9/50,11.74%,SMAD7;CAV1;ARRB1;HSPA1B;VPS28;PRKCG;ADGRB1;NXN;DTX3L
prerank,zymogen activation (GO:0031638),0.38450765036382345,1.0106701913672234,0.4582210242587601,0.8215333073703418,1.0,8/39,13.33%,CASP8;OMA1;FURIN;PGK1;CIDEB;VSIR;APOH;TBC1D10A
prerank,purine ribonucleotide metabolic process (GO:0009150),0.352403909567234,1.0106271546820809,0.4491094147582697,0.821075840297562,1.0,19/68,23.03%,ACSM3;GLYAT;SULT6B1;RAB23;LRRK2;ACOT13;GTPBP1;MFN1;BPNT1;RAN;EFL1;CROT;NT5C2;ACAT1;SULT1A1;EPHA2;OXSM;ADSS2;ACLY
prerank,regulation of mononuclear cell migration (GO:0071675),0.41827776779118553,1.0104104736148822,0.47007299270072994,0.8210473642717638,1.0,5/23,9.01%,STK10;MSN;MAPK1;CMKLR1;PTK2
prerank,mitochondrial RNA metabolic process (GO:0000959),0.46311492961840833,1.0101622064871292,0.4556765163297045,0.8211044044843614,1.0,5/14,15.44%,SLC25A33;MTERF2;FASTKD5;TFB2M;TEFM
prerank,cellular macromolecule catabolic process (GO:0044265),0.3697769786373747,1.0101522267615144,0.4521625163826999,0.8205710089607212,1.0,15/49,20.70%,DENND3;DAB2IP;MANBA;DFFB;SIAH2;RNASEH2B;XRN2;FBXO2;RNASE6;OGA;FBXO6;NGLY1;NEU4;RNF5;RAB12
prerank,cellular protein metabolic process (GO:0044267),0.3033406817918639,1.0100220221560652,0.4796747967479675,0.8203522476678599,1.0,74/396,15.37%,GATA6;LMCD1;DENND3;FBXL2;ST3GAL6;DUSP12;MSRB3;MMP1;DAB2IP;GOLM1;APP;CSF2RB;UBA7;APOA1;RPS21;RPL27;MANBA;OMA1;PCSK5;STK38;TMEM132A;FURIN;RPL7;FARSB;WARS1;CHRM3;ADAM17;MRPL18;IGFBP7;PRKCSH;MRPL41;HSP90B1;PCMT1;UBA52;RPS27A;RPS14;PROC;IGFBP4;YES1;RPL35;APH1A;CSNK1G3;SIAH2;ADAM10;RPL21;RPL37;RPS28;MRPL52;RPL34;RPS9;MRPL36;RPLP2;APLP2;LIPT1;CDH2;FBXW2;CP;RPS25;MRPL23;RPL30;RPL27A;RPS5;NAGPA;ST3GAL1;MRPL24;FBXO2;MRPL32;RPL23A;MRPS12;RPS15;UBE2D3;MSRA;RPL19;RPS18
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.47706924775389503,1.0099120666859387,0.4609250398724083,0.8194873254960048,1.0,3/12,9.94%,ATP2B4;HOMER2;PRNP
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.47706924775389503,1.0099120666859387,0.4609250398724083,0.8194873254960048,1.0,3/12,9.94%,ATP2B4;HOMER2;PRNP
prerank,regulation of gene expression (GO:0010468),0.2998847262309935,1.0091419160074606,0.458,0.8208367860828444,1.0,131/903,13.54%,NANOS1;PLCG2;SOX17;SOX13;NOS3;ENG;GATA2;CLDN5;PDGFB;TRIM14;RPS6KA5;SMARCA2;CASZ1;CCR1;APBB2;MLF2;FOXO4;ESRP2;NOVA2;OCLN;ACVRL1;NOTCH1;ATP2B4;INSR;HEY1;IRF2;IFNGR1;CASP8;TGFB2;LGALS9;TNRC6C;SAP30;DLL4;APP;AFF1;BTG1;SOX18;NOS1AP;HEY2;TLR3;MED26;SLC8A1;PPM1F;KLF4;KRAS;MSN;ING2;PUM2;ANGPT1;WWTR1;GCNT2;TRIM11;MBNL1;YBX2;LEF1;TRIM6;NLK;NKAPL;MEF2C;PPIE;CD34;WARS1;GATA3;SMCR8;IL1A;BCL6B;MAPK1;RYBP;P2RX7;GTF2IRD1;ZC3H12A;HSPA1B;SNAI2;RBL1;PLSCR1;CEBPA;NFE2L2;ZC3H7A;PRKAA1;CDH3;CAVIN4;WWC2;ACTG1;ROCK1;TCF7L1;TCF3;NDFIP2;FOXP1;STAP1;CACTIN;EGR1;SERTAD3;DHH;ADAM10;MLF1;FBXW7;HP1BP3;TCEAL1;PLAG1;HNRNPK;TYROBP;NUP35;TRIM17;AGO4;FGF20;PTBP3;ASCC1;VSIR;PCBP1;VPS35;VSTM2A;NWD1;APLN;TRAPPC2;SAP30L;CLU;BRCA1;TESMIN;HINFP;SOX6;TOB1;PIK3CB;TSKU;TTBK1;ATXN1;TAPBP;PIN1;ATM;HIF1A;UNCX;HNRNPH2
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.48270922268284794,1.0091148547679245,0.4691151919866444,0.8203369592614094,1.0,2/11,2.35%,ARHGEF2;CASP8
prerank,alpha-amino acid catabolic process (GO:1901606),-0.3331674363026643,-1.0089527912575722,0.45098039215686275,0.8126480915049665,1.0,5/29,10.65%,DDO;ALDH4A1;PRODH;GSTZ1;SARDH
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.3863168973391003,1.0088611058025698,0.46364883401920437,0.8203935240519347,1.0,10/38,13.88%,GBP5;PUM2;PLSCR1;NMI;SLC15A4;POLR3B;ACOD1;DHX9;CYBA;RIOK3
prerank,protein trimerization (GO:0070206),-0.3928304549785114,-1.0085912807279267,0.4441687344913151,0.8109372946737481,1.0,4/14,15.66%,SLC1A5;SCARA5;CLYBL;SIGMAR1
prerank,protein homotrimerization (GO:0070207),-0.3928304549785114,-1.0085912807279267,0.4441687344913151,0.8109372946737481,1.0,4/14,15.66%,SLC1A5;SCARA5;CLYBL;SIGMAR1
prerank,negative regulation of reproductive process (GO:2000242),-0.37205212187311953,-1.0081992569904459,0.44935064935064933,0.8106239600775491,1.0,3/17,3.01%,IGF1;SULF1;GJA1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.4131292656988339,1.007983364106534,0.46176470588235297,0.8219041772511443,1.0,7/26,13.45%,GCH1;NOS1AP;ATP7A;NUS1;CDH3;PIK3CB;HIF1A
prerank,hexose metabolic process (GO:0019318),-0.30399081166751096,-1.0078757874106339,0.42448979591836733,0.8102345041357648,1.0,13/39,23.00%,APOD;GALK2;CHST15;IRS2;ADPGK;PGM1;GALK1;PMM1;AKR1A1;GDPGP1;SLC35A2;FUCA2;PPARD
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.45745217876676025,1.007335900910136,0.46214511041009465,0.8228818042188909,1.0,5/13,18.12%,NOTCH1;HEY2;NPY5R;GSK3A;SMAD4
prerank,positive regulation of exosomal secretion (GO:1903543),-0.3777825745204353,-1.0069438008292855,0.44476744186046513,0.8113677365438897,1.0,7/15,26.44%,TSG101;SDCBP;SDC1;SNF8;PDCD6IP;SMPD3;STAM
prerank,copper ion transport (GO:0006825),0.4787678301156211,1.0067229380866445,0.47189097103918226,0.8237554085229147,1.0,3/11,4.59%,ATOX1;ATP7A;SLC31A1
prerank,regulation of protein kinase A signaling (GO:0010738),0.429368788525489,1.006692734584166,0.45592705167173253,0.8232812986121629,1.0,4/20,6.86%,ADRB2;IAPP;AKAP5;LRRK2
prerank,response to hydroxyurea (GO:0072710),0.48053201118956845,1.0066918712438013,0.47394957983193275,0.8227257781677553,1.0,5/11,25.46%,NSMCE3;SPIDR;KAT7;BLM;RTF2
prerank,digestive tract morphogenesis (GO:0048546),0.45899065334831696,1.006489490127883,0.461038961038961,0.822639061875606,1.0,2/14,5.46%,SOX17;BBS7
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.3590263817150979,1.0064366952220418,0.4537275064267352,0.8222165093615672,1.0,21/55,21.13%,PSMD13;PSMD4;PSMA5;PSMB10;RBX1;PSMB8;PSMD14;PSMA7;PSMA8;PSMC3;PSMB5;PSMC1;PSMC5;PSMC6;PSMB9;PSMA4;PSMD5;PSMD9;PSMB6;USP47;PSMB2
prerank,mitochondrial transcription (GO:0006390),0.4883244509443826,1.0063364701062207,0.486088379705401,0.8219064348948802,1.0,4/10,15.44%,SLC25A33;MTERF2;TFB2M;TEFM
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.41476816876568656,-1.006064982081201,0.41605839416058393,0.8124187150091903,1.0,4/12,3.54%,DOCK5;IGFBP5;DOCK7;TPM1
prerank,potassium ion transmembrane transport (GO:0071805),0.32292384342810465,1.0057087048503075,0.4733861834654587,0.8228235382798122,1.0,10/135,3.81%,KCNN4;KCNQ1;KCNE3;KCNH8;ATP1A4;ATP1A3;ATP1A1;KCNN3;KCNG3;SLC12A8
prerank,membrane fusion (GO:0061025),0.3922962312241207,1.0055378371363026,0.4542974079126876,0.8226654368519496,1.0,11/33,24.71%,DYSF;DNM3;VTI1B;MYOF;NSF;VAPA;GCA;NAPG;USO1;UBXN2A;RIMS1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.4578808103081958,1.0053549971913467,0.463884430176565,0.8225463646931989,1.0,5/14,16.50%,NFKBIE;NFKBIB;NFKBIA;KEAP1;TMSB4X
prerank,thyroid hormone generation (GO:0006590),-0.433692604712934,-1.005224960170906,0.5058548009367682,0.8134310347002394,1.0,2/10,6.71%,CPQ;SLC5A5
prerank,photoreceptor cell development (GO:0042461),-0.3804652401189458,-1.0050739256332404,0.4175531914893617,0.8125077465593089,1.0,6/14,28.77%,VEGFA;MFSD2A;TOPORS;ARL3;TULP1;AHI1
prerank,positive regulation of proteolysis (GO:0045862),-0.28166063072694414,-1.0050534917972873,0.45643153526970953,0.8112160253319722,1.0,16/55,19.13%,OGT;CCBE1;APOE;CYFIP2;ADAM9;IST1;ATP5IF1;GPLD1;NDUFA13;ADRA2A;PACSIN3;CTSC;RCN3;STUB1;FBXW11;FGFR4
prerank,relaxation of cardiac muscle (GO:0055119),-0.40090361137272656,-1.0047422206011196,0.47354497354497355,0.8107164252843388,1.0,2/13,0.82%,ATP1A2;GSN
prerank,cortical cytoskeleton organization (GO:0030865),0.3727950476379336,1.0046853357986658,0.466484268125855,0.8235755210284506,1.0,10/41,14.78%,TRPV4;RND1;RHOB;FMNL3;NCKAP1;ROCK1;RAC1;RND2;RHOH;LCP1
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.3486356066937475,-1.004502673181588,0.43154761904761907,0.8100404879231662,1.0,2/22,1.83%,ALDH1A2;RBP1
prerank,regulation of cilium movement (GO:0003352),0.495887091692119,1.0044817484385355,0.45532646048109965,0.8235158451041432,1.0,2/10,8.76%,CFAP206;CFAP43
prerank,positive regulation of nervous system process (GO:0031646),0.4325456940528025,1.0043307393090677,0.45741324921135645,0.823300614942141,1.0,3/18,10.39%,UNC13B;TNFRSF1B;TENM4
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.30547578871735653,1.0041230107274304,0.47584789311408016,0.8232568241801339,1.0,56/327,17.39%,SOX17;SOX13;ENG;RPS6KA5;SMARCA2;CASZ1;APBB2;MLF2;FOXO4;ACVRL1;NOTCH1;INSR;IRF2;SAP30;BTG1;SOX18;ACTN4;ING2;WWTR1;NLK;MEF2C;PPIE;RYBP;GTF2IRD1;SNAI2;CEBPA;WWC2;TCF7L1;TCF3;SERTAD3;MLF1;HP1BP3;PLAG1;NUP35;ASCC1;TRAPPC2;SAP30L;TESMIN;HINFP;SOX6;ATXN1;HIF1A;RHOH;ELAVL2;YBX1;KAT7;ACVR2B;TRRAP;NFIL3;ESRRG;ESR1;DAXX;FOXN2;DRAP1;SOX7;SOX12
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.31066681571583993,-1.0040721479995636,0.4463087248322148,0.8098474619668804,1.0,8/37,8.37%,IGF1;BMPR1A;IGFBP5;GJA1;TPM1;FGF2;MMP2;EFEMP2
prerank,skin development (GO:0043588),0.355853963738595,1.0040466307078797,0.465495608531995,0.8228886661726954,1.0,7/65,5.19%,JAG1;GATA6;CLIC4;LSR;BCR;ATP7A;COL5A2
prerank,organic acid transport (GO:0015849),0.3347883358823802,1.0038378196711344,0.4762456546929316,0.8228174010676302,1.0,6/94,3.07%,SLC6A6;ABCC4;CEACAM1;SLC7A7;SLC25A32;SLCO1C1
prerank,regulation of macroautophagy (GO:0016241),-0.24907066304927844,-1.0037698037071894,0.4596774193548387,0.8093652181342873,1.0,33/105,22.53%,PRKAG2;DCN;PRKAA2;GPSM1;SNX6;VPS26B;SESN1;ATP6V1B2;SNX32;TBK1;ATP6V0B;PRKACA;CASP3;SESN2;PRKAB2;HDAC6;UCHL1;TSC1;ATP6V1A;WAC;LAMTOR2;LARP1;PRKAG3;TSC2;SNX5;CLN3;MAP3K7;MAPK8;ATP6V0D2;LAMTOR5;CDK5;PAFAH1B2;ATP6V1H
prerank,myelination (GO:0042552),0.3662913048826286,1.003761774301945,0.455026455026455,0.8224493517004624,1.0,13/46,15.70%,MALL;MPZ;ACSBG1;MARVELD1;CMTM8;MAL;EIF2B2;NFASC;B4GALT6;SOX10;ARHGEF10;CXCR4;PLLP
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.3767001486859572,1.003466816806382,0.44,0.822587100630699,1.0,9/43,13.45%,GATA2;PDGFB;TGFB2;KLF4;GATA3;JUN;EGR1;APLN;HIF1A
prerank,transferrin transport (GO:0033572),-0.31025913318211995,-1.0029701523048502,0.44285714285714284,0.8101306032367552,1.0,6/33,8.29%,STEAP3;ATP6V0A4;ATP6V1B2;ATP6V0B;ATP6AP1;TCIRG1
prerank,regulation of protein localization to nucleus (GO:1900180),0.37285838519831555,1.0029441129980812,0.4556291390728477,0.8232269266274904,1.0,18/43,26.46%,CARD10;WWTR1;SUMO3;MFHAS1;CTNNA1;NVL;LIMK2;DTX3L;PIN1;KAT7;SIN3A;GSK3B;YAP1;GLUL;ATP13A2;TPR;TGFB1;PARP9
prerank,regulation of protein secretion (GO:0050708),0.3267980246713705,1.002673809486061,0.4707865168539326,0.8233051214321965,1.0,11/119,6.18%,CD2AP;UNC13B;ITPR3;SLC2A1;CACNA1A;TGFB2;HNF4A;SYT7;RAPGEF4;TMED10;IL1A
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.46686151113304,1.0022055758289725,0.46905537459283386,0.8238138230247755,1.0,2/11,5.49%,ING2;TAF9B
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.30721470931844735,-1.002153629372201,0.45255474452554745,0.8110655749859866,1.0,6/37,10.50%,OGT;FHIT;MAP1A;TAF1;TRIM39;SDCBP
prerank,cellular response to reactive oxygen species (GO:0034614),-0.2774431969072969,-1.0012828959103623,0.4085106382978723,0.8121046841292405,1.0,20/59,22.55%,EGFR;PDGFRA;PTPRK;TPM1;ANXA1;PRDX3;HDAC6;FER;CHUK;MPV17;FXN;PDK2;MAPK9;PRKCD;PAX2;ROMO1;MAPK8;ABL1;NET1;TNFAIP3
prerank,response to amino acid (GO:0043200),0.3914405939835871,1.0008938637937728,0.4536082474226804,0.8262708021795001,1.0,16/31,29.31%,SPAAR;SH3BP4;RRAGD;TMBIM6;GLRA2;RRAGA;RRAGC;LAMTOR3;MEAK7;RPTOR;NSMF;GLRB;LAMTOR4;CAPN2;SLC38A9;LAMTOR1
prerank,nuclear export (GO:0051168),-0.25865421304441966,-1.0006825601716915,0.44324324324324327,0.8124307314969436,1.0,27/80,24.51%,RANBP3L;SRSF5;PHAX;NEMF;NCBP1;SRRM1;CSE1L;SRSF1;NUP155;SRSF6;PKD1;THOC1;RANBP17;NXF1;MAGOH;U2AF2;RANBP3;MAGOHB;UPF3B;SRSF3;SRSF11;POM121;EIF4A3;NCBP2;ZC3H11A;U2AF1;SRSF2
prerank,membrane raft organization (GO:0031579),0.4413286422998737,1.0004526186830753,0.47775947281713343,0.8267640232920925,1.0,6/15,24.00%,EMP2;PPT1;ABCA7;NAXE;FA2H;FLOT2
prerank,transcription preinitiation complex assembly (GO:0070897),-0.40774448243626193,-1.0004523068394136,0.47506561679790027,0.8117424029286117,1.0,8/12,30.87%,TAF1;DR1;GTF2B;TAF7;GTF2A2;BDP1;TBP;POLR1E
prerank,positive regulation of cellular protein localization (GO:1903829),0.3464022302532972,0.9994494068365984,0.46503067484662575,0.8285303238637055,1.0,16/69,16.26%,FYN;GPR137B;CARD10;WWTR1;PRKAA1;APC;VPS28;RTN4;TYROBP;CCDC88A;LIMK2;NUMA1;DTX3L;KAT7;ABCA7;NDC80
prerank,positive regulation of kinase activity (GO:0033674),0.3284522731552018,0.9992183895928276,0.4721233689205219,0.8284887676757775,1.0,12/107,7.68%,TEK;RAPGEF2;FLT1;TIE1;FLT4;MERTK;INSR;IQGAP1;FGFR3;ALK;LMTK2;MAPRE3
prerank,regulation of type I interferon production (GO:0032479),0.3349801850475381,0.9991692862337351,0.4648581997533909,0.8280517747484013,1.0,16/84,14.21%,IFIH1;LRRFIP1;UBA7;TIRAP;DDX41;RNF125;NLRC5;GAPDH;POLR3B;ACOD1;DHX9;TRIM25;POLA1;IRF5;PIN1;CTNNB1
prerank,negative regulation of neuron differentiation (GO:0045665),0.4180904683356895,0.9991038377991345,0.44281524926686217,0.8276571073659086,1.0,2/22,1.99%,B2M;HEY1
prerank,regulation of response to oxidative stress (GO:1902882),0.47209686702355125,0.9988306467858857,0.47863247863247865,0.8277218522582551,1.0,1/11,1.49%,MCTP1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.439134305915492,0.9987177217195846,0.46543778801843316,0.8274503062076467,1.0,4/18,7.87%,CBL;STAT1;JAK2;CEBPA
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.3454709534702031,-0.9984407926315951,0.45132743362831856,0.815791588864547,1.0,6/21,11.12%,SULF1;SULF2;XYLT1;B3GAT3;NDST3;HS2ST1
prerank,inositol phosphate-mediated signaling (GO:0048016),0.4238687143613121,0.9981543291001611,0.44294294294294295,0.8282287282837236,1.0,2/19,7.16%,EDN1;PPP3CA
prerank,regulation of execution phase of apoptosis (GO:1900117),0.47021737857491547,0.997480928450532,0.45818815331010454,0.8292639818866971,1.0,5/11,15.88%,ZC3H12A;BCL2L1;FZD3;DFFA;PTGIS
prerank,regulation of lymphocyte differentiation (GO:0045619),0.43090542230726625,0.99723710202104,0.47393364928909953,0.8292993060010071,1.0,2/18,9.45%,CRTAM;ZFP36L2
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.4533234654058005,0.9972263497406076,0.4664429530201342,0.8287779604634966,1.0,4/13,10.60%,ZC3H12A;PRR5L;CNOT1;GTPBP1
prerank,motile cilium assembly (GO:0044458),0.4666515961573502,0.9971442152909212,0.48392282958199356,0.8284322232016781,1.0,2/12,6.65%,DNAAF3;SPATA6
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3355086068664422,0.9971087707198304,0.4590964590964591,0.827963710157166,1.0,7/75,3.81%,TRPV4;ATP2B4;ATP1A4;ATP1A3;ATP1A1;SLC8A1;SLC12A8
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.29469737849471994,0.996987975124132,0.506,0.8276905826513166,1.0,225/1646,14.01%,PRDM16;NOS1;MECOM;EPAS1;SOX17;SOX13;NOTCH4;KLF8;AFAP1L2;ERG;ENG;GATA6;IRF6;GATA2;SMAD6;TAL2;MSX1;PLCB1;PDGFB;DACH1;EBF1;RPS6KA5;SMAD7;KLF2;SMARCA2;CASZ1;CDK17;TBX1;APBB2;MLF2;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;ACVRL1;NOTCH1;FOXQ1;EGR3;ATP2B4;ZFP69;FOXO1;ELK3;INSR;HEY1;KLF12;TAL1;OLIG2;CDK14;DAB2IP;KLF7;IRF2;ZNF296;ZNF235;LRRFIP1;SAP30;HNF4A;HNF1A;KLF3;ID1;KLF6;ARID3B;HDAC9;BTG1;ZGLP1;SOX18;CRK;HHEX;TEAD4;FLI1;RBBP8;INPP5K;HEY2;MED26;HMBOX1;PPM1F;KLF4;ACVR1;ING2;WWTR1;SIM2;MAFK;IRF9;LEF1;CAMK2D;CCNE1;ZBTB46;ZBTB48;DAP;PKN1;SP4;MAFF;SMAD2;NLK;KARS1;RXRG;ELOC;MEF2C;FOXF2;BBS7;BTAF1;PPIE;COMMD7;FOSL2;PHF6;GATA3;EID2B;BCL6B;PDCD4;TOX3;RAD21;SRCAP;RYBP;STAT1;GTF2IRD1;PHC3;MRGBP;FANK1;KDM3A;ZBTB16;LCORL;ELP4;AATF;ARRB1;TOX4;ELP2;PURA;MAPRE3;EBF3;SNAI2;TMPRSS6;CEBPA;NFE2L2;WWP1;ZHX3;DNAJC2;GATAD2A;WWC2;KMT2E;NR1D1;KMT2B;MBD1;ZBTB40;TCF7L1;TCF3;ERF;KLF11;FOXP1;UXT;ZNF182;ELOA;ARID5A;JUN;BRF2;EGR1;HMGB1;SERTAD3;MLF1;DHX9;HP1BP3;SEC14L2;MAD2L2;ZBTB14;PLAG1;HNRNPK;CHD5;RPS6KA1;NUP35;ZXDB;SFR1;POLA1;BRIP1;ZBTB34;DEAF1;ASCC1;RAI1;NPM1;HDX;SAMD1;ARID5B;TRAPPC2;SAP30L;TIAL1;PHOX2A;E2F7;DTX3L;DMAP1;BRCA1;ILF2;TESMIN;HINFP;NR4A1;CD38;ATP8B1;SOX10;KLF13;CBFB;SOX6;TLX3;ETV6;SETD3;MED30;SUV39H2;ELF2;IRF5;RPS6KA3;YWHAH;ZNF32;CTBP2;ASCL4;TGIF1;PHIP;POU3F2;ATXN1;HIF1A;SMARCC1;RIOX1;TBX20;LRP5;HMGB2;IKZF5;MYT1L;MED27;HES3;RHOH
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.3703282153698782,-0.996980096847539,0.46216216216216216,0.818501322632288,1.0,6/16,14.66%,DDX5;DDX17;SRSF1;PUF60;SRSF6;SCNM1
prerank,positive regulation of catalytic activity (GO:0043085),0.3806475597185812,0.9969380092821021,0.4661134163208852,0.8272639780582313,1.0,15/37,24.61%,NOD2;CAV1;APOA1;ATP7A;SSBP1;APH1A;CHTOP;PSEN2;MAPK14;ABL2;SOD1;XRCC4;NCSTN;WRN;NHEJ1
prerank,myotube cell development (GO:0014904),-0.4259164115057197,-0.9966635046314513,0.4607594936708861,0.8180332315580249,1.0,2/10,7.03%,IGF1;SIX1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.4937717645038826,0.9965212081565044,0.480865224625624,0.8276727905432363,1.0,2/10,4.51%,MSN;SYNE4
prerank,transport across blood-brain barrier (GO:0150104),0.3401452406982401,0.9964234338278752,0.48363636363636364,0.8273676640445913,1.0,9/83,4.67%,ATP2A3;SLC6A6;ABCC4;SLC2A1;ATP2B4;INSR;ATP1A4;SLCO1C1;SLC44A1
prerank,response to interleukin-1 (GO:0070555),0.34379080368995096,0.9963304446974761,0.46782178217821785,0.8270228873072426,1.0,13/73,11.45%,DAB2IP;LGALS9;APP;HYAL2;IRAK2;GBP3;CD47;ZC3H12A;NR1D1;ACOD1;CACTIN;CCL4;GBP2
prerank,regulation of astrocyte differentiation (GO:0048710),0.45699957232291427,0.9963115430151743,0.46271186440677964,0.8265224635808289,1.0,1/12,1.61%,NOTCH1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.397004916924345,-0.9962835927515028,0.4652956298200514,0.8177305444023094,1.0,4/13,10.27%,ERRFI1;CBLB;SNX6;TSG101
prerank,early endosome to late endosome transport (GO:0045022),0.425786631930304,0.9962195159526349,0.4683357879234168,0.8261740299359018,1.0,6/20,18.69%,EMP2;LMTK2;HOOK1;PIK3C3;KIF16B;HOOK2
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.4722170414205135,0.9961458329001364,0.44804088586030666,0.8258167273628846,1.0,5/10,21.85%,UBA52;RPS27A;TUT7;UBB;DIS3L2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.4559380239362324,0.9960366756767237,0.4585987261146497,0.8255331304512477,1.0,2/12,6.78%,PTPN14;UHMK1
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.2583975823528277,-0.995945759608492,0.42857142857142855,0.8172870153546506,1.0,17/91,8.42%,BMP6;SLC39A14;SCARA5;SLC30A10;SLC39A8;ACO1;SLC39A13;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;ATP6AP1;ARF1
prerank,microtubule polymerization (GO:0046785),0.3959612160276925,0.9957523544715611,0.45821325648414984,0.8256484481984411,1.0,6/28,13.32%,TRPV4;CSNK1D;CLASP1;CLASP2;RANBP9;PIN1
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.4707365737619872,0.9956315192264942,0.4482758620689655,0.8253733127934038,1.0,2/10,5.70%,NOTCH1;TNFRSF1B
prerank,spliceosomal snRNP assembly (GO:0000387),-0.30169568990421464,-0.9956121003333744,0.45054945054945056,0.8168853637362206,1.0,13/38,25.22%,PRPF8;COIL;GEMIN5;PRPF31;SMN1;PRPF3;SNRPF;SNUPN;SNRPD3;GEMIN7;CD2BP2;WDR77;SNRPD1
prerank,sodium ion homeostasis (GO:0055078),0.42117699023706034,0.99532063226138,0.44613050075872535,0.8255756301169976,1.0,4/21,3.80%,ATP1A4;ATP1A3;ATP1A1;SLC8A1
prerank,L-serine metabolic process (GO:0006563),0.49656111178145457,0.9952360981640491,0.49056603773584906,0.8252325071175135,1.0,2/10,11.68%,SERINC3;SERINC5
prerank,positive regulation of gene expression (GO:0010628),0.2976765006948798,0.9948677482911595,0.5241448692152918,0.8255361829382722,1.0,76/442,13.61%,PLCG2;NOS3;GATA2;CLDN5;PDGFB;CRTAM;OCLN;NOTCH1;HEY1;IFNGR1;LGALS9;TNRC6C;VIM;CADM1;DLL4;APP;NOS1AP;HEY2;TLR3;MED26;PPM1F;KLF4;KRAS;MSN;ANGPT1;LEF1;MEF2C;CD34;TAF1A;WARS1;IL1A;MAPK1;SETX;P2RX7;PLD1;ZC3H12A;ELAVL1;HSPA1B;PLSCR1;TENT4A;NFE2L2;MYO1C;PRKAA1;CDH3;PASK;ACTG1;GAPDH;ROCK1;ELAVL4;STAP1;POLR1F;EGR1;LURAP1;TYROBP;AGO4;FGF20;METTL5;NPM1;VSIR;VPS35;VSTM2A;NWD1;EEF2;ACTB;CLU;BRCA1;HINFP;PIK3CB;RPS6KB1;TTBK1;METTL14;FXR1;HABP4;ATM;HIF1A;DDX21
prerank,sodium ion export across plasma membrane (GO:0036376),0.46666692496452933,0.9948055685074946,0.47833333333333333,0.8251338496771082,1.0,3/13,2.18%,ATP1A4;ATP1A3;ATP1A1
prerank,histone H3 acetylation (GO:0043966),-0.302465787541339,-0.9947541117404821,0.4444444444444444,0.8178644306337731,1.0,14/40,21.58%,LDB1;TADA2A;KAT2B;DR1;WDR5;MEAF6;TAF6L;NAA60;TAF5;TADA3;SUPT7L;BRPF3;MAP3K7;TAF10
prerank,regulation of myoblast differentiation (GO:0045661),0.39678058260884913,0.9944689354419567,0.4844632768361582,0.8253715820285874,1.0,5/32,6.15%,PLCB1;NOTCH1;BTG1;MEF2C;EID2B
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.3819547504114825,0.9937096270247207,0.48204419889502764,0.8266117287107582,1.0,4/34,5.18%,NOD2;F2RL1;TRIM6;GPI
prerank,tRNA methylation (GO:0030488),0.3828956494441757,0.9930011135000837,0.47390691114245415,0.8277860540213765,1.0,7/34,11.47%,TRDMT1;TRMT61A;TRMT5;METTL2B;METTL2A;TRMT61B;ALKBH8
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.39660750880653967,0.9928949759084952,0.48911465892597966,0.8274937626812428,1.0,5/29,8.39%,CASP8;TLR3;UBE2D1;UBA52;RPS27A
prerank,myeloid cell development (GO:0061515),0.42696962191887566,0.992852042077178,0.4606918238993711,0.8270385842359709,1.0,4/18,9.10%,APP;ALAS1;THPO;FOXP1
prerank,regulation of double-strand break repair (GO:2000779),-0.3022468239575352,-0.9928438407278962,0.4524714828897338,0.8217886786820272,1.0,18/39,33.36%,TRIP12;SLF1;FMN2;ACTR2;RTEL1;DEK;TWIST1;PML;TIMELESS;SLF2;RPA2;RAD51;CHEK1;ZCWPW1;SIRT6;OTUB2;MGMT;RAD51AP1
prerank,maintenance of protein location in nucleus (GO:0051457),0.42247084369798754,0.992832906076798,0.4768,0.8265483281981801,1.0,7/20,21.08%,SYNE1;RANGAP1;ARL2BP;TAF8;TAF3;BARD1;SUN1
prerank,vascular transport (GO:0010232),0.34125885897449876,0.9927527556578393,0.49019607843137253,0.8261933804237539,1.0,9/81,4.67%,ATP2A3;SLC6A6;ABCC4;SLC2A1;ATP2B4;INSR;ATP1A4;SLCO1C1;SLC44A1
prerank,kinetochore organization (GO:0051383),-0.38598849560965925,-0.9912194070989913,0.46359223300970875,0.8250438461851972,1.0,10/13,42.56%,CENPC;MIS12;CENPE;CENPH;CENPF;CENPA;DLGAP5;NUF2;CENPW;POGZ
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.28574469302430605,-0.9907942427433304,0.4743083003952569,0.824887472441788,1.0,10/46,16.54%,ATP1A2;NLGN2;GRM3;CACNG4;TSHZ3;ATAD1;HOMER1;DRD2;CACNG8;UNC13A
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.45984538029363475,0.9907861514209181,0.4765625,0.8302319356294431,1.0,1/13,1.34%,DOC2B
prerank,microtubule depolymerization (GO:0007019),0.43529329773953057,0.9907725905006212,0.4740973312401884,0.829721439566257,1.0,2/17,6.68%,STMN2;KIF2A
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.4082138870658868,0.9906683230668625,0.48125,0.8294323244108491,1.0,7/24,15.58%,AQP11;LRRK2;BCL2L1;LPCAT3;CLU;TMBIM6;RACK1
prerank,regulation of cell death (GO:0010941),0.32904220873986934,0.9902085775035692,0.4982618771726535,0.829969254688269,1.0,19/94,15.09%,ACER2;PRKD1;SNCG;TMEM109;TNFRSF1B;LRRK2;ZC3H12A;HSPA1B;PDE8A;CIDEB;APC;RRAS2;VPS35;DCC;CLU;BNIP3L;BNIP3;RAD18;SARM1
prerank,ureteric bud morphogenesis (GO:0060675),-0.37470497107546547,-0.9901397214075146,0.45429362880886426,0.8252795459942052,1.0,4/16,11.31%,BMP4;FGF2;SIX1;SALL1
prerank,nuclear pore organization (GO:0006999),0.4509428474206279,0.9897408777728218,0.48688524590163934,0.830513383668621,1.0,5/14,16.21%,NUP54;RTN4;NUP35;NUP153;NUP205
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.4020371564670671,0.98936391144693,0.4574314574314574,0.8308306009038077,1.0,5/25,9.92%,HEY1;HEY2;TRIM6;GATA3;MAD2L2
prerank,positive regulation of reproductive process (GO:2000243),-0.3069932123927421,-0.9891728794417328,0.4967948717948718,0.8267136740316465,1.0,12/31,23.78%,PDE3A;SYDE1;VEGFA;ACVR1B;LHFPL2;SIRT2;CACNA1H;CFAP69;INHBA;TACR3;C1QBP;INHBB
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.2755510204752089,-0.98903399721225,0.46919431279620855,0.8257753145378472,1.0,12/52,15.77%,CELF2;DDX5;NOVA1;FXR2;RBMX;DDX17;PUF60;SRSF6;REST;HNRNPL;HNRNPU;MAGOH
prerank,regulation of cellular response to stress (GO:0080135),0.3212100797319285,0.9886554049078045,0.5068027210884354,0.8319471555872489,1.0,22/115,16.94%,NUAK1;FKBP4;ING2;CAMK2D;MAPK1;CHCHD2;MBTPS2;HSPA1B;DNAJC2;NUP54;PTGES3;NUP35;RANBP2;NPM1;NUP153;ATM;NUP160;NUP42;DNAJB6;NUP205;DNAJC7;ARMT1
prerank,import into cell (GO:0098657),0.3672581840747838,0.988566339222804,0.4703448275862069,0.8316056538005245,1.0,2/41,0.35%,SLC6A6;LRRC8C
prerank,regulation of p38MAPK cascade (GO:1900744),0.38199436201305753,0.9885555027979456,0.4648876404494382,0.8310900194828347,1.0,7/35,10.77%,DUSP1;DAB2IP;LGALS9;ZC3H12A;MFHAS1;GADD45G;MINK1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.3921813681630134,0.988242476877068,0.4878048780487805,0.8312512564730606,1.0,5/30,8.39%,CASP8;TLR3;UBE2D1;UBA52;RPS27A
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.3890860770982338,0.9880755689056806,0.5007012622720898,0.8310852165465293,1.0,7/33,14.08%,EDN1;PIK3C2A;PLEKHA1;GATA3;HTR2A;PIK3CB;LTK
prerank,tRNA aminoacylation (GO:0043039),0.3773042262479037,0.9879779842314154,0.47297297297297297,0.8307785611490973,1.0,10/37,19.45%,GARS1;VARS1;KARS1;FARSB;WARS1;FARS2;GATB;EEF1E1;RARS1;DARS1
prerank,phosphate ion homeostasis (GO:0055062),-0.426300854277299,-0.9879299168308705,0.4948717948717949,0.8273039630604982,1.0,3/10,19.13%,ENPP1;SFRP4;FGFR4
prerank,blood vessel endothelial cell migration (GO:0043534),0.41028178125840764,0.9878948775060575,0.47846153846153844,0.8304382627095623,1.0,5/22,5.85%,EGR3;EMP2;ID1;SOX18;MYH9
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.3748600853718782,0.9874106587544523,0.4776536312849162,0.8310449994015526,1.0,4/35,5.24%,FASN;FAR2;PPT1;FAR1
prerank,dendritic spine organization (GO:0097061),0.39994489843837394,0.9871679661795582,0.47653958944281527,0.8310468825904646,1.0,5/26,13.79%,FYN;INSR;SHANK3;PRNP;ITGA3
prerank,positive regulation of transferase activity (GO:0051347),0.3188401740113307,0.9858439245863405,0.5033557046979866,0.8335164080326929,1.0,27/142,14.21%,TEK;FLT1;TIE1;FLT4;MERTK;INSR;HMBOX1;KLF4;FGFR3;MAPK1;ALK;LMTK2;NVL;CD200;NEK7;FBXW7;DKC1;PTGES3;TNKS;POLG2;CCT2;SERINC5;DTX3L;CCT4;PIN1;LTK;CTNNB1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.3193173634858843,-0.9856666692349291,0.45,0.8319995691273859,1.0,6/30,12.58%,DDX5;DAB2;HEYL;KLK2;HDAC1;HDAC6
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.39218938454530156,0.9855093958488983,0.48717948717948717,0.833673395658712,1.0,11/29,23.03%,FASN;PPT1;ACSL5;ACSBG1;ELOVL7;ELOVL5;TECR;HACD2;SLC25A1;ACSL4;ACLY
prerank,meiosis I (GO:0007127),0.4175876695705108,0.984899084214734,0.48405797101449277,0.8345609734830214,1.0,6/23,18.66%,DDX4;ING2;PTTG1;SYCP3;SGO1;TDRD9
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.39043720930829606,-0.9843865434647365,0.46153846153846156,0.8342179652865721,1.0,2/12,4.07%,DPYSL3;DPYD
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.3456774908513232,0.9843561225642821,0.4987244897959184,0.8352230957751635,1.0,24/61,22.68%,AZIN1;CAV1;PSMD13;PSMD4;PSMA5;PSMB10;PSMB8;PSMD14;PSMA7;PSMA8;PSMC3;PSMB5;PSMC1;PSMC5;PSMC6;PSMB9;PSMA4;PSMD5;PSMD9;PSMB6;PSMB2;NCOR2;OAZ2;NQO1
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.4121828374808022,-0.9843480508111032,0.488,0.8329831963991182,1.0,3/11,16.11%,C1QTNF3;SIK1;CLK2
prerank,receptor signaling pathway via STAT (GO:0097696),0.39778238927933546,0.9843416711759305,0.48613138686131385,0.8347152992418757,1.0,6/25,8.61%,IFNAR1;STAT1;SOCS6;JAK2;THPO;NMI
prerank,cellular response to alkaloid (GO:0071312),0.43132932592161677,0.9841899015274075,0.4779299847792998,0.8344927451720824,1.0,6/17,23.42%,SLC8A1;HTR1B;SPIDR;CASP7;BLM;RYR2
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.33240482101921165,0.9839456918297163,0.4987951807228916,0.8344592138804933,1.0,13/83,13.94%,CDK17;PLK3;CDK14;ACVR1;CCNE1;CUL3;KLF11;CUL2;POLA1;HINFP;USP29;RPS6KB1;CDKN2D
prerank,negative regulation of viral entry into host cell (GO:0046597),0.45497778320035737,0.9832080272322183,0.48509933774834435,0.8356744920585943,1.0,2/12,4.54%,LY6E;TRIM11
prerank,ncRNA catabolic process (GO:0034661),0.3911802473160561,0.9829527521492953,0.47391952309985097,0.8357338431740202,1.0,11/28,25.04%,RBM7;TRIR;EXOSC3;EXOSC8;XRN1;POP1;EXOSC9;EXOSC10;DIS3L2;NUDT16;NUDT16L1
prerank,prostanoid biosynthetic process (GO:0046457),0.4375784919052396,0.9826855441738656,0.48333333333333334,0.835805459939636,1.0,1/15,0.48%,EDN1
prerank,regulation of cell projection organization (GO:0031344),0.4552307572605092,0.9826719136548465,0.499194847020934,0.8352933998046395,1.0,2/13,10.41%,MACF1;ERMN
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.46466129521655575,0.9824420080892216,0.4774624373956594,0.8352607607317892,1.0,5/11,19.93%,UQCC3;UQCRB;UQCRFS1;UQCRC1;UQCRC2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.30204003602637486,0.9823238417066045,0.515311510031679,0.8349902305089643,1.0,49/248,14.48%,DKK2;SOX17;SOX13;CCDC88C;FZD6;CCNY;GNAQ;TMEM88;CDK14;DAB2IP;CAV1;HHEX;LGR5;PSMD13;WWTR1;CSNK1D;CUL3;PSMD4;LRRK2;SHISA6;SNAI2;PTPRU;PTPRO;CDH3;APC;IGFBP4;MCC;NKD2;CSNK1G3;SIAH2;PSMA5;PSMB10;AMER3;ZNRF3;RBX1;MAD2L2;PSMB8;TNKS;PSMD14;PSMA7;PSMA8;PIN1;ADGRA2;PSMC3;PSMB5;CTNNB1;PSMC1;FZD9;PSMC5
prerank,regulation of neuron projection development (GO:0010975),0.3092161606845279,0.9820377344059652,0.5075921908893709,0.8351074928501411,1.0,32/163,14.38%,TRPV4;STMN2;RAPGEF2;TANC2;RAPGEF1;FKBP4;DAB2IP;PRKD1;SERPINI1;FES;FBXO7;PDLIM5;CAMSAP2;SHANK3;SETX;LRRK2;TENM3;PTPRO;LRRC4C;SCN1B;PPFIA2;CCDC88A;CDH2;SPOCK1;DCC;MARK2;TSKU;CSMD3;CTNNA2;LTK;CFL1;EFHC2
prerank,regulation of anoikis (GO:2000209),0.4316507011827567,0.9817399156159047,0.5096011816838996,0.8352621597579777,1.0,5/19,13.59%,NOTCH1;CAV1;SNAI2;PTK2;ITGA5
prerank,protein localization to Golgi apparatus (GO:0034067),0.3895251223134157,0.9816922647623004,0.5092198581560283,0.834832966060509,1.0,5/27,9.29%,GBP5;CSNK1D;TMED10;VPS13D;RIPOR1
prerank,sensory perception of chemical stimulus (GO:0007606),0.43625928119303325,0.9811495521888902,0.4748427672955975,0.8355127016307844,1.0,2/15,13.83%,GNAL;SLC24A4
prerank,protein K48-linked ubiquitination (GO:0070936),0.35088070249671516,0.9811115292295821,0.48663101604278075,0.8350509367773686,1.0,12/54,14.81%,ZNRF1;KLHL3;CUL3;UBE2D1;UBE3A;RNF115;RBX1;NEDD4L;DTX3L;UBE2T;UBE2E1;UBE2D3
prerank,protein methylation (GO:0006479),-0.29169952168203556,-0.9810649256338072,0.47924528301886793,0.8405755094134861,1.0,10/40,18.08%,NSD1;NSD3;EHMT1;GSPT1;FAM98B;METTL21A;EEF1AKMT1;N6AMT1;SNRPD3;EEF1AKMT2
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.32463853958454447,-0.9808488978420427,0.48742138364779874,0.839833009248676,1.0,7/25,15.41%,SCAF8;LDB1;CCNK;ELL;THOC1;HMGN1;HTATSF1
prerank,apical protein localization (GO:0045176),0.4658993402583434,0.9805478385444628,0.4991394148020654,0.835777459078305,1.0,4/10,12.21%,GOPC;MAL;ACTB;ATP8B1
prerank,positive regulation of neuron death (GO:1901216),0.36030347795479584,0.9803549502048632,0.487012987012987,0.8356717446398926,1.0,13/46,16.69%,FYN;TGFB2;FCGR2B;ITGAM;GRIN2B;EGR1;PRNP;TYROBP;CLU;CTNNB1;EIF2S1;SARM1;DAXX
prerank,cranial nerve development (GO:0021545),-0.4112231592167298,-0.9802891203055419,0.4754521963824289,0.8399876064895783,1.0,7/11,44.00%,SALL1;PAX2;CHRNB2;TFAP2A;POU4F1;TIFAB;ISL1
prerank,positive regulation of response to external stimulus (GO:0032103),0.3196895358454653,0.9802341365079095,0.5191011235955056,0.8353829799168763,1.0,23/128,13.88%,PDGFB;GBP5;F2RL1;APP;TLR3;PPM1F;PUM2;HYAL2;PDCD4;CD47;PLSCR1;CEBPA;NMI;SLC15A4;POLR3B;ACOD1;DHX9;NFKBIA;CYBA;DDT;ABCC1;APOH;RIOK3
prerank,regulation of interferon-alpha production (GO:0032647),0.405054892020452,0.9799067623573283,0.49343065693430654,0.8355954420788642,1.0,6/23,15.09%,IFIH1;TLR3;STAT1;DHX9;IRF5;HAVCR2
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.3575888602052545,-0.9795929948690693,0.5071633237822349,0.8406081521932232,1.0,7/19,20.63%,WNT4;BMP4;RUNX1;CREB3L1;LARP6;TGFB3;RGCC
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.46778199020030065,0.9793839342275669,0.5134680134680135,0.8362250737776948,1.0,1/11,1.37%,NR4A2
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3520682296512623,0.97921376753874,0.49362244897959184,0.836059471349614,1.0,23/62,24.36%,ELOC;RTF1;EAF1;ELP4;ELP2;POLR2G;ELOA;POLR2D;GTF2H3;EAF2;MLLT3;ELOF1;POLR2I;AFF4;NELFB;NELFA;SETD2;MNAT1;IWS1;POLR2C;POLR2B;POLR2J;CCNH
prerank,cellular response to hydrogen peroxide (GO:0070301),0.3717105772144465,0.9787611989564188,0.5098870056497176,0.8365927888026047,1.0,6/33,11.34%,RHOB;PLEKHA1;SETX;NFE2L2;OSER1;TRPM2
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.34812191329946246,-0.9787250189427014,0.47513812154696133,0.841580204628339,1.0,6/21,22.35%,SAMD4A;CNOT10;TUT4;ZFP36;PNLDC1;SAMD4B
prerank,cellular sodium ion homeostasis (GO:0006883),0.44246336901027333,0.9780547689642742,0.47596153846153844,0.8376642389561962,1.0,4/15,3.80%,ATP1A4;ATP1A3;ATP1A1;SLC8A1
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.39311137038855404,-0.9774948698922108,0.47044334975369456,0.8437154445703909,1.0,2/12,6.09%,ANK2;UBASH3B
prerank,androgen metabolic process (GO:0008209),-0.35782121834677466,-0.977405334101488,0.49700598802395207,0.8426214914771101,1.0,15/18,53.96%,SPP1;SRD5A1;HSD17B11;HSD17B10;SRD5A3;SHH;HSD17B7;SRD5A2;HSD3B2;CYP19A1;MED1;DHRS9;HSD17B6;HSD17B3;AKR1D1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.3498892210434685,0.9772660073529954,0.4909560723514212,0.838945733505599,1.0,19/51,23.84%,HMBOX1;MAPK1;CCT8;NEK7;STN1;TNKS;CCT2;FBXO4;XRN1;CCT4;ATM;CTNNB1;CCT6A;CTC1;MAPKAPK5;EXOSC10;TERF2;TCP1;CCT3
prerank,regulation of dephosphorylation (GO:0035303),0.4359755488967452,0.9771496365399557,0.49074074074074076,0.8386696602430186,1.0,8/15,28.46%,INPP5K;PPP1R16B;PPP1R16A;SMG7;IGBP1;MTMR2;MTMR9;SMG5
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.4592341254823974,0.9767141445616252,0.510569105691057,0.8391146209674486,1.0,8/12,25.18%,CCT8;DKC1;CCT2;CCT4;CCT6A;TCP1;CCT3;WRAP53
prerank,neurotransmitter transport (GO:0006836),0.33939710751983654,0.9764697619611337,0.513317191283293,0.8391716472851465,1.0,19/73,18.16%,UNC13B;APBA1;SYN3;GLS2;GLS;SLC6A4;PPFIA2;SLC6A2;PDZD11;SLC1A1;GABRA2;SLC1A2;STXBP3;HRH3;SLC32A1;CPLX1;SNPH;SYNJ1;SYT1
prerank,regulation of protein dephosphorylation (GO:0035304),0.38508600517479324,0.9763416572001368,0.5028248587570622,0.8389177468570841,1.0,19/37,27.94%,PPP1R16B;MFHAS1;HSP90B1;CALM3;ARPP19;CDCA2;PIN1;CNEP1R1;PPP1R16A;TIPRL;PPP1R7;PPP1R15A;CDH5;NSMF;TGFB1;SYMPK;CALM1;SPPL3;SMPD1
prerank,regulation of lamellipodium assembly (GO:0010591),-0.2961319880975127,-0.9761289764226967,0.49814126394052044,0.8447952632939938,1.0,7/34,13.83%,AUTS2;PLCE1;SLIT2;PIK3R1;CAPZB;FER;ACTR2
prerank,acidic amino acid transport (GO:0015800),0.4298859380369875,0.9754562257361015,0.47619047619047616,0.8403782315525734,1.0,2/17,2.40%,SLC6A6;ARL6IP5
prerank,homotypic cell-cell adhesion (GO:0034109),-0.29833006668709067,-0.9752841018864844,0.5057034220532319,0.8457788770966868,1.0,7/39,9.85%,PLPP3;PDGFRA;MEGF11;UBASH3B;FLNA;MYL9;PPIA
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.4052537551931793,0.9749750586120436,0.49554896142433236,0.840899084166035,1.0,6/23,21.90%,MBOAT2;LPCAT4;LPCAT3;PLA2G12A;PLAAT3;ABHD4
prerank,nucleotide metabolic process (GO:0009117),-0.33789626004523926,-0.9743860415971284,0.5044776119402985,0.8467880344438274,1.0,10/23,19.93%,NMNAT2;FHIT;ME1;ENPP3;AK5;PNP;CMPK2;CTPS2;AK1;NME2
prerank,regulation of mast cell activation (GO:0033003),0.4731291409898286,0.9742263629936676,0.5158069883527454,0.8421057023840504,1.0,2/10,7.85%,MILR1;PLSCR1
prerank,regulation of monocyte chemotaxis (GO:0090025),0.3956707179272689,0.9741046604868385,0.481962481962482,0.8418416410977535,1.0,3/24,3.90%,CCR1;DUSP1;ANO6
prerank,pore complex assembly (GO:0046931),0.4179103801305011,0.9740946129091747,0.5024,0.8413383190306475,1.0,7/19,16.21%,ANO6;P2RX7;RTN4;ADAM10;PDZD11;NUP153;NUP205
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.47004401821496455,0.9739696985645449,0.5059422750424448,0.8410967835485667,1.0,2/10,5.77%,APP;SHANK3
prerank,eye photoreceptor cell development (GO:0042462),-0.3612915020512548,-0.973764625785538,0.5222551928783383,0.8471102716821383,1.0,8/15,41.16%,VEGFA;TOPORS;TULP1;RPGRIP1L;THY1;BBS4;CRB2;NRL
prerank,DNA-dependent DNA replication (GO:0006261),0.31095046907186286,0.9736797863758344,0.5130237825594564,0.8412103425626276,1.0,33/128,18.87%,PSMD13;WRNIP1;SSBP1;PSMD4;ORC3;PURA;UBA52;RPS27A;PSMA5;PSMB10;PSMB8;POLA1;WDHD1;POLG2;POLB;PSMD14;ORC5;PSMA7;PSMA8;PSMC3;DDX21;PSMB5;PSMC1;PSMC5;TEFM;RFC2;PSMC6;PSMB9;MCMBP;PSMA4;PSMD5;PSMD9;PSMB6
prerank,potassium ion homeostasis (GO:0055075),0.3998292324939172,0.9736462965893679,0.5081481481481481,0.8407485438094632,1.0,4/23,3.81%,ATP1A4;ATP1A3;ATP1A1;SLC12A8
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.34253500871087184,-0.9734428043973349,0.4764705882352941,0.8466377410398415,1.0,7/19,23.27%,PPARA;IRS2;IRS1;TWIST1;PRKCD;MTLN;ANGPTL3
prerank,fatty acid metabolic process (GO:0006631),0.3147600336261043,0.9733526801654954,0.5258323765786452,0.8409099772045923,1.0,10/115,8.59%,ADIPOR2;ACSM3;FASN;AOAH;SLC27A6;ACSL5;ACSBG1;ADIPOR1;ACOX1;ELOVL4
prerank,regulation of cation transmembrane transport (GO:1904062),-0.3190800312898447,-0.9729365493206106,0.5033557046979866,0.8466610743315083,1.0,5/29,4.43%,SNTA1;WNK1;KCNIP3;SLMAP;CD63
prerank,cellular protein localization (GO:0034613),0.2999430236486036,0.9722086915693995,0.5677618069815195,0.8429004097792443,1.0,55/285,14.68%,FBLN5;RABGAP1;OCLN;TRAPPC8;ARHGEF2;RAB6B;HERC2;EMP2;ID1;ESAM;HHEX;HEY2;STX7;TBC1D30;EHD1;SCG5;ANGPT1;SGSM1;TBC1D8;TMED10;PACSIN1;RAB23;CEP68;LRRK2;RAB3GAP2;TBC1D12;TLK1;PTPRU;TBC1D5;STX12;TBC1D1;ARF3;RRAGD;TM9SF1;NPM1;LAPTM5;VPS35;REEP1;SMURF1;TMED9;RAB19;TM9SF3;YWHAH;STX19;USP6NL;WDR11;TBC1D10A;STXBP3;TBC1D4;MESD;NSF;TBC1D9;CTNNB1;RUNDC1;TMED4
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.3766658759986324,-0.9718241976252153,0.4930747922437673,0.8483193320624209,1.0,5/14,22.58%,FUS;ACTR2;FANCB;TIMELESS;PARP1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.4175873204222378,0.9717479537383602,0.48442367601246106,0.8434275542400268,1.0,2/17,3.59%,SMAD7;INPP5K
prerank,heterotypic cell-cell adhesion (GO:0034113),0.3919731570873479,0.9715179802428694,0.523121387283237,0.8434152523999454,1.0,4/25,9.33%,VCAM1;IZUMO1;CD200;DSP
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.3348810851352818,-0.970931336256082,0.49074074074074076,0.8494243376671411,1.0,9/23,16.50%,UACA;BMP7;CCN3;PPM1A;C1QTNF3;DDX3X;CYLD;PPM1B;NLRC3
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.40324139842596957,0.9708078576183669,0.4947994056463596,0.8445141872751744,1.0,2/24,3.85%,RAPGEF2;PDE3B
prerank,fatty acid elongation (GO:0030497),0.4502376119081455,0.9704377698516974,0.50814332247557,0.844836028772899,1.0,6/13,18.83%,ELOVL4;HACD4;ELOVL7;ELOVL5;TECR;HACD2
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.33244785034522395,0.9703466993171902,0.5006134969325153,0.844533347004452,1.0,11/75,13.57%,EDN1;RGS3;PLCB1;GIT2;MRAP2;NMT1;ROCK1;GNG4;KCTD8;METAP2;RGS12
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.41711580946481125,-0.9698640780115297,0.4987012987012987,0.8509971867681861,1.0,6/10,36.58%,TICAM1;MYD88;CD68;TREM2;TLR6;CD36
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.44417823485025343,0.9698521961890276,0.498371335504886,0.8451479198017817,1.0,2/12,5.49%,ING2;TAF9B
prerank,neuropeptide signaling pathway (GO:0007218),0.34250369363983835,0.9692154540219308,0.517948717948718,0.8460324921706454,1.0,14/58,23.51%,RAPGEF2;HCRTR1;GAL;NXPH2;NMU;GLRA2;GPR149;PENK;SORCS1;SORT1;HCRTR2;SORL1;PDYN;NTS
prerank,pharyngeal system development (GO:0060037),0.4411137313255183,0.9691931815455368,0.5247524752475248,0.8455515540680432,1.0,4/15,6.13%,BMPR2;TBX1;TGFB2;GATA3
prerank,cellular protein catabolic process (GO:0044257),0.3445639209254619,0.9689678748734465,0.5184210526315789,0.8455151788053633,1.0,17/59,20.70%,DENND3;DAB2IP;CASP8;AP2B1;SIAH2;AP2M1;RSPRY1;VLDLR;BNIP3L;BNIP3;CTSO;CTSK;MALT1;PISD;RNF5;CTSH;RAB12
prerank,postsynaptic membrane organization (GO:0001941),-0.3608082967925541,-0.9686958551417816,0.4897959183673469,0.8528332212824018,1.0,5/17,8.99%,APOE;NLGN2;DLG4;DNAJA3;LRRC4
prerank,rRNA 3'-end processing (GO:0031125),0.45889868525915,0.9685176500769229,0.4956521739130435,0.8459339260990862,1.0,5/10,21.57%,RPS21;EXOSC3;EXOSC8;EXOSC9;EXOSC10
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.33438264842640547,0.9683374203885255,0.527027027027027,0.8458246159783581,1.0,11/66,11.72%,PLCB1;CCND2;CCND3;FAM107A;KLF4;ADAM17;RBL1;KMT2E;APC;ADAMTS1;E2F7
prerank,ncRNA transcription (GO:0098781),0.44766110698125067,0.9678735874360945,0.5051194539249146,0.8463147118481287,1.0,6/13,24.23%,CAVIN1;USPL1;SPIN1;ANG;BRF1;SNAPC3
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.4482192897145417,0.967815854430113,0.5023622047244094,0.8459153288296865,1.0,1/14,1.77%,PAEP
prerank,polarized epithelial cell differentiation (GO:0030859),0.45158001272637716,0.9678013089328482,0.5136436597110754,0.8454147956159265,1.0,2/13,4.51%,MSN;SYNE4
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.38579259078778366,0.9676284128737794,0.4862119013062409,0.8452802116297836,1.0,9/29,21.29%,SMAD7;FBXW7;DTX3L;PIN1;BMI1;TRIB3;ARRDC4;FEM1A;DCUN1D2
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.33588337557886383,0.9671338033470103,0.5107398568019093,0.8458274385746875,1.0,15/74,10.93%,SMAD7;DAB2IP;TGFB2;IL17RD;WWTR1;GCNT2;LEF1;EFNA1;SMAD2;GATA3;ADIPOR1;CLASP1;CLASP2;MAD2L2;MCRIP1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.27959981532836287,-0.9670773084636531,0.5109170305676856,0.855774190535886,1.0,6/49,9.11%,IGF1;IL31RA;KIT;IL6R;VEGFA;GHR
prerank,negative regulation of microtubule polymerization (GO:0031115),0.4510060930941077,0.9667975054441662,0.5024469820554649,0.8460381014408717,1.0,1/12,0.61%,STMN2
prerank,regulation of centrosome cycle (GO:0046605),0.4083687896178644,0.9666467864957693,0.5275707898658718,0.8458769300870401,1.0,10/21,26.25%,CHMP1B;NPM1;CHMP3;CHMP2B;MARK4;CHMP1A;GEN1;FBXW5;VPS4B;CHMP4B
prerank,regulation of actin filament bundle assembly (GO:0032231),0.3892816329430003,0.9665469685399044,0.491970802919708,0.8455649047464434,1.0,5/26,10.32%,SYNPO;SHANK3;ACTG1;ROCK1;RAC1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.4653321403891061,0.9664094401123977,0.5260416666666666,0.8453218279720999,1.0,3/10,9.16%,F2RL1;ANO6;STAP1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.3775974051025887,0.9658613547988975,0.49654218533886585,0.8460446002216421,1.0,5/32,6.54%,ADIPOR2;CEACAM1;APOA1;SIRT4;ADIPOR1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.43890528275802093,0.9650463836306019,0.5247524752475248,0.8472734513595638,1.0,4/13,15.58%,LRRK2;PDE8A;NFE2L2;RACK1
prerank,regulation of lipase activity (GO:0060191),0.45191678013914827,0.9649513720771409,0.5033003300330033,0.8469795412084604,1.0,2/13,5.58%,PCSK5;FURIN
prerank,cellular response to radiation (GO:0071478),0.3604010460071672,0.9645373562658994,0.5033647375504711,0.8473535953581863,1.0,12/40,21.84%,RHOB;RRH;NSMCE3;SPIDR;RAD1;KDM4D;RAD9B;MAPK14;EEF1D;HUS1;BLM;ECT2
prerank,negative regulation of interleukin-10 production (GO:0032693),0.4230436993041604,0.9642621055068172,0.4951923076923077,0.8474337245276972,1.0,3/16,11.22%,FCGR2B;TYROBP;VSIR
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.45095280897453743,0.9637845842790574,0.5212765957446809,0.8479737287947794,1.0,4/12,13.14%,KLF2;CNOT1;CTBP2;CYP26C1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.4379559989241118,0.9636683700120954,0.5111821086261981,0.8476863752458975,1.0,3/14,18.03%,DAB2IP;PTPN1;COPS5
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.44291291325345417,0.963572799211941,0.5025380710659898,0.8473799739684797,1.0,3/13,3.85%,PLXNA4;SEMA3F;PLXND1
prerank,negative regulation of binding (GO:0051100),0.3279277266873188,0.9634243007999961,0.530940594059406,0.8471884188110446,1.0,20/81,15.76%,PDGFB;CAV1;SUMO3;LEF1;BTAF1;LRRK2;JAK2;CTNNBIP1;ROCK1;JUN;NFKBIA;ACTB;TMBIM6;ITGB1BP1;TTBK1;HABP4;PIN1;NES;RACK1;SLPI
prerank,positive regulation of insulin secretion (GO:0032024),0.364470595970572,0.9633767837729319,0.504774897680764,0.8467795577197943,1.0,3/36,5.95%,MYRIP;DOC2B;GLUD1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.4191946772362388,0.9633715829630044,0.49122807017543857,0.8462687440557286,1.0,8/14,23.99%,ADAM17;APH1A;ADAM10;ABCA7;PSEN2;DYRK1A;APH1B;NCSTN
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.26216612835679554,-0.9632544184148797,0.5492957746478874,0.8648546436662014,1.0,17/63,15.38%,LEPR;NUPR1;BCL2;KLHL22;GOLGA2;TIMP2;PTPN3;PTPN22;TAB3;GPLD1;DAPL1;MET;FOXK2;KDM4A;MFSD2A;SIRT2;ATRAID
prerank,negative regulation of endopeptidase activity (GO:0010951),0.3481074355689277,0.9628460191693663,0.5181818181818182,0.8469454514033663,1.0,7/47,11.25%,RECK;SERPINI1;SPOCK2;TIMP3;SPOCK3;GAPDH;SPOCK1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.42510412977804235,0.962841256312046,0.5094339622641509,0.8464339167354825,1.0,4/17,11.50%,PRKG1;MEF2C;PDCD4;APLN
prerank,regulation of cartilage development (GO:0061035),0.41315791245518774,0.962603920304827,0.49528301886792453,0.8464486918829836,1.0,4/18,12.33%,BMPR2;MBOAT2;ZBTB16;SOX6
prerank,entry into host (GO:0044409),-0.3830843286986161,-0.9625892936153718,0.5188916876574308,0.8652885907925941,1.0,5/13,10.80%,ITGAV;CDH1;SRC;PPIA;MET
prerank,neuron migration (GO:0001764),0.34913271838655785,0.9620619417030251,0.5074024226110363,0.8471246632232736,1.0,9/48,12.17%,RAPGEF2;CEP85L;NR4A2;MEF2C;NRCAM;RAC1;NAV1;SPOCK1;MARK2
prerank,positive regulation of viral life cycle (GO:1903902),0.4034575923218765,0.9616906345377451,0.5089020771513353,0.8474298508114776,1.0,5/22,15.00%,LGALS9;TRIM11;VPS4A;CHMP3;CHMP2B
prerank,response to progesterone (GO:0032570),0.42371403819386927,0.9612719730457723,0.5037481259370314,0.8477956619704606,1.0,8/18,22.55%,CAV1;TGFB2;UBE3A;ACOD1;ABHD2;WBP2;CATSPER3;YAP1
prerank,negative regulation of immune system process (GO:0002683),-0.36814492356121253,-0.960847674791597,0.5038560411311054,0.8687831118132798,1.0,4/16,16.72%,COL3A1;IL17D;HOXA7;GPER1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.4228260082973029,0.9607208802793165,0.5228346456692914,0.8484496559101192,1.0,4/16,13.94%,SNAI2;BCL2L1;CLU;CDKN2D
prerank,regulation of aerobic respiration (GO:1903715),0.41904318403833524,0.9606000439519606,0.5080385852090032,0.8482026694009098,1.0,5/15,22.54%,ATP7A;SLC25A33;CBFA2T3;UQCC2;NOP53
prerank,peptidyl-lysine acetylation (GO:0018394),-0.4161338516587627,-0.96041229656706,0.5012165450121655,0.8685448106655256,1.0,3/10,12.39%,CREBBP;KAT2B;ESCO1
prerank,cellular defense response (GO:0006968),-0.28533594557882996,-0.9602336368155945,0.5095057034220533,0.8676374087214338,1.0,5/40,8.29%,DCDC2;LBP;LSP1;CCR9;TCIRG1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.4526135099410436,0.9600484683903859,0.5397350993377483,0.8488829485455226,1.0,5/11,20.60%,RNF185;BAG6;UGGT1;RNF5;POMT2
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.34231988648435,0.9598887311122855,0.5150753768844221,0.848705540918484,1.0,23/64,24.36%,ELOC;RTF1;EAF1;ELP4;ELP2;POLR2G;ELOA;POLR2D;GTF2H3;EAF2;MLLT3;ELOF1;POLR2I;AFF4;NELFB;NELFA;SETD2;MNAT1;IWS1;POLR2C;POLR2B;POLR2J;CCNH
prerank,stress granule assembly (GO:0034063),-0.3405209255578808,-0.9597460137319327,0.48732394366197185,0.8676505347430269,1.0,6/20,13.72%,YTHDF1;ATXN2;UBAP2L;YTHDF2;DDX3X;PRRC2C
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.3183361006583428,-0.9597311072052154,0.5434083601286174,0.8663809869822435,1.0,8/26,12.68%,ERRFI1;CBLB;SHC1;SNX6;TGFA;TSG101;ADRA2A;HBEGF
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.38378665325381567,-0.9594416294809212,0.5051813471502591,0.8657967547080232,1.0,5/12,21.89%,NINL;BICD2;KIF3A;CCDC68;CCDC120
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.33309659302760247,0.9592009790953563,0.5045045045045045,0.8496682601664489,1.0,9/63,13.34%,PLK3;BTG2;CASP2;CDC25C;CRADD;CNOT6L;CNOT1;E2F7;ATM
prerank,vesicle transport along microtubule (GO:0047496),-0.3214219626347623,-0.9589831989519487,0.49390243902439024,0.8657026213121303,1.0,9/23,24.59%,TRAK1;NDE1;KIF13A;NDEL1;KIF3A;FBXW11;CLN3;KIF5B;KIF1C
prerank,ribosome assembly (GO:0042255),0.3505107439738419,0.9588953506329188,0.5039370078740157,0.8498546159862519,1.0,18/47,24.89%,BOP1;DHX37;RPS14;RPS28;NPM1;RPS5;RPL23A;RPS15;EIF6;EIF2A;EFL1;PWP2;RSL24D1;RPS19;NOP53;RPF2;RPL3;MDN1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.446724651860037,0.9587888549008214,0.5115894039735099,0.8495765370466724,1.0,2/12,10.31%,DAB2IP;PTPN1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.33093770902796354,-0.9586663482886854,0.48753462603878117,0.8652178189639167,1.0,9/22,22.21%,ANK2;CALM2;ATP1B1;GSTM2;JPH2;SLC9A1;P2RY6;STAC3;GSTO1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.23772414626049407,-0.9586573315362984,0.5472972972972973,0.8639449795088672,1.0,30/101,19.84%,SAMD4A;OGT;CYFIP2;THBS1;FXR2;NIBAN1;DACT1;PLXNB2;YTHDF1;IST1;ERBB2;PCIF1;LARP4B;CPEB3;DDX3X;EIF3D;BCL3;AGTR1;ATG7;RPS4X;NR1H3;EIF3E;AMER1;STUB1;EZR;FBXW11;FGFR4;UPF3B;LARP6;INHBA
prerank,generation of neurons (GO:0048699),0.29744192070864894,0.9585554516914966,0.5709677419354838,0.8495638969461565,1.0,28/190,14.28%,RAPGEF2;CEP85L;NR4A2;NEUROG2;ATP2B2;EML1;HEY1;OLIG2;TGFB2;TAFA1;HEY2;MEF2C;MYEF2;PRUNE1;NGRN;NRCAM;RAC1;NAV1;SPOCK1;MARK2;CX3CR1;POU3F2;PIN1;HMGB2;MYT1L;HES3;CTNNB1;FZD3
prerank,positive regulation of cell growth (GO:0030307),0.31930181875453667,0.9583683519136138,0.5393654524089306,0.8494280889883553,1.0,18/96,13.67%,EDN1;MACF1;ITSN2;TGFB2;NTN1;SHTN1;SEMA7A;BRAT1;TAF9B;ADAM17;SLC25A33;ISLR2;ADAM10;RPS6KA1;NEDD4L;SMURF1;RPS6KA3;RASAL1
prerank,retinal metabolic process (GO:0042574),-0.39064155828926606,-0.9583030784861214,0.5066666666666667,0.863582531042399,1.0,4/12,29.59%,ABCA4;ALDH1A3;DHRS13;BCO2
prerank,cellular response to starvation (GO:0009267),0.3059892925858269,0.9574473681436634,0.5549389567147613,0.8509881216932403,1.0,18/147,10.26%,NUAK1;BMPR2;FAS;CASTOR1;FOXO1;PRKD1;STK24;DAP;GABARAPL1;MAPK1;LRRK2;ZC3H12A;WDR59;SIK2;PRKAA1;PIK3C3;RIPOR1;RRAGD
prerank,intracellular protein transport (GO:0006886),-0.21400744919538528,-0.9569130886488793,0.68,0.8659455001541712,1.0,80/304,18.27%,RANBP3L;WLS;APPL2;SGSM2;STX4;GGA2;TBC1D2B;TRAK1;SNX6;VPS26B;UNC93B1;SIL1;COPZ2;TBC1D9B;NUP107;C2CD5;SURF4;VIPAS39;COPA;CLIP3;VPS45;LMAN1;HEATR3;KIF13B;CSE1L;ARF1;GRTP1;PPP1R10;KIF13A;SEC31A;STX3;ADPRH;COX18;RAB22A;NUP155;ARCN1;COPB2;TNPO3;ARF5;TBC1D16;EIF2D;ARL6;RANBP6;STX5;RABGAP1L;HOMER3;TMED3;ARL4A;SNX1;PKD1;VPS33A;STX16;FAM53C;TBC1D17;IPO5;HDAC6;SAR1A;BAG3;NUP93;NAPA;TRIM23;HPS4;TNPO2;IFT27;SNX8;RANBP17;GGA1;SEC16A;ARL5A;STX17;RANBP3;TMED1;GABARAP;TSC2;PHB2;CD74;AP1S3;VPS33B;RAB29;SAR1B
prerank,regulation of NMDA receptor activity (GO:2000310),-0.2988839309341807,-0.956827687554391,0.5287769784172662,0.8648505002015442,1.0,5/32,6.67%,DAPK1;GRIA3;ACTN2;DLG4;SLC6A9
prerank,heterochromatin assembly (GO:0031507),-0.33588537407136165,-0.9567817748046039,0.5205479452054794,0.8636948397982028,1.0,5/20,14.94%,HDAC1;RRP8;HMGA2;SUV39H1;SIRT2
prerank,prostaglandin biosynthetic process (GO:0001516),0.41103422960431035,0.9566997186988009,0.49756888168557534,0.852131400843882,1.0,1/18,0.48%,EDN1
prerank,cellular response to insulin stimulus (GO:0032869),0.3121752962969377,0.9564019311330316,0.5468036529680366,0.8522704677759173,1.0,16/124,8.71%,CEACAM1;FOXO4;IRS4;FOXO1;INSR;CAV2;PIK3C2A;HDAC9;INPP5K;PDE3B;BCAR3;PCK2;SLC25A33;SYAP1;APC;NAMPT
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.3994857087356614,0.9563946906704061,0.5142002989536621,0.8517690149227647,1.0,12/20,29.01%,PLSCR1;PTDSS1;GSS;GAMT;GATM;CHAC2;MTHFS;GGCT;GCLM;FPGS;OPLAH;CNDP2
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.45002248409423057,0.9563680962463919,0.5247208931419458,0.8513218628692243,1.0,5/13,25.31%,DUSP1;NDC80;LCMT1;GEN1;TPR
prerank,positive regulation of stress fiber assembly (GO:0051496),0.35047991182507776,0.9562236040613938,0.5026315789473684,0.8511250392896454,1.0,12/44,13.80%,LIMCH1;ARHGEF15;APOA1;EVL;PPM1F;CD47;RAC1;CCDC88A;NF2;ITGB1BP1;SORBS3;ARHGEF10
prerank,water transport (GO:0006833),0.4495103139782055,0.9562138277135721,0.5310457516339869,0.8506227327256386,1.0,1/12,2.28%,AQP11
prerank,"wound healing, spreading of cells (GO:0044319)",0.3921240495436293,0.9560464278413461,0.5132867132867133,0.8504684615278424,1.0,7/24,15.17%,CEACAM1;ACVRL1;ADAM17;MRTFA;ITGA5;LCP1;PDCD10
prerank,transition metal ion transport (GO:0000041),0.36734700582406415,0.9559974923295065,0.5133614627285513,0.8500656645011923,1.0,10/35,17.97%,ATOX1;ATP2C1;ATP7A;SLC31A1;SLC30A1;CP;TRPC7;TRPC5;HEPH;ATP7B
prerank,gas transport (GO:0015669),-0.40953418776234624,-0.9559458312504033,0.5142857142857142,0.8646336642275391,1.0,7/10,45.73%,CA2;CYGB;MYC;AQP1;MB;NGB;RHAG
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.29765839770321095,-0.9553003304728388,0.5,0.8650784968437853,1.0,5/32,7.01%,AUTS2;PLCE1;RREB1;SRC;PIK3R1
prerank,gluconeogenesis (GO:0006094),-0.2875873529486594,-0.9552938562541607,0.5,0.8638104830875908,1.0,13/39,21.23%,SLC39A14;SLC25A13;RBP4;ENO2;PGM1;MDH2;SLC25A12;GOT1;PFKFB1;CRTC2;G6PC3;TPI1;ENO3
prerank,regulation of presynapse assembly (GO:1905606),-0.3476234203148075,-0.9552443650978122,0.5165745856353591,0.8613766518152297,1.0,1/18,0.01%,GPC6
prerank,regulation of presynapse organization (GO:0099174),-0.3476234203148075,-0.9552443650978122,0.5165745856353591,0.8613766518152297,1.0,1/18,0.01%,GPC6
prerank,negative regulation of coagulation (GO:0050819),0.44116084203834,0.9551174776166281,0.5194805194805194,0.8515281888717142,1.0,5/14,12.94%,EDN1;CD34;PROC;HS3ST5;APOH
prerank,regulation of autophagy (GO:0010506),0.2993895553869595,0.9550941460798149,0.5692963752665245,0.8510655942966583,1.0,53/216,19.95%,ACER2;RASIP1;TRIM14;DRAM1;FBXL2;FOXO1;PRKD1;PIK3C2A;ATG101;GPR137B;DAP;TRIM6;SMCR8;SH3BP4;DEPP1;LRRK2;IRGM;ZC3H12A;HSPB1;PRKAA1;GAPDH;ROCK1;HMGB1;FBXW7;RRAGD;TPCN2;EXOC8;TAB2;VPS35;TRIM8;DRAM2;PIK3CB;KEAP1;ATM;BNIP3;RHEB;RUBCN;RMC1;UBQLN2;VDAC1;TRIB3;ATP6V1G1;EXOC4;BMF;GSK3A;ATP6V1C1;CAPN1;RRAGA;RRAGC;ERN1;MCL1;ATP6V0A1;GSK3B
prerank,nuclear membrane organization (GO:0071763),-0.33930634493960177,-0.9548957678274281,0.5044510385756676,0.8609969409768066,1.0,7/19,16.72%,TOR1AIP1;TOR1B;UBXN2B;TARDBP;SPAST;AKAP8L;GPER1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.2809516954349027,-0.9548876346885833,0.5320754716981132,0.8597396318954897,1.0,7/41,13.74%,PRKAG2;OGT;NUP107;LACC1;NUP155;AAAS;NUP93
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.38055223891460277,0.9548293680250954,0.5291666666666667,0.8511148305455369,1.0,4/29,10.46%,SYCP2;RAD21;MEI4;BAG6
prerank,triglyceride metabolic process (GO:0006641),-0.2761066757426924,-0.9546998725810001,0.5109170305676856,0.8589398382245184,1.0,6/48,9.95%,AGMO;LPGAT1;APOE;MOGAT3;DGAT1;GK
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.4108923782898146,0.9544892517638977,0.5362537764350453,0.8513421061186737,1.0,10/19,27.90%,CEBPA;BRF2;ICE1;TENM1;ZC3H8;POLR3C;DHX36;RPTOR;PRDX5;ICE2
prerank,regulation of intracellular transport (GO:0032386),0.36123901769131356,0.9534324315702276,0.5344352617079889,0.8531458622900837,1.0,10/38,18.63%,MYBPC3;LRRK2;NEFH;PTPN1;NUMA1;INPP5F;LCP1;MAP2;RNF139;HAP1
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.29933232554559325,-0.9533947706062185,0.5616438356164384,0.8612181694992207,1.0,13/33,23.49%,SCAF8;NUDT21;NCBP1;PABPN1;SNRPF;PCF11;CSTF2T;SNRPD3;LSM11;SLBP;PAPOLA;NCBP2;LSM10
prerank,negative regulation of leukocyte activation (GO:0002695),0.4239416343122104,0.9531782018065571,0.5205047318611987,0.8531912963207842,1.0,4/15,8.17%,FCGR2B;MILR1;ZC3H12A;CD200
prerank,membrane lipid catabolic process (GO:0046466),0.46877634399727147,0.9527875428424951,0.5291095890410958,0.8535615759357933,1.0,1/10,3.23%,PPT1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.4292647656844937,0.9527029212329573,0.4876847290640394,0.8532391141169137,1.0,5/13,16.22%,PTPN1;PPP1R15B;ABCA7;RACK1;NCK1
prerank,COPII-coated vesicle budding (GO:0090114),-0.2579674689934344,-0.952687607208843,0.5943396226415094,0.8618947425818733,1.0,35/68,29.14%,SEC24D;GOLGA2;TGFA;TRAPPC10;LMAN1;SEC31A;STX5;SEC24C;SAR1A;TRAPPC3;SEC16B;VAPB;NAPA;F5;CTSC;SEC23B;SEC16A;SCAP;TBC1D20;SAR1B;PPP6R1;BET1;SEC13;PREB;SEC23A;TRAPPC6A;COL7A1;TRAPPC4;CTSZ;CNIH3;F8;SEC31B;GORASP1;TRAPPC2L;PPP6R3
prerank,regulation of T cell activation (GO:0050863),0.35975707720997313,0.9525874884480356,0.5080428954423593,0.852964799750356,1.0,5/42,11.28%,CRTAM;TNFRSF1B;CD47;DUSP3;LAPTM5
prerank,protein-containing complex disassembly (GO:0032984),0.34656988786098963,0.9525093851595993,0.5380645161290323,0.852607597006548,1.0,12/54,14.45%,CAV1;VTI1B;GABARAPL1;TECPR1;VAMP8;APC;VAMP7;LIX1;VPS4A;CHMP3;CTNNB1;MAP1LC3A
prerank,RNA splicing (GO:0008380),-0.24196555339067682,-0.9521534150374905,0.6114649681528662,0.8620875142482429,1.0,32/95,25.22%,NOVA1;SNRNP40;SCAF11;NCBP1;PRPF8;SRRM1;FUS;CDK12;PRPF3;TARDBP;SNRPF;WBP4;SNRPA1;SCNM1;MAGOH;PPP2CA;BCAS2;SNRPD3;MAGOHB;MPHOSPH10;LSM6;SF3B1;SRPK2;DHX8;SRSF11;NCBP2;TCERG1;DHX15;WDR83;U2AF1;SRSF2;SNRPD1
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.42266782466438696,0.951989295847884,0.540453074433657,0.8532494703671005,1.0,3/15,9.00%,EDN1;CAMK2D;ROCK1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.2494167167524471,-0.9517297255599155,0.5314285714285715,0.861881421972483,1.0,23/80,19.45%,SAMD4A;ROCK2;SLC2A13;THBS1;FXR2;NIBAN1;PLXNB2;YTHDF1;SIRT3;CASP3;ERBB2;PCIF1;LARP4B;CPEB3;DDX3X;EIF3D;BCL3;RPS4X;EIF3E;PLA2G6;PRKCD;UPF3B;LARP6
prerank,GPI anchor metabolic process (GO:0006505),-0.31448931832779636,-0.9511246799654677,0.5077399380804953,0.8621520479446491,1.0,14/26,26.87%,PIGA;GPLD1;PIGB;PIGN;PIGH;PGAP2;DPM2;PIGG;PIGP;PIGZ;PGAP4;PGAP3;PIGL;PIGW
prerank,glycosphingolipid metabolic process (GO:0006687),0.35526199805419106,0.9506967124935084,0.5398936170212766,0.8555205631610536,1.0,5/42,10.15%,ST6GALNAC3;ESYT2;GLTP;A4GALT;B4GALT6
prerank,neuron apoptotic process (GO:0051402),0.4009529594844796,0.9506679266610876,0.5296803652968036,0.855056186113633,1.0,5/19,14.50%,FAS;APP;GAPDH;BNIP3;TRPC5
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.36326101446356135,-0.9491667177381734,0.5471698113207547,0.8659191534876837,1.0,6/15,15.72%,GPLD1;SLC27A1;SREBF1;MFSD2A;SIK1;NR1H3
prerank,proteasomal protein catabolic process (GO:0010498),0.29443406018412294,0.9481627461958584,0.564755838641189,0.8598823973399797,1.0,55/201,20.48%,ZNRF1;PSMD13;RHBDD1;RNF185;CUL3;PSMD4;KLHL20;SOCS6;ARRB1;NFE2L2;WWP1;FEM1C;NR1D1;PPP2R5C;SIAH2;PSMA5;PSMB10;FBXW7;RBX1;ENC1;BAG6;PSMB8;NEDD4L;PSMD14;SMURF1;KCTD10;RMND5B;PSMA7;PSMA8;PSMC3;PSMB5;CTNNB1;PSMC1;PSMC5;UBE2D3;NHLRC1;TRIM2;PSMC6;PSMB9;SPOPL;RNF139;UBXN6;PSMA4;SEL1L;GSK3A;CCDC47;PSMD5;PSMD9;PSMB6;FBXO45;MAEA;ZFAND2A;KCTD2;RNF5;RNF34
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.4005594949457684,-0.9474125779926015,0.511002444987775,0.8692033385393693,1.0,7/10,33.77%,MTHFD1;MTHFD2L;TYMS;MTHFR;DHFR;SHMT2;SHMT1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.37602707957621606,0.9471567837370207,0.5369030390738061,0.8615719315472371,1.0,9/28,20.25%,DAB2IP;CASP8;CRADD;DELE1;CASP8AP2;DAXX;DDX47;BID;SORT1
prerank,gene expression (GO:0010467),0.2861131032563057,0.9465556580152998,0.6138211382113821,0.8623924387736247,1.0,92/348,20.95%,NR4A2;ADARB1;RBPMS;HHEX;RPS21;RPL27;TSPAN14;DDX39A;RPL7;TSPAN32;FARSB;WARS1;MRPL18;SETX;CPSF1;MRPL41;RPS27A;RPS14;POLR2G;RPL35;ELAVL4;ADAR;NUP54;MLF1;RPL21;DKC1;DUSP11;POLR2D;RPL37;HNRNPK;NFKBIB;RPS28;NUP35;MRPL52;RPL34;RPS9;MRPL36;FIP1L1;RPLP2;RANBP2;XRN2;RPS25;MRPL23;CHTOP;NUP153;RPL30;SRSF9;RPL27A;RPS5;ATXN1;MRPL24;NUP160;THOC3;MRPL32;TAF1B;RPL23A;MRPS12;NUP42;RPS15;PRPF4;RPL19;RPS18;RPL32;POLR2I;DHX38;NUP205;DROSHA;RPL37A;MMS19;PWP1;RPL18A;POLDIP3;MRPS18B;COPS5;DDX39B;HOXD3;GOLPH3;HNRNPUL1;LMF2;SYNCRIP;MEF2A;SMG7;PTMA;DARS1;RRAGC;CPSF3;YTHDC1;MRPL11;RSL24D1;RPL18;RPL39;SORL1
prerank,mitotic cell cycle phase transition (GO:0044772),0.29938901276272917,0.946161652319032,0.5879873551106428,0.8627470376167785,1.0,44/203,21.17%,PLCB1;CCNY;CCND2;PLK3;CCND3;CDK14;ACVR1;CCNE1;CSNK1D;TUBB;CUL3;CDC25C;TUBB4B;CLASP1;NEDD1;HAUS3;CEP135;PCM1;TPD52L1;CLASP2;CUL2;CEP76;DYNLL1;HINFP;ARPP19;USP29;RPS6KB1;TUBA1A;CDKN2D;CDC27;CHMP7;NES;ANAPC7;CACUL1;E2F3;ACTR1A;FBXL6;FBXL15;PPME1;CEP192;MAX;LCMT1;BCAT1;MNAT1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.4428354940138682,0.946101832403996,0.5124792013311148,0.8623625326800795,1.0,3/10,13.71%,TBX1;STAT1;LRP5
prerank,negative regulation of cell cycle (GO:0045786),0.32142047288510106,0.9457065051670981,0.5444305381727159,0.8627459364245467,1.0,14/73,12.02%,DUSP1;RHOB;BTG2;BTG1;HHEX;PPP1R13B;GMNC;GATA3;PDCD4;CEBPA;APC;ANGEL2;NPPC;NR4A1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.3961385500150153,0.9455563924632723,0.5236641221374045,0.8625315917084012,1.0,7/20,19.95%,FAS;CASP2;BCL2L1;DCC;GSK3A;MCL1;GSK3B
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.36838949336813487,-0.9452839971553595,0.5252525252525253,0.873682827851906,1.0,5/15,13.44%,APOE;ADAM9;GPLD1;ADRA2A;PACSIN3
prerank,positive regulation of receptor internalization (GO:0002092),0.3862371893765173,0.9447003455695696,0.5494011976047904,0.8638566349929724,1.0,5/22,11.50%,INSR;ANGPT1;ARRB1;TBC1D5;APLN
prerank,B cell mediated immunity (GO:0019724),0.4577289875994922,0.9446432308381154,0.5435168738898757,0.8634462640968626,1.0,1/10,4.01%,FCGR2B
prerank,negative regulation of lipid catabolic process (GO:0050995),0.4116153818171533,0.9444121284379757,0.5215384615384615,0.8634377065815575,1.0,3/17,8.31%,PDE3B;ALK;PRKAA1
prerank,heterocycle biosynthetic process (GO:0018130),0.4293518149928869,0.9443237095367132,0.5286624203821656,0.8631203085012701,1.0,2/14,3.89%,GCH1;GPHN
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.4288607819330782,0.9439759068662954,0.5236541598694943,0.8633169250616263,1.0,1/13,0.28%,KCNQ1
prerank,regulation of axon regeneration (GO:0048679),-0.3788170507835338,-0.9437112967143786,0.5515463917525774,0.8764727318092851,1.0,1/12,0.30%,PTN
prerank,neuromuscular junction development (GO:0007528),0.39270016958733234,0.9437039001454398,0.5477611940298508,0.8633860351406161,1.0,5/24,6.86%,UNC13B;AGRN;PPFIBP1;GPHN;LRRK2
prerank,peripheral nervous system development (GO:0007422),0.38707725930624237,0.9433365095130635,0.5426008968609866,0.8636803798490202,1.0,6/23,14.74%,SERPINI1;ASIC2;NFASC;ADGRB1;SOX10;GFRA3
prerank,protein-containing complex assembly (GO:0065003),0.28943019288055405,0.942880387762441,0.6118626430801248,0.8641577877910566,1.0,48/259,16.08%,CD2AP;SKAP2;MAGI1;FAS;SLC2A1;OCLN;AIM2;CASP8;ANO6;CARD10;LEF1;CSNK1D;TMED10;TRAF1;MCFD2;CUL3;CD247;P2RX7;LRRK2;ZC3H12A;IL1RAP;GRIA1;APC;TCF7L1;ADAM10;DHX9;RBX1;AP2M1;RANBP9;PDZD11;TRAPPC2;TRAPPC6B;ITGB1BP1;CAPG;TAPBP;SEC24B;NOL3;NSF;PPIH;CTNNB1;KPNA3;CSNK2B;TRAPPC5;TRRAP;CLDN14;VIL1;FERMT3;SAMM50
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.4036512638362191,0.9423789016624514,0.5195007800312013,0.8647253709405497,1.0,7/18,23.75%,PUM2;RNF125;SEC14L1;DHX58;ANKRD17;NOP53;OASL
prerank,mRNA modification (GO:0016556),0.3934020886459213,0.9423100452237361,0.523168908819133,0.8643648091047152,1.0,6/22,13.15%,TRMT61A;DKC1;TRUB1;TRMT61B;VIRMA;METTL14
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.3530169999110554,-0.9420312191771218,0.5190217391304348,0.8796464673074439,1.0,7/17,20.63%,WNT4;BMP4;RUNX1;CREB3L1;LARP6;TGFB3;RGCC
prerank,protein depolymerization (GO:0051261),-0.3045847673998009,-0.941850339562413,0.5530546623794212,0.8788629790085525,1.0,6/27,9.69%,MICAL3;GSN;MICAL2;NCKAP5;CKAP5;STMN4
prerank,response to reactive oxygen species (GO:0000302),-0.26353289864940155,-0.9416586814967878,0.5306122448979592,0.878091648332197,1.0,14/54,15.22%,EGFR;PDGFRA;PTPRK;APOD;APOE;TPM1;CAT;ADAM9;HYAL1;PRDX3;FER;CHUK;MPV17;PDK2
prerank,long-chain fatty acid import into cell (GO:0044539),0.45064211950214,0.9413939632256,0.5570934256055363,0.8658361493981352,1.0,3/10,14.03%,SLC2A1;RPS6KB1;SLC27A2
prerank,gliogenesis (GO:0042063),0.4253470418079098,0.9413547580011009,0.5434439178515008,0.8653986617345635,1.0,4/15,14.61%,TGFB2;CDH2;METTL14;CD9
prerank,canonical Wnt signaling pathway (GO:0060070),0.32582885991702726,0.9411717228600176,0.5703883495145631,0.8652694939970195,1.0,13/68,14.28%,FZD6;NR4A2;CAV1;LEF1;GATA3;LRRK2;CDH3;APC;TCF7L1;LRP5;CTNNB1;FZD9;FZD3
prerank,endocytic recycling (GO:0032456),0.3451639708625199,0.9410473956170795,0.546916890080429,0.865042766845208,1.0,6/50,13.40%,EHD4;EHD1;LMTK2;RAB35;VPS35;RAB11FIP4
prerank,DNA double-strand break processing (GO:0000729),0.40321484848125355,0.9409969930519423,0.5168195718654435,0.8646457145002,1.0,7/18,20.78%,RBBP8;EXD2;BRCA1;SMARCAD1;ATM;BARD1;BLM
prerank,modification-dependent protein catabolic process (GO:0019941),0.2942904061213445,0.9407295603196444,0.5987193169690501,0.8647226604523222,1.0,52/193,20.84%,CBL;FBXO7;PSMD13;FBXL14;KLHL3;ELOC;RNF125;RNF185;ARIH1;CUL3;ARRDC1;UBE2D1;PTTG1;ARRB1;UBE4A;FEM1C;UBA52;RPS27A;NDFIP2;SIAH2;ZNRF3;RNF128;RBX1;TRIM25;RNF144B;BAG6;NEDD4L;PSMD14;DTX3L;SMURF1;KCTD10;KEAP1;UBE2E1;CDC27;UBE3B;KLHL25;RNF150;UBQLN2;ANAPC7;UBQLN4;FBXO8;FBXO10;PSMD9;FEM1A;FBXO45;ANAPC4;RNF166;KCTD21;RNF5;RNF11;RNF34;UBA1
prerank,sodium ion transmembrane transport (GO:0035725),0.31667202555217827,0.9406890043852696,0.5547533092659447,0.8642937571431242,1.0,13/84,10.09%,SLC6A6;ATP1A4;ATP1A3;ATP1A1;SLC8A1;ANO6;SCN11A;SLC6A4;SCN1B;ASIC2;SLC9A7;SLC6A17;SLC6A2
prerank,negative regulation of protein phosphorylation (GO:0001933),0.2973845654197704,0.9398381860950955,0.5982532751091703,0.8655598492854524,1.0,21/150,9.94%,ENG;SMAD6;CEACAM1;CNKSR3;SMAD7;OCLN;GNAQ;DAB2IP;CAV1;INPP5K;PPM1F;WWTR1;WARS1;SMCR8;LRRK2;ZC3H12A;HSPB1;PRR5L;CACTIN;PMEPA1;PRNP
prerank,regulation of erythrocyte differentiation (GO:0045646),0.3572036238879885,0.9397260710850245,0.5625,0.8652831068452022,1.0,12/35,22.65%,TAL1;STAT1;HSPA1B;BRD1;HIF1A;HMGB2;ACVR2A;MAPK14;ETS1;FAM210B;ZFP36L1;MAPK11
prerank,regulation of signal transduction (GO:0009966),0.2950569766362843,0.9396365682994331,0.6056338028169014,0.8649700303881123,1.0,35/190,13.79%,RGS3;PLCB1;FYN;MFNG;LIFR;CASTOR1;KAZALD1;PRKD1;APP;CRK;LRIT3;ACVR1;GIT2;WWTR1;KIF26A;TMEM204;IRAK2;TSPAN12;GATA3;IGFBP7;LRRK2;SIK2;PLSCR1;IGFBP4;TCF7L1;PRNP;PTPN1;GNG4;KCTD8;CLU;CBFB;ITGB1BP1;WDR11;RGS12;ITGA3
prerank,regulation of viral genome replication (GO:0045069),0.33884429010497547,0.9394468100065477,0.5694618272841051,0.8648711618488191,1.0,17/56,21.28%,ADARB1;IFIH1;TRIM6;PPIE;PLSCR1;OAS2;ADAR;PPIH;PKN2;SLPI;SRPK1;RSAD2;IFITM3;PPID;ZC3HAV1;EIF2AK2;BANF1
prerank,positive regulation of embryonic development (GO:0040019),0.4001764180135998,0.9392670878374731,0.540625,0.8647519999396881,1.0,5/19,18.12%,PLCB1;TENM4;CFL1;RACK1;ZBED3
prerank,cilium organization (GO:0044782),0.2954272163389061,0.9390297144316375,0.6187961985216474,0.8647379710443257,1.0,24/209,11.00%,EXOC6;EHD4;ABCC4;ABLIM1;NOTCH1;RAB11A;TTC29;EHD1;TEKT5;FAM161A;BBS7;TTBK2;TTC36;SNX10;FNBP1L;RAB23;TMEM216;IFT140;CFAP43;PCM1;CDC14A;CFAP52;DYNLL1;EXOC8
prerank,anterior/posterior pattern specification (GO:0009952),0.3381958390300941,0.9387587572321827,0.5381679389312977,0.864788115819672,1.0,7/53,5.12%,BMPR2;TBX1;HEY1;HHEX;HEY2;PCSK5;SMAD2
prerank,prostaglandin metabolic process (GO:0006693),0.37374687509072113,0.9387278475102949,0.5442477876106194,0.8643318399480281,1.0,3/26,10.24%,EDN1;ACOX1;PTGES3
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.4353787233160118,0.9387065108132135,0.5297202797202797,0.8638767022995908,1.0,5/12,14.46%,KPNB1;MBTPS2;SEC14L2;LPCAT3;RAN
prerank,negative regulation of bone mineralization (GO:0030502),0.4279555953664357,0.9384035457913097,0.554858934169279,0.864009864948371,1.0,1/13,1.15%,CCR1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.32342166511806436,-0.9382191800840742,0.5525525525525525,0.886105704220847,1.0,9/22,24.12%,DMD;AHNAK;CACNB1;CACNB2;DRD2;PDE4B;CACNB3;STAC3;CBARP
prerank,negative regulation of phosphatase activity (GO:0010923),0.3888600856503465,0.9378556172221085,0.5493562231759657,0.8646979841607756,1.0,4/25,6.40%,TGFB2;FKBP1A;ZCCHC9;GPATCH2
prerank,sulfur compound transport (GO:0072348),0.3772975538330146,0.9375736068265432,0.5396825396825397,0.8648006136512763,1.0,1/27,0.19%,SLC6A6
prerank,regulation of humoral immune response (GO:0002920),0.3440655858372127,0.9371835331355794,0.546284224250326,0.8650728057402487,1.0,7/44,13.58%,GATA6;FCGR2B;SUSD4;CR1L;CLU;CFB;CR2
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.39068578112859886,0.9369475788333482,0.543509272467903,0.8650891073359941,1.0,6/24,16.32%,FYN;ITGAM;MYO1C;PRNP;ITGB1BP1;ANK3
prerank,snRNA metabolic process (GO:0016073),0.4097296352487422,0.9369360056578578,0.5256609642301711,0.8646052932814189,1.0,4/17,14.31%,RBM7;INTS11;INTS12;INTS5
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.364883265124612,-0.9367046225105287,0.5457063711911357,0.8885534489927871,1.0,3/15,4.98%,LACTB2;DICER1;NYNRIN
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.31855965007011333,0.9366768373955473,0.5529265255292652,0.8646284115048362,1.0,14/79,13.68%,MFSD6;AP1S2;AP2B1;FCGR2B;KIF26A;ACTR1B;KIF2A;OSBPL1A;AP2M1;DYNLL1;KLC2;DYNC1LI2;SEC24B;AP1B1
prerank,fatty acid transport (GO:0015908),-0.33794195239742447,-0.9365721671271168,0.5230352303523035,0.8876098727666557,1.0,5/17,14.80%,ACSL1;APOE;SLC27A1;PPARG;MFSD2A
prerank,regulation of nuclear division (GO:0051783),0.3988586500859319,0.9362884108471601,0.5517241379310345,0.8649507305333397,1.0,3/20,13.32%,CAV2;CDC25C;PIN1
prerank,cellular response to nutrient levels (GO:0031669),0.3274664059007586,0.9362105239630383,0.5448798988621998,0.8646030798505302,1.0,8/62,10.26%,BMPR2;FOXO1;FAM107A;STK24;LRRK2;PRKAA1;RIPOR1;RRAGD
prerank,mRNA methylation (GO:0080009),0.4209367988396745,0.9361130497037128,0.5415282392026578,0.8643195424151192,1.0,4/15,13.15%,TRMT61A;TRMT61B;VIRMA;METTL14
prerank,negative regulation of biosynthetic process (GO:0009890),0.40984341409073877,0.9359903630750293,0.5418641390205371,0.8640803695699233,1.0,1/16,0.80%,CEACAM1
prerank,cellular response to purine-containing compound (GO:0071415),0.45163285446374596,0.9355254027764394,0.552212389380531,0.8646288238204293,1.0,4/10,23.42%,SLC8A1;TRPM2;P2RY1;RYR2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.3507371522311733,-0.9351990215592844,0.5331632653061225,0.8898393399265973,1.0,4/15,9.01%,BMPER;FGF1;FGF2;VEGFA
prerank,regulation of fibroblast proliferation (GO:0048145),-0.27526545991162205,-0.9351676568392019,0.5766129032258065,0.8886290862860282,1.0,16/45,21.80%,IGF1;PDGFRA;PDGFC;WNT5A;S100A6;PEX2;SPHK1;CD300A;CDKN1A;NLRC3;CD74;MORC3;AGT;NF1;CDK4;E2F1
prerank,mitochondrial translation (GO:0032543),0.30824267390444116,0.9351573495530647,0.5768772348033373,0.8648919536666086,1.0,44/104,29.00%,MRPL4;MRPL18;MRPL41;MRPL1;MRPS31;MRPL15;MRPL19;TUFM;MRPL47;MRPL52;MRPL36;MRPL23;MRPL24;MRPL14;MRPL32;MRPS34;MRPS12;MTIF2;MRPL39;GATB;MRPL54;MRPS18B;MRPS30;GFM1;MTRF1L;MRPL11;MRPS28;MRPS35;MRPS9;MRPS27;TSFM;MRPL34;MRPS24;MRPL35;MRPL10;MRPL27;MRPL38;MRPS18C;MRPL13;AURKAIP1;MRPS18A;MRPL40;ERAL1;IARS2
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.3353233491693307,0.9349530299667228,0.5496083550913838,0.8648263066764261,1.0,9/55,8.99%,FAS;DAB2IP;CAV1;TNFSF10;HYAL2;BBC3;CRADD;BCL2L1;TPD52L1
prerank,ERBB signaling pathway (GO:0038127),0.3252630888343082,0.93455365537525,0.5612244897959183,0.8651679649778743,1.0,14/64,15.86%,PTPRR;RPS6KA5;PIK3C2A;CBL;IQGAP1;ADAM17;MAPK1;PTPN12;PTK2;PLCG1;MATK;SOS1;KIF16B;VIL1
prerank,organophosphate ester transport (GO:0015748),-0.32188593700726276,-0.9343763045319985,0.5396341463414634,0.889475682522847,1.0,10/24,22.80%,OSBPL8;PITPNB;SCP2;TNFAIP8L3;MTTP;PITPNC1;PRELID2;PCTP;PRELID1;PITPNM1
prerank,extracellular transport (GO:0006858),0.4326020044221691,0.9339758612907588,0.5535117056856187,0.865877649975615,1.0,3/12,14.33%,ADCY10;ARRDC1;SPA17
prerank,monocarboxylic acid transport (GO:0015718),0.3400867896463944,0.9339649750016507,0.5562659846547314,0.8653976744557418,1.0,6/51,7.63%,ABCC4;CEACAM1;SLCO1C1;ABCB4;SLC16A2;SLC16A4
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.35173822926950726,-0.9336138219242328,0.5597826086956522,0.8902248614206227,1.0,8/14,31.02%,SLC27A1;CHKB;ETNK2;SELENOI;CHKA;LPIN3;LPIN1;ETNK1
prerank,autonomic nervous system development (GO:0048483),0.40726223389746297,0.9335826278653591,0.5377207062600321,0.8656898071780506,1.0,4/17,12.22%,KIF26A;GATA3;PHOX2A;SOX10
prerank,receptor catabolic process (GO:0032801),0.38548411881004435,0.9332118810769602,0.5434462444771723,0.8659703458723218,1.0,15/24,29.84%,AP2B1;ZNRF3;AP2M1;SMURF1;VLDLR;KIF16B;MVB12A;SNX25;UVRAG;TGFB1;GPRASP1;AP2A1;CLTC;SH3GLB1;AP2S1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.37707590822543396,0.9329129488154944,0.5464949928469242,0.8660718049532853,1.0,8/25,20.60%,OMA1;RNF185;CUL3;BAG6;UGGT1;NGLY1;RNF5;POMT2
prerank,organic anion transport (GO:0015711),0.3209850513790642,0.9327880980936588,0.559322033898305,0.8658241321881106,1.0,8/76,9.15%,LRRC8C;ABCC4;SLCO1C1;SLC17A9;CYB5R1;SLC16A2;MFSD10;SLC4A9
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.29634650630601655,0.9327147806518745,0.6055734190782422,0.8654703318847099,1.0,22/158,11.69%,TRIM14;NOD1;NOD2;CASP8;PRKD1;F2RL1;LGALS9;FKBP1A;TIRAP;ATP2C1;TRIM6;TNFSF10;PLEKHG5;JMJD8;GAPDH;NDFIP2;CASP1;TRIM25;LURAP1;MAP3K3;TAB2;TRIM8
prerank,glycerophospholipid catabolic process (GO:0046475),0.3773214000192785,0.9324676466482327,0.5252525252525253,0.8654773677173615,1.0,5/27,12.19%,GPCPD1;PNPLA6;GDPD1;ENPP6;INPP5F
prerank,negative regulation of cell communication (GO:0010648),0.3968495946433276,0.9323080851014698,0.5423976608187134,0.8652995644862563,1.0,6/21,23.38%,ACVR1;KIF26A;PTPN1;SOCS5;BRAP;HHIP
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.3255952764379331,0.9321166504302483,0.5723350253807107,0.8652063626770379,1.0,22/65,21.13%,PSMD13;PSMD4;PSMA5;PSMB10;RBX1;PSMB8;PSMD14;VPS4A;PSMA7;PSMA8;PSMC3;PSMB5;PSMC1;PSMC5;PSMC6;PSMB9;PSMA4;PSMD5;PSMD9;PSMB6;USP47;PSMB2
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.24579032314579086,-0.9318714316139507,0.6038647342995169,0.8934698269282664,1.0,11/69,8.20%,BCL2;SLC30A10;NDNF;APOE;SET;PRKN;SNX6;NTRK2;NGF;SIX1;PRKCI
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.44908612229204237,0.931462807204461,0.548885077186964,0.8660681984674358,1.0,3/10,11.20%,CAMK2D;STK39;NEDD4L
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.3268227342136948,-0.9311248821798439,0.5497076023391813,0.8940843771862417,1.0,10/20,22.36%,GSN;PLA2R1;THBS1;SFRP4;PRKCI;ITGA4;GPER1;RGCC;CD40;PIAS4
prerank,regulation of necroptotic process (GO:0060544),0.3888165193981895,0.9310648153423094,0.5618320610687023,0.866382580451123,1.0,3/23,2.50%,ARHGEF2;CASP8;SPATA2
prerank,protein processing (GO:0016485),-0.23115910201459813,-0.9308164835879421,0.6641221374045801,0.8935984973006486,1.0,21/102,14.76%,AEBP1;OGT;MMP14;CPE;BACE1;ADAMTS3;HM13;ADAM19;F3;CPXM2;TMEM208;PTCH1;YME1L1;MMP16;KLK2;ZMPSTE24;CPXM1;SPCS3;PCSK7;CLN5;FXN
prerank,RNA biosynthetic process (GO:0032774),-0.29981973798497363,-0.9299397456475934,0.5794701986754967,0.8945416188651983,1.0,10/31,15.83%,RSF1;TAF4;SMN1;SMARCA5;HELB;TTF1;GTF2B;TERT;TAF7;TAF5
prerank,response to nutrient levels (GO:0031667),0.4133543494568887,0.9296639340813411,0.5489296636085627,0.8687939375976722,1.0,7/17,26.95%,FAM107A;PRKAA1;RPS6KB1;EIF4G1;MEAK7;RPTOR;ULK1
prerank,positive regulation of viral transcription (GO:0050434),0.3749726683323806,0.9294885425565929,0.5389221556886228,0.868654173306185,1.0,9/25,23.89%,POLR2G;DHX9;POLR2D;POLR2I;NELFB;NELFA;POLR2C;POLR2B;POLR2J
prerank,regulation of hippo signaling (GO:0035330),0.4080362128811496,0.9289289472973292,0.5524691358024691,0.8693448833243531,1.0,7/17,19.82%,WWC2;MARK3;NF2;MAPK14;SCHIP1;SOX11;SHANK2
prerank,cation transport (GO:0006812),0.2952588747005919,0.9287333890119949,0.6114160263446762,0.869249658237141,1.0,21/167,12.69%,SLC6A6;KCNN4;PIEZO1;RHCG;ATP1A4;SLC5A10;SLC8A1;ANO6;SCN11A;MCOLN1;SLC7A1;KCNC1;NDFIP2;SGK1;SLC6A17;NEDD4L;TRPM2;KCNK9;SLC1A1;KCNC4;KCNA1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.3007047168304333,-0.9286239073467929,0.5824915824915825,0.8966455153038754,1.0,5/30,10.50%,OGT;FHIT;MAP1A;TRIM39;SDCBP
prerank,phospholipid homeostasis (GO:0055091),0.4441918981683226,0.9283321923283313,0.5436241610738255,0.8695877328639978,1.0,2/11,3.52%,HNF4A;APOA1
prerank,positive regulation of inflammatory response (GO:0050729),0.3174671549629505,0.928232838412138,0.5911799761620977,0.8692909878818398,1.0,14/86,12.83%,APP;TLR3;KARS1;HYAL2;PDCD4;CD47;VAMP8;CEBPA;NMI;VAMP7;DHX9;NFKBIA;DDT;ABCC1
prerank,ERK1 and ERK2 cascade (GO:0070371),0.3874514144771866,0.9281028722501211,0.5485294117647059,0.8690691475196827,1.0,5/21,9.45%,LGALS9;APOA1;KARS1;MAPK1;ZFP36L2
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.3453524740719393,0.9279250940390651,0.5571030640668524,0.8689772364138058,1.0,10/42,16.11%,WRNIP1;USP43;POLK;UBA52;RPS27A;TRIM25;POLA1;CDKN2D;RFC2;SPRTN
prerank,amyloid precursor protein metabolic process (GO:0042982),0.3925203153214051,0.9277939007621325,0.5403726708074534,0.8687505566621175,1.0,10/18,23.99%,ADAM17;APH1A;ADAM10;ACHE;LDLRAP1;TMCC2;PSEN2;NSG1;APH1B;NCSTN
prerank,contractile actin filament bundle assembly (GO:0030038),-0.3545967854941568,-0.9275911595113135,0.5444743935309974,0.8968031089032155,1.0,5/15,8.63%,SORBS1;ITGB5;PHACTR1;SRC;FAM171A1
prerank,stress fiber assembly (GO:0043149),-0.3545967854941568,-0.9275911595113135,0.5444743935309974,0.8968031089032155,1.0,5/15,8.63%,SORBS1;ITGB5;PHACTR1;SRC;FAM171A1
prerank,positive regulation of dendritic spine development (GO:0060999),-0.3282403758836757,-0.9275484250324715,0.5670391061452514,0.8956457422396096,1.0,5/20,13.03%,APOE;CAMK1;LLPH;DBN1;CPEB3
prerank,protein acylation (GO:0043543),0.3492347551738806,0.9270155539452448,0.5749656121045392,0.869868592844328,1.0,3/38,2.56%,FOXO1;ZDHHC22;NAT9
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.2928363764303184,-0.9270007923673546,0.5827067669172933,0.8957133273882927,1.0,11/35,16.96%,PPARGC1B;DDX5;ZMIZ1;DDX17;SRC;CALCOCO1;PADI2;SAFB;GPER1;TADA3;AR
prerank,acetyl-CoA metabolic process (GO:0006084),0.41627048336852124,0.926997531280956,0.5561312607944733,0.8694056086234527,1.0,7/15,23.07%,ACACB;HMGCS1;PPCS;MVD;ACAT1;ACLY;MVK
prerank,negative regulation of signal transduction (GO:0009968),0.28781133385341545,0.9264766367618924,0.6470588235294118,0.870009752369782,1.0,44/249,13.14%,PTPRJ;MMRN2;GATA2;NR4A2;EGFL7;HEY1;DAB2IP;DLL4;HHEX;INPP5K;ACVR1;NTN1;KIF26A;PTPRE;NLK;ASAH2;GATA3;ARRDC1;NFKBIL1;LRRK2;CD47;PTPN12;ARRB1;SNAI2;CTNNBIP1;NKD2;CACTIN;TAX1BP3;SIAH2;FBXW7;EPN2;CNOT1;PTPN1;NXN;HIF1AN;APLN;DCC;TMBIM6;HMGXB4;PIK3CB;RPS6KB1;TSKU;CX3CR1;CYP26C1
prerank,renal system development (GO:0072001),0.33291482726547894,0.9262700092596965,0.5757180156657964,0.8699433061110582,1.0,7/52,6.83%,SOX17;ACE;TGFB2;PCSK5;HYAL2;GATA3;STAT1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.432919205288276,0.9261715417680056,0.5454545454545454,0.86914561447582,1.0,1/12,0.75%,LMCD1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.432919205288276,0.9261715417680056,0.5454545454545454,0.86914561447582,1.0,1/12,0.75%,LMCD1
prerank,detection of mechanical stimulus (GO:0050982),0.39155128054413463,0.926161908831323,0.541727672035139,0.8686656916946868,1.0,4/19,14.21%,PIEZO1;PTK2;CDH2;CTNNB1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.2943287421819745,0.9261497265642441,0.5934065934065934,0.8681904077954776,1.0,18/152,13.09%,ADGRL4;S1PR1;ADGRE5;GNAQ;GNAL;ADRB2;LGR5;IAPP;AKAP5;GNAI2;MC4R;HTR1B;ADCY4;ADGRB1;GLP1R;HTR1F;WASF2;GPR26
prerank,cellular component disassembly (GO:0022411),-0.2571992877440194,-0.9260296758586248,0.5949367088607594,0.8969249154769613,1.0,13/53,13.99%,GSN;MMP14;TLL1;ADAMTS5;TIMP2;SH3PXD2B;ADAMTS15;MMP2;SCUBE1;MMP16;KLK2;MMP19;KIF9
prerank,regulation of muscle cell differentiation (GO:0051147),0.36563010272501695,0.9259474295160912,0.5566860465116279,0.8681205332123371,1.0,11/31,18.93%,HDAC9;MEF2C;SPAG9;CTNNA1;CDH15;TCF3;CDH2;CTNNA2;CTNNB1;MAPK14;MEF2A
prerank,proteolysis (GO:0006508),-0.20822903965410916,-0.9254100643653128,0.6666666666666666,0.8972448576592642,1.0,41/252,13.41%,TRABD2B;AEBP1;ADAMTS12;CPQ;OGT;ADGRV1;BACE2;MMP14;HTRA3;ANPEP;CPE;DPP4;BACE1;ADAMTS3;HM13;CLPX;UFSP2;ADAM19;FAP;F3;ADAMTS9;ERMP1;ADAM33;MMP2;PRCP;CASP3;NAALAD2;CPXM2;ATG4D;PTCH1;YME1L1;GGT5;MMP16;ZMPSTE24;CPXM1;ENPEP;MMP19;SENP1;RNPEP;SPCS3;MDM2
prerank,chemical homeostasis (GO:0048878),-0.25262898263517986,-0.9251780642691614,0.5891089108910891,0.8965835795682002,1.0,13/61,13.96%,ZBTB20;SLC4A10;RBP1;WNK1;WNK4;TLCD2;IRS2;SLC4A2;NR1D2;PPARG;TENT4B;DDX3X;SLC4A3
prerank,cell cycle checkpoint signaling (GO:0000075),-0.3828769565212532,-0.9250166993053976,0.5429292929292929,0.8957582754866401,1.0,7/12,28.54%,NABP1;ZWILCH;ZW10;CHFR;BUB1B;ZWINT;NABP2
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.3960759439172496,0.9249296919893234,0.5617469879518072,0.8697339728636126,1.0,8/22,16.69%,HNF1A;MED30;PSMC3;MED17;MED4;PSMC5;PSMC6;ESR1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.3950986491821271,-0.9243877910253103,0.572538860103627,0.8961360124061621,1.0,5/10,27.07%,SMARCB1;CAMK1;PIH1D1;SPHK2;CHEK1
prerank,negative regulation of type I interferon production (GO:0032480),0.34329479009796093,0.9241972474762961,0.541095890410959,0.8707511990357341,1.0,10/40,16.63%,IFIH1;UBA7;RNF125;NLRC5;ACOD1;CACTIN;TRIM25;PIN1;HAVCR2;PYCARD
prerank,extracellular matrix disassembly (GO:0022617),-0.2568364460609562,-0.9241080052003086,0.6313559322033898,0.8955611270940145,1.0,13/53,13.99%,GSN;MMP14;TLL1;ADAMTS5;TIMP2;SH3PXD2B;ADAMTS15;MMP2;SCUBE1;MMP16;KLK2;MMP19;KIF9
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.3913118645547392,-0.9239185563700537,0.5675,0.8948131087242286,1.0,3/10,8.56%,APOE;ABCA1;PRKACA
prerank,organelle disassembly (GO:1903008),-0.2861048903635211,-0.9237009938998778,0.5719557195571956,0.8941026411519868,1.0,11/33,15.85%,GOLGA2;TEX264;UBA5;DENR;ATG2A;MRRF;EIF2D;ULK2;STX5;KIF9;PLK5
prerank,regulation of protein export from nucleus (GO:0046825),0.3786285861863484,0.9234743162052353,0.5381231671554252,0.8717486201768987,1.0,6/23,19.95%,PTPN14;UHMK1;RANGAP1;ANP32B;BARD1;GSK3B
prerank,chromosome organization (GO:0051276),-0.22987390394673424,-0.9234393351873386,0.6376811594202898,0.8935493709905915,1.0,33/99,24.47%,TCF7L2;LDB1;NUCKS1;TOP2B;DDB2;MTF2;EHMT1;SETD7;CUL4B;DOT1L;CUL4A;NUP155;HDAC1;COPS7B;HMGN1;PADI2;HMGA2;MSH6;AXIN2;SUV39H1;SAFB;LATS1;RFWD3;COPS6;SOX2;GPS1;ABL1;MTHFR;HDAC8;PARP1;HDAC10;TOP2A;BRWD1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.29677699609645597,0.9231403369498259,0.5970654627539503,0.8719341215706078,1.0,36/148,20.89%,NUAK1;PLK3;BOP1;PPP1R13B;RBBP8;ING2;TAF9B;PAK1IP1;PRKAA1;PPP2R5C;SGK1;RPL37;CHD5;BRIP1;BRCA1;PIN1;ATM;RAD1;RPS15;CSNK2B;RICTOR;TAF11;RFC2;RAD9B;DAXX;MAPK14;ATRIP;TAF3;BARD1;MAPKAPK5;RBBP4;HUS1;RNF34;SMYD2;BLM;HEXIM1
prerank,keratan sulfate metabolic process (GO:0042339),-0.29967596614419767,-0.9228406133277394,0.5972696245733788,0.8937372257477094,1.0,8/31,7.33%,OGN;FMOD;B3GNT2;GNS;PRELP;ST3GAL4;HEXA;B4GALT1
prerank,alpha-amino acid metabolic process (GO:1901605),0.3385581011481074,0.9228167099488391,0.5697211155378487,0.8721048674816242,1.0,6/45,6.03%,HNF4A;GLS2;GLS;ATP7A;GLUD1;ASS1
prerank,axonal transport (GO:0098930),0.351629828271372,0.9225340050771428,0.5669824086603519,0.8722300708787128,1.0,16/36,29.73%,BLOC1S6;DST;AP3S1;HIF1A;SYBU;KIF1A;AP3M1;HAP1;AP3D1;SOD1;AP3B1;RAB21;BLOC1S5;AP3M2;DCTN1;DYNC1H1
prerank,organelle organization (GO:0006996),0.2789530999925213,0.9222540375934081,0.6871846619576185,0.8722639084795706,1.0,66/388,15.15%,NOS3;FGD5;SYNE1;IRAG2;TRAPPC8;ATL2;CAV1;PRKD1;CAV2;MAST4;NEDD9;SIPA1L3;DIAPH1;SH3KBP1;DOP1B;PACSIN2;ARAP3;STX7;TTC29;DST;ATP7A;RAB34;SSBP1;CSNK1D;FAM161A;FMNL3;FGD6;TMED10;FNBP1L;ATL1;PACSIN1;SIRT4;CHCHD2;SLC25A33;KLHL20;ALAS1;CLASP1;MAST1;LRRK2;MCOLN1;VPS13D;CHMP1B;HPS3;CLASP2;RANBP9;NUMA1;POLG2;SNX11;CHGA;ATP8B1;VPS4A;TTC17;TMED9;CHMP3;RHOT2;USP6NL;CYP26C1;PHIP;CEP55;CFL1;TFB2M;VAPA;TMED4;CHMP2B;CHMP7;ANK1
prerank,response to ATP (GO:0033198),-0.3374258765040117,-0.9219399000383935,0.5558659217877095,0.8948382225056993,1.0,4/18,8.15%,TRPC3;ABCC9;P2RX4;TAF1
prerank,positive regulation of neuron differentiation (GO:0045666),0.3399806124762319,0.9217208303191922,0.5803324099722992,0.8728453076263958,1.0,14/40,22.18%,ARHGEF2;MEF2C;NRCAM;TCF3;FGF20;ZC4H2;MMD;PCP4;SIN3A;HOXD3;SOX11;MMD2;ECT2;ZEB1
prerank,regulation of amyloid-beta formation (GO:1902003),0.35604489786286797,0.9216456806052304,0.552437223042836,0.8724962918143815,1.0,14/34,18.63%,IFNGR1;EFNA1;TMED10;RTN1;ROCK1;RTN4;PRNP;CLU;RTN3;PIN1;ABCA7;GSK3A;RELA;HAP1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.4272601972822728,0.921333417571571,0.5586776859504132,0.8726604268959626,1.0,6/13,18.83%,ELOVL4;HACD4;ELOVL7;ELOVL5;TECR;HACD2
prerank,lipid homeostasis (GO:0055088),-0.2575372584983944,-0.9213238266892558,0.5978835978835979,0.89517016548698,1.0,19/57,23.43%,ZBTB20;RBP1;PRKAA2;APOE;ABCA1;TLCD2;IRS2;NR1D2;PPARG;DDX3X;NR1H3;RCN3;ABHD8;ORMDL2;DGAT2;MLXIPL;TLCD1;ANGPTL3;FITM2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.39823234562600907,-0.9211559487335438,0.5628140703517588,0.8943558555685529,1.0,2/10,16.55%,RPS6KA6;TFAP4
prerank,histone ubiquitination (GO:0016574),-0.32589148864736384,-0.9207060992687764,0.590625,0.8941913890192024,1.0,6/21,15.98%,UBE2N;PAF1;CTR9;USP22;ATXN7L3;WAC
prerank,endomembrane system organization (GO:0010256),0.29199206887211576,0.9206149670642035,0.6260869565217392,0.873603495841201,1.0,40/178,19.52%,SYNE1;ALS2CL;TRAPPC8;DYSF;ATL2;PRKD1;CAV2;DOP1B;CSNK1D;TMED10;SNX10;ATL1;CLASP1;LRRK2;SUN3;HOOK1;A4GALT;CLASP2;MYOF;EXOC8;ATP8B1;VPS4A;TMED9;REEP3;USP6NL;VAPA;TMED4;CHMP2B;PLEKHM2;ANK3;SRGN;SPTBN1;GOLPH3L;PHETA1;GOLPH3;TOR1AIP2;HOOK2;TMED7;ATP8B2;MYO18A
prerank,positive regulation of cholesterol transport (GO:0032376),0.3654173583399986,0.9204217501351227,0.5648414985590778,0.8735026164740409,1.0,8/27,16.80%,CAV1;APOA1;PLTP;ABCB4;LPCAT3;NFKBIA;ABCA7;EEPD1
prerank,response to ketone (GO:1901654),-0.31218259620339533,-0.9203261051634581,0.5694915254237288,0.8939180272081799,1.0,4/24,6.88%,TGFBR3;SLIT2;THBS1;CATSPER2
prerank,regulation of fat cell differentiation (GO:0045598),0.31516996779014006,0.9201937419366522,0.5825977301387137,0.8734788648636957,1.0,11/74,9.45%,GATA2;FOXO1;TRIO;WWTR1;GATA3;CMKLR1;ZC3H12A;ZBTB16;SYAP1;NR1D1;ZFP36L2
prerank,response to glucocorticoid (GO:0051384),-0.311273374818667,-0.9197185556252195,0.5919003115264797,0.8942520996517648,1.0,7/26,14.87%,SLIT2;ANXA1;ADAM9;REST;UBE2L3;GOT1;HNRNPU
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.4024748948554435,0.9191695258906991,0.573228346456693,0.8751276134585118,1.0,3/18,9.45%,FAM107A;PCK2;ZFP36L2
prerank,regulation of T cell differentiation (GO:0045580),0.3553829694341835,0.9190492899670609,0.5479833101529903,0.8748901175780509,1.0,6/33,16.98%,CRTAM;TNFRSF18;GATA3;CBFB;RHOH;CLPTM1
prerank,regulation of defense response to virus (GO:0050688),-0.358937803741392,-0.9185295082971955,0.5582010582010583,0.8959786560087193,1.0,8/14,33.72%,ZMPSTE24;PPM1B;ELMOD2;TNFAIP3;C1QBP;TRAF3IP1;RNF26;IFNLR1
prerank,mitochondrial translational termination (GO:0070126),0.30486914964341794,0.9184711933375191,0.5871446229913473,0.8755841314573756,1.0,38/88,28.95%,MRPL4;MRPL18;MRPL41;MRPL1;MRPS31;MRPL15;MRPL19;MRPL47;MRPL52;MRPL36;MRPL23;MRPL24;MRPL14;MRPL32;MRPS34;MRPS12;MRPL39;MRPL54;MRPS18B;MRPS30;MTRF1L;MRPL11;MRPS28;MRPS35;MRPS9;MRPS27;MRPL34;MRPS24;MRPL35;MRPL10;MRPL27;MRPL38;MRPS18C;MRPL13;AURKAIP1;MRPS18A;MRPL40;ERAL1
prerank,regulation of extracellular matrix organization (GO:1903053),0.41243311518386416,0.9182396456919233,0.5634028892455859,0.8755812006705839,1.0,2/15,1.61%,TIE1;NOTCH1
prerank,regulation of actin nucleation (GO:0051125),-0.3749748463416983,-0.9181942544198084,0.5700483091787439,0.8955641326126568,1.0,5/12,21.36%,GSN;ARF1;ARPIN;PICK1;ARFIP1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.4436809480834284,0.9180851573578386,0.5557432432432432,0.875429883631651,1.0,3/10,12.33%,ACVRL1;ZBTB16;SOX6
prerank,tRNA wobble uridine modification (GO:0002098),0.4128220191177686,0.9180127063128088,0.5636942675159236,0.8750779211514018,1.0,6/14,20.83%,ELP4;ALKBH8;ELP3;DPH3;TRMU;KTI12
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.38550748789016054,0.9174026431827352,0.5675675675675675,0.8752738145367822,1.0,4/23,7.59%,CASP8;PPP1R13B;BBC3;NMT1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.38550748789016054,0.9174026431827352,0.5675675675675675,0.8752738145367822,1.0,4/23,7.59%,CASP8;PPP1R13B;BBC3;NMT1
prerank,dendritic cell differentiation (GO:0097028),0.3821002642488576,0.9171529742142864,0.5657492354740061,0.8752895030065992,1.0,2/22,2.63%,F2RL1;LGALS9
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.3647440741350533,-0.9171466479049037,0.5734597156398105,0.8969766422681661,1.0,4/12,18.88%,ACSL1;SCP2;FADS2;ELOVL1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.34684549292916866,0.9170947185644454,0.5681198910081744,0.8748969661241492,1.0,14/40,19.18%,HRK;TNFSF10;BBC3;CIDEB;BCL2L1;CLU;NOL3;BNIP3;PYCARD;PLAUR;BMF;BID;PPIF;PLSCR3
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.29105127730306796,0.9165090485651889,0.6343852013057671,0.875659175891497,1.0,34/166,15.02%,EDN1;PDGFB;KLF2;INSR;VIM;NOS1AP;APOA1;KLF4;ATP7A;PAOX;BCAR3;ASS1;PLD1;ELAVL1;CDH3;PASK;NR1D1;EGR1;DHX9;STN1;METTL5;NPM1;EEF2;CLU;PRKD2;ARPP19;RPS6KB1;METTL14;FXR1;HIF1A;CNEP1R1;ELOVL5;EIF6;KAT7
prerank,tRNA transport (GO:0051031),0.353660399871544,0.9164832560733451,0.5702479338842975,0.8752168412755752,1.0,10/35,16.21%,TOMM20L;NUP54;NUP35;RANBP2;NUP153;NUP160;NUP42;RAN;YBX1;NUP205
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.30886034382849514,0.9156811294074008,0.5956416464891041,0.8763648260622959,1.0,11/86,7.75%,ENG;BMPR2;ACVRL1;NOTCH1;RBPMS;TGFB2;ACVR1;ING2;SMAD2;ADAM17;JAK2
prerank,regulation of microglial cell activation (GO:1903978),0.40484374843687354,0.9156276808222781,0.5591054313099042,0.8759811863756007,1.0,3/15,12.89%,NR1D1;STAP1;TTBK1
prerank,metanephros development (GO:0001656),0.3619694492898404,0.9155470398774946,0.5557142857142857,0.8756594122555234,1.0,1/26,0.23%,SOX17
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.3987775451910151,0.9155151279924234,0.5595776772247361,0.8752152104213043,1.0,7/21,19.95%,FKBP1A;PPP1R16B;MFHAS1;ARPP19;BOD1;TIPRL;GSK3B
prerank,activation of protein kinase activity (GO:0032147),0.29926904676193916,0.9154737024455665,0.6168981481481481,0.8748030522256851,1.0,19/106,12.61%,PDGFB;INSR;TGFB2;ADRB2;EMP2;TIRAP;TLR3;CARD10;ANGPT1;MAP4K4;JAK2;TOM1L1;TAOK2;ADCY4;CCDC88A;MINK1;MARK2;COPS8;ITGB1BP1
prerank,protein localization to chromatin (GO:0071168),0.39653047277457065,0.9153363125132873,0.5559105431309904,0.8745845104351976,1.0,9/18,28.06%,RAD21;TASOR;SGF29;CHMP7;ESR1;PPHLN1;RUVBL2;LRWD1;WAPL
prerank,negative regulation of cell cycle process (GO:0010948),0.3202338049516756,0.9152395523246638,0.6073298429319371,0.8742814380845353,1.0,10/61,12.34%,FOXO4;DAB2IP;RBBP8;RYBP;PHC3;TOM1L1;UXT;E2F7;BRCA1;VPS4A
prerank,regulation of gene silencing by RNA (GO:0060966),0.33373125707464796,0.9149537177378667,0.5658409387222947,0.8738994684164567,1.0,20/50,25.31%,PUM2;POLR2G;NUP54;POLR2D;NUP35;RANBP2;NUP153;NUP160;NUP42;POLR2I;NUP205;H3-3A;NUP50;POLR2C;RAE1;POLR2B;EIF4G1;POLR2J;SEH1L;TPR
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.33373125707464796,0.9149537177378667,0.5658409387222947,0.8738994684164567,1.0,20/50,25.31%,PUM2;POLR2G;NUP54;POLR2D;NUP35;RANBP2;NUP153;NUP160;NUP42;POLR2I;NUP205;H3-3A;NUP50;POLR2C;RAE1;POLR2B;EIF4G1;POLR2J;SEH1L;TPR
prerank,axon development (GO:0061564),0.31051944661163505,0.9148155672982625,0.5917874396135265,0.8736722083857259,1.0,17/78,12.76%,KLF7;APP;VASH2;SHTN1;CAMSAP2;ATL1;LMTK2;NRCAM;RTN4;TAOK2;NEFH;ADGRB1;DCC;ACTB;MARK2;SLITRK2;CTNNA2
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.33901713370633685,-0.9145372577569104,0.5814606741573034,0.9021821222901052,1.0,13/16,45.26%,TOP2B;HFM1;TOP2A;EME2;CENPX;FANCM;SLX4;MEIOB;MSH4;MUS81;EME1;SHOC1;CENPS
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.3810578948284565,0.9144948839704439,0.5846153846153846,0.8738395601127976,1.0,5/21,11.54%,NPR2;ADCY10;NPR1;ADCY4;NPPC
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3595303353684477,0.9143133183955591,0.5793413173652695,0.8737353996546157,1.0,3/28,7.48%,FCHSD2;ESAM;WDR1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.2626944773587963,-0.9141802261235885,0.6171003717472119,0.9018129634995375,1.0,15/48,20.22%,DOCK5;CUX1;RREB1;OBSL1;FLNA;MDK;TRIOBP;S100A10;PTPRD;FBXW8;CUX2;TESK1;P4HB;SS18L2;CIB1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.3305751172242192,-0.9137193058525034,0.6147540983606558,0.9017108874537797,1.0,7/18,17.83%,APOE;DACT1;ATP5IF1;CD81;CTSC;AMER1;EZR
prerank,regulation of cellular protein catabolic process (GO:1903362),0.39838047028340495,0.9136888551428024,0.5790273556231003,0.8745533367884051,1.0,4/18,14.25%,DAB2IP;MSN;VPS35;NELL1
prerank,positive regulation of protein catabolic process (GO:0045732),0.30874483563111554,0.9134485133430101,0.6140567200986436,0.8745533049653909,1.0,13/84,12.07%,PLK3;FOXO1;DAB2IP;MSN;FURIN;TNFRSF1B;ASB5;WWP1;APC;VPS28;NEDD4L;VPS35;SMURF1
prerank,negative regulation of viral life cycle (GO:1903901),0.4094894445114664,0.9131362241189526,0.5642276422764227,0.8746998256453183,1.0,2/15,4.54%,LY6E;TRIM11
prerank,regulation of TORC1 signaling (GO:1903432),0.35392844499386805,0.9129204922767297,0.586552217453505,0.8746740649630672,1.0,4/33,6.16%,SPAAR;CASTOR1;GPR137B;SMCR8
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.3842663953801704,-0.9127391866696798,0.5717592592592593,0.902990988700866,1.0,4/10,19.78%,SH3RF1;RUNX1;NCKAP1L;ZBTB7B
prerank,DNA strand elongation (GO:0022616),-0.3367604698022477,-0.9127020447606191,0.5846560846560847,0.9018502432981399,1.0,11/18,39.25%,RAD50;TERT;DCLRE1B;POLD2;GINS1;RFC4;MCM7;POLD3;GINS3;GINS2;MRE11
prerank,positive regulation of protein metabolic process (GO:0051247),0.2987486903430616,0.9125159017860036,0.6278801843317973,0.8749735759722775,1.0,15/110,12.07%,KLF2;PAEP;FOXO1;DAB2IP;APP;KLF4;ASB5;WWP1;APC;VPS28;NFKBIA;RANBP9;NEDD4L;CLU;SMURF1
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.3574364156584668,-0.9123702645885439,0.5531914893617021,0.9014050103914194,1.0,3/15,13.15%,TCF7L2;CAMK1;BAG3
prerank,glucose metabolic process (GO:0006006),-0.2525499388526031,-0.9122407939396078,0.6422018348623854,0.9004956141946883,1.0,18/58,21.23%,APOD;SLC39A14;SLC25A13;RBP4;IRS2;ENO2;ADPGK;PGM1;MDH2;SLC25A12;GOT1;AKR1A1;PFKFB1;GDPGP1;CRTC2;G6PC3;TPI1;ENO3
prerank,regulation of primary metabolic process (GO:0080090),0.2949099116834453,0.9122209358158442,0.6420323325635104,0.8750957037568168,1.0,46/126,24.12%,AZIN1;FASN;ZFP69;HNF4A;PLPP1;PSMD13;PSMD4;ADIPOR1;NR1D1;PSMA5;PSMB10;ACACB;PSMB8;LACTB;PSMD14;HELZ2;HMGCS1;PSMA7;PSMA8;PSMC3;PSMB5;PSMC1;PSMC5;ABCA7;PSMC6;PSMB9;PSMA4;MVD;SIN3A;PSMD5;PSMD9;NCOA6;PSMB6;DHCR7;PSMB2;NCOR2;GGPS1;SREBF2;OAZ2;NQO1;CERS2;MVK;EDF1;IDI1;PSMD2;NCOA2
prerank,positive regulation of exocytosis (GO:0045921),0.35217618525038025,0.9121118055487575,0.595460614152203,0.8748114552874354,1.0,8/35,18.49%,CADPS2;CLASP1;CLASP2;CADPS;VPS4A;RAB27B;STXBP5;RAB27A
prerank,fluid transport (GO:0042044),0.43268358571742493,0.9118835109644363,0.5695364238410596,0.8747822779281652,1.0,1/12,2.28%,AQP11
prerank,cellular response to nitrogen compound (GO:1901699),0.3868654923679907,0.9117126486205059,0.582089552238806,0.8746542448987904,1.0,5/20,16.69%,ATP2B4;NSMCE3;SPIDR;RIOK3;DAXX
prerank,histone H3-K36 demethylation (GO:0070544),-0.39205252715636546,-0.9115266642634645,0.5864864864864865,0.9011051134311081,1.0,5/10,19.44%,KDM7A;KDM4A;RIOX2;KDM8;PHF8
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.3855509991664242,-0.9115113330680309,0.6004962779156328,0.8999174966143914,1.0,2/10,9.83%,ADGRV1;WHRN
prerank,ESCRT complex disassembly (GO:1904896),0.4432886243494588,0.9114082483816436,0.5836120401337793,0.8742867747949119,1.0,6/10,26.04%,CHMP1B;VPS4A;CHMP2B;CHMP7;CHMP1A;VPS4B
prerank,ESCRT III complex disassembly (GO:1904903),0.4432886243494588,0.9114082483816436,0.5836120401337793,0.8742867747949119,1.0,6/10,26.04%,CHMP1B;VPS4A;CHMP2B;CHMP7;CHMP1A;VPS4B
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.3631241220214151,-0.9113719236825127,0.5977653631284916,0.8990032658032754,1.0,2/15,4.11%,IGF1;PRKN
prerank,negative regulation of bone remodeling (GO:0046851),0.43173484993200717,0.9113308204141883,0.580226904376013,0.8739498749194118,1.0,2/11,6.69%,GPR137B;P2RX7
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.3954620959221742,0.9111834278776938,0.5784023668639053,0.8737590844640755,1.0,3/18,9.68%,GPR137B;TLR3;FBXW7
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.35938617729607564,-0.9110645351011537,0.57,0.8985596643044407,1.0,5/13,16.96%,BMP7;BMP4;CALCOCO1;GPER1;AR
prerank,heme catabolic process (GO:0042167),-0.3433466543817187,-0.910991966963076,0.56353591160221,0.896254398525764,1.0,2/14,11.52%,SLCO2B1;BLVRB
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.3433466543817187,-0.910991966963076,0.56353591160221,0.896254398525764,1.0,2/14,11.52%,SLCO2B1;BLVRB
prerank,positive regulation of interleukin-17 production (GO:0032740),0.37972149311336656,0.9106987465240232,0.5906432748538012,0.8742293202629576,1.0,1/22,1.74%,NOD2
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.27806206809910594,-0.9106891642337203,0.6220472440944882,0.8957676101537319,1.0,10/36,16.82%,AFDN;VAMP5;GGA2;GCC2;OPTN;KIF13A;GGA1;GOLGA4;GORASP2;NECTIN3
prerank,male meiosis I (GO:0007141),0.40337066402598143,0.909881043435034,0.5636094674556213,0.8753628723399662,1.0,4/16,18.66%,DDX4;ING2;SYCP3;TDRD9
prerank,transition metal ion homeostasis (GO:0055076),0.3614874128158296,0.909190692824898,0.5782414307004471,0.8762687172252696,1.0,8/28,18.54%,B2M;FBXL5;TMPRSS6;HMOX2;CP;CYBRD1;HEPH;XIAP
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.4204544037704947,0.9086103847169698,0.5687919463087249,0.8769483679090517,1.0,4/13,16.89%,CASP8;CIDEB;TBC1D10A;GRIN2A
prerank,negative regulation of translation (GO:0017148),0.3060680707427979,0.9079389869727715,0.6123188405797102,0.877802555699199,1.0,3/87,2.90%,NANOS1;NANOS3;BTG2
prerank,negative regulation of hemostasis (GO:1900047),0.43199385156690334,0.9077953403607395,0.5889261744966443,0.877585388164868,1.0,4/12,12.94%,EDN1;CD34;PROC;APOH
prerank,protein prenylation (GO:0018342),0.43221437973513177,0.907692993626403,0.5634782608695652,0.8772859961792457,1.0,1/10,6.49%,PGGT1B
prerank,protein localization to cilium (GO:0061512),-0.2906427702416801,-0.9075132836083011,0.6059602649006622,0.9023291851216234,1.0,15/32,22.94%,TULP3;INVS;BBS9;WDR35;ARL6;TCTN2;TTC21B;WDR19;ZNF423;ARL3;IFT20;RAB29;NPHP4;RABEP1;TULP1
prerank,positive regulation of cell aging (GO:0090343),0.4325869191781595,0.9073564856625214,0.56957928802589,0.8774673483384797,1.0,1/11,1.75%,B2M
prerank,positive regulation of macrophage activation (GO:0043032),-0.3419407479537938,-0.9072961199695769,0.5823863636363636,0.9016279586035724,1.0,3/17,3.31%,LBP;WNT5A;THBS1
prerank,primary neural tube formation (GO:0014020),-0.28769774250180524,-0.9071310081155629,0.5974025974025974,0.9008197605862417,1.0,10/30,22.74%,LMO4;COBL;PLXNB2;MTHFD1;TSC2;SEMA4C;PAX2;MTHFR;STIL;PHACTR4
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.3254253225655237,0.9069740412489808,0.6085858585858586,0.877781087996304,1.0,13/54,20.39%,SMAD7;CAV1;ARRB1;HSPA1B;VPS28;PRKCG;ADGRB1;NXN;CTNNB1;SPOPL;CRY1;COPS9;DNAJA1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.36737923926074545,0.9065001342109488,0.5644257703081232,0.8782416554462574,1.0,13/27,24.34%,ZC3H12A;TRIR;RNASE1;NHP2;XRN1;RNASE6;POP1;KHNYN;ERN1;CPSF3;RNASE4;NUDT16;RNASEH1
prerank,positive regulation of cellular component organization (GO:0051130),0.29374409427533343,0.906439718029938,0.6119909502262444,0.877867608001775,1.0,11/107,6.10%,ATP10A;INSR;TAL1;MMP1;DAB2IP;TGFB2;TIRAP;HRK;SHANK3;ABCB4;WARS1
prerank,peptidyl-amino acid modification (GO:0018193),0.45119854278443816,0.9063477252004878,0.563573883161512,0.8775672014382342,1.0,3/10,12.60%,APOA1;ATP7A;METAP2
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.4274806416357539,0.9060041058060431,0.5663265306122449,0.8777619675319163,1.0,4/11,13.71%,TBX1;STAT1;CTNNBIP1;LRP5
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.2534109811592754,-0.9058362586633619,0.6425339366515838,0.9027082223404037,1.0,13/52,15.58%,ME1;IDH2;ADHFE1;SLC19A1;GCLC;L2HGDH;MTHFD1;MDH2;IDH1;MTHFD2L;ALDH18A1;GOT1;DLST
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.29945733034297606,-0.905552008025311,0.6105610561056105,0.9021846137224274,1.0,4/26,6.24%,SULF1;CCBE1;SULF2;RORA
prerank,negative regulation of interleukin-17 production (GO:0032700),0.4384512427000135,0.9052334447581141,0.5833333333333334,0.8788905064513388,1.0,2/10,11.22%,PRNP;VSIR
prerank,lysosome localization (GO:0032418),0.3431360046194978,0.9049365082487724,0.5813953488372093,0.8789994099215485,1.0,9/37,16.24%,RAB34;MILR1;SPAG9;MYH9;PLEKHM1;KLC2;CHGA;TMEM106B;PLEKHM2
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.3858318833547358,-0.9047207983057299,0.6129032258064516,0.9030445608592051,1.0,5/10,20.58%,GALNT1;POGLUT2;POGLUT3;GALNT16;GALNT3
prerank,regulation of protein kinase activity (GO:0045859),0.29746382844193664,0.904357540685754,0.62004662004662,0.8796404254570187,1.0,14/106,11.05%,RAPGEF2;CEACAM1;GNAQ;IQGAP1;INPP5K;PPM1F;WWTR1;WARS1;SMCR8;HSPB1;MAPRE3;PTK2;MMD;TAB2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.3722370318385573,-0.9042548048350375,0.5755968169761273,0.9029250354881372,1.0,3/13,10.98%,PRPF8;PRPF31;PRPF3
prerank,positive regulation of phospholipid transport (GO:2001140),0.4321719846789936,0.9041957065958459,0.5787671232876712,0.8794656914688667,1.0,3/10,15.36%,APOA1;ABCB4;ABCA7
prerank,negative regulation of organelle assembly (GO:1902116),-0.2741478886885106,-0.9034010985825587,0.6067796610169491,0.9038012186923102,1.0,10/35,13.40%,NUPR1;KAT2B;RBM14;ODF2L;MDM1;CEP97;FEZ2;CCP110;TMEM39A;CDK10
prerank,negative regulation by host of viral transcription (GO:0043922),0.42097068816075905,0.9032231664581822,0.5826645264847512,0.8809702900780362,1.0,4/12,13.44%,INPP5K;JUN;CCL4;PSMC3
prerank,positive regulation of acute inflammatory response (GO:0002675),0.4181315921647414,0.9029838034605379,0.5735056542810986,0.8809695110850401,1.0,14/14,58.22%,OSMR;PTGER3;PTGS2;C2CD4A;C2CD4B;IL1B;FFAR2;OSM;CREB3L3;TNF;IL6ST;IL6;ADAM8;PARK7
prerank,membrane depolarization (GO:0051899),0.35176936414947096,0.9025696587752943,0.5848527349228612,0.8813186570713604,1.0,9/32,18.14%,CACNA1A;CAV1;SCN11A;P2RX7;SCN1B;YWHAH;SCN9A;CACNA1E;SCN1A
prerank,regulation of phosphorylation (GO:0042325),0.2913795612410319,0.9022149557577146,0.6312217194570136,0.8815497190445738,1.0,29/120,16.65%,CCDC88C;LDB2;EMP2;APP;JMJD8;HSPB1;NLRC5;NDUFS4;ROCK1;PTK2;STAP1;NUP54;PTGES3;CCDC88A;NUP35;DYNLL1;RANBP2;GRM5;NUP153;PHIP;PIN1;HIF1A;NUP160;CDKN2D;NUP42;EIF6;KDM4D;NUP205;ATG14
prerank,negative regulation of mRNA processing (GO:0050686),-0.3344521078927974,-0.9013215230247488,0.6109660574412533,0.9076207720722738,1.0,8/15,34.97%,RBMX;SRSF6;PCBP4;U2AF2;C1QBP;SAP18;SRSF10;RNPS1
prerank,negative regulation of B cell activation (GO:0050869),0.37717749393836586,0.9009336839876052,0.5523076923076923,0.8836514460798071,1.0,6/21,20.15%,FCGR2B;TYROBP;LAPTM5;ATM;BANK1;FOXJ1
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.40820951137531375,0.9007891194421173,0.5782208588957055,0.8834582798958711,1.0,2/13,7.23%,F2RL1;ITGAM
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.33955731072836665,0.9006433877294132,0.5978695073235686,0.8832591721278495,1.0,10/40,17.81%,FOXF2;UBE3A;PTK2;XPO1;FBXW7;LAPTM5;CLU;SMURF1;RNF139;UBQLN4
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.3582347168750648,-0.9005845214269476,0.5754189944134078,0.9082193421189465,1.0,10/12,53.50%,CCR2;SLC11A1;PRKCQ;IL12RB1;CARD9;IL23A;IL12B;IL23R;CLEC6A;IL1B
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.34111108809682833,0.9002229413965364,0.5986111111111111,0.8835993803359995,1.0,6/37,6.92%,SMAD7;APP;INPP5K;TRIM6;MAPK1;IRGM
prerank,megakaryocyte differentiation (GO:0030219),0.4330473606858101,0.8999771487492348,0.6065292096219931,0.8836083326177653,1.0,2/11,8.04%,TAL1;THPO
prerank,amyloid-beta metabolic process (GO:0050435),0.3924997874770084,0.8997760801880753,0.6071428571428571,0.8835156076699512,1.0,8/16,23.99%,ACE;APH1A;ABCA7;PSEN2;DYRK1A;APH1B;MME;NCSTN
prerank,response to nitric oxide (GO:0071731),0.4104170710915872,0.8996993015558369,0.5970394736842105,0.8831723063621892,1.0,1/13,1.88%,FOXO1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.28443688047716337,0.8996313472099394,0.6681175190424374,0.8828399850759816,1.0,39/166,18.98%,NOTCH4;NR4A2;NOTCH1;NR1I3;HNF4A;HDAC9;HDAC7;TEAD4;MED26;WWTR1;RXRG;TAF9B;TAF1A;POLR2G;NR1D1;POLR1F;BRF2;POLR2D;MAML2;TBPL1;CAVIN1;GTF2H3;NR4A1;GTF2A1;MED27;TAF1B;MED17;TFB2M;TAF11;NR2C1;POLR2I;ESRRG;ESR1;RARA;TAF8;E2F3;NCOA6;NR2C2AP;TAF3
prerank,regulation of T cell proliferation (GO:0042129),0.31866172497758083,0.8992634006694192,0.6017811704834606,0.883069065273871,1.0,4/61,7.88%,VCAM1;TNFRSF1B;ARG1;SLC7A1
prerank,positive regulation by host of viral transcription (GO:0043923),-0.3382365729790836,-0.8989390230445361,0.6147959183673469,0.9109236615625957,1.0,3/15,5.26%,SNW1;NUCKS1;SMARCB1
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.268174971945938,-0.8988950790881371,0.6718146718146718,0.9098121126313508,1.0,15/40,24.35%,FXR2;UBE2V2;UBE2N;USP1;BCLAF1;HMGA2;WDR76;NEK4;RFWD3;PRKCD;PARG;CASP9;ABL1;FEM1B;RPA2
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.3541940152528641,0.8986922367621035,0.6093979441997063,0.8837326520389509,1.0,5/29,10.59%,MCTP1;APP;SHISA8;SHISA6;GRIK2
prerank,regulation of B cell apoptotic process (GO:0002902),-0.36252436291959955,-0.897895227362133,0.5963060686015831,0.9111093855830676,1.0,3/12,9.96%,IRS2;BCL6;FNIP1
prerank,regulation of organelle organization (GO:0033043),0.3058747127728816,0.8977535410814471,0.6260762607626076,0.885121379700943,1.0,15/80,15.59%,F11R;DIAPH1;CLIC4;MSN;CAMSAP2;MAPK1;PTK2;TJP1;VPS35;MARK2;TMED9;RHOT2;USP6NL;PDCD10;PAK2
prerank,positive regulation of cell communication (GO:0010647),0.36278215562719585,0.8974070998636464,0.5701754385964912,0.8853354662936905,1.0,9/28,18.79%,EDN1;GATA3;GRIK2;RIMS3;NMU;ANK3;CDKN2AIP;SYT1;SOX11
prerank,positive regulation of myoblast differentiation (GO:0045663),0.3962102427225228,0.8967644973771565,0.5952,0.8861319361262342,1.0,3/16,5.43%,PLCB1;BTG1;MEF2C
prerank,negative regulation of cation channel activity (GO:2001258),0.3606566117984604,0.8967221098165062,0.6062322946175638,0.8857406881090119,1.0,2/26,2.72%,KCNE3;FKBP1A
prerank,stem cell differentiation (GO:0048863),0.3376399837934526,0.896566379605722,0.6146540027137042,0.8855577587396491,1.0,4/39,5.43%,ACE;FOXO4;TGFB2;MEF2C
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.42988118188945784,0.8964959171889878,0.5934959349593496,0.8852100318087499,1.0,1/11,0.92%,FYN
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.3536146530618369,0.8964690731991107,0.6023391812865497,0.8847782887253256,1.0,12/30,22.29%,SLC27A6;ACSBG1;ACOX1;ELOVL4;HACD4;ELOVL7;SLC27A2;ELOVL5;TECR;HACD2;ABCD2;ABCD4
prerank,homocysteine metabolic process (GO:0050667),0.44179895561373367,0.8964366707801746,0.606418918918919,0.8843503481707635,1.0,1/11,2.93%,TST
prerank,cellular response to hydroxyurea (GO:0072711),0.43374854771301596,0.8963559498219166,0.6024305555555556,0.8840238200250702,1.0,4/10,25.46%,NSMCE3;SPIDR;BLM;RTF2
prerank,receptor internalization (GO:0031623),0.33498251466772544,0.8957014072576909,0.624484181568088,0.8848700648128414,1.0,7/44,14.61%,CEACAM1;CAV1;DNM3;ARRB1;AP2M1;LDLRAP1;CD9
prerank,negative regulation of kinase activity (GO:0033673),0.3129789621016613,0.8956165490308118,0.6305970149253731,0.8845652167626245,1.0,8/62,7.53%,CEACAM1;GNAQ;INPP5K;PPM1F;WWTR1;WARS1;SMCR8;HSPB1
prerank,lipid droplet organization (GO:0034389),-0.30650886114742915,-0.8954695267817603,0.6030769230769231,0.9157997315026107,1.0,7/22,28.55%,PPIA;BSCL2;SQLE;PLA2G4C;FITM2;RAB3GAP1;AUP1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.32611846106746567,0.895088794850585,0.6131105398457584,0.8851588484142607,1.0,12/49,19.80%,SGMS1;CAV1;BBC3;BCL2L1;RTKN2;RACK1;PYCARD;PLAUR;BMF;BID;PPIF;MCL1
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.33656157816422144,0.8950424447079125,0.6032388663967612,0.8847711618190546,1.0,11/42,19.45%,GARS1;VARS1;VARS2;KARS1;FARSB;WARS1;FARS2;TARS3;EEF1E1;RARS1;DARS1
prerank,positive regulation of growth (GO:0045927),0.3118842086479013,0.894758825877721,0.6253101736972705,0.8848562657778896,1.0,10/64,10.48%,PLCB1;INSR;TGFB2;PPM1F;BRAT1;TAF9B;ADAM17;SLC25A33;ADAM10;RPS6KA1
prerank,negative regulation of transferase activity (GO:0051348),0.35139932648734057,0.8945649941614505,0.5965909090909091,0.8847693493734868,1.0,7/28,19.95%,SMAD7;INPP5K;DTX3L;ERCC4;MEN1;GSK3A;GSK3B
prerank,apoptotic DNA fragmentation (GO:0006309),0.39571699748974004,0.8945555878660266,0.5847860538827259,0.8843062615424694,1.0,6/16,15.24%,KPNB1;DFFB;HMGB1;HMGB2;EXOG;DFFA
prerank,positive regulation of translation (GO:0045727),-0.22659796220746337,-0.8943661577713071,0.7558139534883721,0.9171888343294176,1.0,24/94,16.84%,SAMD4A;THBS1;FXR2;NIBAN1;PLXNB2;YTHDF1;RMND1;TRUB2;YBX3;CDC123;ERBB2;PCIF1;LARP4B;YTHDF2;CPEB3;DDX3X;EIF3D;BCL3;RCC1L;RPS4X;EIF3E;RPUSD4;LARP1;JMJD4
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.41579860454585427,0.8940952685620455,0.5956375838926175,0.8847548398410334,1.0,2/11,11.28%,NOVA2;PCBP1
prerank,regulation of mRNA processing (GO:0050684),-0.2830521059871767,-0.8939905358224599,0.6420664206642066,0.9168920942420866,1.0,16/32,25.30%,SON;NCBP1;JMJD6;PABPN1;RBM39;SAFB;AHCYL1;SRSF3;SF1;SRPK2;SLTM;PAPOLA;CDK11B;KHDRBS1;QKI;LARP7
prerank,mRNA 3'-end processing (GO:0031124),-0.23395138149180855,-0.89390592293342,0.6607142857142857,0.9159022925394278,1.0,31/78,24.51%,SRSF5;SCAF8;NUDT21;NCBP1;SRRM1;SRSF1;PAF1;SRSF6;PABPN1;THOC1;TENT4B;TUT1;PCF11;MAGOH;CSTF2T;U2AF2;AHCYL1;PABPC1;MAGOHB;LSM11;UPF3B;SRSF3;SLBP;PAPOLB;SRSF11;PAPOLA;EIF4A3;NCBP2;ZC3H11A;U2AF1;SRSF2
prerank,protein deneddylation (GO:0000338),0.42966895403218675,0.8937569761068077,0.5711920529801324,0.8849319376273193,1.0,3/10,18.03%,COPS4;COPS8;COPS5
prerank,phosphatidylserine metabolic process (GO:0006658),0.3523652053975323,0.8936594772050106,0.5952045133991537,0.8846405190783992,1.0,8/32,18.49%,MBOAT2;LPCAT4;PLSCR1;LPCAT3;PTDSS1;SERINC5;PLA2G12A;PLAAT3
prerank,regulation of transposition (GO:0010528),0.4128011243729019,0.893410289204841,0.5830721003134797,0.8846476805061763,1.0,1/13,3.88%,DDX4
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.2868138447537317,0.8933873731301046,0.6611661166116611,0.8842079586267207,1.0,29/138,17.56%,NOTCH4;NR4A2;NOTCH1;NR1I3;HNF4A;HDAC9;HDAC7;TEAD4;MED26;WWTR1;RXRG;TAF9B;POLR2G;NR1D1;POLR2D;MAML2;GTF2H3;NR4A1;GTF2A1;MED27;MED17;TAF11;NR2C1;POLR2I;ESRRG;ESR1;RARA;TAF8;E2F3
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.34406605596630485,-0.8933619914431397,0.6197604790419161,0.9159628669153617,1.0,4/15,20.88%,BMP4;SFRP4;NME2;ETV4
prerank,regulation of gene silencing by miRNA (GO:0060964),0.3155989745129114,0.8931567218037624,0.599250936329588,0.8841756956301369,1.0,24/62,25.68%,PUM2;ELAVL1;POLR2G;NUP54;DHX9;POLR2D;NUP35;RANBP2;NUP153;FXR1;NUP160;NUP42;POLR2I;NUP205;H3-3A;NUP50;POLR2C;RAE1;POLR2B;EIF4G1;POLR2J;SEH1L;TPR;TGFB1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3164021736564264,0.8930921830983408,0.6357786357786358,0.8838220228145716,1.0,13/60,14.42%,TNRC6C;HNF1A;HEY2;MED26;LEF1;AGO4;CBFB;MED30;PPM1D;MED27;CTNNB1;MED17;MED4
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.3162905095095633,-0.8929971765750396,0.6228571428571429,0.9155957485194043,1.0,4/22,8.37%,AEBP1;APOE;MAP1A;EFEMP2
prerank,ribosomal subunit export from nucleus (GO:0000054),0.4026091433665574,0.8928891063078203,0.567524115755627,0.8837151879832135,1.0,5/13,14.75%,XPO1;NPM1;RAN;RPS15;EIF6
prerank,regulation of RNA splicing (GO:0043484),-0.2428482838666038,-0.89262617281662,0.7215909090909091,0.9152244726059118,1.0,20/69,17.40%,SON;SNRNP70;AFF2;AHNAK2;HNRNPH1;BRDT;AHNAK;PIK3R1;CLK1;FUS;JMJD6;CLK4;RBM20;RBM39;HNRNPLL;HNRNPL;RPS26;CLK2;ZPR1;U2AF2
prerank,amino acid transmembrane transport (GO:0003333),0.32636531624751886,0.8920635025390686,0.6021798365122616,0.8848389706951062,1.0,5/45,7.88%,SLC6A6;SLC7A7;SFXN1;SLC16A2;SLC7A1
prerank,positive regulation of synaptic transmission (GO:0050806),-0.2386142262070955,-0.8919298935354137,0.6965174129353234,0.9156557635872616,1.0,19/72,19.34%,ADCY1;SLC8A3;STX4;NLGN2;DLG4;CLSTN2;CACNG4;TSHZ3;GRIN2D;PRKCZ;DTNBP1;ADRA1A;EIF2AK4;CACNG8;GPER1;SLC8A2;KCTD13;EPHB2;LGMN
prerank,response to interferon-alpha (GO:0035455),0.39315154145219855,0.8918073435570499,0.5950540958268934,0.8848630364392682,1.0,4/16,9.21%,IFNAR1;GATA3;KLHL20;ADAR
prerank,reverse cholesterol transport (GO:0043691),0.4001003335074743,0.8917289935498427,0.5866454689984102,0.8845295299866639,1.0,4/13,17.92%,APOA1;LCAT;CLU;SCARB1
prerank,positive regulation of response to wounding (GO:1903036),0.36240400545609125,0.8915913273962217,0.6082474226804123,0.8843105619808551,1.0,4/24,9.01%,OCLN;MYLK;ACTG1;PTK2
prerank,mitochondrion localization (GO:0051646),0.37488013756583255,0.8914815508251471,0.560530679933665,0.884051781000314,1.0,7/19,18.93%,BRAT1;LRRK2;MFN1;MARK2;ZBED3;HAP1;MEF2A
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.3872207650090168,-0.891478447499988,0.5911330049261084,0.915543705614668,1.0,3/10,9.87%,PRKAA2;FLCN;KLF15
prerank,tryptophan metabolic process (GO:0006568),0.42746944600663,0.8913849462336645,0.5798611111111112,0.8837691533733285,1.0,3/11,22.07%,ATP7A;KYAT1;KYNU
prerank,positive regulation of interleukin-4 production (GO:0032753),0.38735494387376174,0.8911677815027261,0.6006051437216339,0.8837170073378536,1.0,4/17,16.99%,LGALS9;GATA3;HAVCR2;RARA
prerank,regulation of cytokinesis (GO:0032465),0.30625182331973594,0.8911457083360814,0.654126213592233,0.8832793076043425,1.0,21/78,22.24%,PLK3;RAB11A;CUL3;BCL2L1;PIK3C3;CDC14A;E2F7;CALM3;VPS4A;PRC1;PIN1;RAB11FIP4;PKN2;KLHL9;GIT1;MAP10;GIPC1;RAB11FIP3;SETD2;ECT2;KIF23
prerank,autophagosome assembly (GO:0000045),0.31779526304715766,0.8908247245839641,0.6115384615384616,0.883445365924888,1.0,12/52,16.65%,TRAPPC8;ATG101;GABARAPL1;RAB23;IRGM;STX12;PIK3C3;SMURF1;RAB19;MAP1LC3A;UBQLN2;ATG14
prerank,tube closure (GO:0060606),-0.28330308237929047,-0.8905206120432819,0.6378737541528239,0.9166464789430535,1.0,10/31,22.74%,LMO4;COBL;PLXNB2;MTHFD1;TSC2;SEMA4C;PAX2;MTHFR;STIL;PHACTR4
prerank,regulation of inclusion body assembly (GO:0090083),0.42303807052119263,0.8904388730255913,0.5844370860927153,0.8837141091292285,1.0,4/11,17.80%,HSPA1B;SNCAIP;DNAJB6;DNAJB8
prerank,positive regulation of histone deacetylation (GO:0031065),0.42413531403656457,0.8904009923561552,0.6044303797468354,0.8833033686238281,1.0,3/12,12.00%,PRKD1;ING2;PRKD2
prerank,tRNA processing (GO:0008033),0.3164055648892457,0.8903698397568254,0.6175349428208387,0.8828941643238514,1.0,8/61,10.20%,ADAT2;TRDMT1;TRMT61A;KARS1;TRPT1;CPSF1;FARS2;TRUB1
prerank,regulation of secretion by cell (GO:1903530),0.31896925427964307,0.8898391627892124,0.6146907216494846,0.8834861590376832,1.0,11/54,18.63%,MCTP1;SCG5;MEF2C;VAMP8;SNCAIP;NSF;CPLX1;STXBP5;STXBP5L;SYT1;HAP1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.29105112143451334,0.8896208484268625,0.6640883977900552,0.8834441896246161,1.0,16/128,10.53%,PLCB1;CCNY;PLK3;CDK14;CSNK1D;TUBB;CDC25C;TUBB4B;CLASP1;NEDD1;HAUS3;CEP135;PCM1;TPD52L1;CEP76;DYNLL1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.36238909239903205,0.8895810827747205,0.5773195876288659,0.8830513951941341,1.0,5/22,12.34%,VPS36;TOM1L1;VPS28;RNF115;VPS4A
prerank,regulation of cell cycle process (GO:0010564),0.29749330401973134,0.8895741619676765,0.6733490566037735,0.882589759915807,1.0,16/104,14.21%,PLK3;RAB11A;CAV2;TTL;CDC25C;BCL2L1;APC;PIK3C3;RPRD1B;NUMA1;CALM3;PRC1;PIN1;RAB11FIP4;BUB1;CTNNB1
prerank,response to steroid hormone (GO:0048545),0.35745970131255544,0.8894396556957005,0.6184397163120567,0.8823788175008381,1.0,6/31,8.78%,ATP1A3;ATP1A1;CAV1;TGFB2;PAQR8;UBE3A
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.4017986506796452,0.8893793075275627,0.5748792270531401,0.882013379633633,1.0,6/16,17.92%,GCH1;NOS1AP;NUS1;PIK3CB;HIF1A;SCARB1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.30750445949835,0.8893177742251293,0.629950495049505,0.8816673921388203,1.0,14/70,18.49%,APOA1;SLC44A1;MBOAT2;LPCAT4;LCAT;PCYT1A;TMEM86B;CEPT1;LPCAT3;ACHE;STARD10;CSNK2B;PLA2G12A;PLAAT3
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.4251563676058444,0.8884672251163782,0.5858585858585859,0.8828798539668316,1.0,5/11,22.19%,EXOSC3;DKC1;FBLL1;EXOSC10;FBL
prerank,cellular response to decreased oxygen levels (GO:0036294),0.31312998684195836,0.8882961653384992,0.6402048655569782,0.8827306716446436,1.0,2/65,0.56%,EPAS1;GATA6
prerank,cellular response to amino acid starvation (GO:0034198),0.30728239028646964,0.8881468212988373,0.6385390428211587,0.8825555552625656,1.0,19/71,20.65%,FAS;CASTOR1;PRKD1;DAP;MAPK1;WDR59;RRAGD;GCN1;RHEB;EIF2S1;MIOS;ATP6V1G1;ATP6V1C1;RRAGA;RRAGC;NPRL3;ATP6V1D;EIF2AK2;LAMTOR3
prerank,aromatic amino acid family metabolic process (GO:0009072),0.43161346604987005,0.8879941433335898,0.5797598627787307,0.8823730199667336,1.0,4/10,22.07%,ATP7A;KYAT1;QDPR;KYNU
prerank,regulation of smooth muscle contraction (GO:0006940),0.3804110126254878,0.88773209494943,0.5856697819314641,0.8823791169204719,1.0,6/20,19.29%,CAV1;ADRB2;CHRM3;SETD3;NMU;ATP2B1
prerank,glycolipid biosynthetic process (GO:0009247),-0.2657413412087012,-0.8876868623985644,0.6666666666666666,0.9220560424874868,1.0,18/38,20.29%,LARGE1;ST3GAL5;ST3GAL4;PIGA;GBGT1;SCCPDH;PIGB;PIGN;ST6GALNAC5;PIGH;PGAP2;DPM2;PIGG;ST8SIA1;ST8SIA3;PIGP;PIGZ;PGAP4
prerank,regulation of cellular protein localization (GO:1903827),-0.2633593050136179,-0.887581949236647,0.6679841897233202,0.9210940617251769,1.0,3/45,2.81%,GPC6;GPC3;PRKAA2
prerank,cilium movement (GO:0003341),0.327428272285362,0.8874571323182373,0.6201859229747676,0.882429170425798,1.0,4/47,4.31%,CFAP206;ADCY10;TTC29;TEKT5
prerank,epithelial structure maintenance (GO:0010669),0.4177086870653555,0.8872787701456479,0.6006493506493507,0.88233053532632,1.0,1/11,1.74%,NOD2
prerank,regulation of fatty acid metabolic process (GO:0019217),0.39612079071915185,0.8871718612871401,0.6089030206677265,0.8820736911678956,1.0,3/17,6.54%,ADIPOR2;CAV1;ADIPOR1
prerank,cell cycle G2/M phase transition (GO:0044839),0.29084793247908214,0.8869050520185671,0.6714443219404631,0.8821064874345678,1.0,16/129,10.53%,PLCB1;CCNY;PLK3;CDK14;CSNK1D;TUBB;CDC25C;TUBB4B;CLASP1;NEDD1;HAUS3;CEP135;PCM1;TPD52L1;CEP76;DYNLL1
prerank,pyruvate metabolic process (GO:0006090),0.3196769465148043,0.886631996442542,0.6259541984732825,0.8821435813938355,1.0,11/52,16.37%,GPI;PCK2;PGK1;BSG;GAPDH;LDHC;DLD;LDHAL6B;ME3;VDAC1;PFKM
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.3119772098620765,-0.8865992526150348,0.6211699164345403,0.9221088842965793,1.0,7/22,13.44%,APOE;TIMP2;PTPN3;ADAM9;GPLD1;ADRA2A;PACSIN3
prerank,establishment of apical/basal cell polarity (GO:0035089),0.4045644948483009,0.8865583059900451,0.603448275862069,0.8818130900041217,1.0,7/14,28.13%,MSN;SYNE4;OPHN1;FOXJ1;SCRIB;FSCN1;RAP2A
prerank,peptidyl-lysine modification (GO:0018205),-0.2293392856717428,-0.8861736862543861,0.7318840579710145,0.9218773061773144,1.0,29/99,18.24%,EYA1;LOXL1;LOXL3;KAT2B;P3H3;NUP107;SENP3;VIPAS39;SIRT3;PIAS3;NUP155;METTL21A;NNAT;HDAC4;PLOD2;ESCO1;HDAC6;AAAS;EEF1AKMT1;SENP1;NUP93;SIRT2;TOPORS;SENP2;EEF1AKMT2;GCSH;VPS33B;PLOD3;P3H4
prerank,secondary alcohol biosynthetic process (GO:1902653),0.3514984480925518,0.8861249103067572,0.6070422535211267,0.8821343341069148,1.0,16/30,29.85%,APOA1;PLPP6;HMGCS1;MVD;ACAA2;DHCR7;GGPS1;ACLY;MVK;IDI1;INSIG1;HMGCR;FDFT1;LBR;TM7SF2;MSMO1
prerank,negative regulation of cilium assembly (GO:1902018),0.41358476485037754,0.8859364454818145,0.6,0.882013461614785,1.0,3/12,10.85%,MAP4;TBC1D30;LIMK2
prerank,substantia nigra development (GO:0021762),-0.26721612087062807,-0.8857524222313992,0.6945454545454546,0.9216742469278199,1.0,14/37,18.20%,NDRG2;NDUFS3;CALM2;PLP1;MAPKAP1;CKB;PADI2;YWHAQ;MBP;SIRT2;SEC16A;CNP;BASP1;FGF9
prerank,L-amino acid transport (GO:0015807),-0.295551691315884,-0.8855237577216897,0.639871382636656,0.9210218987426478,1.0,3/28,2.95%,SLC1A3;SLC7A2;SLC25A13
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.2133806626906115,-0.8853130209578943,0.8137254901960784,0.9202738146376842,1.0,39/132,25.22%,CELF2;SRSF5;SCAF11;DICER1;NUDT21;NCBP1;TRAF7;RPL24;COIL;DENR;EIF2S2;SRSF1;GEMIN5;EIF2D;PUF60;SMN1;SRSF6;DDX1;SNRPF;RRP7A;XRCC5;RPLP0;SNUPN;RAMAC;SNRPD3;MRPS11;XAB2;SF1;LUC7L;RRS1;SF3B1;SRPK2;GEMIN7;SF3A2;NAF1;WDR77;CELF5;CELF1;SNRPD1
prerank,cell cycle G1/S phase transition (GO:0044843),0.3142248821752404,0.8852513975910786,0.648171500630517,0.8828422682494879,1.0,18/61,24.36%,PLK3;ACVR1;CCNE1;CUL3;MAP3K11;CUL2;HINFP;USP29;RPS6KB1;CDKN2D;CACUL1;E2F3;MAX;BCAT1;MNAT1;CDKN1B;CCND1;CCNH
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.41809382552551666,0.885096583894918,0.6013745704467354,0.882670373129494,1.0,3/11,15.58%,FBXO7;HIF1A;RACK1
prerank,membrane protein proteolysis (GO:0033619),0.33018886663338165,0.884745526987254,0.6053748231966054,0.8828970796978554,1.0,21/37,28.01%,SPPL2A;RHBDD1;MYH9;ADAM17;MBTPS2;TMPRSS6;APH1A;ADAM10;PSEN2;RELA;CTSH;SPPL2B;APH1B;ERAP1;AFG3L2;NCSTN;PARL;TGFB1;RET;SPPL3;TRAF6
prerank,receptor recycling (GO:0001881),0.4252689324259093,0.8844452856718761,0.6134751773049646,0.8830167089745282,1.0,5/10,20.95%,LMTK2;PHETA1;NSG1;REP15;SORL1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.37302724295134615,0.8843955585357635,0.6234939759036144,0.8826330553282402,1.0,3/20,8.24%,MCUB;SMDT1;MCUR1
prerank,cellular response to UV-A (GO:0071492),0.4258989052189492,0.8842781902006298,0.6124401913875598,0.8824152831380689,1.0,4/11,23.11%,MMP1;PPID;TIMP1;MME
prerank,protein sumoylation (GO:0016925),0.32398478900828015,0.88394785211091,0.6057818659658344,0.8825748426279232,1.0,11/49,16.21%,IFIH1;SUMO3;SUMO2;RANGAP1;NUP54;NUP35;RANBP2;NUP153;NUP160;NUP42;NUP205
prerank,cell-matrix adhesion (GO:0007160),0.295500663502574,0.8839233951959735,0.662621359223301,0.8821538069257311,1.0,13/95,10.32%,FBLN5;VCAM1;ITGA1;ZYX;EMP2;BCAM;BCR;ADAM15;CD34;WHAMM;TAOK2;PPFIA2;RAC1
prerank,B cell activation involved in immune response (GO:0002312),0.4114121421083945,0.8839190179579282,0.6041009463722398,0.8816971628871592,1.0,2/13,7.32%,FCGR2B;EXOSC3
prerank,regulation of chromosome segregation (GO:0051983),0.3925278314830403,0.8834338151627307,0.5996810207336523,0.8821564356214999,1.0,4/16,14.38%,PUM2;NUMA1;BUB1;RAD18
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.336910471439211,-0.8832051026333291,0.6081424936386769,0.9241304190232585,1.0,6/14,19.93%,ENPP1;ENPP3;AK5;CMPK2;AK1;NME2
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.2942954979307411,0.8830631276363623,0.6465116279069767,0.8824007301104585,1.0,14/88,15.86%,SYNPO;TAL1;MMP1;DAB2IP;TIRAP;HRK;WARS1;SPIDR;CLU;CHGA;VPS4A;ICE1;RACK1;VIL1
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.3843241155205465,0.8828955564933745,0.6158536585365854,0.8822541584135035,1.0,7/18,19.95%,UFM1;RAB23;MFHAS1;CTNNA1;CABP1;SIN3A;GSK3B
prerank,regulation of mitochondrial fission (GO:0090140),-0.30758449843942914,-0.882648453739182,0.6397306397306397,0.9241905348085179,1.0,4/24,8.74%,DCN;PRKN;DDHD1;MYO19
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.3752184422659478,0.8825021277312026,0.5869918699186992,0.8825287512796812,1.0,10/17,20.95%,RTN1;ROCK1;RTN4;PRNP;CLU;RTN3;PIN1;ABCA7;HAP1;SORL1
prerank,positive regulation of type I interferon production (GO:0032481),0.3036024667403736,0.8822990337172247,0.6417177914110429,0.8824756558204059,1.0,17/73,20.61%,IFIH1;LRRFIP1;TLR3;DDX41;STAT1;OAS2;GAPDH;POLR3B;DHX9;IRF5;RIOK3;CTNNB1;RELA;G3BP1;SETD2;DHX58;POLR3C
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.2772449940945546,-0.8820624962103611,0.6397306397306397,0.9244055366274788,1.0,8/33,16.96%,DDX5;UBA5;UFSP2;RUNX1;KLK2;HDAC6;LATS1;AR
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.37769570618337023,0.8818687705224542,0.5969230769230769,0.8828286963517334,1.0,4/20,3.80%,ATP1A4;ATP1A3;ATP1A1;SLC8A1
prerank,response to interleukin-6 (GO:0070741),-0.3771443974650696,-0.8816272912607308,0.6142857142857143,0.9242486133072131,1.0,1/10,0.12%,PID1
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.4250291909519721,0.8815561311833082,0.5993150684931506,0.882963686734068,1.0,3/11,11.20%,GOPC;TAX1BP3;NEDD4L
prerank,nervous system development (GO:0007399),0.265207516494955,0.8814283726436041,0.7731854838709677,0.8827443271578965,1.0,71/429,15.48%,JAG1;KALRN;EFNA5;LDB2;RNF103;SLC2A1;MERTK;APBA1;MPZ;GDA;RAPGEF5;NRGN;GJB1;SERPINI1;PPT1;DNM3;EVL;SNTG2;PLXND1;SPOCK2;WWTR1;MBNL1;MEF2C;PCDH1;SHANK3;SH3GL1;CHRM3;ZBTB16;NRCAM;WWP1;FLRT3;NCKAP1;APC;MAL;ASIC2;EIF2B2;NFASC;FAT4;ADGRB1;ZC4H2;KIRREL3;CDH2;NAV1;SPOCK1;NCAN;BPNT1;GSS;ACHE;PCDHB16;SOX10;SOX6;RPS6KA3;CYP26C1;CAPG;POU3F2;ATXN1;ADGRA2;RBM45;VLDLR;NAV3;SDCBP2;MYT1L;CXCR4;NELL1;FZD9;TRPC5;GFRA3;PCDHB14;APLP1;NES;GRIK1
prerank,ovarian follicle development (GO:0001541),-0.34727167500709344,-0.8813144733344995,0.6163682864450127,0.9238092186431343,1.0,7/13,30.18%,KIT;CEBPB;VEGFA;INHBA;INHBB;FOXL2;LHCGR
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.35226248911673697,0.8810480595336498,0.6140602582496413,0.8830259690176061,1.0,11/31,21.60%,MSN;SYNE4;WDR1;PDZD11;MARK2;ANK1;OPHN1;LRRC7;ERBIN;MTCL1;CRB1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.22988891922488008,-0.880914936710411,0.7159763313609467,0.9235454919337301,1.0,18/76,21.55%,LPAR1;PLCE1;ADRA1B;ACTN2;ANO1;GPR4;PTH1R;HOMER1;ADRA2A;AGTR1;DRD2;ADRA1A;LPAR4;TRHR;P2RY6;OPRK1;AGT;HRH1
prerank,pseudouridine synthesis (GO:0001522),0.40712081077300977,0.8805393388196199,0.6053882725832013,0.8835449862866497,1.0,4/13,18.19%,DKC1;TRUB1;NHP2;RPUSD2
prerank,cellular response to topologically incorrect protein (GO:0035967),0.34647967510837896,0.8805043297847728,0.6112676056338028,0.8831421564674788,1.0,8/31,19.55%,DAB2IP;RHBDD1;HSPA1B;PTPN1;TMBIM6;TM7SF3;DAXX;ERN1
prerank,cellular potassium ion homeostasis (GO:0030007),0.4097041506285213,0.8804685544687205,0.5983606557377049,0.8827408212675606,1.0,3/13,2.18%,ATP1A4;ATP1A3;ATP1A1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.32539259752203575,-0.8802695726366042,0.6071428571428571,0.9238818521573117,1.0,7/17,16.52%,PTPN22;ANXA1;SSC5D;OTUD7B;MAPKBP1;BCL3;ANXA4
prerank,RNA 3'-end processing (GO:0031123),-0.23245591546606176,-0.8798253989969157,0.7248677248677249,0.9237715015220412,1.0,27/69,24.51%,SRSF5;NUDT21;NCBP1;LIN28B;SRRM1;SRSF1;SRSF6;PABPN1;THOC1;TENT4B;TUT1;SUPV3L1;PCF11;MAGOH;CSTF2T;U2AF2;TUT4;MAGOHB;UPF3B;SRSF3;SRSF11;PAPOLA;EIF4A3;NCBP2;ZC3H11A;U2AF1;SRSF2
prerank,negative regulation of myotube differentiation (GO:0010832),0.40879696491262885,0.8797170476450233,0.6026272577996716,0.8836867296937457,1.0,1/12,1.61%,NOTCH1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.36907723820466387,0.8793733521916952,0.5997001499250375,0.8838549565742467,1.0,8/22,21.81%,MSX1;RPL37;CHD5;ATM;RPS15;EEF1E1;HEXIM1;UBB
prerank,myeloid dendritic cell activation (GO:0001773),0.41246462697295366,0.8786877550961917,0.6128,0.8846556650271387,1.0,4/12,22.97%,HMGB1;DOCK2;PYCARD;CAMK4
prerank,neuron cell-cell adhesion (GO:0007158),0.39740913976788567,0.8784483199232163,0.5903010033444817,0.884640176895259,1.0,9/14,31.56%,NCAM2;ASTN1;NRXN3;CNTN4;NRXN1;NLGN1;RET;CDK5R1;ASTN2
prerank,Golgi inheritance (GO:0048313),0.41477459659053495,0.8783540464066856,0.6225165562913907,0.8843596413848437,1.0,3/11,15.17%,PLK3;VRK1;PDCD10
prerank,negative regulation of complement activation (GO:0045916),-0.3786128051895192,-0.8782336424909277,0.6178660049627791,0.9263217775151408,1.0,2/10,4.70%,SERPING1;CD55
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.4222104389283421,0.8780844159301416,0.6003401360544217,0.8844157535357209,1.0,2/11,7.49%,ADRB2;ARRB1
prerank,ribosomal small subunit assembly (GO:0000028),0.38304489727110885,0.8776220778012652,0.6251993620414673,0.8848474070804246,1.0,6/16,21.64%,RPS14;RPS28;RPS5;RPS15;PWP2;RPS19
prerank,secretory granule organization (GO:0033363),-0.3876991797634371,-0.8775277912248796,0.6096256684491979,0.9268119000393451,1.0,4/10,19.41%,ABCA1;DTNBP1;VPS33B;BLOC1S2
prerank,histone H2A acetylation (GO:0043968),0.39392945858222067,0.8773186224814775,0.6404494382022472,0.8849979865524825,1.0,4/16,15.62%,ING3;BRD8;DMAP1;TRRAP
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.2981384664513341,-0.8773183618274322,0.6563467492260062,0.9260944004699334,1.0,9/25,24.26%,SNRNP40;SCAF11;PRPF8;SRRM1;PRPF3;BCAS2;MPHOSPH10;SF3B1;WDR83
prerank,positive regulation of protein deacetylation (GO:0090312),-0.34423457920102785,-0.8768800655114468,0.6415094339622641,0.9259057718442916,1.0,6/14,22.71%,NIPBL;AKAP8L;SAP30BP;NNMT;ZBTB7B;APLNR
prerank,positive regulation of macrophage migration (GO:1905523),-0.3026439032027587,-0.8768497895573689,0.5845697329376854,0.9247918489031889,1.0,3/19,7.36%,IL34;THBS1;P2RX4
prerank,phospholipid transport (GO:0015914),0.3168581276235072,0.876842802613611,0.6431273644388399,0.8854224944022411,1.0,8/52,12.83%,ATP10A;APOA1;PLTP;ABCB4;PITPNA;ATP11C;ATP8B1;ABCC1
prerank,protein deubiquitination (GO:0016579),0.2701199429801663,0.8768250486880604,0.7515657620041754,0.8849874936322976,1.0,53/242,18.87%,SMAD7;FOXO4;USP38;SPATA2;IFIH1;ADRB2;PSMD13;SMAD2;TAF9B;GATA3;UBE2D1;PSMD4;ZC3H12A;UBA52;RPS27A;APC;BABAM2;SIAH2;PSMA5;PSMB10;RNF128;NFKBIA;PSMB8;USP12;POLB;PSMD14;ACTB;EIF3F;BRCA1;USP29;YOD1;KEAP1;PSMA7;PSMA8;PSMC3;HIF1A;PSMB5;PSMC1;PSMC5;USP9Y;MINDY1;TRRAP;PSMC6;PSMB9;ESR1;USP35;PSMA4;COPS5;SMAD4;PSMD5;PSMD9;INO80D;PSMB6
prerank,negative regulation of response to wounding (GO:1903035),-0.31176329893183735,-0.876726250994069,0.6347826086956522,0.9238932891389449,1.0,5/19,14.04%,CASK;FGF2;SERPINE1;MDK;PTPRS
prerank,establishment of protein localization to organelle (GO:0072594),-0.233124784423012,-0.8767200514832573,0.7612612612612613,0.922721497437242,1.0,21/72,23.77%,APPL2;NUP107;HEATR3;CSE1L;PPP1R10;NUP155;TNPO3;RANBP6;HK2;FAM53C;IPO5;NUP93;TNPO2;RANBP17;TSC2;PHB2;SEC13;SYK;IPO7;POM121;IPO8
prerank,acute inflammatory response (GO:0002526),-0.29822408388161026,-0.876229757427601,0.6626506024096386,0.9226695393983222,1.0,4/23,8.41%,LBP;IL6R;F3;CEBPB
prerank,protein localization to vacuole (GO:0072665),0.39812253578609924,0.8757926603394283,0.6235489220563848,0.8864482759973183,1.0,3/13,9.75%,SH3BP4;RTN4;RNF128
prerank,peptidyl-proline modification (GO:0018208),-0.2915688876035033,-0.8757428760638806,0.632996632996633,0.922641235492618,1.0,8/25,11.49%,FKBP5;NKTR;PPIC;FKBP10;PPIA;FKBP7;P3H2;PPIL2
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.38510049907725014,0.8752770098482356,0.6168521462639109,0.8869170533134328,1.0,3/16,9.00%,EDN1;CAMK2D;ROCK1
prerank,cellular response to interleukin-6 (GO:0071354),0.35146402442879915,0.8751685733370137,0.62339514978602,0.8866540267291745,1.0,5/26,7.87%,ST3GAL6;CBL;STAT1;JAK2;CEBPA
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.34835248248101247,0.8744340250886671,0.6303116147308782,0.8875696804597997,1.0,3/31,3.17%,SMAD6;NOTCH1;HDAC7
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.37008758541058995,-0.8742526996447247,0.6309523809523809,0.9248681797372504,1.0,3/11,5.92%,NBL1;SLIT2;CCN3
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.4203721325361952,0.8741903295168504,0.6088379705400983,0.8875532863990928,1.0,1/11,3.51%,NOS1AP
prerank,synapse organization (GO:0050808),0.28467758902931123,0.874161074368575,0.6935483870967742,0.8871466400375823,1.0,26/125,13.32%,UNC13B;APBB2;AGRN;APP;PPFIBP1;DNM3;SNCG;PLXND1;GPHN;SPOCK2;SHANK3;LRRK2;NRCAM;FLRT3;LRRC4C;PPFIA2;CYFIP1;ZC4H2;KIRREL3;CDH2;GRM5;ACHE;PCDHB16;SLITRK2;CX3CR1;PIN1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.41615341550732854,0.8738136179065826,0.6076158940397351,0.8873154474305863,1.0,3/11,12.65%,KLF2;EPN2;PIK3CB
prerank,cardiac myofibril assembly (GO:0055003),0.3966892575518251,0.8737456010393961,0.6103678929765887,0.8869829792598329,1.0,1/15,0.61%,NEBL
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.322655856579989,-0.873468806945856,0.6498599439775911,0.9253915791982992,1.0,8/18,33.70%,FLNA;ERBB2;MAF1;UBTF;PHF8;DHX33;POLR2L;HEATR1
prerank,keratan sulfate biosynthetic process (GO:0018146),0.35292179759622283,0.8732877256831657,0.6217008797653959,0.8873613485793265,1.0,8/26,15.29%,ST3GAL6;B4GALT4;SLC35D2;B3GNT3;B4GALT6;CHST1;ST3GAL1;ST3GAL2
prerank,sister chromatid segregation (GO:0000819),-0.2835920803670093,-0.873252676352778,0.6394557823129252,0.9247198663811982,1.0,16/31,32.35%,KLHL22;TOP2B;NCAPG2;MIS12;LATS1;CENPK;ZW10;NUSAP1;TOP2A;ZWINT;SPAG5;KIF18B;KIFC1;NSL1;CDCA8;TUBG2
prerank,DNA damage checkpoint signaling (GO:0000077),0.34405232883442827,0.8732324547325481,0.6183644189383071,0.8870101542707051,1.0,10/28,19.78%,BRIP1;HINFP;STK33;ATM;RAD1;MAP3K20;FBXO6;TIPRL;ATRIP;HUS1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.28628936432905483,0.8732280053642476,0.6607773851590106,0.8865572539378537,1.0,24/100,17.88%,SMAD7;SUMO2;CSNK1D;FOXF2;BBS7;ARIH1;RYBP;LRRK2;HSPA1B;CEBPA;NKD2;XPO1;RBX1;RNF144B;BAG6;CLU;KEAP1;EIF3H;RACK1;CBFA2T3;TRIB3;SOCS5;UBQLN4;GSK3A
prerank,'de novo' posttranslational protein folding (GO:0051084),0.3452294316867068,0.8730080525489987,0.6042857142857143,0.886520832558404,1.0,7/30,18.51%,HSPA1B;HSPE1;PTGES3;CCT2;UGGT1;DNAJC7;DNAJB5
prerank,cell projection organization (GO:0030030),0.34293995271445465,0.8729786084266923,0.6294706723891274,0.886118321893484,1.0,8/30,14.01%,PARVB;PACSIN2;NCKAP1;NEFH;RAC1;CYFIP1;CAPG;RHOH
prerank,regulation of spindle organization (GO:0090224),-0.3225660884736921,-0.8729522920157164,0.6222826086956522,0.9242112103077036,1.0,8/18,29.88%,GNAI1;GPSM2;RNF4;PARP3;BORA;TPX2;NUP62;FSD1
prerank,glutamine family amino acid metabolic process (GO:0009064),0.34190460586911015,0.8723735971336003,0.6320224719101124,0.8867813012436797,1.0,6/33,8.82%,DGLUCY;GLS2;GLS;GLUD1;SIRT4;CAD
prerank,T cell differentiation in thymus (GO:0033077),-0.3443484690112597,-0.8722275839633952,0.6589147286821705,0.9247617434760168,1.0,1/14,0.43%,GLI3
prerank,regulation of protein processing (GO:0070613),-0.3029653037281156,-0.872157066110772,0.647887323943662,0.9237506160845185,1.0,4/21,7.19%,CCBE1;GAS1;SERPINE2;RUNX1
prerank,glycerol metabolic process (GO:0006071),-0.37780506403322905,-0.8716199262697394,0.6363636363636364,0.9237715015220413,1.0,5/10,23.27%,GK;GOT1;COQ2;TPI1;ANGPTL3
prerank,organelle assembly (GO:0070925),0.26445976054318443,0.8711685724209756,0.7941176470588235,0.8885793549785176,1.0,58/384,15.42%,EXOC6;SYNPO;EHD4;ABCC4;ABLIM1;NOTCH1;RAB11A;ATG101;FLII;STX7;EHD1;TEKT5;DHX37;CSNK1D;FAM161A;BBS7;TTBK2;TTC36;CD34;SNX10;FNBP1L;GABARAPL1;VPS36;RAB23;IRGM;TMEM216;MAPRE3;IFT140;STX12;STARD9;HAUS3;CFAP43;PCM1;NEK7;PIK3C3;VPS28;CHMP1B;CDC14A;CFAP52;DYNLL1;EXOC8;TNKS;NPM1;OCRL;VPS4A;CHMP3;RAB19;WDR11;TMOD3;KIF24;MAP1LC3A;CEP83;EIF2A;EIF2S1;CHMP2B;CHMP7;EDC3;DDX6
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.3441665835960783,-0.871152415107609,0.6463104325699746,0.9236489566406139,1.0,7/14,25.74%,RMND1;TRUB2;RCC1L;RPUSD4;MPV17L2;C1QBP;FASTKD3
prerank,protein modification by small protein removal (GO:0070646),0.2672601419428804,0.8706803366396717,0.7735263702171665,0.889016704194968,1.0,65/252,21.81%,SMAD7;FOXO4;USP38;IFIH1;ADRB2;COPS4;PSMD13;SMAD2;TAF9B;GATA3;UBE2D1;PSMD4;ZC3H12A;SENP5;UBA52;RPS27A;APC;BABAM2;SIAH2;PSMA5;PSMB10;RNF128;NFKBIA;PSMB8;USP12;POLB;PSMD14;ACTB;EIF3F;BRCA1;COPS8;USP29;YOD1;KEAP1;PSMA7;PSMA8;PSMC3;HIF1A;PSMB5;PSMC1;PSMC5;USP9Y;TRRAP;PSMC6;PSMB9;ESR1;USP35;PSMA4;SENP7;COPS5;USPL1;SMAD4;PSMD5;PSMD9;INO80D;PSMB6;BARD1;STAM2;SENP6;TAB1;USP47;PSMB2;USP14;USP30;UBB
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.314646446390834,-0.8705210385999087,0.6297297297297297,0.9238779809551876,1.0,3/18,5.44%,WNK1;PPARA;PTPN22
prerank,response to amino acid starvation (GO:1990928),0.3006815917986647,0.8704472510387549,0.650314465408805,0.8889690807031941,1.0,19/72,20.65%,FAS;CASTOR1;PRKD1;DAP;MAPK1;WDR59;RRAGD;GCN1;RHEB;EIF2S1;MIOS;ATP6V1G1;ATP6V1C1;RRAGA;RRAGC;NPRL3;ATP6V1D;EIF2AK2;LAMTOR3
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.24591312020094652,-0.8700524933737691,0.7377777777777778,0.9237006047494041,1.0,17/55,21.92%,PID1;PDGFRB;THBS1;PRKN;XDH;DHRS4;PDK3;MPV17;AGTR1;SIRT2;TGFBR2;CDKN1A;ACE2;PAX2;ROMO1;AGT;SPHK2
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.26437958777069054,0.8697954952794953,0.7979591836734694,0.8896982287978704,1.0,84/341,20.14%,ZNRF1;CBL;FBXO7;PSMD13;FBXL14;KLHL3;ELOC;RNF125;RNF185;ARIH1;CUL3;ARRDC1;UBE2D1;PSMD4;KLHL20;PTTG1;ARRB1;TOM1L1;NFE2L2;UBE4A;WWP1;FEM1C;PPP2R5C;NDFIP2;VPS28;SIAH2;PSMA5;PSMB10;RNF115;FBXW7;ZNRF3;RNF128;RBX1;TRIM25;RNF144B;BAG6;PSMB8;NEDD4L;PSMD14;DTX3L;SMURF1;KCTD10;VPS4A;RMND5B;KEAP1;PSMA7;PSMA8;PSMC3;UBE2E1;CDC27;PSMB5;CTNNB1;PSMC1;PSMC5;UBE3B;UBE2D3;NHLRC1;TRIM2;KLHL25;PSMC6;PSMB9;RNF150;UBQLN2;SPOPL;ANAPC7;PSMA4;UBQLN4;GSK3A;FBXO8;FBXO10;PSMD5;PSMD9;PSMB6;FEM1A;FBXO45;ANAPC4;RNF166;MVB12A;MAEA;ZFAND2A;KCTD2;KCTD21;RNF5;RNF11
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.3772954299217973,0.8697647296796769,0.6254019292604501,0.8892926885373881,1.0,2/18,6.12%,RAB11A;CDC25C
prerank,negative regulation of cellular component movement (GO:0051271),0.3849523095515116,0.8695708907371773,0.6388443017656501,0.8891965670036727,1.0,7/15,15.68%,CRK;SPOCK3;GATA3;SPINT2;PIN1;CD9;FRMD5
prerank,histone lysine methylation (GO:0034968),-0.27045919868911894,-0.8694467982742766,0.6548042704626335,0.9238899209315787,1.0,9/33,17.44%,PRDM5;ASH2L;SETD1B;DOT1L;WDR5;DPY30;SUV39H1;N6AMT1;SETDB2
prerank,vitamin transport (GO:0051180),0.3440938745863327,0.8693036855479442,0.6193181818181818,0.8892568052072624,1.0,3/29,3.52%,SLC25A32;TTPA;APOA1
prerank,regulation of interleukin-17 production (GO:0032660),0.3370781017998294,0.868413890845304,0.6337448559670782,0.8904228532326495,1.0,3/31,11.22%,NOD2;PRNP;VSIR
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.3238728393045478,-0.8683690132548061,0.6344086021505376,0.9251127128595247,1.0,8/16,24.34%,SIK3;KLHL22;FLCN;PIH1D1;TELO2;GPR137;LAMTOR5;RRAGB
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.34490149404232645,0.8675685502636779,0.6237337192474675,0.8915072776324181,1.0,3/27,5.53%,F2RL1;GPR157;LPAR6
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.419861747293671,0.8674817852719329,0.6319569120287253,0.8911995582791686,1.0,2/10,2.95%,NOTCH1;DLL4
prerank,transcription by RNA polymerase II (GO:0006366),0.26450398703467426,0.8674412093532573,0.7678018575851393,0.8908039515454668,1.0,68/305,17.71%,NOTCH4;TSC22D1;NR4A2;NOTCH1;NR1I3;HNF4A;HDAC9;HDAC7;TEAD4;MED26;WWTR1;IRF9;YBX2;PIR;RXRG;ELOC;TAF9B;TAF1A;INTS11;RTF1;EAF1;SETX;TRIM24;CPSF1;ELP4;ELP2;POLR2G;NR1D1;MBD1;ELOA;POLR2D;ELL2;RPRD1B;SNRPE;FIP1L1;MAML2;DEAF1;TBPL1;GTF2H3;INTS12;EAF2;NR4A1;KLF13;CBFB;GTF2A1;DDX21;MED27;MED17;INTS5;MED4;ICE1;MLLT3;SNAPC4;ELOF1;TAF11;NR2C1;POLR2I;AFF4;NELFB;ESRRG;ESR1;NELFA;RARA;DRAP1;TAF8;RPRD2;E2F3;RPAP1
prerank,regulation of complement activation (GO:0030449),-0.2629058216913465,-0.867426049690776,0.7033898305084746,0.92607305142512,1.0,14/40,26.61%,SERPING1;VTN;CD55;CD81;C1QC;C4B;C1QA;CFHR2;PHB2;C1QB;C2;C1QBP;C3AR1;C3
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.34347637795071695,0.8667348850775553,0.6369958275382476,0.8916634685456633,1.0,6/31,13.94%,FAM107A;KLF4;RBL1;APC;E2F7;CDKN2D
prerank,aerobic respiration (GO:0009060),-0.3104013471367639,-0.8667003424098094,0.6498599439775911,0.9266648968780798,1.0,10/20,26.14%,SIRT3;MDH2;NDUFS7;MTFR1L;SDHB;UQCRH;ATP5F1D;SLC25A14;MTFR2;NDUFS8
prerank,steroid metabolic process (GO:0008202),-0.2322696672956295,-0.8662744640179588,0.7569060773480663,0.9264426252019743,1.0,21/72,29.66%,CYP27A1;CYP26B1;LIPA;SCP2;DHRS4;FDX1;AMACR;GBA2;CYP2A6;LGMN;CYP51A1;PIAS4;STAR;SRD5A1;HSD11B1;HSD17B10;LSS;PRLR;ARV1;CYP2R1;CYP46A1
prerank,positive regulation of organelle assembly (GO:1902117),0.32134553560589424,0.8652696981344552,0.65,0.8938857795233405,1.0,13/44,21.42%,SAXO1;RAB3GAP2;CNOT6L;CNOT1;CCDC88A;NUMA1;CAPG;LCP1;CEP120;CNOT2;G3BP1;MARK4;RALB
prerank,GPI anchor biosynthetic process (GO:0006506),-0.27665886900076814,-0.8649301860606883,0.6622950819672131,0.9283160700142693,1.0,14/30,26.87%,PIGA;PIGB;PIGN;PIGH;PGAP2;DPM2;PIGG;PIGP;PIGZ;PGAP4;PGAP3;GPAA1;PIGL;PIGW
prerank,spermatid development (GO:0007286),0.34091431810922496,0.8644864927939563,0.6549789621318373,0.8948586660439164,1.0,2/32,4.16%,JAM2;ING2
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.31274125268867264,0.8644270660692299,0.6626826029216467,0.8945138567194687,1.0,15/52,19.09%,LSM1;EXOSC3;CNOT6L;DCP1B;DCPS;POLR2D;CNOT1;EXOSC8;EDC3;DDX6;NT5C3B;CNOT2;TUT7;EXOSC9;LSM2
prerank,inorganic anion transmembrane transport (GO:0098661),0.29974709705164393,0.8644194045534372,0.669620253164557,0.8940667623933874,1.0,17/63,18.69%,SLC12A8;ANO6;GABRQ;CLCN3;SLC25A30;CLCN1;GABRA4;XPR1;SLC37A2;SLC1A1;GABRA2;GABRE;SLC37A3;GLRA2;SLC25A10;GABRG3;GABRB1
prerank,histone methylation (GO:0016571),-0.2843055383566912,-0.8634879864098911,0.6646525679758308,0.9303762738919215,1.0,6/26,16.24%,CREBBP;NSD1;NSD3;EHMT1;SUV39H1;N6AMT1
prerank,negative regulation of protein catabolic process (GO:0042177),0.32568989612899707,0.8630983799400506,0.6617842876165113,0.8960613145730805,1.0,9/40,14.25%,AZIN1;DAB2IP;TIMP3;ROCK1;MAD2L2;PRKCG;ADGRB1;PIN1;NELL1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.37296303992413815,-0.8628325202703446,0.6231527093596059,0.9306185292478926,1.0,6/10,30.14%,PIH1D1;ZNHIT6;NAF1;ZNHIT3;TAF9;PIH1D2
prerank,microtubule anchoring at centrosome (GO:0034454),-0.3645292288285447,-0.8627129010262675,0.6384039900249376,0.9297337271450355,1.0,5/10,27.68%,NINL;KIF3A;CCDC68;CCDC120;CEP19
prerank,ether lipid metabolic process (GO:0046485),-0.3409071867102843,-0.8626525484914699,0.6491228070175439,0.928719550985999,1.0,3/14,7.72%,AGMO;GNPAT;PEDS1
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3120464868658347,0.8620991847106241,0.6571056062581486,0.8975008484892532,1.0,8/42,14.11%,SMARCA2;SRCAP;ACTR6;ACTB;DMAP1;SMARCAD1;SMARCC1;VPS72
prerank,lipid transport (GO:0006869),0.28580178854148924,0.8618307215929636,0.6950354609929078,0.8975412654979606,1.0,11/97,10.17%,ABCC4;CEACAM1;TTPA;SLCO1C1;APOA1;SPNS2;PLTP;GLTP;CERT1;PITPNA;ABCG4
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.35141917022173685,0.8616579225401555,0.6141141141141141,0.8973726007103732,1.0,4/26,8.68%,EFNA5;KLF7;NR1D1;PIM3
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.4010332546607625,0.8615126006510058,0.6256077795786061,0.8971691136345217,1.0,2/13,7.75%,MGAT5;JAK2
prerank,response to histamine (GO:0034776),0.41804464195546875,0.8613549925302909,0.6312292358803987,0.897012299729847,1.0,3/10,21.18%,DIAPH1;GABRB1;GABRB3
prerank,histone mRNA catabolic process (GO:0071044),0.3800934536707965,0.860967236074853,0.6385737439222042,0.8972835175472406,1.0,7/15,21.57%,LSM1;MTPAP;XRN1;ATM;TUT7;TENT2;EXOSC10
prerank,innate immune response in mucosa (GO:0002227),0.4216057269237507,0.8606282992651915,0.64349376114082,0.8974616248459316,1.0,1/10,4.09%,DEFA6
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.34519516176955034,-0.8598563683628162,0.6719160104986877,0.9336444411601101,1.0,1/12,0.28%,CACNA1C
prerank,acylglycerol homeostasis (GO:0055090),0.36074497251312126,0.8595003522148127,0.6365030674846626,0.8991240863733647,1.0,2/20,3.52%,HNF4A;APOA1
prerank,regulation of cell killing (GO:0031341),0.37911932221982303,0.8588519619295454,0.6225854383358098,0.8998939487180085,1.0,4/16,11.25%,TGFB2;CR1L;RAC1;CYBA
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.3375146328702632,0.8586374770916181,0.6406926406926406,0.899837677983594,1.0,6/29,18.49%,MBOAT2;LPCAT4;TMEM86B;LPCAT3;PLA2G12A;PLAAT3
prerank,respiratory chain complex IV assembly (GO:0008535),-0.2965399975107192,-0.8585536538622263,0.6843657817109144,0.9352228411679775,1.0,10/21,29.82%,COX17;COX16;COX18;COX10;SMIM20;TIMM21;COA6;FASTKD3;COX14;COX19
prerank,regulation of histone deacetylation (GO:0031063),0.40120314119242856,0.858534658097264,0.6480891719745223,0.8995722429598244,1.0,2/13,4.76%,ING2;CAMK2D
prerank,regulation of cilium assembly (GO:1902017),0.29749316635519457,0.8580074623378333,0.676039119804401,0.9000967224886204,1.0,11/62,13.33%,RABGAP1;SAXO1;TBC1D30;TBC1D8;IFT140;TBC1D5;TBC1D1;CCDC88A;LIMK2;USP6NL;TBC1D10A
prerank,ncRNA 3'-end processing (GO:0043628),-0.32559516836455793,-0.857514743854288,0.6581632653061225,0.9362344877693013,1.0,6/14,19.58%,INTS14;SSB;INTS2;PTCD1;TOE1;TRNT1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.3955396504725408,0.8574546919192281,0.6214405360134003,0.9006638170818134,1.0,5/13,14.58%,KPNB1;NUP54;NUP35;RANBP2;KPNA3
prerank,cilium assembly (GO:0060271),0.26582864204334683,0.8573157147247374,0.8016443987667009,0.900444096158122,1.0,34/296,11.00%,EXOC6;EHD4;ABCC4;ABLIM1;NOTCH1;RAB11A;CFAP206;EHD1;TEKT5;DNAAF3;CSNK1D;FAM161A;TUBB;BBS7;TTBK2;TTC36;SNX10;FNBP1L;RAB23;SPATA6;TUBB4B;CLASP1;TMEM216;NEDD1;IFT140;HAUS3;CEP135;CFAP43;PCM1;CDC14A;CFAP52;CEP76;DYNLL1;EXOC8
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.2527408972214924,-0.8571694232338036,0.7330827067669173,0.9358106523413485,1.0,2/41,0.80%,PRKAG2;OGT
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.38680625405406166,0.857166944747226,0.6347402597402597,0.9002334300342921,1.0,6/15,29.11%,HSP90B1;SEL1L;TMEM129;SELENOS;HERPUD1;UFD1
prerank,vitamin D metabolic process (GO:0042359),-0.34215230343639613,-0.8569371708579745,0.6065573770491803,0.9351599294982456,1.0,10/13,49.93%,LGMN;PIAS4;CYP2R1;CUBN;LRP2;VDR;CYP1A1;CYP24A1;FGF23;CYP27B1
prerank,regulation of glycogen metabolic process (GO:0070873),0.3900909039705399,0.8568303137579275,0.6534653465346535,0.9003801342049939,1.0,1/12,3.59%,INPP5K
prerank,defense response to Gram-negative bacterium (GO:0050829),0.31898883718939214,0.856611038049237,0.6477732793522267,0.9003518343325707,1.0,10/42,16.91%,DEFA6;IRGM;GALP;ADGRB1;CHGA;RPL30;HMGB2;RNASE6;PYCARD;DROSHA
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3054133302857447,0.8565622275294158,0.6657754010695187,0.8999745533679799,1.0,11/51,10.77%,DAB2IP;TRIO;ATP7A;SHTN1;MAP4K4;PACSIN1;LRRK2;NCKAP1;SGK1;TAOK2;MINK1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.3977891788136019,0.8564308173421051,0.6275862068965518,0.8997573019246465,1.0,7/12,23.74%,GLUD1;ASS1;SIRT4;IDH3B;ACLY;IREB2;IDH3G
prerank,regulation of lamellipodium organization (GO:1902743),-0.32708364451112437,-0.8561837508684799,0.6518324607329843,0.9356886292108546,1.0,3/14,12.98%,PDPN;CAPZB;FER
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.3565120875364132,0.8561344072448653,0.6467153284671533,0.8998169157213437,1.0,7/23,18.03%,COPS4;UBA52;RPS27A;RBX1;COPS8;XPC;COPS5
prerank,regulation of pH (GO:0006885),0.4069655359946612,0.8558171936302565,0.6333333333333333,0.899959833351423,1.0,3/11,9.73%,ATP1A4;CLCN3;SLC9A7
prerank,negative regulation of immune effector process (GO:0002698),-0.3396284501045689,-0.8556241986941927,0.6607142857142857,0.9357768332273372,1.0,5/13,17.52%,CD55;ENPP3;FER;CD300A;RC3H1
prerank,secondary palate development (GO:0062009),0.38456644735143136,0.8549233048974029,0.63125,0.9011609519499632,1.0,3/14,5.12%,TGFB2;LEF1;SMAD2
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.37992483938921884,0.8545015162679335,0.6385911179173047,0.9010401664736153,1.0,7/15,29.03%,BLOC1S6;AP3S1;AP3M1;AP3D1;AP3B1;BLOC1S5;AP3M2
prerank,anterograde synaptic vesicle transport (GO:0048490),0.37992483938921884,0.8545015162679335,0.6385911179173047,0.9010401664736153,1.0,7/15,29.03%,BLOC1S6;AP3S1;AP3M1;AP3D1;AP3B1;BLOC1S5;AP3M2
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3328005074250728,0.8540878123194215,0.6511954992967651,0.901281382363688,1.0,9/29,19.13%,SRARP;UFM1;CNOT1;STRN3;BRCA1;CBFB;ESR1;CNOT2;WBP2
prerank,positive regulation of cellular component movement (GO:0051272),0.3531554706285137,0.8530613652921744,0.6776611694152923,0.9027443297710124,1.0,5/24,11.35%,ACTN4;SPOCK2;NTN1;ADAM17;CAVIN1
prerank,bone morphogenesis (GO:0060349),0.3946393846505415,0.8524829104195825,0.6495016611295681,0.9033117094429423,1.0,2/14,5.44%,BMPR2;FGFR3
prerank,translational termination (GO:0006415),0.280392932459952,0.8524330694623298,0.7046568627450981,0.9029436135125765,1.0,40/95,28.95%,MRPL4;MRPL18;MRPL41;MRPL1;MRPS31;ETF1;MRPL15;MRPL19;MRPL47;MRPL52;MRPL36;MRPL23;MRPL24;MRPL14;MRPL32;MRPS34;MRPS12;MRPL39;MRPL54;MRPS18B;MRPS30;MTRF1L;MRPL11;MRPS28;MRPS35;MRPS9;MRPS27;MRPL34;MRPS24;MRPL35;MRPL10;MRPL27;MRPL38;MRPS18C;APEH;MRPL13;AURKAIP1;MRPS18A;MRPL40;ERAL1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.2845007850052367,0.8524177406073336,0.6927437641723356,0.902516072721575,1.0,17/104,16.95%,CCND2;CCND3;DAB2IP;ADRB2;SLC8A1;CCNE1;SERTAD1;CDC25C;IRGM;SYAP1;ACTB;CALM3;LRP5;CDKN2D;PDCD10;PYCARD;TRIB3
prerank,regulation of synapse assembly (GO:0051963),-0.23750157329437543,-0.852038319252364,0.7245762711864406,0.9423979366742176,1.0,13/46,20.34%,GPC6;NLGN2;CLSTN2;SLITRK1;MDGA1;SRPX2;EPHB2;PTPRD;EPHB3;LHFPL4;GPC4;CUX2;IL1RAPL2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.3458678845257335,0.8518996625641417,0.6404160475482912,0.9029919882326066,1.0,7/26,22.32%,DUSP1;CUL3;CDC27;ANAPC7;ANAPC4;LCMT1;ANAPC11
prerank,positive regulation of coagulation (GO:0050820),-0.3624380997969397,-0.8515191638533228,0.6544117647058824,0.9412277877545306,1.0,3/10,11.21%,THBS1;ST3GAL4;SERPINE1
prerank,positive regulation of hemostasis (GO:1900048),-0.3624380997969397,-0.8515191638533228,0.6544117647058824,0.9412277877545306,1.0,3/10,11.21%,THBS1;ST3GAL4;SERPINE1
prerank,negative regulation of transmembrane transport (GO:0034763),0.41140821150602075,0.8513597825249432,0.644891122278057,0.9035163601501531,1.0,2/10,5.39%,INPP5K;CTTNBP2NL
prerank,B cell proliferation (GO:0042100),0.37202652649793505,0.8510220179661885,0.6486486486486487,0.9036668971400346,1.0,4/17,16.06%,CTPS1;MEF2C;CR2;CD79A
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.3991988715039695,0.8509454108838297,0.6527545909849749,0.903348960781286,1.0,2/11,4.05%,ARL6IP5;STK24
prerank,nuclear body organization (GO:0030575),-0.35043070307309176,-0.8503181043293763,0.6609756097560976,0.9427127339204541,1.0,5/12,21.40%,AFF2;USP50;ZPR1;PML;SRPK2
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.23649503740265307,-0.8492852763005543,0.7589285714285714,0.9414258841167823,1.0,30/61,29.14%,SEC24D;GOLGA2;TGFA;TRAPPC10;LMAN1;SEC31A;STX5;SEC24C;TRAPPC3;SEC16B;NAPA;F5;CTSC;SEC16A;TBC1D20;SAR1B;PPP6R1;BET1;SEC13;PREB;SEC23A;TRAPPC6A;COL7A1;TRAPPC4;CTSZ;CNIH3;F8;GORASP1;TRAPPC2L;PPP6R3
prerank,vesicle coating (GO:0006901),-0.23649503740265307,-0.8492852763005543,0.7589285714285714,0.9414258841167823,1.0,30/61,29.14%,SEC24D;GOLGA2;TGFA;TRAPPC10;LMAN1;SEC31A;STX5;SEC24C;TRAPPC3;SEC16B;NAPA;F5;CTSC;SEC16A;TBC1D20;SAR1B;PPP6R1;BET1;SEC13;PREB;SEC23A;TRAPPC6A;COL7A1;TRAPPC4;CTSZ;CNIH3;F8;GORASP1;TRAPPC2L;PPP6R3
prerank,COPII vesicle coating (GO:0048208),-0.23649503740265307,-0.8492852763005543,0.7589285714285714,0.9414258841167823,1.0,30/61,29.14%,SEC24D;GOLGA2;TGFA;TRAPPC10;LMAN1;SEC31A;STX5;SEC24C;TRAPPC3;SEC16B;NAPA;F5;CTSC;SEC16A;TBC1D20;SAR1B;PPP6R1;BET1;SEC13;PREB;SEC23A;TRAPPC6A;COL7A1;TRAPPC4;CTSZ;CNIH3;F8;GORASP1;TRAPPC2L;PPP6R3
prerank,endosome organization (GO:0007032),0.32022972859484694,0.848994846074418,0.6640106241699867,0.9064380634912765,1.0,9/41,18.69%,ALS2CL;SNX10;HOOK1;CLCN3;EXOC8;CHMP2B;PHETA1;RAB27A;HOOK2
prerank,mitotic metaphase plate congression (GO:0007080),0.30536116934939106,0.8483783577560816,0.6921086675291074,0.9071375068559336,1.0,11/51,16.26%,RAB11A;CUL3;KPNB1;CHMP1B;VPS4A;CHMP3;CEP55;CHMP2B;CHMP7;BOD1;NDC80
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.3502563229912836,-0.8480859487729034,0.6713286713286714,0.9428168217595904,1.0,5/12,24.65%,PARP8;PARP6;PARP1;PARP3;PARP2
prerank,regulation of lipid metabolic process (GO:0019216),-0.2180675986159947,-0.8473533287249172,0.8670886075949367,0.9433261663080676,1.0,14/88,11.11%,PRKAG2;CHD9;TBL1XR1;PPARA;CREBBP;NFYC;IRS2;RORA;OPA3;NR1D2;C1QTNF2;TNFAIP8L3;CCDC3;PPARG
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.3649098469035542,-0.8470337271240281,0.6723300970873787,0.9428649385406782,1.0,5/10,24.35%,THOC1;WDR76;RFWD3;FEM1B;RPA2
prerank,glycogen biosynthetic process (GO:0005978),0.3935408517837773,0.8469724412382429,0.6402640264026402,0.908746894657588,1.0,3/12,14.84%,PGM2L1;NR1D1;NHLRC1
prerank,glucan biosynthetic process (GO:0009250),0.3935408517837773,0.8469724412382429,0.6402640264026402,0.908746894657588,1.0,3/12,14.84%,PGM2L1;NR1D1;NHLRC1
prerank,fatty acid biosynthetic process (GO:0006633),0.2952939017945118,0.8468323246764826,0.6920103092783505,0.9085442303771605,1.0,11/63,18.90%,ACSM3;ASAH2;ACSBG1;ELOVL4;HACD4;ELOVL7;ELOVL5;TECR;ABHD2;HACD2;DECR2
prerank,sensory organ development (GO:0007423),-0.24293345473737488,-0.8463624261206535,0.7767441860465116,0.9431592824337764,1.0,6/51,6.60%,SMOC1;PBX3;RBP4;SH3PXD2B;MEIS1;SHROOM2
prerank,cholesterol biosynthetic process (GO:0006695),0.33221254171988773,0.846143819255079,0.6615168539325843,0.9093525278769252,1.0,16/31,29.85%,APOA1;PLPP6;HMGCS1;MVD;ACAA2;DHCR7;GGPS1;ACLY;MVK;IDI1;INSIG1;HMGCR;FDFT1;LBR;TM7SF2;MSMO1
prerank,steroid biosynthetic process (GO:0006694),-0.23127329506922092,-0.8456506746848067,0.7767441860465116,0.9435779089223679,1.0,19/56,30.64%,PRKAG2;CYP27A1;SCP2;INSIG2;AMACR;OSBPL7;SQLE;CYP51A1;STAR;SC5D;SRD5A1;HSD11B1;HSD17B10;LSS;PRLR;CYP46A1;HSD3B7;EBP;PMVK
prerank,cell projection assembly (GO:0030031),0.34564475898880465,0.8451848642669071,0.6460843373493976,0.9106307711913929,1.0,7/22,14.01%,PARVB;NCKAP1;NEFH;RAC1;CYFIP1;CAPG;RHOH
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3035040164072463,-0.8450889702946119,0.6878306878306878,0.9436056660464647,1.0,3/17,7.11%,PDGFRB;MAGI2;CALM2
prerank,genitalia development (GO:0048806),-0.33758280509109884,-0.8448265821320295,0.6454293628808865,0.9430192899417273,1.0,3/12,11.56%,WNT5A;STRA6;PKD1
prerank,positive regulation of type 2 immune response (GO:0002830),0.3752277063800348,0.8444474249060779,0.6677265500794912,0.9115104909972293,1.0,3/14,17.07%,NOD2;RARA;RSAD2
prerank,L-glutamate transmembrane transport (GO:0015813),-0.36627001949462545,-0.8443351850091108,0.6739130434782609,0.9428855144149924,1.0,2/10,2.95%,SLC1A3;SLC25A13
prerank,potassium ion import across plasma membrane (GO:1990573),0.3136507977848775,0.8441784187881135,0.6644113667117727,0.9115404464627274,1.0,4/41,3.81%,ATP1A4;ATP1A3;ATP1A1;SLC12A8
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.34490577455975857,-0.8441744429568493,0.6592039800995025,0.9420772870651362,1.0,3/12,11.18%,CENPC;RMDN1;MIS12
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.32303721069660274,0.8441169797032826,0.6685796269727403,0.9111853195650877,1.0,4/34,4.13%,NEDD9;CRK;APOA1;LIMS2
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.35396288614628757,0.843955613951437,0.6583850931677019,0.9109989265898206,1.0,3/21,11.21%,RAB11A;CDC25C;NPM1
prerank,regulation of endopeptidase activity (GO:0052548),0.2959635726053916,0.8437617760950485,0.6750629722921915,0.9108904728968199,1.0,10/59,11.25%,SERPINI1;SPOCK2;TIMP3;FURIN;SPOCK3;GAPDH;APH1A;PSMB8;VSIR;SPOCK1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.33249679838819923,-0.8435938279495756,0.6481012658227848,0.9422004927918061,1.0,5/13,13.11%,ZMIZ1;ARID1B;SMARCD1;ZMIZ2;PADI2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.28683022875455405,0.8434947603830895,0.6931677018633541,0.9104010172584458,1.0,23/78,24.51%,AP1S2;AP2B1;FCGR2B;KIF26A;ACTR1B;KIF2A;OSBPL1A;AP2M1;DYNLL1;KLC2;DYNC1LI2;SEC24B;AP1B1;SEC24A;ACTR1A;DYNLL2;CAPZA2;DCTN4;DYNC1I2;KIF23;KIF18A;KIF5A;CANX
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.28683022875455405,0.8434947603830895,0.6931677018633541,0.9104010172584458,1.0,23/78,24.51%,AP1S2;AP2B1;FCGR2B;KIF26A;ACTR1B;KIF2A;OSBPL1A;AP2M1;DYNLL1;KLC2;DYNC1LI2;SEC24B;AP1B1;SEC24A;ACTR1A;DYNLL2;CAPZA2;DCTN4;DYNC1I2;KIF23;KIF18A;KIF5A;CANX
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.29801720341833204,0.8432425777935643,0.6971214017521903,0.9103849633721284,1.0,8/59,14.03%,ACSM3;CYP39A1;OSBPL1A;ELOVL4;OSBPL9;GAMT;GATM;SLC27A2
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.3236143597776194,-0.8432332571447528,0.6732954545454546,0.9418516134866818,1.0,2/14,3.31%,IL34;THBS1
prerank,positive regulation of DNA binding (GO:0043388),-0.266156077283283,-0.8432266271633859,0.7371794871794872,0.9407260071617387,1.0,5/31,11.20%,IGF1;PRKN;NGF;PPARG;TXN
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.25383917402811007,-0.8427390062760631,0.7220216606498195,0.9405642680808921,1.0,16/39,24.35%,DDB2;FAN1;RFC1;CUL4B;CUL4A;ERCC5;ERCC2;GTF2H5;GTF2H1;RPA3;GTF2H4;RPA1;PARP1;CHD1L;POLD2;RPA2
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.301912490269482,0.8415869839936899,0.717391304347826,0.9127973248475699,1.0,10/57,11.47%,BOP1;DHX37;RPL7;PAK1IP1;NVL;XPO1;RPS28;MRPL36;NPM1;RPS25
prerank,insulin receptor signaling pathway (GO:0008286),0.2919853635813177,0.8414549103214093,0.7038413878562577,0.9125826205162262,1.0,24/69,23.00%,FOXO4;IRS4;FOXO1;INSR;CAV2;PIK3C2A;BCAR3;APC;NAMPT;AP3S1;PHIP;SOS1;GRB14;ATP6V1G1;PTPN2;GSK3A;ATP6V1C1;ATP6V0A1;GSK3B;ATP6V1D;BCAR1;PIK3R3;ZNF106;PIK3CA
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.3100032351862949,-0.841358393004907,0.7188405797101449,0.942285588106755,1.0,5/18,13.69%,PTN;IL34;DAAM2;MDK;SLC45A3
prerank,positive regulation of signaling (GO:0023056),0.32245836260089444,0.8412594498737294,0.6694444444444444,0.9124895065352683,1.0,10/37,18.79%,EDN1;GATA3;GRIK2;INPP5F;RIMS3;NSF;NMU;CDKN2AIP;SYT1;SOX11
prerank,natural killer cell activation (GO:0030101),0.3462049297477775,0.8410157399617536,0.6685796269727403,0.9124780413146532,1.0,4/23,16.27%,CASP8;BAG6;KAT7;NFIL3
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.2866387217946586,-0.840840421205157,0.693939393939394,0.9421654705495429,1.0,4/25,11.12%,B3GALT1;B3GNT2;NDST3;HS2ST1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.2997352114296257,0.8407948717635616,0.6726114649681528,0.9124120750808324,1.0,17/53,22.86%,ECSCR;DAB2IP;FOXF2;XPO1;FBXW7;PRKCG;PSMD14;PSMC3;PSMC5;PSMC6;OPHN1;UBQLN4;PSME3IP1;USP14;TMF1;UBB;GLMN
prerank,cardiolipin metabolic process (GO:0032048),0.37377673076479345,0.8407766179583402,0.6706484641638225,0.9119866750053959,1.0,5/13,19.18%,CRLS1;LCLAT1;HADHB;HADHA;PLSCR3
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.32376595187772006,-0.8407596755365901,0.6892950391644909,0.9411984958330427,1.0,6/14,20.39%,DPYD;NT5M;NT5E;UPB1;DHODH;NT5C1A
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.30639212843846997,-0.8392107633916187,0.6573033707865169,0.9432336490669475,1.0,7/16,17.73%,ATP5PD;DMAC2L;ATP5F1B;ATP5MF;ATP5MC2;ATP5MG;ATP5F1D
prerank,regulation of T cell migration (GO:2000404),0.3634781923410911,0.839123957369213,0.6617886178861788,0.9144311693544647,1.0,6/18,20.41%,APP;LRCH1;CD200;PYCARD;CXCL10;CD200R1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.35154235514414117,0.8391153517444193,0.6553398058252428,0.9139939914796215,1.0,10/19,20.95%,RTN1;ROCK1;RTN4;PRNP;CLU;RTN3;PIN1;ABCA7;HAP1;SORL1
prerank,response to hexose (GO:0009746),-0.2834100539989435,-0.83891637329164,0.7106741573033708,0.9426879476861265,1.0,4/25,7.56%,TCF7L2;THBS1;IRS2;GPLD1
prerank,response to sterol (GO:0036314),-0.349508458074343,-0.8376995174239245,0.6691542288557214,0.944041629837068,1.0,2/11,6.24%,TGFBR1;RORA
prerank,mitochondrion disassembly (GO:0061726),-0.2602141979432641,-0.83750391221782,0.7553956834532374,0.9433445559238788,1.0,13/34,22.26%,PRKN;ATG3;AMBRA1;ATG5;ATG2A;ULK2;FUNDC2;ATG7;WIPI2;GABARAP;MAP1LC3B;WDR45;BECN1
prerank,signal peptide processing (GO:0006465),0.4032330337335786,0.8374549188489795,0.6501597444089456,0.9164894286990036,1.0,2/11,5.58%,PCSK5;FURIN
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.25009438062927836,-0.8369897341900728,0.724,0.9432529526719513,1.0,16/38,27.26%,NDUFS3;NDUFA13;NDUFC2;NDUFV2;NDUFAF1;NDUFB10;NDUFS6;NDUFS7;NDUFA1;NDUFB8;NDUFB11;NDUFB3;NDUFS5;NDUFS8;NDUFB2;NDUFS2
prerank,negative regulation of transposition (GO:0010529),0.3678175637477167,0.8369779572696663,0.6661654135338346,0.9168998187203758,1.0,3/16,18.66%,DDX4;TUT7;TDRD9
prerank,mitotic spindle assembly (GO:0090307),0.31301181007717976,0.8369346512690142,0.7076923076923077,0.9165179332243466,1.0,8/42,13.80%,RAB11A;KIF2A;CLASP1;KPNB1;STAG1;CLASP2;PRC1;ARHGEF10
prerank,lymphocyte proliferation (GO:0046651),0.35028664284472116,0.8368830348194192,0.6811594202898551,0.9161587681369254,1.0,5/22,16.06%,MSN;CTPS1;MEF2C;CR2;CD79A
prerank,regulation of chemotaxis (GO:0050920),0.3278850659566105,0.836806732467044,0.6800595238095238,0.9158177225274525,1.0,8/30,14.18%,PDGFB;F2RL1;PPM1F;DUSP3;ZSWIM6;ZSWIM4;ADGRA2;CXCR4
prerank,regulation of cholesterol storage (GO:0010885),-0.3257346815346584,-0.8366626465112339,0.6703601108033241,0.9428103445127871,1.0,7/15,24.77%,ABCA1;PPARA;PPARG;NR1H3;LPL;PPARD;MSR1
prerank,negative regulation of cell development (GO:0010721),0.34242810793465034,0.8366168981069593,0.6812411847672779,0.9157087941401015,1.0,4/25,9.68%,NOTCH1;B2M;PCM1;FBXW7
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.4067629876279177,0.8364038193517559,0.6877192982456141,0.9156319103439925,1.0,2/10,11.72%,SSBP1;E2F7
prerank,fatty acid catabolic process (GO:0009062),-0.22566065952619696,-0.8350718327657557,0.8056872037914692,0.9449571321077145,1.0,21/67,23.47%,PCCA;ABCD3;SCP2;PEX2;BDH2;ACAT2;EHHADH;ACADM;ECHDC2;PLA2G15;ECI2;HACL1;CPT2;ACAD11;ACADVL;PEX13;NUDT19;FAAH;MTLN;PPARD;PHYH
prerank,embryonic appendage morphogenesis (GO:0035113),0.3852851711485312,0.8349275191032618,0.6750788643533123,0.9178224112332665,1.0,2/12,4.67%,TGFB2;MBNL1
prerank,cell chemotaxis (GO:0060326),0.2942354009556105,0.8347194767130468,0.7068322981366459,0.9177146699444395,1.0,10/60,14.18%,PDGFB;CCR1;EGR3;LEF1;PLEKHG5;NR4A1;CX3CR1;ABCC1;HMGB2;CXCR4
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.32233879427060874,-0.8343626977167898,0.716931216931217,0.9452869394955125,1.0,5/15,11.47%,DAB2;BMP2K;AAK1;SNAP91;DGKD
prerank,negative regulation of RNA metabolic process (GO:0051253),0.36613940535555595,0.8343315147513546,0.6905132192846034,0.9179491969384226,1.0,9/18,25.68%,ZC3H12A;PTBP3;TMBIM6;ESR1;SHQ1;PTBP2;NCOR2;NUDT16;TGFB1
prerank,cellular response to glucose starvation (GO:0042149),0.3151899285747537,0.8339076173113494,0.6860622462787551,0.9182472334222942,1.0,5/41,9.23%,NUAK1;ZC3H12A;SIK2;PRKAA1;PIK3C3
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.34227211231997445,-0.8338997366459979,0.6691729323308271,0.9450956105647353,1.0,8/11,55.62%,RTP4;LPO;RTP3;TAS1R2;GNAT3;GNAT2;PIGR;TAS1R3
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.32922241031772503,0.8336547338926495,0.6695906432748538,0.9182142775856662,1.0,17/32,27.94%,ITGA1;PPP1R16B;CALM3;CDCA2;PIN1;CNEP1R1;DUSP26;PPP1R15B;PPP1R7;PPP1R15A;CDH5;NSMF;TGFB1;SYMPK;CALM1;SPPL3;SMPD1
prerank,negative regulation of interferon-beta production (GO:0032688),-0.3457024300519382,-0.8335168375299755,0.6836027713625866,0.9447495047730201,1.0,4/10,16.50%,PTPRS;PPM1B;RELB;NLRC3
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.31557439377087926,0.83299690199112,0.6946354883081155,0.9189389454265928,1.0,4/37,6.94%,GBP5;NOD2;PDCD4;ZC3H12A
prerank,regulation of cell morphogenesis (GO:0022604),0.324482223672293,0.8328479017856673,0.6756373937677054,0.9187319075652041,1.0,2/30,2.09%,EFNA5;MACF1
prerank,protein localization to organelle (GO:0033365),0.2645137634467375,0.8323913627436595,0.7584330794341676,0.919088537537014,1.0,25/133,15.36%,MSX1;GBP5;RAB11A;APP;HHEX;PACSIN2;EHD1;CSNK1D;SNX10;CEP68;LRRK2;IFT140;RAB35;RIPOR1;DHX9;PRNP;GET1;VPS35;GBP2;UBE2J2;CNEP1R1;TUB;VAPA;YBX1;ABCA7
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.29668523610683506,-0.8323196269872893,0.7390029325513197,0.9460557553426431,1.0,1/20,0.35%,IGF1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.2917305616581632,0.8323060034319352,0.7390243902439024,0.9187807029122355,1.0,12/69,12.66%,EDN1;PLCB1;PLCB4;PIK3C2A;PLEKHA1;GATA3;GPR143;PIK3C3;HTR2A;INPP5F;PIK3CB;RPS6KB1
prerank,mitotic cytokinesis (GO:0000281),-0.2383525573418572,-0.8322603043618053,0.7692307692307693,0.9450359635742513,1.0,17/47,23.39%,ROCK2;SON;JTB;KLHDC8B;EFHC1;ANLN;SPAST;RTKN;USP8;STMN1;SNX18;ARL3;INCENP;PDCD6IP;RACGAP1;TTC19;NUSAP1
prerank,photoperiodism (GO:0009648),-0.2682040102944957,-0.8322150786461504,0.707936507936508,0.9440117079801676,1.0,13/28,36.38%,CLOCK;CRY2;SIK1;PER3;FBXL3;PML;USP2;FBXL8;FBXL12;FBXL22;PER2;TP53;PPP1CB
prerank,regulation of peptidase activity (GO:0052547),0.3530884310957055,0.8316793886699594,0.6453576864535768,0.919489018621533,1.0,5/19,20.26%,CAV1;FURIN;PSMB8;CST3;CTSH
prerank,mitochondrial protein processing (GO:0034982),0.38494536586675066,0.8313245888397299,0.6530278232405892,0.919643587673916,1.0,2/11,7.93%,OMA1;IMMP2L
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.33725450306285987,-0.8308150074875517,0.6802168021680217,0.9456506646520791,1.0,1/12,1.16%,IL34
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.2890793800243031,-0.8306351254503861,0.7739130434782608,0.9448807200754272,1.0,12/21,42.53%,GOLGA2;CDC14B;FZR1;BTRC;BAG2;MAD2L1;GORASP1;PLK1;CDC20;RPL5;UBE2C;RAB1A
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.3784115228296977,0.8301959645364011,0.6479099678456591,0.9211821876477285,1.0,5/13,24.20%,RHOT2;BNIP3L;BNIP3;BMF;VDAC2
prerank,muscle cell migration (GO:0014812),-0.3578461491194417,-0.830055388052993,0.7082405345211581,0.9449414863090589,1.0,4/10,16.20%,CCN3;SIX1;DDR1;AAMP
prerank,cytoplasmic sequestering of protein (GO:0051220),0.37932790097869246,0.8299106211154795,0.6495016611295681,0.9212289900228252,1.0,4/13,13.03%,NFKBIE;GOPC;NFKBIA;KEAP1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.3653527661392654,0.829600072547939,0.6661237785016286,0.9213316220693807,1.0,10/16,27.89%,MAD2L2;DTX3L;KDM4D;RIF1;SHLD3;SHLD2;WRAP53;SHLD1;PARP9;SMCHD1
prerank,response to purine-containing compound (GO:0014074),0.36007073431205966,0.8294453160201718,0.6757188498402555,0.9211317656653337,1.0,6/17,19.51%,P2RX7;STAT1;NDUFS4;TRPM2;P2RY1;VGF
prerank,autophagosome maturation (GO:0097352),0.3255003921066775,0.8292808891416523,0.6871428571428572,0.9209733445518338,1.0,10/32,18.09%,VTI1B;GABARAPL1;TECPR1;VAMP8;VAMP7;LIX1;CHMP3;MAP1LC3A;ATG14;LAMP2
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.2751033534806613,-0.8290482730138053,0.746875,0.9457559061962489,1.0,10/25,19.76%,SLIT2;ARHGAP24;CAPZB;ODF2L;CEP97;CCP110;CDK10;PFN2;PRKCD;TESK1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.23991421312016917,-0.8289687513570596,0.7883817427385892,0.944769854956688,1.0,7/44,15.76%,PRKAG2;CYP27A1;SCP2;INSIG2;AMACR;OSBPL7;SQLE
prerank,organelle transport along microtubule (GO:0072384),-0.2586517975848997,-0.8288117668638133,0.796875,0.943955637372386,1.0,10/31,25.66%,TRAK1;COPG1;NDE1;NDEL1;BICD2;ARHGAP21;FBXW11;CLN3;KIF5B;BORCS5
prerank,neurogenesis (GO:0022008),-0.2398960559748294,-0.8287546054670271,0.7829457364341085,0.9429603720779105,1.0,5/43,7.83%,LPAR1;TRAK1;ANXA1;SIX1;BTBD2
prerank,positive regulation of protein maturation (GO:1903319),0.3881677219466818,0.8282535843387416,0.6637931034482759,0.9223265186085602,1.0,2/11,9.13%,RHBDD1;NKD2
prerank,regulation of cholesterol transport (GO:0032374),0.34724182370902135,0.8281794938523664,0.6688,0.9220063948436781,1.0,4/20,8.96%,APOA1;ABCB4;NUS1;TSPO
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.3637456076356367,0.8277991072907522,0.7078125,0.9222148414008958,1.0,1/17,1.34%,DOC2B
prerank,regulation of lipid kinase activity (GO:0043550),-0.3472928527761137,-0.8277429074911307,0.6935866983372921,0.943877721468373,1.0,4/11,15.63%,PIK3R1;PIK3R2;WDR81;WDR91
prerank,protein acetylation (GO:0006473),0.32649965940461023,0.8277214436008012,0.7043740573152338,0.9218960938463071,1.0,2/30,2.56%,FOXO1;NAT9
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.3741474734193731,0.8274410715259063,0.6519685039370079,0.9219253015330057,1.0,1/13,0.81%,MSX1
prerank,regulation of cellular metabolic process (GO:0031323),-0.24138680644623728,-0.8271323916305523,0.7819548872180451,0.9439267634576448,1.0,15/45,25.50%,PID1;PPARA;PRKN;ARF1;TBC1D16;PDK3;MPV17;PDK2;STUB1;ACACA;PANK2;MKLN1;MBOAT7;SSH1;PDK4
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.3697222087906037,0.8267813997915857,0.6527777777777778,0.9226699728357506,1.0,4/15,14.96%,WHAMM;ARPC5;ARPC3;ARPC2
prerank,autophagy of mitochondrion (GO:0000422),-0.2502769248092578,-0.8255226194209927,0.7536764705882353,0.9459562494973459,1.0,12/38,17.84%,PRKN;ATG3;AMBRA1;ATG5;ATG2A;ULK2;FUNDC2;ATG7;WIPI2;GABARAP;MAP1LC3B;PHB2
prerank,fatty acid oxidation (GO:0019395),0.2891810739366115,0.8249853008368804,0.7051442910915935,0.9253037379204594,1.0,17/57,22.74%,ADIPOR2;ADIPOR1;ACOX1;ACAD10;SLC27A2;ADH5;HADHB;CROT;ACAT1;ECI1;HADH;HADHA;ACAA2;ILVBL;ABCD2;ABCD4;HSD17B4
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.38545801708432703,0.8243297600610175,0.6766666666666666,0.9259899021375331,1.0,6/12,26.25%,SGTB;SEC62;SEC63;SGTA;CHMP4A;CHMP4B
prerank,thymus development (GO:0048538),0.37417919572505404,0.8239790035076073,0.6811352253756261,0.9261141561749859,1.0,1/13,1.29%,TBX1
prerank,immunoglobulin mediated immune response (GO:0016064),0.389805354506534,0.8237997647117028,0.6626297577854672,0.9259690691248441,1.0,1/10,4.01%,FCGR2B
prerank,proton transmembrane transport (GO:1902600),0.3130730161074436,0.8232582212366046,0.7055555555555556,0.9264703305929486,1.0,3/36,2.18%,ATP1A4;ATP1A3;ATP1A1
prerank,positive regulation of translational initiation (GO:0045948),0.35660010177690393,0.8229888351405238,0.6909385113268608,0.9264771842749833,1.0,5/18,13.30%,UHMK1;POLR2G;POLR2D;RPS6KB1;HABP4
prerank,response to insulin (GO:0032868),0.2809129553923074,0.8229347799275059,0.751219512195122,0.9261167769509039,1.0,9/80,8.44%,CEACAM1;FOXO1;INSR;HDAC9;INPP5K;PDE3B;PCK2;SLC25A33;SYAP1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.3473929326027587,0.8229255394036293,0.6721804511278195,0.9256773172014776,1.0,6/21,22.44%,MBOAT2;LPCAT4;LPCAT3;PLA2G12A;PLAAT3;OSBPL5
prerank,glial cell differentiation (GO:0010001),-0.26518314321901076,-0.8226872627239625,0.7645161290322581,0.950383399450233,1.0,9/28,22.33%,ADGRG6;SLC8A3;NFIB;GPC1;PAX2;PICK1;SOX2;TPPP;CDK5
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.33345493188236136,0.822632428306276,0.7184325108853411,0.9257090108965901,1.0,10/27,23.67%,FBXO7;FCGR2B;CCDC88A;VPS35;CTNNA2;EFHC2;GSK3A;GSK3B;IL1RAPL1;BRSK2
prerank,positive regulation of glycolytic process (GO:0045821),0.34532475266430634,0.8225600661813293,0.6806853582554517,0.9249270386309076,1.0,5/20,9.26%,INSR;APP;P2RX7;PRKAA1;PFKFB3
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.34532475266430634,0.8225600661813293,0.6806853582554517,0.9249270386309076,1.0,5/20,9.26%,INSR;APP;P2RX7;PRKAA1;PFKFB3
prerank,necroptotic process (GO:0070266),0.36326986365786545,0.8223330974035413,0.6677115987460815,0.924855878198882,1.0,2/16,9.20%,TLR3;MLKL
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.29226463806123765,0.8221356025518024,0.7320754716981132,0.9247573871941556,1.0,22/58,25.84%,HERC2;BABAM2;HMGB1;POLA1;POLB;PSMD14;BRCA1;ATM;HMGB2;ERCC4;KDM2A;MDC1;BARD1;NSD2;RIF1;CYREN;PAXIP1;XRCC4;NHEJ1;UVRAG;BABAM1;RNF8
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.33663461347305573,-0.8217535827534106,0.7004608294930875,0.9510889836809493,1.0,4/12,17.52%,PTPN22;RUNX1;CD300A;RC3H1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.2376548035526561,-0.8216159599764735,0.807843137254902,0.9502289071838211,1.0,8/44,13.12%,SH3RF1;THBS1;NGF;SRC;VEGFA;RAF1;FNIP1;DDX3X
prerank,regulation of cholesterol metabolic process (GO:0090181),0.3535873558856292,0.8215256635188953,0.6613418530351438,0.9253810159779453,1.0,9/20,23.46%,KPNB1;MBTPS2;SEC14L2;LPCAT3;LDLRAP1;RAN;FMO5;SREBF2;TTC39B
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.27997344527672996,-0.8214305404908915,0.7186544342507645,0.9494384585398552,1.0,10/24,22.96%,APOE;ATP5IF1;PRKACA;PKD1;NUB1;CTSC;LATS1;RHBDF1;PSME1;GPX1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.27158558952444456,-0.8210254856381697,0.7206349206349206,0.949095670269961,1.0,6/26,14.63%,DAB2;KANK2;HEYL;CLOCK;HDAC1;CRY2
prerank,protein lipidation (GO:0006497),-0.2226681061421414,-0.8206081667249533,0.8407960199004975,0.9488402648161581,1.0,23/59,26.87%,PIGA;GPLD1;ATG5;PIGB;ZDHHC17;PIGN;PIGH;PGAP2;ATG7;DPM2;WIPI2;PIGG;ZDHHC1;PIGP;PIGZ;PGAP4;ZDHHC8;WDR45;ZDHHC16;PORCN;PGAP3;PIGL;PIGW
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.39938750811249446,0.8202949631227302,0.6589403973509934,0.927084046193096,1.0,5/10,25.48%,INPP5F;NF2;PTPN2;PARP14;PPP2R1A
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.25167635288853346,-0.8201236644507421,0.7862318840579711,0.9487067579164843,1.0,12/38,18.74%,PRKN;ATP5IF1;LMAN1;RNF31;UBL5;SREBF1;UBE2L3;ARIH2;HPS4;MICALL2;HTRA2;ABLIM3
prerank,cellular response to ATP (GO:0071318),0.3719558972900781,0.8199965026431615,0.6661264181523501,0.9271388183700066,1.0,4/14,17.32%,P2RX7;HSP90B1;P2RY1;CIB2
prerank,neuron fate commitment (GO:0048663),0.3692474359699262,0.8195053396490285,0.6724683544303798,0.9275177202569828,1.0,3/14,13.84%,DLL4;POU3F2;MYT1L
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.2672185656518074,-0.8194361035050148,0.7750865051903114,0.9489067672522157,1.0,13/29,24.35%,DDB2;CUL4B;CUL4A;ERCC5;ERCC2;GTF2H5;GTF2H1;RPA3;GTF2H4;RPA1;PARP1;CHD1L;RPA2
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.39737044294728974,0.8193344140630813,0.6776859504132231,0.9269004643010583,1.0,5/10,22.81%,PPP3CA;NFATC1;NFATC3;PPP3CC;PPP3R1
prerank,calcineurin-mediated signaling (GO:0097720),0.39737044294728974,0.8193344140630813,0.6776859504132231,0.9269004643010583,1.0,5/10,22.81%,PPP3CA;NFATC1;NFATC3;PPP3CC;PPP3R1
prerank,positive regulation of cholesterol efflux (GO:0010875),0.3426442490853703,0.8189724058724631,0.6843702579666161,0.9270927448884128,1.0,6/21,16.80%,CAV1;APOA1;PLTP;NFKBIA;ABCA7;EEPD1
prerank,amino acid transport (GO:0006865),0.29727842291215323,0.8186053496833479,0.710204081632653,0.9272704461922571,1.0,5/49,9.90%,SLC6A6;SLC7A7;SH3BP4;SLC7A1;SLC6A17
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.2988646298424928,0.8185500497272967,0.7336884154460719,0.9269013848131845,1.0,13/48,19.75%,NPR2;SLC25A16;ADCY10;NPR1;SLC35B3;ADCY4;NPPC;PAPSS1;PANK3;PPCS;ACAT1;ADSL;GUCY1A1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.3222455856838604,0.818414201769477,0.7063829787234043,0.9266918217021548,1.0,5/29,8.61%,IFNAR1;STAT1;SOCS6;JAK2;NMI
prerank,rRNA methylation (GO:0031167),0.3387103318401195,0.818212547134421,0.7190201729106628,0.9265632319894573,1.0,9/22,22.19%,MRM2;METTL5;FBLL1;TFB2M;NSUN5;FTSJ3;MRM3;NSUN4;FBL
prerank,positive regulation of vasoconstriction (GO:0045907),0.3869751930945039,0.8180407230560565,0.7021276595744681,0.9264119855665888,1.0,1/13,2.34%,CAV1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.3438457343301124,0.8175314588717607,0.6764252696456087,0.9268336340910458,1.0,8/22,22.25%,IFNGR1;EFNA1;RANBP9;CLU;GSK3A;RELA;AGER;EPHA4
prerank,sympathetic nervous system development (GO:0048485),0.3622573239251477,0.817016427733067,0.6878048780487804,0.9272227097531924,1.0,5/15,18.79%,SEMA3F;GATA3;CTNNB1;FZD3;SOX11
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.3003850781426424,-0.8169231738455314,0.7229916897506925,0.9523605735086856,1.0,4/17,12.13%,EMC2;EMC7;EMC1;GET4
prerank,piRNA metabolic process (GO:0034587),0.35600869406019575,0.8164025149807432,0.6875981161695447,0.9278121907590237,1.0,3/19,18.66%,DDX4;EXD1;TDRD9
prerank,epiboly involved in wound healing (GO:0090505),0.36169781535490464,0.8160560464107418,0.691358024691358,0.9279245882061726,1.0,4/16,15.17%,CEACAM1;MRTFA;LCP1;PDCD10
prerank,negative regulation of receptor internalization (GO:0002091),-0.3357198629109307,-0.8157421767695163,0.7149643705463183,0.953512919248659,1.0,4/12,14.35%,DLG4;ATXN2;SDCBP;ANKRD13D
prerank,positive regulation of rRNA processing (GO:2000234),-0.34778848768139387,-0.8156885849976118,0.7031630170316302,0.9525249377976329,1.0,5/10,33.70%,BUD23;RIOK2;TRMT112;DIMT1;HEATR1
prerank,regulation of lysosomal lumen pH (GO:0035751),0.38491113372366736,0.8153439560881438,0.6879194630872483,0.928675204633805,1.0,6/12,24.91%,PPT1;LRRK2;ATP6AP2;CCDC115;TMEM199;GRN
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.30351345278288655,-0.8146693027031021,0.723342939481268,0.9532500779381095,1.0,3/18,7.09%,NLGN2;CACNG4;TSHZ3
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.265089016484442,0.814033873439668,0.7741203178206584,0.9304981638025345,1.0,24/125,16.33%,EML1;MAP4;CENPU;CLIP1;KIF2A;CLASP1;RANGAP1;KPNB1;DSN1;XPO1;CLASP2;DYNLL1;RANBP2;TNKS;CENPI;DYNC1LI2;NUP160;BUB1;ITGB3BP;EFHC2;RAN;NEK9;NDC80;SGO1
prerank,potassium ion transport (GO:0006813),0.26472178671979524,0.8138299877041021,0.7767548906789413,0.9303766120091177,1.0,6/120,3.70%,KCNN4;KCNQ1;KCNH8;ATP1A4;KCNN3;KCNG3
prerank,mitochondrion organization (GO:0007005),0.2582647457472144,0.8136269681627163,0.8043956043956044,0.9302610986610061,1.0,28/165,16.08%,NOS3;CAV2;FBXO7;DNM3;ATP7A;OMA1;SSBP1;CHCHD3;SIRT4;CHCHD2;SLC25A33;AKT3;ALAS1;LRRK2;IMMP2L;BCL2L1;VPS13D;TSPO;MIGA1;MFN1;POLG2;RHOT2;BNIP3L;TFB2M;BNIP3;NUBPL;PTCD2;SAMM50
prerank,regulation of ATP metabolic process (GO:1903578),-0.23280611247403865,-0.8136000533853899,0.8354978354978355,0.9541687537193628,1.0,9/54,13.74%,PRKAG2;OGT;NUP107;ATP5IF1;NUP155;COX7A2;AAAS;COX7A2L;NUP93
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.3405211113429077,0.8135367075731609,0.7167182662538699,0.9299524022632973,1.0,5/21,12.62%,FCGR2B;FOXP1;STAP1;CBFB;ELF2
prerank,carbohydrate catabolic process (GO:0016052),0.31292861924817295,0.8135154113380145,0.7198917456021651,0.9295365624870333,1.0,8/38,19.53%,MANBA;GPI;PGK1;GAPDH;MAN2C1;PFKM;MAN2B2;NEU4
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.3357874234800253,0.8132256381749047,0.6681481481481482,0.9295792647951034,1.0,2/23,7.75%,NOTCH1;JAK2
prerank,positive regulation of cellular respiration (GO:1901857),-0.33341138776594914,-0.8132140365209092,0.6945701357466063,0.953796220103431,1.0,1/11,1.86%,NUPR1
prerank,ribosomal large subunit biogenesis (GO:0042273),0.28890627439264144,0.8131849790024853,0.7269230769230769,0.9292038933826602,1.0,22/54,27.93%,BOP1;RPL7;PAK1IP1;NVL;MRPL1;RRP15;NHP2;NPM1;RPL23A;EIF6;LAS1L;RSL24D1;NOP53;RPF2;RPL3;MRTO4;MDN1;NIP7;RPL26;MAK16;RPL14;RPL11
prerank,regulation of protein transport (GO:0051223),0.3347954716920727,0.8131607619243739,0.6956521739130435,0.9288013265914726,1.0,8/27,21.52%,PPM1F;NDFIP2;PTPN1;LCP1;STXBP5;STXBP5L;DNAJA1;WWP2
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.3835548643939697,0.8131013760520182,0.6967213114754098,0.9284453896033417,1.0,3/11,13.22%,PUM2;DHX9;FXR1
prerank,regulation of cytoplasmic transport (GO:1903649),0.38745591834988374,0.8128087282159071,0.6705882352941176,0.9284649385447797,1.0,4/11,19.05%,MAPK1;LRRK2;CHMP3;MAP2K1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.27977007074033794,0.8124634361667673,0.7472256473489519,0.92861371375573,1.0,12/72,11.62%,ESRP2;CBL;FGFR3;MAPK1;SETX;SHOC2;FRS3;FLRT3;POLR2G;POLR2D;FGF20;TIAL1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.37305881274986424,0.8121321777778255,0.7024390243902439,0.9287338558004529,1.0,1/13,0.89%,PDGFB
prerank,regulation of centriole replication (GO:0046599),-0.30102112612984977,-0.8120132192718109,0.6997389033942559,0.9549147059518169,1.0,4/17,10.75%,KAT2B;ALMS1;RBM14;MDM1
prerank,neural tube closure (GO:0001843),-0.25514236895308523,-0.8119639351313656,0.7684210526315789,0.9539041031708158,1.0,10/34,22.74%,LMO4;COBL;PLXNB2;MTHFD1;TSC2;SEMA4C;PAX2;MTHFR;STIL;PHACTR4
prerank,oxoacid metabolic process (GO:0043436),0.33071015212170635,0.8117209014041616,0.7218045112781954,0.9289928204323741,1.0,5/27,11.65%,MINPP1;SULT6B1;LIPT2;LIPT1;BPNT1
prerank,Golgi organization (GO:0007030),0.26535724331394694,0.8116208870927177,0.7782857142857142,0.9287048801970189,1.0,25/112,20.20%,SYNE1;PLK3;TRAPPC8;ATL2;PRKD1;VTI1B;CSNK1D;TMED10;CLASP1;LRRK2;CLASP2;ATP8B1;VRK1;TMED9;USP6NL;TMED4;PDCD10;PLEKHM2;VTI1A;GOLPH3L;GOLPH3;TMED7;ATP8B2;MYO18A;DNAJC28
prerank,regulation of DNA replication (GO:0006275),0.2969385810944366,0.8110443085177308,0.7370517928286853,0.929254950476715,1.0,10/49,12.36%,ACVRL1;BCAR3;GMNC;ORC3;DHX9;STN1;CCDC88A;CDAN1;OBI1;ORC5
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.3670639611539105,0.8108568917501152,0.6976744186046512,0.9291117822382456,1.0,4/15,12.00%,NOTCH1;PRKD1;HSPB1;PRKD2
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.29242740980475473,-0.8108430469230302,0.7292817679558011,0.9548611239029439,1.0,3/18,9.40%,NLGN2;DLG4;PRKCZ
prerank,organic substance transport (GO:0071702),0.2647326227807444,0.8105543464068717,0.7912946428571429,0.9292108129195977,1.0,15/121,10.43%,RHCG;ARL6IP5;PPT1;APOA1;SPNS2;PLTP;MYH9;ARRDC1;HSP90B1;SLC6A4;CHMP1B;TAP1;SLC6A2;ABCG4;SLC22A5
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.39059767598838485,0.8105106121030144,0.6845528455284553,0.9288390845729737,1.0,5/10,16.69%,HMGB1;PSMC3;PSMC5;PSMC6;ESR1
prerank,synaptic vesicle transport (GO:0048489),-0.3382751249062589,-0.8105052104860239,0.719626168224299,0.9543819229564714,1.0,5/11,23.33%,SPG11;KIF5C;CDK5;KIF5B;TOR1A
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.2904042658123456,-0.8103825089705977,0.7082066869300911,0.9535194087387959,1.0,3/19,15.39%,APOE;RIC3;CHRNB1
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.40022720527950034,0.8102922401581871,0.7145214521452146,0.9287580051909555,1.0,4/10,20.64%,F2RL1;WDR1;VIL1;CARMIL1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.3330999242426531,0.8102496579980435,0.7014925373134329,0.9283858758885501,1.0,9/22,26.26%,RPS21;EXOSC3;EXOSC8;EXOSC9;FTSJ3;EXOSC10;URB1;UTP20;ERI1
prerank,cellular glucose homeostasis (GO:0001678),0.3015704421788836,0.8102290250835309,0.7045454545454546,0.9279700908359422,1.0,5/41,8.61%,UNC13B;FOXO1;PCK2;PRKAA1;NR1D1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.35709110129987864,0.8097172314674874,0.6884735202492211,0.928392053985622,1.0,1/15,1.59%,GBP5
prerank,telomere maintenance via recombination (GO:0000722),-0.3371669867758552,-0.8095979565399731,0.7135922330097088,0.9538373300134855,1.0,2/11,6.57%,SMC6;RAD50
prerank,negative regulation of centrosome duplication (GO:0010826),-0.3420293899922069,-0.8095730548890719,0.7261904761904762,0.9528116118272411,1.0,3/11,10.75%,KAT2B;RBM14;MDM1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.37724403884482405,0.8091731907752299,0.7011686143572621,0.9288683315658808,1.0,1/13,0.83%,PLCB1
prerank,positive regulation of dephosphorylation (GO:0035306),0.3226697201955274,0.8089694221289384,0.6901615271659325,0.9287542258027479,1.0,14/27,27.94%,PPP1R16B;CALM3;CDCA2;PIN1;CNEP1R1;PPP1R7;CDH5;NSMF;TGFB1;SYMPK;CALM1;MTMR9;SPPL3;SMPD1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.33926414806719285,-0.8087294055407874,0.7388059701492538,0.953311778439467,1.0,5/11,13.11%,ZMIZ1;ARID1B;SMARCD1;ZMIZ2;PADI2
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.3590930431470267,0.8083818082803725,0.713128038897893,0.9293518982547054,1.0,7/17,29.11%,RHBDD1;HSP90B1;SEL1L;TMEM129;SELENOS;HERPUD1;UFD1
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.3080477874407942,-0.8083583077951757,0.7293233082706767,0.9528933069364669,1.0,2/16,3.00%,LRP1;APOE
prerank,cellular response to lipid (GO:0071396),0.25202409397835107,0.8082526487611346,0.8338692390139335,0.9291161880072856,1.0,27/191,10.26%,TBX1;NOD2;ATP1A3;ATP1A1;DAB2IP;VIM;FES;DEFA6;MSN;ADAM15;MEF2C;TNFRSF1B;ABCB4;IL1A;PDCD4;NFKBIL1;SETX;IRGM;ZC3H12A;NR1D1;NCOA4;ACOD1;STAP1;CACTIN;HMGB1;CASP1;NFKBIB
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.3092877212844697,0.8082062202613384,0.7346101231190151,0.9287514792569943,1.0,4/37,8.13%,MSX1;CAV1;BBC3;BCL2L1
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.29280117943678974,-0.8077222522981282,0.7146974063400576,0.9530111210344693,1.0,7/17,17.73%,ATP5PD;DMAC2L;ATP5F1B;ATP5MF;ATP5MC2;ATP5MG;ATP5F1D
prerank,ganglion development (GO:0061548),-0.3370026845266637,-0.8074950711808766,0.7146401985111662,0.9523573846595188,1.0,2/11,5.37%,NRP2;SEMA3A
prerank,regulation of defense response (GO:0031347),0.27570202081389056,0.8071271474445832,0.7506265664160401,0.9301135216692741,1.0,10/76,9.61%,NOD2;CASP8;SPATA2;TIRAP;FCGR2B;SEMA7A;BCL6B;JAK2;FOXP1;CASP1
prerank,DNA conformation change (GO:0071103),0.3517377945368444,0.8068891593888822,0.7058823529411765,0.9300677830839224,1.0,3/17,13.72%,HHEX;HMGB1;HMGB2
prerank,chloride transmembrane transport (GO:1902476),0.290129099209623,0.8066722586194357,0.7367021276595744,0.9299768030465658,1.0,12/48,18.69%,SLC12A8;ANO6;GABRQ;CLCN3;CLCN1;GABRA4;SLC1A1;GABRA2;GABRE;GLRA2;GABRG3;GABRB1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.29700065699918404,0.8065630775320526,0.7190412782956058,0.9297189702429551,1.0,5/47,8.44%,SOX13;CMKLR1;ZC3H12A;ZBTB16;SYAP1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.2882947411510798,0.8065541459230645,0.75,0.929287714366505,1.0,9/59,11.05%,DAB2IP;TLR3;IRAK2;NFKBIL1;UBA52;RPS27A;ROCK1;NFKBIA;TAB2
prerank,regulation of receptor recycling (GO:0001919),-0.3030189349019969,-0.8059668601925634,0.7282051282051282,0.9540306434980977,1.0,3/16,9.89%,ANXA2;OPTN;TBC1D16
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.3495181067484589,0.8057062565348235,0.6996805111821086,0.9302392496308476,1.0,9/17,22.49%,KPNB1;MBTPS2;PRKAA1;SEC14L2;LPCAT3;RAN;ERLIN2;SREBF2;SOD1
prerank,histone H3-K9 demethylation (GO:0033169),-0.32784940372006666,-0.8050321593305747,0.7047353760445683,0.9546462541721423,1.0,4/11,19.44%,KDM7A;JMJD1C;KDM4A;PHF8
prerank,cell junction maintenance (GO:0034331),0.3594640989284749,0.8047472416442107,0.6828046744574291,0.9314100327418868,1.0,1/14,2.47%,F2RL1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.3468567697831873,0.8045550648019371,0.7002967359050445,0.9312953102300575,1.0,7/20,19.00%,FKBP4;FKBP1A;PPIE;PIN1;PPIH;PPID;PPIF
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.34306516065220993,0.8044099940702264,0.7009063444108762,0.9310991269429736,1.0,4/20,14.75%,TNRC6C;CNOT1;AGO4;EIF6
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.38006259230036943,0.8040859249306699,0.6992,0.9312137283287691,1.0,2/12,2.22%,ATP2B4;DAB2IP
prerank,engulfment of apoptotic cell (GO:0043652),0.3564421964788763,0.8038048208460453,0.6871961102106969,0.9312496378264766,1.0,4/15,14.01%,XKR6;RAC1;ADGRB1;RHOH
prerank,glycine metabolic process (GO:0006544),0.3728632742846605,0.8035488487011506,0.6721044045676998,0.9312355741294411,1.0,2/12,14.46%,GLYAT;DLD
prerank,negative regulation of insulin secretion (GO:0046676),0.3504165439934744,0.8035349371829772,0.6949685534591195,0.9308139659037468,1.0,4/17,12.13%,KLF7;SIRT4;PIM3;CHGA
prerank,metal ion homeostasis (GO:0055065),0.30305625092226424,0.8033382009012722,0.7387755102040816,0.9307076074228297,1.0,7/40,17.32%,CAV1;SLC8A1;SLC12A8;TESMIN;KCNA1;ANK3;CIB2
prerank,histone monoubiquitination (GO:0010390),-0.27549215809597516,-0.8022153691964138,0.7507163323782235,0.9586893125005514,1.0,7/24,15.98%,DDB2;CUL4B;PAF1;CTR9;ATXN7L3;BCOR;WAC
prerank,response to metal ion (GO:0010038),0.27965872779215234,0.8022150105017873,0.7530562347188264,0.9321220596803387,1.0,12/67,14.73%,ITPR3;CAV1;GPHN;IL1A;PPP3CA;MT2A;PLSCR1;NEDD4L;TESMIN;CALM3;HIF1A;PPP2CB
prerank,positive regulation of leukocyte migration (GO:0002687),0.32340740335141865,0.8021592220855165,0.6991279069767442,0.9317645091589878,1.0,3/27,6.29%,F2RL1;TNFRSF18;ADAM17
prerank,in utero embryonic development (GO:0001701),0.32268142629185376,0.8017055459344257,0.7016742770167428,0.9320593085433979,1.0,5/25,12.01%,PTPRR;MBNL1;EGFL8;ADAM10;HINFP
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.35647929737426914,0.8016415359374671,0.7043618739903069,0.9317146989677363,1.0,6/15,25.22%,SRP14;RAB3GAP2;SRPRA;ZFAND2A;RYR2;SPCS2
prerank,protein autoubiquitination (GO:0051865),0.28135763470656283,0.8015074792461883,0.7509627727856226,0.9315115196355277,1.0,14/61,16.08%,ASB4;RNF185;CUL3;UBE3A;RNF141;RNF115;TRIM17;OBI1;DTX3L;BRCA1;UBE2T;RAD18;UBE2D3;KLHL24
prerank,erythrocyte development (GO:0048821),0.38712047062475274,0.8014948520088084,0.6962233169129721,0.9310868396342238,1.0,1/10,6.84%,ALAS1
prerank,positive regulation of B cell activation (GO:0050871),0.29001180810755084,0.8008600069440805,0.7578947368421053,0.9317174039209898,1.0,7/50,12.82%,NOD2;SH3KBP1;TIRAP;MEF2C;MAD2L2;CD38;BTK
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.2693226506280355,-0.8006923610142809,0.7569230769230769,0.9602073570951435,1.0,5/24,15.01%,LPGAT1;PLA2G4A;SLC27A1;PGS1;PLA2G15
prerank,protein-DNA complex assembly (GO:0065004),0.26137063964687635,0.8006423806487948,0.7885057471264367,0.9316356296533478,1.0,32/116,18.87%,PSMD13;PSMD4;ORC3;UBA52;RPS27A;PSMA5;ASF1A;PSMB10;RBX1;PSMB8;NPM1;PSMD14;GTF2H3;ORC5;PSMA7;PSMA8;PSMC3;HMGB2;PSMB5;PSMC1;ANP32B;PSMC5;XPC;PSMC6;PSMB9;DAXX;PSMA4;PSMD5;PSMD9;NAP1L4;H3-3A;PSMB6
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.3335451491872909,-0.8000815622506081,0.718421052631579,0.9602012427664908,1.0,4/11,17.83%,DAB2;PRKN;PTPN23;EZR
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.200538729189101,-0.7991832575971412,0.9047619047619048,0.9606880033691912,1.0,43/95,31.71%,NUCKS1;SMC6;ZFYVE26;RAD51B;NIPBL;UBE2N;FAN1;SWI5;FBH1;REV3L;RAD50;XRCC1;ERCC5;LIG3;NABP1;CDC7;POLN;RFWD3;RECQL;RPA3;FANCB;RAD54L;PALB2;RPA1;PARP1;POLQ;MCM8;RPA2;CDC45;RAD51;MMS22L;RAD51AP2;ZSWIM7;NSMCE2;NABP2;FANCM;AP5S1;XRCC3;MCM7;MCM5;SLX4;MORF4L1;POLL
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.33712833452789864,0.7977709970785011,0.7244094488188977,0.9359062497584563,1.0,7/18,25.82%,FCGR2B;RNF185;BAG6;NCK1;ERN1;RNFT1;DDIT3
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.33794486038406735,0.7977325575220134,0.7067901234567902,0.935532833353458,1.0,5/19,14.90%,EXT1;HS3ST5;EXTL3;NDST4;GLCE
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.32932065807136046,0.7974356041811812,0.7097744360902256,0.9355977699966576,1.0,7/23,17.12%,CAV1;CBL;HYAL2;GPRC5A;DUSP22;SH3BP5L;SOCS5
prerank,acylglycerol metabolic process (GO:0006639),0.30257900909012375,0.7970153119477085,0.7486187845303868,0.935832174055937,1.0,11/37,21.31%,CAV1;DGKH;ABHD6;APOH;DGKI;GK5;ABHD2;SEL1L;PLAAT3;DGKA;PNPLA2
prerank,chromatin remodeling (GO:0006338),-0.20094716897294443,-0.796693189615443,0.9319727891156463,0.9639364765162552,1.0,22/100,17.25%,CHD4;TADA2A;BAZ1B;JARID2;KAT2B;BRDT;SMARCB1;RSF1;ARID1B;DR1;SMARCD1;SMARCA5;HDAC4;TAF6L;HDAC1;BPTF;HMGA2;KDM4A;PIH1D1;MTA2;KDM6B;MBD3
prerank,regulation of myelination (GO:0031641),-0.26797208851587767,-0.7964509505439109,0.808641975308642,0.9632676106648381,1.0,3/25,4.52%,PTN;PARD3;DICER1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.2918475039252225,-0.795898143179053,0.7847025495750708,0.963157884923413,1.0,8/18,29.82%,COX17;COX16;COX18;SMIM20;TIMM21;FASTKD3;COX14;COX19
prerank,modulation by host of symbiont process (GO:0051851),0.3127115339535712,0.7956109134436171,0.7470760233918129,0.937679486882043,1.0,7/31,15.53%,SAP30;INPP5K;LEF1;JUN;CCL4;CX3CR1;TAF11
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.2566550411183983,0.7955994476636684,0.8495475113122172,0.9372486797456671,1.0,34/145,18.87%,RAB11A;PSMD13;CSNK1D;TUBB;CDC25C;PSMD4;TUBB4B;CLASP1;NEDD1;HAUS3;CEP135;PCM1;PSMA5;PSMB10;RBX1;CEP76;DYNLL1;PSMB8;PSMD14;PSMA7;TUBA1A;PSMA8;PSMC3;PSMB5;PSMC1;PSMC5;PSMC6;PSMB9;PSMA4;KCNH5;PSMD5;PSMD9;ACTR1A;PSMB6
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.2113389916545643,-0.7947634641551564,0.8764044943820225,0.9640416695664117,1.0,21/73,22.96%,BAZ1B;JARID2;MTF2;KAT2B;MECP2;TAF1D;IGF2;DNMT3A;SMARCA5;RBBP7;HDAC4;HDAC6;MYBBP1A;MPHOSPH8;DEK;DNMT3B;SF3B1;POLR1H;POLR1A;SPHK2;GPX1
prerank,androgen receptor signaling pathway (GO:0030521),-0.34079139837947103,-0.7940566093366691,0.7253886010362695,0.9641595275639107,1.0,3/11,4.44%,DDX5;ZMIZ1;DDX17
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.3498935485061011,0.7931159646398483,0.7296,0.9409307237595266,1.0,2/17,6.63%,LPCAT4;CRLS1
prerank,response to organophosphorus (GO:0046683),0.35326206296563456,0.7925282148003933,0.7047913446676971,0.9414683609756518,1.0,3/16,8.24%,P2RX7;STAT1;NDUFS4
prerank,central nervous system development (GO:0007417),0.24612703095052554,0.7919051159158313,0.867570385818561,0.9420088516668957,1.0,66/250,22.21%,SHROOM4;RNF103;SLC2A1;NR4A2;EML1;SERPINI1;PPT1;LSR;SNTG2;DHX37;AMIGO2;SH3GL1;UFM1;MAST1;ZBTB16;ITGAM;NRCAM;WWP1;NDUFS4;GRIN2B;NCKAP1;UBE3A;MAL;GRIN2C;ASIC2;EIF2B2;SLC6A17;BAG6;CDH2;SPOCK1;NCAN;SOX10;SOX6;RPS6KA3;CX3CR1;CYP26C1;CAPG;ATXN1;ADGRA2;CXCR4;MEIS2;NES;GRIK1;ADGRG1;GRIN2A;SOX12;SYNJ1;NPTX1;TBX6;NCOA6;HAP1;SOX11;ELP3;POU3F3;DCX;FOXJ1;ATP6AP2;CNTN4;CNTN6;EEF1AKMT4-ECE2;CIC;CDK5RAP1;BTD;SMG9;BCAN;TBX3
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.3604424837382744,0.7914298211357143,0.7271268057784912,0.9423336792289163,1.0,2/13,9.23%,IRAK2;PIK3C3
prerank,negative regulation of inclusion body assembly (GO:0090084),0.38212867133811157,0.7911238338293075,0.7066895368782161,0.9423961082003127,1.0,4/10,20.95%,HSPA1B;DNAJB6;DNAJB8;SORL1
prerank,negative regulation of innate immune response (GO:0045824),0.3048980929633837,0.7898404178506537,0.7454798331015299,0.9440317179131511,1.0,12/34,25.05%,SUSD4;NLRC5;NMI;ACOD1;CACTIN;FAM3A;PTPN2;DHX58;RPS19;A2M;GRN;TTLL12
prerank,protein alkylation (GO:0008213),-0.268439043508493,-0.7893760722482828,0.7694610778443114,0.9710146707451158,1.0,6/22,18.08%,GSPT1;FAM98B;METTL21A;EEF1AKMT1;SNRPD3;EEF1AKMT2
prerank,regulation of nervous system development (GO:0051960),0.3026758917928326,0.7893584294925092,0.7570224719101124,0.944362320430167,1.0,9/37,14.21%,HEY1;HEY2;TNFRSF1B;PRUNE1;TENM4;CX3CR1;HMGB2;HES3;CTNNB1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.3362578269021971,0.7892333537790556,0.7209302325581395,0.9441255525406795,1.0,12/20,31.38%,PFDN6;PTGES3;CCT2;CLU;PSMG2;HOPX;MKKS;HSP90AA1;HSP90AB1;HSPA1A;TMEM35A;LONP1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.2220256298634477,-0.7890912814830818,0.8888888888888888,0.970388251566571,1.0,6/57,9.11%,IGF1;IL31RA;KIT;IL6R;VEGFA;GHR
prerank,brain development (GO:0007420),0.25746492258510506,0.7890775423162196,0.8116100766703176,0.9439450646515284,1.0,29/136,18.63%,RAPGEF2;SHROOM4;EML1;PPT1;DHX37;AMIGO2;SHANK3;UFM1;MAST1;SLC6A4;NDUFS4;GRIN2B;UBE3A;GRIN2C;SLC6A17;BAG6;CDH2;SOX6;CTNNA2;CX3CR1;ATXN1;CXCR4;MEIS2;NES;ADGRG1;GRIN2A;SYNJ1;NCOA6;HAP1
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.3536093016727182,0.7890163766822157,0.7161290322580646,0.9435957007402301,1.0,5/16,24.75%,SSBP1;PURA;BLM;WRN;MCMDC2
prerank,positive regulation of telomere capping (GO:1904355),0.340909240175545,0.788927712316117,0.7192982456140351,0.9432887889106524,1.0,3/17,11.03%,MAPK1;NEK7;TNKS
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.3376005622423145,0.7874418466296146,0.7316341829085458,0.9452188429976625,1.0,6/21,14.42%,HNF1A;SETX;JUN;MED30;MED17;MED4
prerank,establishment of protein localization to membrane (GO:0090150),0.2769507324004548,0.7870136376093164,0.8063694267515924,0.9454556551082468,1.0,8/66,11.49%,RAB11A;AQP11;ZDHHC22;NACAD;RAB3GAP2;MYO1C;TAOK2;REEP1
prerank,mitochondrion distribution (GO:0048311),-0.32007469718144643,-0.7868379596498604,0.7703349282296651,0.9731033593105334,1.0,4/12,17.81%,TRAK1;CLUH;ATCAY;DNM1L
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.30911081162716436,-0.7868257757351373,0.7427184466019418,0.9720378614432555,1.0,4/14,12.66%,PRKN;TXNDC12;CREB3L1;CREB3
prerank,cellular response to DNA damage stimulus (GO:0006974),0.238790190822839,0.7866354903778159,0.9006147540983607,0.9456004712597081,1.0,74/336,21.28%,ACER2;PLK3;FOXO1;HERC2;BTG2;UBA7;RBBP8;CASP2;BRAT1;TNFRSF1B;APEX1;SIRT4;SETX;ENDOV;ZC3H12A;AATF;CIDEB;POLK;BCL2L1;APC;FEN1;ZBTB40;FOXP1;BABAM2;ASF1A;TAOK2;NSMCE3;SPIDR;POLA1;WDHD1;POLB;NPM1;ALKBH8;GTF2H3;DTX3L;BRCA1;HINFP;LIG1;UBE2T;STK33;ATM;ERCC4;RAD1;RAD51D;NSMCE4A;RAD18;XPC;TRAIP;RFC2;TRRAP;RAD9B;SPRTN;CBX1;MMS19;MAPK14;FBXO6;MEN1;UBQLN4;CDKN2AIP;ATRIP;XIAP;NCOA6;CRY1;BID;FBXO45;BARD1;HUS1;MCL1;BLM;USP47;UBA1;RIF1;MNAT1;MAPKAPK2
prerank,centromere complex assembly (GO:0034508),-0.2419863442186374,-0.7856878014149866,0.8207885304659498,0.9728766576863609,1.0,18/36,31.87%,RSF1;CENPC;SMARCA5;RBBP7;MIS12;CENPK;KNL1;MIS18BP1;CENPE;CENPQ;CENPX;NASP;HELLS;CENPH;MIS18A;CENPF;CENPN;CENPA
prerank,modulation by host of viral genome replication (GO:0044827),0.35553794344121536,0.7856858340598805,0.7389162561576355,0.9466681767661725,1.0,2/13,6.94%,FBXL2;ZC3H12A
prerank,mitotic spindle organization (GO:0007052),0.25164776787814364,0.7852851577611766,0.8446927374301676,0.9468595606444796,1.0,28/153,16.33%,RAB11A;EML1;MAP4;CENPU;CLIP1;KIF2A;CLASP1;RANGAP1;KPNB1;DSN1;STAG1;XPO1;CLASP2;DYNLL1;RANBP2;TNKS;CENPI;PRC1;DYNC1LI2;NUP160;BUB1;ITGB3BP;ARHGEF10;EFHC2;RAN;NEK9;NDC80;SGO1
prerank,regulation of monocyte differentiation (GO:0045655),0.3594918956498129,0.7850867409475775,0.7241379310344828,0.9467071034714655,1.0,3/14,9.10%,FES;CTNNBIP1;FOXP1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.25933547916982347,-0.7848883487174326,0.7898305084745763,0.9731177392756131,1.0,9/31,23.08%,GOLGA2;UBE2N;DCUN1D3;UBE2L3;TOPORS;CDC14B;DCUN1D4;FZR1;BTRC
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.29304532319131754,0.7845440197263633,0.7662517289073306,0.9471401693272886,1.0,7/39,12.99%,UTRN;CAMK2D;FXYD5;STK39;SCN1B;NEDD4L;YWHAH
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.32698606278379444,-0.784096542955434,0.7481108312342569,0.9732483049311479,1.0,7/12,40.07%,CDC7;CDC45;MCM7;MCM5;MCM2;GINS2;MUS81
prerank,lytic vacuole organization (GO:0080171),0.3093671145658959,0.7838745912913535,0.7571428571428571,0.9477149310895552,1.0,9/32,20.43%,LRRK2;HOOK1;GNPTAB;TPCN2;NAGPA;CLVS1;TMEM106B;HOOK2;MYO7A
prerank,myelin assembly (GO:0032288),-0.3410547750892964,-0.7836886157922365,0.7415458937198067,0.9728282164005839,1.0,6/10,31.28%,DICER1;EPB41L3;GPC1;TPPP;NCMAP;CNTNAP1
prerank,ncRNA metabolic process (GO:0034660),0.30201639573102007,0.7836815585677017,0.7417582417582418,0.9475684829410315,1.0,7/37,18.66%,DTD2;DDX4;RAN;DROSHA;EXD1;TUT7;TDRD9
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.2681642967993719,0.7833017052130123,0.7982989064398542,0.9477323147491804,1.0,19/75,16.32%,KLF7;APP;SHTN1;MEF2C;ATL1;LMTK2;NRCAM;TAOK2;NEFH;ADGRB1;MINK1;DCC;ACTB;SLITRK2;CTNNA2;MAP2;TMEM106B;OPHN1;ANK3
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.24679086898493416,0.7827420234622383,0.8563772775991425,0.9482193222724418,1.0,44/184,19.13%,PSMD13;CSNK1D;TUBB;CUL3;UBE2D1;PSMD4;TUBB4B;CLASP1;NEDD1;UBA52;RPS27A;HAUS3;CEP135;PCM1;PSMA5;ZFP36L2;PSMB10;CDC14A;CEP76;DYNLL1;PSMB8;PSMD14;NEK11;PSMA7;TUBA1A;PSMA8;PSMC3;UBE2E1;CDC27;PSMB5;PSMC1;PSMC5;XPC;PSMC6;PSMB9;ANAPC7;PSMA4;KCNH5;PPP1R9B;PSMD5;PSMD9;ACTR1A;PSMB6;ANAPC4
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.29923882090785053,0.7825579343201723,0.7763713080168776,0.9480642762651381,1.0,7/39,12.99%,UTRN;CHRM3;FXYD5;STK39;SCN1B;NEDD4L;YWHAH
prerank,recombinational repair (GO:0000725),-0.20493591576112588,-0.7821276356929903,0.9209039548022598,0.9743251277907676,1.0,36/77,31.71%,NUCKS1;SMC6;ZFYVE26;RAD51B;UBE2N;FAN1;SWI5;FBH1;REV3L;RAD50;XRCC1;ERCC5;LIG3;NABP1;RHNO1;POLN;RFWD3;RECQL;RPA3;PALB2;RPA1;PARP1;POLQ;MCM8;RPA2;RAD51;MMS22L;RAD51AP2;ZSWIM7;NSMCE2;NABP2;AP5S1;XRCC3;SLX4;MORF4L1;POLL
prerank,lymphocyte chemotaxis (GO:0048247),-0.24672500675926304,-0.7818198618644747,0.8402777777777778,0.9737403561807709,1.0,22/34,51.37%,SLC12A2;CXCL16;CCL25;CKLF;GPR183;CCL19;HSD3B7;PIK3CG;CCL2;CCL14;GAS6;CX3CL1;CCL5;CCL8;MSMP;ADAM8;CCL7;CCL1;CCL3;CCL11;CCL13;CXCL13
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.2300949781164806,-0.781519385387408,0.8546099290780141,0.9731633204769673,1.0,3/40,6.52%,PID1;BCL2;ATP5IF1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.33649612404805807,0.7815071964046593,0.729264475743349,0.9492714137114139,1.0,6/21,20.15%,FCGR2B;DUSP3;LAPTM5;SOX11;BANK1;FOXJ1
prerank,P-body assembly (GO:0033962),-0.31565974432733407,-0.781491419453487,0.7493472584856397,0.9721361366938691,1.0,3/12,17.52%,LIMD1;ATXN2;RC3H1
prerank,positive regulation of ATPase activity (GO:0032781),0.2950196738202649,0.7810376375770294,0.7770177838577291,0.9495539685915788,1.0,11/41,20.00%,MYBPC3;SSBP1;PLSCR1;DHX9;DYNLL1;CHTOP;AHSA1;TOR1AIP2;DNAJC10;DYNLL2;DNAL4
prerank,integrated stress response signaling (GO:0140467),0.35782958965198153,0.7809858060340092,0.7360890302066773,0.9491955651878384,1.0,6/14,26.62%,OMA1;NFE2L2;EIF2S1;EIF2AK1;DDIT3;HERPUD1
prerank,positive regulation of catabolic process (GO:0009896),0.2722952910986929,0.7809047601584549,0.7932752179327521,0.9488878551411501,1.0,17/65,23.60%,FOXO1;DAB2IP;ASB5;WWP1;APC;VPS28;NEDD4L;VSIR;SMURF1;NSF;GSK3A;BARD1;GSK3B;SORL1;WWP2;OAZ2;CDKN1B
prerank,proteoglycan biosynthetic process (GO:0030166),0.30447455051385686,0.7808223527854441,0.75,0.9485699868647517,1.0,8/31,19.57%,BMPR2;EXT1;CHST11;B3GAT2;EXTL3;GLCE;CSGALNACT2;CHST9
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.28032493630605543,0.7808148692395914,0.7770448548812665,0.948136133513665,1.0,11/49,20.95%,SMAD6;IAPP;PMEPA1;HMGB1;AIDA;CLU;RIOK3;PYDC1;GSK3B;LCMT1;SORL1
prerank,regulation of exit from mitosis (GO:0007096),0.2961676282469594,0.7807221456249954,0.7550744248985115,0.9478435836820934,1.0,11/38,22.32%,UBE2D1;UBA52;RPS27A;CDC14A;UBE2E1;CDC27;ANAPC7;PPP1R9B;ANAPC4;UBB;ANAPC11
prerank,DNA geometric change (GO:0032392),-0.26522858106778385,-0.7803168046616135,0.8069164265129684,0.9730048974731375,1.0,8/24,20.97%,HNRNPA2B1;ANXA1;RAD50;DDX1;SUPV3L1;RTEL1;RECQL;ZRANB3
prerank,regulation of protein catabolic process (GO:0042176),0.2590594187284646,0.7802658070581747,0.8248847926267281,0.9481089429195529,1.0,15/99,14.03%,AZIN1;FOXO1;DAB2IP;FURIN;ASB5;WWP1;APC;VPS28;MAD2L2;PRKCG;ADGRB1;NEDD4L;SMURF1;PIN1;NSF
prerank,positive regulation of TOR signaling (GO:0032008),0.29046903089361775,0.7794665346110558,0.7692307692307693,0.9489020429910567,1.0,20/40,27.51%,GPR137B;SMCR8;WDR59;RRAGD;RHEB;RICTOR;MIOS;GPR137C;GOLPH3;RRAGA;RRAGC;HTR6;LAMTOR3;WDR24;PIK3CA;SEH1L;RPTOR;MLST8;LAMTOR4;CLEC16A
prerank,signal release from synapse (GO:0099643),0.2949323665647926,0.7791829959451989,0.7725437415881561,0.9489241062948547,1.0,9/43,18.16%,SYN3;PIP5K1C;PDZD11;STXBP3;HRH3;SLC32A1;CPLX1;SNPH;SYT1
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.33712212364841077,-0.7788022211068202,0.7333333333333333,0.9744034810939626,1.0,3/10,13.11%,APOD;RIPOR2;PADI2
prerank,glial cell development (GO:0021782),0.3159440051550487,0.7787810572228843,0.7467994310099573,0.9491374490052326,1.0,5/25,18.79%,APP;EIF2B2;SOX10;NSUN5;SOX11
prerank,spindle assembly checkpoint signaling (GO:0071173),0.3290633246513404,0.7787719397378114,0.7450682852807283,0.9478219850140119,1.0,5/20,13.67%,IK;APC;MAD2L2;ATM;BUB1
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.3290633246513404,0.7787719397378114,0.7450682852807283,0.9478219850140119,1.0,5/20,13.67%,IK;APC;MAD2L2;ATM;BUB1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.3290633246513404,0.7787719397378114,0.7450682852807283,0.9478219850140119,1.0,5/20,13.67%,IK;APC;MAD2L2;ATM;BUB1
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.2106599687300989,-0.7783163813243421,0.8802083333333334,0.9741285697025066,1.0,23/68,23.49%,SCAF8;NUDT21;NCBP1;TAF1D;SMN1;PABPN1;SNRPF;TTF1;ERCC2;PCF11;CSTF2T;UBTF;GTF2H5;SNRPD3;GTF2H1;LSM11;GTF2H4;SLBP;POLR1H;POLR1A;PAPOLA;NCBP2;LSM10
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.33580896127773197,0.7780327020542791,0.7334360554699538,0.9485709352284143,1.0,7/17,20.52%,NUS1;ALG14;DOLK;MVD;DPAGT1;ALG1;DOLPP1
prerank,regulation of vacuole organization (GO:0044088),-0.28031066374960845,-0.7779033559502073,0.807799442896936,0.9737250910107424,1.0,7/20,24.34%,ANXA2;ENO2;ADPRH;IFT20;IFT88;ENO3;NPRL2
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.3019854793527781,0.7777092176289744,0.7689075630252101,0.9485945084127284,1.0,10/30,26.30%,SNAI2;BCL2L1;CLU;CDKN2D;DDX39B;DYRK1A;YJU2;TMEM161A;THOC5;PSMD10
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.3394485254905059,0.7775521361090532,0.7625,0.9484022683328532,1.0,7/18,19.81%,CAV1;CAMK2D;STK39;NEDD4L;EPO;PPIF;CAB39
prerank,negative regulation of signaling (GO:0023057),0.3174249081807479,0.7773070875078906,0.743988684582744,0.9483551024543599,1.0,6/25,23.38%,ACVR1;KIF26A;PTPN1;SOCS5;BRAP;HHIP
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.2532760997332543,0.7769105205114908,0.8316268486916951,0.9485466866804012,1.0,22/122,13.22%,PDGFB;NOD2;INSR;TGFB2;VIM;KLF4;BCAR3;PLD1;ELAVL1;JAK2;NLRC5;PASK;NAMPT;DHX9;STN1;METTL5;NPM1;EEF2;PRKD2;RPS6KB1;METTL14;FXR1
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.31965262615376383,-0.7767212815724144,0.7460732984293194,0.9745381614621756,1.0,5/11,23.32%,NCBP1;PAF1;AHCYL1;PAPOLA;NCBP2
prerank,microtubule-based transport (GO:0099111),0.3600388019007697,0.7766897936697867,0.7074829931972789,0.9484471574608246,1.0,3/12,21.65%,ADCY10;SPA17;DYNC1I2
prerank,monosaccharide transmembrane transport (GO:0015749),0.3409415924980562,0.776582947615997,0.7403846153846154,0.9481615523803424,1.0,2/16,8.57%,SLC5A10;SLC2A9
prerank,neuromuscular process controlling balance (GO:0050885),0.35530140840759017,0.77652134373379,0.7170731707317073,0.9478135574321098,1.0,3/12,21.32%,PCDH15;MYO7A;NRXN1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.2917586396502934,0.7760955077430732,0.754874651810585,0.9480234013064297,1.0,3/37,7.41%,EDN1;ANKRD13A;AATF
prerank,hippo signaling (GO:0035329),0.30876308546032205,0.7749873346547919,0.7507418397626113,0.9493381500512904,1.0,5/26,10.54%,TEAD4;WWTR1;TJP2;TJP1;FAT4
prerank,regulation of activated T cell proliferation (GO:0046006),0.3020716616310879,0.7749127318683132,0.7771509167842031,0.9490051475304921,1.0,8/30,20.17%,CRTAM;LGALS9;HMGB1;PRNP;IL27RA;PYCARD;CD24;AGER
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.23649699980505884,-0.773974835432515,0.8615916955017301,0.9777951391299347,1.0,6/36,10.50%,OGT;FHIT;MAP1A;PSMF1;TRIM39;SDCBP
prerank,regulation of RNA export from nucleus (GO:0046831),0.3657880685762656,0.7738817593082624,0.7095709570957096,0.950163518476645,1.0,5/11,25.31%,DHX9;NUP153;SETD2;IWS1;TPR
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.3702450763758781,0.77384540843203,0.7399328859060402,0.9497731019308335,1.0,2/10,7.58%,ATP5MC1;ATP5F1A
prerank,purine nucleotide catabolic process (GO:0006195),0.3633785242269031,0.7738313251127714,0.7446808510638298,0.9493557999708296,1.0,1/13,1.76%,GDA
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.32395322081805467,0.773188732952734,0.7507552870090635,0.9499456327678941,1.0,5/21,13.67%,IK;APC;MAD2L2;ATM;BUB1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.2736430934873223,0.7731151080341152,0.7833125778331258,0.9496272005053463,1.0,13/57,18.32%,APP;SHISA8;MEF2C;SHISA6;GRIA1;GRIN2B;MINK1;LYNX1;NPTX2;GRIN2A;NPTX1;LRRC7;CAPN1
prerank,peptidyl-lysine methylation (GO:0018022),-0.2623997047582477,-0.7730083450551363,0.8141025641025641,0.9782167785677579,1.0,16/26,34.78%,EHMT1;SETD7;METTL21A;EEF1AKMT1;SUV39H1;SETD4;N6AMT1;EEF1AKMT2;ANTKMT;TRMT112;KMT5A;ATPSCKMT;ETFBKMT;EEF1AKMT3;EHMT2;METTL21C
prerank,regulation of centrosome duplication (GO:0010824),0.30367493513183014,0.7728699100793862,0.7679324894514767,0.9495572331323936,1.0,11/29,26.25%,CHMP1B;CEP76;NPM1;CHMP3;CHMP2B;CEP120;CHMP1A;GEN1;FBXW5;VPS4B;CHMP4B
prerank,negative regulation of DNA replication (GO:0008156),0.3555569564415573,0.772850089048987,0.7334410339256866,0.9491440858832162,1.0,2/13,10.63%,GMNC;CDAN1
prerank,positive regulation of intracellular protein transport (GO:0090316),0.24785169756806805,0.7727605375906965,0.8486547085201793,0.948858806283168,1.0,40/144,22.81%,FYN;PLK3;CASP8;PPP1R13B;AKAP5;HYAL2;BBC3;ZC3H12A;ITGAM;NMT1;PRR5L;MYO1C;PCM1;RIPOR1;FBXW7;PRNP;DMAP1;ITGB1BP1;YWHAH;UBE2J2;ANP32B;ICE1;RAN;UBE2D3;PDCD10;ANK3;TENM1;GSK3A;TOMM7;BID;GSK3B;JUP;MTCL1;SORL1;PPP3CC;LEPROT;ECT2;SREBF2;OAZ2;PPP3R1
prerank,inner mitochondrial membrane organization (GO:0007007),-0.2295058745607143,-0.7725190708633105,0.8888888888888888,0.9779434445661396,1.0,21/47,27.84%,MICOS10;ATP5PD;NDUFA13;DMAC2L;ATP5F1B;ATP5MF;MICOS13;ATP5MC2;ATP5MG;MTX3;ATP5F1D;MTX1;MTX2;ROMO1;TIMM29;IMMT;APOO;SPG7;ATP5F1E;OPA1;ATP5MC3
prerank,regulation of neutrophil migration (GO:1902622),0.3707813612947938,0.7724045391762802,0.7656529516994633,0.9489963592921314,1.0,2/10,14.01%,RAC1;RHOH
prerank,striated muscle cell differentiation (GO:0051146),0.3487299009193755,0.7723143150951444,0.7424,0.948686593658765,1.0,5/16,20.25%,MEF2C;MYEF2;POPDC3;SKI;SORT1
prerank,regulation of protein kinase C signaling (GO:0090036),0.35957610015124586,0.7722675137248945,0.7511737089201878,0.948327033145749,1.0,1/14,1.02%,FLT4
prerank,regulation of cell division (GO:0051302),0.2638381903844765,0.7715049077756199,0.816884661117717,0.9491065052644896,1.0,16/72,20.78%,PLK3;RAB11A;TAL1;BCL2L1;PIK3C3;CALM3;PRC1;PIN1;RAB11FIP4;MLLT3;RACK1;KLHL9;GIT1;RAB11FIP3;SETD2;BLM
prerank,peptidyl-arginine modification (GO:0018195),-0.29252137891527774,-0.771340448191305,0.7752525252525253,0.9787515175966256,1.0,3/15,13.11%,ART3;NDUFAF5;PADI2
prerank,negative regulation of cell division (GO:0051782),0.3646050480681222,0.7712800159021427,0.722495894909688,0.9490197024304012,1.0,3/11,20.78%,E2F7;VPS4A;BLM
prerank,actin filament network formation (GO:0051639),0.37814971485364723,0.7711014756104846,0.7380530973451327,0.9488595979652412,1.0,4/11,20.64%,PLS3;LCP1;SPIRE1;CARMIL1
prerank,positive regulation of viral process (GO:0048524),0.277429038828994,0.7706639453302022,0.7920298879202988,0.9491004849331989,1.0,14/60,18.08%,ADARB1;PPIE;POLR2G;ADAR;DHX9;POLR2D;VPS4A;PPIH;PKN2;POLR2I;NELFB;NELFA;SRPK1;PPID
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.23547882817032906,-0.7705895149967535,0.8551236749116607,0.9788865030519318,1.0,15/37,24.35%,DDB2;RFC1;CUL4B;CUL4A;ERCC5;ERCC2;GTF2H5;GTF2H1;RPA3;GTF2H4;RPA1;PARP1;CHD1L;POLD2;RPA2
prerank,carboxylic acid catabolic process (GO:0046395),-0.31393300374451594,-0.770102164178141,0.7296587926509186,0.9786006207632925,1.0,7/12,39.26%,RENBP;NAGK;AMDHD2;NPL;GNPDA1;IL4I1;ACOT8
prerank,mitochondrial membrane organization (GO:0007006),-0.2409177464228029,-0.7698168361033254,0.8185185185185185,0.9779619170123593,1.0,14/32,29.39%,BCL2;MICOS10;SLC25A4;RCC1L;MICOS13;MTX3;MTX1;MTX2;IMMT;APOO;SPG7;OPA1;BAD;TIMM50
prerank,secondary alcohol metabolic process (GO:1902652),-0.2332178111806675,-0.7695803849636937,0.8902439024390244,0.9772495545663812,1.0,9/42,16.43%,CYP27A1;APOE;ABCA1;IDH2;FDX1;IDH1;GBA2;SQLE;SCAP
prerank,cellular response to hexose stimulus (GO:0071331),0.3176285558004919,0.7695440579399109,0.7551622418879056,0.9504315216316153,1.0,3/23,8.31%,UNC13B;PCK2;PRKAA1
prerank,regulation of catabolic process (GO:0009894),-0.27994482446791374,-0.769421649969138,0.800531914893617,0.9764225934532589,1.0,13/18,37.91%,FAP;ODC1;HPGD;MDM2;SNF8;RARRES2;CENATAC;ZDHHC2;TMEM9;CHMP6;FAF1;FAM83D;HGS
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.291688026966084,-0.7693223433105497,0.7715877437325905,0.9755394199044038,1.0,5/16,17.90%,AMPD3;LHPP;ATIC;NUDT2;IMPDH2
prerank,nucleotide catabolic process (GO:0009166),0.34188321524382287,0.7693072569422259,0.7576736672051696,0.9503657390662529,1.0,1/16,1.76%,GDA
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.3231226584057043,0.7693057738582941,0.7557603686635944,0.9499323846271351,1.0,5/20,16.95%,CEACAM1;FBXW7;BRCA1;ERLIN2;TRIB3
prerank,superoxide anion generation (GO:0042554),0.35372984235917765,0.7689829658005572,0.7390599675850892,0.9499886028551032,1.0,3/13,15.12%,TAFA4;CYBA;NCF2
prerank,negative regulation of cellular protein localization (GO:1903828),0.30131136952346316,0.7687766176402608,0.7762039660056658,0.9498760377471009,1.0,7/34,11.20%,GOPC;TTBK2;ANKRD13A;MFHAS1;CTNNA1;TAX1BP3;NEDD4L
prerank,positive regulation of T cell proliferation (GO:0042102),-0.21643289319746428,-0.7684359018414975,0.9,0.9757844856273119,1.0,7/55,13.07%,IGF1;IGFBP2;ANXA1;IGF2;NCKAP1L;PNP;CD80
prerank,regulation of mRNA stability (GO:0043488),0.24540824019292004,0.7683656619319059,0.8790593505039194,0.9500654761958774,1.0,45/145,23.48%,VIM;PSMD13;PUM2;APEX1;PSMD4;ELAVL1;EXOSC3;HSPB1;UBA52;RPS27A;ROCK1;PSMA5;XPO1;ZFP36L2;PSMB10;PSMB8;EXOSC8;NPM1;PSMD14;XRN1;PSMA7;METTL14;FXR1;PSMA8;PSMC3;PSMB5;PSMC1;PSMC5;YBX1;PSMC6;PSMB9;PSMA4;EXOSC9;PSMD5;PSMD9;PSMB6;ZFP36L1;PSMB2;MAPKAPK2;UBB;EXOSC1;MEX3D;TBRG4;EIF4G1;DHX36
prerank,regulation of receptor internalization (GO:0002090),0.29210145402531,0.7682969060130438,0.7777777777777778,0.9497424913948175,1.0,5/35,8.23%,INSR;ANGPT1;ANKRD13A;ARRB1;TBC1D5
prerank,macroautophagy (GO:0016236),0.251746973295003,0.7681792997321351,0.8428899082568807,0.9494854341824915,1.0,31/118,19.90%,ATG101;VTI1B;KLHL3;GABARAPL1;VPS36;TECPR1;VAMP8;PLEKHM1;TBC1D5;PRKAA1;NBR1;VAMP7;PIK3C3;VPS28;DYNLL1;MFN1;LIX1;VPS4A;CHMP3;YOD1;MAP1LC3A;CHMP2B;CSNK2B;VDAC1;UBXN6;ATG14;LAMP2;TOMM7;DYNLL2;MVB12A;STAM2
prerank,nucleic acid metabolic process (GO:0090304),0.26739196900595796,0.7680734502693465,0.7920792079207921,0.9492202384576863,1.0,16/69,17.52%,EXD2;LSM1;HNRNPA0;POLR2G;FEN1;DUSP11;POLR2D;HNRNPK;XRN2;PCBP1;METTL14;HNRNPH2;RAN;POLR2I;MMS19;DXO
prerank,regulation of response to stress (GO:0080134),0.3666206377102684,0.7680599563237291,0.7252032520325203,0.9488060083383548,1.0,10/10,63.36%,EIF4G1;ADCY8;MLC1;OPRM1;STOX1;IL10;SLC38A2;CRHBP;DYRK3;CORO2B
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.27006732245839377,-0.7680391015999645,0.8012422360248447,0.975360697181791,1.0,6/22,15.15%,RELL1;SASH1;XDH;VEGFA;GADD45B;SPHK1
prerank,membrane assembly (GO:0071709),-0.23614241691257298,-0.7664532510807712,0.8698630136986302,0.9766935559131483,1.0,7/34,15.12%,ANXA2;STX4;NLGN2;TLCD2;UBXN2B;SPAST;S100A10
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.3244177092310021,-0.7662067531090233,0.7833333333333333,0.9760103026719816,1.0,3/11,23.70%,PARP8;PARP6;PARP3
prerank,negative regulation of mitochondrion organization (GO:0010823),0.2933369115384262,0.766202112341895,0.759493670886076,0.9512229520576686,1.0,8/33,14.37%,OMA1;IAPP;BCL2L1;CLU;TMEM14A;NOL3;FZD9;BNIP3
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.26862701724881755,-0.7661844332778259,0.7918918918918919,0.9749896824530845,1.0,5/19,15.26%,GNL3L;SRC;TENT4B;HNRNPU;TEN1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.2961633572399234,0.7660565099519652,0.7592592592592593,0.9510107549987901,1.0,4/31,13.34%,FCGR2B;ARG1;TYROBP;ATM
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.27659746599591006,-0.7658864994013805,0.7786885245901639,0.9744239722943613,1.0,7/18,18.08%,EHMT1;SETD1A;SETD1B;SETD7;SUV39H1;SETD4;EEF1AKMT2
prerank,cellular response to misfolded protein (GO:0071218),0.3200444458003486,0.7654035492659153,0.7388724035608308,0.951601700927132,1.0,6/20,20.60%,RNF185;CUL3;BAG6;UGGT1;RNF5;POMT2
prerank,regulation of fibroblast migration (GO:0010762),0.3192188939426278,0.7653270798542116,0.7555555555555555,0.9512757987717059,1.0,5/20,12.61%,HYAL2;PRR5L;PTK2;RAC1;ITGB1BP1
prerank,neurotransmitter secretion (GO:0007269),0.28725777404469266,0.7652709431327751,0.7776298268974701,0.9509242124480797,1.0,9/44,18.16%,SYN3;PIP5K1C;PDZD11;STXBP3;HRH3;SLC32A1;CPLX1;SNPH;SYT1
prerank,cell differentiation in hindbrain (GO:0021533),0.3663047982027664,0.7652658766601392,0.7545605306799337,0.9504954995393688,1.0,3/11,20.17%,ATP7A;OPHN1;GRID2
prerank,phagosome acidification (GO:0090383),-0.25326501066364515,-0.7649500400663433,0.8439490445859873,0.9747440237776831,1.0,8/26,22.53%,ATP6V0A4;ATP6V1B2;ATP6V0B;TCIRG1;ATP6V1A;ATP6V1F;ATP6V0D2;ATP6V1H
prerank,response to UV-A (GO:0070141),-0.29797033826489844,-0.7642887029769151,0.7851239669421488,0.9746900829014765,1.0,2/14,8.32%,EGFR;MMP2
prerank,regulation of isotype switching (GO:0045191),0.3471793836722753,0.7640669750959367,0.7610474631751227,0.9519042304571326,1.0,7/14,26.42%,SLC15A4;MAD2L2;RIF1;SHLD3;PAXIP1;SHLD2;SHLD1
prerank,peptidyl-methionine modification (GO:0018206),0.3594130681586011,0.7633879986068999,0.743103448275862,0.9524721032197064,1.0,4/12,21.58%,APOA1;METAP2;NAA30;NAA25
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.3486875274840174,0.7631822090352086,0.7428115015974441,0.9523392088468412,1.0,1/13,3.78%,STX7
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.36750507733741394,0.7629782537437263,0.7722602739726028,0.9522096763023009,1.0,1/11,0.83%,PLCB1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.3143405888045579,0.7629324747516519,0.7803138373751783,0.9518410440459607,1.0,6/24,14.96%,OCLN;NCKAP1;RAC1;CYFIP1;WASF2;ARPC2
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.30691912057706605,0.7629257681116908,0.7860326894502229,0.9514167866467134,1.0,4/28,5.77%,FAM107A;APP;AKAP5;SHANK3
prerank,protein maturation (GO:0051604),0.25359059517568394,0.7625980552044359,0.8459687123947052,0.9514968036134879,1.0,27/95,21.40%,CPD;TSPAN14;CASP2;LIPT2;PCSK5;FURIN;TSPAN32;ADAM17;APH1A;ADAM10;BOLA2;LIPT1;GLRX3;METAP2;CPM;PSEN2;XPNPEP3;MMS19;SRGN;LONP2;TYSND1;LMF2;SORL1;ECE2;EEF1AKMT4-ECE2;APH1B;CCS
prerank,negative regulation of cellular senescence (GO:2000773),0.3480180250585076,0.7625297254781538,0.734959349593496,0.9511576491175913,1.0,4/13,14.97%,AKT3;RBL1;MAP3K3;YBX1
prerank,glutathione derivative metabolic process (GO:1901685),-0.26288334290224025,-0.7623534530372129,0.8142414860681114,0.9755351849448605,1.0,8/20,22.21%,GSTT1;GSTZ1;GSTA3;GSTM1;GSTM2;AKR1A1;GSTM5;GSTO1
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.26288334290224025,-0.7623534530372129,0.8142414860681114,0.9755351849448605,1.0,8/20,22.21%,GSTT1;GSTZ1;GSTA3;GSTM1;GSTM2;AKR1A1;GSTM5;GSTO1
prerank,nuclear pore complex assembly (GO:0051292),0.3690829444558476,0.7622841722319714,0.7396551724137931,0.9510991531066294,1.0,3/10,16.21%,RTN4;NUP153;NUP205
prerank,diacylglycerol metabolic process (GO:0046339),-0.2613599378788648,-0.7619556818490404,0.8,0.9751115965817523,1.0,5/23,15.01%,PLCE1;DGAT1;DGKD;PGS1;PLA2G15
prerank,positive regulation of macroautophagy (GO:0016239),0.2816414402998958,0.7611820729739328,0.8056628056628057,0.9523522582682583,1.0,12/48,15.98%,ADRB2;SPTLC2;SPTLC1;SMCR8;IRGM;RAB3GAP2;FYCO1;VPS13D;BNIP3L;BNIP3;EPM2A;VDAC1
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.26647371929777963,-0.7610534817769733,0.8348082595870207,0.9754312729612288,1.0,11/22,28.42%,NFU1;NFS1;CIAPIN1;FXN;CIAO3;NDOR1;CIAO1;CIAO2A;NUBP1;LYRM4;CIAO2B
prerank,negative regulation of TOR signaling (GO:0032007),0.2905370788826764,0.7607860666244016,0.801994301994302,0.9524907677972327,1.0,10/36,21.75%,SPAAR;CASTOR1;SH3BP4;PRKAA1;ATM;EPM2A;GSK3A;MAPKAPK5;NPRL3;AKT1S1
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.22718623042587854,-0.7607164623679461,0.9072164948453608,0.9748963792841765,1.0,25/43,39.25%,BRSK1;TRIM39;NABP1;HMGA2;CDC14B;CDKN1A;DONSON;ORC1;CHFR;FZR1;RINT1;TAOK1;TAOK3;CHEK1;NABP2;DTL;FOXN3;UIMC1;CDK5RAP3;HUS1B;CDK1;PLK1;CDC6;TICRR;MRE11
prerank,negative regulation of cell aging (GO:0090344),0.33502975546543823,0.7600511225962967,0.744408945686901,0.9531420388003806,1.0,4/16,14.97%,AKT3;RBL1;MAP3K3;YBX1
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.3228657274718474,0.7597466651823676,0.7732115677321156,0.9531883200026187,1.0,3/21,14.21%,CAV1;APC;CTNNB1
prerank,sodium-independent organic anion transport (GO:0043252),0.36935962959158,0.7585703182327517,0.7479541734860884,0.9545022483382741,1.0,3/10,9.11%,SLCO1C1;SLC16A2;MFSD10
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.3021360841812286,0.7583744109717151,0.7554904831625183,0.9543737620593091,1.0,7/29,17.66%,RAB6B;VTI1B;COG5;NSF;GOSR1;COG6;VTI1A
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.3160306301782576,-0.7582201528702486,0.760705289672544,0.9765117719229023,1.0,10/10,68.42%,TULP1;GNAT1;REEP6;GNAT2;CACNA1F;CNGB1;GRM6;RPE65;CEP250;CACNA2D4
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.3160306301782576,-0.7582201528702486,0.760705289672544,0.9765117719229023,1.0,10/10,68.42%,TULP1;GNAT1;REEP6;GNAT2;CACNA1F;CNGB1;GRM6;RPE65;CEP250;CACNA2D4
prerank,neuronal action potential (GO:0019228),-0.26546204136857965,-0.758020776222994,0.8397790055248618,0.97572655345349,1.0,6/22,17.41%,SCN7A;SCN2A;CACNA1G;KCNMB2;GPER1;CACNA1H
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.33266029648604695,0.7577811025257324,0.7769110764430577,0.9548038475497888,1.0,5/17,22.56%,HSPB1;NFE2L2;NOL3;SOD1;NME5
prerank,regulation of neuroblast proliferation (GO:1902692),0.33803469666804237,0.7577462356231449,0.762214983713355,0.9544286831704096,1.0,5/15,14.28%,TAFA1;LRRK2;CX3CR1;CTNNB1;FZD3
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.30801466274927386,-0.7573874138329659,0.7828282828282829,0.9756482625216553,1.0,4/12,20.17%,DGAT1;MTTP;MFSD2A;P4HB
prerank,establishment of vesicle localization (GO:0051650),0.3242867692134888,0.7570483927483341,0.7765273311897106,0.9549843860529328,1.0,4/18,18.49%,RAB11A;LIMK2;SYNJ1;RAB27A
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.3613025772270883,0.757010337811441,0.7586776859504132,0.9546030434899514,1.0,5/12,25.68%,ZC3H12A;ELAVL1;ESR1;NCOR2;TGFB1
prerank,positive regulation of chromosome organization (GO:2001252),-0.28994721623566233,-0.7565839599251061,0.7932692307692307,0.9758018675392033,1.0,8/15,29.36%,RAD50;PPP1R10;RTEL1;PML;ATRX;GNL3;LIG4;SIRT6
prerank,cellular polysaccharide catabolic process (GO:0044247),0.3322525321879382,0.7560247817462104,0.7395498392282959,0.9556443739588315,1.0,2/16,4.36%,AOAH;PGM2L1
prerank,glutathione metabolic process (GO:0006749),-0.23177814360251817,-0.7558530783988575,0.8571428571428571,0.9757587988762267,1.0,9/38,16.68%,GSTT1;GCLC;GSTZ1;GGT5;ETHE1;GSTA3;GSTM1;GSTM2;GGT7
prerank,regulation of cholesterol efflux (GO:0010874),0.29880650773851425,0.7557281000985587,0.7991137370753324,0.9556755725488976,1.0,7/30,17.35%,CAV1;APOA1;PLTP;NFKBIA;ABCA7;EEPD1;NAXE
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.3265227488212262,0.7551032486525322,0.7823343848580442,0.9561773613398605,1.0,2/17,3.56%,BTG1;TMEM100
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.3482001020338888,0.7550225330630136,0.7646076794657763,0.9558535358218416,1.0,6/13,30.54%,NAMPT;PTGIS;NAXE;PARP9;NUDT12;PARP16
prerank,cellular response to ionizing radiation (GO:0071479),0.27346448533434325,0.7547033428149392,0.817470664928292,0.9558786339399178,1.0,14/47,22.55%,RHOB;TMEM109;SPIDR;ATM;RAD1;MAP3K20;KDM4D;RAD9B;MAPK14;EEF1D;HUS1;BLM;ECT2;YAP1
prerank,actin-myosin filament sliding (GO:0033275),0.29014455195903877,0.7544650865914877,0.7699468085106383,0.9553787908745301,1.0,4/38,12.23%,MYBPC3;VIM;MYL6;TPM4
prerank,muscle filament sliding (GO:0030049),0.29014455195903877,0.7544650865914877,0.7699468085106383,0.9553787908745301,1.0,4/38,12.23%,MYBPC3;VIM;MYL6;TPM4
prerank,regulation of cellular component size (GO:0032535),0.2984228005379116,0.7541581578916317,0.7930555555555555,0.9553843711842546,1.0,13/30,27.56%,MSN;RAP1GAP2;HP1BP3;AP2M1;RAC1;PEX11A;PEX11G;PPP1R15A;ATP13A2;RPTOR;RDX;LAMTOR4;RIN3
prerank,ERBB2 signaling pathway (GO:0038128),-0.24533602195009308,-0.753871302059479,0.8359621451104101,0.9775481550362387,1.0,9/31,17.39%,EGFR;SHC1;SRC;PIK3R1;PRKCA;ERBB2;HBEGF;GAB1;STUB1
prerank,positive regulation of secretion (GO:0051047),0.3578069424700676,0.7536735929771706,0.7545304777594728,0.9556591887871594,1.0,1/11,6.97%,NPR1
prerank,DNA replication checkpoint signaling (GO:0000076),-0.2869462485621226,-0.7535634349111787,0.7844155844155845,0.9769516271108796,1.0,9/16,38.08%,TIPIN;ORC1;TIMELESS;CDC45;RAD9A;HUS1B;DNA2;CDC6;TICRR
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.302985909352551,-0.7530465765123755,0.7741935483870968,0.9766180140409103,1.0,1/13,1.87%,AXL
prerank,protein targeting to membrane (GO:0006612),-0.18954226910269234,-0.7527915872923233,0.9615384615384616,0.9759640573004185,1.0,17/83,15.16%,ABCD3;PARD3;SIL1;ATG3;RAB3IP;SSR1;PRKCI;ATAD1;TRAM1;PEX2;PXMP4;ARL6;SDCBP;SSR2;PXMP2;RABGEF1;GDAP1
prerank,regulation of immunoglobulin production (GO:0002637),0.31088330030003286,0.7526485249082737,0.7852941176470588,0.9567058783178183,1.0,2/23,5.18%,FCGR2B;GPI
prerank,regulation of myoblast fusion (GO:1901739),0.3531080694532153,0.7526042857137816,0.7508417508417509,0.956336174436618,1.0,3/11,17.20%,EHD1;ADGRB1;MAPK14
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.2649990942277478,0.7523797778501329,0.8213399503722084,0.9562494003188954,1.0,14/66,15.02%,CARD10;WWTR1;HYAL2;ZC3H12A;CCT8;DKC1;LIMK2;CCT2;DTX3L;DMAP1;CCT4;CCT6A;RAN;KAT7
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.2665038850857442,0.7523215240670975,0.821656050955414,0.9558962332681186,1.0,19/62,22.66%,ARHGEF2;LRRK2;HSPB1;SNAI2;NFE2L2;BCL2L1;CLU;TMBIM6;RTKN2;NOL3;CDKN2D;ARMC10;PLAUR;EPO;PPIF;MCL1;DNAJA1;NME5;TMEM161A
prerank,mRNA transport (GO:0051028),-0.1868291845620761,-0.7522618065230295,0.9805194805194806,0.9756630366973772,1.0,33/101,24.51%,SRSF5;NUP107;HNRNPA2B1;NCBP1;UPF2;SRRM1;SRSF1;NUP155;SRSF6;THOC1;AAAS;AGFG1;NUP93;NXF1;MAGOH;U2AF2;MAGOHB;ZFP36;MCM3AP;UPF3B;SRSF3;KIF5C;SLBP;SEC13;SRSF11;DDX25;POM121;EIF4A3;NCBP2;DDX19B;ZC3H11A;U2AF1;SRSF2
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.2999805706988047,0.7521440410457952,0.7884344146685472,0.9557252161088007,1.0,4/32,10.61%,CAV1;P2RX7;CASQ1;PLCG1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.29591394717169595,-0.7517165989726375,0.8096446700507615,0.9754437736284048,1.0,2/13,2.93%,AXL;WNT5A
prerank,negative regulation of catabolic process (GO:0009895),0.2767504609480548,0.7516888439900808,0.8131578947368421,0.9559900038834082,1.0,10/47,16.79%,AZIN1;PDE3B;ALK;PRKAA1;MAD2L2;PRKCG;ADGRB1;PIN1;CBFA2T3;CST3
prerank,sensory perception of taste (GO:0050909),0.36586743660557375,0.7513431979392571,0.7512605042016807,0.9560546274338704,1.0,10/10,63.44%,ASIC2;PKD1L3;PKD2L1;TAS1R3;GNAT3;TAS1R2;TAS1R1;ASIC3;ASIC1;CD36
prerank,divalent inorganic cation homeostasis (GO:0072507),0.30417642913983217,0.7504208162015156,0.7743362831858407,0.9569956409735336,1.0,5/25,17.32%,CAV1;SLC8A1;KCNA1;ANK3;CIB2
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.31920090264859136,0.7502158056855679,0.7802197802197802,0.956878249668305,1.0,4/20,11.20%,CAMK2D;GOPC;STK39;NEDD4L
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.3307063142482104,0.7500519173319501,0.7643207855973814,0.9567035287276179,1.0,3/15,17.16%,NLRC5;CACTIN;PTPN2
prerank,cellular response to gamma radiation (GO:0071480),0.32778907956328235,0.7496507154799305,0.7796875,0.9568474505323026,1.0,6/17,25.82%,TMEM109;ATM;MAP3K20;YAP1;WRN;RPL26
prerank,"transcription, DNA-templated (GO:0006351)",0.23551355918574146,0.749599513253876,0.9016042780748663,0.9564898194020306,1.0,49/207,19.92%,TSC22D1;NR4A2;IRF9;YBX2;PIR;ELOC;TAF9B;TAF1A;RTF1;EAF1;SETX;TRIM24;SLC25A33;POLR2G;MBD1;ELOA;BRF2;MLF1;POLR2D;NFKBIB;DEAF1;TBPL1;GTF2H3;EAF2;KLF13;CBFB;GTF2A1;DDX21;TAF1B;TFB2M;MED4;MLLT3;TEFM;TAF11;POLR2I;AFF4;NELFB;NELFA;MMS19;PWP1;DRAP1;RPAP1;HOXD3;NCOA6;MEF2A;TAF3;PTMA;RRAGC;PKNOX1
prerank,protein autoprocessing (GO:0016540),0.3309857564038655,0.7494414541752604,0.782608695652174,0.9563082248954532,1.0,3/17,16.11%,OMA1;CASP1;SPRTN
prerank,cellular respiration (GO:0045333),0.2761172086483806,0.7490709781138856,0.8066298342541437,0.9564348396976068,1.0,10/41,16.45%,ETFDH;ETFB;ETFA;NDUFS4;UQCRB;UQCRFS1;UQCRC1;COX15;ME3;SDHC
prerank,snRNA 3'-end processing (GO:0034472),0.32058486136350633,0.7484119128687374,0.7715654952076677,0.9569774941449491,1.0,6/19,17.55%,EXOSC3;EXOSC8;INTS12;INTS5;INTS6L;EXOSC9
prerank,mitochondrial fusion (GO:0008053),0.3201768280138663,0.7480704272499193,0.7550387596899225,0.957042322963078,1.0,8/18,27.72%,CHCHD3;MIGA1;MFN1;USP30;STOML2;AFG3L2;FIS1;MIEF1
prerank,mitotic recombination (GO:0006312),0.34273975721048294,0.7479367121626432,0.7657512116316639,0.9568094587243138,1.0,1/15,1.70%,RAD54B
prerank,toxin transport (GO:1901998),-0.3273156725844564,-0.7479178800363324,0.7884130982367759,0.9797680038395236,1.0,4/10,18.70%,ANTXR2;RAB29;SLC22A2;ANTXR1
prerank,erythrocyte differentiation (GO:0030218),0.27175686512965047,0.7478321965677509,0.7983870967741935,0.9565459175862879,1.0,6/44,8.51%,TAL1;ALAS1;MFHAS1;JAK2;KMT2E;RPS14
prerank,peptidyl-asparagine modification (GO:0018196),0.2958230206730948,0.7475959324366203,0.8144329896907216,0.9564710214662338,1.0,13/31,24.50%,MGAT5;MCFD2;OSTC;DPM1;MGAT1;HIF1AN;UGGT1;DDOST;DAD1;MGAT2;NUDT14;FUT8;DPM3
prerank,positive regulation of peptidase activity (GO:0010952),0.31104332346196173,0.7473508504524131,0.7793427230046949,0.9564039069247386,1.0,8/20,27.53%,APH1A;VSIR;CTSH;APH1B;NCSTN;GRN;TANK;DDRGK1
prerank,regulation of translational initiation (GO:0006446),0.26136759710914853,0.7465586123665904,0.8407643312101911,0.95716783087523,1.0,16/63,17.93%,UHMK1;HSPB1;POLR2G;EIF3B;EIF2B2;EIF1;POLR2D;NPM1;RPS6KB1;HABP4;PPP1R15B;EIF3H;MTIF2;KLHL25;NCK1;CTIF
prerank,synapse assembly (GO:0007416),0.26168612425554383,0.7462223111962979,0.8640406607369758,0.9572110912638304,1.0,22/67,21.77%,DNM3;PLXND1;SPOCK2;SHANK3;NRCAM;FLRT3;CBLN4;KIRREL3;CDH2;ACHE;GABRA2;PCDHB16;LGI2;PCDHB14;PCDHB9;DSCAM;SHANK2;GRID2;BDNF;GABRB3;NRXN1;NLGN1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.33381097841674356,-0.7460435703118877,0.789873417721519,0.9812837160237363,1.0,1/10,2.93%,WNT5A
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.2642813885038088,0.7459127103795108,0.8426527958387516,0.9572339196277038,1.0,13/59,14.42%,TNRC6C;MED26;LEF1;SETX;JUN;AGO4;CBFB;MED30;PPM1D;MED27;CTNNB1;MED17;MED4
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.27320388053758937,-0.745666137313105,0.8028985507246377,0.980737808272699,1.0,2/17,6.99%,LPGAT1;PLA2G4A
prerank,covalent chromatin modification (GO:0016569),-0.2943148016867752,-0.745281888210891,0.8154269972451791,0.9802288397262239,1.0,4/14,27.37%,HDAC1;HLCS;PARP2;HELLS
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.2953723379077895,-0.7451145944649339,0.8181818181818182,0.9794339240814302,1.0,1/12,1.74%,BMP7
prerank,activin receptor signaling pathway (GO:0032924),0.3328943901694106,0.7445997687994177,0.7770382695507487,0.9587067246644361,1.0,4/15,15.23%,ACVR1;SMAD2;ACVR2A;ACVR2B
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.3128535212315609,-0.7440203859862934,0.8081841432225064,0.9798436715056301,1.0,2/10,6.44%,DCN;XDH
prerank,cell proliferation in forebrain (GO:0021846),-0.3168985834392336,-0.7439397552006285,0.7823834196891192,0.9789264811374245,1.0,2/10,8.97%,DOCK7;NUMBL
prerank,negative regulation of neuron death (GO:1901215),0.2484825800912004,0.7439326221462008,0.8746987951807229,0.9592192252141609,1.0,13/93,12.13%,FOXQ1;PPT1;FBXO7;MEF2C;CD34;TNFRSF1B;TOX3;LRRK2;CD200;PRKCG;FGF20;VPS35;CHGA
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.3107094306613838,0.743735454310154,0.7865853658536586,0.9590478753377716,1.0,6/20,18.45%,NOTCH1;NFE2L2;CHD6;HIF1A;SMAD4;RELA
prerank,regulation of macromolecule metabolic process (GO:0060255),0.23510597373442776,0.7437184424291244,0.9023051591657519,0.9586418953819075,1.0,31/170,16.78%,TRIM14;NOVA2;APP;AFF1;SLC8A1;TRIM11;YBX2;TRIM6;NKAPL;ZC3H12A;CAVIN4;FOXP1;CACTIN;DHH;HNRNPK;TRIM17;PCBP1;HINFP;TOB1;TSKU;TAPBP;PIN1;HIF1A;UNCX;NELL1;ATXN7L3B;YBX1;KIF16B;AFF4;ZNF711;BMI1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.32659651895686037,0.7436302571696344,0.7885245901639344,0.9583470603751393,1.0,7/18,21.83%,ACSL5;ACSBG1;ELOVL7;ELOVL5;TECR;HACD2;ACSL4
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.3631912623187497,0.7433253996772476,0.7756714060031595,0.9583462703815897,1.0,11/11,63.71%,MALT1;NFKBIZ;NLRP10;CLEC6A;IL23R;IL12B;IL23A;CARD9;IL12RB1;PRKCQ;NFKBID
prerank,response to unfolded protein (GO:0006986),0.27544839209025895,0.7426786589806209,0.8315649867374005,0.958840621898091,1.0,12/48,20.39%,DAB2IP;RHBDD1;HSPB1;HSPA1B;HSPE1;PTPN1;TMBIM6;TM7SF3;DAXX;DNAJB5;ERN1;DNAJA1
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.2654645514471653,-0.7424518981855025,0.827893175074184,0.9798724941755607,1.0,4/20,12.45%,IL1R1;CD55;PRKCZ;CD81
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.2944320214945386,0.7417129256094867,0.790436005625879,0.9597698457988411,1.0,7/29,17.40%,PUM2;SMAD2;ZC3H7A;ADAR;AGO4;DROSHA;TUT7
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.30979207441694184,0.7413983860885198,0.7902511078286558,0.9597756449969695,1.0,4/24,13.45%,FLT4;IL1A;BRCA1;HIF1A
prerank,RNA metabolic process (GO:0016070),0.24059148680036088,0.7413252680051547,0.8755656108597285,0.9594520868478945,1.0,30/127,18.85%,ADARB1;RBPMS;SETX;LSM1;ZC3H12A;HNRNPA0;POLR2G;ELAVL4;ADAR;DHX9;DKC1;DUSP11;POLR2D;HNRNPK;RNASE1;AGO4;RNASEH2B;XRN2;PCBP1;METTL14;ATXN1;HNRNPH2;RNASE6;PRPF4;POLR2I;DROSHA;TENT2;DDX39B;HNRNPUL1;SYNCRIP
prerank,mRNA destabilization (GO:0061157),-0.22483129380291456,-0.7410568739965123,0.8830188679245283,0.9806741229243277,1.0,11/38,18.69%,ROCK2;YTHDF1;FTO;PUM1;TARDBP;YTHDF2;CPEB3;GIGYF2;RC3H1;TUT4;ZFP36
prerank,skeletal muscle organ development (GO:0060538),0.3030316303463838,0.7409593384955239,0.8002958579881657,0.9595382943516567,1.0,5/26,15.27%,CAV1;MEF2C;MYL6;FXR1;POPDC3
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.27906525964325946,0.7402776163526549,0.8092715231788079,0.9600711342442922,1.0,8/41,16.99%,LGALS9;CD34;NFKBIL1;ZC3H12A;CACTIN;VSIR;HAVCR2;RARA
prerank,protein deacylation (GO:0035601),0.3073463158699661,0.7398761443498397,0.7918552036199095,0.9602097059999568,1.0,2/23,3.23%,HDAC7;PPT1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.29190054854497277,-0.7397149021614023,0.8086253369272237,0.9813064196924945,1.0,4/14,17.90%,ADK;LHPP;ATIC;IMPDH2
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.26764587564798686,-0.7388084744446292,0.8495821727019499,0.9815110900746778,1.0,2/18,4.48%,BCL2;SLC25A4
prerank,regulation of immune effector process (GO:0002697),-0.22097280618829668,-0.7387468452037113,0.8958333333333334,0.9805604505985609,1.0,11/41,20.65%,SERPING1;VTN;CD55;CD81;C1QC;C4B;C1QA;CFHR2;PHB2;C1QB;C2
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.2554179256025749,0.7384446015866728,0.8471882640586798,0.9617866213453743,1.0,14/72,15.90%,COPS4;PPIE;POLK;UBA52;RPS27A;POLR2G;RBX1;POLR2D;GTF2H3;LIG1;COPS8;ERCC4;RFC2;POLR2I
prerank,regulation of chromosome organization (GO:0033044),-0.25526976093620574,-0.7383098906257843,0.8380681818181818,0.9801263429146007,1.0,9/22,30.45%,YLPM1;XRCC5;HDAC8;RMI2;SETMAR;LIG4;HNRNPD;SMG6;UPF1
prerank,quinone biosynthetic process (GO:1901663),0.3314379128087237,0.7382164033686928,0.7539936102236422,0.961690672128854,1.0,5/14,18.73%,COQ3;PDSS2;PDSS1;COQ5;COQ7
prerank,axoneme assembly (GO:0035082),0.2954315039515117,0.7376717568117783,0.7900709219858156,0.9620479232117951,1.0,3/30,7.45%,CFAP206;DNAAF3;TTC12
prerank,mitochondrial gene expression (GO:0140053),0.2742416954444553,0.7376523178865924,0.8283093053735255,0.9616492509339015,1.0,10/42,17.93%,SLC25A33;MRPL47;MRPL23;FASTKD5;TFB2M;MRPS34;MRPS12;TEFM;GATB;MRPS18B
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.27606572362709214,-0.7369205269966207,0.8254847645429363,0.9808618013886072,1.0,5/16,15.72%,GPLD1;SLC27A1;SREBF1;MFSD2A;NR1H3
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.35207121658016916,0.7368957865769074,0.8060897435897436,0.9618568523685911,1.0,2/11,12.09%,FKBP1A;CALM3
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.35207121658016916,0.7368957865769074,0.8060897435897436,0.9618568523685911,1.0,2/11,12.09%,FKBP1A;CALM3
prerank,neuron differentiation (GO:0030182),0.2308787108561786,0.736737080061397,0.9237569060773481,0.9616604711504838,1.0,27/165,19.24%,NR4A2;NEUROG2;ATP2B2;OLIG2;TGFB2;PPT1;MEF2C;MYEF2;ALK;NGRN;TENM3;TENM4;SPOCK1;PHOX2A;POU3F2;PIN1;MYT1L;CTNNB1;FZD3;OPHN1;TENM2;SNPH;TENM1;ADNP2;SOX11;MAP2K1;IRX3
prerank,regulation of mitotic spindle assembly (GO:1901673),0.309789991521963,0.7361563596931424,0.7903225806451613,0.9620510657919866,1.0,10/19,30.02%,HSPA1B;CHMP1B;CHMP3;CHMP2B;CHMP1A;TPR;VPS4B;CHMP4B;EML3;HSPA1A
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.20776315131085188,-0.7356412341278176,0.9112149532710281,0.9815674244535558,1.0,10/50,14.65%,SH3RF1;THBS1;NGF;SRC;VEGFA;RAF1;FNIP1;BCL2L12;DDX3X;PIH1D1
prerank,triglyceride homeostasis (GO:0070328),0.29370813822282793,0.7355842554835137,0.8350364963503649,0.9624449046257377,1.0,2/26,3.52%,HNF4A;APOA1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.29813428446288753,0.7355404852697323,0.8048780487804879,0.96207447833701,1.0,5/25,18.51%,HSPA1B;HSPE1;PTGES3;DNAJC7;DNAJB5
prerank,catecholamine metabolic process (GO:0006584),0.32595055009974416,0.7355141367203406,0.8068535825545171,0.961691825428259,1.0,2/14,12.19%,ATP7A;SNCAIP
prerank,inorganic ion transmembrane transport (GO:0098660),-0.2974976492373108,-0.735207587005595,0.8223350253807107,0.9810881870806923,1.0,3/12,19.68%,ABCC9;CACNA1H;KCNJ8
prerank,protein localization to condensed chromosome (GO:1903083),0.34337751484765516,0.7347912605533479,0.801980198019802,0.9622798081975371,1.0,2/12,8.08%,IK;MTBP
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.2517524808754909,-0.7347611764211266,0.8754098360655738,0.98063213777756,1.0,11/23,35.15%,HSPA4;NDUFA13;COX18;TOMM22;ROMO1;TIMM29;BAD;TIMM10;BAX;TIMM9;PMAIP1
prerank,ribosomal large subunit assembly (GO:0000027),0.2983312445198533,0.7342091748557228,0.8041543026706232,0.9626948002923236,1.0,14/24,32.02%,BOP1;DDX28;RPL23A;RSL24D1;NOP53;RPF2;RPL3;MDN1;RPL11;NOP2;FASTKD2;NLE1;RPL10;RPL6
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.3509838327631092,0.7341497633193501,0.7893835616438356,0.9623585016897096,1.0,4/10,22.99%,APEX1;TERF2IP;RIF1;TERF2
prerank,axonemal dynein complex assembly (GO:0070286),-0.2396871661392696,-0.7335221247633975,0.8476190476190476,0.981139313277081,1.0,20/27,42.62%,DNAI4;DNAAF5;ODAD1;DNAH5;DNAL1;ODAD2;DRC1;CCDC39;ODAD3;CCDC65;DNAAF2;ODAD4;CFAP100;DNAH17;CCDC40;CCDC63;DNAH8;DNAAF4;DNAH1;SPAG1
prerank,positive regulation of cell division (GO:0051781),-0.2232066697984912,-0.7334524702287178,0.9148936170212766,0.980222140917729,1.0,7/38,16.10%,FGFR2;FGF1;SVIL;SPAST;DRD2;SIRT2;CDC14B
prerank,organelle fission (GO:0048285),-0.2480626790992958,-0.7332360449429886,0.8425925925925926,0.9794597118224398,1.0,10/24,29.11%,PRKN;SEC16B;TMCC1;GDAP1;MTFR1L;DNM1L;PEX11B;MTFR2;OPA1;MTFP1
prerank,mitotic DNA replication (GO:1902969),0.35507116124906324,0.7328999428910404,0.7525951557093425,0.9636490071787739,1.0,2/10,12.05%,POLA1;LIG1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.2487026798895958,0.7328314210444151,0.8483754512635379,0.963324216196603,1.0,18/80,19.08%,NOD1;ARL6IP5;PPM1F;KLF4;TNFSF10;GRAMD4;SIAH2;DELE1;HMGB1;CASP1;RPS6KA1;RPS6KA3;CDKN2D;DNAJB6;PYCARD;SOX7;XIAP;MALT1
prerank,glycine transport (GO:0015816),-0.31357725925255236,-0.7318748248243874,0.7951807228915663,0.9802166428374706,1.0,2/10,10.66%,SLC6A9;SLC38A5
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.2926749410107487,-0.7318375064335086,0.8368794326241135,0.9792541050712089,1.0,1/12,1.86%,NUPR1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.31087442925215436,0.7316649614797319,0.8150470219435737,0.9644722931194398,1.0,3/20,9.20%,CASP8;SPATA2;MLKL
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.27354967646960826,0.7314242981485769,0.8344370860927153,0.964403102682347,1.0,8/43,16.99%,LGALS9;CD34;NFKBIL1;ZC3H12A;CACTIN;VSIR;HAVCR2;RARA
prerank,negative regulation of histone acetylation (GO:0035067),-0.30287700230665004,-0.7310108299563662,0.8134715025906736,0.9792809314594888,1.0,3/11,19.17%,SET;TAF7;NOC2L
prerank,regulation of phosphatase activity (GO:0010921),0.30308516135700314,0.7309200624625085,0.7960426179604262,0.9646851509630484,1.0,3/24,7.36%,ZCCHC9;GPATCH2;HSP90B1
prerank,oligodendrocyte development (GO:0014003),0.3243927526439623,0.7307625497454245,0.7713841368584758,0.964481949484211,1.0,4/15,17.48%,EIF2B2;B4GALT6;SOX10;NSUN5
prerank,histone deubiquitination (GO:0016578),-0.2605500936690369,-0.7306612580074919,0.8286604361370716,0.97868384643216,1.0,4/18,21.58%,USP3;USP22;ATXN7L3;TAF10
prerank,ubiquinone biosynthetic process (GO:0006744),0.3250108429623189,0.7300917711249404,0.7717908082408875,0.9649770924501943,1.0,6/15,22.21%,COQ3;PDSS2;PDSS1;COQ5;COQ7;NDUFA9
prerank,myelin maintenance (GO:0043217),-0.315560112611534,-0.7300201917327186,0.8028846153846154,0.9784141048042082,1.0,2/10,9.03%,EPB41L3;DEGS1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.31995437880518746,0.7294963214771105,0.7868098159509203,0.9653611415708623,1.0,6/17,20.98%,BBC3;BCL2L1;CLU;FZD9;BID;GGCT
prerank,protein import into mitochondrial matrix (GO:0030150),0.3150383983025177,0.7294068419082798,0.7852664576802508,0.9650611279250562,1.0,2/18,7.45%,TOMM20L;DNLZ
prerank,histone exchange (GO:0043486),0.2813598253993763,0.7280398607623756,0.8310439560439561,0.9664982468077762,1.0,8/37,14.11%,CENPU;SRCAP;NPM1;ACTR6;DMAP1;CENPI;ITGB3BP;VPS72
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.3116808889736872,0.7279400919335381,0.8009118541033434,0.9662069092219985,1.0,9/19,26.48%,CLIC4;MARK2;LRRC7;ERBIN;FOXJ1;MTCL1;CRB1;SCRIB;FSCN1
prerank,mitotic sister chromatid segregation (GO:0000070),0.24261532406700517,0.7275744452443746,0.8913813459268005,0.9662708244922213,1.0,32/98,26.25%,RAB11A;CUL3;RAD21;KPNB1;TENT4A;DSN1;CHMP1B;VPS4A;CHMP3;PRC1;NCAPG;CEP55;RAN;CHMP2B;CSNK2B;CHMP7;BOD1;NDC80;SGO1;SMC4;DIS3L2;CHMP1A;KIF23;KIF18A;MCPH1;REC8;CSNK2A2;WRAP73;SEH1L;VPS4B;CHMP4A;CHMP4B
prerank,regulation of store-operated calcium entry (GO:2001256),0.3552925022282082,0.7275472739983182,0.7836456558773425,0.9658827847616206,1.0,2/10,7.86%,HOMER2;CASQ1
prerank,protein monoubiquitination (GO:0006513),0.2782544796909339,0.7273934887794072,0.8146551724137931,0.9656673105397889,1.0,9/36,14.81%,CUL3;RBX1;TRIM25;OBI1;DTX3L;UBE2T;UBE2E1;RAD18;UBE2D3
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.25472797170211114,0.7272212086895489,0.8582183186951067,0.9654858325491047,1.0,4/63,7.88%,VCAM1;TIRAP;MEF2C;SLC7A1
prerank,anterior/posterior axis specification (GO:0009948),0.32799444013751733,0.7268001725920821,0.777059773828756,0.9656495501564191,1.0,6/15,25.82%,TBXT;TASOR;SKI;TBX3;RIPPLY2;DDIT3
prerank,osteoclast differentiation (GO:0030316),0.30543126286444955,0.7264206252842698,0.788109756097561,0.9657389027653688,1.0,9/22,24.94%,SNX10;OSCAR;FOXP1;TYROBP;MAPK14;TNFRSF11A;EPHA2;CSF1;SBNO2
prerank,regulation of B cell proliferation (GO:0030888),0.2718569722135695,0.7264200660849928,0.8573369565217391,0.9653159630105056,1.0,6/44,13.34%,TIRAP;FCGR2B;MEF2C;TYROBP;CD38;ATM
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.30842179631207006,0.7262085725436183,0.7917304747320061,0.9651873549787813,1.0,5/19,18.64%,APOA1;ZC3H12A;CX3CR1;PYDC1;GIT1
prerank,iron ion homeostasis (GO:0055072),0.2593202317515304,0.7260883025481353,0.8653113087674714,0.9649217082882798,1.0,20/58,25.16%,B2M;FBXL5;TMPRSS6;HMOX2;BOLA2;CYB561A3;CP;GLRX3;CYBRD1;HEPH;FRRS1;ATP6V1G1;SMAD4;CCDC115;SOD1;IREB2;TMEM199;FTH1;FTL;ATP13A2
prerank,cellular response to glucose stimulus (GO:0071333),0.2838338412657558,0.7255796451437182,0.8073654390934845,0.9651696100906462,1.0,3/30,8.31%,UNC13B;PCK2;PRKAA1
prerank,T cell activation involved in immune response (GO:0002286),0.3400666136552318,0.7251883306918505,0.7862190812720848,0.9652722812268151,1.0,1/12,2.47%,F2RL1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.20213737878538293,-0.7246971798635797,0.9049773755656109,0.9838579705601491,1.0,23/56,28.40%,ROCK2;SON;IST1;JTB;EFHC1;ANLN;SPAST;RTKN;USP8;STMN1;SNX18;ARL3;DCTN3;INCENP;PDCD6IP;RACGAP1;TTC19;NUSAP1;CKAP2;RHOA;CIT;SNX33;ALKBH4
prerank,positive regulation of myelination (GO:0031643),-0.3081654533124349,-0.7246409638314988,0.8341584158415841,0.9829086185006369,1.0,2/11,4.52%,PARD3;DICER1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.2948934706595665,-0.7244388984695292,0.8247978436657682,0.9821317501203288,1.0,4/13,15.86%,NUDT21;NCBP1;TUT1;CSTF2T
prerank,regulation of endocytic recycling (GO:2001135),0.34666463259742675,0.7239680520148054,0.7781512605042017,0.9664950132360713,1.0,4/11,21.76%,EHD1;INPP5F;SORL1;ARHGAP1
prerank,postreplication repair (GO:0006301),0.26582647804646614,0.7239323605633862,0.8590604026845637,0.9661189326889031,1.0,9/45,16.11%,USP43;POLK;UBA52;RPS27A;TRIM25;BRCA1;RAD18;RFC2;SPRTN
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.23830259537303988,-0.7237900446205815,0.8640776699029126,0.9819193475093854,1.0,12/27,36.38%,CRY2;SIK1;PER3;FBXL3;PML;USP2;FBXL8;FBXL12;FBXL22;PER2;TP53;PPP1CB
prerank,eosinophil chemotaxis (GO:0048245),0.32690858864892036,0.7234550326755529,0.7952380952380952,0.9659259919648383,1.0,14/14,67.34%,CCL4;LGALS3;SCG2;CCL26;CCL24;CCL13;CCL11;CCL3;CCL1;CCL7;CCL8;CCL5;CX3CL1;CCL2
prerank,eosinophil migration (GO:0072677),0.32690858864892036,0.7234550326755529,0.7952380952380952,0.9659259919648383,1.0,14/14,67.34%,CCL4;LGALS3;SCG2;CCL26;CCL24;CCL13;CCL11;CCL3;CCL1;CCL7;CCL8;CCL5;CX3CL1;CCL2
prerank,negative regulation of DNA recombination (GO:0045910),0.2739061480996423,0.7229856898569493,0.8419618528610354,0.9661303258200209,1.0,18/43,26.42%,POLR2G;PARPBP;MAD2L2;POLR2D;POLR2I;DAXX;UBQLN4;TERF2IP;BLM;RIF1;SHLD3;POLR2C;TERF2;POLR2B;SHLD2;POLR2J;TINF2;SHLD1
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.236804655109552,-0.722880756275845,0.896551724137931,0.9819940001845854,1.0,6/31,18.25%,STX4;RBP4;KMT5C;KMT5B;PHB2;EPHB2
prerank,histone H4 acetylation (GO:0043967),0.2622339695459986,0.7227098245716117,0.8445040214477212,0.9660744056559376,1.0,9/47,15.62%,ING3;LEF1;BRD8;JADE2;CHD5;DMAP1;KANSL1;KAT7;TRRAP
prerank,purine nucleotide metabolic process (GO:0006163),0.29840988065608226,0.7226799916818865,0.8202764976958525,0.9656878341141493,1.0,2/24,3.72%,GDA;GART
prerank,peroxisome organization (GO:0007031),-0.238817253777434,-0.7224675204360906,0.8978978978978979,0.9815197098115555,1.0,8/25,24.61%,ABCD3;PEX2;SEC16B;DNM1L;PEX7;PEX11B;PEX3;PEX16
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.32379701541681116,0.7214772965038534,0.7808,0.96682843238715,1.0,3/14,8.61%,TNFRSF1B;CD200;NR1D1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.35117163541295227,0.7213237888013789,0.783068783068783,0.9666176765565676,1.0,2/10,8.52%,PLPP1;DGKH
prerank,motor neuron axon guidance (GO:0008045),0.3263409011287898,0.7213085902902785,0.7925117004680188,0.9662216598563609,1.0,4/15,14.01%,NTN1;TMEFF1;RAC1;RHOH
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.31406478935511073,0.7210770236891535,0.7990580847723705,0.9661057991371053,1.0,5/18,18.45%,IFNGR1;EFNA1;CLU;GSK3A;RELA
prerank,programmed necrotic cell death (GO:0097300),0.3130743087104998,0.7209708152875681,0.7926267281105991,0.9658224022362606,1.0,2/18,9.20%,TLR3;MLKL
prerank,cristae formation (GO:0042407),0.28914122784893337,0.7208885950141521,0.8375706214689266,0.9655057391594766,1.0,6/27,16.08%,CHCHD3;UQCC3;ATP5MC1;ATP5F1A;ATP5ME;SAMM50
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.2570123823192831,-0.7205167969535621,0.8654434250764526,0.9828152199838932,1.0,6/18,17.83%,DAB2;SRC;MAP2K2;SNX12;PTPN23;EZR
prerank,positive regulation of cell killing (GO:0031343),-0.28578028082456686,-0.7204137893887622,0.8253164556962025,0.98192832579911,1.0,5/13,27.00%,WNT5A;FZD7;MAPK8;SYK;NOXO1
prerank,sensory perception of pain (GO:0019233),0.30238039566843267,0.7198586140251175,0.8033033033033034,0.9664433319311737,1.0,4/21,13.71%,NIPSNAP1;P2RX7;ALOXE3;SCN9A
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.2908392087342555,-0.7198496189003217,0.837696335078534,0.9816200858632085,1.0,6/13,30.54%,BCAP31;UBE2G2;SVIP;ERLEC1;EDEM2;DERL2
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.3172649001451529,0.7195577678570639,0.8180379746835443,0.9664236216249209,1.0,2/15,5.49%,ING2;TAF9B
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.24350274078833134,0.7193070280453684,0.9014423076923077,0.9663431555582631,1.0,17/87,18.05%,OMA1;TMEM126B;SCO1;UQCC3;SLC25A33;IMMP2L;NDUFS4;NDUFA12;NDUFB5;NDUFB7;UQCRFS1;TIMMDC1;ACAD9;NUBPL;SAMM50;PET100;NDUFB4
prerank,protein transport (GO:0015031),0.21940213995477842,0.7183630110870526,0.9694501018329938,0.9670973633826512,1.0,79/332,22.11%,RABGAP1;ARHGEF2;MACF1;RAB6B;ARL6IP5;HERC2;PPT1;STX7;TBC1D30;EHD1;SCG5;SGSM1;RAB34;TBC1D8;TMED10;MYH9;ARRDC1;RAB23;RAB3GAP2;LMTK2;HSP90B1;TBC1D12;MCOLN1;TLK1;TBC1D5;STX12;TBC1D1;CHMP1B;ARF3;NPM1;LAPTM5;VPS35;CLU;TMED9;CHMP3;RAB19;YWHAH;STX19;USP6NL;WDR11;TBC1D10A;STXBP3;VLDLR;TBC1D4;NSF;TBC1D9;RUNDC1;TMED4;CHMP2B;TANGO6;ARL5B;ANK3;ARFIP2;RUFY1;SEL1L;ATP6V1G1;ARL4C;SPTBN1;TBC1D8B;GOLPH3L;ARRDC4;LAMP2;ATP6V1C1;GOLPH3;RAB5C;TMED7;TVP23A;ATP6V0A1;REP15;RAB31;ATP6V1D;RAB12;SCAMP1;AP3D1;LRP1B;MYO6;ARHGAP1;CHMP1A;TBC1D14
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.32417426251778103,0.718177368423846,0.8076311605723371,0.9669361544929619,1.0,3/16,14.37%,INSR;ETF1;BNIP3
prerank,homologous chromosome segregation (GO:0045143),0.30875581682311,0.7178843989190663,0.8300751879699249,0.9668819593380582,1.0,5/20,20.30%,PTTG1;MEI4;SGO1;TERB1;PRDM9
prerank,rRNA transcription (GO:0009303),0.3150061023579038,0.7177580495548818,0.8025682182985554,0.9666225091083192,1.0,6/17,20.85%,CAVIN1;TAF1B;TCOF1;SPIN1;ANG;BRF1
prerank,negative regulation of protein transport (GO:0051224),-0.2399446423771091,-0.7177451866912492,0.8986486486486487,0.9831808369515012,1.0,8/25,22.45%,APOE;PKDCC;SNX12;DRD2;SERGEF;RHBDF1;CYP51A1;ERP29
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.2816353727490337,-0.7174649671664773,0.8397129186602871,0.9825099329179409,1.0,6/13,30.00%,DDO;GOT1;QPRT;ASPA;GOT2;ACSF3
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.30157602657754917,0.7170887797009604,0.8204379562043795,0.9670861436413581,1.0,3/21,12.02%,PGM2L1;GPI;TALDO1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.3191744284308177,0.7158892157846547,0.7899686520376176,0.9682490822721311,1.0,4/15,17.20%,EHD1;TYROBP;ADGRB1;MAPK14
prerank,retrograde axonal transport (GO:0008090),0.31014621494490313,0.7156935814038377,0.8043478260869565,0.9680820159910062,1.0,5/16,24.43%,DST;KIF1A;HAP1;SOD1;KIF5A
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.28431829726845376,0.71564060111074,0.8284923928077456,0.9677307742768425,1.0,6/30,17.16%,CAV1;HYAL2;INPP5F;NF2;SH3BP5L;PTPN2
prerank,protein localization to kinetochore (GO:0034501),0.3233890404863982,0.7156112675204204,0.8136645962732919,0.9673557099556188,1.0,2/14,8.08%,IK;MTBP
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.3336620788776986,0.7154600980309267,0.7958477508650519,0.9671318065474114,1.0,3/13,10.59%,SHISA8;SHISA6;GRIK2
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.2796573017982135,0.7145030270770298,0.8409742120343839,0.9679862853780274,1.0,4/29,9.46%,RPS21;DHX37;RPS14;WDR46
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.2975485156245823,0.713867549407753,0.8220588235294117,0.9683782694987544,1.0,6/24,14.21%,TGFB2;ITGAM;FBXW7;PRNP;TYROBP;CTNNB1
prerank,pentose-phosphate shunt (GO:0006098),-0.2954143337127355,-0.7137729087344631,0.8267716535433071,0.9856752282574585,1.0,5/11,27.14%,RPIA;H6PD;PGD;PGLS;SHPK
prerank,positive regulation of vacuole organization (GO:0044090),-0.3085077281986672,-0.7137268395397564,0.8553921568627451,0.9847297244310388,1.0,2/10,8.24%,ANXA2;PIP4K2A
prerank,regulation of biosynthetic process (GO:0009889),0.34666766364094453,0.7135018852859253,0.815831987075929,0.968433600549162,1.0,1/11,6.58%,SLC25A33
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.2940642318367638,0.7134299134525272,0.8284839203675345,0.9681137577120185,1.0,6/24,15.54%,POLK;UBA52;RPS27A;POLB;LIG1;RFC2
prerank,aromatic amino acid family catabolic process (GO:0009074),0.31457642019879956,0.7131804854539359,0.7938808373590982,0.9680195195707991,1.0,4/15,22.07%,HGD;KYAT1;QDPR;KYNU
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.2615657289179515,0.7131067969363999,0.863395225464191,0.96770844103369,1.0,12/49,18.84%,TNRC6C;MEF2C;THPO;KMT2E;KMT2B;AGO4;CBFB;HMGB2;EIF6;RBM15;SIN3A;H3-3A
prerank,response to UV-B (GO:0010224),-0.2943852638122492,-0.7128500457612101,0.8195121951219512,0.9847041974600707,1.0,4/12,16.13%,HYAL1;CRIP1;MFAP4;CDKN1A
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.2532490850475101,-0.7127611048281767,0.867231638418079,0.9837960804109614,1.0,5/21,14.81%,PRKN;TXNDC12;CREB3L1;CREB3;BOK
prerank,synaptic vesicle cycle (GO:0099504),0.280658742015431,0.7127535759651363,0.847672778561354,0.9677521624259251,1.0,8/30,27.03%,SYT7;PIP5K1C;SLC32A1;CPLX1;NLGN1;RIMS1;PLD2;SNCA
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.253528334013676,-0.7127428148084726,0.8836565096952909,0.9828169844920078,1.0,1/20,0.19%,NR2F2
prerank,regulation of acute inflammatory response (GO:0002673),-0.26560154131207947,-0.7127422520494172,0.8529411764705882,0.9818202127024622,1.0,13/18,54.70%,PTGES;KLKB1;IL4;GSTP1;ADAM8;IL6;IL6ST;CREB3L3;OSM;FFAR2;DNASE1;PLA2G2D;C2CD4B
prerank,positive regulation of macrophage differentiation (GO:0045651),0.3359521988076884,0.7127090752210036,0.8010033444816054,0.967392964346264,1.0,1/11,2.35%,CASP8
prerank,tRNA export from nucleus (GO:0006409),0.2797293269541678,0.7125523460653783,0.829302987197724,0.9667457874967222,1.0,12/32,25.31%,NUP54;NUP35;RANBP2;NUP153;NUP160;NUP42;RAN;NUP205;NUP50;RAE1;SEH1L;TPR
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.2797293269541678,0.7125523460653783,0.829302987197724,0.9667457874967222,1.0,12/32,25.31%,NUP54;NUP35;RANBP2;NUP153;NUP160;NUP42;RAN;NUP205;NUP50;RAE1;SEH1L;TPR
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.27856488238940436,0.7124518192999557,0.8362831858407079,0.9664529469784493,1.0,3/29,5.46%,CAV1;TNFSF10;HYAL2
prerank,negative regulation of proteolysis (GO:0045861),0.27759853227015524,0.7123852500843526,0.8516483516483516,0.9661206632342138,1.0,6/34,10.46%,TIMP3;EFNA1;LRRK2;ROCK1;PRNP;BAG6
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.25871162445912604,0.7121997524317379,0.8708827404479579,0.9659417101966414,1.0,15/52,22.81%,CASP8;PPP1R13B;BBC3;NMT1;FBXW7;YWHAH;UBE2J2;UBE2D3;GSK3A;TOMM7;BID;PPP3CC;LEPROT;SREBF2;PPP3R1
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.27926395443925056,0.7109966242080967,0.8363892806770099,0.9670856775637372,1.0,13/33,26.95%,ZBTB48;STN1;DKC1;PTGES3;NHP2;CTC1;TERF2IP;SHQ1;TERF2;ANKRD28;WRAP53;TINF2;HSP90AA1
prerank,establishment of spindle orientation (GO:0051294),-0.22785703456183742,-0.7108593712476355,0.8996763754045307,0.9828790261194614,1.0,5/28,9.97%,GJA1;GPSM2;NDE1;UBXN2B;NDEL1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.2612990031283694,0.7107115665033154,0.8697916666666666,0.9666359563127617,1.0,12/51,16.21%,RANGAP1;KPNB1;NUP35;VPS4A;VRK1;REEP3;CHMP3;NUP160;RAN;CHMP2B;CHMP7;NUP205
prerank,mitotic nuclear membrane organization (GO:0101024),0.2612990031283694,0.7107115665033154,0.8697916666666666,0.9666359563127617,1.0,12/51,16.21%,RANGAP1;KPNB1;NUP35;VPS4A;VRK1;REEP3;CHMP3;NUP160;RAN;CHMP2B;CHMP7;NUP205
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.23930042421998304,-0.7102693847442187,0.8835820895522388,0.9825238886111248,1.0,5/24,13.74%,JARID2;MTF2;DNMT3A;RBBP7;MPHOSPH8
prerank,aggrephagy (GO:0035973),0.28773445674399967,0.7096527539598292,0.8421807747489239,0.967544843482832,1.0,8/27,21.81%,VIM;UBA52;RPS27A;DYNLL1;DYNC1LI2;DYNLL2;DYNC1I2;UBB
prerank,DNA dealkylation (GO:0035510),0.3439246358630596,0.7091049599193351,0.7879799666110183,0.9673988688128939,1.0,2/10,11.11%,ASCC3;ASCC1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.3439246358630596,0.7091049599193351,0.7879799666110183,0.9673988688128939,1.0,2/10,11.11%,ASCC3;ASCC1
prerank,UV-damage excision repair (GO:0070914),-0.293238766681259,-0.7088461009520604,0.8430379746835444,0.9830927340617424,1.0,2/12,7.95%,DDB2;CUL4B
prerank,snRNA transcription (GO:0009301),0.24504532380131855,0.7079102004471185,0.8955974842767296,0.968465799557201,1.0,24/70,24.23%,INTS11;POLR2G;POLR2D;ELL2;RPRD1B;INTS12;GTF2A1;INTS5;ICE1;SNAPC4;TAF11;POLR2I;TAF8;RPRD2;USPL1;ZC3H8;POU2F2;SNAPC1;RPRD1A;POLR2C;POLR2B;INTS6;POLR2J;SNAPC3
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.31893238215412445,0.707858639336402,0.8161888701517707,0.9681230718391478,1.0,2/15,9.45%,FAM107A;ZFP36L2
prerank,response to gamma radiation (GO:0010332),0.2913069208780398,0.707725186445015,0.8223880597014925,0.9678705469043748,1.0,8/24,25.82%,TMEM109;PRKAA1;ATM;MAP3K20;MEN1;YAP1;WRN;RPL26
prerank,intracellular pH reduction (GO:0051452),-0.22155594863032557,-0.7071023372588249,0.9032258064516129,0.9839796238487644,1.0,16/33,33.76%,ATP6V0A4;ATP6V1B2;ATP6V0B;TCIRG1;ATP6V1A;ATP6V1F;ATP6V0D2;ATP6V1H;ATP6V0C;GPR89B;GPR89A;DMXL1;SLC11A1;ATP6V0E2;TMEM9;RAB20
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.2876740934824641,0.7069015039277989,0.8246376811594203,0.9684778687804046,1.0,6/27,15.62%,BRD8;MRGBP;BAG6;SGF29;KAT7;TRRAP
prerank,nucleotide-excision repair (GO:0006289),0.23453232035223925,0.7066124079531586,0.9144196951934349,0.968413317569559,1.0,28/101,24.36%,COPS4;PPIE;POLK;UBA52;RPS27A;POLR2G;RBX1;POLR2D;POLA1;BRIP1;POLB;GTF2H3;LIG1;COPS8;ERCC4;XPC;RFC2;POLR2I;MMS19;COPS5;HUS1;MNAT1;UBB;POLR2C;POLR2B;POLR2J;CETN2;CCNH
prerank,protein kinase B signaling (GO:0043491),0.2850068386933087,0.7056036106259957,0.8333333333333334,0.9692489256445018,1.0,2/23,6.50%,PLK3;SETX
prerank,visual system development (GO:0150063),0.27270579632076103,0.7053468971290384,0.8613333333333333,0.9691706581589278,1.0,4/37,7.23%,TGFB2;SIPA1L3;ADAMTS18;ITGAM
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.27576451592929346,0.7049352928006878,0.8616010854816825,0.969266256638235,1.0,2/31,3.89%,GCH1;GPHN
prerank,aminoglycan metabolic process (GO:0006022),-0.3041679090514401,-0.704532831712894,0.8454106280193237,0.9857078745750876,1.0,4/10,24.49%,XYLT1;B3GAT3;B3GAT1;CLN6
prerank,chloride transport (GO:0006821),0.2401992807235125,0.7045230406928574,0.9058679706601467,0.9693457439127149,1.0,16/74,18.69%,CLIC4;SLC12A8;ANO6;GABRQ;BEST1;TTYH3;CLCN3;CLCN1;GABRA4;SLC1A1;GABRA2;GABRE;GLRA2;GABRG3;CLIC5;GABRB1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.23600919778397175,0.7039545301300733,0.9220023282887078,0.9696473145939006,1.0,13/98,9.94%,FYN;ATP2B4;CASP8;PPP1R13B;DPP10;AKAP5;STAC;BBC3;ITGAM;NMT1;MYO1C;NKD2;PRNP
prerank,positive regulation of transporter activity (GO:0032411),0.33084386919309877,0.7038814769450997,0.8082644628099174,0.969321415558273,1.0,2/13,9.26%,STK39;SGK1
prerank,regulation of protein-containing complex assembly (GO:0043254),0.22634989809075412,0.7038223283969491,0.9316628701594533,0.9689802185759592,1.0,11/110,10.01%,FBLIM1;TAL1;MMP1;DAB2IP;TIRAP;HRK;IAPP;WARS1;IRGM;SPIDR;AIDA
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.28228407311700765,0.7035828460722989,0.8590308370044053,0.9688642071649913,1.0,7/27,20.69%,MSX1;SNAI2;ATM;EEF1E1;DYRK1A;YJU2;SMYD2
prerank,response to glucose (GO:0009749),0.25688984919236096,0.703365188961371,0.8717598908594816,0.9687184657242321,1.0,5/46,9.60%,UNC13B;HNF4A;PCK2;PRKAA1;EIF2B2
prerank,regulation of stem cell proliferation (GO:0072091),0.30549163781190364,0.7030829541546852,0.8118195956454122,0.9686566799064351,1.0,1/17,1.04%,ACE
prerank,sterol biosynthetic process (GO:0016126),-0.22054421436856836,-0.7026443085076847,0.9298245614035088,0.9867144377405853,1.0,1/33,0.10%,PRKAG2
prerank,organonitrogen compound catabolic process (GO:1901565),0.2540883368537549,0.7024819016113573,0.8942675159235669,0.9689802336992531,1.0,4/57,6.56%,ACE;TST;PPT1;TRIM24
prerank,mitochondrial genome maintenance (GO:0000002),0.33867154349093226,0.7012508209178254,0.7989949748743719,0.9700707350628814,1.0,2/11,6.71%,SLC25A33;AKT3
prerank,regulation of protein localization to centrosome (GO:1904779),0.3451969385514122,0.7010217384287603,0.8073701842546064,0.9699363803894872,1.0,5/10,28.57%,APC;GSK3B;MARK4;CEP72;BICD1
prerank,ion homeostasis (GO:0050801),0.2799064015362241,0.7009731126837125,0.8100890207715133,0.9695799771504313,1.0,5/30,11.20%,RHCG;KLHL3;CAMK2D;SLC4A9;NEDD4L
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.3372719634574213,0.7009194822648294,0.8241379310344827,0.9692294828439159,1.0,3/10,14.28%,CX3CR1;CTNNB1;FZD3
prerank,transcription by RNA polymerase III (GO:0006383),-0.229713792075932,-0.7008796461749047,0.907051282051282,0.9876135479678788,1.0,11/27,30.97%,GTF3C3;ELL;CRCP;GTF3C2;GTF3A;TBP;GTF3C1;GTF3C4;POLR3K;POLR2L;SNAPC2
prerank,C4-dicarboxylate transport (GO:0015740),-0.2686721332833269,-0.7008367068937069,0.8600508905852418,0.9866589802138704,1.0,6/14,22.39%,SLC25A13;LRRC8D;SLC25A12;SLC25A18;SLC25A14;SLC13A5
prerank,regulation of mitochondrion organization (GO:0010821),0.25567756036605654,0.6992040442012314,0.8794701986754967,0.9708490362508948,1.0,17/47,25.16%,OMA1;IAPP;LRRK2;FBXW7;VPS35;INF2;RHOT2;VDAC1;GSK3A;GOLPH3;PLSCR3;PISD;GSK3B;SREBF2;CSNK2A2;PARL;ATP13A2
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.25147860828239665,0.6991148766326358,0.8710106382978723,0.9705443996719388,1.0,6/48,9.18%,F2RL1;APOA1;ARG1;NLRC5;STAP1;CACTIN
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.2846717735281001,0.6988136045285002,0.8552437223042836,0.9705061643769871,1.0,4/26,9.18%,NFKBIL1;NMI;ACOD1;CACTIN
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.3021091823296227,-0.6980058209247285,0.834625322997416,0.9886211406324071,1.0,1/10,2.62%,KIT
prerank,fatty acid beta-oxidation (GO:0006635),0.2513916913102941,0.6977528821054299,0.8720626631853786,0.9713805539530136,1.0,18/51,22.74%,ETFDH;ETFB;ETFA;ACOX1;ACAD10;SLC27A2;HADHB;ACOX3;CROT;ACAT1;ECI1;DECR2;HADH;HADHA;ACAA2;ABCD2;ABCD4;HSD17B4
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.3437488902536286,0.6974781337592716,0.8006814310051107,0.9712826167009511,1.0,1/10,2.63%,LGALS9
prerank,purine-containing compound catabolic process (GO:0072523),0.3206163758803368,0.697029110825253,0.8229665071770335,0.9713925021836379,1.0,1/13,1.76%,GDA
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.2875267617832347,0.6967491805244921,0.8380809595202399,0.9713109799334116,1.0,3/23,13.67%,PLK3;VPS4A;BUB1
prerank,sensory perception (GO:0007600),0.2536247474618543,0.696731533226281,0.8763297872340425,0.9709205452922715,1.0,7/45,13.71%,GNAL;NIPSNAP1;P2RX7;PCDH15;TMEM150C;ALOXE3;SCN9A
prerank,cellular response to leucine starvation (GO:1990253),-0.30089127847301295,-0.6967046660517975,0.8407494145199064,0.9889930076367426,1.0,3/10,15.14%,SESN1;SESN2;EIF2AK4
prerank,glucose catabolic process to pyruvate (GO:0061718),0.28767735408805456,0.696635466481837,0.8432510885341074,0.9702162384109261,1.0,3/24,8.66%,GPI;PGK1;GAPDH
prerank,canonical glycolysis (GO:0061621),0.28767735408805456,0.696635466481837,0.8432510885341074,0.9702162384109261,1.0,3/24,8.66%,GPI;PGK1;GAPDH
prerank,establishment of mitotic spindle localization (GO:0040001),-0.2243497042676657,-0.6958731702350782,0.9049180327868852,0.9888507823839143,1.0,5/28,9.97%,GJA1;GPSM2;NDE1;UBXN2B;NDEL1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.2330490926496137,0.6957403288455107,0.9202813599062134,0.9708782835476613,1.0,16/94,14.68%,RAB11A;CSNK1D;TUBB;TTBK2;TUBB4B;CLASP1;TMEM216;NEDD1;HAUS3;CEP135;PCM1;CEP76;DYNLL1;TUBA1A;KIF24;CEP83
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.33482181718035386,0.695525545792711,0.8277591973244147,0.970711349546964,1.0,2/10,9.68%,ADAM17;FBXW7
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.3273846796941011,0.6954349571562741,0.8127147766323024,0.9704030434064349,1.0,1/11,3.58%,IPPK
prerank,protein heterooligomerization (GO:0051291),0.30292867299278675,0.6953926688866768,0.829153605015674,0.970050418793969,1.0,5/17,20.54%,FARSB;GRIN2B;KCNC2;TMEM120B;MAT2A
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.24031258359681493,0.6938344242237671,0.8969325153374234,0.9714989346844546,1.0,16/72,15.54%,EXD2;ZC3H12A;POLK;DCP1B;UBA52;RPS27A;MEI4;FEN1;RBX1;RNASE1;XRN2;GTF2H3;ERCC4;RNASE6;EDC3;RFC2
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.27417621031456946,0.692964788658681,0.8602941176470589,0.9721247758162207,1.0,12/30,24.50%,MGAT5;MCFD2;OSTC;DPM1;MGAT1;UGGT1;DDOST;DAD1;MGAT2;NUDT14;FUT8;DPM3
prerank,cellular lipid catabolic process (GO:0044242),0.2752720803647629,0.69284685887345,0.8544395924308588,0.9718485013370689,1.0,2/27,7.85%,AOAH;ACOX1
prerank,RNA stabilization (GO:0043489),-0.217679250520202,-0.6927792730696534,0.9272151898734177,0.9909903613885065,1.0,11/33,23.12%,PHAX;TENT5A;NOCT;FUS;AXIN2;HNRNPU;LARP1;PABPC1;TENT5D;E2F1;NAF1
prerank,protein targeting to mitochondrion (GO:0006626),0.2515813237987678,0.6926456038976876,0.9007832898172323,0.9716597565121181,1.0,9/52,18.57%,FBXO7;TOMM20L;DNLZ;IMMP2L;TSPO;AGK;SAMM50;PAM16;TOMM7
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.3020262104052506,-0.6926362563513774,0.8491879350348028,0.9901293695869487,1.0,3/10,20.07%,JARID2;DNMT3B;ATRX
prerank,double-strand break repair (GO:0006302),0.21976844491474357,0.6926015851315978,0.9449339207048458,0.971308201149885,1.0,26/158,13.95%,RAD54B;HERC2;RBBP8;RAD21;SETX;EXD2;TENT4A;FEN1;BABAM2;HMGB1;SPIDR;MAD2L2;SFR1;POLA1;BRIP1;POLB;PSMD14;DTX3L;AP5Z1;BRCA1;SMARCAD1;EYA3;ATM;HMGB2;ERCC4;RAD51D
prerank,nucleocytoplasmic transport (GO:0006913),0.2607208783206445,0.6923120071599698,0.8787878787878788,0.9712511051097629,1.0,11/40,22.59%,BACH2;XPO1;SNRPE;NPM1;RSRC1;ATXN1;NUP205;MALT1;GEMIN8;LSG1;NXT2
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.2993967106167317,0.6921740775028653,0.8409448818897638,0.970998743811732,1.0,1/18,2.22%,DAB2IP
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.2956926519091189,-0.6920208922492149,0.8302325581395349,0.9897450714749181,1.0,4/10,18.08%,EHMT1;SETD7;SETD4;EEF1AKMT2
prerank,serine family amino acid biosynthetic process (GO:0009070),0.330467688294659,0.6919930345269666,0.7975077881619937,0.9707991410799168,1.0,2/12,11.68%,SERINC3;SERINC5
prerank,sarcomere organization (GO:0045214),0.2778807027452106,0.6914738966865216,0.8616262482168331,0.9709874420611615,1.0,3/27,7.86%,CSRP2;WDR1;CASQ1
prerank,positive regulation of B cell proliferation (GO:0030890),-0.22899734568832664,-0.6914605144372805,0.916955017301038,0.9893237750869163,1.0,11/29,26.35%,BCL2;IRS2;NCKAP1L;CD81;CD74;EPHB2;CD40;GPR183;PTPRC;NFATC2;CD320
prerank,maturation of SSU-rRNA (GO:0030490),0.2658518086524714,0.6912109886946005,0.862937062937063,0.9708819173959696,1.0,10/34,22.22%,DHX37;RPS14;WDR46;RPS28;RIOK3;NOB1;DCAF13;PWP2;RPS19;RPS8
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.2566538535587556,0.6911400168017672,0.8836898395721925,0.9705460841881173,1.0,4/46,8.96%,FBXO7;TOMM20L;DNLZ;TSPO
prerank,regulation of telomere capping (GO:1904353),0.2798890959475894,0.690640277801687,0.8505231689088192,0.9707389452262203,1.0,4/23,13.34%,MAPK1;NEK7;TNKS;ATM
prerank,glutathione biosynthetic process (GO:0006750),0.32619287930415325,0.690362792883841,0.8115942028985508,0.9706477262801166,1.0,6/11,29.01%,GSS;CHAC2;GGCT;GCLM;OPLAH;CNDP2
prerank,response to light stimulus (GO:0009416),-0.19606465966033151,-0.6903349973540912,0.9653679653679653,0.9894431261435472,1.0,12/55,15.13%,DDB2;BRSK1;USP1;ERCC5;MAP2K7;CLOCK;UVSSA;REV1;MSH6;DRD2;CRY2;ERCC2
prerank,histone lysine demethylation (GO:0070076),-0.22742882616455412,-0.6899660161748148,0.9108910891089109,0.9888074568197639,1.0,7/25,19.44%,KDM7A;JMJD1C;KDM4A;RIOX2;KDM6B;KDM8;PHF8
prerank,positive regulation of DNA recombination (GO:0045911),-0.22737327902522772,-0.6899163077927374,0.920265780730897,0.9878814823913951,1.0,8/27,22.58%,KMT5C;FUS;KMT5B;ACTR2;ERCC2;FANCB;TIMELESS;PARP1
prerank,chromosome condensation (GO:0030261),-0.21311015282242401,-0.6898181395545006,0.9169675090252708,0.9870017180420442,1.0,15/36,28.84%,SET;NCAPG2;AKAP8L;GPER1;NCAPH2;INCENP;PHF8;NCAPD2;H1-0;NUSAP1;TOP2A;ACIN1;KMT5A;NCAPH;TTN
prerank,positive regulation of blood coagulation (GO:0030194),0.3048037145831111,0.6897518707917529,0.8291139240506329,0.9709473393949138,1.0,3/17,12.94%,ANO6;ENPP4;APOH
prerank,protein insertion into ER membrane (GO:0045048),0.26267262365594446,0.6895961005691362,0.8894952251023193,0.9707087327474816,1.0,12/37,23.74%,APP;PRNP;GET1;BAG6;UBE2J2;VAPA;CCDC47;EMC3;CYB5A;EMC10;EMD;SGTA
prerank,camera-type eye morphogenesis (GO:0048593),-0.29669329588112553,-0.6890913601462949,0.8341708542713567,0.98669219647185,1.0,3/10,11.28%,SHROOM2;VEGFA;TBX2
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.2718043602662788,0.689009316197,0.8474820143884892,0.9709748587435175,1.0,4/29,10.31%,TRIM6;NLRC5;CACTIN;PTPN1
prerank,protein targeting (GO:0006605),0.22459424380047824,0.6890008042063994,0.9361948955916474,0.9705802506464382,1.0,22/118,21.95%,AQP11;ZDHHC22;NACAD;FBXO7;SRP14;RASSF9;MYO1C;TSPO;TAOK2;SRPRA;ZDHHC14;LONP2;LAMP2;ZDHHC23;TOMM7;HAP1;ZFAND2A;GIPC1;PEX1;SORL1;NLGN1;SEC63
prerank,bile acid biosynthetic process (GO:0006699),0.287516272377483,0.688955601818191,0.8651026392961877,0.9702361720216713,1.0,4/24,14.03%,CYP39A1;OSBPL1A;OSBPL9;SLC27A2
prerank,regulation of cholesterol esterification (GO:0010872),0.3286084908008495,0.6889273214652359,0.8065630397236615,0.9698592142728151,1.0,1/10,3.52%,APOA1
prerank,negative regulation of synaptic transmission (GO:0050805),0.2845832018178829,0.6886153508899207,0.8731563421828908,0.9698102871941532,1.0,6/23,23.10%,LRRK2;SLC30A1;ACHE;SHANK2;SLC24A2;MTMR2
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.2519072038002666,0.6885192890347916,0.8896189224704336,0.9695124256113293,1.0,5/46,8.52%,ACP6;LPCAT4;LCLAT1;PLD1;DGKH
prerank,positive regulation of phosphatase activity (GO:0010922),0.2863050967314113,0.6882904876645333,0.8377952755905512,0.9693723754938919,1.0,4/21,15.06%,ITGA1;MEF2C;CALM3;PPP1R15B
prerank,positive regulation of protein acetylation (GO:1901985),0.32228619081689464,0.6881660685722873,0.8382352941176471,0.9690974463353489,1.0,4/12,18.20%,FAM161A;PRKAA1;DIP2B;TERF2IP
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.29419452098825816,0.6875603687970314,0.8523076923076923,0.9693896645582015,1.0,4/19,12.97%,SULT6B1;SLC35B3;BPNT1;PAPSS1
prerank,mitochondrial transport (GO:0006839),0.24772946470296078,0.6874497071089652,0.9034749034749034,0.9691001126713058,1.0,22/53,30.76%,SLC25A16;FBXO7;BCL2L1;TSPO;TMEM14A;BNIP3;TOMM7;PPIF;BCS1L;TIMM17A;MAIP1;PITRM1;HSP90AA1;FIS1;TIMM22;FLVCR1;TOMM70;SLC25A5;TOMM34;MFF;STARD3;TIMM8B
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.2789756531686086,0.6869822154523963,0.8429629629629629,0.9692487786294783,1.0,3/26,6.86%,APP;SHANK3;LRRK2
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.2833434916583367,0.6868075215218016,0.8528528528528528,0.9690629367128009,1.0,3/23,12.37%,ASAH2;ACSBG1;ALOXE3
prerank,histone H2A monoubiquitination (GO:0035518),-0.25417111157675437,-0.686599971737139,0.9,0.9879542395718366,1.0,4/17,14.99%,DDB2;PCGF3;CUL4B;BCOR
prerank,macromolecule catabolic process (GO:0009057),0.27951962019448284,0.686368253608883,0.8602620087336245,0.9691415950316883,1.0,9/26,26.19%,PPT1;TRIM24;SMURF1;KIF16B;MVB12A;SNX25;UVRAG;TGFB1;CLN8
prerank,body fluid secretion (GO:0007589),-0.2578798000844313,-0.6857962760192502,0.9272727272727272,0.9877040086587461,1.0,4/15,19.78%,SLC22A4;VEGFA;SLC22A2;ZBTB7B
prerank,histone H4 deacetylation (GO:0070933),0.3228266226963519,0.685703726761856,0.8202443280977313,0.9694492754330802,1.0,2/10,12.10%,HDAC9;SMARCAD1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.3048110236946971,0.6844671047275211,0.8435054773082942,0.9704199717458131,1.0,3/16,14.15%,DCPS;CACTIN;SART1
prerank,nuclear membrane disassembly (GO:0051081),-0.2708446303960091,-0.6844039743988525,0.876010781671159,0.9880085883292058,1.0,4/14,17.62%,PRKCB;PRKCA;AKAP8L;NEK6
prerank,negative regulation of JUN kinase activity (GO:0043508),0.33034478650936266,0.6842800494863402,0.8243478260869566,0.9702144886458852,1.0,2/10,10.01%,PDCD4;AIDA
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.2906042012097473,0.683930855618751,0.8491446345256609,0.9702028754986716,1.0,1/18,1.61%,NOTCH1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.23562114044512605,-0.6838074374414669,0.9230769230769231,0.9875649331098049,1.0,1/22,0.19%,NR2F2
prerank,positive regulation of synapse assembly (GO:0051965),0.2749927279757287,0.6824472608304835,0.8668555240793201,0.9713897566679262,1.0,9/27,23.12%,AGRN;IL1RAP;SLITRK2;LRRC4B;GRID2;BDNF;NRXN1;NLGN1;IL1RAPL1
prerank,lipoprotein catabolic process (GO:0042159),0.32341485085102467,0.6822155911023448,0.818815331010453,0.9712344120055106,1.0,4/11,22.73%,PPT1;ABHD17B;LYPLAL1;LYPLA1
prerank,melanosome organization (GO:0032438),-0.22027470616934755,-0.6812186879688347,0.93,0.9889246683287507,1.0,9/26,22.41%,SHROOM2;AP1M1;KIF13A;DTNBP1;HPS4;RAB29;BLOC1S2;RAB32;TRAPPC6A
prerank,negative regulation of double-strand break repair (GO:2000780),-0.21501126725983633,-0.6807722625003092,0.956081081081081,0.9883756227230943,1.0,10/30,24.78%,TRIP12;FBH1;HELB;HMGA2;TWIST1;KLHL15;FANCB;CGAS;POLQ;RMI2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.24747254870635016,0.680650009161953,0.8979310344827586,0.9725449021744375,1.0,10/48,16.63%,TMEM109;CASP2;TNFRSF1B;CIDEB;BCL2L1;BAG6;BRCA1;ATM;PHLDA3;PYCARD
prerank,regulation of TOR signaling (GO:0032006),0.23446987736966965,0.6806355120477939,0.918546365914787,0.9721628970925885,1.0,27/67,26.83%,SMCR8;SH3BP4;WDR59;PRKAA1;RRAGD;RHEB;EPM2A;RICTOR;MIOS;GSK3A;GOLPH3;RRAGA;MAPKAPK5;RRAGC;HTR6;NPRL3;LAMTOR3;AKT1S1;WDR24;PIK3CA;ITFG2;SEH1L;RPTOR;MLST8;TBC1D7;PDCD6;LAMTOR4
prerank,regulation of DNA recombination (GO:0000018),-0.2123979121203568,-0.6802932107067383,0.9452554744525548,0.9878410575827689,1.0,12/32,29.36%,RAD50;KPNA1;THOC1;MSH6;RTEL1;ZRANB3;H1-0;RPA2;RAD51;CHEK1;ZCWPW1;SIRT6
prerank,rRNA pseudouridine synthesis (GO:0031118),0.33552265583783464,0.6800616886394474,0.8079584775086506,0.9723978130182084,1.0,3/10,18.19%,DKC1;NHP2;RPUSD2
prerank,regulation of dendrite morphogenesis (GO:0048814),0.2639190871123878,0.6800124020753515,0.8614958448753463,0.9720452959929675,1.0,7/32,19.95%,RAPGEF2;LZTS1;NEDD4L;YWHAH;SARM1;CDKL3;GSK3B
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.23589147819713302,0.6791003094091831,0.9117276166456494,0.9726406105923214,1.0,23/69,24.23%,INTS11;POLR2G;POLR2D;ELL2;RPRD1B;INTS12;GTF2A1;INTS5;ICE1;SNAPC4;TAF11;POLR2I;TAF8;RPRD2;ZC3H8;POU2F2;SNAPC1;RPRD1A;POLR2C;POLR2B;INTS6;POLR2J;SNAPC3
prerank,RNA interference (GO:0016246),-0.24882402962377326,-0.6788372041907967,0.9072463768115943,0.9881678988932937,1.0,6/17,24.93%,DICER1;TERT;AGO3;TSNAX;CELF1;MRPL44
prerank,actin nucleation (GO:0045010),0.2837242712558328,0.6787001001010241,0.8446745562130178,0.9726516317258446,1.0,8/21,27.85%,WHAMM;ARPC5;ARPC3;ARPC2;SPIRE1;ARPC1B;WASHC1;ARPC1A
prerank,positive regulation of nervous system development (GO:0051962),0.2518199703914328,0.6786416305022206,0.8951724137931034,0.9723163024799252,1.0,14/42,23.12%,RASSF10;IL1RAP;NUMB;SLITRK2;CX3CR1;LRRC4B;SPEN;SOX11;GRID2;BDNF;NRXN1;NLGN1;MME;IL1RAPL1
prerank,DNA alkylation (GO:0006305),0.29009506454885636,0.6784996592867405,0.8427672955974843,0.9716548996648313,1.0,4/19,12.90%,GATAD2A;KMT2E;DMAP1;PPM1D
prerank,DNA methylation or demethylation (GO:0044728),0.29009506454885636,0.6784996592867405,0.8427672955974843,0.9716548996648313,1.0,4/19,12.90%,GATAD2A;KMT2E;DMAP1;PPM1D
prerank,telomere organization (GO:0032200),0.24880989966802344,0.6778476565651946,0.8934426229508197,0.971954149129493,1.0,16/43,26.53%,APEX1;STN1;PTGES3;ATM;ERCC4;RAD51D;CTC1;TERF2IP;H3-3A;HUS1;BLM;RIF1;TERF2;WRN;TINF2;PCNA
prerank,lipid phosphorylation (GO:0046834),0.33138380790420985,0.6777976676688263,0.8315972222222222,0.9716007374066402,1.0,5/10,29.81%,DGKH;DGKI;DGKA;DGKB;DGKG
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.23307465000332303,0.6773275005823534,0.9158291457286433,0.9716886873104037,1.0,16/71,20.26%,CASP8;OMA1;RHBDD1;SOCS6;UBA52;RPS27A;NR1D1;BAG6;RSPRY1;VPS4A;PSMA8;CTSO;CTSK;NGLY1;MALT1;CTSH
prerank,selective autophagy (GO:0061912),0.2446511840660472,0.6773127467674834,0.9248407643312102,0.9713024758585537,1.0,9/56,13.34%,VIM;KLHL3;UFM1;UBA52;RPS27A;NBR1;DYNLL1;DYNC1LI2;ATM
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.28072301763360397,0.6771509752762392,0.8595419847328244,0.9710669864925899,1.0,5/22,13.94%,INPP5K;ROCK1;STAP1;DYNLL1;CDKN2D
prerank,chromatin remodeling at centromere (GO:0031055),-0.21349543798795112,-0.677033469776763,0.9401993355481728,0.9887786876530616,1.0,15/31,31.87%,RSF1;CENPC;SMARCA5;RBBP7;CENPK;KNL1;MIS18BP1;CENPQ;CENPX;NASP;HELLS;CENPH;MIS18A;CENPN;CENPA
prerank,regulation of leukocyte migration (GO:0002685),0.29505734832939917,0.6766522566734163,0.84185303514377,0.9711911633281964,1.0,3/16,14.01%,TNFRSF18;RAC1;RHOH
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.32635633732499414,0.6762182175126183,0.8280467445742905,0.9712531114984341,1.0,3/10,19.43%,JAK2;PTPN1;STAT5A
prerank,regulation of Golgi organization (GO:1903358),0.2993417665854124,0.6756311974949604,0.8557692307692307,0.9714706781104546,1.0,7/17,23.79%,CAMSAP2;MAPK1;USP6NL;PDCD10;MAP2K1;PDE4DIP;MYO5A
prerank,t-circle formation (GO:0090656),-0.29329527307876024,-0.6749295476268545,0.8759305210918115,0.987672059264052,1.0,6/10,37.64%,SMARCAL1;XRCC3;SLX4;EXO1;DNA2;ERCC1
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.29329527307876024,-0.6749295476268545,0.8759305210918115,0.987672059264052,1.0,6/10,37.64%,SMARCAL1;XRCC3;SLX4;EXO1;DNA2;ERCC1
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.29329527307876024,-0.6749295476268545,0.8759305210918115,0.987672059264052,1.0,6/10,37.64%,SMARCAL1;XRCC3;SLX4;EXO1;DNA2;ERCC1
prerank,regulation of synapse organization (GO:0050807),0.27159929916159525,0.6745482135856464,0.8694444444444445,0.972234151183513,1.0,7/26,23.12%,PDLIM5;MEF2C;SLITRK2;CTNNA2;ABHD17B;EPHA4;IL1RAPL1
prerank,negative regulation by host of viral process (GO:0044793),0.3254857512908339,0.6744910106722678,0.845771144278607,0.9718943708009182,1.0,3/10,14.54%,ZC3H12A;PSMC3;VAPA
prerank,protein heterotetramerization (GO:0051290),0.30808208517236735,0.6732710678925905,0.8389154704944178,0.9728074848712223,1.0,2/13,8.45%,FARSB;GRIN2B
prerank,autophagosome organization (GO:1905037),0.2427151716404212,0.6732502270958074,0.9037711313394018,0.9724237637797458,1.0,10/50,16.65%,ATG101;GABARAPL1;RAB23;IRGM;STX12;PIK3C3;RAB19;MAP1LC3A;UBQLN2;ATG14
prerank,inhibitory synapse assembly (GO:1904862),0.3302453630489469,0.6730246190959845,0.8528896672504378,0.9722660542413311,1.0,3/11,12.40%,CBLN4;GABRA2;LGI2
prerank,synaptic vesicle localization (GO:0097479),-0.27118324661357346,-0.6724726647429221,0.9104477611940298,0.9887746389569554,1.0,5/13,23.33%,SPG11;KIF5C;CDK5;KIF5B;TOR1A
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.3105162049254314,0.6722249207678335,0.845,0.9726885923706805,1.0,4/12,21.80%,CAD;UMPS;UPP2;TK1
prerank,negative regulation of hippo signaling (GO:0035331),0.3151895290245055,0.67186710254561,0.8237232289950577,0.9726547448799722,1.0,4/12,19.82%,WWC2;MARK3;MAPK14;SHANK2
prerank,iron-sulfur cluster assembly (GO:0016226),0.27918601297900764,0.6714622623954004,0.8684603886397608,0.9726786382560759,1.0,8/24,19.53%,BOLA2;ISCA2;GLRX5;GLRX3;HSCB;NUBPL;MMS19;IBA57
prerank,negative regulation of cellular component organization (GO:0051129),0.2283875557562357,0.6712165984584405,0.9272503082614056,0.9725306986714131,1.0,19/74,23.10%,MCTP1;PRKD1;APOA1;IAPP;HSPA1B;AIDA;CLU;RIOK3;RUBCN;DNAJB6;ABCA7;DNAJB8;GSK3B;LCMT1;CARMIL1;SORL1;NOP53;TERF2;MTMR2
prerank,growth hormone receptor signaling pathway (GO:0060396),0.312578212529686,0.6709822143987912,0.861244019138756,0.9723711808868901,1.0,3/14,10.31%,JAK2;PTK2;PTPN1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.24480755760506545,0.6706272378251511,0.921957671957672,0.9723078638763752,1.0,10/48,15.51%,SERTAD2;SERTAD1;TAF1A;MYO1C;POLR1F;ASF1A;ACTB;DDX21;TAF1B;ELOF1
prerank,nuclear membrane reassembly (GO:0031468),0.24489684498863756,0.6699078807001636,0.9048239895697523,0.9726508463568412,1.0,20/54,26.25%,RANGAP1;KPNB1;NUP35;VPS4A;VRK1;REEP3;CHMP3;NUP160;RAN;CHMP2B;CHMP7;NUP205;BANF1;EMD;UBXN2A;PPP2R2A;SEH1L;PPP2R1A;CHMP4A;CHMP4B
prerank,DNA recombination (GO:0006310),-0.205054395822666,-0.6699033510109667,0.965034965034965,0.9899140199940842,1.0,14/37,25.71%,RAD51B;FBH1;RAD50;DMC1;SUPV3L1;RHNO1;IGHMBP2;RTEL1;RECQL;RAD54L;RPA1;HDAC10;RAD51;LIG4
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.28135025625392374,0.6693701814109422,0.8590704647676162,0.9724185927906205,1.0,1/22,2.53%,ZDHHC22
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.28135025625392374,0.6693701814109422,0.8590704647676162,0.9724185927906205,1.0,1/22,2.53%,ZDHHC22
prerank,mucosal immune response (GO:0002385),0.3016112226649247,0.6691233461252591,0.8633333333333333,0.9722802996114178,1.0,1/15,4.09%,DEFA6
prerank,mRNA catabolic process (GO:0006402),0.2519572345677144,0.6689586575297514,0.8852005532503457,0.9720374950310681,1.0,18/44,26.07%,HSPA1B;ZFP36L2;AGO4;XRN2;XRN1;TUT7;DXO;EXOSC9;NBDY;LSM2;ERN1;EXOSC10;DIS3L2;NUDT16;RNH1;MRTO4;NUDT16L1;LSM5
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.2852812935790333,-0.66874123385953,0.8582474226804123,0.9899213917496638,1.0,3/10,19.55%,MFSD2A;PHB2;MTMR4
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.27220605455145525,-0.6673470407475011,0.8688946015424165,0.9900719671141618,1.0,5/12,27.93%,FDX1;AKR1B1;CACNA1H;STAR;TSPOAP1
prerank,DNA biosynthetic process (GO:0071897),0.29451039263296536,0.6671331890014991,0.8738019169329073,0.973526120630462,1.0,3/16,13.94%,WRNIP1;POLA1;CDKN2D
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.2764447950651063,-0.6669547648558096,0.8764044943820225,0.9894045239535739,1.0,2/11,7.87%,EFNB2;FZD7
prerank,mRNA polyadenylation (GO:0006378),0.26875767715238735,0.666445877997314,0.8893805309734514,0.9734164392443646,1.0,4/26,10.82%,APP;CPSF1;MTPAP;FIP1L1
prerank,RNA polyadenylation (GO:0043631),0.26875767715238735,0.666445877997314,0.8893805309734514,0.9734164392443646,1.0,4/26,10.82%,APP;CPSF1;MTPAP;FIP1L1
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.25027790175397147,-0.665971709308093,0.917098445595855,0.9892505011278119,1.0,2/16,5.14%,MAU2;NIPBL
prerank,hyaluronan catabolic process (GO:0030214),0.29125889980532654,0.665683138913431,0.8539325842696629,0.9737632495481492,1.0,2/18,5.46%,CEMIP2;HYAL2
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.23645926315161647,-0.6652946958411767,0.9111111111111111,0.9888471172507913,1.0,8/21,29.44%,CYP26B1;PLA2G15;AGXT;NUDT19;FAAH;PPARD;LPIN3;LPIN1
prerank,cellular amide metabolic process (GO:0043603),0.22118459557653847,0.6652805091650753,0.9490740740740741,0.9737724171180452,1.0,7/102,6.04%,ACSM3;SLC25A32;CPD;PLPP1;GLYAT;DNPEP;ASAH2
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.28046430801871436,0.665030943193636,0.8661417322834646,0.9736298075698241,1.0,6/18,24.71%,LRRK2;RIMS3;GSK3B;NLGN1;RAP1B;RIMS1
prerank,protein K11-linked ubiquitination (GO:0070979),-0.2215965905954176,-0.6650171458149859,0.9480122324159022,0.9881318021201178,1.0,4/27,12.99%,UBE2E2;PRKN;RNF4;UBE2L3
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.2878060228905754,0.6650018810159437,0.8593508500772797,0.9732657807264452,1.0,4/18,13.81%,HSPB1;NFE2L2;HIF1A;NOL3
prerank,RNA catabolic process (GO:0006401),0.24601651868285113,0.6647149468067546,0.9087248322147651,0.973159641396652,1.0,17/46,26.07%,HSPA1B;FEN1;ZFP36L2;AGO4;RNASEH2B;XRN2;RNASE6;DXO;LSM2;ERN1;DIS3L2;RNASEH2A;NUDT16;RNASEH1;RNH1;NUDT16L1;LSM5
prerank,apoptotic nuclear changes (GO:0030262),0.26674144376611475,0.6645772730522654,0.8708272859216255,0.9729078202159828,1.0,6/24,15.24%,KPNB1;DFFB;HMGB1;HMGB2;EXOG;DFFA
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.3005452298439595,0.6645641187941919,0.8743882544861338,0.9725241953773895,1.0,2/14,6.82%,TRPT1;CPSF1
prerank,transcription by RNA polymerase I (GO:0006360),-0.20368990675876664,-0.6632923102475113,0.9591836734693877,0.9885089661756543,1.0,11/34,21.67%,RRN3;TAF1D;TAF1;TTF1;ERCC2;UBTF;GTF2H5;GTF2H1;GTF2H4;POLR1H;POLR1A
prerank,intracellular sterol transport (GO:0032366),-0.26055292795535023,-0.6630259703428921,0.8853658536585366,0.9877595403843553,1.0,1/13,3.26%,ABCA1
prerank,steroid hormone biosynthetic process (GO:0120178),-0.2127974798284522,-0.6629242174067371,0.9472049689440993,0.9868853416386953,1.0,9/29,29.02%,FDX1;AKR1B1;HSD17B8;STAR;SRD5A1;HSD17B11;HSD17B2;TSPOAP1;SRD5A3
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.2638223662030229,-0.6628093010914751,0.9098360655737705,0.9860128403663279,1.0,4/14,15.86%,NUDT21;NCBP1;TUT1;CSTF2T
prerank,negative regulation of macroautophagy (GO:0016242),0.2686232104167735,0.6614344014952578,0.8692528735632183,0.9752924735900012,1.0,11/26,27.51%,SMCR8;LRRK2;LZTS1;RUBCN;UBQLN4;FEZ1;PIK3CA;CHMP4A;CHMP4B;SCFD1;CLEC16A
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.30142213569027976,0.6611928653958502,0.8470031545741324,0.9751280232152749,1.0,4/15,16.50%,PRKD1;HSPB1;PRKD2;TMSB4X
prerank,response to ionizing radiation (GO:0010212),0.22972644396465197,0.6610346653507173,0.9485924112607099,0.9748691749282816,1.0,28/70,28.10%,RHOB;BRAT1;PRKAA1;BABAM2;SPIDR;BRCA1;EYA3;ATM;RAD1;KDM4D;RAD9B;MAPK14;MEN1;EEF1D;HUS1;BLM;ECT2;PAXIP1;XRCC4;NHEJ1;COP1;XRRA1;BABAM1;RNF8;MTA1;TANK;SMPD1;INO80
prerank,placenta development (GO:0001890),0.31074006200951887,0.6607447860008219,0.8789808917197452,0.9747431612882305,1.0,4/12,22.49%,PTK2;E2F7;ANG;SOD1
prerank,phosphatidic acid metabolic process (GO:0046473),0.2409178014442455,0.6605976226847097,0.9285714285714286,0.9744896533207675,1.0,5/48,8.52%,ACP6;LPCAT4;LCLAT1;PLD1;DGKH
prerank,negative regulation of ATPase activity (GO:0032780),0.2951550773227672,0.6603843593850871,0.865414710485133,0.9743175176919824,1.0,3/16,19.00%,PXK;PAM16;PPIF
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.24429688269869848,-0.6598504659649898,0.9043715846994536,0.9873796702591588,1.0,5/17,18.64%,PRKN;MDM2;CD74;TWIST1;SNAI1
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.285525985438112,-0.6597349988536326,0.8761682242990654,0.9865149557930015,1.0,10/10,71.47%,PDE6A;PDE6G;PDE6B;RHO;GNAT1;CNGB1;GRK1;CNGA1;GNB1;SAG
prerank,positive regulation of bone resorption (GO:0045780),0.31911669758261935,0.6582257722274654,0.8536184210526315,0.975996242596997,1.0,2/11,7.55%,MC4R;PLEKHM1
prerank,skeletal muscle contraction (GO:0003009),-0.2349675776582974,-0.6581839549205782,0.8914285714285715,0.9867488630239071,1.0,9/19,39.24%,RCSD1;TNNT3;STAC3;TNNI1;STAC2;TNNC1;TNNI3;CCDC78;TCAP
prerank,glycolytic process (GO:0006096),0.26583389169587873,0.6580998568431704,0.9025787965616046,0.9757272240258025,1.0,3/28,8.66%,GPI;PGK1;GAPDH
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.29396207836592836,0.657903997409319,0.8702791461412152,0.9755183971753852,1.0,1/14,2.63%,LGALS9
prerank,regulation of axon guidance (GO:1902667),-0.277143230575814,-0.6568342690754907,0.8677884615384616,0.9868688855875739,1.0,2/10,9.01%,YTHDF1;VEGFA
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.26816507318255034,0.6554564605783957,0.8808823529411764,0.9774728171434934,1.0,6/23,15.24%,KPNB1;DFFB;HMGB1;HMGB2;EXOG;DFFA
prerank,epithelial cell development (GO:0002064),0.276564893899636,0.6548118699874521,0.8938714499252616,0.9776796049898697,1.0,1/20,3.18%,SIPA1L3
prerank,microtubule bundle formation (GO:0001578),0.24140681890684396,0.654262172126387,0.9064935064935065,0.977823433803261,1.0,9/42,21.35%,CFAP206;CLIP1;CLASP1;NUMA1;NAV1;DCX;FOXJ1;MTCL1;MARK4
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.32267289299314034,0.6534551492748165,0.8591304347826086,0.9781603950543465,1.0,3/10,16.22%,JUN;HIF1AN;NCK1
prerank,DNA duplex unwinding (GO:0032508),0.23984012452748,0.6520244373595029,0.9224704336399474,0.9790720542751007,1.0,8/50,11.53%,SSBP1;PURA;UBA52;RPS27A;DHX9;RBX1;ASCC3;GTF2H3
prerank,microtubule nucleation (GO:0007020),0.27974589225598756,0.6520060487530279,0.881559220389805,0.9786895003258752,1.0,4/19,10.76%,CSNK1D;CLASP1;CLASP2;RANBP9
prerank,error-prone translesion synthesis (GO:0042276),0.27490786707025794,0.6511787735249193,0.8855799373040752,0.9790397200202205,1.0,5/21,15.54%,POLK;UBA52;RPS27A;MAD2L2;RFC2
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.2603445579026908,0.6510127502742356,0.903271692745377,0.9787782811098253,1.0,8/30,20.28%,MACF1;RAB34;NSF;ANK3;SPTBN1;GOLPH3L;GOLPH3;RAB31
prerank,ribosomal small subunit biogenesis (GO:0042274),0.24642631232014153,0.6508134206411801,0.9183673469387755,0.9785735107562432,1.0,10/39,21.64%,RPS14;RPS28;NPM1;RPS25;RPS5;RIOK3;RPS15;NOB1;PWP2;RPS19
prerank,magnesium ion transport (GO:0015693),0.30385709064565236,0.6505530459139175,0.8550247116968699,0.9784154537839412,1.0,3/12,10.43%,NIPAL2;NIPAL3;NIPA2
prerank,peptide catabolic process (GO:0043171),0.272652637504408,0.6485941458279382,0.8870229007633588,0.9798176539746973,1.0,1/23,1.04%,ACE
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.2011509743257069,0.6483984232256351,0.9926778242677824,0.9795958359929159,1.0,72/241,26.55%,NOVA2;DDX39A;DDX41;PPIE;BUD13;IK;CPSF1;HNRNPA0;ELAVL1;U2SURP;POLR2G;CWF19L2;CACTIN;DHX9;SNRNP48;POLR2D;HNRNPK;PRPF38A;SNRPE;FIP1L1;PCBP1;RBM17;SMNDC1;SRSF9;RSRC1;METTL14;HNRNPH2;PPIH;SART1;SYF2;SF3B4;CRNKL1;ELAVL2;YBX1;PRPF4;SF3A1;POLR2I;RBM15;SPEN;DHX38;ZMAT5;SMU1;DDX39B;HNRNPUL1;CSTF2;SYNCRIP;SF3B6;LSM2;CPSF3;YTHDC1;SF3B2;SF3A3;CWC25;PRCC;PQBP1;SF3B3;POLR2C;POLR2B;ZCRB1;POLR2J;PRPF40B;FRG1;ALYREF;PRPF6;CTNNBL1;PHF5A;LSM7;LSM5;WDR33;SYMPK;DDX23;HNRNPF
prerank,icosanoid biosynthetic process (GO:0046456),-0.2787685527372998,-0.648035640972262,0.8679706601466992,0.9923569850441627,1.0,5/10,36.96%,PLA2G4A;MGST2;ALOX5;PLA2G5;ALOX5AP
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.20365340367313148,-0.6475022726437644,0.9614243323442137,0.9917602711441846,1.0,19/32,39.25%,BRSK1;TRIM39;HMGA2;CDC14B;CDKN1A;DONSON;FZR1;RINT1;TAOK1;TAOK3;CHEK1;DTL;FOXN3;UIMC1;CDK5RAP3;CDK1;PLK1;TICRR;MRE11
prerank,ncRNA export from nucleus (GO:0097064),0.25030449420467743,0.647336863486128,0.9032258064516129,0.9801863367732021,1.0,9/36,16.21%,NUP54;NUP35;RANBP2;NPM1;NUP153;NUP160;NUP42;RAN;NUP205
prerank,lysosome organization (GO:0007040),0.25013633206986297,0.6472980727369881,0.9162011173184358,0.979821022688423,1.0,9/36,20.43%,LRRK2;HOOK1;GNPTAB;TPCN2;NAGPA;CLVS1;TMEM106B;HOOK2;MYO7A
prerank,positive regulation of behavior (GO:0048520),0.31779651037480094,0.6472540564325372,0.8504201680672269,0.9794613490957987,1.0,1/10,5.43%,MEF2C
prerank,positive regulation of cation channel activity (GO:2001259),0.24655498949539217,0.6470379703706028,0.9174560216508796,0.97926099218249,1.0,9/40,18.63%,ADRB2;STAC;SHANK3;GAL;CASQ1;CALM3;ANK3;TMSB4X;HAP1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.1803860989223352,-0.6469299470632804,0.984251968503937,0.9911936851691581,1.0,30/57,38.08%,TIPIN;BRSK1;TRIM39;ATF2;HMGA2;WAC;CDC14B;CDKN1A;DONSON;RFWD3;FZR1;RINT1;TAOK1;TAOK3;FANCD2;RPA2;EME2;RAD9A;CHEK1;DTL;FBXO31;FOXN3;UIMC1;CDK5RAP3;HUS1B;TP53;CDK1;PRKDC;PLK1;TICRR
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.3141156978736519,0.6465268203006276,0.8703703703703703,0.9793450371679221,1.0,2/10,12.09%,NOS1AP;CALM3
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.2711665052924993,0.6465086036607481,0.8977777777777778,0.9789601268350958,1.0,3/20,10.58%,PUM2;ZC3H7A;AGO4
prerank,regulation of oxidative phosphorylation (GO:0002082),0.2837363837115523,0.6461673882287962,0.8704,0.9788722604757935,1.0,2/16,6.58%,ATP7A;SLC25A33
prerank,lipoxygenase pathway (GO:0019372),0.29229971693668355,0.6461213443635011,0.8692185007974481,0.9785198528584784,1.0,3/14,15.73%,ALOXE3;PON2;PON3
prerank,histone H3 deacetylation (GO:0070932),0.2902473924089173,0.6460467142362518,0.8932676518883416,0.9781894650214653,1.0,2/15,12.10%,HDAC9;SMARCAD1
prerank,Golgi localization (GO:0051645),-0.26505197305571787,-0.6459763156530925,0.8861386138613861,0.9909008733130915,1.0,3/11,15.61%,COPG1;ARCN1;ARHGAP21
prerank,positive regulation of lipid storage (GO:0010884),0.27280233423894856,0.6459388837626998,0.8945736434108527,0.9778859892801791,1.0,3/21,11.33%,EHD1;ZC3H12A;VSTM2A
prerank,apoptotic mitochondrial changes (GO:0008637),-0.20228094266721977,-0.6450453514360164,0.9407894736842105,0.9905974297568969,1.0,7/32,14.81%,BCL2;IFIT2;ATG3;AIFM2;HK2;THEM4;BOK
prerank,pre-miRNA processing (GO:0031054),0.2896496780732114,0.6443750173694824,0.8726708074534162,0.9788591430334586,1.0,4/14,17.40%,ADAR;AGO4;DROSHA;TUT7
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.20217702193169593,0.6441405938839727,0.9837310195227765,0.9786686883609191,1.0,37/173,19.72%,TRAPPC8;ATL2;VTI1B;GOPC;TMED10;COG5;MCFD2;CUL3;PGAP1;WHAMM;ERGIC1;GRIA1;PROC;VAMP7;DYNLL1;TRAPPC2;TRAPPC6B;TEX261;TMED9;DYNC1LI2;SPTAN1;SEC24B;NSF;VAPA;TMED4;ANK1;TRAPPC5;GOSR1;COG6;ANK3;SPTBN1;VTI1A;SEC24A;ACTR1A;DYNLL2;TMED7;PROS1
prerank,carnitine metabolic process (GO:0009437),-0.26025047818781677,-0.6436185685785525,0.8933002481389578,0.9906431557311199,1.0,5/12,21.74%,CPT1C;ACADM;TMLHE;CPT2;BBOX1
prerank,regulation of rRNA processing (GO:2000232),-0.2418723901253944,-0.6435978777221583,0.9289617486338798,0.989704565399168,1.0,6/16,29.46%,KAT2B;BUD23;YTHDF2;RIOK2;TRMT112;DIMT1
prerank,positive regulation of viral genome replication (GO:0045070),0.2599382202800579,0.6435057540294284,0.9068493150684932,0.9788333573312686,1.0,7/29,18.08%,ADARB1;PPIE;ADAR;PPIH;PKN2;SRPK1;PPID
prerank,lipid biosynthetic process (GO:0008610),0.21926862855531773,0.6434201554121982,0.9561510353227771,0.9785190618479582,1.0,15/77,23.07%,ACSM3;ACSL5;PRKAA1;ELOVL4;ACSS2;PDSS2;PDSS1;MVD;DOLPP1;AGPAT5;GGPS1;OXSM;AGPS;ACLY;MVK
prerank,carbohydrate derivative transport (GO:1901264),0.28209362388406306,0.6429404041750549,0.8765432098765432,0.978535566810487,1.0,6/18,22.46%,PLTP;SLC15A4;VLDLR;SCARB1;SLC25A19;SLC10A7
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.3103454990520746,0.6428686316307907,0.8807495741056218,0.9782024255850984,1.0,4/10,26.43%,CALM3;GNB5;CRHR1;CALM1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.24171402121503877,-0.6428053641567089,0.922879177377892,0.9892812796232024,1.0,7/16,36.28%,ST3GAL4;MDK;ITGB2;RHOA;NFAT5;SELP;ALOX5
prerank,cellular response to interleukin-2 (GO:0071352),-0.2654371001611229,-0.6419846532298152,0.9005102040816326,0.987993328731115,1.0,7/11,43.38%,SHC1;SYK;JAK3;IL2RA;PTK2B;IL2RB;STAT5B
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.2654371001611229,-0.6419846532298152,0.9005102040816326,0.987993328731115,1.0,7/11,43.38%,SHC1;SYK;JAK3;IL2RA;PTK2B;IL2RB;STAT5B
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.27325929983759856,0.6419636825938738,0.8901273885350318,0.9786249459955406,1.0,4/19,16.63%,TMEM109;BAG6;PHLDA3;PYCARD
prerank,cellular iron ion homeostasis (GO:0006879),0.22993525720981156,0.6414008545712954,0.9452229299363057,0.9786973661614352,1.0,19/55,25.16%,FBXL5;TMPRSS6;HMOX2;BOLA2;CYB561A3;CP;GLRX3;CYBRD1;HEPH;FRRS1;ATP6V1G1;SMAD4;CCDC115;SOD1;IREB2;TMEM199;FTH1;FTL;ATP13A2
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.22394121121475855,-0.6406240522756586,0.9190751445086706,0.9879365103797765,1.0,6/22,19.44%,SMARCB1;ERBB2;PIH1D1;UBTF;NCL;PHF8
prerank,negative regulation of autophagosome assembly (GO:1902902),0.29103817835737833,0.6406103486464072,0.8841059602649006,0.9790074358712886,1.0,2/13,6.86%,SMCR8;LRRK2
prerank,regulation of water loss via skin (GO:0033561),0.2883674378971587,0.6400473983917582,0.856687898089172,0.978700838335536,1.0,2/15,12.37%,LSR;ALOXE3
prerank,establishment of skin barrier (GO:0061436),0.2883674378971587,0.6400473983917582,0.856687898089172,0.978700838335536,1.0,2/15,12.37%,LSR;ALOXE3
prerank,regulation of B cell differentiation (GO:0045577),-0.23956858581769822,-0.6394836119901949,0.9315068493150684,0.9877926907048876,1.0,4/17,21.22%,MMP14;NCKAP1L;INHBA;SYK
prerank,negative regulation of RNA splicing (GO:0033119),-0.2286346619369762,-0.6394797976649614,0.9459459459459459,0.9868510918217159,1.0,5/19,17.40%,RBMX;SRSF6;PCBP4;RPS26;U2AF2
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.2728377318408492,0.6380981775241364,0.9036334913112164,0.9800242620293272,1.0,8/19,26.88%,FBXO7;FBXW7;VDAC1;GSK3A;SREBF2;CSNK2A2;ATP13A2;HAX1
prerank,regulation of spindle assembly (GO:0090169),0.2575904297178066,0.6377423784736322,0.9191919191919192,0.9799169599655078,1.0,13/25,30.02%,HSPA1B;CHMP1B;NUMA1;CHMP3;CHMP2B;SENP6;CHMP1A;TPR;VPS4B;CHMP4B;EML3;DYNC1H1;HSPA1A
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.26116556759779935,0.6375588627838553,0.8957142857142857,0.979673602021565,1.0,3/25,8.66%,GPI;PGK1;GAPDH
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.29860040506525387,0.6374379522047695,0.8892455858747994,0.9793892875845447,1.0,1/12,3.72%,GART
prerank,primary miRNA processing (GO:0031053),-0.274203089054092,-0.6373499913505747,0.8957345971563981,0.987363435034678,1.0,2/10,6.42%,HNRNPA2B1;SMAD3
prerank,regulation of mRNA metabolic process (GO:1903311),0.3068697152309378,0.6369553162502151,0.8775862068965518,0.9793955949962437,1.0,5/11,21.23%,DHX9;PTCD2;SAFB2;SRPK1;IWS1
prerank,telomere maintenance (GO:0000723),0.22535792813542926,0.6368937652342709,0.9463350785340314,0.9790460743745617,1.0,12/50,20.88%,ZBTB48;APEX1;STN1;PTGES3;ATM;ERCC4;RAD51D;CTC1;TERF2IP;HUS1;BLM;RIF1
prerank,DNA metabolic process (GO:0006259),0.19380908727648435,0.6366881088787449,0.9947753396029259,0.9788388623441227,1.0,63/270,23.23%,BTG2;RBBP8;APEX1;RAD21;ENDOV;EXD2;ORC3;PURA;POLK;UBA52;RPS27A;DFFB;FEN1;ASF1A;HMGB1;NSMCE3;STN1;PTGES3;POLA1;WDHD1;POLB;NPM1;GTF2H3;BRCA1;HINFP;LIG1;SMARCAD1;ORC5;UBE2T;ATM;DDX21;HMGB2;ERCC4;RAD1;RAD51D;NSMCE4A;RAD18;RAN;XPC;RFC2;TRRAP;RAD9B;MMS19;FBXO6;MEN1;CTC1;ATRIP;TERF2IP;BARD1;HUS1;BLM;UHRF2;RIF1;MNAT1;UBB;GEN1;NOP53;TOP3B;MUTYH;TERF2;RNASEH2A;ORC4;CNBP
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.28283736076130245,0.6360288705140131,0.9022435897435898,0.9789739297841294,1.0,4/15,19.55%,TRPT1;CPSF1;CSTF2;ERN1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.29528327455025133,0.6355786582080349,0.8752052545155994,0.9789543694290203,1.0,3/13,18.70%,SULT6B1;BPNT1;SULT1A1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.19492324121499408,-0.6348260438114535,0.951048951048951,0.9880901054224649,1.0,8/32,22.71%,CEMIP;CALM2;GSTM2;JPH2;GPER1;P2RY6;GSTO1;APLNR
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.17944352294363872,-0.6339905748267833,0.985981308411215,0.986766884791121,1.0,15/56,19.72%,NDUFS3;NDUFA13;NDUFC2;NDUFV2;NDUFAF5;NDUFAF1;NDUFB10;NDUFS6;NDUFS7;NDUFA1;NDUFB8;TIMM21;NDUFAF6;NDUFB11;NDUFB3
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.17944352294363872,-0.6339905748267833,0.985981308411215,0.986766884791121,1.0,15/56,19.72%,NDUFS3;NDUFA13;NDUFC2;NDUFV2;NDUFAF5;NDUFAF1;NDUFB10;NDUFS6;NDUFS7;NDUFA1;NDUFB8;TIMM21;NDUFAF6;NDUFB11;NDUFB3
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.20370217058947998,-0.6338184994520261,0.9606557377049181,0.9849792145646769,1.0,14/29,31.87%,RSF1;CENPC;SMARCA5;RBBP7;CENPK;KNL1;MIS18BP1;CENPQ;CENPX;NASP;CENPH;MIS18A;CENPN;CENPA
prerank,CENP-A containing chromatin organization (GO:0061641),-0.20370217058947998,-0.6338184994520261,0.9606557377049181,0.9849792145646769,1.0,14/29,31.87%,RSF1;CENPC;SMARCA5;RBBP7;CENPK;KNL1;MIS18BP1;CENPQ;CENPX;NASP;CENPH;MIS18A;CENPN;CENPA
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.19849834020857962,-0.6337807640822424,0.96,0.9840704498832477,1.0,12/32,26.45%,RRN3;TAF1D;TAF1;ERCC2;UBTF;GTF2H5;GTF2H1;GTF2H4;POLR1H;POLR1A;POLR2H;TBP
prerank,cytoplasmic translational initiation (GO:0002183),-0.23871290781722307,-0.633722506303074,0.9226519337016574,0.9831790275142059,1.0,4/17,13.47%,DENR;EIF2S2;EIF2D;EIF3D
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.2686677369035697,-0.6329053049364856,0.9226932668329177,0.9827445848144205,1.0,6/11,38.24%,NDUFA13;ROMO1;TIMM29;TIMM10;TIMM9;TIMM13
prerank,bile acid metabolic process (GO:0008206),0.2594174974166342,0.6328465967697644,0.9217391304347826,0.9808435932170146,1.0,4/27,14.03%,CYP39A1;OSBPL1A;OSBPL9;SLC27A2
prerank,protein export from nucleus (GO:0006611),0.25436586716936743,0.632692587583176,0.9120715350223547,0.9805782976325598,1.0,6/27,14.46%,DUSP16;XPO6;XPO1;SMURF1;NUP42;RAN
prerank,long-chain fatty acid metabolic process (GO:0001676),0.2188856585022003,0.6324780621188634,0.9510309278350515,0.9803712928802035,1.0,9/64,14.64%,ACSL5;ASAH2;ACSBG1;ACOX1;ALOXE3;ACAD9;CPT1A;SLC27A2;ELOVL5
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.19904678799628903,-0.6323289765367641,0.967741935483871,0.9812514885716823,1.0,11/31,25.10%,NCBP1;ERCC2;CMTR1;GTF2F1;RAMAC;GTF2H5;GTF2H1;RNGTT;GTF2H4;NCBP2;POLR2H
prerank,7-methylguanosine RNA capping (GO:0009452),-0.19904678799628903,-0.6323289765367641,0.967741935483871,0.9812514885716823,1.0,11/31,25.10%,NCBP1;ERCC2;CMTR1;GTF2F1;RAMAC;GTF2H5;GTF2H1;RNGTT;GTF2H4;NCBP2;POLR2H
prerank,mRNA stabilization (GO:0048255),0.23765948753968216,0.6322116264447667,0.9360544217687075,0.9801851588920908,1.0,9/40,18.85%,TIRAP;HNRNPA0;ELAVL1;ELAVL4;DHX9;ANGEL2;YBX1;MAPK14;SYNCRIP
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.2837593140628405,0.6321806930893958,0.8814935064935064,0.9798141220090312,1.0,3/15,18.72%,HOMER2;GRM5;GRM7
prerank,regulation of chromatin organization (GO:1902275),-0.24965925484199092,-0.6318879304337198,0.9149484536082474,0.9805949265933962,1.0,6/14,28.94%,SETD1A;IGF2;HNRNPU;PARG;ALKBH4;HPF1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.2485719611356695,-0.6316013251349528,0.907608695652174,0.9798426704100864,1.0,3/14,13.07%,ANXA1;PRKCZ;CD80
prerank,negative regulation of interleukin-6 production (GO:0032715),0.25995239723896846,0.6313649172573832,0.9048951048951049,0.9800835030873274,1.0,3/27,8.17%,ZC3H12A;ARRB1;CD200
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.2314168633077139,0.6307900099763933,0.9504814305364512,0.9801580329111396,1.0,9/45,15.53%,BTG2;BTG1;TOM1L1;ZFP36L2;ANGEL2;BUB1;CTNNB1;FZD3;BTG3
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.26623469413872763,0.6302539680419931,0.8874074074074074,0.9801964288506518,1.0,6/22,19.95%,FKBP1A;MGAT5;ROCK1;BOD1;TIPRL;GSK3B
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.19286613424861965,-0.6300264292695468,0.9747292418772563,0.9798976277828845,1.0,18/38,31.87%,RSF1;CENPC;HAT1;SMARCA5;RBBP7;CABIN1;CENPK;ATRX;KNL1;MIS18BP1;CENPQ;CENPX;NASP;CENPH;MIS18A;HIRA;CENPN;CENPA
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.2743457530497039,0.6296477433259202,0.9080824088748018,0.9802919225907212,1.0,3/17,15.52%,IK;MTBP;BOD1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.2391025177720316,0.6296351528650744,0.9430555555555555,0.9799114593977712,1.0,10/36,19.78%,BRIP1;HINFP;ATM;RAD1;MAP3K20;RAD9B;FBXO6;TIPRL;ATRIP;HUS1
prerank,PERK-mediated unfolded protein response (GO:0036499),0.3106755784395098,0.6295311142821461,0.8662207357859532,0.9795985041415054,1.0,4/10,26.62%,NFE2L2;EIF2S1;DDIT3;HERPUD1
prerank,ubiquinone metabolic process (GO:0006743),0.2816053387899229,0.6288834229561312,0.8936170212765957,0.9797050486544966,1.0,5/15,18.73%,COQ3;PDSS2;PDSS1;COQ5;COQ7
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.2998184566060608,0.6281867675703332,0.8760330578512396,0.9798649047063076,1.0,5/12,25.84%,EAPP;NELFB;NELFA;HEXIM1;RNF8
prerank,regulation of protein acetylation (GO:1901983),0.29236907827447656,0.6281793629039908,0.8957345971563981,0.9794807712537841,1.0,3/12,19.95%,FAM161A;TERF2IP;GSK3B
prerank,snRNA processing (GO:0016180),0.2744868887848012,0.6281661270804799,0.8959627329192547,0.9791017946141745,1.0,4/16,16.35%,INTS11;INTS12;INTS5;INTS6L
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.22407744102536792,-0.6278138142543951,0.936231884057971,0.9803540873125317,1.0,6/20,29.66%,FDX1;AKR1B1;STAR;HSD17B10;TSPOAP1;CYP46A1
prerank,protein ADP-ribosylation (GO:0006471),-0.2059810530614442,-0.6268335712000421,0.9462025316455697,0.9800282056009556,1.0,10/28,29.36%,PARP8;SIRT3;ART3;SIRT2;PARP6;PARP1;PARP3;PARP2;HPF1;SIRT6
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.2461816913166269,-0.6265441627563171,0.9070904645476773,0.9792884203253964,1.0,4/13,18.64%,MDM2;CD74;TWIST1;SNAI1
prerank,non-motile cilium assembly (GO:1905515),0.24699033469025222,0.6262689797949585,0.9451476793248945,0.9801930026266077,1.0,3/30,8.88%,CSNK1D;TMEM216;PCM1
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.23802834873909334,-0.6252668573956645,0.9269662921348315,0.9791024969164005,1.0,1/14,3.31%,THBS1
prerank,global genome nucleotide-excision repair (GO:0070911),0.25263868181241067,0.6249640419818471,0.9113924050632911,0.9808415017513421,1.0,6/26,15.27%,UBA52;RPS27A;RBX1;GTF2H3;ERCC4;XPC
prerank,histone mRNA metabolic process (GO:0008334),0.25080886026659943,0.6241302695906278,0.9254843517138599,0.9810857702303607,1.0,9/27,21.57%,LSM1;MTPAP;SNRPE;XRN1;ATM;TUT7;TENT2;CPSF3;EXOSC10
prerank,neuromuscular process (GO:0050905),0.27398302253174406,0.6234276079675113,0.905511811023622,0.9812584152457233,1.0,2/16,12.69%,GCH1;KCNA1
prerank,positive regulation of double-strand break repair (GO:2000781),-0.18813861462344217,-0.6231905516183677,0.9740740740740741,0.9794143177507737,1.0,13/39,27.29%,KMT5C;SLF1;FMN2;FUS;KMT5B;ACTR2;FANCB;TIMELESS;SLF2;PARP1;PARP3;SETMAR;ZCWPW1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.3017728357689985,0.6231452423731636,0.8631578947368421,0.9810807781278224,1.0,2/10,15.92%,PDE3B;PDE4D
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.19199363323632768,0.6230173472692774,0.9969040247678018,0.9807819095636675,1.0,56/264,20.55%,NOVA2;DDX39A;DDX41;PPIE;BUD13;IK;CPSF1;HNRNPA0;ELAVL1;DCPS;U2SURP;POLR2G;CWF19L2;CACTIN;DHX9;SNRNP48;CELF4;POLR2D;HNRNPK;PRPF38A;SNRPE;FIP1L1;PCBP1;RBM17;SMNDC1;SRSF9;RSRC1;METTL14;HNRNPH2;CLNS1A;PPIH;SART1;SYF2;SF3B4;CRNKL1;ELAVL2;YBX1;PRPF4;SF3A1;POLR2I;RBM15;SPEN;DHX38;SRPK1;ZMAT5;SMU1;DDX39B;HNRNPUL1;CSTF2;SYNCRIP;SF3B6;LSM2;CPSF3;GEMIN8;YTHDC1;SF3B2
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.2586097942878962,0.6229739872061203,0.9111791730474732,0.9804228180276566,1.0,3/23,9.73%,SLC12A8;CLCN3;SLC9A7
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.18146706803516052,-0.6229419024926866,0.9808429118773946,0.9786317646617865,1.0,15/42,27.07%,FBH1;FUS;HELB;ACTR2;RTEL1;KLHL15;FANCB;TIMELESS;CGAS;PARP1;POLQ;RPA2;RMI2;RAD51;CHEK1
prerank,positive regulation of isotype switching (GO:0045830),0.28017932300019077,0.6223261097577808,0.8964968152866242,0.9805035882811154,1.0,8/15,26.42%,MAD2L2;RIF1;SHLD3;PAXIP1;SHLD2;TGFB1;CLCF1;SHLD1
prerank,regulation of autophagosome assembly (GO:2000785),0.24183253263310328,0.6213632425754263,0.9376770538243626,0.9808380275610712,1.0,15/33,29.47%,SMCR8;LRRK2;RAB3GAP2;TBC1D12;UBQLN2;NPRL3;RALB;TBC1D14;FEZ1;CHMP4A;CHMP4B;SCFD1;PIP4K2B;SH3GLB1;PIKFYVE
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.2900626445206789,0.6212179302273091,0.8922829581993569,0.9805506003623239,1.0,5/13,25.84%,EAPP;NELFB;NELFA;HEXIM1;RNF8
prerank,regulation of lipid storage (GO:0010883),0.2605420551582999,0.6209762742893579,0.924924924924925,0.980362399552509,1.0,4/22,11.33%,ZC3H12A;FBXW7;NFKBIA;VSTM2A
prerank,receptor metabolic process (GO:0043112),0.2221019270352559,0.6202304235359191,0.9536679536679536,0.9805569083694963,1.0,13/53,20.28%,CAV1;DNM3;LMTK2;AP2M1;SMURF1;LDLRAP1;CD9;KIF16B;PHETA1;MVB12A;NSG1;REP15;RAB31
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.2726943175528127,0.619910868968976,0.9092356687898089,0.9803921769109185,1.0,6/16,26.25%,VPS36;VPS28;CHMP7;LEPROT;CHMP4A;CHMP4B
prerank,axonal transport of mitochondrion (GO:0019896),-0.26327884330515844,-0.6196897422224005,0.930622009569378,0.9795923851677236,1.0,2/11,12.48%,TRAK1;SPAST
prerank,heme biosynthetic process (GO:0006783),0.26080016721136795,0.6185389049683524,0.9008746355685131,0.9810547941153379,1.0,5/22,17.68%,ALAS1;TSPO;COX15;NFE2L1;CPOX
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.27842343726399504,0.6182155418045711,0.9110378912685337,0.9808944155982029,1.0,1/13,3.50%,UBA7
prerank,nuclear envelope organization (GO:0006998),0.2642285615309125,0.6175517619314812,0.9159021406727829,0.9809839803996676,1.0,9/20,25.00%,TMEM43;SUN3;VPS4A;REEP3;SUN1;NEMP1;LEMD3;EMD;CTDNEP1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.255557604323007,-0.6172002721824834,0.9069767441860465,0.9800941997175285,1.0,2/11,10.61%,CEBPB;CREB3L1
prerank,hyaluronan metabolic process (GO:0030212),0.25972038524869734,0.6160092175379396,0.9284578696343402,0.9817146291871172,1.0,2/23,5.46%,CEMIP2;HYAL2
prerank,cellular response to oxygen levels (GO:0071453),-0.2644312753433167,-0.6131764084338958,0.9230769230769231,0.9814647555593962,1.0,4/10,27.26%,ATP6AP1;ATP6V1A;PICK1;NDUFS2
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.2562897990777703,0.6123927641589405,0.9323076923076923,0.9839480275286651,1.0,4/22,17.39%,TNFRSF18;VSIR;CBFB;SOX12
prerank,translesion synthesis (GO:0019985),0.22857824173192628,0.612102317735221,0.9471488178025035,0.9837779321462728,1.0,8/42,16.11%,USP43;POLK;UBA52;RPS27A;MAD2L2;TRIM25;RFC2;SPRTN
prerank,mitotic chromosome condensation (GO:0007076),-0.20241448167369083,-0.6115950663642093,0.9674267100977199,0.981417222465136,1.0,10/26,28.84%,SET;NCAPG2;AKAP8L;NCAPH2;PHF8;NCAPD2;NUSAP1;KMT5A;NCAPH;TTN
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.27977753745790385,0.6087410007521673,0.9093904448105437,0.98583591622259,1.0,1/13,3.69%,RPS21
prerank,mRNA processing (GO:0006397),0.18716818469795887,0.6087171726068098,0.997946611909651,0.9854627847370372,1.0,85/287,26.55%,NOVA2;DDX39A;DDX41;PPIE;BUD13;IK;CPSF1;HNRNPA0;ELAVL1;U2SURP;POLR2G;CWF19L2;CACTIN;DHX9;SNRNP48;POLR2D;HNRNPK;PRPF38A;RPRD1B;SNRPE;FIP1L1;PCBP1;GTF2H3;CHTOP;RBM17;SMNDC1;SRSF9;RSRC1;METTL14;HNRNPH2;THOC3;PPIH;SART1;SYF2;SF3B4;CRNKL1;ELAVL2;YBX1;PRPF4;SF3A1;POLR2I;RBM15;SPEN;DHX38;ZMAT5;POLDIP3;RPRD2;SMU1;DDX39B;HNRNPUL1;CSTF2;SYNCRIP;SF3B6;LSM2;ERN1;CPSF3;YTHDC1;SF3B2;MNAT1;SF3A3;CWC25;PRCC;PQBP1;RPRD1A;SF3B3;POLR2C;TBRG4;KIN;POLR2B;ZCRB1;POLR2J;PRPF40B;CCNH;FRG1;ALYREF;PRPF6;THOC5;CTNNBL1;PHF5A;LSM7;LSM5;WDR33;SYMPK;DDX23;HNRNPF
prerank,DNA repair (GO:0006281),0.1858259923684714,0.6084274835572708,1.0,0.9852842785561035,1.0,48/284,17.41%,HERC2;BTG2;RBBP8;WRNIP1;APEX1;RAD21;SETX;ENDOV;EXD2;TENT4A;POLK;UBA52;RPS27A;FEN1;BABAM2;ASF1A;NSMCE3;MAD2L2;POLA1;BRIP1;ASCC3;WDHD1;ASCC1;POLB;NPM1;GTF2H3;DTX3L;BRCA1;HINFP;LIG1;EYA3;UBE2T;ATM;ERCC4;RAD1;CDKN2D;RAD51D;NSMCE4A;RAD18;XPC;TRAIP;RFC2;TRRAP;RAD9B;SPRTN;MMS19;FBXO6;MEN1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.2432643222254987,0.6082362008015711,0.9290989660265879,0.9850218037619832,1.0,12/28,27.89%,MAD2L2;DTX3L;KDM4D;RIF1;SHLD3;CYREN;SHLD2;NUDT16L1;WRAP53;SHLD1;PARP9;SMCHD1
prerank,regulation of macrophage differentiation (GO:0045649),0.27479417836184933,0.6081062143386481,0.9159935379644588,0.9847227028646303,1.0,1/15,2.35%,CASP8
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.25072594754776223,0.6064906976698251,0.9387144992526159,0.9854339584973633,1.0,11/25,29.90%,EFNA1;PRKCG;OPHN1;PSME3IP1;EPHA4;SGTA;CSNK2A2;RPL11;F8A1;HSP90AB1;RPS7
prerank,negative regulation of telomere maintenance (GO:0032205),0.27231976177680683,0.6060320837082546,0.9043062200956937,0.9853701593518808,1.0,5/15,22.99%,TNKS;ATM;ERCC4;TERF2IP;TERF2
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.2563022515454309,-0.604100876963119,0.9302884615384616,0.9843636695352596,1.0,4/11,18.15%,RESF1;MPHOSPH8;SETDB2;ATF7IP
prerank,protein localization to chromosome (GO:0034502),0.22596996782268228,0.6011540626111669,0.940677966101695,0.9881664257107352,1.0,12/34,28.06%,RAD21;TNKS;CHMP7;BOD1;ESR1;TERF2IP;TERF2;XRCC4;CTCF;TINF2;TNKS2;WAPL
prerank,protein kinase A signaling (GO:0010737),0.28067280373033876,0.5997361102420632,0.9205087440381559,0.9886872071362728,1.0,6/12,29.71%,GAL;LCP1;RDX;PRKACB;RAB13;MYOM1
prerank,NAD biosynthetic process (GO:0009435),-0.21401830834914085,-0.5995847474160088,0.95,0.9857670666755435,1.0,1/20,1.37%,NMNAT2
prerank,nucleosome assembly (GO:0006334),0.23593179746211676,0.5984517406413149,0.9408284023668639,0.9891308594719166,1.0,10/31,21.08%,ASF1A;NPM1;HMGB2;ANP32B;DAXX;NAP1L4;H3-3A;RBBP4;NAP1L3;IPO4
prerank,chromatin assembly (GO:0031497),0.22971496188610696,0.5984166704471825,0.9332425068119891,0.9887633447569729,1.0,11/38,21.05%,ASF1A;CDAN1;NPM1;HMGB2;ANP32B;DAXX;NAP1L4;H3-3A;RBBP4;PRDM9;NAP1L3
prerank,mitotic nuclear division (GO:0140014),0.2055381165184994,0.598256727839274,0.9726708074534162,0.9884679864547476,1.0,12/71,16.33%,RAB11A;KIF2A;CLASP1;KPNB1;DSN1;STAG1;CLASP2;ARHGEF10;RAN;CHMP7;NDC80;SGO1
prerank,regulation of microtubule-based movement (GO:0060632),0.2733418327637268,0.598077994760143,0.904,0.9881932150507705,1.0,4/11,22.00%,NEFH;MAP2;HAP1;IGBP1
prerank,base-excision repair (GO:0006284),-0.17125312059323405,-0.5966808656932621,0.9916666666666667,0.9862364271614906,1.0,24/48,38.53%,RFC1;XRCC1;ERCC5;LIG3;HMGA2;RPA3;PARG;RPA1;PARP1;POLQ;POLD2;NEIL1;RPA2;POLE;RFC4;APEX2;POLL;POLD3;RFC5;TDG;NEIL2;DNA2;XPA;POLD1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.20407356410584424,0.5964634230400536,0.9817518248175182,0.9888306497324768,1.0,11/82,11.21%,CSNK1D;TUBB;TUBB4B;CLASP1;NEDD1;HAUS3;CEP135;PCM1;CEP76;DYNLL1;NPM1
prerank,anterograde axonal transport (GO:0008089),0.22917972639782755,0.5957554277160131,0.9539748953974896,0.9888889403847041,1.0,14/37,29.03%,BLOC1S6;HSPB1;AP3S1;KIF1A;AP3M1;RAB27B;HAP1;AP3D1;SOD1;KIF5A;AP3B1;RAB21;BLOC1S5;AP3M2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.24373339187341236,0.5952201129544441,0.9381598793363499,0.9888140421685525,1.0,3/25,10.32%,APP;ANKRD13A;RAC1
prerank,error-free translesion synthesis (GO:0070987),-0.20265623066510383,-0.5949252243424923,0.9464285714285714,0.9861801236585926,1.0,8/22,27.02%,RCHY1;RFC1;POLDIP2;REV1;RPA3;RPA1;RPA2;RFC4
prerank,intracellular protein transmembrane transport (GO:0065002),-0.17420608853678257,-0.5944011412152396,0.984251968503937,0.9855014275615047,1.0,13/42,25.75%,C2CD5;PEX2;TIMM17B;CHCHD4;TIMM21;PEX7;GRPEL2;ROMO1;SEC61A2;DNAJC15;ZFAND2B;PEX16;SEC61G
prerank,macrophage chemotaxis (GO:0048246),0.2852667515324032,0.5942322940976588,0.9222972972972973,0.9890149475571202,1.0,1/10,7.63%,TAFA4
prerank,cellular response to pH (GO:0071467),0.2579635038507587,0.593566198427467,0.9113924050632911,0.9890460113773852,1.0,2/17,10.53%,MCOLN1;GPR68
prerank,platelet aggregation (GO:0070527),0.23319521409981125,0.5933773229543666,0.949438202247191,0.9887664845386375,1.0,7/33,16.04%,MYH9;HSPB1;ACTG1;ACTB;PIK3CB;STXBP3;FERMT3
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2441203963680279,0.5928767351967277,0.9262536873156342,0.9886961301519668,1.0,10/25,27.35%,EAF1;EAF2;EAPP;NELFB;NELFA;HEXIM1;WDR43;ZMYND11;RNF8;CDC73
prerank,positive regulation of stem cell proliferation (GO:2000648),0.26090936895722655,0.5917762962556276,0.9381933438985737,0.9889795189525257,1.0,4/17,18.79%,CCNE1;THPO;KAT7;SOX11
prerank,histone acetylation (GO:0016573),0.2066975856331484,0.5917115413701961,0.98375,0.9886303533439903,1.0,11/69,15.62%,ING3;LEF1;BRD8;MRGBP;JADE2;CHD5;BRD1;DMAP1;SGF29;KAT7;TRRAP
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.24586812600361857,0.5900875053787905,0.93033381712627,0.9892124934528758,1.0,6/24,21.26%,ALAS1;TSPO;COX15;NFE2L1;CPOX;RSAD1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.2447881501257781,0.5896372451426369,0.9231863442389758,0.9890888254469964,1.0,5/22,15.27%,UBA52;RPS27A;RBX1;GTF2H3;XPC
prerank,protein palmitoylation (GO:0018345),0.2324555960333433,0.5891815152476944,0.9429763560500696,0.9889660488483522,1.0,7/30,24.61%,ZDHHC22;ZDHHC14;ZDHHC5;ZDHHC23;SELENOK;ZDHHC13;GLUL
prerank,protein insertion into membrane (GO:0051205),0.22842169229332082,0.586382877604131,0.947075208913649,0.9901469483565868,1.0,11/32,25.08%,APP;PRNP;GET1;REEP1;UBE2J2;VAPA;CCDC47;CYB5A;EMD;SGTA;MAIP1
prerank,C-terminal protein amino acid modification (GO:0018410),0.28244790410426035,0.5847123231163043,0.9270833333333334,0.9907160718218372,1.0,4/11,22.88%,TTL;LCMT1;AGBL4;FOLH1
prerank,chromatin assembly or disassembly (GO:0006333),0.27910875872537777,0.5838914438344381,0.9113300492610837,0.9907963395574381,1.0,4/11,23.94%,CDAN1;SUV39H2;RBBP4;HIRIP3
prerank,mitochondrial fission (GO:0000266),0.2597257268766483,0.5822528380525915,0.9420289855072463,0.9913298622527036,1.0,1/16,3.37%,DNM3
prerank,regulation of protein localization to cell surface (GO:2000008),0.225256011556387,0.5820716333658775,0.9608938547486033,0.9910367691686754,1.0,9/33,21.60%,GOPC;TAX1BP3;TYROBP;NEDD4L;CTNNB1;ABCA7;KCNAB2;BDNF;LEPROT
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.24907622436212634,0.5817710160383311,0.9467084639498433,0.9908120677768013,1.0,2/18,10.46%,CMKLR1;BAG6
prerank,positive regulation of telomere maintenance (GO:0032206),-0.1869737909671192,-0.5797605028810844,0.9873817034700315,0.99091898052112,1.0,12/31,29.36%,HNRNPA2B1;RAD50;PPP1R10;MAP2K7;RTEL1;PML;ATRX;GNL3;NAF1;HNRNPD;NABP2;SIRT6
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.24472437092987642,0.579006432491079,0.9456869009584664,0.9919130210195864,1.0,5/20,19.59%,CAMK2D;RAP1GDS1;CCDC47;SELENOK;PACS2
prerank,purine nucleotide biosynthetic process (GO:0006164),0.26724832402586124,0.5784595772602734,0.94,0.9918259551024922,1.0,1/12,3.72%,GART
prerank,mRNA export from nucleus (GO:0006406),0.19229387807568432,0.5782633997092007,0.9919354838709677,0.9915386677944021,1.0,31/102,26.78%,HHEX;DDX39A;CPSF1;NUP54;POLR2D;NUP35;FIP1L1;RANBP2;CHTOP;NUP153;SRSF9;NUP160;THOC3;NUP42;DHX38;NUP205;POLDIP3;DDX39B;SMG7;CPSF3;YTHDC1;IWS1;NUP50;RAE1;ALYREF;SEH1L;THOC5;TPR;WDR33;SYMPK;DDX19A
prerank,mismatch repair (GO:0006298),-0.18812834171351034,-0.5778225674032962,0.9817073170731707,0.9908162278963119,1.0,17/27,40.16%,MLH3;MLH1;MSH6;PMS1;RPA3;RPA1;ABL1;POLD2;RPA2;EXO1;POLD3;PMS2;TDG;ERCC1;MSH4;POLD1;MCM9
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.18281154634899152,-0.5771400492721774,0.987460815047022,0.9901746499684413,1.0,8/30,18.74%,RNF31;UBL5;UBE2L3;ARIH2;HPS4;MICALL2;HTRA2;ABLIM3
prerank,cholesterol metabolic process (GO:0008203),0.20121747956402056,0.5763853815624955,0.9877600979192166,0.9921857919012403,1.0,20/68,26.19%,APOA1;LCAT;OSBPL1A;PLPP6;HMGCS1;TSKU;LDLRAP1;MVD;SOAT1;ACAA2;DHCR7;GGPS1;OSBPL5;ACLY;MVK;IDI1;INSIG1;HMGCR;FDFT1;CLN8
prerank,aerobic electron transport chain (GO:0019646),0.1990959477925642,0.5748901089613458,0.9852579852579852,0.9925682035598189,1.0,18/68,23.35%,UQCC3;NDUFS4;NDUFA12;UQCRB;NDUFB5;COX5A;NDUFB7;UQCRFS1;UQCRC1;COX15;SDHC;NDUFB4;COX6A1;UQCRC2;COX7C;NDUFA9;NDUFV1;NDUFC1
prerank,striated muscle cell development (GO:0055002),0.26332454922514453,0.574610355289743,0.9397394136807817,0.9923280114223273,1.0,4/14,24.02%,FLII;TMOD3;TMOD1;KLHL41
prerank,RNA export from nucleus (GO:0006405),0.19137657360479596,0.5731390031974929,0.9929245283018868,0.992700584247451,1.0,21/100,20.30%,HHEX;DDX39A;CPSF1;NUP54;NUP35;FIP1L1;RANBP2;CHTOP;NUP153;SRSF9;NUP160;THOC3;NUP42;RAN;DHX38;NUP205;POLDIP3;DDX39B;SMG7;CPSF3;YTHDC1
prerank,organelle fusion (GO:0048284),0.23959970589660562,0.5729876306228725,0.9398148148148148,0.992396528504557,1.0,4/22,13.14%,CHCHD3;MIGA1;MFN1;CYP26C1
prerank,organic cation transport (GO:0015695),0.24715642494769452,0.571965714126057,0.95,0.9925274983065403,1.0,6/20,22.84%,SLC44A1;SLC22A5;SEC14L1;SLC29A4;SLC25A19;SLC25A42
prerank,nucleosome organization (GO:0034728),0.20521164284214713,0.5718528224678673,0.9806949806949807,0.9922044041620975,1.0,15/55,21.05%,SRCAP;ASF1A;NPM1;ACTR6;DMAP1;SMARCC1;HMGB2;VPS72;ANP32B;DAXX;NAP1L4;H3-3A;SETD2;PRDM9;NAP1L3
prerank,hydrogen peroxide metabolic process (GO:0042743),0.23933204611577955,0.5703374637074999,0.9375,0.9925788123639715,1.0,6/19,27.17%,ACOX1;CYBA;SOD1;MAOB;NOX1;PRDX5
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.19648340610093187,-0.5698302665704766,0.9736070381231672,0.9921640165695336,1.0,8/20,32.51%,GRK3;MET;STMN1;PLEK;RPGRIP1L;GRK2;ADA;RGS2
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.23714444593448564,-0.569002304905972,0.9538461538461539,0.9915421061971196,1.0,2/12,8.57%,PRKCB;PRKCA
prerank,DNA packaging (GO:0006323),-0.2139969592869126,-0.5677233573290714,0.9646739130434783,0.9910960397924524,1.0,5/16,25.54%,HAT1;NOC2L;H1-0;NAA10;CHAF1A
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.2550786906047036,0.5667761699728062,0.948220064724919,0.9939512622043959,1.0,8/16,28.46%,TNKS;ATM;ERCC4;TERF2;DHX36;TINF2;TNKS2;SMG5
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.24593886523368824,0.5667013283561881,0.9390444810543658,0.9935999967222249,1.0,1/15,2.94%,SYN3
prerank,protein import into peroxisome matrix (GO:0016558),-0.22790712874976835,-0.566052252406738,0.9680589680589681,0.9907743128840716,1.0,5/12,29.96%,PEX2;PEX7;PEX13;PEX16;PEX12
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.26307304518187435,0.565680509714771,0.928,0.9937077780112521,1.0,6/12,27.89%,BRCA1;RBM15;YTHDC1;LRIF1;CDYL;SMCHD1
prerank,DNA catabolic process (GO:0006308),0.2690564796737839,0.5613516657075835,0.9311531841652324,0.995339004211523,1.0,2/11,10.95%,DFFB;XRN2
prerank,histone H2B ubiquitination (GO:0033523),0.2725716714086565,0.5613143898352074,0.925,0.9949687051507119,1.0,6/10,27.35%,DTX3L;UBE2E1;RNF20;RNF40;RNF8;CDC73
prerank,phagosome maturation (GO:0090382),0.2182031151501267,0.5612690781706318,0.9715909090909091,0.9946030242481251,1.0,8/35,20.33%,RAB39A;RAB34;MCOLN1;ATP6V1G1;ATP6V1C1;ATP6V0A1;RAB31;ATP6V1D
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.2615916885144668,0.5611113435275723,0.928698752228164,0.9942935076464314,1.0,4/11,21.08%,ASF1A;H3-3A;RBBP4;IPO4
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.19379920257755973,0.5603789662025708,0.9902200488997555,0.9942481828316939,1.0,18/69,23.35%,UQCC3;NDUFS4;NDUFA12;UQCRB;NDUFB5;COX5A;NDUFB7;UQCRFS1;UQCRC1;COX15;SDHC;NDUFB4;COX6A1;UQCRC2;COX7C;NDUFA9;NDUFV1;NDUFC1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.2037117925277287,-0.5602565749800088,0.9622641509433962,0.9918669348713837,1.0,10/18,34.88%,NPHP3;OFD1;RFX3;CABYR;CFAP53;ROPN1L;CCDC39;SPAG17;DNAAF2;ODAD4
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.20289305450237044,-0.5601643266120998,0.9792284866468842,0.9909867206829857,1.0,4/20,17.90%,AMPD3;LHPP;ATIC;IMPDH2
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.18707924161342188,0.5594572471834979,0.9953051643192489,0.9942846824676776,1.0,20/96,20.30%,HHEX;DDX39A;CPSF1;NUP54;NUP35;FIP1L1;RANBP2;CHTOP;NUP153;SRSF9;NUP160;THOC3;NUP42;DHX38;NUP205;POLDIP3;DDX39B;SMG7;CPSF3;YTHDC1
prerank,long-term memory (GO:0007616),-0.20696128709119524,-0.5593642662634021,0.9625668449197861,0.9903330549213126,1.0,3/19,15.14%,APOE;CPEB3;EIF2AK4
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.2736401742258794,0.5585981852761491,0.9385964912280702,0.9942956045535317,1.0,2/10,14.64%,APOA1;ELOVL5
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.21683028056308679,-0.557225639065076,0.957345971563981,0.9901674862324316,1.0,4/14,20.07%,ATR;TERT;XRCC5;ATRX
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.25352365109128466,0.5563512645824871,0.9499165275459098,0.9948935297832551,1.0,6/14,26.42%,MAD2L2;RIF1;SHLD3;PAXIP1;SHLD2;SHLD1
prerank,phospholipid metabolic process (GO:0006644),0.1957277471215229,0.5542213809440542,0.9935979513444302,0.9954183308245593,1.0,4/71,5.31%,PLPP1;ACP6;LPCAT4;LCAT
prerank,negative regulation of cholesterol transport (GO:0032375),-0.2420777229606845,-0.5519519187320623,0.9405940594059405,0.9909813521213674,1.0,7/10,55.39%,NFKB1;APOC1;SHH;ABCA2;ABCG5;APOA2;PLA2G10
prerank,regulation of adaptive immune response (GO:0002819),0.23727770942801868,0.5516565825968895,0.956386292834891,0.9961135097946523,1.0,1/18,4.01%,FCGR2B
prerank,termination of RNA polymerase I transcription (GO:0006363),0.21785111968296808,0.5510014542994756,0.9710982658959537,0.995999690500499,1.0,5/30,14.21%,TAF1A;POLR1F;CAVIN1;GTF2H3;TAF1B
prerank,regulation of mitochondrial translation (GO:0070129),0.23190249970418958,0.5497803777130151,0.9656716417910448,0.9961291879816211,1.0,2/21,7.35%,MTG2;NGRN
prerank,folic acid-containing compound metabolic process (GO:0006760),0.2365741840486441,0.5496426954750397,0.9546165884194053,0.9958044726991153,1.0,1/19,2.73%,SLC25A32
prerank,maturation of 5.8S rRNA (GO:0000460),0.24006326206717574,0.5487305812374342,0.9652996845425867,0.9958100732732084,1.0,7/17,22.90%,RRP15;EIF6;LAS1L;FTSJ3;C1D;EXOSC10;URB1
prerank,sulfur amino acid metabolic process (GO:0000096),0.22867154345174318,0.5479954252702885,0.9598214285714286,0.9957345567401455,1.0,4/24,19.44%,TST;SMS;MSRA;CDO1
prerank,tryptophan catabolic process (GO:0006569),0.2612516477308394,0.5470599152477204,0.9392361111111112,0.9957315626611716,1.0,11/11,73.89%,KYAT1;KYNU;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;IL4I1;AFMID;KMO
prerank,vacuolar acidification (GO:0007035),-0.19122360891021517,-0.5468515342715067,0.9854227405247813,0.9916575364459069,1.0,11/21,33.55%,ATP6V0A4;TCIRG1;CLN5;CLN3;ATP6V0D2;ATP6V1H;CLN6;DMXL1;SLC11A1;ATP6V0E2;TMEM9
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.17696177542988373,-0.5448912520106081,0.9862068965517241,0.9913222425480761,1.0,6/29,16.63%,RFC1;RAD50;PPIA;TERT;TELO2;RTEL1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.24195830389896852,0.5421072388714223,0.9541139240506329,0.9972884915062263,1.0,8/16,27.89%,PARPBP;MAD2L2;UBQLN4;RIF1;SHLD3;SHLD2;SHLD1;SMCHD1
prerank,DNA replication (GO:0006260),0.17855648762409257,0.5409170476018628,1.0,0.9973463485648439,1.0,25/105,23.21%,RBBP8;WRNIP1;ORC3;FEN1;POLA1;BRIP1;WDHD1;POLG2;POLB;BRCA1;ORC5;ATM;RAD1;KAT7;RFC2;RAD9B;MCMBP;ATRIP;BARD1;HUS1;BLM;RMI1;KIN;RNASEH2A;ORC4
prerank,insulin secretion (GO:0030073),0.22786119789835485,0.5396250163053831,0.9573170731707317,0.9974812360113433,1.0,6/19,29.26%,GAL;SNX19;RAB11FIP2;PTPRN2;SELENOT;MAFA
prerank,positive regulation of cytokinesis (GO:0032467),0.21210991990420078,0.5387302240166651,0.9678321678321679,0.9974318145422161,1.0,7/32,22.24%,CUL3;CDC14A;PKN2;MAP10;GIPC1;ECT2;KIF23
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.23151334854633676,0.5386078487362306,0.9504643962848297,0.9970927431110392,1.0,1/18,3.36%,HHEX
prerank,DNA modification (GO:0006304),0.22594221105527637,0.5384127963995377,0.9775112443778111,0.9967871504713298,1.0,22/22,77.44%,EXOSC3;TERF2IP;MUTYH;TERF2;TINF2;OGG1;NTHL1;ACD;TERF1;SMUG1;NEIL3;MPG;MBD4;UNG;NEIL2;TDG;EXOSC4;EXOSC5;PARP2;NEIL1;PARP3;PARP1
prerank,DNA methylation (GO:0006306),0.22172684968775885,0.5377792159607955,0.9740061162079511,0.996638830999748,1.0,4/23,12.90%,GATAD2A;KMT2E;DMAP1;PPM1D
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.25222468402644926,0.5366578397310856,0.956953642384106,0.9966565841509041,1.0,1/11,7.75%,JAK2
prerank,branched-chain amino acid metabolic process (GO:0009081),0.23027018389318882,0.5363296284048503,0.9702380952380952,0.9960185824989854,1.0,5/20,20.97%,BCAT2;DLD;BCKDHB;ACAT1;BCAT1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.23027018389318882,0.5363296284048503,0.9702380952380952,0.9960185824989854,1.0,5/20,20.97%,BCAT2;DLD;BCKDHB;ACAT1;BCAT1
prerank,indolalkylamine catabolic process (GO:0046218),0.26123524981169977,0.5359501385665499,0.9630281690140845,0.9957713272135552,1.0,10/10,73.89%,KYAT1;KYNU;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;IL4I1;KMO
prerank,cilium-dependent cell motility (GO:0060285),-0.187472252972057,-0.5319745599806858,0.9871794871794872,0.994088353169027,1.0,11/22,36.24%,CFAP44;EFHC1;RFX3;GAS8;RSPH9;DRC1;CCDC39;CCDC65;DNAAF2;TEKT2;DNAH17
prerank,folic acid metabolic process (GO:0046655),0.23124714492466653,0.5316793586394746,0.9667194928684627,0.9969005709265805,1.0,1/18,2.73%,SLC25A32
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.21751447983856378,0.5310583152400179,0.9711246200607903,0.9967283862769908,1.0,11/24,29.06%,STN1;TNKS;XRN1;ERCC4;CTC1;EXOSC10;TERF2;TINF2;TNKS2;HNRNPC;HNRNPA1
prerank,neuron projection fasciculation (GO:0106030),0.2605899816264019,0.5309474387679568,0.946551724137931,0.9963876418338057,1.0,4/10,22.25%,NRCAM;RTN4;CNTN4;EPHA4
prerank,isotype switching (GO:0045190),0.2652893136669714,0.5306078443472523,0.9511784511784511,0.9961297205022481,1.0,1/10,7.32%,EXOSC3
prerank,cellular response to arsenic-containing substance (GO:0071243),0.23398946881710847,0.5301252301023688,0.9648562300319489,0.9959194907255152,1.0,6/15,29.06%,ZC3H12A;DAXX;PPIF;DHX36;ZFAND1;HNRNPA1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.23576353392441102,0.5295687633201613,0.9653543307086614,0.9957277120201765,1.0,4/16,18.15%,MRAP2;CHGA;GSK3A;NECAB2
prerank,water-soluble vitamin metabolic process (GO:0006767),0.18255018050954597,0.5289541252865546,0.995049504950495,0.9955419154208832,1.0,7/68,12.83%,SLC2A1;SLC25A32;THTPA;RFK;MMAA;PDZD11;ABCC1
prerank,glycoprotein catabolic process (GO:0006516),0.23480589449322242,0.5275478739040442,0.957345971563981,0.9956366164038304,1.0,6/17,19.53%,MANBA;FBXO2;OGA;FBXO6;NGLY1;NEU4
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.2538915221364929,0.520662283878881,0.9521367521367521,0.9974675351182041,1.0,4/10,28.11%,APC;ECT2;KNSTRN;RCC2
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.2356826594307453,0.5202617103807636,0.9614767255216693,0.9972086274633866,1.0,5/14,22.74%,ACOX1;ACOX3;CROT;DECR2;HSD17B4
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.18722635416141215,-0.517804313794239,0.9778393351800554,0.9966878426512944,1.0,3/17,13.32%,AFG1L;COX10;COX7A2L
prerank,tRNA 5'-end processing (GO:0099116),-0.19659248203782942,-0.5175220135393686,0.973753280839895,0.9958451344155137,1.0,8/15,40.35%,SSB;RPP14;POP4;HSD17B10;RPP25L;POP7;RPP40;POP5
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.2080027282473141,0.5172508305872507,0.9739130434782609,0.9977290381649656,1.0,2/27,7.35%,CTPS1;CMPK1
prerank,negative regulation of secretion (GO:0051048),0.2516381135411375,0.5171120979168403,0.9347442680776014,0.9973871440813544,1.0,1/10,7.44%,VAMP8
prerank,acylglycerol catabolic process (GO:0046464),0.20322010737181787,0.5165598549727852,0.9824046920821115,0.9971619410605224,1.0,5/30,23.64%,ABHD6;ABHD2;FABP3;PNPLA2;MGLL
prerank,steroid catabolic process (GO:0006706),-0.2205503312265245,-0.5159262114724207,0.972972972972973,0.9952697793973736,1.0,3/10,26.18%,SPP1;HSD11B1;HSD17B11
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.23146177753765218,0.5121414268918613,0.9761526232114467,0.9980088126483814,1.0,3/15,16.07%,PTTG1;CDC27;ANAPC7
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.18664478593571565,-0.5121399967635895,0.9868073878627969,0.9952213035913045,1.0,10/18,37.39%,LIG3;POLD2;GINS1;POLE;RFC4;MCM7;POLD3;POLE3;GINS3;GINS2
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.22228689097463905,0.5117654599679413,0.9693721286370597,0.997729639857265,1.0,2/16,9.45%,ZC3H12A;ZFP36L2
prerank,cellular response to light stimulus (GO:0071482),0.17672769790611384,0.5097258275945619,0.9987593052109182,0.9979100481004799,1.0,19/66,28.54%,RRH;RHBDD1;POLK;NSMCE3;NPM1;ERCC4;EIF2S1;BMF;COPS9;USP47;TMEM161A;DHX36;RPL26;RUVBL2;PCNA;SMPD1;INO80;ZBTB1;SAG
prerank,telomere maintenance via telomerase (GO:0007004),0.20266117911949372,0.5024768558289081,0.9831460674157303,0.9993919429674734,1.0,12/28,29.82%,DKC1;PTGES3;NHP2;TERF2IP;SHQ1;TERF2;ANKRD28;WRAP53;TINF2;HSP90AA1;NOP10;HSP90AB1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.23461593500991296,0.5023299327811315,0.9805825242718447,0.9990424502681318,1.0,6/12,29.01%,GSS;CHAC2;GGCT;GCLM;OPLAH;CNDP2
prerank,cellular response to UV (GO:0034644),0.17150402807967816,0.5006161241565312,0.9975932611311673,0.9990932099689959,1.0,21/76,26.53%,MMP1;HYAL2;RHBDD1;POLK;NSMCE3;NPM1;ERCC4;EIF2S1;XPC;BMF;PPID;TIMP1;COPS9;USP47;TMEM161A;MME;DHX36;CARD16;RPL26;RUVBL2;PCNA
prerank,lysine catabolic process (GO:0006554),0.23277156750574113,0.49806267880563215,0.9666666666666667,0.9989272570505059,1.0,4/12,22.76%,DLD;AASS;PHYKPL;PIPOX
prerank,lysine metabolic process (GO:0006553),0.23277156750574113,0.49806267880563215,0.9666666666666667,0.9989272570505059,1.0,4/12,22.76%,DLD;AASS;PHYKPL;PIPOX
prerank,regulation of phosphate metabolic process (GO:0019220),-0.18749215119929677,-0.4921098293759618,0.9882352941176471,0.9981100923123923,1.0,16/16,81.28%,SIRT2;SRPX2;TIGAR;PSEN1;SMG6;MCM7;GNB3;IL4;RAD17;IKBKB;SMG5;PGAM1;IGBP1;BARD1;SMG7;CD24
prerank,detection of calcium ion (GO:0005513),0.22179055627926877,0.4882676659248698,0.9808,1.0,1.0,5/13,26.43%,CALM3;SYT1;KCNIP2;RYR2;CALM1
prerank,Golgi to lysosome transport (GO:0090160),0.23160359262525612,0.4878437157643154,0.9810126582278481,1.0,1.0,3/11,20.25%,LAPTM5;CCDC91;SORT1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.20388407638827513,-0.48348212750692005,0.9777227722772277,0.9986051922457662,1.0,3/11,20.90%,SIRT2;STMN1;MST1R
prerank,DNA replication initiation (GO:0006270),0.1807797823543082,0.4820512249657286,0.992721979621543,1.0,1.0,4/37,12.36%,ORC3;PURA;POLA1;ORC5
prerank,glycerolipid metabolic process (GO:0046486),-0.20249827380578744,-0.48196033025671975,0.9828850855745721,0.9979093567910121,1.0,11/11,79.77%,PLA2G15;GAL3ST1;PDXP;PNPLA3;DGKZ;PGP;DGKQ;PIP5K1A;DGKG;DGKB;DGKA
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.22795632791680945,0.4816292641310787,0.9749582637729549,1.0,1.0,1/11,9.92%,MAD2L2
prerank,"base-excision repair, gap-filling (GO:0006287)",0.1844044774313829,0.48093735021767,0.9915492957746479,1.0,1.0,5/35,15.54%,APEX1;FEN1;POLB;LIG1;RFC2
prerank,intracellular cholesterol transport (GO:0032367),0.2154644973603331,0.4787813819724586,0.9806138933764136,1.0,1.0,3/15,19.11%,VPS4A;LDLRAP1;RELCH
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.2065524622147843,-0.4781030788638891,0.9787735849056604,0.9975622999492454,1.0,4/10,30.54%,UBE2G2;SVIP;ERLEC1;DERL2
prerank,regulation of lymphocyte proliferation (GO:0050670),0.2101150208210617,0.4744713621528416,0.9754500818330606,1.0,1.0,1/16,5.70%,TNFRSF1B
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.1839870777579914,-0.4696832796874435,0.9853658536585366,0.9977490056265681,1.0,4/13,30.18%,MDK;ITGB2;RHOA;NFAT5
prerank,estrogen metabolic process (GO:0008210),0.20600238588560305,0.468081672548015,0.9825396825396825,1.0,1.0,15/15,79.42%,SULT1A1;HSD17B4;UGT1A7;UGT1A1;HSD3B1;CYP1B1;CYP19A1;CYP1A1;HSD17B7;HSD17B1;HSD17B14;HSD17B2;HSD17B10;HSD17B11;HSD17B8
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.22099036628798097,0.46765924219360644,0.9851239669421488,1.0,1.0,3/11,21.92%,THTPA;SLC25A19;NT5C3A
prerank,nucleoside salvage (GO:0043174),0.22652523223700732,0.46734812899737754,0.9744525547445255,1.0,1.0,10/10,77.36%,UPP2;TK1;UCK2;HPRT1;UCKL1;UPP1;TK2;DCK;UCK1;CDA
prerank,macrophage migration (GO:1905517),-0.18443512780392585,-0.4645153400354876,0.9894736842105263,0.9974872441036102,1.0,7/13,40.56%,P2RX4;EDNRB;CKLF;CCR2;CCL2;CXCL17;CCL5
prerank,tRNA 5'-leader removal (GO:0001682),-0.18437145050345452,-0.4627691261599014,0.9865229110512129,0.996782634302025,1.0,7/13,40.35%,SSB;RPP14;POP4;RPP25L;POP7;RPP40;POP5
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.21907442901026358,0.4601604282349053,0.9849246231155779,1.0,1.0,4/12,25.68%,ZC3H12A;ESR1;NCOR2;TGFB1
prerank,serine family amino acid metabolic process (GO:0009069),0.20581263662425708,0.4587701994535011,0.9801829268292683,1.0,1.0,3/16,19.44%,GLYAT;SEPSECS;CDO1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.21232544151100158,0.45659413582556047,0.9791666666666666,1.0,1.0,5/12,30.27%,STK33;HUS1;CHEK2;NAE1;TOPBP1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.2046118084548876,0.45625545524132416,0.9855769230769231,1.0,1.0,4/15,19.78%,NEK11;RAD9B;MDC1;HUS1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.22207453153224838,0.4559382872191804,0.9904,1.0,1.0,3/10,26.80%,NUMA1;PRKCH;NCOA3
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.2112097469713305,0.45537869182100515,0.9918831168831169,1.0,1.0,4/13,20.29%,ALG14;ALG11;DPAGT1;ALG1
prerank,triglyceride catabolic process (GO:0019433),0.1920492369528355,0.4539769358523035,0.9860681114551083,1.0,1.0,19/19,80.82%,FABP3;PNPLA2;PNLIPRP2;PNPLA1;FABP2;LIPI;PNPLA5;FABP6;APOC3;FABP5;CPS1;LIPG;PNPLA3;FABP12;FABP4;LIPC;LIPH;FABP7;LPL
prerank,histone H2A ubiquitination (GO:0033522),0.1979235170782324,0.45396603470021557,0.985691573926868,1.0,1.0,3/17,16.92%,RYBP;DTX3L;KDM2B
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.1740174962358107,0.4519185786712335,0.9971988795518207,1.0,1.0,9/31,28.80%,TOMM20L;DNLZ;PAM16;PEX1;TIMM17A;PEX26;PEX10;PEX6;TOMM70
prerank,icosanoid metabolic process (GO:0006690),0.1696924038335063,0.45145260012143373,1.0,0.9998718882791097,1.0,12/40,27.47%,ALOXE3;ABCC1;PON2;ABCC10;PON3;PTGIS;MAPKAPK2;MGLL;TBXAS1;DPEP2;LTA4H;EPHX1
prerank,regulation of mitotic spindle organization (GO:0060236),0.17189562418762036,0.4512344571971961,0.9930843706777317,0.9995180981414896,1.0,15/35,30.02%,HSPA1B;CHMP1B;NUMA1;CHMP3;CHMP2B;CHMP1A;RAE1;TPR;VPS4B;CHMP4B;EML3;CLTC;DCTN1;DYNC1H1;HSPA1A
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.19783498567512023,0.4502519097660261,0.990909090909091,0.9988887971127183,1.0,1/17,3.96%,CISH
prerank,cellular response to interleukin-7 (GO:0098761),0.19783498567512023,0.4502519097660261,0.990909090909091,0.9988887971127183,1.0,1/17,3.96%,CISH
prerank,"base-excision repair, AP site formation (GO:0006285)",0.19783172097376725,0.4457169324170803,0.9953051643192489,0.9990790560200311,1.0,8/17,32.36%,TERF2IP;MUTYH;TERF2;TINF2;OGG1;NTHL1;ACD;TERF1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.18588795907000058,0.44503420869123456,0.9909228441754917,0.998782055970722,1.0,7/23,26.62%,HSP90B1;TMED9;SEL1L;TECPR2;TMEM129;SELENOS;HERPUD1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.21532490149436492,0.4440809204451291,0.9900166389351082,0.9985193771506005,1.0,4/11,25.81%,ANK3;PLAUR;RDX;JAK1
prerank,fibrinolysis (GO:0042730),-0.17333165923786806,-0.4412890708540892,0.9897435897435898,0.9978975648582075,1.0,13/13,82.69%,SERPINE1;PLAU;HRG;PLG;SERPINB2;CPB2;GP1BA;F2;KRT1;SERPINF2;FGG;PLAT;PLAUR
prerank,cobalamin metabolic process (GO:0009235),0.1858532172530413,0.4370774495556406,0.986322188449848,0.9989512100474583,1.0,2/17,12.83%,MMAA;ABCC1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.17730611651408806,0.43242368627792027,0.9955817378497791,0.9990293747160356,1.0,4/27,18.45%,CD47;PYCARD;ETS1;RELA
prerank,protein localization to mitochondrion (GO:0070585),0.20785729949090295,0.4312538925618363,0.9966666666666667,0.9987741709088455,1.0,1/11,6.86%,LRRK2
prerank,central nervous system neuron axonogenesis (GO:0021955),0.20575484599587476,0.430149126133855,0.9898648648648649,0.9985073013515674,1.0,6/12,30.74%,B4GALT6;HSP90AA1;MYCBP2;B4GALT5;HSP90AB1;SPTBN4
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.17745527628047536,0.4294800987694739,0.9954128440366973,0.9981993355571137,1.0,2/23,12.60%,NMT1;METAP2
prerank,sensory perception of smell (GO:0007608),0.2025785158193644,0.4284221301546593,0.9932546374367622,0.997924474861462,1.0,3/11,29.65%,SLC24A4;MKKS;ADCY3
prerank,telomere capping (GO:0016233),0.18535920724700994,0.4255881365450305,0.9917763157894737,0.9978137411741596,1.0,5/16,25.72%,STN1;CTC1;TERF2IP;TERF2;TINF2
prerank,protein neddylation (GO:0045116),0.19646658384953808,0.42332658354975383,0.9983498349834984,0.9976351032897859,1.0,5/13,32.17%,RBX1;DCUN1D2;RNF7;NAE1;UBE2M
prerank,tetrapyrrole metabolic process (GO:0033013),0.1723099650771184,0.40878987093179026,0.9910979228486647,0.9983889783709385,1.0,2/18,12.83%,MMAA;ABCC1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.19540025917306925,0.4037194823151204,0.9915966386554622,0.9983533829571896,1.0,2/10,17.63%,NPTX2;NPTX1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.16058760750831816,-0.39389350146371266,0.9972527472527473,0.9993353416493185,1.0,13/13,83.96%,NT5M;NEIL1;TDG;NEIL2;DCTPP1;UNG;DUT;MBD4;SMUG1;NTHL1;OGG1;NT5C;UPP2
prerank,leukotriene metabolic process (GO:0006691),0.16463708212535721,0.38642137121671405,0.9969650986342944,0.998900016626482,1.0,6/19,27.02%,ABCC1;ABCC10;MGST3;MAPKAPK2;DPEP2;LTA4H
prerank,serine family amino acid catabolic process (GO:0009071),0.18114486567913618,0.38356802126208045,0.996551724137931,0.9986445818168782,1.0,10/10,81.90%,DLD;THNSL2;CBS;SDS;AMT;DAO;GLDC;SHMT1;SHMT2;GCSH
